data_2n3l_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n3l _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.541 0.597 0 N-CA-C 110.451 -0.203 . . . . 73.52 110.451 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.21 158.5 44.26 Favored 'General case' 0 N--CA 1.509 2.518 0 CA-C-O 118.666 -0.683 . . . . 63.41 112.163 -177.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.2 mt -117.66 143.0 29.37 Favored 'Isoleucine or valine' 0 C--N 1.371 1.518 0 N-CA-C 107.258 -1.386 . . . . 71.22 107.258 -176.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -104.95 113.23 26.7 Favored 'General case' 0 CA--C 1.564 1.499 0 CA-C-O 117.996 -1.002 . . . . 74.24 111.413 -176.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.2 m -127.24 107.45 16.85 Favored 'Isoleucine or valine' 0 C--N 1.376 1.728 0 CA-C-N 121.166 1.803 . . . . 72.31 110.309 178.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.426 ' H ' ' HG3' ' A' ' 77' ' ' ARG . . . -134.7 -179.05 16.1 Favored Glycine 0 N--CA 1.485 1.941 0 O-C-N 120.86 -1.15 . . . . 64.1 113.987 -174.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.4 m120 49.72 23.22 0.94 Allowed 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 113.875 1.065 . . . . 53.42 113.875 -178.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -91.14 141.59 26.51 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.236 1.014 . . . . 71.53 110.561 -167.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -64.46 133.55 37.77 Favored 'Trans proline' 0 C--N 1.365 1.404 0 C-N-CA 122.367 2.045 . . . . 71.33 111.807 177.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.5 p 82.13 -39.67 0.11 Allowed 'General case' 0 C--N 1.379 1.859 0 C-N-CA 126.73 2.012 . . . . 65.44 112.053 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 67.19 117.58 0.03 OUTLIER 'General case' 0 C--N 1.357 0.926 0 C-N-CA 125.278 1.431 . . . . 70.45 110.999 -173.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.8 m -71.82 116.3 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.594 2.643 0 N-CA-C 107.312 -1.366 . . . . 64.21 107.312 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -79.25 155.8 28.4 Favored 'General case' 0 C--N 1.38 1.908 0 O-C-N 120.789 -1.194 . . . . 72.32 110.727 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 69.9 m -48.81 -43.34 38.19 Favored 'General case' 0 C--N 1.381 1.963 0 N-CA-C 115.911 1.819 . . . . 71.52 115.911 -173.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.99 -47.52 71.35 Favored 'General case' 0 CA--C 1.589 2.445 0 N-CA-C 113.865 1.061 . . . . 74.34 113.865 174.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -72.88 -35.97 67.25 Favored 'General case' 0 C--N 1.361 1.072 0 CA-C-O 119.089 -0.482 . . . . 75.22 112.286 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.488 ' O ' ' HB2' ' A' ' 28' ' ' PHE 0.262 1.7 p -69.41 -44.12 80.38 Favored 'Isoleucine or valine' 0 C--N 1.36 1.025 0 CA-C-O 118.107 -0.949 . . . . 43.02 110.683 176.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.482 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 22.1 tt0 -49.12 -60.44 2.79 Favored 'General case' 0 N--CA 1.507 2.405 0 CA-C-O 116.809 -1.567 . . . . 54.13 112.165 165.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -70.21 -61.82 1.63 Allowed 'General case' 0 C--O 1.303 3.912 0 CA-C-N 121.467 1.94 . . . . 64.42 114.417 -173.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -70.42 -34.34 72.39 Favored 'General case' 0 C--N 1.369 1.421 0 CA-C-O 117.111 -1.423 . . . . 72.12 112.622 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.488 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 1.2 m-85 -77.57 -35.82 52.7 Favored 'General case' 0 C--N 1.364 1.23 0 CA-C-N 121.939 2.154 . . . . 75.15 112.271 177.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.482 ' HB3' ' O ' ' A' ' 25' ' ' GLU . 5.2 ptt85 -53.21 -28.51 27.28 Favored 'General case' 0 N--CA 1.509 2.513 0 CA-C-O 115.87 -2.014 . . . . 75.33 115.338 166.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.63 -47.04 73.94 Favored 'General case' 0 N--CA 1.522 3.142 0 CA-C-N 123.485 2.857 . . . . 72.32 111.666 167.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.453 ' HB3' ' HA ' ' A' ' 59' ' ' ALA . 94.6 m-85 -76.39 -38.26 55.96 Favored 'General case' 0 CA--C 1.554 1.103 0 CA-C-O 118.302 -0.856 . . . . 71.34 112.532 -166.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -148.94 -175.43 21.39 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-N 120.001 1.273 . . . . 73.15 111.605 170.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -99.48 98.77 9.64 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 119.23 -0.988 . . . . 65.51 109.362 -166.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.49 134.6 29.17 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.409 0 N-CA-C 113.761 1.023 . . . . 71.41 113.761 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.46 -26.36 11.47 Favored 'General case' 0 CA--C 1.562 1.407 0 N-CA-C 110.092 -0.336 . . . . 70.0 110.092 172.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.8 pttm -153.92 153.82 32.72 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.528 0.731 . . . . 70.15 110.121 168.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -139.52 105.47 5.19 Favored 'General case' 0 C--N 1.356 0.873 0 N-CA-C 108.13 -1.063 . . . . 63.2 108.13 175.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -112.45 144.5 41.8 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 118.864 -1.135 . . . . 71.43 114.054 -176.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 69.4 t -97.09 113.93 32.75 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 N-CA-C 108.837 -0.801 . . . . 62.21 108.837 175.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -115.28 131.37 56.95 Favored 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 107.948 -1.13 . . . . 71.3 107.948 175.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.44 141.52 51.38 Favored 'General case' 0 CA--C 1.564 1.492 0 CA-C-N 121.8 2.091 . . . . 73.54 108.354 -170.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.426 HG21 ' H ' ' A' ' 44' ' ' SER . 6.4 t -100.81 173.51 6.48 Favored 'General case' 0 CA--C 1.565 1.539 0 CA-C-N 120.853 1.66 . . . . 71.42 111.977 -178.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.9 t -75.74 -9.3 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.305 0 C-N-CA 123.749 0.819 . . . . 73.3 112.377 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.426 ' H ' HG21 ' A' ' 42' ' ' THR . 0.8 OUTLIER -89.19 7.66 34.14 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 121.705 -0.622 . . . . 44.05 110.499 -175.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.54 -5.09 75.47 Favored Glycine 0 C--N 1.347 1.178 0 N-CA-C 115.436 0.934 . . . . 62.12 115.436 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.09 131.95 34.75 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 118.022 0.911 . . . . 75.01 110.031 176.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -105.63 146.26 29.93 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 109.393 -0.595 . . . . 62.13 109.393 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -129.3 148.75 51.25 Favored 'General case' 0 C--N 1.347 0.496 0 N-CA-C 108.942 -0.762 . . . . 73.13 108.942 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -121.29 135.57 55.09 Favored 'General case' 0 C--O 1.247 0.964 0 C-N-CA 119.855 -0.738 . . . . 61.23 110.257 168.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -108.92 122.15 46.62 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 114.048 -1.433 . . . . 75.31 108.229 -172.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.92 108.6 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 C-N-CA 118.953 -1.099 . . . . 73.33 109.975 -165.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -89.27 103.99 16.57 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 120.508 -0.477 . . . . 74.54 110.905 -171.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -113.22 142.33 45.93 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 113.645 0.98 . . . . 74.33 113.645 -172.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -82.81 -34.5 26.94 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.742 -0.783 . . . . 73.34 112.565 172.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -117.75 120.25 37.38 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 108.991 -0.744 . . . . 62.33 108.991 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.411 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -77.87 -38.37 46.15 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 115.425 1.639 . . . . 73.04 115.425 167.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -60.21 -40.11 88.97 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 113.593 0.96 . . . . 73.21 113.593 -168.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -69.53 -49.18 56.87 Favored 'General case' 0 CA--C 1.582 2.18 0 N-CA-C 114.835 1.42 . . . . 71.14 114.835 169.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.453 ' HA ' ' HB3' ' A' ' 31' ' ' TYR . . . -52.76 -21.63 4.35 Favored 'General case' 0 CA--C 1.587 2.37 0 N-CA-C 115.541 1.682 . . . . 38.7 115.541 172.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.472 ' O ' ' HG3' ' A' ' 64' ' ' LYS . . . -47.01 -34.61 5.81 Favored 'General case' 0 CA--C 1.561 1.383 0 CA-C-O 116.269 -1.824 . . . . 38.7 114.565 173.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.42 ' O ' ' HB3' ' A' ' 65' ' ' GLU . 29.3 m-20 -52.5 -53.89 39.87 Favored 'General case' 0 N--CA 1.51 2.539 0 CA-C-N 121.517 1.962 . . . . 51.1 111.835 168.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.08 -43.54 95.11 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 118.504 0.593 . . . . 71.43 111.809 178.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.435 HD12 HG13 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -67.37 -39.61 83.06 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.415 0 C-N-CA 118.748 -1.181 . . . . 72.34 113.458 -174.454 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -65.92 -32.58 74.16 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.813 1.042 . . . . 75.02 113.813 167.492 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 61' ' ' ASP . 0.6 OUTLIER -76.95 -17.1 59.12 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.059 0.391 . . . . 73.53 111.196 -176.19 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt -109.78 12.01 24.18 Favored 'General case' 0 CA--C 1.577 1.984 0 CA-C-O 119.742 -0.171 . . . . 73.11 111.056 169.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.45 ' HB3' ' HA ' ' A' ' 64' ' ' LYS 0.373 0.0 OUTLIER -78.45 159.63 28.16 Favored 'General case' 0 N--CA 1.506 2.344 0 C-N-CA 123.664 0.786 . . . . 64.52 112.406 -176.028 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.55 29.55 2.24 Favored Glycine 0 N--CA 1.439 -1.166 0 CA-C-O 117.819 -1.545 . . . . 61.33 114.406 -161.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.804 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 18.2 t -49.63 126.16 13.03 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-N 118.314 1.057 . . . . 74.51 112.125 -175.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.53 145.47 47.08 Favored 'General case' 0 C--O 1.251 1.172 0 CA-C-N 113.208 -1.814 . . . . 72.42 112.464 -172.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -147.8 147.36 29.75 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 105.947 -1.872 . . . . 74.24 105.947 -168.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 72.35 63.03 0.12 Allowed 'General case' 0 N--CA 1.483 1.175 0 CA-C-O 122.347 1.07 . . . . 62.4 112.995 176.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 97.5 -13.92 63.77 Favored Glycine 0 N--CA 1.471 0.998 0 N-CA-C 116.632 1.413 . . . . 70.02 116.632 172.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -113.23 121.19 43.72 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 105.1 -2.185 . . . . 73.35 105.1 156.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.49 102.8 14.65 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 117.438 -1.268 . . . . 73.15 109.826 -173.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.804 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -162.94 72.53 0.32 Allowed 'General case' 0 N--CA 1.512 2.672 0 CA-C-N 121.328 1.876 . . . . 74.42 115.668 178.834 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.426 ' HG3' ' H ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -96.6 118.03 32.23 Favored 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 123.769 2.986 . . . . 75.12 111.702 -175.319 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.0 t -131.78 119.4 41.6 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.772 0 O-C-N 120.189 -1.569 . . . . 74.23 108.056 172.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -146.99 134.57 20.96 Favored 'General case' 0 C--N 1.384 2.107 0 CA-C-N 121.088 1.767 . . . . 74.01 112.841 -172.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.435 HG13 HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -93.12 126.54 50.62 Favored Pre-proline 0 N--CA 1.45 -0.467 0 CA-C-N 114.197 -1.365 . . . . 72.35 112.095 169.901 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -85.85 25.5 0.69 Allowed 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 122.147 1.898 . . . . 72.2 111.842 165.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.411 ' CD2' ' HB2' ' A' ' 56' ' ' ALA . 9.2 m-85 -110.95 -28.13 8.48 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 115.595 -0.73 . . . . 75.3 110.161 176.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 O-C-N 124.75 1.281 . . . . 74.11 112.145 -172.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.546 0.821 0 N-CA-C 109.649 -0.5 . . . . 74.35 109.649 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.567 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -140.49 159.84 41.3 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 118.633 -0.698 . . . . 73.21 112.322 -178.783 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.425 ' CD1' HG13 ' A' ' 63' ' ' ILE . 4.5 mt -114.04 138.73 42.93 Favored 'Isoleucine or valine' 0 C--O 1.264 1.855 0 CA-C-N 119.927 1.24 . . . . 53.42 107.725 170.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -102.79 114.53 28.86 Favored 'General case' 0 CA--C 1.561 1.401 0 O-C-N 125.903 2.002 . . . . 64.3 109.399 172.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.1 p -125.58 106.04 15.62 Favored 'Isoleucine or valine' 0 C--N 1.37 1.475 0 CA-C-N 120.62 1.555 . . . . 73.0 109.322 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -115.31 168.32 12.57 Favored Glycine 0 C--N 1.354 1.549 0 C-N-CA 120.687 -0.768 . . . . 64.11 112.274 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.0 m120 50.79 24.92 1.91 Allowed 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 114.617 1.34 . . . . 70.25 114.617 -177.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -75.69 136.2 70.96 Favored Pre-proline 0 C--O 1.239 0.522 0 C-N-CA 123.335 0.654 . . . . 61.24 110.709 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -73.71 126.35 10.71 Favored 'Trans proline' 0 CA--C 1.553 1.468 0 C-N-CA 121.422 1.414 . . . . 71.11 111.685 175.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.5 t 60.33 100.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.005 0.922 . . . . 73.13 111.129 -174.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 -64.79 132.9 50.79 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.086 -0.506 . . . . 72.42 111.789 -177.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.7 m -66.02 121.43 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.895 0 CA-C-N 114.557 -1.201 . . . . 72.43 109.614 -176.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.84 154.06 28.66 Favored 'General case' 0 C--N 1.377 1.768 0 CA-C-N 119.212 0.914 . . . . 64.4 110.576 -176.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.9 p -47.18 -48.09 23.88 Favored 'General case' 0 C--N 1.375 1.699 0 N-CA-C 116.036 1.865 . . . . 72.32 116.036 -174.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.19 -46.46 75.84 Favored 'General case' 0 C--O 1.285 2.93 0 N-CA-C 114.41 1.263 . . . . 52.24 114.41 175.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -64.34 -35.45 80.9 Favored 'General case' 0 C--N 1.372 1.545 0 CA-C-O 118.002 -0.999 . . . . 74.22 110.142 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.522 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 1.2 t -66.82 -44.43 89.11 Favored 'Isoleucine or valine' 0 C--N 1.385 2.139 0 CA-C-O 116.552 -1.689 . . . . 72.11 110.722 174.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.01 -56.15 24.17 Favored 'General case' 0 C--N 1.373 1.602 0 CA-C-N 120.641 1.564 . . . . 72.35 110.747 177.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.553 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 12.9 m-80 -81.33 -57.01 3.68 Favored 'General case' 0 C--O 1.294 3.418 0 CA-C-N 122.156 2.253 . . . . 74.44 116.364 -176.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -68.36 -26.99 65.86 Favored 'General case' 0 C--N 1.354 0.777 0 C-N-CA 119.566 -0.854 . . . . 54.42 111.218 -175.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.522 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 35.7 m-85 -90.98 -22.55 20.77 Favored 'General case' 0 CA--C 1.565 1.544 0 C-N-CA 118.337 -1.345 . . . . 73.41 114.222 173.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.553 ' HG3' ' O ' ' A' ' 26' ' ' ASN 0.259 2.5 ppt_? -54.27 -28.34 41.12 Favored 'General case' 0 N--CA 1.503 2.218 0 CA-C-N 120.161 1.346 . . . . 74.54 112.285 163.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.562 ' O ' ' HD2' ' A' ' 30' ' ' LYS 0.257 1.7 tptm -52.03 -28.63 17.88 Favored 'General case' 0 N--CA 1.518 2.946 0 C-N-CA 118.445 -1.302 . . . . 64.25 113.742 168.433 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -80.22 -44.17 20.18 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 120.023 1.283 . . . . 63.0 111.488 -166.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -169.24 44.28 0.21 Allowed Glycine 0 C--N 1.341 0.859 0 C-N-CA 117.712 -2.185 . . . . 72.01 114.45 162.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 60.38 87.33 0.09 Allowed 'General case' 0 C--N 1.359 1.005 0 C-N-CA 123.983 0.913 . . . . 74.43 109.9 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.36 138.45 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-N 114.976 -1.011 . . . . 70.43 112.471 -178.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.31 -26.49 12.92 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 109.63 -0.507 . . . . 72.15 109.63 173.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp -149.66 137.36 20.17 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-O 118.826 -0.606 . . . . 65.32 109.889 -173.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -140.84 110.06 6.22 Favored 'General case' 0 C--N 1.364 1.226 0 CA-C-N 119.564 1.075 . . . . 71.14 109.268 176.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -109.13 146.59 33.84 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 117.762 -1.575 . . . . 73.33 112.847 177.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.8 t -114.27 110.6 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 106.317 -1.735 . . . . 74.52 106.317 176.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.0 mttm -121.45 137.25 54.8 Favored 'General case' 0 CA--C 1.563 1.446 0 CA-C-O 118.909 -0.567 . . . . 73.13 110.301 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.97 143.92 50.9 Favored 'General case' 0 C--N 1.371 1.516 0 CA-C-N 120.437 1.471 . . . . 64.1 108.122 -168.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.429 HG21 ' H ' ' A' ' 44' ' ' SER . 6.4 t -99.98 172.1 7.43 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-N 120.683 1.583 . . . . 71.22 110.941 -178.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.8 t -75.37 -9.95 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.208 0 C-N-CA 123.502 0.721 . . . . 64.04 112.077 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.429 ' H ' HG21 ' A' ' 42' ' ' THR . 0.8 OUTLIER -89.27 7.57 34.85 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 121.735 -0.603 . . . . 74.03 110.24 -177.307 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.73 -4.63 78.43 Favored Glycine 0 CA--C 1.537 1.417 0 N-CA-C 115.952 1.141 . . . . 61.34 115.952 178.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.94 131.79 33.99 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 118.429 1.115 . . . . 61.33 109.903 176.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.93 146.89 28.4 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 108.606 -0.887 . . . . 61.41 108.606 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -127.49 146.84 50.36 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 119.211 -0.995 . . . . 74.35 108.555 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -121.4 139.08 53.91 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 119.486 -0.886 . . . . 51.23 110.295 172.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -125.28 117.14 23.15 Favored 'General case' 0 C--O 1.263 1.803 0 N-CA-C 106.864 -1.532 . . . . 72.55 106.864 -167.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.33 113.12 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 114.351 1.241 . . . . 74.05 114.351 -163.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -90.21 108.81 19.98 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 115.002 -0.999 . . . . 70.4 112.604 -171.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -108.51 155.61 20.43 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 112.145 0.424 . . . . 73.21 112.145 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -81.72 -26.36 34.66 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 113.809 1.04 . . . . 70.12 113.809 173.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.48 120.89 39.49 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 119.208 0.913 . . . . 42.3 110.328 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.91 -35.87 59.64 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 114.773 1.397 . . . . 71.42 114.773 172.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.27 0.0 OUTLIER -80.71 -30.0 36.38 Favored 'General case' 0 CA--C 1.564 1.5 0 CA-C-N 120.828 1.649 . . . . 70.5 113.435 -167.144 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -62.21 -50.57 71.27 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-N 118.85 0.75 . . . . 74.34 112.521 175.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.0 -25.53 21.53 Favored 'General case' 0 CA--C 1.57 1.712 0 N-CA-C 116.369 1.989 . . . . 72.45 116.369 177.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.73 -43.05 57.9 Favored 'General case' 0 CA--C 1.581 2.171 0 C-N-CA 125.482 1.513 . . . . 72.11 114.231 178.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -53.54 -48.14 69.34 Favored 'General case' 0 N--CA 1.518 2.944 0 CA-C-N 119.654 1.116 . . . . 75.32 113.771 169.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.634 ' O ' ' HD2' ' A' ' 66' ' ' LYS . . . -72.19 -32.91 67.25 Favored 'General case' 0 C--N 1.31 -1.131 0 O-C-N 120.786 -1.197 . . . . 60.02 111.777 179.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.425 HG13 ' CD1' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -73.33 -41.04 57.51 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.053 0 CA-C-O 117.247 -1.358 . . . . 73.35 112.141 -177.264 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.48 -34.0 70.41 Favored 'General case' 0 CA--C 1.557 1.219 0 CA-C-N 120.505 1.502 . . . . 71.24 114.285 161.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.54 -23.89 66.98 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 120.816 1.644 . . . . 64.45 112.773 175.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.634 ' HD2' ' O ' ' A' ' 62' ' ' ALA 0.283 0.0 OUTLIER -110.48 16.89 21.29 Favored 'General case' 0 N--CA 1.514 2.738 0 N-CA-C 117.1 2.259 . . . . 72.25 117.1 160.64 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.418 0.0 OUTLIER -79.72 160.03 26.41 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 120.016 1.28 . . . . 71.15 113.945 -176.381 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.14 29.33 2.38 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 119.095 -1.526 . . . . 36.67 114.593 -158.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.773 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -53.06 125.95 19.01 Favored 'General case' 0 C--N 1.37 1.472 0 CA-C-N 117.268 0.534 . . . . 54.33 111.19 -178.195 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -131.23 150.76 52.01 Favored 'General case' 0 C--O 1.259 1.6 0 CA-C-N 115.63 -0.713 . . . . 70.23 112.018 -174.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -147.59 146.66 29.47 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 127.872 2.469 . . . . 70.33 107.508 -168.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 73.22 62.54 0.1 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.975 0.893 . . . . 42.11 112.844 -176.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.44 -13.19 61.5 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 117.157 1.623 . . . . 51.15 117.157 169.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -112.79 122.23 47.04 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 106.947 -1.501 . . . . 55.45 106.947 154.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.93 103.52 15.39 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 117.719 -1.134 . . . . 60.25 109.433 -175.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.773 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 14.3 tp -165.92 66.97 0.11 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 120.651 1.569 . . . . 54.33 112.485 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -96.54 110.83 23.15 Favored 'General case' 0 CA--C 1.569 1.704 0 CA-C-N 122.584 2.447 . . . . 74.25 109.733 -173.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.484 ' H ' ' HB3' ' A' ' 69' ' ' CYS . 22.6 t -123.48 115.54 45.69 Favored 'Isoleucine or valine' 0 C--N 1.358 0.967 0 O-C-N 120.577 -1.327 . . . . 74.34 107.806 170.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -138.7 143.12 38.98 Favored 'General case' 0 C--O 1.254 1.298 0 CA-C-N 120.574 1.533 . . . . 53.21 111.317 176.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.8 m -88.01 122.28 70.12 Favored Pre-proline 0 N--CA 1.437 -1.11 0 CA-C-N 114.622 -1.172 . . . . 72.44 111.412 168.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.567 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 61.2 Cg_endo -91.76 32.98 0.29 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.67 2.247 . . . . 63.22 111.447 159.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.3 10.62 5.33 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 112.58 0.585 . . . . 74.24 112.58 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 t30 . . . . . 0 N--CA 1.493 1.719 0 O-C-N 123.174 0.296 . . . . 65.23 111.427 -167.69 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 p . . . . . 0 CA--C 1.54 0.594 0 N-CA-C 109.723 -0.473 . . . . 60.32 109.723 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.432 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 3.2 ptt180 -124.99 151.29 45.74 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 120.251 -0.58 . . . . 64.0 111.716 -170.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.7 mt -116.94 137.17 51.71 Favored 'Isoleucine or valine' 0 C--O 1.259 1.569 0 CA-C-N 120.041 1.291 . . . . 74.3 108.855 -175.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -106.05 113.71 27.41 Favored 'General case' 0 CA--C 1.574 1.876 0 O-C-N 125.903 2.002 . . . . 73.32 110.359 176.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.1 p -125.87 103.89 12.37 Favored 'Isoleucine or valine' 0 C--N 1.375 1.674 0 CA-C-N 120.194 1.361 . . . . 61.11 108.949 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -118.26 175.01 15.53 Favored Glycine 0 C--N 1.353 1.478 0 C-N-CA 120.652 -0.785 . . . . 75.43 113.354 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 51.34 29.11 4.8 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 115.697 1.74 . . . . 70.3 115.697 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.406 HD11 ' H ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -87.26 150.86 50.29 Favored Pre-proline 0 CA--C 1.555 1.15 0 CA-C-N 119.27 0.941 . . . . 55.23 110.406 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -82.94 128.86 5.23 Favored 'Trans proline' 0 CA--C 1.567 2.149 0 C-N-CA 120.8 1.0 . . . . 51.1 112.487 177.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.5 p 113.6 -29.16 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.631 0 C-N-CA 128.736 2.814 . . . . 75.24 111.045 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 68.17 105.28 0.05 Allowed 'General case' 0 C--N 1.358 0.949 0 C-N-CA 124.859 1.264 . . . . 72.23 110.285 -167.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.425 HG22 HG13 ' A' ' 24' ' ' VAL . 7.4 p -76.6 118.32 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.292 0 CA-C-N 114.874 -1.057 . . . . 65.11 108.936 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.9 m -82.23 160.0 23.09 Favored 'General case' 0 CA--C 1.559 1.303 0 CA-C-O 117.744 -1.122 . . . . 73.42 108.449 178.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.441 ' O ' ' HB3' ' A' ' 25' ' ' GLU . 5.6 p -50.64 -39.77 51.37 Favored 'General case' 0 C--N 1.378 1.834 0 N-CA-C 115.3 1.592 . . . . 73.53 115.3 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.34 -33.08 73.03 Favored 'General case' 0 CA--C 1.576 1.963 0 N-CA-C 115.51 1.67 . . . . 71.34 115.51 177.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -68.34 -54.11 19.57 Favored 'General case' 0 C--O 1.283 2.844 0 CA-C-N 119.719 1.145 . . . . 75.41 111.295 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.425 HG13 HG22 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -57.7 -54.04 36.82 Favored 'Isoleucine or valine' 0 C--N 1.368 1.398 0 O-C-N 124.573 1.17 . . . . 62.2 111.389 176.668 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.441 ' HB3' ' O ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -49.36 -46.79 47.57 Favored 'General case' 0 CA--C 1.566 1.559 0 CA-C-O 116.931 -1.509 . . . . 74.31 114.836 170.205 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -71.39 -55.58 7.68 Favored 'General case' 0 C--O 1.295 3.481 0 CA-C-N 122.525 2.42 . . . . 70.42 112.634 -177.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -57.77 -38.82 76.1 Favored 'General case' 0 C--N 1.396 2.598 0 CA-C-O 118.965 -0.541 . . . . 55.12 111.551 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -83.54 -35.61 24.66 Favored 'General case' 0 C--N 1.359 1.008 0 C-N-CA 118.564 -1.255 . . . . 73.45 113.277 -178.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.4 ptt85 -52.27 -36.62 53.22 Favored 'General case' 0 N--CA 1.507 2.409 0 CA-C-O 117.923 -1.037 . . . . 71.22 112.099 171.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.492 ' HE2' ' CG ' ' A' ' 31' ' ' TYR 0.289 0.0 OUTLIER -71.92 -30.84 65.77 Favored 'General case' 0 C--N 1.374 1.653 0 C-N-CA 116.311 -2.156 . . . . 62.44 112.71 -173.322 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.546 ' CB ' ' HA ' ' A' ' 59' ' ' ALA . 54.4 m-85 -82.75 -46.27 13.35 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 112.169 0.433 . . . . 74.1 112.169 177.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -150.14 143.76 11.1 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 118.671 0.669 . . . . 45.2 112.217 169.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -63.18 117.96 7.28 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 113.331 0.863 . . . . 72.2 113.331 -166.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.44 140.98 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-N 115.539 -0.755 . . . . 73.31 111.525 174.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.0 mp -103.8 -24.35 13.32 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 119.538 -0.865 . . . . 71.22 112.91 170.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.33 135.4 12.98 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 108.632 -0.877 . . . . 73.03 108.632 -175.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 41.8 t -145.96 115.2 7.07 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 120.125 1.33 . . . . 71.43 110.396 174.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.09 150.2 50.58 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 119.56 -0.856 . . . . 54.24 111.947 -176.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -116.07 116.72 53.21 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.53 0 CA-C-O 121.45 0.643 . . . . 73.22 110.578 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.0 mttp -108.53 141.99 39.61 Favored 'General case' 0 CA--C 1.565 1.531 0 C-N-CA 125.698 1.599 . . . . 70.44 107.762 -170.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.79 142.65 50.65 Favored 'General case' 0 CA--C 1.57 1.729 0 CA-C-N 122.329 2.331 . . . . 75.24 109.567 -177.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.0 t -100.59 176.88 5.18 Favored 'General case' 0 CA--C 1.568 1.64 0 CA-C-N 120.957 1.708 . . . . 64.22 111.572 176.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.4 t -77.33 -9.5 12.55 Favored 'Isoleucine or valine' 0 C--N 1.373 1.623 0 C-N-CA 123.834 0.854 . . . . 64.43 112.698 -176.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.9 t -90.72 2.62 55.83 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 121.584 -0.698 . . . . 60.34 111.03 -173.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.18 -7.26 68.02 Favored Glycine 0 CA--C 1.537 1.414 0 N-CA-C 115.184 0.834 . . . . 71.44 115.184 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.35 132.5 37.43 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 117.886 0.843 . . . . 74.44 108.89 167.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.75 145.55 43.42 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.743 -0.836 . . . . 74.35 108.743 -173.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -128.57 150.3 50.26 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.836 0.743 . . . . 74.33 110.693 -168.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -129.5 146.81 51.29 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.394 0.616 . . . . 74.3 112.045 175.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -132.9 114.09 13.63 Favored 'General case' 0 C--O 1.263 1.764 0 N-CA-C 106.442 -1.688 . . . . 71.33 106.442 -158.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -124.29 110.52 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.662 0 C-N-CA 118.493 -1.283 . . . . 64.23 109.491 -173.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -109.74 103.09 11.86 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.464 -1.244 . . . . 62.32 110.158 -174.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.455 ' CE2' ' HB1' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -111.43 161.44 16.12 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 115.306 -0.861 . . . . 75.44 113.241 -174.502 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.14 -42.0 69.75 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 112.281 0.474 . . . . 71.1 112.281 173.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -113.17 114.8 27.29 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 118.54 -1.264 . . . . 74.43 109.901 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.401 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -75.97 -21.8 56.58 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 115.902 1.816 . . . . 61.53 115.902 169.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.293 10.6 ptm180 -75.69 -40.96 54.95 Favored 'General case' 0 CA--C 1.567 1.601 0 CA-C-N 120.402 1.455 . . . . 74.34 114.364 -172.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -77.68 -36.33 51.35 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 117.064 2.246 . . . . 53.13 117.064 177.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.546 ' HA ' ' CB ' ' A' ' 31' ' ' TYR 0.303 . . -75.27 -14.6 60.52 Favored 'General case' 0 CA--C 1.584 2.252 0 CA-C-N 120.564 1.529 . . . . 36.76 112.266 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -44.88 -35.74 2.96 Favored 'General case' 0 CA--C 1.583 2.239 0 CA-C-N 114.159 -1.382 . . . . 51.45 114.24 161.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.464 ' O ' ' HB3' ' A' ' 65' ' ' GLU . 46.3 m-20 -52.98 -54.75 30.46 Favored 'General case' 0 N--CA 1.507 2.384 0 CA-C-N 120.822 1.646 . . . . 54.33 113.311 164.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.09 -35.78 69.81 Favored 'General case' 0 N--CA 1.507 2.385 0 CA-C-N 119.533 1.06 . . . . 61.42 113.816 171.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.448 HG21 HD12 ' A' ' 63' ' ' ILE 0.251 0.2 OUTLIER -73.53 -45.33 51.8 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.419 0 C-N-CA 119.157 -1.017 . . . . 36.76 113.443 -177.437 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.426 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -56.6 -30.46 63.25 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 120.319 1.418 . . . . 73.54 114.495 162.403 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.464 ' HB3' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -79.7 -20.46 46.47 Favored 'General case' 0 CA--C 1.55 0.967 0 O-C-N 120.825 -1.172 . . . . 72.21 111.84 -178.133 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.7 mmtt -98.35 9.54 42.82 Favored 'General case' 0 CA--C 1.598 2.804 0 CA-C-O 118.697 -0.668 . . . . 64.41 112.533 163.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.426 ' HB3' ' HA ' ' A' ' 64' ' ' LYS 0.408 0.0 OUTLIER -79.79 160.54 26.12 Favored 'General case' 0 N--CA 1.516 2.858 0 CA-C-N 120.475 1.489 . . . . 71.21 114.619 -173.165 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.83 30.64 2.11 Favored Glycine 0 N--CA 1.439 -1.116 0 C-N-CA 118.529 -1.796 . . . . 74.22 115.466 -164.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.707 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -51.09 124.67 11.97 Favored 'General case' 0 C--N 1.372 1.577 0 O-C-N 124.65 0.853 . . . . 65.24 112.391 -173.791 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -133.4 150.73 51.79 Favored 'General case' 0 C--O 1.255 1.377 0 CA-C-N 115.574 -0.739 . . . . 62.35 112.311 -176.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -147.77 145.67 28.89 Favored 'General case' 0 C--N 1.354 0.795 0 C-N-CA 127.305 2.242 . . . . 75.34 106.574 -169.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 74.01 63.44 0.08 Allowed 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 113.17 0.804 . . . . 75.54 113.17 -175.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.32 -12.95 63.37 Favored Glycine 0 N--CA 1.472 1.057 0 N-CA-C 116.757 1.463 . . . . 73.21 116.757 168.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -113.43 121.28 43.84 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 106.309 -1.738 . . . . 64.51 106.309 152.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.28 104.05 15.93 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 117.431 -1.271 . . . . 74.32 109.454 -176.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.707 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -168.63 69.82 0.08 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 120.422 1.464 . . . . 71.24 112.273 179.347 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -95.77 108.83 21.19 Favored 'General case' 0 C--N 1.369 1.448 0 CA-C-N 122.443 2.383 . . . . 73.32 109.375 -171.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.529 ' H ' ' HB3' ' A' ' 69' ' ' CYS . 50.1 t -127.77 118.39 48.88 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.888 0 O-C-N 120.828 -1.17 . . . . 64.34 109.098 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -146.61 144.9 29.85 Favored 'General case' 0 C--O 1.269 2.093 0 CA-C-N 120.651 1.569 . . . . 64.13 110.512 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.6 m -89.4 124.45 64.4 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-N 115.447 -0.797 . . . . 61.55 111.842 166.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.432 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 66.8 Cg_endo -86.57 29.9 0.49 Allowed 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 123.023 2.482 . . . . 71.11 113.747 168.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.401 ' CE1' ' HB1' ' A' ' 56' ' ' ALA . 9.0 p90 -128.71 -27.42 2.58 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.354 0.502 . . . . 71.44 112.354 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 N--CA 1.492 1.655 0 C-N-CA 124.581 1.152 . . . . 73.42 113.286 -176.756 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.506 ' OG ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 121.157 0.503 . . . . 71.2 112.127 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 11.3 ptt180 -143.81 152.9 41.8 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 113.792 1.034 . . . . 72.41 113.792 -172.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.8 mt -115.31 135.35 55.56 Favored 'Isoleucine or valine' 0 C--N 1.375 1.693 0 CA-C-N 120.199 1.363 . . . . 74.35 107.995 177.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -99.56 122.04 42.05 Favored 'General case' 0 CA--C 1.572 1.796 0 O-C-N 125.43 1.706 . . . . 75.2 110.283 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 67.3 t -124.71 110.99 26.48 Favored 'Isoleucine or valine' 0 C--N 1.366 1.32 0 O-C-N 120.643 -1.286 . . . . 72.33 108.594 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.33 162.97 12.42 Favored Glycine 0 C--N 1.341 0.823 0 C-N-CA 119.135 -1.507 . . . . 53.2 112.209 173.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 51.16 22.93 1.42 Allowed 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 116.379 1.992 . . . . 71.41 116.379 178.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.02 125.41 91.41 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 123.45 0.7 . . . . 63.04 111.054 169.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -91.34 123.35 0.78 Allowed 'Trans proline' 0 CA--C 1.556 1.586 0 C-N-CA 121.873 1.715 . . . . 73.22 111.495 169.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.5 m 34.75 -100.66 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 124.741 1.216 . . . . 73.32 114.03 -173.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.4 t60 53.26 -88.95 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 126.243 1.817 . . . . 72.24 112.408 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.2 m -98.18 117.03 42.4 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.863 0 C-N-CA 119.435 -0.906 . . . . 71.33 109.713 177.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.9 m -80.76 170.96 15.62 Favored 'General case' 0 C--N 1.387 2.234 0 CA-C-O 117.197 -1.383 . . . . 75.22 109.076 166.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.9 m -46.53 -49.46 18.57 Favored 'General case' 0 C--O 1.27 2.148 0 CA-C-N 120.134 1.334 . . . . 72.14 114.492 -173.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.71 -43.59 97.64 Favored 'General case' 0 CA--C 1.578 2.03 0 CA-C-N 115.271 -0.877 . . . . 75.25 113.277 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.511 10.7 m-20 -76.99 -18.94 57.88 Favored 'General case' 0 CA--C 1.559 1.309 0 CA-C-O 115.715 -2.088 . . . . 74.21 114.146 172.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.414 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 2.0 t -59.65 -44.57 93.76 Favored 'Isoleucine or valine' 0 C--N 1.424 3.83 0 CA-C-N 123.411 2.823 . . . . 71.45 108.281 163.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.48 -54.52 45.61 Favored 'General case' 0 C--N 1.376 1.731 0 CA-C-O 116.455 -1.736 . . . . 75.53 112.677 174.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -73.81 -54.39 8.11 Favored 'General case' 1 C--O 1.309 4.187 0 CA-C-N 122.369 2.349 . . . . 72.24 114.793 -174.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -58.21 -37.06 74.08 Favored 'General case' 0 C--N 1.383 2.063 0 CA-C-O 117.325 -1.322 . . . . 73.24 110.428 177.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.414 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 47.3 m-85 -84.46 -24.2 29.58 Favored 'General case' 0 C--N 1.373 1.629 0 C-N-CA 115.716 -2.393 . . . . 75.14 113.457 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.429 ' HA ' HG22 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -64.95 -30.79 71.8 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 117.286 -1.34 . . . . 74.24 114.055 175.534 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.464 ' HE2' ' CD1' ' A' ' 31' ' ' TYR 0.323 0.0 OUTLIER -72.82 -34.8 67.09 Favored 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 113.354 -3.338 . . . . 74.45 111.986 175.338 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.48 ' HB3' ' HA ' ' A' ' 59' ' ' ALA . 57.8 m-85 -76.79 -40.96 46.41 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-O 118.975 -0.536 . . . . 62.32 110.783 -169.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -140.21 165.21 26.06 Favored Glycine 0 C--N 1.341 0.812 0 CA-C-O 118.309 -1.273 . . . . 73.2 110.666 152.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -76.71 102.77 6.35 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-N 119.95 1.875 . . . . 75.22 110.45 -174.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.429 HG22 ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -71.32 136.73 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 113.824 1.046 . . . . 74.02 113.824 -176.113 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.4 mt -89.55 -49.02 6.92 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 113.266 0.839 . . . . 74.14 113.266 166.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.65 128.2 20.18 Favored 'General case' 0 CA--C 1.585 2.322 0 CA-C-N 120.077 1.308 . . . . 73.41 111.901 173.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.403 ' SG ' HG13 ' A' ' 34' ' ' ILE . 4.8 m -105.65 111.03 23.56 Favored 'General case' 0 C--N 1.388 2.259 0 N-CA-C 107.473 -1.306 . . . . 73.53 107.473 166.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -113.11 139.93 48.31 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 117.855 -1.538 . . . . 75.35 111.41 176.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 t -113.0 110.09 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 106.77 -1.567 . . . . 74.12 106.77 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.7 mmtt -107.08 142.4 36.8 Favored 'General case' 0 CA--C 1.556 1.181 0 CA-C-O 118.792 -0.623 . . . . 73.12 109.455 175.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.39 142.78 51.01 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 120.063 1.302 . . . . 71.23 108.384 -170.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.421 HG21 ' H ' ' A' ' 44' ' ' SER . 12.0 t -100.01 167.75 10.29 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 120.45 1.477 . . . . 60.22 111.42 -178.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.0 m -61.84 -7.5 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.746 0 N-CA-C 115.993 1.849 . . . . 72.52 115.993 175.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.421 ' H ' HG21 ' A' ' 42' ' ' THR . 8.1 t -98.05 7.57 46.11 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 119.36 0.982 . . . . 71.25 110.517 -174.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.25 -4.35 77.22 Favored Glycine 0 CA--C 1.544 1.887 0 N-CA-C 115.717 1.047 . . . . 72.31 115.717 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -83.37 134.75 34.88 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-N 117.954 0.877 . . . . 74.31 110.485 177.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.31 149.75 25.07 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.619 -0.882 . . . . 65.14 108.619 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -125.12 145.02 50.13 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 118.915 -1.114 . . . . 73.12 109.568 175.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -115.47 137.88 51.59 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.915 -0.402 . . . . 72.14 109.915 176.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.47 115.85 16.71 Favored 'General case' 0 C--O 1.256 1.446 0 N-CA-C 108.168 -1.049 . . . . 73.42 108.168 -173.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 0.2 OUTLIER -123.76 108.77 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 C-N-CA 118.358 -1.337 . . . . 71.43 110.827 -171.693 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -102.81 108.34 19.53 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 115.147 -0.933 . . . . 70.34 110.92 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.95 156.33 25.23 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 118.748 -0.644 . . . . 60.54 112.673 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -59.29 -32.44 70.04 Favored 'General case' 0 N--CA 1.516 2.834 0 N-CA-C 112.937 0.717 . . . . 74.42 112.937 166.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -115.41 113.0 23.16 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 119.151 -1.02 . . . . 73.42 109.966 -177.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.517 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -77.33 -41.39 40.71 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 116.084 1.883 . . . . 71.51 116.084 170.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.26 6.5 ptt180 -75.78 -33.33 60.17 Favored 'General case' 0 CA--C 1.573 1.864 0 N-CA-C 114.516 1.302 . . . . 65.22 114.516 -168.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.43 -44.97 73.79 Favored 'General case' 0 N--CA 1.518 2.934 0 CA-C-N 120.737 1.608 . . . . 74.14 114.034 173.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.48 ' HA ' ' HB3' ' A' ' 31' ' ' TYR . . . -50.02 -21.08 1.11 Allowed 'General case' 0 CA--C 1.598 2.821 0 N-CA-C 117.281 2.326 . . . . 73.02 117.281 171.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.405 ' O ' ' HG3' ' A' ' 64' ' ' LYS . . . -49.14 -34.15 13.61 Favored 'General case' 0 CA--C 1.585 2.319 0 CA-C-O 117.645 -1.169 . . . . 74.33 113.797 167.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -52.39 -45.06 65.68 Favored 'General case' 0 C--N 1.394 2.519 0 CA-C-N 120.171 1.35 . . . . 74.24 113.789 165.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.5 ' O ' ' HD2' ' A' ' 66' ' ' LYS . . . -60.48 -54.02 50.49 Favored 'General case' 0 C--O 1.258 1.53 0 O-C-N 121.907 -0.496 . . . . 70.02 111.212 172.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . 0.262 0.4 OUTLIER -62.5 -41.22 91.09 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 C-N-CA 117.465 -1.694 . . . . 64.14 113.786 -173.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.405 ' HG3' ' O ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -62.06 -34.85 77.04 Favored 'General case' 0 CA--C 1.557 1.215 0 N-CA-C 115.588 1.699 . . . . 74.43 115.588 167.854 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.64 -34.83 79.13 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 121.168 1.804 . . . . 73.41 111.268 176.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.5 ' HD2' ' O ' ' A' ' 62' ' ' ALA 0.258 0.0 OUTLIER -103.07 18.42 21.73 Favored 'General case' 0 CA--C 1.575 1.921 0 C-N-CA 118.432 -1.307 . . . . 63.41 114.149 173.946 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.323 0.5 OUTLIER -71.37 162.79 28.86 Favored 'General case' 0 N--CA 1.508 2.435 0 CA-C-N 118.975 0.807 . . . . 61.24 112.88 -174.857 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 120.44 31.99 1.19 Allowed Glycine 0 N--CA 1.438 -1.218 0 C-N-CA 119.024 -1.56 . . . . 63.35 115.533 -162.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.741 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -51.51 125.09 13.62 Favored 'General case' 0 C--N 1.375 1.704 0 CA-C-N 118.1 0.95 . . . . 74.4 111.768 176.444 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -133.66 149.36 51.56 Favored 'General case' 0 C--O 1.255 1.363 0 CA-C-N 114.766 -1.106 . . . . 73.23 111.482 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -148.25 144.66 27.8 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 126.225 1.81 . . . . 72.0 106.746 -166.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 68.89 65.98 0.29 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 124.244 0.965 . . . . 70.42 113.162 177.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.9 -12.34 60.81 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 116.86 1.504 . . . . 71.43 116.86 173.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -118.85 121.9 41.09 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 105.929 -1.878 . . . . 73.31 105.929 154.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.97 102.52 14.61 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 117.553 -1.213 . . . . 74.41 109.874 -172.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.741 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -169.2 58.64 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 CA-C-N 120.572 1.533 . . . . 73.14 114.419 -175.14 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.1 tpp85 -90.99 112.25 24.06 Favored 'General case' 0 CA--C 1.571 1.767 0 CA-C-N 122.258 2.299 . . . . 71.43 109.945 -170.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.46 ' H ' ' HB3' ' A' ' 69' ' ' CYS . 0.9 OUTLIER -119.78 121.69 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 O-C-N 120.325 -1.484 . . . . 73.12 108.678 173.928 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -146.58 132.5 19.13 Favored 'General case' 0 C--N 1.361 1.091 0 CA-C-N 119.75 1.159 . . . . 61.03 110.791 -165.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.537 HG13 ' CZ ' ' A' ' 82' ' ' PHE . 7.8 m -89.62 124.56 63.78 Favored Pre-proline 0 C--N 1.349 0.559 0 C-N-CA 119.817 -0.753 . . . . 75.0 111.569 167.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.438 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 87.8 Cg_endo -89.91 17.17 1.58 Allowed 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 122.48 2.12 . . . . 72.34 113.625 166.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.537 ' CZ ' HG13 ' A' ' 80' ' ' VAL . 5.6 p90 -110.74 -32.01 7.0 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.039 0.385 . . . . 74.34 112.039 175.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.0 t30 . . . . . 0 N--CA 1.501 2.096 0 C-N-CA 124.574 1.15 . . . . 73.33 110.692 -176.938 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.439 -0.994 0 N-CA-C 108.115 -1.068 . . . . 74.31 108.115 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.515 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 0.2 OUTLIER -118.83 153.27 34.77 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 121.305 -0.872 . . . . 71.23 109.036 -177.407 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.41 HG13 HG11 ' A' ' 80' ' ' VAL . 4.5 mp -138.16 134.92 44.78 Favored 'Isoleucine or valine' 0 C--O 1.264 1.82 0 CA-C-N 119.811 1.187 . . . . 70.42 108.269 -178.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -105.33 114.95 29.44 Favored 'General case' 0 CA--C 1.571 1.751 0 O-C-N 125.664 1.852 . . . . 65.32 110.407 177.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.0 p -123.84 104.41 14.07 Favored 'Isoleucine or valine' 0 C--N 1.369 1.432 0 CA-C-N 120.333 1.424 . . . . 75.23 108.079 178.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.407 ' H ' ' HG3' ' A' ' 77' ' ' ARG . . . -121.33 177.24 16.41 Favored Glycine 0 C--N 1.346 1.134 0 C-N-CA 120.362 -0.923 . . . . 37.25 112.722 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.6 m120 50.72 24.34 1.67 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 114.792 1.405 . . . . 62.14 114.792 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.425 ' H ' HD21 ' A' ' 15' ' ' LEU . 1.7 pt? -79.71 123.54 83.94 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 123.812 0.845 . . . . 70.1 110.6 -178.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -89.51 120.11 0.95 Allowed 'Trans proline' 0 CA--C 1.559 1.729 0 C-N-CA 121.053 1.168 . . . . 73.11 112.186 172.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.7 m 39.05 43.42 0.8 Allowed 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 124.989 1.316 . . . . 74.01 114.034 178.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -95.11 -93.37 0.19 Allowed 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 119.418 -0.325 . . . . 74.54 110.64 -166.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.7 m -103.23 119.16 51.33 Favored 'Isoleucine or valine' 0 CA--C 1.596 2.745 0 CA-C-N 118.627 0.649 . . . . 75.44 109.943 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.75 155.17 25.62 Favored 'General case' 0 C--N 1.392 2.429 0 CA-C-N 120.888 1.676 . . . . 63.14 110.155 171.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.0 t -48.12 -48.8 33.76 Favored 'General case' 0 C--N 1.371 1.53 0 N-CA-C 115.477 1.658 . . . . 64.21 115.477 -173.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.94 -43.46 86.36 Favored 'General case' 0 CA--C 1.582 2.208 0 N-CA-C 114.206 1.187 . . . . 73.44 114.206 176.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.03 -30.2 70.22 Favored 'General case' 0 C--N 1.364 1.204 0 CA-C-O 117.397 -1.287 . . . . 72.23 111.223 173.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.525 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 1.6 t -66.78 -43.05 90.1 Favored 'Isoleucine or valine' 0 C--N 1.391 2.399 0 CA-C-O 116.633 -1.651 . . . . 72.04 110.021 171.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.504 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 4.3 tt0 -61.05 -55.01 37.7 Favored 'General case' 0 C--N 1.365 1.247 0 CA-C-N 121.476 1.944 . . . . 74.11 111.48 176.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -71.82 -59.26 2.84 Favored 'General case' 0 C--O 1.284 2.901 0 CA-C-N 121.21 1.823 . . . . 74.23 112.796 -176.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -71.12 -31.52 67.86 Favored 'General case' 0 C--N 1.364 1.21 0 CA-C-O 117.178 -1.391 . . . . 74.11 112.711 -176.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.525 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 5.1 m-85 -82.78 -29.01 29.94 Favored 'General case' 0 C--N 1.375 1.698 0 CA-C-N 122.057 2.208 . . . . 73.54 112.55 176.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.504 ' HB3' ' O ' ' A' ' 25' ' ' GLU . 2.9 ptt180 -54.27 -32.52 56.42 Favored 'General case' 0 C--N 1.379 1.884 0 CA-C-O 115.777 -2.059 . . . . 73.04 114.824 161.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.85 -48.06 73.38 Favored 'General case' 0 N--CA 1.518 2.965 0 CA-C-N 122.479 2.4 . . . . 64.21 111.674 167.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -75.71 -38.29 58.71 Favored 'General case' 0 C--O 1.213 -0.865 0 CA-C-O 118.639 -0.696 . . . . 65.35 111.803 -168.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -149.2 154.92 26.07 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 119.473 1.033 . . . . 64.33 111.148 168.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -77.22 105.19 8.17 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-N 118.075 0.937 . . . . 71.3 110.722 -175.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.733 HG13 ' SG ' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -73.61 132.83 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 N-CA-C 114.286 1.217 . . . . 74.5 114.286 -176.748 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 11.1 mp -108.67 -23.26 11.88 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.883 -1.053 . . . . 74.34 110.861 175.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -152.2 131.66 12.97 Favored 'General case' 0 CA--C 1.565 1.52 0 N-CA-C 108.576 -0.898 . . . . 51.4 108.576 -172.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.733 ' SG ' HG13 ' A' ' 34' ' ' ILE . 19.5 m -139.48 110.39 6.81 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 107.251 -1.388 . . . . 52.43 107.251 175.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -122.3 127.67 50.13 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 117.563 -1.655 . . . . 74.12 110.635 176.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -117.88 112.86 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-O 121.841 0.829 . . . . 72.24 110.042 -178.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.3 mtmt -120.38 146.85 45.77 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 114.439 -1.255 . . . . 73.54 109.98 -170.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.11 145.98 49.68 Favored 'General case' 0 C--N 1.368 1.397 0 CA-C-N 120.68 1.582 . . . . 71.25 108.464 -172.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.43 HG21 ' H ' ' A' ' 44' ' ' SER . 4.0 t -99.79 167.09 10.76 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 121.129 1.786 . . . . 74.34 111.138 174.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.5 m -66.74 -3.7 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.575 0 N-CA-C 116.038 1.866 . . . . 71.31 116.038 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.43 ' H ' HG21 ' A' ' 42' ' ' THR . 10.2 t -98.27 7.22 46.54 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 119.253 0.933 . . . . 65.11 109.639 -171.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.78 -5.7 73.76 Favored Glycine 0 CA--C 1.54 1.606 0 N-CA-C 115.2 0.84 . . . . 70.31 115.2 -175.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.45 130.89 34.34 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 118.201 1.0 . . . . 71.2 109.578 175.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.28 146.94 39.81 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 108.854 -0.795 . . . . 75.41 108.854 -175.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -129.63 150.84 50.78 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.526 1.057 . . . . 73.52 110.754 -176.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -127.34 147.47 50.26 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-O 121.713 0.768 . . . . 70.13 111.572 171.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -132.74 118.58 19.24 Favored 'General case' 0 C--O 1.266 1.924 0 N-CA-C 106.367 -1.716 . . . . 73.4 106.367 -164.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.79 114.02 26.35 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.079 0 C-N-CA 120.09 -0.644 . . . . 71.44 109.885 -162.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -109.44 109.14 19.9 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 120.541 -0.464 . . . . 75.33 112.108 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -107.0 160.63 15.39 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 119.4 -0.333 . . . . 73.03 111.428 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -80.49 -25.99 38.47 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 113.514 0.931 . . . . 74.42 113.514 177.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -115.86 119.57 36.4 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.402 -0.592 . . . . 62.32 109.402 -178.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.425 ' HB3' ' CD1' ' A' ' 82' ' ' PHE . . . -76.6 -33.12 58.44 Favored 'General case' 0 CA--C 1.56 1.356 0 N-CA-C 117.024 2.231 . . . . 73.11 117.024 174.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.352 0.0 OUTLIER -79.58 -29.25 41.19 Favored 'General case' 0 C--N 1.377 1.78 0 CA-C-N 122.095 2.225 . . . . 73.14 114.448 -170.391 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.2 -31.14 60.82 Favored 'General case' 0 CA--C 1.586 2.363 0 CA-C-N 121.281 1.855 . . . . 73.43 115.955 171.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.47 -24.27 54.77 Favored 'General case' 0 CA--C 1.586 2.36 0 CA-C-N 120.563 1.528 . . . . 64.53 114.222 170.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -49.78 -37.81 31.48 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-O 116.608 -1.663 . . . . 75.32 113.958 173.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.574 ' O ' ' HB3' ' A' ' 65' ' ' GLU . 31.7 m-20 -54.09 -51.65 63.49 Favored 'General case' 0 C--N 1.395 2.56 0 CA-C-N 120.178 1.354 . . . . 72.22 112.066 169.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.59 -39.22 87.32 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 117.144 -1.408 . . . . 72.42 113.04 174.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . 0.305 0.6 OUTLIER -73.78 -45.97 48.45 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 116.601 -2.04 . . . . 63.21 113.348 -176.854 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.98 -34.49 59.95 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 114.368 1.247 . . . . 74.12 114.368 166.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.574 ' HB3' ' O ' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -83.05 -22.47 33.52 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-N 119.454 1.025 . . . . 75.31 112.158 -175.098 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -100.07 14.23 31.38 Favored 'General case' 0 CA--C 1.57 1.735 0 CA-C-O 118.981 -0.533 . . . . 74.24 110.866 174.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.361 0.0 OUTLIER -77.36 162.89 26.91 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 113.674 0.99 . . . . 73.23 113.674 -168.651 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.75 29.58 2.01 Favored Glycine 0 N--CA 1.437 -1.269 0 CA-C-O 117.886 -1.508 . . . . 73.13 115.007 -158.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.676 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 44.8 t -51.37 126.23 16.49 Favored 'General case' 0 C--N 1.383 2.041 0 CA-C-O 122.123 0.963 . . . . 71.53 110.317 170.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -135.17 143.0 46.23 Favored 'General case' 0 C--O 1.252 1.236 0 CA-C-N 113.282 -1.781 . . . . 70.1 111.705 -176.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -155.51 144.8 20.94 Favored 'General case' 0 C--N 1.348 0.541 0 N-CA-C 106.695 -1.594 . . . . 75.15 106.695 -164.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 71.11 65.64 0.16 Allowed 'General case' 0 N--CA 1.512 2.658 0 CA-C-O 121.608 0.718 . . . . 54.55 111.86 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.2 -13.68 63.03 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 116.995 1.558 . . . . 41.51 116.995 174.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -122.93 125.37 45.19 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 106.037 -1.838 . . . . 70.31 106.037 161.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.69 105.9 18.1 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 117.506 -1.235 . . . . 73.22 110.491 -172.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.676 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.3 OUTLIER -169.1 69.71 0.07 Allowed 'General case' 0 N--CA 1.505 2.31 0 CA-C-N 120.944 1.702 . . . . 64.1 113.688 179.327 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.407 ' HG3' ' H ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -92.35 118.09 30.56 Favored 'General case' 0 CA--C 1.576 1.961 0 CA-C-N 122.761 2.528 . . . . 71.34 111.604 -172.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.6 t -126.87 115.89 42.96 Favored 'Isoleucine or valine' 0 C--N 1.371 1.536 0 O-C-N 120.761 -1.212 . . . . 62.23 107.753 168.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -149.83 137.65 20.18 Favored 'General case' 0 C--N 1.37 1.483 0 CA-C-N 119.852 1.205 . . . . 72.42 111.651 -179.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.41 HG11 HG13 ' A' ' 10' ' ' ILE . 35.5 m -90.81 128.35 48.51 Favored Pre-proline 0 N--CA 1.445 -0.71 0 CA-C-N 115.317 -0.856 . . . . 63.41 110.389 170.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.515 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 43.8 Cg_endo -87.06 31.25 0.45 Allowed 'Trans proline' 0 CA--C 1.553 1.428 0 C-N-CA 122.198 1.932 . . . . 71.24 112.482 162.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.425 ' CD1' ' HB3' ' A' ' 56' ' ' ALA . 3.1 p90 -120.51 -30.67 4.48 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 111.483 0.179 . . . . 74.33 111.483 175.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 15.7 m120 . . . . . 0 N--CA 1.497 1.885 0 C-N-CA 126.156 1.782 . . . . 61.41 113.485 -174.34 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.529 0.162 0 N-CA-C 110.043 -0.354 . . . . 73.25 110.043 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -126.13 152.95 45.25 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 117.519 -1.229 . . . . 73.41 110.61 -179.343 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 mt -115.56 143.98 24.22 Favored 'Isoleucine or valine' 0 C--O 1.255 1.342 0 CA-C-N 121.223 1.829 . . . . 73.15 108.692 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -106.32 120.85 42.94 Favored 'General case' 0 CA--C 1.564 1.504 0 O-C-N 124.157 0.91 . . . . 74.34 110.324 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 p -124.57 105.84 15.81 Favored 'Isoleucine or valine' 0 C--N 1.376 1.753 0 CA-C-N 120.457 1.48 . . . . 75.34 109.024 177.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 77' ' ' ARG . . . -114.57 166.79 12.19 Favored Glycine 0 C--N 1.355 1.618 0 C-N-CA 120.339 -0.934 . . . . 55.14 113.453 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 50.12 24.24 1.36 Allowed 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 115.102 1.519 . . . . 74.32 115.102 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -71.47 141.52 85.58 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 124.297 1.039 . . . . 73.05 110.717 175.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -72.98 141.47 33.16 Favored 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 121.411 1.407 . . . . 70.42 111.169 173.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.9 p 86.25 -34.16 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 126.36 1.864 . . . . 71.23 112.652 170.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 71.08 121.82 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.106 1.362 . . . . 74.42 111.188 -175.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.0 m -75.84 118.15 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.442 0 N-CA-C 107.43 -1.322 . . . . 72.44 107.43 176.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.37 157.32 27.65 Favored 'General case' 0 C--N 1.383 2.036 0 O-C-N 120.025 -1.672 . . . . 72.22 109.472 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 44.8 p -49.84 -37.61 31.43 Favored 'General case' 0 C--N 1.38 1.934 0 N-CA-C 116.123 1.897 . . . . 62.12 116.123 -173.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -38.97 75.98 Favored 'General case' 0 CA--C 1.595 2.678 0 N-CA-C 114.637 1.347 . . . . 73.43 114.637 176.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.5 -32.59 68.39 Favored 'General case' 0 C--N 1.374 1.655 0 CA-C-N 120.301 1.409 . . . . 71.43 110.596 176.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.588 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 7.5 p -75.46 -34.03 28.86 Favored 'Isoleucine or valine' 0 C--N 1.391 2.403 0 N-CA-C 108.663 -0.866 . . . . 52.21 108.663 178.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.488 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 0.5 OUTLIER -60.16 -55.63 31.45 Favored 'General case' 0 CA--C 1.576 1.967 0 CA-C-O 117.187 -1.387 . . . . 72.43 113.717 168.83 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -65.4 -58.88 4.78 Favored 'General case' 0 C--O 1.299 3.666 0 CA-C-N 121.654 2.025 . . . . 73.52 113.37 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -57.7 -44.95 86.23 Favored 'General case' 0 C--N 1.385 2.133 0 CA-C-O 117.902 -1.047 . . . . 62.31 112.075 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.588 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 3.1 m-85 -79.66 -17.22 54.23 Favored 'General case' 0 CA--C 1.568 1.671 0 CA-C-N 120.373 1.442 . . . . 65.34 114.121 -176.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.488 ' HG3' ' O ' ' A' ' 25' ' ' GLU 0.322 70.3 mtp180 -60.33 -32.01 70.84 Favored 'General case' 0 N--CA 1.535 3.819 0 CA-C-N 122.022 2.192 . . . . 64.53 110.942 170.368 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.507 ' O ' ' HD2' ' A' ' 30' ' ' LYS 0.283 0.2 OUTLIER -58.51 -21.1 50.92 Favored 'General case' 0 N--CA 1.509 2.486 0 C-N-CA 117.805 -1.558 . . . . 72.21 114.109 175.006 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.409 ' OH ' ' HE3' ' A' ' 66' ' ' LYS . 1.5 m-85 -84.86 -27.53 26.64 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.37 -0.831 . . . . 74.43 110.306 -165.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 175.32 32.99 0.04 OUTLIER Glycine 0 N--CA 1.437 -1.275 0 CA-C-O 118.783 -1.009 . . . . 37.61 113.598 174.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.2 t30 57.27 80.72 0.16 Allowed 'General case' 0 C--N 1.357 0.914 0 C-N-CA 124.525 1.13 . . . . 63.01 110.641 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.46 ' HA ' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -68.49 141.24 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 CA-C-N 114.935 -1.03 . . . . 64.25 113.6 -175.424 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.39 -25.25 11.52 Favored 'General case' 0 C--N 1.375 1.686 0 N-CA-C 110.577 -0.157 . . . . 71.03 110.577 176.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.84 130.91 26.36 Favored 'General case' 0 CA--C 1.56 1.343 0 N-CA-C 108.896 -0.779 . . . . 73.4 108.896 -168.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -141.28 111.08 6.54 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.025 -0.732 . . . . 52.24 109.025 -175.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -129.04 143.28 50.82 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 117.802 -1.559 . . . . 73.12 113.483 -177.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.0 t -116.21 114.6 46.58 Favored 'Isoleucine or valine' 0 C--N 1.345 0.383 0 N-CA-C 108.737 -0.838 . . . . 75.33 108.737 176.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -107.12 130.41 54.7 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-O 118.601 -0.714 . . . . 74.2 109.618 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.15 128.04 53.63 Favored 'General case' 0 C--N 1.379 1.857 0 CA-C-N 120.519 1.509 . . . . 65.35 112.391 -174.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.406 HG21 ' H ' ' A' ' 44' ' ' SER . 1.4 t -90.76 160.0 16.02 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 119.139 -1.024 . . . . 65.52 111.187 170.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.0 t -76.29 -9.95 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.415 0 C-N-CA 123.698 0.799 . . . . 73.24 112.376 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.406 ' H ' HG21 ' A' ' 42' ' ' THR . 7.3 m -83.16 7.84 14.89 Favored 'General case' 0 CA--C 1.556 1.185 0 O-C-N 121.873 -0.517 . . . . 73.45 111.282 -177.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.31 -4.57 76.55 Favored Glycine 0 C--N 1.351 1.385 0 N-CA-C 115.563 0.985 . . . . 53.24 115.563 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.77 134.42 33.68 Favored 'General case' 0 CA--C 1.561 1.366 0 CA-C-N 118.01 0.905 . . . . 63.44 110.776 176.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -103.86 144.97 30.79 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 107.333 -1.358 . . . . 71.45 107.333 176.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -132.57 149.87 52.25 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.225 0.92 . . . . 73.33 108.562 175.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -117.79 137.0 53.03 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 119.071 -1.052 . . . . 53.2 111.391 170.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -106.12 118.85 37.69 Favored 'General case' 0 C--O 1.268 2.068 0 CA-C-N 113.92 -1.491 . . . . 72.04 107.762 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 0.3 OUTLIER -125.96 111.36 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.505 0 C-N-CA 119.066 -1.054 . . . . 60.41 111.905 -174.486 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.59 105.8 17.71 Favored 'General case' 0 CA--C 1.556 1.205 0 CA-C-N 115.643 -0.708 . . . . 71.32 111.474 -174.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.46 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 3.0 p90 -115.2 166.87 11.36 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 114.493 1.294 . . . . 74.53 114.493 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -80.8 -27.82 36.51 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 114.843 1.423 . . . . 74.21 114.843 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.35 118.6 32.69 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 120.011 1.278 . . . . 70.11 111.593 175.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.42 -34.33 54.7 Favored 'General case' 0 CA--C 1.552 1.023 0 N-CA-C 116.78 2.141 . . . . 75.11 116.78 172.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.267 0.0 OUTLIER -80.35 -29.33 37.94 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-N 121.879 2.127 . . . . 74.12 113.034 -170.538 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.22 -38.18 90.14 Favored 'General case' 0 N--CA 1.506 2.364 0 N-CA-C 114.067 1.136 . . . . 73.53 114.067 176.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.58 -22.45 8.51 Favored 'General case' 0 CA--C 1.561 1.383 0 N-CA-C 115.755 1.761 . . . . 75.51 115.755 173.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.93 -45.89 60.64 Favored 'General case' 0 CA--C 1.582 2.211 0 N-CA-C 114.807 1.41 . . . . 53.53 114.807 -178.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -50.66 -51.7 46.78 Favored 'General case' 0 N--CA 1.524 3.268 0 CA-C-N 119.745 1.157 . . . . 74.1 112.459 170.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.488 ' O ' ' HD2' ' A' ' 66' ' ' LYS . . . -75.05 -31.61 61.33 Favored 'General case' 0 CA--C 1.555 1.151 0 O-C-N 121.213 -0.929 . . . . 75.2 111.994 -176.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . 0.296 0.0 OUTLIER -73.63 -42.37 55.25 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.875 0 O-C-N 120.058 -1.651 . . . . 73.25 113.118 179.293 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.47 ' HD2' ' N ' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -55.72 -33.84 64.6 Favored 'General case' 0 CA--C 1.559 1.291 0 CA-C-N 120.383 1.447 . . . . 63.1 114.815 162.861 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.47 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -63.65 -32.62 74.15 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 120.058 1.299 . . . . 74.45 112.252 172.364 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.488 ' HD2' ' O ' ' A' ' 62' ' ' ALA 0.269 0.0 OUTLIER -105.0 16.72 25.42 Favored 'General case' 0 CA--C 1.581 2.151 0 C-N-CA 117.09 -1.844 . . . . 71.23 115.566 166.661 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.403 ' HB3' ' HA ' ' A' ' 64' ' ' LYS 0.363 0.0 OUTLIER -79.26 159.61 27.2 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-N 119.092 0.86 . . . . 72.43 112.845 -177.361 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.1 31.44 2.05 Favored Glycine 0 N--CA 1.436 -1.365 0 C-N-CA 118.202 -1.951 . . . . 72.05 113.866 -164.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.704 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -50.97 124.82 12.1 Favored 'General case' 0 C--N 1.374 1.631 0 O-C-N 124.449 0.735 . . . . 74.31 111.328 -173.86 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -133.79 150.79 51.45 Favored 'General case' 0 C--O 1.252 1.232 0 CA-C-N 115.044 -0.98 . . . . 73.13 110.735 -173.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -149.65 142.47 24.7 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 105.159 -2.163 . . . . 64.31 105.159 -170.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 73.52 66.1 0.1 Allowed 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 113.014 0.746 . . . . 72.54 113.014 -176.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.33 -14.0 61.23 Favored Glycine 0 N--CA 1.478 1.463 0 N-CA-C 117.187 1.635 . . . . 72.34 117.187 169.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 -114.55 120.29 39.71 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 105.349 -2.093 . . . . 72.14 105.349 149.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.56 101.84 13.52 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.587 -1.245 . . . . 75.52 108.747 -175.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.704 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 13.1 tp -172.0 70.54 0.04 OUTLIER 'General case' 0 C--N 1.387 2.207 0 CA-C-N 120.809 1.641 . . . . 71.22 112.599 -174.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.409 ' HB3' ' O ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -96.51 113.26 24.82 Favored 'General case' 0 CA--C 1.566 1.572 0 CA-C-N 122.375 2.352 . . . . 73.14 109.56 -174.257 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.469 ' H ' ' HB3' ' A' ' 69' ' ' CYS . 13.9 t -128.71 118.03 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.481 0 O-C-N 120.286 -1.509 . . . . 62.4 109.381 174.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -134.48 135.58 42.54 Favored 'General case' 0 C--O 1.263 1.807 0 CA-C-N 119.475 1.034 . . . . 75.4 109.944 -175.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.8 m -72.41 123.81 89.99 Favored Pre-proline 0 CA--C 1.551 1.017 0 CA-C-N 115.753 -0.658 . . . . 64.21 110.288 159.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -92.09 23.06 0.6 Allowed 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.441 2.094 . . . . 74.31 112.663 168.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -121.9 -57.61 1.79 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 121.403 -0.119 . . . . 75.2 110.88 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.6 t30 . . . . . 0 N--CA 1.496 1.83 0 C-N-CA 125.58 1.552 . . . . 73.15 112.764 -175.272 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.7 m . . . . . 0 CA--C 1.547 0.841 0 CA-C-O 120.26 0.076 . . . . 74.14 110.979 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -140.65 160.04 40.89 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 113.682 0.993 . . . . 74.5 113.682 -177.069 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.2 mt -112.57 136.56 48.44 Favored 'Isoleucine or valine' 0 C--O 1.259 1.564 0 N-CA-C 106.866 -1.531 . . . . 44.42 106.866 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -92.92 115.06 27.77 Favored 'General case' 0 CA--C 1.565 1.541 0 O-C-N 125.815 1.947 . . . . 74.41 109.045 177.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.5 t -123.57 115.29 44.86 Favored 'Isoleucine or valine' 0 C--N 1.366 1.316 0 CA-C-N 119.922 1.237 . . . . 75.44 109.042 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -121.63 171.03 14.95 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 119.276 -1.44 . . . . 64.41 113.738 173.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 50.81 25.69 2.25 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 115.367 1.618 . . . . 51.12 115.367 176.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.24 140.84 57.06 Favored Pre-proline 0 CA--C 1.551 1.006 0 CA-C-N 119.144 0.883 . . . . 73.21 112.257 -170.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -76.15 142.69 24.75 Favored 'Trans proline' 0 CA--C 1.552 1.378 0 C-N-CA 122.992 2.461 . . . . 61.14 112.176 173.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.1 p 88.53 -32.25 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 126.719 2.008 . . . . 73.03 111.955 175.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 82.5 t60 69.13 105.29 0.06 Allowed 'General case' 0 C--N 1.361 1.069 0 C-N-CA 124.924 1.29 . . . . 75.41 111.184 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.8 m -77.99 117.8 23.88 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.849 0 N-CA-C 109.127 -0.694 . . . . 74.24 109.127 -176.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.8 154.92 29.51 Favored 'General case' 0 C--N 1.378 1.839 0 CA-C-O 118.165 -0.921 . . . . 55.11 111.028 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.0 t -49.42 -46.52 47.74 Favored 'General case' 0 C--N 1.38 1.893 0 N-CA-C 114.821 1.415 . . . . 74.13 114.821 -177.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . 0.314 0.0 OUTLIER -55.23 -43.29 74.41 Favored 'General case' 0 CA--C 1.588 2.414 0 N-CA-C 115.246 1.573 . . . . 73.01 115.246 172.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.92 -37.84 87.12 Favored 'General case' 0 C--N 1.378 1.812 0 CA-C-O 117.903 -1.046 . . . . 73.55 110.726 176.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.2 t -64.89 -43.75 96.28 Favored 'Isoleucine or valine' 0 C--N 1.403 2.931 0 CA-C-N 119.551 1.069 . . . . 71.02 110.657 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.62 -52.72 63.77 Favored 'General case' 0 C--N 1.378 1.818 0 CA-C-O 116.201 -1.857 . . . . 62.13 111.12 176.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.552 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 1.8 m-20 -77.54 -55.28 5.5 Favored 'General case' 0 C--O 1.3 3.72 0 CA-C-N 122.713 2.506 . . . . 71.1 116.576 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.449 ' O ' ' HD2' ' A' ' 31' ' ' TYR . 19.8 tt0 -59.93 -39.96 87.26 Favored 'General case' 0 C--N 1.371 1.522 0 CA-C-O 117.335 -1.317 . . . . 71.24 111.698 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . 0.263 73.9 m-85 -82.28 -21.64 36.09 Favored 'General case' 0 CA--C 1.575 1.909 0 CA-C-N 121.918 2.145 . . . . 74.15 113.986 174.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.552 ' HG3' ' O ' ' A' ' 26' ' ' ASN 0.269 0.0 OUTLIER -59.72 -28.45 67.35 Favored 'General case' 0 N--CA 1.531 3.583 0 CA-C-N 120.864 1.665 . . . . 74.41 112.719 169.627 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.432 ' HE2' ' CD1' ' A' ' 31' ' ' TYR 0.325 0.0 OUTLIER -76.1 -36.21 59.01 Favored 'General case' 0 N--CA 1.506 2.338 0 C-N-CA 114.518 -2.873 . . . . 75.35 113.216 170.305 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.523 ' HB3' ' HA ' ' A' ' 59' ' ' ALA . 20.8 m-85 -76.68 -43.85 36.13 Favored 'General case' 0 CA--C 1.564 1.481 0 N-CA-C 112.681 0.623 . . . . 73.04 112.681 -164.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -132.45 -175.93 14.19 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.557 -1.017 . . . . 72.35 110.557 151.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -87.01 98.13 11.1 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.839 1.82 . . . . 63.12 109.6 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.424 HG13 ' SG ' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -75.37 141.02 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 113.349 0.87 . . . . 72.1 113.349 -178.653 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 11.1 mp -108.67 -24.14 11.48 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 122.758 0.423 . . . . 74.51 110.246 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.62 139.42 15.19 Favored 'General case' 0 CA--C 1.58 2.102 0 C-N-CA 123.794 0.837 . . . . 45.21 110.41 -170.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.424 ' SG ' HG13 ' A' ' 34' ' ' ILE . 62.0 m -138.79 112.3 8.22 Favored 'General case' 0 N--CA 1.507 2.382 0 N-CA-C 107.622 -1.251 . . . . 75.31 107.622 177.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -118.32 136.98 53.39 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 116.454 -2.098 . . . . 73.53 111.746 175.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -123.83 111.8 30.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 121.893 0.854 . . . . 43.43 109.266 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -115.77 152.61 32.95 Favored 'General case' 0 CA--C 1.559 1.318 0 CA-C-N 114.848 -1.069 . . . . 74.53 109.428 -172.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.39 146.24 50.85 Favored 'General case' 0 CA--C 1.565 1.528 0 CA-C-N 120.945 1.702 . . . . 73.13 108.838 -172.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.3 t -100.7 175.43 5.65 Favored 'General case' 0 CA--C 1.563 1.474 0 CA-C-N 120.698 1.59 . . . . 63.44 110.852 174.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.4 t -78.67 -8.53 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 123.545 0.738 . . . . 72.42 112.411 -175.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.1 t -89.15 4.72 47.58 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 122.937 0.495 . . . . 74.22 110.27 -175.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.13 -7.25 64.19 Favored Glycine 0 CA--C 1.534 1.26 0 N-CA-C 114.921 0.728 . . . . 75.04 114.921 -178.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.06 130.85 35.95 Favored 'General case' 0 CA--C 1.556 1.187 0 CA-C-N 117.877 0.838 . . . . 72.13 109.724 172.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.16 146.03 42.61 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.057 -0.72 . . . . 36.79 109.057 -173.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -128.29 148.51 50.66 Favored 'General case' 0 C--N 1.36 1.037 0 CA-C-N 119.63 1.105 . . . . 64.4 111.483 -173.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -123.61 146.27 48.3 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.162 0.801 . . . . 54.1 113.162 169.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -132.97 115.26 14.97 Favored 'General case' 0 C--O 1.267 2.005 0 N-CA-C 105.596 -2.002 . . . . 74.25 105.596 -165.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 1.4 mp -120.54 110.19 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.497 0 C-N-CA 118.371 -1.331 . . . . 61.41 111.378 -169.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -105.37 104.0 13.64 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-O 121.35 0.595 . . . . 71.34 111.754 -173.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -117.55 168.75 10.12 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 114.123 1.157 . . . . 75.44 114.123 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -81.35 -33.86 32.14 Favored 'General case' 0 C--N 1.367 1.34 0 N-CA-C 113.963 1.098 . . . . 74.54 113.963 175.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -111.41 116.03 30.25 Favored 'General case' 0 C--N 1.349 0.576 0 N-CA-C 107.386 -1.338 . . . . 72.23 107.386 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.439 ' HB3' ' CD2' ' A' ' 82' ' ' PHE . . . -81.75 -28.78 33.15 Favored 'General case' 0 C--N 1.355 0.808 0 N-CA-C 114.647 1.351 . . . . 64.31 114.647 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.2 tmm_? -76.54 -41.07 47.96 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 114.2 1.185 . . . . 63.2 114.2 -170.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -70.65 -31.33 68.22 Favored 'General case' 0 CA--C 1.583 2.226 0 CA-C-N 121.459 1.936 . . . . 74.21 115.381 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.523 ' HA ' ' HB3' ' A' ' 31' ' ' TYR . . . -57.59 -22.16 43.32 Favored 'General case' 0 CA--C 1.596 2.743 0 N-CA-C 116.697 2.11 . . . . 62.21 116.697 169.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.47 -28.63 8.71 Favored 'General case' 0 CA--C 1.573 1.858 0 N-CA-C 114.758 1.392 . . . . 73.21 114.758 172.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -51.64 -54.42 28.15 Favored 'General case' 0 N--CA 1.504 2.266 0 CA-C-N 120.235 1.38 . . . . 73.32 112.644 162.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.64 -33.29 75.3 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 121.054 -1.029 . . . . 72.35 112.79 174.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . 0.303 0.0 OUTLIER -71.42 -46.41 64.31 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.607 0 C-N-CA 116.616 -2.034 . . . . 64.41 113.016 -178.619 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.445 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -55.06 -32.7 62.11 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 114.706 1.373 . . . . 72.41 114.706 164.221 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.51 -18.37 41.81 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.702 1.137 . . . . 63.34 112.413 -176.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -101.29 15.05 30.04 Favored 'General case' 0 CA--C 1.588 2.428 0 CA-C-O 119.413 -0.327 . . . . 73.32 111.653 166.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.445 ' HB3' ' HA ' ' A' ' 64' ' ' LYS 0.378 0.2 OUTLIER -77.86 163.87 25.67 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 115.629 1.715 . . . . 72.4 115.629 -166.861 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.74 30.14 2.26 Favored Glycine 0 N--CA 1.432 -1.601 0 CA-C-O 117.224 -1.876 . . . . 72.1 115.62 -170.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.837 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -52.01 123.33 10.19 Favored 'General case' 0 C--N 1.382 2.019 0 CA-C-N 118.307 1.053 . . . . 73.24 111.577 -169.864 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.2 151.79 51.5 Favored 'General case' 0 C--O 1.258 1.504 0 CA-C-N 114.53 -1.213 . . . . 63.23 111.996 -170.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -148.75 145.28 27.55 Favored 'General case' 0 C--N 1.361 1.108 0 C-N-CA 126.97 2.108 . . . . 73.44 107.036 -163.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 70.42 64.33 0.2 Allowed 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 114.098 1.147 . . . . 72.14 114.098 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.21 -13.96 61.42 Favored Glycine 0 N--CA 1.476 1.31 0 N-CA-C 116.523 1.369 . . . . 75.41 116.523 172.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -118.42 120.34 37.29 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 105.956 -1.868 . . . . 71.22 105.956 153.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.53 107.37 19.78 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 118.051 -0.976 . . . . 74.2 109.774 -178.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.837 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 22.1 tp -163.08 70.44 0.25 Allowed 'General case' 0 C--O 1.192 -1.955 0 CA-C-N 120.114 1.324 . . . . 71.23 111.201 178.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -101.3 110.8 22.87 Favored 'General case' 0 CA--C 1.556 1.203 0 CA-C-N 122.537 2.426 . . . . 74.45 110.213 -170.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.433 ' H ' ' HB3' ' A' ' 69' ' ' CYS . 90.8 t -126.88 118.23 49.97 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.732 0 O-C-N 120.097 -1.627 . . . . 62.3 107.5 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -145.28 131.43 19.41 Favored 'General case' 0 C--N 1.386 2.194 0 CA-C-N 120.694 1.588 . . . . 65.24 111.741 -170.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.401 ' HB ' ' CD2' ' A' ' 82' ' ' PHE . 15.7 m -88.44 134.24 34.79 Favored Pre-proline 0 C--N 1.349 0.576 0 CA-C-N 115.696 -0.684 . . . . 75.33 112.534 165.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -82.7 38.19 0.72 Allowed 'Trans proline' 0 CA--C 1.548 1.197 0 C-N-CA 122.322 2.014 . . . . 74.43 111.347 161.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.439 ' CD2' ' HB3' ' A' ' 56' ' ' ALA . 10.3 m-85 -125.56 52.01 1.67 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.452 -0.944 . . . . 53.32 108.452 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 61.7 m-20 . . . . . 0 CA--C 1.549 0.937 0 CA-C-N 115.597 -0.729 . . . . 71.5 110.055 175.022 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.622 0 CA-C-O 119.368 -0.348 . . . . 74.03 110.19 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.476 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 0.3 OUTLIER -138.71 159.19 42.72 Favored 'General case' 0 N--CA 1.509 2.524 0 CA-C-N 118.618 0.645 . . . . 60.31 111.909 -173.519 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.408 ' HB ' ' CD1' ' A' ' 51' ' ' ILE . 5.2 mp -134.48 133.77 54.79 Favored 'Isoleucine or valine' 0 C--O 1.269 2.082 0 N-CA-C 107.84 -1.17 . . . . 72.32 107.84 -177.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -108.54 114.4 28.2 Favored 'General case' 0 CA--C 1.57 1.731 0 O-C-N 125.877 1.986 . . . . 75.24 110.061 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.6 p -123.43 104.76 14.72 Favored 'Isoleucine or valine' 0 C--N 1.372 1.563 0 CA-C-N 120.555 1.525 . . . . 37.78 108.915 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -128.9 169.63 20.28 Favored Glycine 0 C--N 1.364 2.103 0 C-N-CA 120.374 -0.917 . . . . 63.02 114.747 -174.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.5 m120 49.24 24.8 1.06 Allowed 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 114.037 1.125 . . . . 70.14 114.037 -175.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.474 ' CD1' HG12 ' A' ' 19' ' ' VAL . 2.0 pt? -85.12 149.98 54.03 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 125.439 1.496 . . . . 73.13 111.775 -171.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -72.13 140.98 35.27 Favored 'Trans proline' 0 C--N 1.367 1.532 0 C-N-CA 121.925 1.75 . . . . 74.34 111.56 173.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.4 p 82.5 -34.38 0.09 Allowed 'General case' 0 C--N 1.386 2.177 0 C-N-CA 126.857 2.063 . . . . 43.33 111.483 177.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 45.7 m-70 64.21 84.77 0.14 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.509 1.523 . . . . 74.31 110.109 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.474 HG12 ' CD1' ' A' ' 15' ' ' LEU . 5.5 p -59.88 120.49 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.517 0 O-C-N 124.095 0.872 . . . . 75.13 110.503 -176.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.0 m -80.98 156.69 25.81 Favored 'General case' 0 C--N 1.363 1.174 0 CA-C-O 118.204 -0.903 . . . . 54.54 108.931 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.7 p -48.98 -37.29 19.79 Favored 'General case' 0 C--N 1.375 1.7 0 N-CA-C 115.795 1.776 . . . . 73.1 115.795 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . 0.255 0.0 OUTLIER -56.1 -47.62 77.71 Favored 'General case' 0 CA--C 1.588 2.433 0 N-CA-C 113.948 1.092 . . . . 62.14 113.948 173.191 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.401 ' HB2' HG21 ' A' ' 19' ' ' VAL . 13.6 m-20 -62.68 -50.97 69.06 Favored 'General case' 0 C--O 1.266 1.945 0 C-N-CA 123.686 0.794 . . . . 75.44 112.238 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.687 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -59.92 -46.18 94.26 Favored 'Isoleucine or valine' 0 C--N 1.372 1.55 0 CA-C-O 118.527 -0.749 . . . . 75.14 111.795 175.643 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.543 ' O ' ' HB3' ' A' ' 29' ' ' ARG 0.281 0.7 OUTLIER -52.5 -51.14 60.98 Favored 'General case' 0 C--O 1.202 -1.405 0 CA-C-O 115.647 -2.12 . . . . 72.53 112.049 171.217 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -71.73 -62.93 1.24 Allowed 'General case' 1 C--O 1.305 4.016 0 CA-C-N 124.537 3.335 . . . . 72.41 114.123 -178.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -72.8 -29.85 63.59 Favored 'General case' 0 C--N 1.371 1.512 0 O-C-N 120.495 -1.378 . . . . 71.42 112.118 -173.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.687 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 6.8 m-85 -84.05 -31.93 25.12 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 117.374 -1.298 . . . . 74.54 112.582 177.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.543 ' HB3' ' O ' ' A' ' 25' ' ' GLU . 3.3 ptt85 -51.46 -29.33 15.87 Favored 'General case' 0 N--CA 1.508 2.46 0 CA-C-O 116.353 -1.784 . . . . 70.4 114.355 164.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.41 -48.16 71.94 Favored 'General case' 0 N--CA 1.514 2.765 0 C-N-CA 114.775 -2.77 . . . . 63.21 113.2 164.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -79.99 -40.32 28.18 Favored 'General case' 0 CA--C 1.563 1.477 0 CA-C-N 119.082 0.856 . . . . 75.55 112.058 -170.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 29' ' ' ARG . . . -137.18 156.9 23.62 Favored Glycine 0 C--N 1.357 1.716 0 CA-C-N 120.245 1.384 . . . . 64.32 112.249 167.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -84.47 109.92 18.26 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.045 -0.724 . . . . 74.4 109.045 -170.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.74 121.42 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 113.439 0.904 . . . . 63.33 113.439 -176.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.81 -17.83 14.9 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.9 -0.778 . . . . 62.42 108.9 170.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -156.47 128.86 7.57 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 109.071 -0.714 . . . . 74.4 109.071 -165.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.4 p -143.04 107.99 4.92 Favored 'General case' 0 C--N 1.362 1.118 0 CA-C-N 119.34 0.973 . . . . 74.32 108.957 174.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -116.78 146.84 42.57 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 118.524 -1.27 . . . . 44.25 111.994 178.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.6 t -108.85 121.45 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 108.308 -0.997 . . . . 74.34 108.308 177.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -120.56 130.96 54.44 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 109.151 -0.685 . . . . 71.32 109.151 -176.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.98 128.6 51.66 Favored 'General case' 0 C--N 1.372 1.55 0 C-N-CA 117.839 -1.544 . . . . 63.13 111.127 -165.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.6 t -100.09 159.36 15.16 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 118.168 -1.413 . . . . 71.42 112.436 177.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.8 t -73.99 -7.99 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.408 0 C-N-CA 123.868 0.867 . . . . 75.14 112.377 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.4 t -85.23 7.78 20.81 Favored 'General case' 0 CA--C 1.55 0.968 0 O-C-N 121.489 -0.757 . . . . 65.43 110.601 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.34 -5.96 70.46 Favored Glycine 0 CA--C 1.532 1.13 0 N-CA-C 115.241 0.856 . . . . 52.05 115.241 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.48 132.38 33.94 Favored 'General case' 0 CA--C 1.558 1.283 0 CA-C-N 118.078 0.939 . . . . 74.44 110.713 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.91 142.38 34.87 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 107.439 -1.319 . . . . 37.78 107.439 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -130.79 145.99 52.12 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 106.944 -1.502 . . . . 71.21 106.944 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -118.22 138.2 52.5 Favored 'General case' 0 C--O 1.253 1.248 0 C-N-CA 119.114 -1.034 . . . . 65.04 109.798 173.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -116.84 120.45 38.54 Favored 'General case' 0 C--O 1.252 1.207 0 CA-C-N 114.516 -1.22 . . . . 72.45 108.848 -169.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.408 ' CD1' ' HB ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -132.84 112.66 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 123.122 0.263 . . . . 70.35 110.581 -166.902 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -103.07 113.11 26.31 Favored 'General case' 0 CA--C 1.565 1.529 0 CA-C-N 118.554 0.615 . . . . 72.13 112.169 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -108.74 164.14 12.64 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 112.742 0.645 . . . . 61.23 112.742 -176.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -78.85 -39.64 34.8 Favored 'General case' 0 N--CA 1.51 2.532 0 N-CA-C 113.37 0.878 . . . . 74.51 113.37 174.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.95 117.7 32.79 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 118.96 0.8 . . . . 72.24 109.615 -177.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.79 -26.32 57.21 Favored 'General case' 0 CA--C 1.556 1.19 0 N-CA-C 115.022 1.49 . . . . 73.22 115.022 175.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.321 0.0 OUTLIER -79.57 -28.2 41.16 Favored 'General case' 0 CA--C 1.57 1.74 0 CA-C-N 121.649 2.022 . . . . 74.12 114.803 -176.7 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.02 -30.23 49.89 Favored 'General case' 0 CA--C 1.591 2.552 0 CA-C-N 121.837 2.108 . . . . 73.2 115.668 174.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.74 -24.33 21.78 Favored 'General case' 0 CA--C 1.597 2.787 0 CA-C-N 120.551 1.523 . . . . 62.14 114.615 166.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.524 ' O ' ' HG3' ' A' ' 64' ' ' LYS . . . -48.41 -39.37 22.28 Favored 'General case' 0 CA--C 1.569 1.691 0 C-N-CA 125.368 1.467 . . . . 62.32 114.061 173.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.423 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 2.1 m-20 -53.76 -50.82 65.17 Favored 'General case' 0 C--N 1.382 2.005 0 CA-C-N 120.473 1.488 . . . . 75.52 112.771 169.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.09 -44.99 91.98 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 118.454 -0.784 . . . . 62.31 112.65 174.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . 0.254 2.3 tt -69.94 -50.04 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 117.247 -1.781 . . . . 73.03 112.504 -174.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -56.9 -26.33 58.84 Favored 'General case' 0 CA--C 1.561 1.399 0 N-CA-C 115.57 1.692 . . . . 73.33 115.57 167.741 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.47 -20.11 37.53 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 121.369 1.895 . . . . 75.42 111.03 179.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.5 mttt -110.21 16.72 21.57 Favored 'General case' 0 CA--C 1.578 2.023 0 O-C-N 122.304 -0.248 . . . . 63.42 111.318 176.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.32 0.1 OUTLIER -78.23 161.4 27.32 Favored 'General case' 0 C--N 1.377 1.772 0 N-CA-C 112.988 0.736 . . . . 71.34 112.988 -176.188 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.38 26.04 3.57 Favored Glycine 0 N--CA 1.434 -1.499 0 C-N-CA 119.226 -1.464 . . . . 63.35 113.574 -160.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.801 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -55.15 123.63 14.29 Favored 'General case' 0 C--N 1.365 1.28 0 CA-C-N 117.545 0.672 . . . . 62.01 110.317 -176.628 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -133.19 151.3 51.96 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-N 115.792 -0.64 . . . . 72.42 112.122 -169.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -149.12 144.19 26.48 Favored 'General case' 0 C--N 1.354 0.78 0 C-N-CA 126.764 2.026 . . . . 62.24 106.779 -165.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 71.43 64.37 0.15 Allowed 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 113.43 0.9 . . . . 75.32 113.43 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.66 -13.72 62.35 Favored Glycine 0 N--CA 1.47 0.951 0 N-CA-C 117.081 1.592 . . . . 73.44 117.081 172.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -119.23 119.4 33.99 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 106.079 -1.823 . . . . 73.31 106.079 153.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.99 102.9 14.74 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 118.732 -1.187 . . . . 73.54 108.05 -171.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.801 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -160.57 65.99 0.32 Allowed 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 116.796 -1.574 . . . . 73.11 115.171 -177.673 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.29 114.86 27.29 Favored 'General case' 0 CA--C 1.578 2.05 0 CA-C-N 124.109 3.141 . . . . 73.4 111.962 -172.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.9 t -120.28 116.57 50.67 Favored 'Isoleucine or valine' 0 C--N 1.363 1.17 0 O-C-N 119.752 -1.842 . . . . 72.54 107.793 165.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -142.95 142.06 31.58 Favored 'General case' 0 C--N 1.362 1.116 0 C-N-CA 117.193 -1.803 . . . . 74.03 111.622 168.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.9 m -82.96 127.15 70.65 Favored Pre-proline 0 N--CA 1.442 -0.828 0 CA-C-N 114.676 -1.147 . . . . 71.42 110.556 169.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.476 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 57.9 Cg_endo -85.5 25.32 0.7 Allowed 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 121.6 1.533 . . . . 74.42 112.341 164.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -105.3 -31.59 9.01 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 120.414 -0.514 . . . . 74.41 111.048 174.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 N--CA 1.489 1.485 0 C-N-CA 125.057 1.343 . . . . 74.42 113.26 -177.481 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.546 0.794 0 N-CA-C 109.625 -0.509 . . . . 72.32 109.625 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.505 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 4.9 ptt180 -140.59 157.53 45.34 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 118.837 -0.601 . . . . 63.42 112.394 -177.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.8 mt -118.15 135.17 59.42 Favored 'Isoleucine or valine' 0 C--N 1.368 1.41 0 CA-C-N 119.47 1.032 . . . . 74.54 109.075 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -105.97 118.54 36.86 Favored 'General case' 0 CA--C 1.568 1.661 0 O-C-N 125.281 1.613 . . . . 63.54 110.445 -177.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.3 t -124.2 107.52 18.76 Favored 'Isoleucine or valine' 0 C--N 1.373 1.619 0 CA-C-N 120.439 1.472 . . . . 71.32 109.287 -177.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -120.18 163.93 13.88 Favored Glycine 0 C--N 1.344 1.021 0 C-N-CA 118.845 -1.645 . . . . 74.32 112.818 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.3 m120 50.45 26.89 2.53 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 114.772 1.397 . . . . 73.32 114.772 177.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.69 149.72 86.09 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.543 1.537 . . . . 74.21 111.415 -177.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -79.92 129.17 7.89 Favored 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 121.565 1.51 . . . . 73.24 111.27 176.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 96.7 p 57.55 102.56 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 124.647 1.179 . . . . 73.13 112.357 -171.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 32.0 p-80 -57.15 125.31 22.13 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.529 -0.76 . . . . 65.52 111.781 -177.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.9 p -77.61 119.29 26.01 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 CA-C-N 114.85 -1.068 . . . . 63.44 109.006 -176.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.0 m -79.4 157.37 27.6 Favored 'General case' 0 C--N 1.369 1.45 0 CA-C-O 117.955 -1.022 . . . . 73.02 108.581 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.8 p -48.97 -37.53 20.43 Favored 'General case' 0 C--N 1.375 1.698 0 N-CA-C 115.926 1.825 . . . . 71.14 115.926 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.491 ' H ' ' HD3' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -56.6 -40.72 75.79 Favored 'General case' 0 N--CA 1.507 2.381 0 N-CA-C 114.547 1.314 . . . . 75.14 114.547 172.692 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -70.7 -45.93 64.07 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 118.955 0.798 . . . . 75.03 111.173 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.685 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 2.4 m -61.63 -49.75 83.07 Favored 'Isoleucine or valine' 0 C--N 1.372 1.572 0 N-CA-C 112.085 0.402 . . . . 72.43 112.085 174.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -50.09 -53.69 25.51 Favored 'General case' 0 CA--C 1.562 1.411 0 CA-C-O 116.528 -1.701 . . . . 74.21 113.226 171.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -73.09 -63.07 1.25 Allowed 'General case' 0 C--O 1.302 3.843 0 CA-C-N 122.901 2.591 . . . . 52.14 114.29 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -72.54 -30.79 64.76 Favored 'General case' 0 C--N 1.365 1.265 0 C-N-CA 119.031 -1.068 . . . . 74.21 111.172 -174.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.685 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 17.9 m-85 -85.85 -23.19 27.21 Favored 'General case' 0 CA--C 1.56 1.341 0 CA-C-N 119.536 1.062 . . . . 72.34 111.391 -178.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . 0.295 1.8 ppt_? -60.62 -24.5 65.56 Favored 'General case' 0 C--N 1.401 2.828 0 CA-C-N 120.602 1.546 . . . . 71.25 112.341 165.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . 0.297 0.0 OUTLIER -53.55 -30.77 43.47 Favored 'General case' 0 N--CA 1.508 2.466 0 C-N-CA 117.123 -1.831 . . . . 71.52 114.042 164.237 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -85.67 -49.47 7.96 Favored 'General case' 0 C--O 1.214 -0.793 0 CA-C-N 121.564 1.984 . . . . 73.04 112.279 -157.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -160.55 39.9 0.44 Allowed Glycine 0 C--N 1.355 1.613 0 C-N-CA 117.89 -2.1 . . . . 64.11 114.507 171.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.3 t30 69.33 93.78 0.08 Allowed 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 124.37 1.068 . . . . 72.32 111.435 173.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.95 129.75 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-N 115.537 -0.756 . . . . 72.51 112.553 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.79 -21.73 12.54 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 109.553 -0.536 . . . . 73.35 109.553 174.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.22 131.63 15.67 Favored 'General case' 0 CA--C 1.561 1.394 0 N-CA-C 108.57 -0.9 . . . . 62.52 108.57 -173.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -138.55 110.59 7.28 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 120.126 1.33 . . . . 64.31 109.803 176.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -118.64 145.98 45.02 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 117.875 -1.53 . . . . 73.31 111.499 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 37.1 t -114.9 112.76 41.36 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 N-CA-C 107.623 -1.251 . . . . 72.53 107.623 172.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -114.7 129.83 56.74 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 114.825 -1.079 . . . . 75.42 108.739 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.09 144.52 51.48 Favored 'General case' 0 C--N 1.369 1.433 0 CA-C-N 121.004 1.729 . . . . 64.21 108.998 -171.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.415 HG21 ' H ' ' A' ' 44' ' ' SER . 8.8 t -99.06 170.99 8.32 Favored 'General case' 0 CA--C 1.558 1.288 0 CA-C-N 120.499 1.5 . . . . 43.42 111.738 -178.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.7 t -73.63 -7.07 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.368 0 C-N-CA 124.113 0.965 . . . . 73.23 112.577 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.415 ' H ' HG21 ' A' ' 42' ' ' THR . 8.5 t -85.41 8.36 19.19 Favored 'General case' 0 CA--C 1.55 0.965 0 O-C-N 121.59 -0.694 . . . . 65.41 111.04 -177.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.42 -4.89 75.73 Favored Glycine 0 C--N 1.351 1.4 0 N-CA-C 115.178 0.831 . . . . 54.21 115.178 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.19 131.27 34.24 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 117.726 0.763 . . . . 71.5 110.484 176.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -105.34 147.76 27.81 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 108.045 -1.094 . . . . 43.45 108.045 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -126.67 147.27 49.95 Favored 'General case' 0 C--N 1.352 0.7 0 C-N-CA 118.609 -1.236 . . . . 74.1 109.7 177.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -117.08 138.75 51.41 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 120.538 -0.465 . . . . 74.14 109.751 176.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.13 113.83 15.58 Favored 'General case' 0 C--O 1.261 1.662 0 N-CA-C 106.709 -1.589 . . . . 64.33 106.709 -175.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.18 113.9 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 C-N-CA 118.699 -1.2 . . . . 71.52 109.72 -170.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -91.62 115.38 28.0 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 114.567 -1.197 . . . . 61.34 112.481 -172.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -109.39 159.58 16.89 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 114.279 1.214 . . . . 71.51 114.279 -177.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -82.04 -43.33 18.07 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 120.115 -0.634 . . . . 63.14 112.315 172.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.452 ' OD1' ' HD2' ' A' ' 57' ' ' ARG . 6.0 t0 -116.41 127.02 54.26 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 118.923 0.783 . . . . 74.41 110.896 -174.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.03 -22.21 53.38 Favored 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 115.548 1.684 . . . . 63.1 115.548 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.452 ' HD2' ' OD1' ' A' ' 55' ' ' ASP 0.289 0.0 OUTLIER -76.73 -41.32 45.47 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 121.939 2.154 . . . . 65.41 113.273 -173.191 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -62.69 -48.85 77.5 Favored 'General case' 0 N--CA 1.505 2.319 0 CA-C-N 120.217 1.371 . . . . 72.32 113.499 178.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.55 -24.62 33.25 Favored 'General case' 0 CA--C 1.567 1.596 0 N-CA-C 115.477 1.658 . . . . 71.44 115.477 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -46.68 -44.37 18.55 Favored 'General case' 0 CA--C 1.576 1.967 0 C-N-CA 125.31 1.444 . . . . 73.31 114.025 173.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -51.83 -53.47 39.81 Favored 'General case' 0 N--CA 1.514 2.739 0 CA-C-N 119.523 1.056 . . . . 65.51 112.822 173.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.622 ' O ' ' HD2' ' A' ' 66' ' ' LYS . . . -75.67 -30.21 59.32 Favored 'General case' 0 C--N 1.31 -1.141 0 O-C-N 120.467 -1.396 . . . . 73.2 112.868 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.496 HD12 HG21 ' A' ' 63' ' ' ILE 0.256 5.9 mm -68.78 -46.23 79.78 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.921 0 C-N-CA 118.174 -1.41 . . . . 54.43 111.915 179.205 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.94 -32.83 66.38 Favored 'General case' 0 CA--C 1.562 1.44 0 N-CA-C 115.155 1.539 . . . . 71.21 115.155 164.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -64.36 -28.39 69.66 Favored 'General case' 0 N--CA 1.507 2.377 0 CA-C-N 120.542 1.519 . . . . 75.41 113.201 173.12 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.622 ' HD2' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -107.41 15.17 25.19 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 116.221 1.934 . . . . 74.52 116.221 164.6 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.33 0.0 OUTLIER -78.63 157.21 28.73 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 120.238 1.381 . . . . 73.13 110.941 179.597 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.52 30.85 1.77 Allowed Glycine 0 N--CA 1.428 -1.889 0 C-N-CA 117.526 -2.273 . . . . 73.3 113.622 -151.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.75 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 6.9 t -49.07 132.69 19.04 Favored 'General case' 0 C--N 1.376 1.74 0 CA-C-O 122.062 0.934 . . . . 65.43 111.049 172.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -128.92 147.13 50.81 Favored 'General case' 0 C--O 1.246 0.914 0 CA-C-N 113.951 -1.477 . . . . 72.4 112.836 -170.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.63 144.91 24.72 Favored 'General case' 0 C--N 1.355 0.83 0 C-N-CA 126.83 2.052 . . . . 74.22 108.154 -156.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 70.91 62.28 0.18 Allowed 'General case' 0 N--CA 1.501 2.086 0 O-C-N 123.611 0.569 . . . . 74.51 112.473 173.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.95 -14.79 64.15 Favored Glycine 0 N--CA 1.472 1.036 0 N-CA-C 116.952 1.541 . . . . 73.33 116.952 173.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -123.11 119.74 31.19 Favored 'General case' 0 C--O 1.211 -0.942 0 N-CA-C 104.592 -2.373 . . . . 74.43 104.592 159.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.54 131.44 51.93 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 118.02 -1.472 . . . . 73.42 111.281 -177.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.75 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -171.33 70.69 0.05 OUTLIER 'General case' 0 C--O 1.199 -1.594 0 CA-C-O 117.981 -1.009 . . . . 72.41 110.589 -178.417 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.0 tpp85 -93.0 115.62 28.29 Favored 'General case' 0 CA--C 1.571 1.763 0 CA-C-N 121.572 1.987 . . . . 74.25 111.411 -172.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.04 116.09 48.76 Favored 'Isoleucine or valine' 0 C--N 1.361 1.079 0 N-CA-C 107.558 -1.275 . . . . 64.03 107.558 163.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.2 tp10 -134.46 138.66 44.93 Favored 'General case' 0 C--N 1.363 1.178 0 CA-C-N 119.576 1.08 . . . . 75.42 110.427 174.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.0 m -90.3 122.39 67.48 Favored Pre-proline 0 N--CA 1.439 -0.998 0 C-N-CA 120.016 -0.673 . . . . 71.51 110.579 170.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.505 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 75.5 Cg_endo -89.74 22.77 0.76 Allowed 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 121.887 1.725 . . . . 74.1 113.378 168.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.447 ' HD2' ' N ' ' A' ' 9' ' ' ARG . 0.8 OUTLIER -113.32 -16.84 12.43 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 120.009 -0.676 . . . . 70.34 112.417 175.426 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.6 m120 . . . . . 0 N--CA 1.49 1.545 0 O-C-N 124.957 1.411 . . . . 71.42 110.271 -171.13 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.548 0.877 0 N-CA-C 112.092 0.405 . . . . 74.22 112.092 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.491 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -126.59 154.76 43.5 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.044 0.757 . . . . 73.43 113.044 -176.299 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.416 HD13 HG13 ' A' ' 63' ' ' ILE . 23.4 mt -116.79 141.17 36.07 Favored 'Isoleucine or valine' 0 C--O 1.254 1.31 0 CA-C-N 119.446 1.021 . . . . 75.34 108.637 179.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -101.71 116.99 33.96 Favored 'General case' 0 CA--C 1.572 1.797 0 O-C-N 125.991 2.057 . . . . 70.41 110.073 177.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.37 105.67 14.15 Favored 'Isoleucine or valine' 0 C--N 1.381 1.95 0 CA-C-N 119.348 0.977 . . . . 73.12 108.754 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -113.12 -175.66 19.36 Favored Glycine 0 CA--C 1.521 0.445 0 CA-C-O 118.504 -1.164 . . . . 73.33 112.991 176.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.7 m120 54.09 28.8 9.34 Favored 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 115.701 1.741 . . . . 74.1 115.701 170.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.3 mt -89.08 150.79 45.87 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 123.51 0.724 . . . . 73.54 111.629 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -59.35 130.73 37.21 Favored 'Trans proline' 0 CA--C 1.556 1.582 0 C-N-CA 123.095 2.53 . . . . 61.22 113.232 173.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.0 p 71.98 -5.11 1.79 Allowed 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 126.473 1.909 . . . . 71.22 114.525 168.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 71.54 129.8 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.062 1.345 . . . . 74.13 110.605 -173.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.9 m -91.68 119.78 39.61 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.443 0 N-CA-C 107.424 -1.324 . . . . 73.15 107.424 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.44 157.47 24.91 Favored 'General case' 0 C--N 1.381 1.972 0 O-C-N 120.263 -1.523 . . . . 64.02 109.991 -175.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.0 p -58.96 -34.25 71.58 Favored 'General case' 0 C--N 1.378 1.836 0 N-CA-C 115.835 1.791 . . . . 72.24 115.835 -174.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . 0.274 0.0 OUTLIER -60.75 -39.14 87.61 Favored 'General case' 0 CA--C 1.582 2.199 0 N-CA-C 115.477 1.658 . . . . 73.21 115.477 172.377 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -65.32 -50.47 65.54 Favored 'General case' 0 C--O 1.279 2.622 0 CA-C-N 119.87 1.214 . . . . 73.4 111.329 178.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.7 m -62.94 -43.75 99.19 Favored 'Isoleucine or valine' 0 C--N 1.376 1.759 0 O-C-N 123.546 0.529 . . . . 53.31 111.877 177.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.13 -50.16 67.54 Favored 'General case' 0 C--O 1.191 -2.015 0 CA-C-O 115.195 -2.336 . . . . 75.44 115.202 169.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.41 -56.63 7.81 Favored 'General case' 0 C--O 1.283 2.85 0 CA-C-N 123.257 2.753 . . . . 51.32 114.071 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -61.18 -44.56 97.1 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 117.903 -1.046 . . . . 64.3 111.71 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -74.59 -28.54 60.95 Favored 'General case' 0 C--O 1.209 -1.04 0 CA-C-N 120.857 1.662 . . . . 62.33 114.194 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . 0.379 0.0 OUTLIER -57.62 -37.88 74.03 Favored 'General case' 0 N--CA 1.526 3.353 0 CA-C-N 121.285 1.857 . . . . 74.33 114.252 164.025 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.417 ' HE2' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -56.6 -47.75 78.91 Favored 'General case' 0 N--CA 1.508 2.475 0 C-N-CA 116.194 -2.202 . . . . 64.3 110.319 167.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.486 ' HB3' ' HA ' ' A' ' 59' ' ' ALA . 35.2 m-85 -72.64 -39.47 67.16 Favored 'General case' 0 CA--C 1.564 1.505 0 CA-C-O 118.065 -0.969 . . . . 70.32 112.79 -166.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -150.11 176.07 28.91 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-N 119.965 1.257 . . . . 74.22 110.722 161.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 47.1 m-20 -83.58 101.14 11.26 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.249 2.024 . . . . 75.31 111.077 -176.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.91 134.41 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.108 0.48 . . . . 64.31 112.034 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.5 mp -102.77 -24.86 13.69 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 116.097 -0.501 . . . . 74.51 111.992 171.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.53 138.0 13.97 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 109.249 -0.648 . . . . 74.43 109.249 -173.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -140.27 108.73 5.86 Favored 'General case' 0 C--N 1.359 0.982 0 CA-C-N 118.727 0.694 . . . . 72.43 109.545 178.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -120.8 143.68 48.71 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 117.852 -1.539 . . . . 61.15 112.643 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -127.15 112.8 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 CA-C-O 121.452 0.644 . . . . 62.43 110.284 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.5 mttm -113.41 152.43 30.07 Favored 'General case' 0 CA--C 1.56 1.336 0 CA-C-O 118.018 -0.991 . . . . 73.23 108.874 -174.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.37 147.19 50.27 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-N 121.755 2.071 . . . . 70.51 109.061 -174.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.417 HG21 ' H ' ' A' ' 44' ' ' SER . 5.8 t -98.88 175.65 5.87 Favored 'General case' 0 CA--C 1.565 1.53 0 CA-C-N 120.816 1.644 . . . . 72.11 111.356 175.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.5 t -77.51 -8.99 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.387 0 C-N-CA 123.486 0.714 . . . . 71.32 112.115 -178.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.417 ' H ' HG21 ' A' ' 42' ' ' THR . 8.2 t -86.14 -0.8 56.53 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 121.773 -0.579 . . . . 54.03 110.753 -177.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.06 -7.46 66.81 Favored Glycine 0 CA--C 1.534 1.258 0 N-CA-C 114.977 0.751 . . . . 52.23 114.977 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.31 132.26 37.38 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 117.728 0.764 . . . . 73.32 108.952 170.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.88 145.35 44.68 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.022 -0.733 . . . . 51.21 109.022 -171.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -127.04 151.16 48.97 Favored 'General case' 0 C--N 1.363 1.16 0 CA-C-N 119.783 1.174 . . . . 74.53 112.0 -170.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -127.57 147.0 50.34 Favored 'General case' 0 C--N 1.351 0.642 0 CA-C-O 121.705 0.764 . . . . 70.05 111.831 175.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -132.69 113.31 12.84 Favored 'General case' 0 C--O 1.256 1.407 0 N-CA-C 105.392 -2.077 . . . . 73.33 105.392 -164.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 0.6 OUTLIER -126.38 108.91 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 C-N-CA 118.186 -1.406 . . . . 73.15 108.865 -170.525 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -106.27 106.0 16.3 Favored 'General case' 0 CA--C 1.549 0.905 0 O-C-N 124.6 1.187 . . . . 72.43 110.233 -173.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.19 146.6 39.0 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-O 118.681 -0.676 . . . . 74.21 112.766 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -57.46 -24.21 54.4 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 114.657 1.354 . . . . 72.25 114.657 166.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -114.09 113.42 24.7 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 119.603 1.092 . . . . 74.43 109.015 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.29 -43.68 32.37 Favored 'General case' 0 CA--C 1.554 1.103 0 N-CA-C 115.426 1.639 . . . . 72.43 115.426 172.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.305 0.0 OUTLIER -77.49 -29.57 52.66 Favored 'General case' 0 C--N 1.373 1.589 0 CA-C-N 121.117 1.78 . . . . 75.35 114.916 -167.831 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.17 -30.17 63.36 Favored 'General case' 0 CA--C 1.581 2.17 0 N-CA-C 116.353 1.983 . . . . 74.43 116.353 176.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.486 ' HA ' ' HB3' ' A' ' 31' ' ' TYR . . . -72.99 -19.28 61.24 Favored 'General case' 0 CA--C 1.585 2.302 0 CA-C-N 120.367 1.439 . . . . 44.13 111.993 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -48.58 -29.78 4.62 Favored 'General case' 0 CA--C 1.572 1.825 0 CA-C-O 116.97 -1.49 . . . . 53.34 114.325 170.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.556 ' O ' ' HB3' ' A' ' 65' ' ' GLU . 18.8 m-20 -51.88 -53.38 41.31 Favored 'General case' 0 C--N 1.398 2.708 0 CA-C-N 121.025 1.739 . . . . 62.32 111.571 164.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.02 -34.8 79.3 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-O 117.824 -1.084 . . . . 72.33 113.689 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.416 HG13 HD13 ' A' ' 10' ' ' ILE 0.281 0.0 OUTLIER -72.92 -35.93 50.34 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.685 0 C-N-CA 116.457 -2.097 . . . . 74.22 113.727 -178.741 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.61 -32.95 74.58 Favored 'General case' 0 C--N 1.362 1.143 0 CA-C-N 119.848 1.204 . . . . 73.52 113.678 163.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.556 ' HB3' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -83.38 -19.28 36.35 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 113.206 0.817 . . . . 74.41 113.206 -172.804 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -100.35 13.64 33.75 Favored 'General case' 0 CA--C 1.571 1.784 0 O-C-N 122.207 -0.308 . . . . 74.33 110.329 173.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.302 0.1 OUTLIER -77.02 161.94 27.93 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 118.422 0.555 . . . . 71.43 112.296 -167.463 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 119.85 28.41 1.89 Allowed Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 119.452 -1.356 . . . . 72.23 114.681 -155.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.691 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 0.8 OUTLIER -47.94 132.68 15.02 Favored 'General case' 0 C--N 1.377 1.768 0 C-N-CA 124.573 1.149 . . . . 75.3 109.811 179.238 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.455 ' H ' ' HA ' ' A' ' 77' ' ' ARG . 9.8 t0 -56.95 102.06 0.07 Allowed 'General case' 0 C--N 1.384 2.105 0 O-C-N 125.216 1.573 . . . . 74.42 112.362 -160.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -153.92 139.3 17.64 Favored 'General case' 0 N--CA 1.439 -0.998 0 O-C-N 125.252 1.595 . . . . 71.22 107.303 -178.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 67.32 54.12 0.73 Allowed 'General case' 0 N--CA 1.508 2.461 0 C-N-CA 123.501 0.72 . . . . 64.41 111.892 172.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.73 -9.06 32.01 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 117.893 1.917 . . . . 75.31 117.893 176.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -115.54 119.54 36.52 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.245 1.522 . . . . 70.44 107.993 -174.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.03 100.83 12.59 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 117.966 -1.016 . . . . 63.34 111.643 -167.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.691 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -162.49 103.95 1.08 Allowed 'General case' 0 C--O 1.158 -3.749 0 CA-C-O 117.081 -1.438 . . . . 74.03 107.935 170.498 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.455 ' HA ' ' H ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -92.67 109.9 21.33 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 123.533 2.879 . . . . 72.52 107.257 -170.031 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 88.4 t -128.38 117.21 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.548 0 CA-C-N 120.481 1.491 . . . . 63.22 108.573 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -150.22 135.53 18.02 Favored 'General case' 0 C--N 1.381 1.972 0 CA-C-N 120.339 1.427 . . . . 72.24 110.144 -174.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.0 m -77.93 122.27 85.29 Favored Pre-proline 0 C--N 1.36 1.052 0 CA-C-O 121.618 0.723 . . . . 73.43 110.892 161.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.491 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 72.2 Cg_endo -90.78 13.69 2.13 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.402 2.068 . . . . 72.4 113.362 165.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -102.41 -45.72 5.0 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.055 -0.72 . . . . 73.41 109.055 170.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 . . . . . 0 N--CA 1.492 1.668 0 O-C-N 125.058 1.474 . . . . 63.22 110.302 -178.2 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 111.725 0.268 . . . . 63.23 111.725 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -141.16 154.66 45.97 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 113.351 0.871 . . . . 75.51 113.351 -175.06 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.6 mt -116.65 141.72 33.45 Favored 'Isoleucine or valine' 0 C--O 1.26 1.644 0 N-CA-C 108.418 -0.956 . . . . 71.11 108.418 -179.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -100.7 118.02 35.97 Favored 'General case' 0 CA--C 1.566 1.568 0 O-C-N 125.775 1.922 . . . . 74.32 110.374 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.9 t -125.78 106.24 15.79 Favored 'Isoleucine or valine' 0 C--N 1.375 1.677 0 CA-C-N 119.849 1.204 . . . . 73.12 109.889 177.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.17 -178.07 20.9 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 118.582 -1.121 . . . . 54.43 111.818 174.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.5 m120 50.13 24.2 1.36 Allowed 'General case' 0 N--CA 1.509 2.489 0 N-CA-C 116.579 2.066 . . . . 63.2 116.579 172.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -89.18 123.93 66.01 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 123.401 0.681 . . . . 61.34 111.001 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -84.33 126.67 3.72 Favored 'Trans proline' 0 CA--C 1.559 1.74 0 C-N-CA 121.415 1.41 . . . . 62.33 112.855 174.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.1 m 33.42 60.55 0.47 Allowed 'General case' 0 C--N 1.386 2.154 0 C-N-CA 125.772 1.629 . . . . 55.53 114.271 174.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -109.58 -128.29 0.28 Allowed 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.65 -0.704 . . . . 73.31 109.671 -168.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.9 m -83.37 121.59 36.41 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.695 0 CA-C-N 118.384 0.538 . . . . 70.35 110.983 -174.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -81.43 165.56 21.17 Favored 'General case' 0 C--N 1.369 1.434 0 CA-C-O 117.571 -1.204 . . . . 72.14 109.134 176.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.6 p -47.79 -46.78 30.84 Favored 'General case' 0 C--N 1.382 2.008 0 N-CA-C 116.065 1.876 . . . . 63.24 116.065 -173.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.25 -42.03 96.69 Favored 'General case' 0 CA--C 1.577 2.0 0 N-CA-C 114.517 1.303 . . . . 71.43 114.517 178.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.352 0.6 OUTLIER -67.41 -27.24 66.91 Favored 'General case' 0 CA--C 1.565 1.543 0 CA-C-N 120.036 1.289 . . . . 61.41 112.958 172.783 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.433 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 2.3 t -71.11 -38.78 72.65 Favored 'Isoleucine or valine' 0 C--N 1.406 3.055 0 CA-C-N 120.266 1.394 . . . . 64.34 107.734 175.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.589 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -65.79 -56.82 9.94 Favored 'General case' 0 CA--C 1.555 1.138 0 CA-C-O 117.129 -1.415 . . . . 75.4 112.198 179.488 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.11 -54.92 19.69 Favored 'General case' 0 C--O 1.299 3.666 0 CA-C-N 121.739 2.063 . . . . 72.32 115.58 176.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.78 -37.83 80.18 Favored 'General case' 0 C--N 1.387 2.209 0 CA-C-O 118.126 -0.94 . . . . 53.25 112.136 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.433 ' HB2' ' O ' ' A' ' 24' ' ' VAL 0.256 63.4 m-85 -83.87 -21.9 31.82 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-O 115.832 -2.033 . . . . 72.22 114.188 178.312 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.589 ' HG3' ' O ' ' A' ' 25' ' ' GLU 0.372 10.6 mtp180 -61.95 -36.05 80.25 Favored 'General case' 0 N--CA 1.524 3.225 0 CA-C-N 122.689 2.495 . . . . 72.12 109.115 169.466 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.84 -45.86 89.06 Favored 'General case' 0 N--CA 1.509 2.52 0 C-N-CA 116.879 -1.929 . . . . 64.32 112.179 172.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.518 ' HB3' ' HA ' ' A' ' 59' ' ' ALA . 13.7 m-85 -71.83 -40.35 69.16 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 112.746 0.647 . . . . 75.01 112.746 -169.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -151.5 163.72 30.01 Favored Glycine 0 C--O 1.213 -1.184 0 CA-C-O 117.346 -1.808 . . . . 71.31 108.591 156.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -72.59 101.18 2.95 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 121.188 2.494 . . . . 44.42 111.402 -170.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.451 HD13 ' SG ' ' A' ' 37' ' ' CYS . 2.1 pp -73.81 142.41 14.91 Favored 'Isoleucine or valine' 0 C--N 1.359 0.983 0 C-N-CA 120.089 -0.645 . . . . 73.45 112.602 -174.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.1 mp -97.37 -45.5 6.44 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 115.912 -0.585 . . . . 74.32 112.131 174.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.05 152.99 38.34 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-N 118.697 0.681 . . . . 73.02 110.558 172.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.451 ' SG ' HD13 ' A' ' 34' ' ' ILE . 3.3 m -137.62 107.4 6.26 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 106.756 -1.572 . . . . 72.52 106.756 176.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -115.88 143.41 45.46 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 118.544 -1.263 . . . . 63.41 111.288 -175.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -123.62 113.14 36.05 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-O 121.27 0.557 . . . . 74.34 110.239 -173.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 48.1 mttm -116.76 146.14 43.02 Favored 'General case' 0 CA--C 1.563 1.445 0 CA-C-O 117.968 -1.015 . . . . 55.34 109.956 -173.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.42 146.31 50.13 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 121.508 1.958 . . . . 71.12 108.771 -170.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.1 t -99.33 167.41 10.67 Favored 'General case' 0 C--N 1.363 1.164 0 CA-C-N 120.358 1.435 . . . . 75.24 111.398 175.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.3 m -66.39 -5.32 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.472 0 N-CA-C 116.262 1.949 . . . . 75.43 116.262 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -98.83 4.81 47.64 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 119.507 1.049 . . . . 75.4 110.14 -172.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.37 -6.82 74.99 Favored Glycine 0 CA--C 1.543 1.781 0 N-CA-C 115.238 0.855 . . . . 62.22 115.238 -176.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -80.78 131.52 35.43 Favored 'General case' 0 CA--C 1.554 1.133 0 CA-C-N 118.267 1.034 . . . . 73.31 109.248 171.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.93 147.45 43.13 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-O 118.565 -0.731 . . . . 73.3 109.319 -171.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -129.57 151.62 49.99 Favored 'General case' 0 C--N 1.367 1.327 0 CA-C-N 119.541 1.064 . . . . 74.24 111.619 -173.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -134.29 144.01 48.08 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.919 0.866 . . . . 75.44 111.598 175.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -131.59 114.67 15.12 Favored 'General case' 0 C--O 1.265 1.88 0 N-CA-C 105.591 -2.003 . . . . 71.25 105.591 -159.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 0.3 OUTLIER -120.01 107.6 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 C-N-CA 119.271 -0.972 . . . . 75.02 109.713 -165.79 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -114.04 104.7 12.4 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.126 -0.488 . . . . 61.53 111.04 -169.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.402 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -114.12 160.73 18.62 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.831 1.048 . . . . 74.32 113.831 -177.035 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -73.09 -28.7 62.44 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 112.741 0.645 . . . . 61.41 112.741 167.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -113.8 112.42 23.37 Favored 'General case' 0 C--N 1.351 0.659 0 C-N-CA 118.571 -1.252 . . . . 63.13 109.277 176.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.34 -44.71 35.47 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 116.058 1.873 . . . . 72.44 116.058 170.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.97 -34.9 76.08 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 113.846 1.054 . . . . 73.32 113.846 -169.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -75.96 -32.64 59.6 Favored 'General case' 0 CA--C 1.586 2.358 0 N-CA-C 115.897 1.814 . . . . 64.44 115.897 176.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.518 ' HA ' ' HB3' ' A' ' 31' ' ' TYR . . . -64.93 -19.81 66.13 Favored 'General case' 0 CA--C 1.595 2.694 0 N-CA-C 114.884 1.439 . . . . 75.44 114.884 173.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -48.46 -31.83 6.89 Favored 'General case' 0 CA--C 1.578 2.055 0 N-CA-C 115.047 1.499 . . . . 74.1 115.047 171.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -51.21 -52.97 39.5 Favored 'General case' 0 N--CA 1.507 2.424 0 CA-C-N 119.915 1.234 . . . . 62.21 111.77 164.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.58 -31.32 71.95 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 117.13 -1.414 . . . . 73.21 114.023 175.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . 0.343 0.3 OUTLIER -73.59 -42.49 55.51 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.199 0 C-N-CA 115.578 -2.449 . . . . 74.51 113.895 177.612 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.16 -27.42 65.65 Favored 'General case' 0 CA--C 1.56 1.328 0 CA-C-N 120.158 1.345 . . . . 72.53 113.691 165.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -77.59 -29.31 51.91 Favored 'General case' 0 CA--C 1.549 0.937 0 O-C-N 121.31 -0.869 . . . . 73.13 112.45 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 43.0 mmtt -96.01 13.0 28.48 Favored 'General case' 0 CA--C 1.584 2.259 0 N-CA-C 112.861 0.689 . . . . 74.4 112.861 172.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.323 0.2 OUTLIER -76.23 164.97 25.54 Favored 'General case' 0 N--CA 1.51 2.534 0 CA-C-N 119.825 1.193 . . . . 74.4 111.922 -171.059 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.76 31.19 1.05 Allowed Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 118.652 -1.737 . . . . 74.14 114.801 -153.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.628 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 59.5 m -44.68 139.49 2.89 Favored 'General case' 0 C--N 1.393 2.492 0 CA-C-N 117.767 0.784 . . . . 74.03 111.852 171.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -58.05 99.79 0.05 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 O-C-N 125.038 1.461 . . . . 71.43 110.774 -169.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -155.63 139.29 16.05 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 125.551 1.54 . . . . 75.44 109.63 -175.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 66.06 51.39 1.31 Allowed 'General case' 0 N--CA 1.509 2.506 0 C-N-CA 123.148 0.579 . . . . 73.23 111.935 168.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.9 -11.01 36.84 Favored Glycine 0 CA--C 1.541 1.69 0 N-CA-C 117.456 1.742 . . . . 53.32 117.456 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -114.83 118.9 34.84 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 119.608 1.704 . . . . 74.51 108.84 -177.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.96 107.59 19.88 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 113.57 0.952 . . . . 70.32 113.57 -176.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.628 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -159.35 108.87 1.89 Allowed 'General case' 0 C--O 1.167 -3.261 0 N-CA-C 107.48 -1.304 . . . . 74.04 107.48 165.847 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 -90.79 107.58 19.28 Favored 'General case' 0 CA--C 1.554 1.098 0 CA-C-N 122.728 2.513 . . . . 72.03 108.028 -175.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.7 t -127.28 111.46 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 O-C-N 120.771 -1.206 . . . . 55.21 108.776 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -149.44 133.68 17.33 Favored 'General case' 0 C--O 1.257 1.475 0 CA-C-N 120.565 1.529 . . . . 64.32 110.615 -166.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.8 m -73.47 126.14 90.16 Favored Pre-proline 0 C--N 1.37 1.491 0 CA-C-O 121.363 0.601 . . . . 73.11 111.88 164.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -96.49 17.31 0.68 Allowed 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.367 2.711 . . . . 75.11 113.959 164.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -114.32 -26.38 8.02 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 120.574 -0.45 . . . . 75.32 112.063 176.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 CA--C 1.569 1.683 0 O-C-N 124.583 1.177 . . . . 72.44 113.43 -175.998 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 t . . . . . 0 CA--C 1.548 0.878 0 N-CA-C 110.188 -0.301 . . . . 74.35 110.188 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.551 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 0.3 OUTLIER -141.87 160.34 40.4 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 112.66 0.615 . . . . 73.21 112.66 -176.726 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.7 mt -113.64 136.9 48.59 Favored 'Isoleucine or valine' 0 C--O 1.246 0.911 0 N-CA-C 109.075 -0.713 . . . . 53.42 109.075 176.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -111.35 112.86 24.93 Favored 'General case' 0 C--N 1.354 0.761 0 O-C-N 124.619 1.2 . . . . 64.3 108.923 172.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 4.0 p -124.42 110.38 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-O 121.577 0.703 . . . . 73.0 111.422 175.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -117.62 159.24 14.22 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.918 -0.583 . . . . 64.11 112.458 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.1 m120 60.87 28.98 18.72 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.996 0.918 . . . . 70.25 111.925 175.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -85.04 137.46 37.5 Favored Pre-proline 0 C--O 1.239 0.528 0 CA-C-N 115.873 -0.603 . . . . 61.24 111.564 -172.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -69.23 126.92 14.26 Favored 'Trans proline' 0 C--N 1.36 1.142 0 C-N-CA 122.23 1.954 . . . . 71.11 112.055 174.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.6 t 52.23 92.24 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.96 0 O-C-N 124.672 1.233 . . . . 73.13 111.956 -173.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 34.0 p-80 -58.71 131.61 51.41 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.652 -0.703 . . . . 72.42 111.325 -177.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.3 m -72.45 133.54 31.58 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-N 115.079 -0.964 . . . . 72.43 111.525 -176.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.405 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -83.03 157.08 23.05 Favored 'General case' 0 C--O 1.212 -0.888 0 CA-C-N 114.968 -1.015 . . . . 64.4 110.541 -178.923 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.2 p -60.17 -31.42 70.1 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.097 1.517 . . . . 72.32 115.097 -166.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.63 -47.11 67.47 Favored 'General case' 0 C--O 1.249 1.058 0 CA-C-O 121.747 0.784 . . . . 52.24 110.673 176.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -66.62 -40.23 88.68 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 113.686 -1.597 . . . . 74.22 110.436 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.579 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 57.2 t -59.93 -46.73 93.62 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 O-C-N 123.899 0.749 . . . . 72.11 109.654 170.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.519 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 0.3 OUTLIER -58.92 -54.4 47.52 Favored 'General case' 0 C--O 1.204 -1.327 0 CA-C-O 118.667 -0.683 . . . . 72.35 111.326 -175.784 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.476 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 5.7 m-80 -79.97 -49.78 11.36 Favored 'General case' 0 C--O 1.278 2.564 0 N-CA-C 114.523 1.305 . . . . 74.44 114.523 -177.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -68.69 -35.54 77.33 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 120.407 -0.517 . . . . 54.42 109.961 -173.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.579 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 59.0 m-85 -85.31 -18.22 34.52 Favored 'General case' 0 CA--C 1.556 1.195 0 N-CA-C 113.671 0.989 . . . . 73.41 113.671 172.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.519 ' HB3' ' O ' ' A' ' 25' ' ' GLU . 2.3 ppt_? -64.85 -25.36 67.87 Favored 'General case' 0 N--CA 1.503 2.191 0 CA-C-N 120.387 1.448 . . . . 74.54 110.768 167.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.76 -30.95 57.84 Favored 'General case' 0 CA--C 1.565 1.523 0 O-C-N 123.455 0.472 . . . . 64.25 111.879 168.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.497 ' CD1' ' HA ' ' A' ' 28' ' ' PHE . 1.0 OUTLIER -74.9 -17.57 60.55 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.493 0.717 . . . . 63.0 111.659 -175.448 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 140.84 57.73 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 119.358 -1.401 . . . . 72.01 113.399 174.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 55.28 98.0 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 125.573 1.549 . . . . 74.43 113.302 173.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.91 124.54 36.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.295 -1.32 . . . . 70.43 110.993 -177.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -90.01 -42.68 11.0 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 114.898 -1.047 . . . . 72.15 109.744 175.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -144.34 139.43 28.5 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.842 -0.617 . . . . 65.32 110.693 -177.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 8.5 p -129.57 123.24 30.86 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.133 -0.485 . . . . 71.14 110.009 172.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -130.33 128.14 40.87 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 116.497 -0.319 . . . . 73.33 110.21 177.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.9 t -109.81 116.99 53.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 120.945 0.402 . . . . 74.52 109.925 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt -108.25 157.55 18.24 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.095 -0.502 . . . . 73.13 110.741 -177.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.98 147.98 52.68 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 122.248 -0.282 . . . . 64.1 110.401 173.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.1 t -101.16 165.28 11.38 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.81 -0.441 . . . . 71.22 109.81 171.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.5 t -74.52 -15.23 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 123.787 0.835 . . . . 64.04 110.797 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.9 m -75.56 -9.8 58.89 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.952 -0.567 . . . . 74.03 111.929 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.43 -4.31 47.49 Favored Glycine 0 C--N 1.342 0.912 0 C-N-CA 121.534 -0.365 . . . . 61.34 113.7 175.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -89.53 141.58 28.45 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.1 0.476 . . . . 61.33 111.37 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -106.23 149.6 26.71 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.614 -0.721 . . . . 61.41 110.041 176.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.462 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 2.1 m-85 -136.68 151.29 49.11 Favored 'General case' 0 C--O 1.223 -0.303 0 N-CA-C 109.25 -0.648 . . . . 74.35 109.25 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -127.35 139.61 52.75 Favored 'General case' 0 C--O 1.248 0.976 0 N-CA-C 109.528 -0.545 . . . . 51.23 109.528 169.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -120.53 115.44 23.44 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 106.717 -1.586 . . . . 72.55 106.717 -176.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -133.67 112.26 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 N-CA-C 113.787 1.032 . . . . 74.05 113.787 -166.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -90.84 114.76 27.26 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.531 0.567 . . . . 70.4 112.531 -173.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -110.24 161.94 15.1 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 115.967 -0.56 . . . . 73.21 110.713 176.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -83.09 -30.12 28.23 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.237 0.458 . . . . 70.12 112.237 174.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.48 125.65 49.4 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.836 0.827 . . . . 42.3 112.409 -176.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.53 -45.73 24.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 113.893 -1.503 . . . . 71.42 113.492 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -23.43 53.63 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.005 0.743 . . . . 70.5 113.005 -168.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -73.61 -34.01 64.84 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.786 0.803 . . . . 74.34 109.887 176.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.01 -27.74 61.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.708 -1.133 . . . . 72.45 112.658 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.56 -33.44 63.87 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.246 1.202 . . . . 72.11 114.246 -175.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.509 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 17.4 m-20 -70.99 -37.67 72.71 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.564 0.697 . . . . 75.32 112.711 177.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.479 ' O ' ' HG3' ' A' ' 65' ' ' GLU . . . -75.74 -36.08 60.01 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.736 0.779 . . . . 60.02 111.097 177.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.452 ' O ' ' HB3' ' A' ' 67' ' ' ASP . 0.4 OUTLIER -68.13 -31.83 53.42 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.231 0 CA-C-O 117.918 -1.039 . . . . 73.35 109.748 174.892 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.509 ' HG3' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -77.11 -20.68 55.34 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 120.201 1.364 . . . . 71.24 111.506 172.659 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.479 ' HG3' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -71.73 -27.47 63.02 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 119.438 -0.905 . . . . 64.45 111.394 170.565 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.42 13.9 19.03 Favored 'General case' 0 N--CA 1.511 2.622 0 N-CA-C 116.578 2.066 . . . . 72.25 116.578 167.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.452 ' HB3' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -73.3 158.21 35.55 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 124.663 1.185 . . . . 71.15 112.229 176.215 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.83 23.38 5.01 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 119.981 -1.104 . . . . 36.67 112.259 -159.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 15.8 p -57.22 134.52 56.0 Favored 'General case' 0 C--O 1.24 0.582 0 O-C-N 124.895 0.997 . . . . 54.33 113.125 -173.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.63 149.07 52.62 Favored 'General case' 0 C--O 1.257 1.462 0 CA-C-N 114.242 -1.345 . . . . 70.23 112.605 -170.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -143.81 145.61 32.48 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 112.504 -2.134 . . . . 70.33 110.778 -171.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 73.02 67.95 0.11 Allowed 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 122.569 1.176 . . . . 42.11 114.142 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.88 -11.2 57.5 Favored Glycine 0 C--N 1.333 0.414 0 CA-C-N 113.786 -1.552 . . . . 51.15 114.081 176.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -121.51 123.78 42.83 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.527 -1.286 . . . . 55.45 107.527 158.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.63 103.4 15.33 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 119.222 -0.418 . . . . 60.25 110.962 178.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 13.9 tp -165.41 70.93 0.15 Allowed 'General case' 0 C--O 1.206 -1.186 0 C-N-CA 119.937 -0.705 . . . . 54.33 112.261 177.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -96.76 111.4 23.58 Favored 'General case' 0 C--O 1.209 -1.075 0 O-C-N 119.834 -1.791 . . . . 74.25 109.701 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 t -129.17 119.64 49.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 107.492 -1.299 . . . . 74.34 107.492 170.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -148.16 141.95 25.69 Favored 'General case' 0 C--O 1.247 0.939 0 C-N-CA 119.81 -0.756 . . . . 53.21 111.289 176.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.444 HG11 ' CZ ' ' A' ' 82' ' ' PHE . 19.1 m -89.9 121.95 68.38 Favored Pre-proline 0 N--CA 1.438 -1.035 0 CA-C-N 114.75 -1.114 . . . . 72.44 110.194 166.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.551 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 72.2 Cg_endo -88.21 21.58 0.99 Allowed 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 121.89 1.727 . . . . 63.22 112.503 164.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.458 ' HD2' ' N ' ' A' ' 9' ' ' ARG . 0.2 OUTLIER -116.71 13.1 15.09 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 113.13 0.789 . . . . 74.24 113.13 179.504 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.3 t30 . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 120.925 0.393 . . . . 65.23 111.137 -171.563 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.4 p . . . . . 0 CA--C 1.538 0.5 0 N-CA-C 112.328 0.492 . . . . 60.32 112.328 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.487 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 8.8 ptt180 -132.56 150.51 52.15 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.7 -0.682 . . . . 64.0 112.39 -171.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 34.2 mt -118.51 142.47 33.16 Favored 'Isoleucine or valine' 0 C--O 1.247 0.937 0 C-N-CA 122.963 0.505 . . . . 74.3 110.121 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -111.81 114.65 27.74 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 124.874 1.359 . . . . 73.32 109.466 175.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 2.7 p -123.27 108.04 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 CA-C-O 122.286 1.041 . . . . 61.11 111.799 175.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -118.66 164.12 13.03 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 114.998 -1.001 . . . . 75.43 113.821 -176.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 58.15 24.74 11.66 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.873 1.269 . . . . 70.3 113.588 170.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -90.25 150.35 42.96 Favored Pre-proline 0 CA--C 1.552 1.023 0 N-CA-C 111.47 0.174 . . . . 55.23 111.47 -174.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 75' ' ' LYS . 57.3 Cg_endo -75.8 150.76 35.21 Favored 'Trans proline' 0 C--N 1.364 1.374 0 C-N-CA 122.771 2.314 . . . . 51.1 113.268 -178.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.7 p 79.88 -21.79 0.31 Allowed 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 127.334 2.254 . . . . 75.24 112.687 -177.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 66.18 107.37 0.04 OUTLIER 'General case' 0 C--N 1.357 0.918 0 C-N-CA 125.236 1.415 . . . . 72.23 110.415 -171.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.9 p -83.04 128.4 38.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 CA-C-N 115.217 -0.902 . . . . 65.11 109.023 175.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 m -91.1 167.95 11.99 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.298 -0.865 . . . . 73.42 109.759 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.4 p -57.28 -39.83 76.5 Favored 'General case' 0 C--O 1.218 -0.605 0 O-C-N 123.892 0.745 . . . . 73.53 112.778 -175.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.4 -39.38 90.5 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.125 0.97 . . . . 71.34 112.78 178.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -75.2 -46.98 30.47 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 116.138 -0.483 . . . . 75.41 111.323 -171.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -67.5 -32.96 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 115.967 -0.56 . . . . 62.2 110.969 173.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -58.96 -44.94 91.58 Favored 'General case' 0 C--O 1.206 -1.231 0 CA-C-O 118.639 -0.696 . . . . 74.31 110.811 172.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.437 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 2.0 t-20 -70.67 -48.92 52.34 Favored 'General case' 0 C--O 1.279 2.647 0 CA-C-O 121.631 0.729 . . . . 70.42 111.336 -177.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -61.7 -42.71 99.3 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-N 114.003 -1.453 . . . . 55.12 111.063 -176.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -82.55 -26.04 32.8 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 117.823 -1.084 . . . . 73.45 112.511 178.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 26' ' ' ASN . 46.8 ptt85 -69.92 -33.06 71.66 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 119.327 0.967 . . . . 71.22 111.374 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.07 -26.57 66.8 Favored 'General case' 0 C--N 1.362 1.13 0 C-N-CA 118.796 -1.162 . . . . 62.44 111.541 -177.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.517 ' CD2' ' HB2' ' A' ' 62' ' ' ALA . 69.2 m-85 -92.89 -39.73 11.0 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 111.622 0.23 . . . . 74.1 111.622 178.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -153.39 133.52 4.02 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 111.647 -0.581 . . . . 45.2 111.647 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -64.74 118.09 8.44 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 113.447 0.906 . . . . 72.2 113.447 -168.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.68 139.45 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 114.686 -1.143 . . . . 73.31 111.278 -174.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.3 mp -102.12 -43.72 5.66 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.085 -0.961 . . . . 71.22 111.509 -176.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.92 132.98 20.32 Favored 'General case' 0 C--O 1.213 -0.842 0 N-CA-C 108.951 -0.759 . . . . 73.03 108.951 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.9 t -137.73 119.64 15.34 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 109.73 -0.47 . . . . 71.43 109.73 175.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -130.82 147.66 52.5 Favored 'General case' 0 C--O 1.22 -0.479 0 C-N-CA 120.592 -0.443 . . . . 54.24 111.315 -177.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.2 p -117.12 124.56 73.16 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 CA-C-O 121.535 0.683 . . . . 73.22 111.428 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.92 163.7 12.9 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.565 -0.743 . . . . 70.44 110.071 -178.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.76 150.92 52.1 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 122.001 -0.437 . . . . 75.24 110.9 172.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 15.3 t -100.32 169.47 9.09 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 110.072 -0.344 . . . . 64.22 110.072 172.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.6 t -74.91 -18.13 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.132 0 C-N-CA 123.79 0.836 . . . . 64.43 111.089 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.6 t -75.79 -12.87 60.26 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 122.866 0.467 . . . . 60.34 111.846 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.46 -3.56 43.21 Favored Glycine 0 C--N 1.34 0.783 0 C-N-CA 121.347 -0.454 . . . . 71.44 113.92 175.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.0 144.63 26.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.976 0.417 . . . . 74.44 110.556 176.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.74 147.9 41.6 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.013 -0.539 . . . . 74.35 110.263 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.455 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 0.9 OUTLIER -136.77 147.28 46.57 Favored 'General case' 0 C--O 1.217 -0.63 0 N-CA-C 109.411 -0.588 . . . . 74.33 109.411 -175.004 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -121.84 140.39 52.44 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 121.385 0.612 . . . . 74.3 109.91 176.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -113.62 118.09 33.42 Favored 'General case' 0 C--O 1.257 1.479 0 CA-C-N 113.633 -1.621 . . . . 71.33 107.833 -176.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.487 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 4.2 mp -118.25 110.07 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 O-C-N 123.607 0.567 . . . . 64.23 110.781 -174.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -115.52 105.06 12.36 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 121.834 0.826 . . . . 62.32 111.214 -171.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -114.11 171.58 7.52 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.137 1.162 . . . . 75.44 114.137 -177.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -75.28 -43.54 50.62 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 114.713 -1.13 . . . . 71.1 111.554 171.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -117.25 121.92 42.53 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 122.331 1.062 . . . . 74.43 112.078 -175.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.489 ' HB3' ' CE1' ' A' ' 82' ' ' PHE . . . -78.45 -43.53 26.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 112.883 -1.962 . . . . 61.53 113.99 -175.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -74.27 -25.86 59.86 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.39 0.885 . . . . 74.34 113.39 -169.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.481 ' HB3' ' O ' ' A' ' 31' ' ' TYR . 1.3 m-20 -80.75 -44.95 17.81 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.971 0.36 . . . . 53.13 111.971 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.48 -24.05 64.64 Favored 'General case' 0 C--O 1.251 1.147 0 C-N-CA 124.221 1.008 . . . . 36.76 111.747 176.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -53.3 -23.36 8.93 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.441 -1.254 . . . . 51.45 114.128 172.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -63.51 -47.05 83.29 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 118.823 0.738 . . . . 54.33 111.674 171.194 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.517 ' HB2' ' CD2' ' A' ' 31' ' ' TYR . . . -65.24 -39.92 93.33 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.938 -0.574 . . . . 61.42 110.24 174.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -66.81 -31.28 52.8 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 C-N-CA 120.28 -0.568 . . . . 36.76 111.381 177.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -80.21 -23.35 40.99 Favored 'General case' 0 C--N 1.351 0.631 0 N-CA-C 112.881 0.697 . . . . 73.54 112.881 176.875 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.454 ' HG2' ' HA ' ' A' ' 62' ' ' ALA . 10.2 pt-20 -81.52 -19.55 41.94 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 118.987 -1.085 . . . . 72.21 111.454 171.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' A' ' 62' ' ' ALA . 68.9 mmtt -92.36 -6.07 50.89 Favored 'General case' 0 CA--C 1.57 1.731 0 CA-C-N 118.451 0.569 . . . . 64.41 111.474 169.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -64.77 153.33 40.21 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 126.321 1.848 . . . . 71.21 112.746 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.71 23.82 4.88 Favored Glycine 0 C--N 1.343 0.942 0 C-N-CA 119.94 -1.124 . . . . 74.22 113.626 -163.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 24.5 p -58.7 133.1 55.63 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-O 122.196 0.998 . . . . 65.24 113.214 -169.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.37 149.13 49.61 Favored 'General case' 0 C--O 1.261 1.69 0 CA-C-N 114.09 -1.413 . . . . 62.35 112.907 -170.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -143.52 145.53 32.63 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 126.112 1.765 . . . . 75.34 111.224 -174.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 73.38 68.61 0.11 Allowed 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 114.554 1.316 . . . . 75.54 114.554 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.66 -10.99 59.37 Favored Glycine 0 N--CA 1.462 0.388 0 CA-C-N 114.188 -1.369 . . . . 73.21 113.778 175.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -120.51 122.6 40.98 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 107.065 -1.458 . . . . 64.51 107.065 155.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.463 ' O ' ' HD3' ' A' ' 16' ' ' PRO . 0.3 OUTLIER -95.08 102.39 14.2 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 117.961 -1.019 . . . . 74.32 110.286 178.573 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.534 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.3 OUTLIER -168.51 67.78 0.07 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 113.599 0.963 . . . . 71.24 113.599 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -95.85 111.1 23.16 Favored 'General case' 0 C--O 1.2 -1.529 0 CA-C-N 120.829 1.649 . . . . 73.32 110.157 -176.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.7 t -130.1 118.12 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 108.317 -0.994 . . . . 64.34 108.317 175.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -149.84 147.26 27.75 Favored 'General case' 0 C--O 1.255 1.345 0 C-N-CA 119.825 -0.75 . . . . 64.13 112.264 176.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.9 m -88.74 124.7 64.99 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 114.791 -1.095 . . . . 61.55 111.373 168.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.484 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 61.5 Cg_endo -87.08 12.03 3.08 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.132 1.888 . . . . 71.11 113.958 167.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.489 ' CE1' ' HB3' ' A' ' 56' ' ' ALA . 10.7 p90 -102.26 -25.79 13.55 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.847 0.684 . . . . 71.44 112.847 177.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.7 m120 . . . . . 0 N--CA 1.488 1.472 0 C-N-CA 124.255 1.022 . . . . 73.42 113.198 -176.366 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 CA--C 1.538 0.493 0 CA-C-O 120.681 0.276 . . . . 71.2 110.814 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 24.2 ptt180 -143.68 152.57 41.49 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-N 115.837 -0.62 . . . . 72.41 111.851 -176.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 52.9 mt -116.98 135.46 57.28 Favored 'Isoleucine or valine' 0 C--O 1.256 1.421 0 C-N-CA 122.924 0.489 . . . . 74.35 109.849 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -103.0 115.13 30.02 Favored 'General case' 0 C--N 1.362 1.142 0 O-C-N 125.644 1.84 . . . . 75.2 109.412 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.9 t -115.77 132.81 64.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 107.657 -1.238 . . . . 72.33 107.657 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -140.89 160.3 26.64 Favored Glycine 0 CA--C 1.519 0.301 0 N-CA-C 111.775 -0.53 . . . . 53.2 111.775 173.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 61.02 27.54 17.4 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.79 0.836 . . . . 71.41 112.105 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.29 125.77 73.53 Favored Pre-proline 0 C--O 1.237 0.413 0 N-CA-C 111.7 0.259 . . . . 63.04 111.7 -174.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.35 150.68 37.05 Favored 'Trans proline' 0 C--N 1.36 1.164 0 C-N-CA 121.794 1.662 . . . . 73.22 110.8 165.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.8 m -22.16 -83.13 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 125.629 1.83 . . . . 73.32 115.788 -163.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.2 t60 52.33 -91.86 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 124.996 1.319 . . . . 72.24 112.01 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.7 m -100.15 120.92 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-O 121.053 0.454 . . . . 71.33 110.775 176.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.488 ' O ' HG22 ' A' ' 24' ' ' VAL . 47.2 m -88.39 177.53 6.8 Favored 'General case' 0 C--O 1.193 -1.887 0 CA-C-O 117.575 -1.202 . . . . 75.22 107.844 170.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.7 m -49.67 -49.97 45.31 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 120.344 1.429 . . . . 72.14 114.391 -169.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -39.35 94.24 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.092 0.957 . . . . 75.25 111.697 177.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.83 -32.51 57.63 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 115.262 -0.881 . . . . 74.21 111.488 -177.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 20' ' ' SER . 47.8 t -62.82 -47.32 93.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 108.228 -1.027 . . . . 71.45 108.228 170.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.13 -51.19 67.24 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 124.422 1.076 . . . . 75.53 111.862 177.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -73.89 -43.85 57.19 Favored 'General case' 0 C--O 1.276 2.46 0 N-CA-C 112.564 0.579 . . . . 72.24 112.564 -174.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -57.78 -46.72 84.19 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 115.177 -0.919 . . . . 73.24 110.132 177.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -78.35 -25.4 46.34 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 117.956 -1.021 . . . . 75.14 112.29 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -72.42 -28.98 63.3 Favored 'General case' 0 C--N 1.358 0.971 0 CA-C-N 118.971 0.805 . . . . 74.24 112.468 -179.654 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.66 -31.16 70.95 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 118.612 -1.235 . . . . 74.45 111.445 176.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.51 ' O ' ' HB3' ' A' ' 58' ' ' ASP . 99.2 m-85 -87.94 -37.17 16.64 Favored 'General case' 0 C--O 1.219 -0.534 0 C-N-CA 121.193 -0.203 . . . . 62.32 111.174 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 29' ' ' ARG . . . -152.29 147.3 16.85 Favored Glycine 0 C--O 1.223 -0.589 0 N-CA-C 111.759 -0.536 . . . . 73.2 111.759 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -74.49 105.12 5.47 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 117.694 0.747 . . . . 75.22 112.937 -172.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.06 130.94 35.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 114.909 -1.041 . . . . 74.02 111.531 -175.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 56.2 mt -93.73 -47.9 6.56 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 114.418 -1.264 . . . . 74.14 111.083 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.07 144.09 31.46 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.234 0.54 . . . . 73.41 109.996 173.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.6 t -132.15 120.47 22.32 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.058 -0.719 . . . . 73.53 109.058 178.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -129.45 125.95 37.64 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 120.454 -0.498 . . . . 75.35 111.384 -174.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 75.9 t -107.94 121.29 60.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 122.642 0.377 . . . . 74.12 110.121 -177.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -108.69 157.49 18.49 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 116.297 -0.41 . . . . 73.12 110.713 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.22 147.59 52.61 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.416 0.15 . . . . 71.23 110.908 172.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.3 t -101.1 167.06 10.47 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 110.014 -0.365 . . . . 60.22 110.014 173.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.9 m -75.43 -11.02 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 123.81 0.844 . . . . 72.52 112.411 177.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -80.25 -11.65 59.7 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 122.629 0.372 . . . . 71.25 111.222 176.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.43 -2.04 46.42 Favored Glycine 0 C--N 1.34 0.786 0 C-N-CA 121.426 -0.416 . . . . 72.31 113.886 176.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.39 143.24 27.12 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.211 0.529 . . . . 74.31 111.596 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -105.56 150.28 25.51 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.157 -0.929 . . . . 65.14 110.673 178.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -134.5 150.1 50.76 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 108.767 -0.827 . . . . 73.12 108.767 -177.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -129.31 137.14 50.84 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.143 0.497 . . . . 72.14 110.631 174.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.94 120.05 37.24 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 108.576 -0.898 . . . . 73.42 108.576 175.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 3.2 mp -120.32 111.56 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 119.158 -1.017 . . . . 71.43 111.114 -174.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -113.45 108.0 16.61 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-O 120.813 0.339 . . . . 70.34 111.71 -172.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.28 170.51 8.24 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.269 -0.878 . . . . 60.54 111.954 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -78.85 -31.49 45.68 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 112.825 0.676 . . . . 74.42 112.825 175.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -120.35 125.01 46.95 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 122.241 1.019 . . . . 73.42 112.607 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.9 -46.01 25.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 113.99 -1.459 . . . . 71.51 113.931 -175.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.18 -25.1 54.86 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.641 0.978 . . . . 65.22 113.641 -165.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.51 ' HB3' ' O ' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -80.0 -35.52 37.29 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.627 0.727 . . . . 74.14 111.707 177.52 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.33 -18.61 59.97 Favored 'General case' 0 C--O 1.257 1.49 0 C-N-CA 124.577 1.151 . . . . 73.02 112.767 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -53.15 -26.42 16.86 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 114.626 -1.17 . . . . 74.33 113.134 170.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.411 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -69.32 -34.69 75.04 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.208 0.603 . . . . 74.24 111.697 172.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.604 ' O ' ' HD2' ' A' ' 66' ' ' LYS . . . -66.57 -48.75 68.63 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 110.425 -0.213 . . . . 70.02 110.425 171.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.46 -30.78 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 C-N-CA 120.296 -0.561 . . . . 64.14 111.002 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.475 ' HA ' ' HB2' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -79.18 -21.04 46.95 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 118.916 0.78 . . . . 74.43 112.777 171.865 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.88 -37.26 76.0 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 118.885 0.766 . . . . 73.41 110.581 171.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.604 ' HD2' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -100.13 12.67 36.42 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 118.284 -1.367 . . . . 63.41 114.28 174.488 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.475 ' HB2' ' HA ' ' A' ' 64' ' ' LYS . 21.0 t70 -51.54 152.83 2.51 Favored 'General case' 0 N--CA 1.506 2.368 0 C-N-CA 126.998 2.119 . . . . 61.24 114.442 170.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.3 25.35 3.82 Favored Glycine 0 C--N 1.35 1.332 0 C-N-CA 119.554 -1.308 . . . . 63.35 113.948 -165.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.609 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 8.6 p -58.48 133.49 55.84 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 122.393 1.092 . . . . 74.4 113.147 -173.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.94 144.46 47.46 Favored 'General case' 0 C--O 1.256 1.404 0 CA-C-N 113.771 -1.559 . . . . 73.23 113.48 -171.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -143.56 147.66 34.76 Favored 'General case' 0 CA--C 1.553 1.089 0 O-C-N 125.834 1.959 . . . . 72.0 110.83 -172.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 74.14 66.07 0.09 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 122.484 1.135 . . . . 70.42 113.463 174.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.74 -10.25 62.45 Favored Glycine 0 N--CA 1.461 0.304 0 CA-C-N 114.263 -1.335 . . . . 71.43 113.302 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -119.64 122.51 41.68 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.063 -1.458 . . . . 73.31 107.063 161.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.59 102.16 13.93 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 118.446 -0.788 . . . . 74.41 110.676 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.609 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -165.49 60.18 0.11 Allowed 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 113.304 0.853 . . . . 73.14 113.304 179.911 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.4 tpp85 -93.67 117.21 29.8 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 120.585 -1.322 . . . . 71.43 111.031 -171.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 66' ' ' LYS . 2.2 m -128.59 120.96 53.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.902 -1.045 . . . . 73.12 109.346 174.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -148.93 145.4 27.39 Favored 'General case' 0 C--O 1.255 1.351 0 CA-C-O 121.97 0.89 . . . . 61.03 112.503 -178.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.1 m -89.47 123.48 66.68 Favored Pre-proline 0 CA--C 1.546 0.792 0 CA-C-N 115.012 -0.995 . . . . 75.0 110.042 167.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.432 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 66.9 Cg_endo -88.79 4.3 5.47 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.162 1.908 . . . . 72.34 113.335 166.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -95.01 -32.29 13.21 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 119.062 -0.494 . . . . 74.34 111.983 176.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.8 t30 . . . . . 0 N--CA 1.486 1.342 0 O-C-N 124.564 1.165 . . . . 73.33 111.118 -174.242 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.524 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . 80.3 p . . . . . 0 CA--C 1.546 0.817 0 N-CA-C 111.257 0.095 . . . . 74.31 111.257 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.474 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 0.9 OUTLIER -126.22 149.98 48.68 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 111.952 0.353 . . . . 71.23 111.952 -177.183 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.0 mp -131.96 134.74 59.57 Favored 'Isoleucine or valine' 0 C--O 1.247 0.927 0 C-N-CA 123.882 0.873 . . . . 70.42 109.208 -178.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -115.82 115.21 25.87 Favored 'General case' 0 C--O 1.242 0.676 0 O-C-N 124.029 0.831 . . . . 65.32 109.613 177.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 p -119.74 111.43 32.8 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.819 0 CA-C-O 121.431 0.634 . . . . 75.23 110.867 172.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -123.52 158.79 18.16 Favored Glycine 0 CA--C 1.52 0.372 0 CA-C-N 116.077 -0.511 . . . . 37.25 113.522 -175.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.7 m120 62.25 26.63 15.96 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.235 1.014 . . . . 62.14 111.648 175.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -82.57 125.11 76.84 Favored Pre-proline 0 CA--C 1.543 0.708 0 CA-C-O 120.878 0.37 . . . . 70.1 111.848 -170.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -86.45 125.99 2.59 Favored 'Trans proline' 0 C--N 1.363 1.326 0 C-N-CA 121.829 1.686 . . . . 73.11 113.081 175.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.8 m 26.01 62.82 0.07 Allowed 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 126.417 1.887 . . . . 74.01 114.887 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -110.4 -134.31 0.35 Allowed 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.611 -0.722 . . . . 74.54 109.091 -171.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.2 m -69.76 126.04 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 111.993 0.368 . . . . 75.44 111.993 174.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.9 m -83.84 173.47 11.23 Favored 'General case' 0 C--O 1.211 -0.938 0 N-CA-C 108.403 -0.962 . . . . 63.14 108.403 173.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.6 t -60.15 -37.39 79.98 Favored 'General case' 0 CA--C 1.557 1.219 0 CA-C-N 118.969 0.804 . . . . 64.21 112.905 -174.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -66.61 -44.96 80.67 Favored 'General case' 0 C--O 1.251 1.172 0 C-N-CA 123.066 0.547 . . . . 73.44 110.808 176.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -68.4 -34.37 75.9 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.096 -0.956 . . . . 72.23 110.679 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.646 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 74.3 t -60.45 -51.72 69.79 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.588 0 N-CA-C 108.969 -0.752 . . . . 72.04 108.969 171.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.412 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 25.2 tt0 -57.01 -53.82 53.76 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 118.873 -0.584 . . . . 74.11 111.61 -177.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -76.4 -52.04 10.66 Favored 'General case' 0 C--O 1.26 1.629 0 CA-C-N 118.63 0.65 . . . . 74.23 112.113 -172.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.84 -39.0 66.92 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 120.685 -0.406 . . . . 74.11 110.057 -172.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.646 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 4.4 m-85 -77.57 -23.02 50.08 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 118.094 -0.955 . . . . 73.54 111.5 177.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.482 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 10.1 ptt180 -72.29 -25.9 61.76 Favored 'General case' 0 C--N 1.374 1.632 0 CA-C-N 120.065 1.302 . . . . 73.04 110.876 170.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.69 -25.86 65.89 Favored 'General case' 0 CA--C 1.561 1.388 0 C-N-CA 120.105 -0.638 . . . . 64.21 111.337 175.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.464 ' CG ' ' HB3' ' A' ' 62' ' ' ALA . 98.4 m-85 -89.32 -35.21 16.24 Favored 'General case' 0 C--O 1.216 -0.676 0 N-CA-C 111.974 0.361 . . . . 65.35 111.974 174.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 29' ' ' ARG . . . -156.9 137.94 5.67 Favored Glycine 0 C--O 1.228 -0.236 0 C-N-CA 120.884 -0.674 . . . . 64.33 111.668 177.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -62.06 114.73 3.57 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.142 0.577 . . . . 71.3 112.133 -175.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.61 124.76 39.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.948 0.88 . . . . 74.5 112.119 -173.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.5 mp -97.62 -36.84 10.15 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.208 -1.36 . . . . 74.34 110.327 175.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -145.43 131.25 19.07 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 120.694 0.283 . . . . 51.4 111.069 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -122.09 121.28 36.59 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 110.043 -0.355 . . . . 52.43 110.043 175.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -131.03 125.63 33.77 Favored 'General case' 0 C--O 1.219 -0.535 0 C-N-CA 120.432 -0.507 . . . . 74.12 110.277 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.01 119.31 61.06 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 CA-C-O 121.955 0.883 . . . . 72.24 110.837 176.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -117.46 157.69 25.8 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.256 -0.883 . . . . 73.54 110.348 -177.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.39 151.22 51.12 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 122.088 -0.382 . . . . 71.25 110.537 173.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.9 t -101.34 164.53 11.73 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 110.119 -0.326 . . . . 74.34 110.119 172.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.6 m -75.63 -10.28 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.78 0.832 . . . . 71.31 112.511 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -78.65 -9.29 59.33 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 122.682 0.393 . . . . 65.11 110.879 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.66 -5.01 43.27 Favored Glycine 0 C--N 1.344 0.999 0 C-N-CA 121.179 -0.534 . . . . 70.31 113.827 176.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -89.38 143.0 27.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.972 0.415 . . . . 71.2 111.444 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -107.71 149.86 27.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.648 -0.705 . . . . 75.41 109.635 175.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -137.49 150.13 47.33 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.426 -0.583 . . . . 73.52 109.426 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -127.6 138.61 52.91 Favored 'General case' 0 C--O 1.253 1.271 0 CA-C-O 121.718 0.771 . . . . 70.13 109.344 170.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -116.47 120.61 39.33 Favored 'General case' 0 C--O 1.252 1.216 0 CA-C-N 113.688 -1.596 . . . . 73.4 107.509 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.87 126.84 73.25 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.67 0 CA-C-N 115.611 -0.722 . . . . 71.44 111.111 -170.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -115.51 114.73 25.39 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 122.331 -0.23 . . . . 75.33 111.539 -178.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -109.47 169.22 8.84 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.351 0.26 . . . . 73.03 110.884 176.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -81.59 -31.18 32.65 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.22 0.452 . . . . 74.42 112.22 169.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -119.29 125.49 49.21 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-O 122.107 0.956 . . . . 62.32 112.816 -172.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.39 -44.99 18.45 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 115.644 1.72 . . . . 73.11 115.644 -177.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.76 -24.76 56.08 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 113.457 0.91 . . . . 73.14 113.457 -167.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.73 -27.43 40.61 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 121.494 0.664 . . . . 73.43 111.272 175.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.84 -25.06 61.82 Favored 'General case' 0 C--O 1.249 1.036 0 C-N-CA 124.265 1.026 . . . . 64.53 112.065 174.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.64 -27.85 63.19 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.048 -0.978 . . . . 75.32 112.859 177.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -67.83 -41.74 82.54 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 122.751 0.421 . . . . 72.22 111.149 174.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.464 ' HB3' ' CG ' ' A' ' 31' ' ' TYR . . . -64.05 -44.95 90.91 Favored 'General case' 0 C--O 1.237 0.417 0 O-C-N 123.55 0.531 . . . . 72.42 111.213 175.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.474 HD12 HG21 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -70.15 -29.93 41.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 119.936 -0.706 . . . . 63.21 110.999 179.145 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.02 -26.44 53.78 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.674 1.125 . . . . 74.12 112.331 176.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -85.98 -18.0 33.77 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 118.621 -1.232 . . . . 75.31 112.524 173.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt -100.14 8.18 44.06 Favored 'General case' 0 CA--C 1.558 1.259 0 O-C-N 121.794 -0.566 . . . . 74.24 111.3 172.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -60.37 152.25 25.83 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 126.596 1.958 . . . . 73.23 111.228 173.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.81 25.07 3.76 Favored Glycine 0 C--N 1.349 1.277 0 C-N-CA 120.166 -1.016 . . . . 73.13 113.715 -160.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.595 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 12.8 t -59.13 132.65 54.66 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.644 0.735 . . . . 71.53 111.439 178.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -135.63 134.7 39.54 Favored 'General case' 0 C--O 1.252 1.214 0 CA-C-N 114.134 -1.394 . . . . 70.1 112.993 -172.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -142.93 148.03 36.25 Favored 'General case' 0 CA--C 1.548 0.886 0 O-C-N 125.658 1.849 . . . . 75.15 109.574 -175.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 75.66 65.86 0.06 Allowed 'General case' 0 N--CA 1.5 2.041 0 CA-C-O 122.828 1.299 . . . . 54.55 114.206 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.02 -10.98 62.2 Favored Glycine 0 C--O 1.227 -0.325 0 CA-C-N 113.579 -1.646 . . . . 41.51 114.174 172.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -121.68 123.99 43.19 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.274 -1.38 . . . . 70.31 107.274 162.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.94 104.77 16.81 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 118.483 -0.77 . . . . 73.22 111.41 -177.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.595 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.4 OUTLIER -166.73 64.31 0.09 Allowed 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 113.394 0.887 . . . . 64.1 113.394 178.48 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.479 ' HD3' ' SG ' ' A' ' 69' ' ' CYS . 0.0 OUTLIER -93.37 115.61 28.17 Favored 'General case' 0 C--O 1.212 -0.907 0 O-C-N 120.909 -1.12 . . . . 71.34 110.324 -173.94 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.5 t -128.25 117.85 46.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 107.757 -1.201 . . . . 62.23 107.757 168.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -151.73 140.97 21.38 Favored 'General case' 0 C--O 1.244 0.775 0 C-N-CA 119.833 -0.747 . . . . 72.42 112.309 -177.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.3 m -91.74 125.46 57.31 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 115.918 -0.583 . . . . 63.41 111.879 168.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.474 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 60.3 Cg_endo -84.59 13.5 2.73 Favored 'Trans proline' 0 CA--C 1.547 1.125 0 C-N-CA 122.363 2.042 . . . . 71.24 113.806 165.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.524 ' CD2' ' HB2' ' A' ' 8' ' ' SER . 1.8 p90 -101.66 -20.45 15.0 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.422 0.555 . . . . 74.33 112.191 176.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.494 1.729 0 C-N-CA 125.022 1.329 . . . . 61.41 112.661 -170.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.547 0.858 0 N-CA-C 112.704 0.631 . . . . 73.52 112.704 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.452 ' HD2' ' CE2' ' A' ' 50' ' ' PHE . 0.6 OUTLIER -136.27 159.7 40.94 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 122.825 0.45 . . . . 63.41 111.21 -173.344 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.1 mt -117.38 142.88 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.118 0.967 . . . . 71.22 108.531 -178.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -112.26 111.18 21.88 Favored 'General case' 0 C--N 1.349 0.58 0 N-CA-C 109.786 -0.449 . . . . 74.24 109.786 -177.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.2 m -123.95 108.08 20.0 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-O 121.946 0.879 . . . . 72.31 111.29 175.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -133.69 168.94 23.01 Favored Glycine 0 CA--C 1.518 0.261 0 N-CA-C 114.873 0.709 . . . . 64.1 114.873 -176.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.8 m120 58.36 21.43 8.32 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.838 1.255 . . . . 53.42 112.071 176.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -90.88 149.78 40.86 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 112.338 0.495 . . . . 71.53 112.338 -167.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 75' ' ' LYS . 24.5 Cg_endo -65.02 137.57 53.2 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 123.144 2.563 . . . . 71.33 112.868 176.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.1 p 73.77 -41.73 0.5 Allowed 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 126.61 1.964 . . . . 65.44 111.692 -173.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 68.41 117.34 0.03 OUTLIER 'General case' 0 C--N 1.365 1.25 0 C-N-CA 125.7 1.6 . . . . 70.45 111.052 -177.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.8 m -69.71 128.84 33.69 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 CA-C-N 114.646 -1.161 . . . . 64.21 110.564 177.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.1 m -83.15 169.14 16.14 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 114.364 -1.289 . . . . 72.32 108.787 176.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.2 m -57.17 -41.87 80.08 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.654 0.612 . . . . 71.52 112.654 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -64.83 -47.68 77.1 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.154 0.581 . . . . 74.34 111.321 178.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -67.77 -44.28 77.82 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 114.646 -1.161 . . . . 75.22 111.037 -174.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.534 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 9.0 p -70.46 -34.93 59.77 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 CA-C-O 118.99 -0.529 . . . . 43.02 110.036 177.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -61.06 -52.7 63.85 Favored 'General case' 0 C--O 1.212 -0.888 0 CA-C-O 118.745 -0.645 . . . . 54.13 110.524 178.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -73.0 -51.11 19.48 Favored 'General case' 0 C--O 1.27 2.158 0 CA-C-N 118.12 0.418 . . . . 64.42 111.622 -174.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -69.22 -44.01 72.93 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 115.467 -0.788 . . . . 72.12 110.457 -173.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.534 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 0.7 OUTLIER -76.85 -25.13 52.81 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 118.676 -0.678 . . . . 75.15 111.534 179.32 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 2.7 ptt85 -72.44 -22.99 61.01 Favored 'General case' 0 C--N 1.365 1.257 0 CA-C-N 119.429 1.013 . . . . 75.33 111.834 174.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -29.71 70.45 Favored 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 119.543 -0.863 . . . . 72.32 111.421 170.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -88.77 -37.23 15.61 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.563 0.579 . . . . 71.34 112.563 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 29' ' ' ARG . . . -154.74 171.83 33.13 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.501 -0.857 . . . . 73.15 112.587 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -82.0 113.09 19.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.571 0.701 . . . . 65.51 111.998 -175.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.86 126.4 43.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 114.803 -1.089 . . . . 71.41 110.586 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 26.2 mt -94.86 -43.11 8.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.488 -1.233 . . . . 70.0 109.568 178.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.05 153.33 33.77 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.491 0.316 . . . . 70.15 110.479 170.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 13.4 p -126.92 124.76 40.26 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.785 -0.45 . . . . 63.2 109.785 173.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -129.68 125.94 37.17 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-N 115.974 -0.557 . . . . 71.43 111.093 -176.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 72.1 t -112.08 123.02 67.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-O 121.041 0.448 . . . . 62.21 111.176 -174.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.13 161.32 22.0 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.069 -0.514 . . . . 71.3 110.869 -174.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.5 152.02 51.85 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 122.457 -0.152 . . . . 73.54 111.004 172.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.4 t -100.62 169.39 9.08 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 109.973 -0.38 . . . . 71.42 109.973 169.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.3 t -75.3 -15.45 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 C-N-CA 123.715 0.806 . . . . 73.3 111.259 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.3 m -75.88 -7.56 54.8 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.107 0.563 . . . . 44.05 112.175 -179.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.76 -4.74 53.53 Favored Glycine 0 C--N 1.341 0.844 0 C-N-CA 121.345 -0.455 . . . . 62.12 113.308 176.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.75 138.38 31.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.832 0.348 . . . . 75.01 110.791 178.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.44 147.93 38.54 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.741 -0.663 . . . . 62.13 110.546 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -136.22 165.91 24.64 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.187 0.517 . . . . 73.13 109.96 -171.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -141.35 139.72 33.6 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-N 115.328 -0.851 . . . . 61.23 109.96 171.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.452 ' CE2' ' HD2' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -114.43 118.69 34.52 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 113.996 -1.456 . . . . 75.31 107.263 -179.655 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.76 112.77 36.44 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.531 0 C-N-CA 119.556 -0.858 . . . . 73.33 111.151 -171.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -88.58 106.98 18.66 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-N 116.545 -0.298 . . . . 74.54 110.233 -170.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -114.27 143.46 44.82 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.58 -0.736 . . . . 74.33 112.021 -174.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -83.06 -28.38 29.61 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 120.558 -0.457 . . . . 73.34 111.83 172.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.61 126.68 49.66 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.864 0.84 . . . . 62.33 112.402 -178.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.41 -45.4 17.73 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 114.19 1.181 . . . . 73.04 114.19 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -75.31 -25.17 57.64 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.963 0.727 . . . . 73.21 112.963 -167.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -80.13 -34.73 37.55 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.505 0.669 . . . . 71.14 109.841 175.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.67 -24.09 65.38 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.785 1.234 . . . . 38.7 112.511 172.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.01 -25.0 60.53 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 114.572 1.323 . . . . 38.7 114.572 -174.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.21 -44.93 78.35 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 118.881 0.764 . . . . 51.1 111.483 173.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.36 -43.38 98.96 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 115.79 -0.641 . . . . 71.43 110.822 173.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.434 HD11 ' O ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -68.21 -32.3 55.26 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.003 0 CA-C-O 118.852 -0.594 . . . . 72.34 111.359 -179.38 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.62 -26.24 41.21 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.384 0.993 . . . . 75.02 112.341 177.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -81.81 -20.68 38.57 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 119.486 -0.886 . . . . 73.53 111.458 175.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -99.39 0.01 41.87 Favored 'General case' 0 CA--C 1.569 1.706 0 C-N-CA 120.189 -0.605 . . . . 73.11 111.335 172.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 35.0 t70 -70.42 154.83 41.47 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 125.695 1.598 . . . . 64.52 111.425 177.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.53 25.11 4.44 Favored Glycine 0 C--N 1.346 1.133 0 C-N-CA 119.637 -1.268 . . . . 61.33 112.058 -159.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.684 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 8.2 t -57.22 131.56 50.36 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 124.496 0.762 . . . . 74.51 111.837 -171.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.63 146.74 46.36 Favored 'General case' 0 C--O 1.252 1.22 0 CA-C-N 114.23 -1.35 . . . . 72.42 113.404 -170.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -143.58 147.8 34.95 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 126.116 1.766 . . . . 74.24 109.807 -173.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 76.3 66.71 0.06 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 122.686 1.232 . . . . 62.4 113.381 173.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.05 -11.71 63.96 Favored Glycine 0 C--N 1.337 0.638 0 CA-C-N 113.729 -1.578 . . . . 70.02 113.313 177.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -119.2 122.09 41.2 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 106.841 -1.54 . . . . 73.35 106.841 163.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.404 ' O ' ' HD3' ' A' ' 16' ' ' PRO . 0.5 OUTLIER -94.78 105.16 17.08 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 117.954 -1.022 . . . . 73.15 111.075 178.531 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.684 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -165.65 64.7 0.11 Allowed 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 115.283 1.586 . . . . 74.42 115.283 179.319 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.502 ' HA ' ' SG ' ' A' ' 69' ' ' CYS . 0.1 OUTLIER -95.34 113.64 25.33 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 121.8 2.091 . . . . 75.12 111.555 -176.199 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 95.3 t -131.52 120.76 46.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 121.22 -0.925 . . . . 74.23 109.474 174.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -149.14 141.99 24.67 Favored 'General case' 0 C--O 1.258 1.525 0 N-CA-C 113.66 0.985 . . . . 74.01 113.66 173.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.3 m -89.76 126.95 56.06 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-N 114.033 -1.44 . . . . 72.35 109.645 159.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -84.24 16.96 1.81 Allowed 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.658 2.238 . . . . 72.2 112.44 170.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -86.33 -30.02 22.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.042 -0.981 . . . . 75.3 110.544 177.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.482 1.142 0 O-C-N 124.824 1.328 . . . . 74.11 110.768 -173.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.3 p . . . . . 0 CA--C 1.53 0.194 0 N-CA-C 112.029 0.381 . . . . 73.25 112.029 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.485 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -138.01 158.43 44.35 Favored 'General case' 0 C--O 1.211 -0.948 0 CA-C-N 115.911 -0.586 . . . . 73.41 111.956 -175.903 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.6 mt -117.9 141.66 35.9 Favored 'Isoleucine or valine' 0 C--O 1.254 1.335 0 N-CA-C 109.842 -0.429 . . . . 73.15 109.842 174.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -108.25 119.41 39.41 Favored 'General case' 0 C--O 1.246 0.875 0 O-C-N 124.653 1.221 . . . . 74.34 109.148 178.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 3.6 p -123.14 110.39 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-O 121.918 0.866 . . . . 75.34 111.328 174.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -115.36 166.57 12.22 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-N 115.072 -0.967 . . . . 55.14 113.126 177.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 55.76 30.25 15.35 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.427 1.091 . . . . 74.32 113.083 175.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -89.16 140.44 28.85 Favored Pre-proline 0 C--O 1.237 0.42 0 CA-C-N 116.341 -0.39 . . . . 73.05 111.773 -172.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -72.05 142.5 38.47 Favored 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 122.527 2.151 . . . . 70.42 112.254 174.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.0 p 77.64 -32.84 0.18 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 127.351 2.26 . . . . 71.23 113.201 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 69.34 120.29 0.03 OUTLIER 'General case' 0 C--N 1.365 1.26 0 C-N-CA 124.869 1.268 . . . . 74.42 110.513 -174.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.8 m -74.87 126.32 35.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 CA-C-O 121.508 0.671 . . . . 72.44 109.479 173.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.54 ' HB2' ' OD2' ' A' ' 23' ' ' ASP . 19.2 m -81.97 160.68 23.27 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.951 -1.129 . . . . 72.22 107.951 177.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.2 p -60.68 -32.43 71.65 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.42 0.896 . . . . 62.12 113.42 -168.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.19 -38.61 51.17 Favored 'General case' 0 C--O 1.253 1.243 0 C-N-CA 123.844 0.858 . . . . 73.43 111.127 -178.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.54 ' OD2' ' HB2' ' A' ' 20' ' ' SER . 51.8 m-20 -67.28 -48.67 67.0 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 114.676 -1.147 . . . . 71.43 110.205 -179.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.458 HG12 ' SG ' ' A' ' 37' ' ' CYS . 9.3 p -69.73 -29.91 42.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 CA-C-N 114.482 -1.235 . . . . 52.21 110.57 177.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -57.75 -53.17 61.24 Favored 'General case' 0 C--N 1.359 1.001 0 CA-C-O 118.812 -0.614 . . . . 72.43 111.188 170.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -67.22 -48.07 68.92 Favored 'General case' 0 C--O 1.295 3.463 0 CA-C-O 122.127 0.965 . . . . 73.52 111.87 -178.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -58.93 -47.78 83.81 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-N 113.777 -1.556 . . . . 62.31 109.945 -175.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.469 ' HA ' ' CD1' ' A' ' 31' ' ' TYR . 14.9 m-85 -81.99 -15.76 52.63 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.092 0.775 . . . . 65.34 113.092 -179.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 23.4 mtp180 -60.4 -35.35 75.56 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 118.149 0.431 . . . . 64.53 110.446 164.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.74 -30.22 70.63 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 119.487 -0.885 . . . . 72.21 112.954 168.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.473 ' OH ' ' HE3' ' A' ' 66' ' ' LYS . 1.1 m-85 -77.65 -11.27 59.85 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 113.247 0.832 . . . . 74.43 113.247 -171.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 141.28 38.18 0.09 OUTLIER Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.125 -1.036 . . . . 37.61 113.102 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 60.4 95.98 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.895 1.278 . . . . 63.01 112.933 174.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.17 132.63 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 115.774 -0.648 . . . . 64.25 110.701 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.33 -28.62 12.87 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.432 -0.803 . . . . 71.03 109.844 174.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -142.72 129.26 20.2 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.444 -0.343 . . . . 73.4 110.478 -173.098 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.458 ' SG ' HG12 ' A' ' 24' ' ' VAL . 0.9 OUTLIER -127.73 113.47 16.04 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.624 -0.509 . . . . 52.24 109.624 175.089 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -128.12 124.02 35.89 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 120.393 -0.523 . . . . 73.12 110.747 -178.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 87.2 t -99.6 128.97 50.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 116.114 -0.493 . . . . 75.33 110.346 -177.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.426 ' HB2' ' HB2' ' A' ' 48' ' ' PHE . 71.6 mmtt -106.54 137.02 45.3 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.628 -0.714 . . . . 74.2 109.731 -178.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -130.75 126.15 35.68 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.843 -0.343 . . . . 65.35 110.6 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.0 t -101.04 164.95 11.56 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 120.915 0.388 . . . . 65.52 111.078 177.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.9 t -75.51 -14.08 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 C-N-CA 124.133 0.973 . . . . 73.24 110.872 178.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.2 m -75.52 -11.59 60.06 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.184 0.594 . . . . 73.45 112.401 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.63 -3.32 56.15 Favored Glycine 0 C--N 1.343 0.955 0 C-N-CA 121.343 -0.456 . . . . 53.24 113.743 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.16 143.72 26.89 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.507 0.67 . . . . 63.44 111.285 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.58 142.81 33.98 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.175 -0.92 . . . . 71.45 109.257 177.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.471 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 7.9 m-85 -137.13 153.31 50.54 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.11 -0.7 . . . . 73.33 109.11 178.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -137.38 139.51 40.79 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-O 121.332 0.587 . . . . 53.2 109.636 170.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -116.35 117.81 31.0 Favored 'General case' 0 C--O 1.252 1.193 0 CA-C-N 113.803 -1.544 . . . . 72.04 106.929 -179.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.485 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 3.1 mp -127.16 112.92 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 119.715 -0.794 . . . . 60.41 111.99 -170.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -107.42 107.53 18.45 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.607 -0.724 . . . . 71.32 111.918 -171.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -112.51 167.34 10.53 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 115.039 -0.982 . . . . 74.53 112.977 -177.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -82.3 -25.27 34.13 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 113.39 0.885 . . . . 74.21 113.39 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.5 121.57 39.72 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.388 0.994 . . . . 70.11 112.421 177.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -81.47 -45.63 15.73 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.294 -1.321 . . . . 75.11 114.563 -177.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.21 -23.59 51.4 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 112.533 0.568 . . . . 74.12 112.533 -171.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -75.28 -26.99 59.2 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.863 0.84 . . . . 73.53 110.142 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.15 -27.14 67.06 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 114.711 -1.131 . . . . 75.51 112.602 175.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.37 -30.53 68.48 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 114.607 1.336 . . . . 53.53 114.607 -171.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.517 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -67.89 -44.18 77.61 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 122.135 0.969 . . . . 74.1 112.21 176.858 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.51 -31.54 57.74 Favored 'General case' 0 C--O 1.253 1.284 0 CA-C-O 122.604 1.192 . . . . 75.2 111.38 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.421 ' O ' ' HB3' ' A' ' 67' ' ' ASP . 0.4 OUTLIER -70.48 -30.6 43.44 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.465 0 CA-C-O 118.456 -0.783 . . . . 73.25 109.714 174.562 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.517 ' HG3' ' O ' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -77.6 -20.93 53.13 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 119.611 1.096 . . . . 63.1 111.551 170.234 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.78 -27.02 63.6 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-O 118.481 -0.771 . . . . 74.45 111.67 170.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.473 ' HE3' ' OH ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -113.42 13.47 18.96 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 116.405 2.002 . . . . 71.23 116.405 166.129 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -73.2 158.21 35.66 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 123.989 0.915 . . . . 72.43 112.539 174.662 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 112.72 24.84 4.79 Favored Glycine 0 C--N 1.345 1.036 0 C-N-CA 120.215 -0.993 . . . . 72.05 111.522 -160.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 6.2 p -57.81 132.41 53.25 Favored 'General case' 0 C--N 1.352 0.699 0 CA-C-O 122.392 1.091 . . . . 74.31 112.248 -168.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -134.14 149.27 51.05 Favored 'General case' 0 C--O 1.263 1.763 0 CA-C-N 113.521 -1.672 . . . . 73.13 112.383 -166.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -143.8 146.34 33.02 Favored 'General case' 0 CA--C 1.557 1.246 0 CA-C-N 112.733 -2.03 . . . . 64.31 109.477 -175.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 75.12 66.86 0.07 Allowed 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 124.706 1.202 . . . . 72.54 114.057 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.55 -11.93 59.68 Favored Glycine 0 N--CA 1.464 0.53 0 CA-C-N 113.605 -1.634 . . . . 72.34 113.796 173.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -118.91 119.64 34.95 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 105.717 -1.957 . . . . 72.14 105.717 157.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.94 103.52 15.48 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 118.975 -0.536 . . . . 75.52 111.17 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.469 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 12.0 tp -168.78 73.79 0.1 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 118.094 0.406 . . . . 71.22 111.323 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.75 109.04 21.86 Favored 'General case' 0 C--O 1.206 -1.228 0 O-C-N 120.202 -1.562 . . . . 73.14 109.008 -175.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.0 t -133.03 125.83 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 O-C-N 121.243 -0.911 . . . . 62.4 109.593 176.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -150.15 163.63 37.72 Favored 'General case' 0 C--O 1.26 1.606 0 CA-C-O 122.6 1.19 . . . . 75.4 113.131 169.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.1 m -87.14 123.39 70.14 Favored Pre-proline 0 CA--C 1.555 1.164 0 CA-C-N 112.649 -2.068 . . . . 64.21 109.047 165.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.452 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 56.5 Cg_endo -85.04 10.36 3.78 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 121.798 1.665 . . . . 74.31 113.941 167.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -102.87 -60.75 1.5 Allowed 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 112.099 0.407 . . . . 75.2 112.099 175.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.6 t30 . . . . . 0 N--CA 1.487 1.418 0 C-N-CA 126.047 1.739 . . . . 73.15 112.355 -173.691 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.3 m . . . . . 0 N--CA 1.452 -0.348 0 CA-C-O 121.018 0.437 . . . . 74.14 110.382 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.609 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -140.56 156.29 46.34 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-N 115.654 -0.703 . . . . 74.5 112.147 -178.934 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.8 mt -113.43 137.91 44.88 Favored 'Isoleucine or valine' 0 C--O 1.258 1.534 0 N-CA-C 108.561 -0.903 . . . . 44.42 108.561 177.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -99.11 112.53 24.64 Favored 'General case' 0 C--N 1.363 1.196 0 O-C-N 126.456 2.347 . . . . 74.41 108.629 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.2 133.05 67.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 107.789 -1.189 . . . . 75.44 107.789 175.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -141.13 159.99 26.7 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 121.223 -0.513 . . . . 64.41 112.801 173.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.496 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 72.8 m-20 60.94 25.59 15.56 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.491 1.116 . . . . 51.12 112.953 171.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.58 146.62 44.58 Favored Pre-proline 0 CA--C 1.549 0.942 0 O-C-N 121.363 -0.836 . . . . 73.21 113.033 -163.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.28 151.7 43.71 Favored 'Trans proline' 0 C--N 1.361 1.234 0 C-N-CA 123.351 2.701 . . . . 61.14 113.407 174.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.5 p 74.6 -30.52 0.2 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 127.421 2.288 . . . . 73.03 113.422 -176.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 71.2 t60 67.47 106.12 0.05 OUTLIER 'General case' 0 C--N 1.359 0.999 0 C-N-CA 125.24 1.416 . . . . 75.41 110.872 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.7 m -82.59 131.06 34.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 CA-C-N 115.636 -0.711 . . . . 74.24 110.328 176.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.543 ' HB2' ' OD2' ' A' ' 23' ' ' ASP . 16.8 m -89.5 160.84 16.53 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-N 115.388 -0.824 . . . . 55.11 109.545 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.6 t -52.79 -43.37 65.83 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.932 0.893 . . . . 74.13 113.078 -174.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.08 -42.16 80.8 Favored 'General case' 0 C--O 1.25 1.085 0 C-N-CA 124.741 1.216 . . . . 73.01 112.36 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.543 ' OD2' ' HB2' ' A' ' 20' ' ' SER . 12.0 m-20 -66.72 -43.09 85.17 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.125 -0.943 . . . . 73.55 110.376 -178.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.474 ' CG1' HG12 ' A' ' 51' ' ' ILE . 39.1 t -64.19 -40.4 88.92 Favored 'Isoleucine or valine' 0 C--N 1.343 0.309 0 CA-C-N 115.082 -0.963 . . . . 71.02 110.088 174.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.497 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 10.9 tt0 -58.71 -49.95 75.71 Favored 'General case' 0 C--O 1.209 -1.049 0 CA-C-O 118.455 -0.783 . . . . 62.13 111.141 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.5 -46.43 22.48 Favored 'General case' 0 C--O 1.282 2.779 0 N-CA-C 113.686 0.995 . . . . 71.1 113.686 -178.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -59.32 -44.6 92.57 Favored 'General case' 0 C--N 1.36 1.037 0 CA-C-N 116.353 -0.385 . . . . 71.24 110.375 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 42.6 m-85 -80.62 -20.63 42.76 Favored 'General case' 0 C--O 1.211 -0.921 0 CA-C-O 117.929 -1.034 . . . . 74.15 112.869 176.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.497 ' HB3' ' O ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -66.61 -29.56 69.64 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 120.031 1.287 . . . . 74.41 111.671 172.544 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.86 -31.01 68.62 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 117.185 -1.806 . . . . 75.35 112.202 173.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.515 ' CD2' ' HB3' ' A' ' 62' ' ' ALA . 85.1 m-85 -87.36 -37.08 17.41 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.307 0.484 . . . . 73.04 112.307 -176.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -143.9 165.16 27.36 Favored Glycine 0 C--O 1.221 -0.669 0 N-CA-C 111.662 -0.575 . . . . 72.35 111.662 174.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -80.37 99.39 7.91 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 117.516 0.658 . . . . 63.12 110.579 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.84 132.57 31.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 121.884 0.849 . . . . 72.1 111.744 -171.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.0 mp -103.1 -38.44 7.3 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.212 -1.358 . . . . 74.51 111.371 -178.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.51 131.44 15.21 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 122.89 0.476 . . . . 45.21 110.487 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.8 m -121.26 124.33 44.36 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.836 -0.54 . . . . 75.31 110.667 171.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -128.44 132.86 48.44 Favored 'General case' 0 C--O 1.212 -0.911 0 CA-C-N 116.299 -0.41 . . . . 73.53 110.669 -178.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 p -119.19 120.15 62.93 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.173 0 CA-C-O 121.684 0.755 . . . . 43.43 111.077 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -108.56 157.84 18.11 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.703 -0.68 . . . . 74.53 110.625 -178.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.04 149.87 52.16 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 122.243 -0.285 . . . . 73.13 111.034 173.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.4 t -101.48 166.37 10.76 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 120.654 0.264 . . . . 63.44 110.339 172.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.9 t -75.32 -13.72 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 C-N-CA 124.224 1.01 . . . . 72.42 111.14 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.0 t -76.25 -12.42 60.08 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.063 0.545 . . . . 74.22 111.594 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.87 -3.7 41.79 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.25 -0.5 . . . . 75.04 113.667 177.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.99 152.74 21.52 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.064 0.459 . . . . 72.13 111.001 177.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.14 148.93 49.29 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.625 -0.716 . . . . 36.79 110.205 -177.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -134.61 149.41 50.57 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 109.458 -0.571 . . . . 64.4 109.458 -170.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -125.09 138.04 54.18 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.099 0.476 . . . . 54.1 110.648 174.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.52 118.65 34.35 Favored 'General case' 0 C--O 1.256 1.423 0 N-CA-C 107.975 -1.121 . . . . 74.25 107.975 173.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.609 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 3.7 mt -115.1 109.29 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 119.069 -1.052 . . . . 61.41 111.183 -174.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -109.09 104.88 14.15 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.975 0.893 . . . . 71.34 111.345 -171.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -117.58 171.88 7.72 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 114.693 -1.14 . . . . 75.44 113.315 -179.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -79.2 -37.07 39.15 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 114.908 -1.042 . . . . 74.54 111.618 168.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -116.19 117.55 30.35 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 122.179 0.99 . . . . 72.23 111.138 -171.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -84.31 -46.11 12.12 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 113.62 -1.627 . . . . 64.31 115.373 -174.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.8 tmm_? -75.07 -28.53 60.39 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 121.294 0.568 . . . . 63.2 111.913 -168.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -79.17 -25.86 42.76 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-O 121.469 0.652 . . . . 74.21 111.54 177.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.35 -23.76 61.18 Favored 'General case' 0 C--O 1.251 1.151 0 CA-C-O 122.291 1.043 . . . . 62.21 112.245 173.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.81 -22.25 23.79 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 114.593 -1.185 . . . . 73.21 113.856 173.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.469 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 0.4 OUTLIER -66.74 -43.04 85.24 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.82 0.819 . . . . 73.32 110.547 173.51 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.515 ' HB3' ' CD2' ' A' ' 31' ' ' TYR . . . -64.03 -43.02 96.86 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 114.696 -1.138 . . . . 72.35 110.659 173.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -66.82 -31.0 51.5 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.411 0 C-N-CA 120.202 -0.599 . . . . 64.41 111.477 178.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -80.18 -21.32 43.12 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.444 0.566 . . . . 72.41 112.172 176.927 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -85.38 -17.96 35.16 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 118.55 -1.26 . . . . 63.34 111.809 170.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 62' ' ' ALA . 67.4 mmtt -99.67 13.65 32.84 Favored 'General case' 0 CA--C 1.575 1.92 0 CA-C-O 121.622 0.725 . . . . 73.32 111.401 170.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -70.77 153.06 43.13 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 127.115 2.166 . . . . 72.4 114.329 -178.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 112.03 24.28 5.22 Favored Glycine 0 C--N 1.351 1.416 0 C-N-CA 120.268 -0.968 . . . . 72.1 114.53 -171.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 20.7 p -58.27 133.62 55.84 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 114.219 1.192 . . . . 73.24 114.219 -167.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.1 149.92 51.13 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-N 113.826 -1.534 . . . . 63.23 113.212 -168.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -143.5 149.38 37.42 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.442 1.897 . . . . 73.44 110.562 -171.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 74.34 64.87 0.08 Allowed 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 122.476 1.131 . . . . 72.14 113.466 174.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.94 -10.64 60.46 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 113.745 -1.57 . . . . 75.41 113.952 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -120.25 122.78 41.64 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.19 -1.411 . . . . 71.22 107.19 160.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.496 ' HB3' ' O ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -96.12 103.25 15.13 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 119.109 -0.472 . . . . 74.2 111.038 178.855 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 41.5 tp -162.29 69.84 0.28 Allowed 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 118.267 0.485 . . . . 71.23 112.01 177.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -97.86 113.14 24.88 Favored 'General case' 0 C--O 1.208 -1.097 0 O-C-N 119.451 -2.031 . . . . 74.45 109.703 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.8 t -130.1 120.48 49.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 107.893 -1.151 . . . . 62.3 107.893 171.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -149.01 141.33 24.12 Favored 'General case' 0 C--O 1.258 1.517 0 CA-C-O 123.075 1.417 . . . . 65.24 113.922 176.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.6 m -88.91 135.86 31.4 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 113.112 -1.858 . . . . 75.33 110.209 165.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -82.96 20.21 1.19 Allowed 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.19 1.927 . . . . 74.43 112.415 166.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -103.34 72.38 1.15 Allowed 'General case' 0 C--N 1.345 0.404 0 CA-C-O 121.828 0.823 . . . . 53.32 109.707 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 . . . . . 0 C--N 1.313 -1.006 0 CA-C-N 114.838 -1.074 . . . . 71.5 109.128 177.387 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.2 p . . . . . 0 CA--C 1.54 0.558 0 N-CA-C 110.555 -0.165 . . . . 74.03 110.555 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.496 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 0.3 OUTLIER -130.52 151.65 50.76 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.338 0.496 . . . . 60.31 112.338 -177.096 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.9 mp -121.13 132.33 70.8 Favored 'Isoleucine or valine' 0 C--O 1.247 0.95 0 N-CA-C 108.948 -0.76 . . . . 72.32 108.948 174.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -113.16 113.95 26.09 Favored 'General case' 0 C--O 1.244 0.813 0 O-C-N 124.21 0.944 . . . . 75.24 109.338 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 7.2 p -122.71 109.69 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 CA-C-O 122.503 1.144 . . . . 37.78 111.651 176.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -128.14 157.34 21.16 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-N 115.32 -0.855 . . . . 63.02 114.946 -174.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.427 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 15.3 m120 59.37 25.07 13.71 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.715 1.206 . . . . 70.14 111.944 175.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -88.37 151.2 48.23 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 112.511 0.559 . . . . 73.13 112.511 -167.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -64.43 144.2 84.7 Favored 'Trans proline' 0 C--N 1.364 1.382 0 C-N-CA 122.901 2.401 . . . . 74.34 112.227 172.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.5 p 73.53 -31.03 0.22 Allowed 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 127.316 2.246 . . . . 43.33 113.046 -176.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 64.78 86.74 0.12 Allowed 'General case' 0 C--N 1.361 1.071 0 C-N-CA 125.746 1.618 . . . . 74.31 110.156 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.2 p -69.18 133.74 31.35 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 CA-C-O 121.653 0.74 . . . . 75.13 110.521 -174.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.405 ' O ' HG22 ' A' ' 24' ' ' VAL . 25.5 m -90.46 169.33 11.14 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.358 -0.837 . . . . 54.54 110.207 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.3 p -61.82 -28.39 69.44 Favored 'General case' 0 C--O 1.21 -1.022 0 N-CA-C 113.509 0.929 . . . . 73.1 113.509 -175.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -71.85 -41.78 67.71 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 123.586 0.754 . . . . 62.14 111.852 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -73.68 -43.55 59.07 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.888 -0.597 . . . . 75.44 109.829 -172.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.405 HG22 ' O ' ' A' ' 20' ' ' SER . 2.2 m -68.62 -30.79 48.48 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.945 0 CA-C-O 118.179 -0.915 . . . . 75.14 111.175 170.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.0 -55.73 21.37 Favored 'General case' 0 C--O 1.195 -1.801 0 CA-C-O 118.003 -0.998 . . . . 72.53 109.094 172.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -73.84 -55.16 6.54 Favored 'General case' 0 C--O 1.276 2.462 0 C-N-CA 119.199 -1.001 . . . . 72.41 112.662 -175.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -76.64 -35.96 57.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.543 -0.753 . . . . 71.42 110.787 -168.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.31 -23.64 30.17 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 118.073 -0.965 . . . . 74.54 110.984 177.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.585 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 4.7 ptt85 -71.52 -22.94 61.71 Favored 'General case' 0 C--N 1.383 2.065 0 CA-C-N 120.193 1.36 . . . . 70.4 111.698 170.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.19 -33.5 67.54 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 119.005 -1.078 . . . . 63.21 110.91 169.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.511 ' CG ' ' HB3' ' A' ' 62' ' ' ALA . 90.0 m-85 -85.41 -38.02 19.16 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.327 0.492 . . . . 75.55 112.327 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.585 ' O ' ' HA ' ' A' ' 29' ' ' ARG . . . -152.62 143.9 10.86 Favored Glycine 0 C--O 1.22 -0.779 0 C-N-CA 121.045 -0.598 . . . . 64.32 111.67 178.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -66.9 117.73 9.4 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 123.718 0.305 . . . . 74.4 111.05 -172.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.36 122.92 35.55 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-O 122.045 0.926 . . . . 63.33 111.278 -174.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 50.0 mt -100.61 -36.19 9.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.937 -1.029 . . . . 62.42 109.431 177.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.84 139.39 21.58 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.682 -0.69 . . . . 74.4 109.545 -177.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 18.7 p -136.9 118.76 15.17 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.252 0.549 . . . . 74.32 110.497 173.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -129.26 144.83 51.37 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 115.589 -0.732 . . . . 44.25 109.623 -179.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 84.9 t -117.64 129.06 74.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 121.069 0.461 . . . . 74.34 110.365 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -106.08 135.32 47.75 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.117 -0.697 . . . . 71.32 109.117 -178.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.91 125.06 36.75 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.753 -0.379 . . . . 63.13 110.424 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.1 t -102.16 164.42 11.7 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.463 -0.335 . . . . 71.42 111.481 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.7 t -75.04 -13.46 15.35 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 C-N-CA 123.748 0.819 . . . . 75.14 110.913 178.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.8 t -75.65 -10.83 59.77 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.066 0.546 . . . . 65.43 111.542 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.42 -4.12 59.95 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 120.92 -0.657 . . . . 52.05 113.226 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.81 139.12 30.85 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.339 0.59 . . . . 74.44 111.135 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.84 142.12 35.29 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.274 -0.876 . . . . 37.78 109.54 177.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.43 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 8.8 m-85 -136.25 149.43 48.5 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.438 -0.949 . . . . 71.21 108.438 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -132.82 138.52 47.11 Favored 'General case' 0 C--O 1.248 1.012 0 N-CA-C 109.212 -0.662 . . . . 65.04 109.212 172.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -118.09 117.93 30.51 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.113 -1.403 . . . . 72.45 107.836 -176.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.94 112.51 27.59 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.468 0 C-N-CA 120.176 -0.609 . . . . 70.35 111.033 -171.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -98.51 114.52 26.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.922 0.391 . . . . 72.13 111.186 -176.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -107.88 166.37 10.76 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.511 -0.768 . . . . 61.23 111.451 -178.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -80.61 -35.08 34.56 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 120.318 -0.553 . . . . 74.51 110.921 172.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.71 124.28 45.84 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.929 0.871 . . . . 72.24 112.363 -171.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.53 -46.16 16.26 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 113.74 -1.573 . . . . 73.22 114.529 -176.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.59 -21.94 57.37 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 112.727 0.64 . . . . 74.12 112.727 -169.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.416 ' HB3' ' O ' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -78.57 -33.1 47.91 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 121.35 0.595 . . . . 73.2 110.807 174.852 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.96 -24.88 63.41 Favored 'General case' 0 C--O 1.25 1.083 0 C-N-CA 124.4 1.08 . . . . 62.14 112.162 174.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.65 -26.63 56.65 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.164 -0.926 . . . . 62.32 113.34 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.27 -39.2 78.53 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 117.84 0.291 . . . . 75.52 111.257 174.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.511 ' HB3' ' CG ' ' A' ' 31' ' ' TYR . . . -66.17 -42.54 88.82 Favored 'General case' 0 C--O 1.245 0.851 0 C-N-CA 122.844 0.457 . . . . 62.31 111.139 174.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.32 -29.05 37.6 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 119.771 -0.772 . . . . 73.03 111.024 178.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.96 -27.2 43.52 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.793 1.179 . . . . 73.33 112.438 174.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.49 -22.53 43.91 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 119.015 -1.074 . . . . 75.42 111.269 176.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -109.04 14.36 24.06 Favored 'General case' 0 CA--C 1.558 1.287 0 CA-C-O 121.35 0.595 . . . . 63.42 111.92 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -67.1 154.02 42.23 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 125.763 1.625 . . . . 71.34 110.902 169.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.15 21.75 5.81 Favored Glycine 0 C--N 1.343 0.931 0 C-N-CA 119.81 -1.186 . . . . 63.35 112.501 -162.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.657 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 14.3 p -59.81 132.03 52.72 Favored 'General case' 0 C--O 1.242 0.672 0 O-C-N 124.239 0.611 . . . . 62.01 111.888 -175.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.5 147.68 50.4 Favored 'General case' 0 C--O 1.254 1.315 0 CA-C-N 115.171 -0.922 . . . . 72.42 112.744 -169.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -143.16 146.34 33.63 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.335 1.854 . . . . 62.24 110.766 -173.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 74.16 67.56 0.09 Allowed 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 114.084 1.142 . . . . 75.32 114.084 177.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.67 -11.78 59.45 Favored Glycine 0 N--CA 1.462 0.415 0 CA-C-N 114.299 -1.319 . . . . 73.44 113.665 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -121.82 123.18 41.18 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.499 -1.297 . . . . 73.31 107.499 157.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.427 ' HB3' ' O ' ' A' ' 14' ' ' ASN . 0.3 OUTLIER -94.15 104.11 16.14 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 118.97 -0.538 . . . . 73.54 110.701 179.202 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.657 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -162.89 58.15 0.2 Allowed 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.438 1.273 . . . . 73.11 114.438 -175.228 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -95.27 113.83 25.55 Favored 'General case' 0 C--O 1.214 -0.774 0 CA-C-N 121.036 1.744 . . . . 73.4 110.838 -173.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.2 t -128.4 117.39 45.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 107.78 -1.192 . . . . 72.54 107.78 170.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -151.98 144.97 24.49 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.799 0.809 . . . . 74.03 111.625 176.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.7 m -89.06 124.83 64.1 Favored Pre-proline 0 C--N 1.317 -0.836 0 CA-C-N 115.81 -0.632 . . . . 71.42 111.077 170.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.496 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 57.8 Cg_endo -80.37 5.92 5.74 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.036 1.824 . . . . 74.42 114.047 169.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -87.37 -32.61 19.5 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 119.933 -0.707 . . . . 74.41 111.809 175.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 N--CA 1.486 1.356 0 C-N-CA 124.887 1.275 . . . . 74.42 112.27 -175.744 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.9 t . . . . . 0 CA--C 1.548 0.881 0 CA-C-O 120.417 0.151 . . . . 72.32 111.401 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.53 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 1.6 ptp180 -143.93 155.86 44.22 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 112.501 0.556 . . . . 63.42 112.501 -175.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 50' ' ' PHE . 6.7 mt -115.28 136.8 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 123.6 0.76 . . . . 74.54 109.896 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -105.63 117.6 34.44 Favored 'General case' 0 C--O 1.249 1.057 0 O-C-N 125.111 1.507 . . . . 63.54 109.728 177.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 59.4 t -119.68 109.51 26.46 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.055 0 CA-C-N 115.495 -0.775 . . . . 71.32 109.504 176.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -123.07 156.84 17.51 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.74 -0.743 . . . . 74.32 113.627 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.2 m120 59.11 32.42 22.12 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.029 0.932 . . . . 73.32 112.255 170.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -87.77 149.23 45.55 Favored Pre-proline 0 CA--C 1.543 0.707 0 N-CA-C 113.277 0.843 . . . . 74.21 113.277 -168.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -69.69 129.94 18.56 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 122.943 2.428 . . . . 73.24 112.647 172.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.7 p 48.3 101.62 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 125.949 1.7 . . . . 73.13 113.021 -169.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 38.0 p-80 -55.42 119.31 5.42 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.778 0.799 . . . . 65.52 112.218 -175.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.5 p -77.12 129.59 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 114.534 -1.212 . . . . 63.44 110.43 -175.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.3 m -83.6 165.75 18.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.401 -0.818 . . . . 73.02 110.207 -178.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 32.0 p -62.88 -28.2 69.88 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.723 0.809 . . . . 71.14 112.54 -174.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.06 -37.59 54.34 Favored 'General case' 0 C--O 1.253 1.249 0 CA-C-O 121.52 0.676 . . . . 75.14 110.809 -177.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -71.03 -44.42 65.86 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 114.652 -1.158 . . . . 75.03 110.564 -178.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.636 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 2.9 m -67.62 -31.52 52.86 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.872 0 CA-C-O 118.978 -0.534 . . . . 72.43 110.588 171.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.419 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 17.1 tt0 -58.41 -54.14 50.43 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 118.946 -0.55 . . . . 74.21 110.476 177.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -72.47 -54.02 10.47 Favored 'General case' 0 C--O 1.29 3.225 0 C-N-CA 119.829 -0.749 . . . . 52.14 112.512 -178.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -69.48 -44.58 70.86 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.676 -1.147 . . . . 74.21 109.689 -169.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.636 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 7.8 m-85 -77.95 -21.99 50.17 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-O 118.099 -0.953 . . . . 72.34 111.384 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.419 ' HB3' ' O ' ' A' ' 25' ' ' GLU . 3.6 ppt_? -68.44 -26.66 65.62 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 121.193 1.815 . . . . 71.25 111.402 171.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.48 -21.05 66.55 Favored 'General case' 0 CA--C 1.561 1.398 0 C-N-CA 118.304 -1.358 . . . . 71.52 112.442 169.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.434 ' OH ' ' HE3' ' A' ' 66' ' ' LYS . 5.2 m-30 -74.76 -37.22 62.52 Favored 'General case' 0 C--O 1.207 -1.173 0 N-CA-C 113.134 0.79 . . . . 73.04 113.134 -175.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 166.54 43.82 0.02 OUTLIER Glycine 0 N--CA 1.469 0.839 0 C-N-CA 118.943 -1.598 . . . . 64.11 114.061 -178.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.5 t30 62.05 99.28 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 125.217 1.407 . . . . 72.32 113.058 175.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.16 127.48 39.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 114.951 -1.022 . . . . 72.51 110.535 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -97.29 -32.25 12.0 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.536 -0.756 . . . . 73.35 109.932 176.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.01 132.15 15.38 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.001 -0.545 . . . . 62.52 109.697 -176.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.1 p -125.2 125.19 43.25 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 120.862 0.363 . . . . 64.31 110.041 172.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -129.41 130.99 46.67 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.825 -0.625 . . . . 73.31 110.144 -179.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.4 t -111.89 114.47 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.285 0.564 . . . . 72.53 110.035 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -107.12 139.93 40.76 Favored 'General case' 0 C--O 1.212 -0.915 0 CA-C-N 115.22 -0.9 . . . . 75.42 108.815 -178.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.83 148.22 52.54 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.313 0.96 . . . . 64.21 112.005 171.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.4 t -100.85 165.76 11.19 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 116.263 -0.426 . . . . 43.42 110.49 177.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.5 t -75.57 -11.47 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 C-N-CA 123.862 0.865 . . . . 73.23 110.937 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -76.46 -8.25 56.77 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 122.837 0.455 . . . . 65.41 111.63 178.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.83 -4.09 52.98 Favored Glycine 0 C--N 1.341 0.815 0 C-N-CA 121.248 -0.501 . . . . 54.21 112.869 175.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.89 135.24 33.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.994 0.426 . . . . 71.5 110.953 178.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.96 148.49 26.65 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.351 -0.841 . . . . 43.45 109.397 177.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.524 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 19.8 m-85 -136.13 153.21 51.35 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 123.641 0.588 . . . . 74.1 109.503 -176.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -136.0 137.86 41.66 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.997 -0.547 . . . . 74.14 109.62 174.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.435 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 0.4 OUTLIER -111.46 119.95 40.5 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 114.736 -1.12 . . . . 64.33 108.448 172.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.3 mp -123.87 113.92 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 119.997 -0.681 . . . . 71.52 111.145 -177.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -92.73 116.15 28.75 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.325 -0.852 . . . . 61.34 111.593 -169.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -109.84 152.94 25.11 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.782 1.03 . . . . 71.51 113.782 -177.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.41 -34.03 25.6 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 115.275 -0.875 . . . . 63.14 112.044 172.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -122.51 129.5 52.04 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.278 0.844 . . . . 74.41 113.278 -177.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.07 -45.99 31.32 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 113.98 -1.464 . . . . 63.1 114.339 -175.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.09 -25.23 52.05 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.324 0.861 . . . . 65.41 113.324 -170.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -76.47 -36.81 57.67 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.859 0.838 . . . . 72.32 109.331 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.65 -27.93 65.46 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 114.505 -1.225 . . . . 71.44 111.743 177.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.02 -35.45 69.28 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 114.227 1.195 . . . . 73.31 114.227 -176.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.545 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 0.5 OUTLIER -69.55 -40.51 76.79 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 122.122 0.963 . . . . 65.51 112.729 -179.437 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.544 ' O ' ' HG3' ' A' ' 65' ' ' GLU . . . -75.92 -36.48 59.39 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.674 -0.693 . . . . 73.2 110.598 178.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -68.83 -28.85 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 O-C-N 121.875 -0.516 . . . . 54.43 110.575 176.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.545 ' HG3' ' O ' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -78.86 -23.0 45.23 Favored 'General case' 0 C--N 1.354 0.803 0 CA-C-N 118.295 0.498 . . . . 71.21 111.833 169.874 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.544 ' HG3' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -69.45 -29.41 67.09 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 120.192 -0.603 . . . . 75.41 110.88 172.189 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.526 ' HD2' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -105.03 7.81 34.13 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 114.767 1.395 . . . . 74.52 114.767 169.033 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -70.1 152.9 43.81 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 123.444 0.698 . . . . 73.13 111.25 173.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.02 23.7 4.49 Favored Glycine 0 C--N 1.342 0.865 0 C-N-CA 119.532 -1.318 . . . . 73.3 112.327 -155.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.544 ' SG ' ' HA ' ' A' ' 77' ' ' ARG . 6.1 t -55.81 136.75 51.03 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.815 0.846 . . . . 65.43 112.059 -178.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -123.82 146.16 48.56 Favored 'General case' 0 C--O 1.249 1.056 0 CA-C-N 114.808 -1.087 . . . . 72.4 112.928 -169.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -142.61 145.78 33.87 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 112.14 -2.3 . . . . 74.22 110.298 -173.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 73.24 66.87 0.1 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 114.302 1.223 . . . . 74.51 114.302 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.67 -12.6 59.56 Favored Glycine 0 C--N 1.335 0.474 0 CA-C-N 114.148 -1.387 . . . . 73.33 114.258 171.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -123.22 120.49 33.31 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 106.483 -1.673 . . . . 74.43 106.483 157.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.1 116.08 28.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 119.579 -0.248 . . . . 73.42 111.319 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -157.91 81.33 0.86 Allowed 'General case' 0 C--O 1.208 -1.107 0 N-CA-C 112.356 0.502 . . . . 72.41 112.356 178.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.544 ' HA ' ' SG ' ' A' ' 69' ' ' CYS . 7.4 tpp85 -97.85 113.26 25.02 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.576 1.08 . . . . 74.25 110.165 -178.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -133.22 115.88 24.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.662 -0.699 . . . . 64.03 109.441 169.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.18 155.09 36.02 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-O 121.802 0.811 . . . . 75.42 112.724 175.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 31.0 m -90.6 123.38 65.37 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 114.824 -1.08 . . . . 71.51 110.764 166.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.53 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 73.8 Cg_endo -88.17 9.15 3.84 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 122.061 1.84 . . . . 74.1 112.576 164.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -97.05 -13.28 22.35 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 120.576 -0.45 . . . . 70.34 111.887 176.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.3 m120 . . . . . 0 N--CA 1.485 1.29 0 O-C-N 124.872 1.358 . . . . 71.42 111.948 -172.484 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.045 0 N-CA-C 111.911 -0.476 . . . . 72.43 111.911 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 13.9 p -158.4 101.43 1.7 Allowed 'General case' 0 C--O 1.242 0.669 0 CA-C-O 121.192 0.52 . . . . 73.42 110.931 178.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . 0.519 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 0.8 OUTLIER -149.07 -174.54 4.67 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 118.791 -0.623 . . . . 74.35 109.407 179.309 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.519 ' SD ' ' HB3' ' A' ' 0' ' ' HIS . 2.7 mpt? 70.75 148.3 0.08 Allowed 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 124.96 1.304 . . . . 63.1 113.743 172.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.0 m -134.34 162.37 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 115.643 -0.708 . . . . 73.5 111.058 177.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.1 tt -153.69 121.24 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 CA-C-O 120.906 0.384 . . . . 73.14 110.664 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -114.56 46.52 1.37 Allowed 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.837 -0.539 . . . . 72.43 112.368 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -157.87 21.24 0.26 Allowed 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 109.866 -0.42 . . . . 63.21 109.866 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.6 t -127.43 178.68 5.92 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.991 -0.443 . . . . 71.23 110.108 -177.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -133.53 105.29 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.915 0 N-CA-C 107.158 -1.423 . . . . 65.32 107.158 177.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.65 119.57 27.04 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.163 -0.926 . . . . 73.52 110.451 -174.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.21 158.5 44.26 Favored 'General case' 0 N--CA 1.509 2.518 0 CA-C-O 118.666 -0.683 . . . . 63.41 112.163 -177.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.2 mt -117.66 143.0 29.37 Favored 'Isoleucine or valine' 0 C--N 1.371 1.518 0 N-CA-C 107.258 -1.386 . . . . 71.22 107.258 -176.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -104.95 113.23 26.7 Favored 'General case' 0 CA--C 1.564 1.499 0 CA-C-O 117.996 -1.002 . . . . 74.24 111.413 -176.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.2 m -127.24 107.45 16.85 Favored 'Isoleucine or valine' 0 C--N 1.376 1.728 0 CA-C-N 121.166 1.803 . . . . 72.31 110.309 178.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.426 ' H ' ' HG3' ' A' ' 77' ' ' ARG . . . -134.7 -179.05 16.1 Favored Glycine 0 N--CA 1.485 1.941 0 O-C-N 120.86 -1.15 . . . . 64.1 113.987 -174.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.4 m120 49.72 23.22 0.94 Allowed 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 113.875 1.065 . . . . 53.42 113.875 -178.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -91.14 141.59 26.51 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.236 1.014 . . . . 71.53 110.561 -167.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -64.46 133.55 37.77 Favored 'Trans proline' 0 C--N 1.365 1.404 0 C-N-CA 122.367 2.045 . . . . 71.33 111.807 177.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.5 p 82.13 -39.67 0.11 Allowed 'General case' 0 C--N 1.379 1.859 0 C-N-CA 126.73 2.012 . . . . 65.44 112.053 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 67.19 117.58 0.03 OUTLIER 'General case' 0 C--N 1.357 0.926 0 C-N-CA 125.278 1.431 . . . . 70.45 110.999 -173.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.8 m -71.82 116.3 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.594 2.643 0 N-CA-C 107.312 -1.366 . . . . 64.21 107.312 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -79.25 155.8 28.4 Favored 'General case' 0 C--N 1.38 1.908 0 O-C-N 120.789 -1.194 . . . . 72.32 110.727 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 69.9 m -48.81 -43.34 38.19 Favored 'General case' 0 C--N 1.381 1.963 0 N-CA-C 115.911 1.819 . . . . 71.52 115.911 -173.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.99 -47.52 71.35 Favored 'General case' 0 CA--C 1.589 2.445 0 N-CA-C 113.865 1.061 . . . . 74.34 113.865 174.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -72.88 -35.97 67.25 Favored 'General case' 0 C--N 1.361 1.072 0 CA-C-O 119.089 -0.482 . . . . 75.22 112.286 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.488 ' O ' ' HB2' ' A' ' 28' ' ' PHE 0.262 1.7 p -69.41 -44.12 80.38 Favored 'Isoleucine or valine' 0 C--N 1.36 1.025 0 CA-C-O 118.107 -0.949 . . . . 43.02 110.683 176.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.482 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 22.1 tt0 -49.12 -60.44 2.79 Favored 'General case' 0 N--CA 1.507 2.405 0 CA-C-O 116.809 -1.567 . . . . 54.13 112.165 165.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -70.21 -61.82 1.63 Allowed 'General case' 0 C--O 1.303 3.912 0 CA-C-N 121.467 1.94 . . . . 64.42 114.417 -173.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -70.42 -34.34 72.39 Favored 'General case' 0 C--N 1.369 1.421 0 CA-C-O 117.111 -1.423 . . . . 72.12 112.622 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.488 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 1.2 m-85 -77.57 -35.82 52.7 Favored 'General case' 0 C--N 1.364 1.23 0 CA-C-N 121.939 2.154 . . . . 75.15 112.271 177.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.482 ' HB3' ' O ' ' A' ' 25' ' ' GLU . 5.2 ptt85 -53.21 -28.51 27.28 Favored 'General case' 0 N--CA 1.509 2.513 0 CA-C-O 115.87 -2.014 . . . . 75.33 115.338 166.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.63 -47.04 73.94 Favored 'General case' 0 N--CA 1.522 3.142 0 CA-C-N 123.485 2.857 . . . . 72.32 111.666 167.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.453 ' HB3' ' HA ' ' A' ' 59' ' ' ALA . 94.6 m-85 -76.39 -38.26 55.96 Favored 'General case' 0 CA--C 1.554 1.103 0 CA-C-O 118.302 -0.856 . . . . 71.34 112.532 -166.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -148.94 -175.43 21.39 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-N 120.001 1.273 . . . . 73.15 111.605 170.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -99.48 98.77 9.64 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 119.23 -0.988 . . . . 65.51 109.362 -166.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.49 134.6 29.17 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.409 0 N-CA-C 113.761 1.023 . . . . 71.41 113.761 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.46 -26.36 11.47 Favored 'General case' 0 CA--C 1.562 1.407 0 N-CA-C 110.092 -0.336 . . . . 70.0 110.092 172.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.8 pttm -153.92 153.82 32.72 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.528 0.731 . . . . 70.15 110.121 168.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -139.52 105.47 5.19 Favored 'General case' 0 C--N 1.356 0.873 0 N-CA-C 108.13 -1.063 . . . . 63.2 108.13 175.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -112.45 144.5 41.8 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 118.864 -1.135 . . . . 71.43 114.054 -176.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 69.4 t -97.09 113.93 32.75 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 N-CA-C 108.837 -0.801 . . . . 62.21 108.837 175.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -115.28 131.37 56.95 Favored 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 107.948 -1.13 . . . . 71.3 107.948 175.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.44 141.52 51.38 Favored 'General case' 0 CA--C 1.564 1.492 0 CA-C-N 121.8 2.091 . . . . 73.54 108.354 -170.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.426 HG21 ' H ' ' A' ' 44' ' ' SER . 6.4 t -100.81 173.51 6.48 Favored 'General case' 0 CA--C 1.565 1.539 0 CA-C-N 120.853 1.66 . . . . 71.42 111.977 -178.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.9 t -75.74 -9.3 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.305 0 C-N-CA 123.749 0.819 . . . . 73.3 112.377 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.426 ' H ' HG21 ' A' ' 42' ' ' THR . 0.8 OUTLIER -89.19 7.66 34.14 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 121.705 -0.622 . . . . 44.05 110.499 -175.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.54 -5.09 75.47 Favored Glycine 0 C--N 1.347 1.178 0 N-CA-C 115.436 0.934 . . . . 62.12 115.436 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.09 131.95 34.75 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 118.022 0.911 . . . . 75.01 110.031 176.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -105.63 146.26 29.93 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 109.393 -0.595 . . . . 62.13 109.393 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -129.3 148.75 51.25 Favored 'General case' 0 C--N 1.347 0.496 0 N-CA-C 108.942 -0.762 . . . . 73.13 108.942 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -121.29 135.57 55.09 Favored 'General case' 0 C--O 1.247 0.964 0 C-N-CA 119.855 -0.738 . . . . 61.23 110.257 168.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -108.92 122.15 46.62 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 114.048 -1.433 . . . . 75.31 108.229 -172.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.92 108.6 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 C-N-CA 118.953 -1.099 . . . . 73.33 109.975 -165.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -89.27 103.99 16.57 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 120.508 -0.477 . . . . 74.54 110.905 -171.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -113.22 142.33 45.93 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 113.645 0.98 . . . . 74.33 113.645 -172.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -82.81 -34.5 26.94 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.742 -0.783 . . . . 73.34 112.565 172.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -117.75 120.25 37.38 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 108.991 -0.744 . . . . 62.33 108.991 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.411 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -77.87 -38.37 46.15 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 115.425 1.639 . . . . 73.04 115.425 167.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -60.21 -40.11 88.97 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 113.593 0.96 . . . . 73.21 113.593 -168.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -69.53 -49.18 56.87 Favored 'General case' 0 CA--C 1.582 2.18 0 N-CA-C 114.835 1.42 . . . . 71.14 114.835 169.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.453 ' HA ' ' HB3' ' A' ' 31' ' ' TYR . . . -52.76 -21.63 4.35 Favored 'General case' 0 CA--C 1.587 2.37 0 N-CA-C 115.541 1.682 . . . . 38.7 115.541 172.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.472 ' O ' ' HG3' ' A' ' 64' ' ' LYS . . . -47.01 -34.61 5.81 Favored 'General case' 0 CA--C 1.561 1.383 0 CA-C-O 116.269 -1.824 . . . . 38.7 114.565 173.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.42 ' O ' ' HB3' ' A' ' 65' ' ' GLU . 29.3 m-20 -52.5 -53.89 39.87 Favored 'General case' 0 N--CA 1.51 2.539 0 CA-C-N 121.517 1.962 . . . . 51.1 111.835 168.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.08 -43.54 95.11 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 118.504 0.593 . . . . 71.43 111.809 178.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.435 HD12 HG13 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -67.37 -39.61 83.06 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.415 0 C-N-CA 118.748 -1.181 . . . . 72.34 113.458 -174.454 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -65.92 -32.58 74.16 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.813 1.042 . . . . 75.02 113.813 167.492 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 61' ' ' ASP . 0.6 OUTLIER -76.95 -17.1 59.12 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.059 0.391 . . . . 73.53 111.196 -176.19 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt -109.78 12.01 24.18 Favored 'General case' 0 CA--C 1.577 1.984 0 CA-C-O 119.742 -0.171 . . . . 73.11 111.056 169.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.45 ' HB3' ' HA ' ' A' ' 64' ' ' LYS 0.373 0.0 OUTLIER -78.45 159.63 28.16 Favored 'General case' 0 N--CA 1.506 2.344 0 C-N-CA 123.664 0.786 . . . . 64.52 112.406 -176.028 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.55 29.55 2.24 Favored Glycine 0 N--CA 1.439 -1.166 0 CA-C-O 117.819 -1.545 . . . . 61.33 114.406 -161.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.804 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 18.2 t -49.63 126.16 13.03 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-N 118.314 1.057 . . . . 74.51 112.125 -175.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.53 145.47 47.08 Favored 'General case' 0 C--O 1.251 1.172 0 CA-C-N 113.208 -1.814 . . . . 72.42 112.464 -172.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -147.8 147.36 29.75 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 105.947 -1.872 . . . . 74.24 105.947 -168.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 72.35 63.03 0.12 Allowed 'General case' 0 N--CA 1.483 1.175 0 CA-C-O 122.347 1.07 . . . . 62.4 112.995 176.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 97.5 -13.92 63.77 Favored Glycine 0 N--CA 1.471 0.998 0 N-CA-C 116.632 1.413 . . . . 70.02 116.632 172.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -113.23 121.19 43.72 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 105.1 -2.185 . . . . 73.35 105.1 156.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.49 102.8 14.65 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 117.438 -1.268 . . . . 73.15 109.826 -173.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.804 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -162.94 72.53 0.32 Allowed 'General case' 0 N--CA 1.512 2.672 0 CA-C-N 121.328 1.876 . . . . 74.42 115.668 178.834 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.426 ' HG3' ' H ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -96.6 118.03 32.23 Favored 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 123.769 2.986 . . . . 75.12 111.702 -175.319 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.0 t -131.78 119.4 41.6 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.772 0 O-C-N 120.189 -1.569 . . . . 74.23 108.056 172.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -146.99 134.57 20.96 Favored 'General case' 0 C--N 1.384 2.107 0 CA-C-N 121.088 1.767 . . . . 74.01 112.841 -172.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.435 HG13 HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -93.12 126.54 50.62 Favored Pre-proline 0 N--CA 1.45 -0.467 0 CA-C-N 114.197 -1.365 . . . . 72.35 112.095 169.901 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -85.85 25.5 0.69 Allowed 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 122.147 1.898 . . . . 72.2 111.842 165.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.411 ' CD2' ' HB2' ' A' ' 56' ' ' ALA . 9.2 m-85 -110.95 -28.13 8.48 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 115.595 -0.73 . . . . 75.3 110.161 176.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 53.77 54.4 9.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 124.75 1.281 . . . . 74.11 112.145 -172.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 68.96 -3.44 1.47 Allowed 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 125.224 1.41 . . . . 74.14 114.135 -175.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 76.12 133.76 0.05 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 125.281 1.613 . . . . 74.31 110.047 -173.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 . . . . . 0 C--O 1.25 1.082 0 CA-C-N 115.575 -0.739 . . . . 64.33 109.055 -175.891 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.84 0 N-CA-C 111.651 -0.58 . . . . 36.67 111.651 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 8.7 t -155.76 145.46 21.2 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 110.13 -0.322 . . . . 75.12 110.13 176.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -137.25 156.53 48.17 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.684 -0.858 . . . . 73.15 108.684 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 mpp? -127.92 14.24 6.85 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.128 0.49 . . . . 72.33 110.832 174.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.6 m -123.72 -173.89 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 109.33 -0.619 . . . . 74.54 109.33 -177.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 55.4 mt 69.89 77.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 O-C-N 124.415 1.072 . . . . 73.4 109.642 177.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.28 88.56 6.52 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-N 115.592 -0.731 . . . . 75.12 110.387 177.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 175.94 173.21 0.34 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.29 1.036 . . . . 65.33 108.713 -172.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.0 m 75.32 -157.67 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.403 1.081 . . . . 70.31 110.386 -178.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.0 p -153.5 135.48 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-O 120.997 0.427 . . . . 73.45 109.889 -175.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.23 128.11 34.21 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.924 -0.58 . . . . 74.35 109.649 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.567 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -140.49 159.84 41.3 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 118.633 -0.698 . . . . 73.21 112.322 -178.783 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.425 ' CD1' HG13 ' A' ' 63' ' ' ILE . 4.5 mt -114.04 138.73 42.93 Favored 'Isoleucine or valine' 0 C--O 1.264 1.855 0 CA-C-N 119.927 1.24 . . . . 53.42 107.725 170.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -102.79 114.53 28.86 Favored 'General case' 0 CA--C 1.561 1.401 0 O-C-N 125.903 2.002 . . . . 64.3 109.399 172.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.1 p -125.58 106.04 15.62 Favored 'Isoleucine or valine' 0 C--N 1.37 1.475 0 CA-C-N 120.62 1.555 . . . . 73.0 109.322 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -115.31 168.32 12.57 Favored Glycine 0 C--N 1.354 1.549 0 C-N-CA 120.687 -0.768 . . . . 64.11 112.274 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.0 m120 50.79 24.92 1.91 Allowed 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 114.617 1.34 . . . . 70.25 114.617 -177.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -75.69 136.2 70.96 Favored Pre-proline 0 C--O 1.239 0.522 0 C-N-CA 123.335 0.654 . . . . 61.24 110.709 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -73.71 126.35 10.71 Favored 'Trans proline' 0 CA--C 1.553 1.468 0 C-N-CA 121.422 1.414 . . . . 71.11 111.685 175.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.5 t 60.33 100.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.005 0.922 . . . . 73.13 111.129 -174.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 -64.79 132.9 50.79 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.086 -0.506 . . . . 72.42 111.789 -177.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.7 m -66.02 121.43 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.895 0 CA-C-N 114.557 -1.201 . . . . 72.43 109.614 -176.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.84 154.06 28.66 Favored 'General case' 0 C--N 1.377 1.768 0 CA-C-N 119.212 0.914 . . . . 64.4 110.576 -176.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.9 p -47.18 -48.09 23.88 Favored 'General case' 0 C--N 1.375 1.699 0 N-CA-C 116.036 1.865 . . . . 72.32 116.036 -174.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.19 -46.46 75.84 Favored 'General case' 0 C--O 1.285 2.93 0 N-CA-C 114.41 1.263 . . . . 52.24 114.41 175.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -64.34 -35.45 80.9 Favored 'General case' 0 C--N 1.372 1.545 0 CA-C-O 118.002 -0.999 . . . . 74.22 110.142 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.522 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 1.2 t -66.82 -44.43 89.11 Favored 'Isoleucine or valine' 0 C--N 1.385 2.139 0 CA-C-O 116.552 -1.689 . . . . 72.11 110.722 174.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.01 -56.15 24.17 Favored 'General case' 0 C--N 1.373 1.602 0 CA-C-N 120.641 1.564 . . . . 72.35 110.747 177.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.553 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 12.9 m-80 -81.33 -57.01 3.68 Favored 'General case' 0 C--O 1.294 3.418 0 CA-C-N 122.156 2.253 . . . . 74.44 116.364 -176.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -68.36 -26.99 65.86 Favored 'General case' 0 C--N 1.354 0.777 0 C-N-CA 119.566 -0.854 . . . . 54.42 111.218 -175.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.522 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 35.7 m-85 -90.98 -22.55 20.77 Favored 'General case' 0 CA--C 1.565 1.544 0 C-N-CA 118.337 -1.345 . . . . 73.41 114.222 173.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.553 ' HG3' ' O ' ' A' ' 26' ' ' ASN 0.259 2.5 ppt_? -54.27 -28.34 41.12 Favored 'General case' 0 N--CA 1.503 2.218 0 CA-C-N 120.161 1.346 . . . . 74.54 112.285 163.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.562 ' O ' ' HD2' ' A' ' 30' ' ' LYS 0.257 1.7 tptm -52.03 -28.63 17.88 Favored 'General case' 0 N--CA 1.518 2.946 0 C-N-CA 118.445 -1.302 . . . . 64.25 113.742 168.433 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -80.22 -44.17 20.18 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 120.023 1.283 . . . . 63.0 111.488 -166.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -169.24 44.28 0.21 Allowed Glycine 0 C--N 1.341 0.859 0 C-N-CA 117.712 -2.185 . . . . 72.01 114.45 162.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 60.38 87.33 0.09 Allowed 'General case' 0 C--N 1.359 1.005 0 C-N-CA 123.983 0.913 . . . . 74.43 109.9 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.36 138.45 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-N 114.976 -1.011 . . . . 70.43 112.471 -178.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.31 -26.49 12.92 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 109.63 -0.507 . . . . 72.15 109.63 173.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp -149.66 137.36 20.17 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-O 118.826 -0.606 . . . . 65.32 109.889 -173.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -140.84 110.06 6.22 Favored 'General case' 0 C--N 1.364 1.226 0 CA-C-N 119.564 1.075 . . . . 71.14 109.268 176.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -109.13 146.59 33.84 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 117.762 -1.575 . . . . 73.33 112.847 177.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.8 t -114.27 110.6 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 106.317 -1.735 . . . . 74.52 106.317 176.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.0 mttm -121.45 137.25 54.8 Favored 'General case' 0 CA--C 1.563 1.446 0 CA-C-O 118.909 -0.567 . . . . 73.13 110.301 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.97 143.92 50.9 Favored 'General case' 0 C--N 1.371 1.516 0 CA-C-N 120.437 1.471 . . . . 64.1 108.122 -168.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.429 HG21 ' H ' ' A' ' 44' ' ' SER . 6.4 t -99.98 172.1 7.43 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-N 120.683 1.583 . . . . 71.22 110.941 -178.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.8 t -75.37 -9.95 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.208 0 C-N-CA 123.502 0.721 . . . . 64.04 112.077 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.429 ' H ' HG21 ' A' ' 42' ' ' THR . 0.8 OUTLIER -89.27 7.57 34.85 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 121.735 -0.603 . . . . 74.03 110.24 -177.307 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.73 -4.63 78.43 Favored Glycine 0 CA--C 1.537 1.417 0 N-CA-C 115.952 1.141 . . . . 61.34 115.952 178.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.94 131.79 33.99 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 118.429 1.115 . . . . 61.33 109.903 176.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.93 146.89 28.4 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 108.606 -0.887 . . . . 61.41 108.606 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -127.49 146.84 50.36 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 119.211 -0.995 . . . . 74.35 108.555 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -121.4 139.08 53.91 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 119.486 -0.886 . . . . 51.23 110.295 172.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -125.28 117.14 23.15 Favored 'General case' 0 C--O 1.263 1.803 0 N-CA-C 106.864 -1.532 . . . . 72.55 106.864 -167.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.33 113.12 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 114.351 1.241 . . . . 74.05 114.351 -163.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -90.21 108.81 19.98 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 115.002 -0.999 . . . . 70.4 112.604 -171.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -108.51 155.61 20.43 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 112.145 0.424 . . . . 73.21 112.145 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -81.72 -26.36 34.66 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 113.809 1.04 . . . . 70.12 113.809 173.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.48 120.89 39.49 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 119.208 0.913 . . . . 42.3 110.328 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.91 -35.87 59.64 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 114.773 1.397 . . . . 71.42 114.773 172.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.27 0.0 OUTLIER -80.71 -30.0 36.38 Favored 'General case' 0 CA--C 1.564 1.5 0 CA-C-N 120.828 1.649 . . . . 70.5 113.435 -167.144 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -62.21 -50.57 71.27 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-N 118.85 0.75 . . . . 74.34 112.521 175.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.0 -25.53 21.53 Favored 'General case' 0 CA--C 1.57 1.712 0 N-CA-C 116.369 1.989 . . . . 72.45 116.369 177.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.73 -43.05 57.9 Favored 'General case' 0 CA--C 1.581 2.171 0 C-N-CA 125.482 1.513 . . . . 72.11 114.231 178.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -53.54 -48.14 69.34 Favored 'General case' 0 N--CA 1.518 2.944 0 CA-C-N 119.654 1.116 . . . . 75.32 113.771 169.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.634 ' O ' ' HD2' ' A' ' 66' ' ' LYS . . . -72.19 -32.91 67.25 Favored 'General case' 0 C--N 1.31 -1.131 0 O-C-N 120.786 -1.197 . . . . 60.02 111.777 179.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.425 HG13 ' CD1' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -73.33 -41.04 57.51 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.053 0 CA-C-O 117.247 -1.358 . . . . 73.35 112.141 -177.264 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.48 -34.0 70.41 Favored 'General case' 0 CA--C 1.557 1.219 0 CA-C-N 120.505 1.502 . . . . 71.24 114.285 161.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.54 -23.89 66.98 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 120.816 1.644 . . . . 64.45 112.773 175.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.634 ' HD2' ' O ' ' A' ' 62' ' ' ALA 0.283 0.0 OUTLIER -110.48 16.89 21.29 Favored 'General case' 0 N--CA 1.514 2.738 0 N-CA-C 117.1 2.259 . . . . 72.25 117.1 160.64 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.418 0.0 OUTLIER -79.72 160.03 26.41 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 120.016 1.28 . . . . 71.15 113.945 -176.381 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.14 29.33 2.38 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 119.095 -1.526 . . . . 36.67 114.593 -158.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.773 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -53.06 125.95 19.01 Favored 'General case' 0 C--N 1.37 1.472 0 CA-C-N 117.268 0.534 . . . . 54.33 111.19 -178.195 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -131.23 150.76 52.01 Favored 'General case' 0 C--O 1.259 1.6 0 CA-C-N 115.63 -0.713 . . . . 70.23 112.018 -174.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -147.59 146.66 29.47 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 127.872 2.469 . . . . 70.33 107.508 -168.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 73.22 62.54 0.1 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.975 0.893 . . . . 42.11 112.844 -176.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.44 -13.19 61.5 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 117.157 1.623 . . . . 51.15 117.157 169.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -112.79 122.23 47.04 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 106.947 -1.501 . . . . 55.45 106.947 154.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.93 103.52 15.39 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 117.719 -1.134 . . . . 60.25 109.433 -175.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.773 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 14.3 tp -165.92 66.97 0.11 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 120.651 1.569 . . . . 54.33 112.485 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -96.54 110.83 23.15 Favored 'General case' 0 CA--C 1.569 1.704 0 CA-C-N 122.584 2.447 . . . . 74.25 109.733 -173.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.484 ' H ' ' HB3' ' A' ' 69' ' ' CYS . 22.6 t -123.48 115.54 45.69 Favored 'Isoleucine or valine' 0 C--N 1.358 0.967 0 O-C-N 120.577 -1.327 . . . . 74.34 107.806 170.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -138.7 143.12 38.98 Favored 'General case' 0 C--O 1.254 1.298 0 CA-C-N 120.574 1.533 . . . . 53.21 111.317 176.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.8 m -88.01 122.28 70.12 Favored Pre-proline 0 N--CA 1.437 -1.11 0 CA-C-N 114.622 -1.172 . . . . 72.44 111.412 168.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.567 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 61.2 Cg_endo -91.76 32.98 0.29 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.67 2.247 . . . . 63.22 111.447 159.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.3 10.62 5.33 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 112.58 0.585 . . . . 74.24 112.58 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -79.31 69.92 5.62 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 123.174 0.296 . . . . 65.23 111.427 -167.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -170.44 40.11 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.014 0.926 . . . . 64.24 109.785 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.5 ttt-85 67.04 -75.28 0.06 Allowed 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 125.805 1.642 . . . . 70.23 113.879 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 . . . . . 0 C--O 1.25 1.125 0 N-CA-C 108.715 -0.846 . . . . 74.23 108.715 171.333 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.932 0 N-CA-C 111.949 -0.46 . . . . 51.31 111.949 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 48.0 t -144.24 124.41 13.71 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.445 0.298 . . . . 51.23 111.036 -177.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -152.7 151.42 30.53 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.339 0.656 . . . . 73.53 110.551 177.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 ptp -152.46 94.99 1.97 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.18 0.592 . . . . 74.1 111.628 175.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.9 t -130.31 151.13 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 109.125 -0.694 . . . . 75.05 109.125 176.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.5 tt -70.44 98.34 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.131 0 CA-C-O 121.636 0.731 . . . . 43.33 111.448 175.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.0 mtm-85 -135.48 151.89 50.82 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 109.322 -0.621 . . . . 75.25 109.322 167.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -112.76 100.05 8.39 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 121.028 -0.269 . . . . 53.13 110.985 -170.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.4 t -153.43 -170.29 3.55 Favored 'General case' 0 CA--C 1.556 1.202 0 N-CA-C 108.919 -0.771 . . . . 71.41 108.919 -174.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.57 114.77 18.66 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.885 0 N-CA-C 107.114 -1.439 . . . . 72.14 107.114 175.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 p -83.64 124.03 30.4 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 114.195 -1.366 . . . . 60.32 109.723 -173.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.432 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 3.2 ptt180 -124.99 151.29 45.74 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 120.251 -0.58 . . . . 64.0 111.716 -170.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.7 mt -116.94 137.17 51.71 Favored 'Isoleucine or valine' 0 C--O 1.259 1.569 0 CA-C-N 120.041 1.291 . . . . 74.3 108.855 -175.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -106.05 113.71 27.41 Favored 'General case' 0 CA--C 1.574 1.876 0 O-C-N 125.903 2.002 . . . . 73.32 110.359 176.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.1 p -125.87 103.89 12.37 Favored 'Isoleucine or valine' 0 C--N 1.375 1.674 0 CA-C-N 120.194 1.361 . . . . 61.11 108.949 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -118.26 175.01 15.53 Favored Glycine 0 C--N 1.353 1.478 0 C-N-CA 120.652 -0.785 . . . . 75.43 113.354 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 51.34 29.11 4.8 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 115.697 1.74 . . . . 70.3 115.697 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.406 HD11 ' H ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -87.26 150.86 50.29 Favored Pre-proline 0 CA--C 1.555 1.15 0 CA-C-N 119.27 0.941 . . . . 55.23 110.406 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -82.94 128.86 5.23 Favored 'Trans proline' 0 CA--C 1.567 2.149 0 C-N-CA 120.8 1.0 . . . . 51.1 112.487 177.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.5 p 113.6 -29.16 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.631 0 C-N-CA 128.736 2.814 . . . . 75.24 111.045 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 68.17 105.28 0.05 Allowed 'General case' 0 C--N 1.358 0.949 0 C-N-CA 124.859 1.264 . . . . 72.23 110.285 -167.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.425 HG22 HG13 ' A' ' 24' ' ' VAL . 7.4 p -76.6 118.32 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.292 0 CA-C-N 114.874 -1.057 . . . . 65.11 108.936 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.9 m -82.23 160.0 23.09 Favored 'General case' 0 CA--C 1.559 1.303 0 CA-C-O 117.744 -1.122 . . . . 73.42 108.449 178.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.441 ' O ' ' HB3' ' A' ' 25' ' ' GLU . 5.6 p -50.64 -39.77 51.37 Favored 'General case' 0 C--N 1.378 1.834 0 N-CA-C 115.3 1.592 . . . . 73.53 115.3 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.34 -33.08 73.03 Favored 'General case' 0 CA--C 1.576 1.963 0 N-CA-C 115.51 1.67 . . . . 71.34 115.51 177.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -68.34 -54.11 19.57 Favored 'General case' 0 C--O 1.283 2.844 0 CA-C-N 119.719 1.145 . . . . 75.41 111.295 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.425 HG13 HG22 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -57.7 -54.04 36.82 Favored 'Isoleucine or valine' 0 C--N 1.368 1.398 0 O-C-N 124.573 1.17 . . . . 62.2 111.389 176.668 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.441 ' HB3' ' O ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -49.36 -46.79 47.57 Favored 'General case' 0 CA--C 1.566 1.559 0 CA-C-O 116.931 -1.509 . . . . 74.31 114.836 170.205 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -71.39 -55.58 7.68 Favored 'General case' 0 C--O 1.295 3.481 0 CA-C-N 122.525 2.42 . . . . 70.42 112.634 -177.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -57.77 -38.82 76.1 Favored 'General case' 0 C--N 1.396 2.598 0 CA-C-O 118.965 -0.541 . . . . 55.12 111.551 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -83.54 -35.61 24.66 Favored 'General case' 0 C--N 1.359 1.008 0 C-N-CA 118.564 -1.255 . . . . 73.45 113.277 -178.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.4 ptt85 -52.27 -36.62 53.22 Favored 'General case' 0 N--CA 1.507 2.409 0 CA-C-O 117.923 -1.037 . . . . 71.22 112.099 171.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.492 ' HE2' ' CG ' ' A' ' 31' ' ' TYR 0.289 0.0 OUTLIER -71.92 -30.84 65.77 Favored 'General case' 0 C--N 1.374 1.653 0 C-N-CA 116.311 -2.156 . . . . 62.44 112.71 -173.322 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.546 ' CB ' ' HA ' ' A' ' 59' ' ' ALA . 54.4 m-85 -82.75 -46.27 13.35 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 112.169 0.433 . . . . 74.1 112.169 177.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -150.14 143.76 11.1 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 118.671 0.669 . . . . 45.2 112.217 169.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -63.18 117.96 7.28 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 113.331 0.863 . . . . 72.2 113.331 -166.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.44 140.98 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-N 115.539 -0.755 . . . . 73.31 111.525 174.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.0 mp -103.8 -24.35 13.32 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 119.538 -0.865 . . . . 71.22 112.91 170.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.33 135.4 12.98 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 108.632 -0.877 . . . . 73.03 108.632 -175.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 41.8 t -145.96 115.2 7.07 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 120.125 1.33 . . . . 71.43 110.396 174.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.09 150.2 50.58 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 119.56 -0.856 . . . . 54.24 111.947 -176.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -116.07 116.72 53.21 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.53 0 CA-C-O 121.45 0.643 . . . . 73.22 110.578 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.0 mttp -108.53 141.99 39.61 Favored 'General case' 0 CA--C 1.565 1.531 0 C-N-CA 125.698 1.599 . . . . 70.44 107.762 -170.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.79 142.65 50.65 Favored 'General case' 0 CA--C 1.57 1.729 0 CA-C-N 122.329 2.331 . . . . 75.24 109.567 -177.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.0 t -100.59 176.88 5.18 Favored 'General case' 0 CA--C 1.568 1.64 0 CA-C-N 120.957 1.708 . . . . 64.22 111.572 176.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.4 t -77.33 -9.5 12.55 Favored 'Isoleucine or valine' 0 C--N 1.373 1.623 0 C-N-CA 123.834 0.854 . . . . 64.43 112.698 -176.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.9 t -90.72 2.62 55.83 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 121.584 -0.698 . . . . 60.34 111.03 -173.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.18 -7.26 68.02 Favored Glycine 0 CA--C 1.537 1.414 0 N-CA-C 115.184 0.834 . . . . 71.44 115.184 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.35 132.5 37.43 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 117.886 0.843 . . . . 74.44 108.89 167.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.75 145.55 43.42 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.743 -0.836 . . . . 74.35 108.743 -173.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -128.57 150.3 50.26 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.836 0.743 . . . . 74.33 110.693 -168.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -129.5 146.81 51.29 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.394 0.616 . . . . 74.3 112.045 175.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -132.9 114.09 13.63 Favored 'General case' 0 C--O 1.263 1.764 0 N-CA-C 106.442 -1.688 . . . . 71.33 106.442 -158.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -124.29 110.52 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.662 0 C-N-CA 118.493 -1.283 . . . . 64.23 109.491 -173.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -109.74 103.09 11.86 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.464 -1.244 . . . . 62.32 110.158 -174.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.455 ' CE2' ' HB1' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -111.43 161.44 16.12 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 115.306 -0.861 . . . . 75.44 113.241 -174.502 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.14 -42.0 69.75 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 112.281 0.474 . . . . 71.1 112.281 173.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -113.17 114.8 27.29 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 118.54 -1.264 . . . . 74.43 109.901 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.401 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -75.97 -21.8 56.58 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 115.902 1.816 . . . . 61.53 115.902 169.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.293 10.6 ptm180 -75.69 -40.96 54.95 Favored 'General case' 0 CA--C 1.567 1.601 0 CA-C-N 120.402 1.455 . . . . 74.34 114.364 -172.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -77.68 -36.33 51.35 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 117.064 2.246 . . . . 53.13 117.064 177.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.546 ' HA ' ' CB ' ' A' ' 31' ' ' TYR 0.303 . . -75.27 -14.6 60.52 Favored 'General case' 0 CA--C 1.584 2.252 0 CA-C-N 120.564 1.529 . . . . 36.76 112.266 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -44.88 -35.74 2.96 Favored 'General case' 0 CA--C 1.583 2.239 0 CA-C-N 114.159 -1.382 . . . . 51.45 114.24 161.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.464 ' O ' ' HB3' ' A' ' 65' ' ' GLU . 46.3 m-20 -52.98 -54.75 30.46 Favored 'General case' 0 N--CA 1.507 2.384 0 CA-C-N 120.822 1.646 . . . . 54.33 113.311 164.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.09 -35.78 69.81 Favored 'General case' 0 N--CA 1.507 2.385 0 CA-C-N 119.533 1.06 . . . . 61.42 113.816 171.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.448 HG21 HD12 ' A' ' 63' ' ' ILE 0.251 0.2 OUTLIER -73.53 -45.33 51.8 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.419 0 C-N-CA 119.157 -1.017 . . . . 36.76 113.443 -177.437 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.426 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -56.6 -30.46 63.25 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 120.319 1.418 . . . . 73.54 114.495 162.403 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.464 ' HB3' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -79.7 -20.46 46.47 Favored 'General case' 0 CA--C 1.55 0.967 0 O-C-N 120.825 -1.172 . . . . 72.21 111.84 -178.133 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.7 mmtt -98.35 9.54 42.82 Favored 'General case' 0 CA--C 1.598 2.804 0 CA-C-O 118.697 -0.668 . . . . 64.41 112.533 163.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.426 ' HB3' ' HA ' ' A' ' 64' ' ' LYS 0.408 0.0 OUTLIER -79.79 160.54 26.12 Favored 'General case' 0 N--CA 1.516 2.858 0 CA-C-N 120.475 1.489 . . . . 71.21 114.619 -173.165 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.83 30.64 2.11 Favored Glycine 0 N--CA 1.439 -1.116 0 C-N-CA 118.529 -1.796 . . . . 74.22 115.466 -164.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.707 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -51.09 124.67 11.97 Favored 'General case' 0 C--N 1.372 1.577 0 O-C-N 124.65 0.853 . . . . 65.24 112.391 -173.791 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -133.4 150.73 51.79 Favored 'General case' 0 C--O 1.255 1.377 0 CA-C-N 115.574 -0.739 . . . . 62.35 112.311 -176.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -147.77 145.67 28.89 Favored 'General case' 0 C--N 1.354 0.795 0 C-N-CA 127.305 2.242 . . . . 75.34 106.574 -169.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 74.01 63.44 0.08 Allowed 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 113.17 0.804 . . . . 75.54 113.17 -175.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.32 -12.95 63.37 Favored Glycine 0 N--CA 1.472 1.057 0 N-CA-C 116.757 1.463 . . . . 73.21 116.757 168.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -113.43 121.28 43.84 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 106.309 -1.738 . . . . 64.51 106.309 152.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.28 104.05 15.93 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 117.431 -1.271 . . . . 74.32 109.454 -176.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.707 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -168.63 69.82 0.08 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 120.422 1.464 . . . . 71.24 112.273 179.347 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -95.77 108.83 21.19 Favored 'General case' 0 C--N 1.369 1.448 0 CA-C-N 122.443 2.383 . . . . 73.32 109.375 -171.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.529 ' H ' ' HB3' ' A' ' 69' ' ' CYS . 50.1 t -127.77 118.39 48.88 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.888 0 O-C-N 120.828 -1.17 . . . . 64.34 109.098 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -146.61 144.9 29.85 Favored 'General case' 0 C--O 1.269 2.093 0 CA-C-N 120.651 1.569 . . . . 64.13 110.512 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.6 m -89.4 124.45 64.4 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-N 115.447 -0.797 . . . . 61.55 111.842 166.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.432 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 66.8 Cg_endo -86.57 29.9 0.49 Allowed 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 123.023 2.482 . . . . 71.11 113.747 168.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.401 ' CE1' ' HB1' ' A' ' 56' ' ' ALA . 9.0 p90 -128.71 -27.42 2.58 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.354 0.502 . . . . 71.44 112.354 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 57.26 77.53 0.27 Allowed 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 124.581 1.152 . . . . 73.42 113.286 -176.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 63.79 -148.19 0.31 Allowed 'General case' 0 C--N 1.373 1.609 0 C-N-CA 123.899 0.879 . . . . 73.53 110.619 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 7.8 ttt85 -129.41 86.89 2.47 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 121.008 -1.057 . . . . 75.43 110.075 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 . . . . . 0 C--N 1.356 0.849 0 CA-C-O 118.427 -0.796 . . . . 71.35 109.703 -165.624 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.896 0 N-CA-C 112.013 -0.435 . . . . 54.44 112.013 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 40.2 m -112.37 -83.91 0.58 Allowed 'General case' 0 C--O 1.219 -0.525 0 CA-C-O 118.717 -0.659 . . . . 60.42 111.489 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 68.76 92.01 0.09 Allowed 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 125.499 1.52 . . . . 75.22 110.334 -177.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpp? -102.92 159.12 15.78 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 120.836 -0.346 . . . . 70.12 110.353 -176.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 66.2 t 77.2 -63.24 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 C-N-CA 125.813 1.645 . . . . 75.2 111.615 176.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.42 HD11 HG23 ' A' ' 3' ' ' ILE . 2.8 mm 69.31 -67.18 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 126.816 2.047 . . . . 73.14 112.121 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -177.18 39.11 0.01 OUTLIER 'General case' 0 C--N 1.366 1.302 0 CA-C-N 119.061 0.846 . . . . 74.15 110.508 -169.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 78.87 121.73 0.05 OUTLIER 'General case' 0 N--CA 1.506 2.338 0 C-N-CA 125.962 1.705 . . . . 71.22 110.727 173.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.4 t -151.5 166.41 31.2 Favored 'General case' 0 CA--C 1.549 0.922 0 O-C-N 120.956 -1.09 . . . . 73.31 110.946 -174.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.3 m -115.0 119.94 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-O 121.22 0.534 . . . . 62.13 110.279 177.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.506 ' OG ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -86.1 121.06 28.17 Favored 'General case' 0 C--O 1.249 1.072 0 CA-C-O 121.157 0.503 . . . . 71.2 112.127 -176.205 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 11.3 ptt180 -143.81 152.9 41.8 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 113.792 1.034 . . . . 72.41 113.792 -172.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.8 mt -115.31 135.35 55.56 Favored 'Isoleucine or valine' 0 C--N 1.375 1.693 0 CA-C-N 120.199 1.363 . . . . 74.35 107.995 177.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -99.56 122.04 42.05 Favored 'General case' 0 CA--C 1.572 1.796 0 O-C-N 125.43 1.706 . . . . 75.2 110.283 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 67.3 t -124.71 110.99 26.48 Favored 'Isoleucine or valine' 0 C--N 1.366 1.32 0 O-C-N 120.643 -1.286 . . . . 72.33 108.594 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.33 162.97 12.42 Favored Glycine 0 C--N 1.341 0.823 0 C-N-CA 119.135 -1.507 . . . . 53.2 112.209 173.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 51.16 22.93 1.42 Allowed 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 116.379 1.992 . . . . 71.41 116.379 178.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.02 125.41 91.41 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 123.45 0.7 . . . . 63.04 111.054 169.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -91.34 123.35 0.78 Allowed 'Trans proline' 0 CA--C 1.556 1.586 0 C-N-CA 121.873 1.715 . . . . 73.22 111.495 169.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.5 m 34.75 -100.66 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 124.741 1.216 . . . . 73.32 114.03 -173.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.4 t60 53.26 -88.95 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 126.243 1.817 . . . . 72.24 112.408 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.2 m -98.18 117.03 42.4 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.863 0 C-N-CA 119.435 -0.906 . . . . 71.33 109.713 177.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.9 m -80.76 170.96 15.62 Favored 'General case' 0 C--N 1.387 2.234 0 CA-C-O 117.197 -1.383 . . . . 75.22 109.076 166.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.9 m -46.53 -49.46 18.57 Favored 'General case' 0 C--O 1.27 2.148 0 CA-C-N 120.134 1.334 . . . . 72.14 114.492 -173.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.71 -43.59 97.64 Favored 'General case' 0 CA--C 1.578 2.03 0 CA-C-N 115.271 -0.877 . . . . 75.25 113.277 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.511 10.7 m-20 -76.99 -18.94 57.88 Favored 'General case' 0 CA--C 1.559 1.309 0 CA-C-O 115.715 -2.088 . . . . 74.21 114.146 172.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.414 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 2.0 t -59.65 -44.57 93.76 Favored 'Isoleucine or valine' 0 C--N 1.424 3.83 0 CA-C-N 123.411 2.823 . . . . 71.45 108.281 163.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.48 -54.52 45.61 Favored 'General case' 0 C--N 1.376 1.731 0 CA-C-O 116.455 -1.736 . . . . 75.53 112.677 174.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -73.81 -54.39 8.11 Favored 'General case' 1 C--O 1.309 4.187 0 CA-C-N 122.369 2.349 . . . . 72.24 114.793 -174.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -58.21 -37.06 74.08 Favored 'General case' 0 C--N 1.383 2.063 0 CA-C-O 117.325 -1.322 . . . . 73.24 110.428 177.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.414 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 47.3 m-85 -84.46 -24.2 29.58 Favored 'General case' 0 C--N 1.373 1.629 0 C-N-CA 115.716 -2.393 . . . . 75.14 113.457 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.429 ' HA ' HG22 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -64.95 -30.79 71.8 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 117.286 -1.34 . . . . 74.24 114.055 175.534 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.464 ' HE2' ' CD1' ' A' ' 31' ' ' TYR 0.323 0.0 OUTLIER -72.82 -34.8 67.09 Favored 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 113.354 -3.338 . . . . 74.45 111.986 175.338 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.48 ' HB3' ' HA ' ' A' ' 59' ' ' ALA . 57.8 m-85 -76.79 -40.96 46.41 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-O 118.975 -0.536 . . . . 62.32 110.783 -169.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -140.21 165.21 26.06 Favored Glycine 0 C--N 1.341 0.812 0 CA-C-O 118.309 -1.273 . . . . 73.2 110.666 152.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -76.71 102.77 6.35 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-N 119.95 1.875 . . . . 75.22 110.45 -174.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.429 HG22 ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -71.32 136.73 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 113.824 1.046 . . . . 74.02 113.824 -176.113 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.4 mt -89.55 -49.02 6.92 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 113.266 0.839 . . . . 74.14 113.266 166.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.65 128.2 20.18 Favored 'General case' 0 CA--C 1.585 2.322 0 CA-C-N 120.077 1.308 . . . . 73.41 111.901 173.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.403 ' SG ' HG13 ' A' ' 34' ' ' ILE . 4.8 m -105.65 111.03 23.56 Favored 'General case' 0 C--N 1.388 2.259 0 N-CA-C 107.473 -1.306 . . . . 73.53 107.473 166.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -113.11 139.93 48.31 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 117.855 -1.538 . . . . 75.35 111.41 176.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 t -113.0 110.09 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 106.77 -1.567 . . . . 74.12 106.77 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.7 mmtt -107.08 142.4 36.8 Favored 'General case' 0 CA--C 1.556 1.181 0 CA-C-O 118.792 -0.623 . . . . 73.12 109.455 175.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.39 142.78 51.01 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 120.063 1.302 . . . . 71.23 108.384 -170.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.421 HG21 ' H ' ' A' ' 44' ' ' SER . 12.0 t -100.01 167.75 10.29 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 120.45 1.477 . . . . 60.22 111.42 -178.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.0 m -61.84 -7.5 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.746 0 N-CA-C 115.993 1.849 . . . . 72.52 115.993 175.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.421 ' H ' HG21 ' A' ' 42' ' ' THR . 8.1 t -98.05 7.57 46.11 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 119.36 0.982 . . . . 71.25 110.517 -174.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.25 -4.35 77.22 Favored Glycine 0 CA--C 1.544 1.887 0 N-CA-C 115.717 1.047 . . . . 72.31 115.717 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -83.37 134.75 34.88 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-N 117.954 0.877 . . . . 74.31 110.485 177.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.31 149.75 25.07 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.619 -0.882 . . . . 65.14 108.619 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -125.12 145.02 50.13 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 118.915 -1.114 . . . . 73.12 109.568 175.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -115.47 137.88 51.59 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.915 -0.402 . . . . 72.14 109.915 176.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.47 115.85 16.71 Favored 'General case' 0 C--O 1.256 1.446 0 N-CA-C 108.168 -1.049 . . . . 73.42 108.168 -173.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 0.2 OUTLIER -123.76 108.77 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 C-N-CA 118.358 -1.337 . . . . 71.43 110.827 -171.693 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -102.81 108.34 19.53 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 115.147 -0.933 . . . . 70.34 110.92 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.95 156.33 25.23 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 118.748 -0.644 . . . . 60.54 112.673 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -59.29 -32.44 70.04 Favored 'General case' 0 N--CA 1.516 2.834 0 N-CA-C 112.937 0.717 . . . . 74.42 112.937 166.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -115.41 113.0 23.16 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 119.151 -1.02 . . . . 73.42 109.966 -177.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.517 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -77.33 -41.39 40.71 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 116.084 1.883 . . . . 71.51 116.084 170.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.26 6.5 ptt180 -75.78 -33.33 60.17 Favored 'General case' 0 CA--C 1.573 1.864 0 N-CA-C 114.516 1.302 . . . . 65.22 114.516 -168.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.43 -44.97 73.79 Favored 'General case' 0 N--CA 1.518 2.934 0 CA-C-N 120.737 1.608 . . . . 74.14 114.034 173.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.48 ' HA ' ' HB3' ' A' ' 31' ' ' TYR . . . -50.02 -21.08 1.11 Allowed 'General case' 0 CA--C 1.598 2.821 0 N-CA-C 117.281 2.326 . . . . 73.02 117.281 171.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.405 ' O ' ' HG3' ' A' ' 64' ' ' LYS . . . -49.14 -34.15 13.61 Favored 'General case' 0 CA--C 1.585 2.319 0 CA-C-O 117.645 -1.169 . . . . 74.33 113.797 167.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -52.39 -45.06 65.68 Favored 'General case' 0 C--N 1.394 2.519 0 CA-C-N 120.171 1.35 . . . . 74.24 113.789 165.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.5 ' O ' ' HD2' ' A' ' 66' ' ' LYS . . . -60.48 -54.02 50.49 Favored 'General case' 0 C--O 1.258 1.53 0 O-C-N 121.907 -0.496 . . . . 70.02 111.212 172.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . 0.262 0.4 OUTLIER -62.5 -41.22 91.09 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 C-N-CA 117.465 -1.694 . . . . 64.14 113.786 -173.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.405 ' HG3' ' O ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -62.06 -34.85 77.04 Favored 'General case' 0 CA--C 1.557 1.215 0 N-CA-C 115.588 1.699 . . . . 74.43 115.588 167.854 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.64 -34.83 79.13 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 121.168 1.804 . . . . 73.41 111.268 176.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.5 ' HD2' ' O ' ' A' ' 62' ' ' ALA 0.258 0.0 OUTLIER -103.07 18.42 21.73 Favored 'General case' 0 CA--C 1.575 1.921 0 C-N-CA 118.432 -1.307 . . . . 63.41 114.149 173.946 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.323 0.5 OUTLIER -71.37 162.79 28.86 Favored 'General case' 0 N--CA 1.508 2.435 0 CA-C-N 118.975 0.807 . . . . 61.24 112.88 -174.857 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 120.44 31.99 1.19 Allowed Glycine 0 N--CA 1.438 -1.218 0 C-N-CA 119.024 -1.56 . . . . 63.35 115.533 -162.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.741 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -51.51 125.09 13.62 Favored 'General case' 0 C--N 1.375 1.704 0 CA-C-N 118.1 0.95 . . . . 74.4 111.768 176.444 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -133.66 149.36 51.56 Favored 'General case' 0 C--O 1.255 1.363 0 CA-C-N 114.766 -1.106 . . . . 73.23 111.482 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -148.25 144.66 27.8 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 126.225 1.81 . . . . 72.0 106.746 -166.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 68.89 65.98 0.29 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 124.244 0.965 . . . . 70.42 113.162 177.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.9 -12.34 60.81 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 116.86 1.504 . . . . 71.43 116.86 173.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -118.85 121.9 41.09 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 105.929 -1.878 . . . . 73.31 105.929 154.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.97 102.52 14.61 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 117.553 -1.213 . . . . 74.41 109.874 -172.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.741 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -169.2 58.64 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 CA-C-N 120.572 1.533 . . . . 73.14 114.419 -175.14 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.1 tpp85 -90.99 112.25 24.06 Favored 'General case' 0 CA--C 1.571 1.767 0 CA-C-N 122.258 2.299 . . . . 71.43 109.945 -170.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.46 ' H ' ' HB3' ' A' ' 69' ' ' CYS . 0.9 OUTLIER -119.78 121.69 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 O-C-N 120.325 -1.484 . . . . 73.12 108.678 173.928 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -146.58 132.5 19.13 Favored 'General case' 0 C--N 1.361 1.091 0 CA-C-N 119.75 1.159 . . . . 61.03 110.791 -165.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.537 HG13 ' CZ ' ' A' ' 82' ' ' PHE . 7.8 m -89.62 124.56 63.78 Favored Pre-proline 0 C--N 1.349 0.559 0 C-N-CA 119.817 -0.753 . . . . 75.0 111.569 167.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.438 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 87.8 Cg_endo -89.91 17.17 1.58 Allowed 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 122.48 2.12 . . . . 72.34 113.625 166.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.537 ' CZ ' HG13 ' A' ' 80' ' ' VAL . 5.6 p90 -110.74 -32.01 7.0 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.039 0.385 . . . . 74.34 112.039 175.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.0 t30 59.65 73.51 0.48 Allowed 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 124.574 1.15 . . . . 73.33 110.692 -176.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 59.62 -156.79 0.34 Allowed 'General case' 0 C--N 1.379 1.851 0 C-N-CA 124.066 0.946 . . . . 51.34 111.371 -178.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -118.29 71.66 0.84 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.806 -1.184 . . . . 74.31 109.003 176.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 . . . . . 0 C--O 1.251 1.177 0 N-CA-C 107.629 -1.248 . . . . 73.23 107.629 -153.633 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.141 0 N-CA-C 111.86 -0.496 . . . . 63.01 111.86 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.08 -176.69 4.15 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 110.19 -0.3 . . . . 73.3 110.19 -177.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -152.27 78.82 1.23 Allowed 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 120.906 0.384 . . . . 60.25 111.08 -171.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 mtt -156.64 139.31 15.08 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.361 1.064 . . . . 73.43 109.345 171.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.2 t -129.35 49.62 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-O 122.357 1.075 . . . . 75.04 108.857 173.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.9 mt -126.54 63.65 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 O-C-N 121.389 -0.819 . . . . 73.04 109.2 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -167.57 -160.57 0.36 Allowed 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 109.438 -0.579 . . . . 74.4 109.438 171.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -166.3 133.72 2.71 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 107.85 -1.167 . . . . 73.41 107.85 -170.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.0 t -169.23 -164.77 0.48 Allowed 'General case' 0 CA--C 1.562 1.439 0 N-CA-C 109.26 -0.644 . . . . 71.22 109.26 -178.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.24 127.52 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 108.448 -0.945 . . . . 74.32 108.448 170.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.1 p -83.72 130.03 34.95 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 114.769 -1.105 . . . . 74.31 108.115 173.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.515 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 0.2 OUTLIER -118.83 153.27 34.77 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 121.305 -0.872 . . . . 71.23 109.036 -177.407 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.41 HG13 HG11 ' A' ' 80' ' ' VAL . 4.5 mp -138.16 134.92 44.78 Favored 'Isoleucine or valine' 0 C--O 1.264 1.82 0 CA-C-N 119.811 1.187 . . . . 70.42 108.269 -178.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -105.33 114.95 29.44 Favored 'General case' 0 CA--C 1.571 1.751 0 O-C-N 125.664 1.852 . . . . 65.32 110.407 177.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.0 p -123.84 104.41 14.07 Favored 'Isoleucine or valine' 0 C--N 1.369 1.432 0 CA-C-N 120.333 1.424 . . . . 75.23 108.079 178.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.407 ' H ' ' HG3' ' A' ' 77' ' ' ARG . . . -121.33 177.24 16.41 Favored Glycine 0 C--N 1.346 1.134 0 C-N-CA 120.362 -0.923 . . . . 37.25 112.722 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.6 m120 50.72 24.34 1.67 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 114.792 1.405 . . . . 62.14 114.792 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.425 ' H ' HD21 ' A' ' 15' ' ' LEU . 1.7 pt? -79.71 123.54 83.94 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 123.812 0.845 . . . . 70.1 110.6 -178.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -89.51 120.11 0.95 Allowed 'Trans proline' 0 CA--C 1.559 1.729 0 C-N-CA 121.053 1.168 . . . . 73.11 112.186 172.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.7 m 39.05 43.42 0.8 Allowed 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 124.989 1.316 . . . . 74.01 114.034 178.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -95.11 -93.37 0.19 Allowed 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 119.418 -0.325 . . . . 74.54 110.64 -166.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.7 m -103.23 119.16 51.33 Favored 'Isoleucine or valine' 0 CA--C 1.596 2.745 0 CA-C-N 118.627 0.649 . . . . 75.44 109.943 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.75 155.17 25.62 Favored 'General case' 0 C--N 1.392 2.429 0 CA-C-N 120.888 1.676 . . . . 63.14 110.155 171.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.0 t -48.12 -48.8 33.76 Favored 'General case' 0 C--N 1.371 1.53 0 N-CA-C 115.477 1.658 . . . . 64.21 115.477 -173.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.94 -43.46 86.36 Favored 'General case' 0 CA--C 1.582 2.208 0 N-CA-C 114.206 1.187 . . . . 73.44 114.206 176.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.03 -30.2 70.22 Favored 'General case' 0 C--N 1.364 1.204 0 CA-C-O 117.397 -1.287 . . . . 72.23 111.223 173.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.525 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 1.6 t -66.78 -43.05 90.1 Favored 'Isoleucine or valine' 0 C--N 1.391 2.399 0 CA-C-O 116.633 -1.651 . . . . 72.04 110.021 171.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.504 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 4.3 tt0 -61.05 -55.01 37.7 Favored 'General case' 0 C--N 1.365 1.247 0 CA-C-N 121.476 1.944 . . . . 74.11 111.48 176.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -71.82 -59.26 2.84 Favored 'General case' 0 C--O 1.284 2.901 0 CA-C-N 121.21 1.823 . . . . 74.23 112.796 -176.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -71.12 -31.52 67.86 Favored 'General case' 0 C--N 1.364 1.21 0 CA-C-O 117.178 -1.391 . . . . 74.11 112.711 -176.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.525 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 5.1 m-85 -82.78 -29.01 29.94 Favored 'General case' 0 C--N 1.375 1.698 0 CA-C-N 122.057 2.208 . . . . 73.54 112.55 176.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.504 ' HB3' ' O ' ' A' ' 25' ' ' GLU . 2.9 ptt180 -54.27 -32.52 56.42 Favored 'General case' 0 C--N 1.379 1.884 0 CA-C-O 115.777 -2.059 . . . . 73.04 114.824 161.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.85 -48.06 73.38 Favored 'General case' 0 N--CA 1.518 2.965 0 CA-C-N 122.479 2.4 . . . . 64.21 111.674 167.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -75.71 -38.29 58.71 Favored 'General case' 0 C--O 1.213 -0.865 0 CA-C-O 118.639 -0.696 . . . . 65.35 111.803 -168.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -149.2 154.92 26.07 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 119.473 1.033 . . . . 64.33 111.148 168.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -77.22 105.19 8.17 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-N 118.075 0.937 . . . . 71.3 110.722 -175.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.733 HG13 ' SG ' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -73.61 132.83 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 N-CA-C 114.286 1.217 . . . . 74.5 114.286 -176.748 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 11.1 mp -108.67 -23.26 11.88 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.883 -1.053 . . . . 74.34 110.861 175.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -152.2 131.66 12.97 Favored 'General case' 0 CA--C 1.565 1.52 0 N-CA-C 108.576 -0.898 . . . . 51.4 108.576 -172.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.733 ' SG ' HG13 ' A' ' 34' ' ' ILE . 19.5 m -139.48 110.39 6.81 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 107.251 -1.388 . . . . 52.43 107.251 175.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -122.3 127.67 50.13 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 117.563 -1.655 . . . . 74.12 110.635 176.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -117.88 112.86 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-O 121.841 0.829 . . . . 72.24 110.042 -178.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.3 mtmt -120.38 146.85 45.77 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 114.439 -1.255 . . . . 73.54 109.98 -170.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.11 145.98 49.68 Favored 'General case' 0 C--N 1.368 1.397 0 CA-C-N 120.68 1.582 . . . . 71.25 108.464 -172.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.43 HG21 ' H ' ' A' ' 44' ' ' SER . 4.0 t -99.79 167.09 10.76 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 121.129 1.786 . . . . 74.34 111.138 174.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.5 m -66.74 -3.7 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.575 0 N-CA-C 116.038 1.866 . . . . 71.31 116.038 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.43 ' H ' HG21 ' A' ' 42' ' ' THR . 10.2 t -98.27 7.22 46.54 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 119.253 0.933 . . . . 65.11 109.639 -171.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.78 -5.7 73.76 Favored Glycine 0 CA--C 1.54 1.606 0 N-CA-C 115.2 0.84 . . . . 70.31 115.2 -175.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.45 130.89 34.34 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 118.201 1.0 . . . . 71.2 109.578 175.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.28 146.94 39.81 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 108.854 -0.795 . . . . 75.41 108.854 -175.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -129.63 150.84 50.78 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.526 1.057 . . . . 73.52 110.754 -176.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -127.34 147.47 50.26 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-O 121.713 0.768 . . . . 70.13 111.572 171.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -132.74 118.58 19.24 Favored 'General case' 0 C--O 1.266 1.924 0 N-CA-C 106.367 -1.716 . . . . 73.4 106.367 -164.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.79 114.02 26.35 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.079 0 C-N-CA 120.09 -0.644 . . . . 71.44 109.885 -162.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -109.44 109.14 19.9 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 120.541 -0.464 . . . . 75.33 112.108 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -107.0 160.63 15.39 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 119.4 -0.333 . . . . 73.03 111.428 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -80.49 -25.99 38.47 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 113.514 0.931 . . . . 74.42 113.514 177.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -115.86 119.57 36.4 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.402 -0.592 . . . . 62.32 109.402 -178.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.425 ' HB3' ' CD1' ' A' ' 82' ' ' PHE . . . -76.6 -33.12 58.44 Favored 'General case' 0 CA--C 1.56 1.356 0 N-CA-C 117.024 2.231 . . . . 73.11 117.024 174.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.352 0.0 OUTLIER -79.58 -29.25 41.19 Favored 'General case' 0 C--N 1.377 1.78 0 CA-C-N 122.095 2.225 . . . . 73.14 114.448 -170.391 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.2 -31.14 60.82 Favored 'General case' 0 CA--C 1.586 2.363 0 CA-C-N 121.281 1.855 . . . . 73.43 115.955 171.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.47 -24.27 54.77 Favored 'General case' 0 CA--C 1.586 2.36 0 CA-C-N 120.563 1.528 . . . . 64.53 114.222 170.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -49.78 -37.81 31.48 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-O 116.608 -1.663 . . . . 75.32 113.958 173.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.574 ' O ' ' HB3' ' A' ' 65' ' ' GLU . 31.7 m-20 -54.09 -51.65 63.49 Favored 'General case' 0 C--N 1.395 2.56 0 CA-C-N 120.178 1.354 . . . . 72.22 112.066 169.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.59 -39.22 87.32 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 117.144 -1.408 . . . . 72.42 113.04 174.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . 0.305 0.6 OUTLIER -73.78 -45.97 48.45 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 116.601 -2.04 . . . . 63.21 113.348 -176.854 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.98 -34.49 59.95 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 114.368 1.247 . . . . 74.12 114.368 166.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.574 ' HB3' ' O ' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -83.05 -22.47 33.52 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-N 119.454 1.025 . . . . 75.31 112.158 -175.098 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -100.07 14.23 31.38 Favored 'General case' 0 CA--C 1.57 1.735 0 CA-C-O 118.981 -0.533 . . . . 74.24 110.866 174.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.361 0.0 OUTLIER -77.36 162.89 26.91 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 113.674 0.99 . . . . 73.23 113.674 -168.651 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.75 29.58 2.01 Favored Glycine 0 N--CA 1.437 -1.269 0 CA-C-O 117.886 -1.508 . . . . 73.13 115.007 -158.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.676 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 44.8 t -51.37 126.23 16.49 Favored 'General case' 0 C--N 1.383 2.041 0 CA-C-O 122.123 0.963 . . . . 71.53 110.317 170.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -135.17 143.0 46.23 Favored 'General case' 0 C--O 1.252 1.236 0 CA-C-N 113.282 -1.781 . . . . 70.1 111.705 -176.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -155.51 144.8 20.94 Favored 'General case' 0 C--N 1.348 0.541 0 N-CA-C 106.695 -1.594 . . . . 75.15 106.695 -164.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 71.11 65.64 0.16 Allowed 'General case' 0 N--CA 1.512 2.658 0 CA-C-O 121.608 0.718 . . . . 54.55 111.86 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.2 -13.68 63.03 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 116.995 1.558 . . . . 41.51 116.995 174.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -122.93 125.37 45.19 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 106.037 -1.838 . . . . 70.31 106.037 161.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.69 105.9 18.1 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 117.506 -1.235 . . . . 73.22 110.491 -172.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.676 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.3 OUTLIER -169.1 69.71 0.07 Allowed 'General case' 0 N--CA 1.505 2.31 0 CA-C-N 120.944 1.702 . . . . 64.1 113.688 179.327 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.407 ' HG3' ' H ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -92.35 118.09 30.56 Favored 'General case' 0 CA--C 1.576 1.961 0 CA-C-N 122.761 2.528 . . . . 71.34 111.604 -172.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.6 t -126.87 115.89 42.96 Favored 'Isoleucine or valine' 0 C--N 1.371 1.536 0 O-C-N 120.761 -1.212 . . . . 62.23 107.753 168.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -149.83 137.65 20.18 Favored 'General case' 0 C--N 1.37 1.483 0 CA-C-N 119.852 1.205 . . . . 72.42 111.651 -179.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.41 HG11 HG13 ' A' ' 10' ' ' ILE . 35.5 m -90.81 128.35 48.51 Favored Pre-proline 0 N--CA 1.445 -0.71 0 CA-C-N 115.317 -0.856 . . . . 63.41 110.389 170.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.515 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 43.8 Cg_endo -87.06 31.25 0.45 Allowed 'Trans proline' 0 CA--C 1.553 1.428 0 C-N-CA 122.198 1.932 . . . . 71.24 112.482 162.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.425 ' CD1' ' HB3' ' A' ' 56' ' ' ALA . 3.1 p90 -120.51 -30.67 4.48 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 111.483 0.179 . . . . 74.33 111.483 175.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 15.7 m120 69.93 -54.25 0.61 Allowed 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 126.156 1.782 . . . . 61.41 113.485 -174.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -175.11 -177.95 1.13 Allowed 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 107.862 -1.162 . . . . 63.31 107.862 -176.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -88.01 155.34 19.87 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 108.354 -0.98 . . . . 64.25 108.354 175.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 . . . . . 0 C--O 1.252 1.188 0 CA-C-O 118.144 -0.931 . . . . 61.3 108.771 -178.633 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.015 0 CA-C-O 119.465 -0.631 . . . . 53.44 112.322 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 4.9 t 70.27 -168.91 0.16 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.05 1.34 . . . . 73.54 111.039 178.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 14.0 t-160 65.77 38.84 5.02 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.435 1.094 . . . . 75.25 110.838 175.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 mtt -136.23 137.71 41.09 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.567 -0.742 . . . . 61.21 109.944 -177.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.3 p -146.82 115.51 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 CA-C-O 122.008 0.909 . . . . 73.05 110.796 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.1 mt -131.3 122.96 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 115.323 -0.853 . . . . 73.52 109.301 -174.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.46 159.74 14.8 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 119.038 -0.506 . . . . 72.5 109.878 176.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 74.38 163.41 0.27 Allowed 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 124.586 1.155 . . . . 71.13 109.391 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.8 t 83.78 -166.28 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 124.564 1.146 . . . . 73.52 108.361 175.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.71 135.88 59.39 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 CA-C-O 121.345 0.593 . . . . 73.52 110.143 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.41 127.88 33.25 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.263 -1.335 . . . . 73.25 110.043 176.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -126.13 152.95 45.25 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 117.519 -1.229 . . . . 73.41 110.61 -179.343 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 mt -115.56 143.98 24.22 Favored 'Isoleucine or valine' 0 C--O 1.255 1.342 0 CA-C-N 121.223 1.829 . . . . 73.15 108.692 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -106.32 120.85 42.94 Favored 'General case' 0 CA--C 1.564 1.504 0 O-C-N 124.157 0.91 . . . . 74.34 110.324 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 p -124.57 105.84 15.81 Favored 'Isoleucine or valine' 0 C--N 1.376 1.753 0 CA-C-N 120.457 1.48 . . . . 75.34 109.024 177.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 77' ' ' ARG . . . -114.57 166.79 12.19 Favored Glycine 0 C--N 1.355 1.618 0 C-N-CA 120.339 -0.934 . . . . 55.14 113.453 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 50.12 24.24 1.36 Allowed 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 115.102 1.519 . . . . 74.32 115.102 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -71.47 141.52 85.58 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 124.297 1.039 . . . . 73.05 110.717 175.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -72.98 141.47 33.16 Favored 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 121.411 1.407 . . . . 70.42 111.169 173.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.9 p 86.25 -34.16 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 126.36 1.864 . . . . 71.23 112.652 170.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 71.08 121.82 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.106 1.362 . . . . 74.42 111.188 -175.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.0 m -75.84 118.15 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.442 0 N-CA-C 107.43 -1.322 . . . . 72.44 107.43 176.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.37 157.32 27.65 Favored 'General case' 0 C--N 1.383 2.036 0 O-C-N 120.025 -1.672 . . . . 72.22 109.472 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 44.8 p -49.84 -37.61 31.43 Favored 'General case' 0 C--N 1.38 1.934 0 N-CA-C 116.123 1.897 . . . . 62.12 116.123 -173.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -38.97 75.98 Favored 'General case' 0 CA--C 1.595 2.678 0 N-CA-C 114.637 1.347 . . . . 73.43 114.637 176.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.5 -32.59 68.39 Favored 'General case' 0 C--N 1.374 1.655 0 CA-C-N 120.301 1.409 . . . . 71.43 110.596 176.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.588 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 7.5 p -75.46 -34.03 28.86 Favored 'Isoleucine or valine' 0 C--N 1.391 2.403 0 N-CA-C 108.663 -0.866 . . . . 52.21 108.663 178.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.488 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 0.5 OUTLIER -60.16 -55.63 31.45 Favored 'General case' 0 CA--C 1.576 1.967 0 CA-C-O 117.187 -1.387 . . . . 72.43 113.717 168.83 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -65.4 -58.88 4.78 Favored 'General case' 0 C--O 1.299 3.666 0 CA-C-N 121.654 2.025 . . . . 73.52 113.37 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -57.7 -44.95 86.23 Favored 'General case' 0 C--N 1.385 2.133 0 CA-C-O 117.902 -1.047 . . . . 62.31 112.075 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.588 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 3.1 m-85 -79.66 -17.22 54.23 Favored 'General case' 0 CA--C 1.568 1.671 0 CA-C-N 120.373 1.442 . . . . 65.34 114.121 -176.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.488 ' HG3' ' O ' ' A' ' 25' ' ' GLU 0.322 70.3 mtp180 -60.33 -32.01 70.84 Favored 'General case' 0 N--CA 1.535 3.819 0 CA-C-N 122.022 2.192 . . . . 64.53 110.942 170.368 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.507 ' O ' ' HD2' ' A' ' 30' ' ' LYS 0.283 0.2 OUTLIER -58.51 -21.1 50.92 Favored 'General case' 0 N--CA 1.509 2.486 0 C-N-CA 117.805 -1.558 . . . . 72.21 114.109 175.006 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.409 ' OH ' ' HE3' ' A' ' 66' ' ' LYS . 1.5 m-85 -84.86 -27.53 26.64 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.37 -0.831 . . . . 74.43 110.306 -165.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 175.32 32.99 0.04 OUTLIER Glycine 0 N--CA 1.437 -1.275 0 CA-C-O 118.783 -1.009 . . . . 37.61 113.598 174.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.2 t30 57.27 80.72 0.16 Allowed 'General case' 0 C--N 1.357 0.914 0 C-N-CA 124.525 1.13 . . . . 63.01 110.641 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.46 ' HA ' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -68.49 141.24 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 CA-C-N 114.935 -1.03 . . . . 64.25 113.6 -175.424 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.39 -25.25 11.52 Favored 'General case' 0 C--N 1.375 1.686 0 N-CA-C 110.577 -0.157 . . . . 71.03 110.577 176.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.84 130.91 26.36 Favored 'General case' 0 CA--C 1.56 1.343 0 N-CA-C 108.896 -0.779 . . . . 73.4 108.896 -168.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -141.28 111.08 6.54 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.025 -0.732 . . . . 52.24 109.025 -175.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -129.04 143.28 50.82 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 117.802 -1.559 . . . . 73.12 113.483 -177.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.0 t -116.21 114.6 46.58 Favored 'Isoleucine or valine' 0 C--N 1.345 0.383 0 N-CA-C 108.737 -0.838 . . . . 75.33 108.737 176.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -107.12 130.41 54.7 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-O 118.601 -0.714 . . . . 74.2 109.618 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.15 128.04 53.63 Favored 'General case' 0 C--N 1.379 1.857 0 CA-C-N 120.519 1.509 . . . . 65.35 112.391 -174.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.406 HG21 ' H ' ' A' ' 44' ' ' SER . 1.4 t -90.76 160.0 16.02 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 119.139 -1.024 . . . . 65.52 111.187 170.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.0 t -76.29 -9.95 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.415 0 C-N-CA 123.698 0.799 . . . . 73.24 112.376 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.406 ' H ' HG21 ' A' ' 42' ' ' THR . 7.3 m -83.16 7.84 14.89 Favored 'General case' 0 CA--C 1.556 1.185 0 O-C-N 121.873 -0.517 . . . . 73.45 111.282 -177.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.31 -4.57 76.55 Favored Glycine 0 C--N 1.351 1.385 0 N-CA-C 115.563 0.985 . . . . 53.24 115.563 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.77 134.42 33.68 Favored 'General case' 0 CA--C 1.561 1.366 0 CA-C-N 118.01 0.905 . . . . 63.44 110.776 176.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -103.86 144.97 30.79 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 107.333 -1.358 . . . . 71.45 107.333 176.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -132.57 149.87 52.25 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.225 0.92 . . . . 73.33 108.562 175.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -117.79 137.0 53.03 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 119.071 -1.052 . . . . 53.2 111.391 170.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -106.12 118.85 37.69 Favored 'General case' 0 C--O 1.268 2.068 0 CA-C-N 113.92 -1.491 . . . . 72.04 107.762 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 0.3 OUTLIER -125.96 111.36 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.505 0 C-N-CA 119.066 -1.054 . . . . 60.41 111.905 -174.486 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.59 105.8 17.71 Favored 'General case' 0 CA--C 1.556 1.205 0 CA-C-N 115.643 -0.708 . . . . 71.32 111.474 -174.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.46 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 3.0 p90 -115.2 166.87 11.36 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 114.493 1.294 . . . . 74.53 114.493 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -80.8 -27.82 36.51 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 114.843 1.423 . . . . 74.21 114.843 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.35 118.6 32.69 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 120.011 1.278 . . . . 70.11 111.593 175.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.42 -34.33 54.7 Favored 'General case' 0 CA--C 1.552 1.023 0 N-CA-C 116.78 2.141 . . . . 75.11 116.78 172.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.267 0.0 OUTLIER -80.35 -29.33 37.94 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-N 121.879 2.127 . . . . 74.12 113.034 -170.538 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.22 -38.18 90.14 Favored 'General case' 0 N--CA 1.506 2.364 0 N-CA-C 114.067 1.136 . . . . 73.53 114.067 176.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.58 -22.45 8.51 Favored 'General case' 0 CA--C 1.561 1.383 0 N-CA-C 115.755 1.761 . . . . 75.51 115.755 173.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.93 -45.89 60.64 Favored 'General case' 0 CA--C 1.582 2.211 0 N-CA-C 114.807 1.41 . . . . 53.53 114.807 -178.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -50.66 -51.7 46.78 Favored 'General case' 0 N--CA 1.524 3.268 0 CA-C-N 119.745 1.157 . . . . 74.1 112.459 170.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.488 ' O ' ' HD2' ' A' ' 66' ' ' LYS . . . -75.05 -31.61 61.33 Favored 'General case' 0 CA--C 1.555 1.151 0 O-C-N 121.213 -0.929 . . . . 75.2 111.994 -176.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . 0.296 0.0 OUTLIER -73.63 -42.37 55.25 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.875 0 O-C-N 120.058 -1.651 . . . . 73.25 113.118 179.293 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.47 ' HD2' ' N ' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -55.72 -33.84 64.6 Favored 'General case' 0 CA--C 1.559 1.291 0 CA-C-N 120.383 1.447 . . . . 63.1 114.815 162.861 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.47 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -63.65 -32.62 74.15 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 120.058 1.299 . . . . 74.45 112.252 172.364 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.488 ' HD2' ' O ' ' A' ' 62' ' ' ALA 0.269 0.0 OUTLIER -105.0 16.72 25.42 Favored 'General case' 0 CA--C 1.581 2.151 0 C-N-CA 117.09 -1.844 . . . . 71.23 115.566 166.661 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.403 ' HB3' ' HA ' ' A' ' 64' ' ' LYS 0.363 0.0 OUTLIER -79.26 159.61 27.2 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-N 119.092 0.86 . . . . 72.43 112.845 -177.361 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.1 31.44 2.05 Favored Glycine 0 N--CA 1.436 -1.365 0 C-N-CA 118.202 -1.951 . . . . 72.05 113.866 -164.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.704 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -50.97 124.82 12.1 Favored 'General case' 0 C--N 1.374 1.631 0 O-C-N 124.449 0.735 . . . . 74.31 111.328 -173.86 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -133.79 150.79 51.45 Favored 'General case' 0 C--O 1.252 1.232 0 CA-C-N 115.044 -0.98 . . . . 73.13 110.735 -173.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -149.65 142.47 24.7 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 105.159 -2.163 . . . . 64.31 105.159 -170.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 73.52 66.1 0.1 Allowed 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 113.014 0.746 . . . . 72.54 113.014 -176.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.33 -14.0 61.23 Favored Glycine 0 N--CA 1.478 1.463 0 N-CA-C 117.187 1.635 . . . . 72.34 117.187 169.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 -114.55 120.29 39.71 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 105.349 -2.093 . . . . 72.14 105.349 149.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.56 101.84 13.52 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.587 -1.245 . . . . 75.52 108.747 -175.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.704 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 13.1 tp -172.0 70.54 0.04 OUTLIER 'General case' 0 C--N 1.387 2.207 0 CA-C-N 120.809 1.641 . . . . 71.22 112.599 -174.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.409 ' HB3' ' O ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -96.51 113.26 24.82 Favored 'General case' 0 CA--C 1.566 1.572 0 CA-C-N 122.375 2.352 . . . . 73.14 109.56 -174.257 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.469 ' H ' ' HB3' ' A' ' 69' ' ' CYS . 13.9 t -128.71 118.03 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.481 0 O-C-N 120.286 -1.509 . . . . 62.4 109.381 174.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -134.48 135.58 42.54 Favored 'General case' 0 C--O 1.263 1.807 0 CA-C-N 119.475 1.034 . . . . 75.4 109.944 -175.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.8 m -72.41 123.81 89.99 Favored Pre-proline 0 CA--C 1.551 1.017 0 CA-C-N 115.753 -0.658 . . . . 64.21 110.288 159.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -92.09 23.06 0.6 Allowed 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.441 2.094 . . . . 74.31 112.663 168.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -121.9 -57.61 1.79 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 121.403 -0.119 . . . . 75.2 110.88 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.6 t30 48.69 43.9 21.03 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 125.58 1.552 . . . . 73.15 112.764 -175.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -161.16 143.84 12.49 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 121.182 -0.949 . . . . 72.52 111.053 -171.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 168.9 150.55 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 C-N-CA 124.739 1.216 . . . . 75.13 109.436 -178.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 C--O 1.249 1.075 0 N-CA-C 107.234 -1.395 . . . . 74.12 107.234 167.161 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.16 0 CA-C-O 120.012 -0.326 . . . . 73.12 112.456 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 42.3 m 64.65 39.71 6.32 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.727 1.211 . . . . 74.44 114.167 170.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -148.12 160.98 42.33 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 109.873 -0.417 . . . . 72.34 109.873 174.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.5 ptp -160.93 97.12 1.14 Allowed 'General case' 0 N--CA 1.478 0.944 0 O-C-N 123.879 0.737 . . . . 73.15 111.188 173.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.7 p -163.59 113.41 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.197 0 CA-C-O 121.378 0.609 . . . . 63.41 110.948 177.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.3 tt -163.31 124.73 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.231 0 O-C-N 122.127 -0.358 . . . . 54.33 111.149 177.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -141.28 136.31 31.49 Favored 'General case' 0 C--N 1.355 0.808 0 N-CA-C 107.695 -1.224 . . . . 73.01 107.695 171.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 73.26 5.29 5.04 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 123.882 0.739 . . . . 74.23 112.71 167.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.9 t -99.46 -12.13 20.48 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.947 -0.47 . . . . 54.45 112.072 -171.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . 0.298 3.4 m 64.14 116.5 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.476 0 C-N-CA 126.751 2.02 . . . . 71.45 113.475 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.7 m -74.68 119.82 19.38 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.941 -0.572 . . . . 74.14 110.979 -177.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -140.65 160.04 40.89 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 113.682 0.993 . . . . 74.5 113.682 -177.069 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.2 mt -112.57 136.56 48.44 Favored 'Isoleucine or valine' 0 C--O 1.259 1.564 0 N-CA-C 106.866 -1.531 . . . . 44.42 106.866 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -92.92 115.06 27.77 Favored 'General case' 0 CA--C 1.565 1.541 0 O-C-N 125.815 1.947 . . . . 74.41 109.045 177.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.5 t -123.57 115.29 44.86 Favored 'Isoleucine or valine' 0 C--N 1.366 1.316 0 CA-C-N 119.922 1.237 . . . . 75.44 109.042 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -121.63 171.03 14.95 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 119.276 -1.44 . . . . 64.41 113.738 173.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 50.81 25.69 2.25 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 115.367 1.618 . . . . 51.12 115.367 176.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.24 140.84 57.06 Favored Pre-proline 0 CA--C 1.551 1.006 0 CA-C-N 119.144 0.883 . . . . 73.21 112.257 -170.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -76.15 142.69 24.75 Favored 'Trans proline' 0 CA--C 1.552 1.378 0 C-N-CA 122.992 2.461 . . . . 61.14 112.176 173.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.1 p 88.53 -32.25 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 126.719 2.008 . . . . 73.03 111.955 175.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 82.5 t60 69.13 105.29 0.06 Allowed 'General case' 0 C--N 1.361 1.069 0 C-N-CA 124.924 1.29 . . . . 75.41 111.184 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.8 m -77.99 117.8 23.88 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.849 0 N-CA-C 109.127 -0.694 . . . . 74.24 109.127 -176.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.8 154.92 29.51 Favored 'General case' 0 C--N 1.378 1.839 0 CA-C-O 118.165 -0.921 . . . . 55.11 111.028 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.0 t -49.42 -46.52 47.74 Favored 'General case' 0 C--N 1.38 1.893 0 N-CA-C 114.821 1.415 . . . . 74.13 114.821 -177.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . 0.314 0.0 OUTLIER -55.23 -43.29 74.41 Favored 'General case' 0 CA--C 1.588 2.414 0 N-CA-C 115.246 1.573 . . . . 73.01 115.246 172.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.92 -37.84 87.12 Favored 'General case' 0 C--N 1.378 1.812 0 CA-C-O 117.903 -1.046 . . . . 73.55 110.726 176.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.2 t -64.89 -43.75 96.28 Favored 'Isoleucine or valine' 0 C--N 1.403 2.931 0 CA-C-N 119.551 1.069 . . . . 71.02 110.657 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.62 -52.72 63.77 Favored 'General case' 0 C--N 1.378 1.818 0 CA-C-O 116.201 -1.857 . . . . 62.13 111.12 176.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.552 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 1.8 m-20 -77.54 -55.28 5.5 Favored 'General case' 0 C--O 1.3 3.72 0 CA-C-N 122.713 2.506 . . . . 71.1 116.576 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.449 ' O ' ' HD2' ' A' ' 31' ' ' TYR . 19.8 tt0 -59.93 -39.96 87.26 Favored 'General case' 0 C--N 1.371 1.522 0 CA-C-O 117.335 -1.317 . . . . 71.24 111.698 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . 0.263 73.9 m-85 -82.28 -21.64 36.09 Favored 'General case' 0 CA--C 1.575 1.909 0 CA-C-N 121.918 2.145 . . . . 74.15 113.986 174.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.552 ' HG3' ' O ' ' A' ' 26' ' ' ASN 0.269 0.0 OUTLIER -59.72 -28.45 67.35 Favored 'General case' 0 N--CA 1.531 3.583 0 CA-C-N 120.864 1.665 . . . . 74.41 112.719 169.627 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.432 ' HE2' ' CD1' ' A' ' 31' ' ' TYR 0.325 0.0 OUTLIER -76.1 -36.21 59.01 Favored 'General case' 0 N--CA 1.506 2.338 0 C-N-CA 114.518 -2.873 . . . . 75.35 113.216 170.305 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.523 ' HB3' ' HA ' ' A' ' 59' ' ' ALA . 20.8 m-85 -76.68 -43.85 36.13 Favored 'General case' 0 CA--C 1.564 1.481 0 N-CA-C 112.681 0.623 . . . . 73.04 112.681 -164.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -132.45 -175.93 14.19 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.557 -1.017 . . . . 72.35 110.557 151.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -87.01 98.13 11.1 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.839 1.82 . . . . 63.12 109.6 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.424 HG13 ' SG ' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -75.37 141.02 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 113.349 0.87 . . . . 72.1 113.349 -178.653 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 11.1 mp -108.67 -24.14 11.48 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 122.758 0.423 . . . . 74.51 110.246 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.62 139.42 15.19 Favored 'General case' 0 CA--C 1.58 2.102 0 C-N-CA 123.794 0.837 . . . . 45.21 110.41 -170.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.424 ' SG ' HG13 ' A' ' 34' ' ' ILE . 62.0 m -138.79 112.3 8.22 Favored 'General case' 0 N--CA 1.507 2.382 0 N-CA-C 107.622 -1.251 . . . . 75.31 107.622 177.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -118.32 136.98 53.39 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 116.454 -2.098 . . . . 73.53 111.746 175.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -123.83 111.8 30.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 121.893 0.854 . . . . 43.43 109.266 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -115.77 152.61 32.95 Favored 'General case' 0 CA--C 1.559 1.318 0 CA-C-N 114.848 -1.069 . . . . 74.53 109.428 -172.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.39 146.24 50.85 Favored 'General case' 0 CA--C 1.565 1.528 0 CA-C-N 120.945 1.702 . . . . 73.13 108.838 -172.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.3 t -100.7 175.43 5.65 Favored 'General case' 0 CA--C 1.563 1.474 0 CA-C-N 120.698 1.59 . . . . 63.44 110.852 174.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.4 t -78.67 -8.53 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 123.545 0.738 . . . . 72.42 112.411 -175.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.1 t -89.15 4.72 47.58 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 122.937 0.495 . . . . 74.22 110.27 -175.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.13 -7.25 64.19 Favored Glycine 0 CA--C 1.534 1.26 0 N-CA-C 114.921 0.728 . . . . 75.04 114.921 -178.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.06 130.85 35.95 Favored 'General case' 0 CA--C 1.556 1.187 0 CA-C-N 117.877 0.838 . . . . 72.13 109.724 172.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.16 146.03 42.61 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.057 -0.72 . . . . 36.79 109.057 -173.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -128.29 148.51 50.66 Favored 'General case' 0 C--N 1.36 1.037 0 CA-C-N 119.63 1.105 . . . . 64.4 111.483 -173.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -123.61 146.27 48.3 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.162 0.801 . . . . 54.1 113.162 169.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -132.97 115.26 14.97 Favored 'General case' 0 C--O 1.267 2.005 0 N-CA-C 105.596 -2.002 . . . . 74.25 105.596 -165.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 1.4 mp -120.54 110.19 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.497 0 C-N-CA 118.371 -1.331 . . . . 61.41 111.378 -169.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -105.37 104.0 13.64 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-O 121.35 0.595 . . . . 71.34 111.754 -173.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -117.55 168.75 10.12 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 114.123 1.157 . . . . 75.44 114.123 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -81.35 -33.86 32.14 Favored 'General case' 0 C--N 1.367 1.34 0 N-CA-C 113.963 1.098 . . . . 74.54 113.963 175.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -111.41 116.03 30.25 Favored 'General case' 0 C--N 1.349 0.576 0 N-CA-C 107.386 -1.338 . . . . 72.23 107.386 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.439 ' HB3' ' CD2' ' A' ' 82' ' ' PHE . . . -81.75 -28.78 33.15 Favored 'General case' 0 C--N 1.355 0.808 0 N-CA-C 114.647 1.351 . . . . 64.31 114.647 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.2 tmm_? -76.54 -41.07 47.96 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 114.2 1.185 . . . . 63.2 114.2 -170.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -70.65 -31.33 68.22 Favored 'General case' 0 CA--C 1.583 2.226 0 CA-C-N 121.459 1.936 . . . . 74.21 115.381 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.523 ' HA ' ' HB3' ' A' ' 31' ' ' TYR . . . -57.59 -22.16 43.32 Favored 'General case' 0 CA--C 1.596 2.743 0 N-CA-C 116.697 2.11 . . . . 62.21 116.697 169.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.47 -28.63 8.71 Favored 'General case' 0 CA--C 1.573 1.858 0 N-CA-C 114.758 1.392 . . . . 73.21 114.758 172.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -51.64 -54.42 28.15 Favored 'General case' 0 N--CA 1.504 2.266 0 CA-C-N 120.235 1.38 . . . . 73.32 112.644 162.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.64 -33.29 75.3 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 121.054 -1.029 . . . . 72.35 112.79 174.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . 0.303 0.0 OUTLIER -71.42 -46.41 64.31 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.607 0 C-N-CA 116.616 -2.034 . . . . 64.41 113.016 -178.619 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.445 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -55.06 -32.7 62.11 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 114.706 1.373 . . . . 72.41 114.706 164.221 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.51 -18.37 41.81 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.702 1.137 . . . . 63.34 112.413 -176.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -101.29 15.05 30.04 Favored 'General case' 0 CA--C 1.588 2.428 0 CA-C-O 119.413 -0.327 . . . . 73.32 111.653 166.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.445 ' HB3' ' HA ' ' A' ' 64' ' ' LYS 0.378 0.2 OUTLIER -77.86 163.87 25.67 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 115.629 1.715 . . . . 72.4 115.629 -166.861 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.74 30.14 2.26 Favored Glycine 0 N--CA 1.432 -1.601 0 CA-C-O 117.224 -1.876 . . . . 72.1 115.62 -170.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.837 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -52.01 123.33 10.19 Favored 'General case' 0 C--N 1.382 2.019 0 CA-C-N 118.307 1.053 . . . . 73.24 111.577 -169.864 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.2 151.79 51.5 Favored 'General case' 0 C--O 1.258 1.504 0 CA-C-N 114.53 -1.213 . . . . 63.23 111.996 -170.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -148.75 145.28 27.55 Favored 'General case' 0 C--N 1.361 1.108 0 C-N-CA 126.97 2.108 . . . . 73.44 107.036 -163.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 70.42 64.33 0.2 Allowed 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 114.098 1.147 . . . . 72.14 114.098 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.21 -13.96 61.42 Favored Glycine 0 N--CA 1.476 1.31 0 N-CA-C 116.523 1.369 . . . . 75.41 116.523 172.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -118.42 120.34 37.29 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 105.956 -1.868 . . . . 71.22 105.956 153.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.53 107.37 19.78 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 118.051 -0.976 . . . . 74.2 109.774 -178.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.837 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 22.1 tp -163.08 70.44 0.25 Allowed 'General case' 0 C--O 1.192 -1.955 0 CA-C-N 120.114 1.324 . . . . 71.23 111.201 178.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -101.3 110.8 22.87 Favored 'General case' 0 CA--C 1.556 1.203 0 CA-C-N 122.537 2.426 . . . . 74.45 110.213 -170.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.433 ' H ' ' HB3' ' A' ' 69' ' ' CYS . 90.8 t -126.88 118.23 49.97 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.732 0 O-C-N 120.097 -1.627 . . . . 62.3 107.5 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -145.28 131.43 19.41 Favored 'General case' 0 C--N 1.386 2.194 0 CA-C-N 120.694 1.588 . . . . 65.24 111.741 -170.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.401 ' HB ' ' CD2' ' A' ' 82' ' ' PHE . 15.7 m -88.44 134.24 34.79 Favored Pre-proline 0 C--N 1.349 0.576 0 CA-C-N 115.696 -0.684 . . . . 75.33 112.534 165.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -82.7 38.19 0.72 Allowed 'Trans proline' 0 CA--C 1.548 1.197 0 C-N-CA 122.322 2.014 . . . . 74.43 111.347 161.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.439 ' CD2' ' HB3' ' A' ' 56' ' ' ALA . 10.3 m-85 -125.56 52.01 1.67 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.452 -0.944 . . . . 53.32 108.452 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 61.7 m-20 -84.45 46.16 1.2 Allowed 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 115.597 -0.729 . . . . 71.5 110.055 175.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -170.16 33.4 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.628 1.171 . . . . 75.33 110.501 -172.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.417 ' HE ' ' HB1' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -144.5 43.48 1.39 Allowed 'General case' 0 N--CA 1.481 1.087 0 O-C-N 122.232 -0.292 . . . . 52.34 111.054 178.437 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.252 1.189 0 CA-C-O 118.419 -0.801 . . . . 71.21 109.992 177.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.077 0 N-CA-C 111.685 -0.566 . . . . 74.11 111.685 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 6.0 t -116.16 -178.32 3.38 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 110.248 -0.279 . . . . 64.24 110.248 -176.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -131.01 154.02 48.62 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 122.524 0.33 . . . . 74.23 111.343 -177.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -113.19 143.74 43.88 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.115 -0.493 . . . . 62.23 111.112 -177.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.4 t -119.88 127.17 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 116.372 -0.377 . . . . 43.12 110.325 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.1 pt -115.07 145.03 21.33 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 N-CA-C 109.756 -0.461 . . . . 75.41 109.756 176.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -135.95 142.54 44.61 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-O 118.485 -0.769 . . . . 72.41 110.893 169.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 68.34 84.08 0.15 Allowed 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 124.433 1.093 . . . . 73.31 111.202 171.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.0 t -145.32 165.14 29.3 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.424 -0.798 . . . . 63.11 110.918 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.7 m -114.72 126.37 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 108.857 -0.794 . . . . 73.01 108.857 176.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.13 137.45 34.07 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 119.368 -0.348 . . . . 74.03 110.19 -177.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.476 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 0.3 OUTLIER -138.71 159.19 42.72 Favored 'General case' 0 N--CA 1.509 2.524 0 CA-C-N 118.618 0.645 . . . . 60.31 111.909 -173.519 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.408 ' HB ' ' CD1' ' A' ' 51' ' ' ILE . 5.2 mp -134.48 133.77 54.79 Favored 'Isoleucine or valine' 0 C--O 1.269 2.082 0 N-CA-C 107.84 -1.17 . . . . 72.32 107.84 -177.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -108.54 114.4 28.2 Favored 'General case' 0 CA--C 1.57 1.731 0 O-C-N 125.877 1.986 . . . . 75.24 110.061 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.6 p -123.43 104.76 14.72 Favored 'Isoleucine or valine' 0 C--N 1.372 1.563 0 CA-C-N 120.555 1.525 . . . . 37.78 108.915 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -128.9 169.63 20.28 Favored Glycine 0 C--N 1.364 2.103 0 C-N-CA 120.374 -0.917 . . . . 63.02 114.747 -174.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.5 m120 49.24 24.8 1.06 Allowed 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 114.037 1.125 . . . . 70.14 114.037 -175.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.474 ' CD1' HG12 ' A' ' 19' ' ' VAL . 2.0 pt? -85.12 149.98 54.03 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 125.439 1.496 . . . . 73.13 111.775 -171.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -72.13 140.98 35.27 Favored 'Trans proline' 0 C--N 1.367 1.532 0 C-N-CA 121.925 1.75 . . . . 74.34 111.56 173.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.4 p 82.5 -34.38 0.09 Allowed 'General case' 0 C--N 1.386 2.177 0 C-N-CA 126.857 2.063 . . . . 43.33 111.483 177.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 45.7 m-70 64.21 84.77 0.14 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.509 1.523 . . . . 74.31 110.109 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.474 HG12 ' CD1' ' A' ' 15' ' ' LEU . 5.5 p -59.88 120.49 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.517 0 O-C-N 124.095 0.872 . . . . 75.13 110.503 -176.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.0 m -80.98 156.69 25.81 Favored 'General case' 0 C--N 1.363 1.174 0 CA-C-O 118.204 -0.903 . . . . 54.54 108.931 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.7 p -48.98 -37.29 19.79 Favored 'General case' 0 C--N 1.375 1.7 0 N-CA-C 115.795 1.776 . . . . 73.1 115.795 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . 0.255 0.0 OUTLIER -56.1 -47.62 77.71 Favored 'General case' 0 CA--C 1.588 2.433 0 N-CA-C 113.948 1.092 . . . . 62.14 113.948 173.191 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.401 ' HB2' HG21 ' A' ' 19' ' ' VAL . 13.6 m-20 -62.68 -50.97 69.06 Favored 'General case' 0 C--O 1.266 1.945 0 C-N-CA 123.686 0.794 . . . . 75.44 112.238 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.687 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -59.92 -46.18 94.26 Favored 'Isoleucine or valine' 0 C--N 1.372 1.55 0 CA-C-O 118.527 -0.749 . . . . 75.14 111.795 175.643 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.543 ' O ' ' HB3' ' A' ' 29' ' ' ARG 0.281 0.7 OUTLIER -52.5 -51.14 60.98 Favored 'General case' 0 C--O 1.202 -1.405 0 CA-C-O 115.647 -2.12 . . . . 72.53 112.049 171.217 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -71.73 -62.93 1.24 Allowed 'General case' 1 C--O 1.305 4.016 0 CA-C-N 124.537 3.335 . . . . 72.41 114.123 -178.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -72.8 -29.85 63.59 Favored 'General case' 0 C--N 1.371 1.512 0 O-C-N 120.495 -1.378 . . . . 71.42 112.118 -173.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.687 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 6.8 m-85 -84.05 -31.93 25.12 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 117.374 -1.298 . . . . 74.54 112.582 177.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.543 ' HB3' ' O ' ' A' ' 25' ' ' GLU . 3.3 ptt85 -51.46 -29.33 15.87 Favored 'General case' 0 N--CA 1.508 2.46 0 CA-C-O 116.353 -1.784 . . . . 70.4 114.355 164.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.41 -48.16 71.94 Favored 'General case' 0 N--CA 1.514 2.765 0 C-N-CA 114.775 -2.77 . . . . 63.21 113.2 164.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -79.99 -40.32 28.18 Favored 'General case' 0 CA--C 1.563 1.477 0 CA-C-N 119.082 0.856 . . . . 75.55 112.058 -170.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 29' ' ' ARG . . . -137.18 156.9 23.62 Favored Glycine 0 C--N 1.357 1.716 0 CA-C-N 120.245 1.384 . . . . 64.32 112.249 167.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -84.47 109.92 18.26 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.045 -0.724 . . . . 74.4 109.045 -170.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.74 121.42 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 113.439 0.904 . . . . 63.33 113.439 -176.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.81 -17.83 14.9 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.9 -0.778 . . . . 62.42 108.9 170.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -156.47 128.86 7.57 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 109.071 -0.714 . . . . 74.4 109.071 -165.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.4 p -143.04 107.99 4.92 Favored 'General case' 0 C--N 1.362 1.118 0 CA-C-N 119.34 0.973 . . . . 74.32 108.957 174.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -116.78 146.84 42.57 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 118.524 -1.27 . . . . 44.25 111.994 178.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.6 t -108.85 121.45 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 108.308 -0.997 . . . . 74.34 108.308 177.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -120.56 130.96 54.44 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 109.151 -0.685 . . . . 71.32 109.151 -176.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.98 128.6 51.66 Favored 'General case' 0 C--N 1.372 1.55 0 C-N-CA 117.839 -1.544 . . . . 63.13 111.127 -165.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.6 t -100.09 159.36 15.16 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 118.168 -1.413 . . . . 71.42 112.436 177.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.8 t -73.99 -7.99 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.408 0 C-N-CA 123.868 0.867 . . . . 75.14 112.377 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.4 t -85.23 7.78 20.81 Favored 'General case' 0 CA--C 1.55 0.968 0 O-C-N 121.489 -0.757 . . . . 65.43 110.601 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.34 -5.96 70.46 Favored Glycine 0 CA--C 1.532 1.13 0 N-CA-C 115.241 0.856 . . . . 52.05 115.241 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.48 132.38 33.94 Favored 'General case' 0 CA--C 1.558 1.283 0 CA-C-N 118.078 0.939 . . . . 74.44 110.713 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.91 142.38 34.87 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 107.439 -1.319 . . . . 37.78 107.439 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -130.79 145.99 52.12 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 106.944 -1.502 . . . . 71.21 106.944 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -118.22 138.2 52.5 Favored 'General case' 0 C--O 1.253 1.248 0 C-N-CA 119.114 -1.034 . . . . 65.04 109.798 173.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -116.84 120.45 38.54 Favored 'General case' 0 C--O 1.252 1.207 0 CA-C-N 114.516 -1.22 . . . . 72.45 108.848 -169.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.408 ' CD1' ' HB ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -132.84 112.66 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 123.122 0.263 . . . . 70.35 110.581 -166.902 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -103.07 113.11 26.31 Favored 'General case' 0 CA--C 1.565 1.529 0 CA-C-N 118.554 0.615 . . . . 72.13 112.169 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -108.74 164.14 12.64 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 112.742 0.645 . . . . 61.23 112.742 -176.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -78.85 -39.64 34.8 Favored 'General case' 0 N--CA 1.51 2.532 0 N-CA-C 113.37 0.878 . . . . 74.51 113.37 174.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.95 117.7 32.79 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 118.96 0.8 . . . . 72.24 109.615 -177.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.79 -26.32 57.21 Favored 'General case' 0 CA--C 1.556 1.19 0 N-CA-C 115.022 1.49 . . . . 73.22 115.022 175.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.321 0.0 OUTLIER -79.57 -28.2 41.16 Favored 'General case' 0 CA--C 1.57 1.74 0 CA-C-N 121.649 2.022 . . . . 74.12 114.803 -176.7 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.02 -30.23 49.89 Favored 'General case' 0 CA--C 1.591 2.552 0 CA-C-N 121.837 2.108 . . . . 73.2 115.668 174.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.74 -24.33 21.78 Favored 'General case' 0 CA--C 1.597 2.787 0 CA-C-N 120.551 1.523 . . . . 62.14 114.615 166.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.524 ' O ' ' HG3' ' A' ' 64' ' ' LYS . . . -48.41 -39.37 22.28 Favored 'General case' 0 CA--C 1.569 1.691 0 C-N-CA 125.368 1.467 . . . . 62.32 114.061 173.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.423 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 2.1 m-20 -53.76 -50.82 65.17 Favored 'General case' 0 C--N 1.382 2.005 0 CA-C-N 120.473 1.488 . . . . 75.52 112.771 169.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.09 -44.99 91.98 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 118.454 -0.784 . . . . 62.31 112.65 174.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . 0.254 2.3 tt -69.94 -50.04 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 117.247 -1.781 . . . . 73.03 112.504 -174.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -56.9 -26.33 58.84 Favored 'General case' 0 CA--C 1.561 1.399 0 N-CA-C 115.57 1.692 . . . . 73.33 115.57 167.741 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.47 -20.11 37.53 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 121.369 1.895 . . . . 75.42 111.03 179.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.5 mttt -110.21 16.72 21.57 Favored 'General case' 0 CA--C 1.578 2.023 0 O-C-N 122.304 -0.248 . . . . 63.42 111.318 176.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.32 0.1 OUTLIER -78.23 161.4 27.32 Favored 'General case' 0 C--N 1.377 1.772 0 N-CA-C 112.988 0.736 . . . . 71.34 112.988 -176.188 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.38 26.04 3.57 Favored Glycine 0 N--CA 1.434 -1.499 0 C-N-CA 119.226 -1.464 . . . . 63.35 113.574 -160.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.801 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -55.15 123.63 14.29 Favored 'General case' 0 C--N 1.365 1.28 0 CA-C-N 117.545 0.672 . . . . 62.01 110.317 -176.628 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -133.19 151.3 51.96 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-N 115.792 -0.64 . . . . 72.42 112.122 -169.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -149.12 144.19 26.48 Favored 'General case' 0 C--N 1.354 0.78 0 C-N-CA 126.764 2.026 . . . . 62.24 106.779 -165.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 71.43 64.37 0.15 Allowed 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 113.43 0.9 . . . . 75.32 113.43 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.66 -13.72 62.35 Favored Glycine 0 N--CA 1.47 0.951 0 N-CA-C 117.081 1.592 . . . . 73.44 117.081 172.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -119.23 119.4 33.99 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 106.079 -1.823 . . . . 73.31 106.079 153.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.99 102.9 14.74 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 118.732 -1.187 . . . . 73.54 108.05 -171.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.801 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -160.57 65.99 0.32 Allowed 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 116.796 -1.574 . . . . 73.11 115.171 -177.673 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.29 114.86 27.29 Favored 'General case' 0 CA--C 1.578 2.05 0 CA-C-N 124.109 3.141 . . . . 73.4 111.962 -172.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.9 t -120.28 116.57 50.67 Favored 'Isoleucine or valine' 0 C--N 1.363 1.17 0 O-C-N 119.752 -1.842 . . . . 72.54 107.793 165.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -142.95 142.06 31.58 Favored 'General case' 0 C--N 1.362 1.116 0 C-N-CA 117.193 -1.803 . . . . 74.03 111.622 168.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.9 m -82.96 127.15 70.65 Favored Pre-proline 0 N--CA 1.442 -0.828 0 CA-C-N 114.676 -1.147 . . . . 71.42 110.556 169.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.476 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 57.9 Cg_endo -85.5 25.32 0.7 Allowed 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 121.6 1.533 . . . . 74.42 112.341 164.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -105.3 -31.59 9.01 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 120.414 -0.514 . . . . 74.41 111.048 174.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 50.7 69.98 0.57 Allowed 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 125.057 1.343 . . . . 74.42 113.26 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 66.47 -157.4 0.25 Allowed 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 124.247 1.019 . . . . 74.33 111.754 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -96.13 -83.7 0.37 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 118.996 0.816 . . . . 63.41 110.254 -172.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 . . . . . 0 C--O 1.256 1.419 0 CA-C-O 118.704 -0.665 . . . . 74.42 109.816 177.684 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.97 0 N-CA-C 112.206 -0.358 . . . . 72.03 112.206 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -1' ' ' SER . . . . . 0.417 ' O ' ' HB3' ' A' ' 86' ' ' GLU . 6.6 p -145.73 159.48 43.11 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 123.041 0.536 . . . . 64.24 109.588 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 47.7 m80 -145.45 121.57 10.78 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 110.033 -0.358 . . . . 75.11 110.033 177.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.3 mtt -135.97 173.49 11.65 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.269 0.228 . . . . 73.12 111.458 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.7 m -97.51 143.54 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 116.307 -0.406 . . . . 63.22 111.737 -177.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.2 pt -127.68 132.53 68.95 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.261 0 CA-C-N 115.796 -0.638 . . . . 71.35 109.667 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 52.9 mtt85 -133.37 123.53 25.55 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-O 117.944 -1.027 . . . . 73.2 108.448 173.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 76.24 72.83 0.08 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 124.141 0.901 . . . . 63.45 110.206 170.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.4 t -140.95 166.35 25.01 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.509 -0.745 . . . . 73.11 110.248 -176.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.08 110.87 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 121.04 0.448 . . . . 73.35 109.943 177.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.79 124.52 31.0 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 115.363 -0.835 . . . . 72.32 109.625 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.505 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 4.9 ptt180 -140.59 157.53 45.34 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 118.837 -0.601 . . . . 63.42 112.394 -177.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.8 mt -118.15 135.17 59.42 Favored 'Isoleucine or valine' 0 C--N 1.368 1.41 0 CA-C-N 119.47 1.032 . . . . 74.54 109.075 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -105.97 118.54 36.86 Favored 'General case' 0 CA--C 1.568 1.661 0 O-C-N 125.281 1.613 . . . . 63.54 110.445 -177.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.3 t -124.2 107.52 18.76 Favored 'Isoleucine or valine' 0 C--N 1.373 1.619 0 CA-C-N 120.439 1.472 . . . . 71.32 109.287 -177.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -120.18 163.93 13.88 Favored Glycine 0 C--N 1.344 1.021 0 C-N-CA 118.845 -1.645 . . . . 74.32 112.818 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.3 m120 50.45 26.89 2.53 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 114.772 1.397 . . . . 73.32 114.772 177.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.69 149.72 86.09 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.543 1.537 . . . . 74.21 111.415 -177.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -79.92 129.17 7.89 Favored 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 121.565 1.51 . . . . 73.24 111.27 176.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 96.7 p 57.55 102.56 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 124.647 1.179 . . . . 73.13 112.357 -171.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 32.0 p-80 -57.15 125.31 22.13 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.529 -0.76 . . . . 65.52 111.781 -177.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.9 p -77.61 119.29 26.01 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 CA-C-N 114.85 -1.068 . . . . 63.44 109.006 -176.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.0 m -79.4 157.37 27.6 Favored 'General case' 0 C--N 1.369 1.45 0 CA-C-O 117.955 -1.022 . . . . 73.02 108.581 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.8 p -48.97 -37.53 20.43 Favored 'General case' 0 C--N 1.375 1.698 0 N-CA-C 115.926 1.825 . . . . 71.14 115.926 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.491 ' H ' ' HD3' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -56.6 -40.72 75.79 Favored 'General case' 0 N--CA 1.507 2.381 0 N-CA-C 114.547 1.314 . . . . 75.14 114.547 172.692 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -70.7 -45.93 64.07 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 118.955 0.798 . . . . 75.03 111.173 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.685 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 2.4 m -61.63 -49.75 83.07 Favored 'Isoleucine or valine' 0 C--N 1.372 1.572 0 N-CA-C 112.085 0.402 . . . . 72.43 112.085 174.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -50.09 -53.69 25.51 Favored 'General case' 0 CA--C 1.562 1.411 0 CA-C-O 116.528 -1.701 . . . . 74.21 113.226 171.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -73.09 -63.07 1.25 Allowed 'General case' 0 C--O 1.302 3.843 0 CA-C-N 122.901 2.591 . . . . 52.14 114.29 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -72.54 -30.79 64.76 Favored 'General case' 0 C--N 1.365 1.265 0 C-N-CA 119.031 -1.068 . . . . 74.21 111.172 -174.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.685 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 17.9 m-85 -85.85 -23.19 27.21 Favored 'General case' 0 CA--C 1.56 1.341 0 CA-C-N 119.536 1.062 . . . . 72.34 111.391 -178.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . 0.295 1.8 ppt_? -60.62 -24.5 65.56 Favored 'General case' 0 C--N 1.401 2.828 0 CA-C-N 120.602 1.546 . . . . 71.25 112.341 165.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . 0.297 0.0 OUTLIER -53.55 -30.77 43.47 Favored 'General case' 0 N--CA 1.508 2.466 0 C-N-CA 117.123 -1.831 . . . . 71.52 114.042 164.237 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -85.67 -49.47 7.96 Favored 'General case' 0 C--O 1.214 -0.793 0 CA-C-N 121.564 1.984 . . . . 73.04 112.279 -157.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -160.55 39.9 0.44 Allowed Glycine 0 C--N 1.355 1.613 0 C-N-CA 117.89 -2.1 . . . . 64.11 114.507 171.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.3 t30 69.33 93.78 0.08 Allowed 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 124.37 1.068 . . . . 72.32 111.435 173.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.95 129.75 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-N 115.537 -0.756 . . . . 72.51 112.553 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.79 -21.73 12.54 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 109.553 -0.536 . . . . 73.35 109.553 174.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.22 131.63 15.67 Favored 'General case' 0 CA--C 1.561 1.394 0 N-CA-C 108.57 -0.9 . . . . 62.52 108.57 -173.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -138.55 110.59 7.28 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 120.126 1.33 . . . . 64.31 109.803 176.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -118.64 145.98 45.02 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 117.875 -1.53 . . . . 73.31 111.499 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 37.1 t -114.9 112.76 41.36 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 N-CA-C 107.623 -1.251 . . . . 72.53 107.623 172.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -114.7 129.83 56.74 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 114.825 -1.079 . . . . 75.42 108.739 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.09 144.52 51.48 Favored 'General case' 0 C--N 1.369 1.433 0 CA-C-N 121.004 1.729 . . . . 64.21 108.998 -171.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.415 HG21 ' H ' ' A' ' 44' ' ' SER . 8.8 t -99.06 170.99 8.32 Favored 'General case' 0 CA--C 1.558 1.288 0 CA-C-N 120.499 1.5 . . . . 43.42 111.738 -178.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.7 t -73.63 -7.07 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.368 0 C-N-CA 124.113 0.965 . . . . 73.23 112.577 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.415 ' H ' HG21 ' A' ' 42' ' ' THR . 8.5 t -85.41 8.36 19.19 Favored 'General case' 0 CA--C 1.55 0.965 0 O-C-N 121.59 -0.694 . . . . 65.41 111.04 -177.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.42 -4.89 75.73 Favored Glycine 0 C--N 1.351 1.4 0 N-CA-C 115.178 0.831 . . . . 54.21 115.178 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.19 131.27 34.24 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 117.726 0.763 . . . . 71.5 110.484 176.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -105.34 147.76 27.81 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 108.045 -1.094 . . . . 43.45 108.045 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -126.67 147.27 49.95 Favored 'General case' 0 C--N 1.352 0.7 0 C-N-CA 118.609 -1.236 . . . . 74.1 109.7 177.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -117.08 138.75 51.41 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 120.538 -0.465 . . . . 74.14 109.751 176.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.13 113.83 15.58 Favored 'General case' 0 C--O 1.261 1.662 0 N-CA-C 106.709 -1.589 . . . . 64.33 106.709 -175.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.18 113.9 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 C-N-CA 118.699 -1.2 . . . . 71.52 109.72 -170.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -91.62 115.38 28.0 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 114.567 -1.197 . . . . 61.34 112.481 -172.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -109.39 159.58 16.89 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 114.279 1.214 . . . . 71.51 114.279 -177.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -82.04 -43.33 18.07 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 120.115 -0.634 . . . . 63.14 112.315 172.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.452 ' OD1' ' HD2' ' A' ' 57' ' ' ARG . 6.0 t0 -116.41 127.02 54.26 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 118.923 0.783 . . . . 74.41 110.896 -174.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.03 -22.21 53.38 Favored 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 115.548 1.684 . . . . 63.1 115.548 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.452 ' HD2' ' OD1' ' A' ' 55' ' ' ASP 0.289 0.0 OUTLIER -76.73 -41.32 45.47 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 121.939 2.154 . . . . 65.41 113.273 -173.191 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -62.69 -48.85 77.5 Favored 'General case' 0 N--CA 1.505 2.319 0 CA-C-N 120.217 1.371 . . . . 72.32 113.499 178.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.55 -24.62 33.25 Favored 'General case' 0 CA--C 1.567 1.596 0 N-CA-C 115.477 1.658 . . . . 71.44 115.477 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -46.68 -44.37 18.55 Favored 'General case' 0 CA--C 1.576 1.967 0 C-N-CA 125.31 1.444 . . . . 73.31 114.025 173.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -51.83 -53.47 39.81 Favored 'General case' 0 N--CA 1.514 2.739 0 CA-C-N 119.523 1.056 . . . . 65.51 112.822 173.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.622 ' O ' ' HD2' ' A' ' 66' ' ' LYS . . . -75.67 -30.21 59.32 Favored 'General case' 0 C--N 1.31 -1.141 0 O-C-N 120.467 -1.396 . . . . 73.2 112.868 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.496 HD12 HG21 ' A' ' 63' ' ' ILE 0.256 5.9 mm -68.78 -46.23 79.78 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.921 0 C-N-CA 118.174 -1.41 . . . . 54.43 111.915 179.205 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.94 -32.83 66.38 Favored 'General case' 0 CA--C 1.562 1.44 0 N-CA-C 115.155 1.539 . . . . 71.21 115.155 164.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -64.36 -28.39 69.66 Favored 'General case' 0 N--CA 1.507 2.377 0 CA-C-N 120.542 1.519 . . . . 75.41 113.201 173.12 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.622 ' HD2' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -107.41 15.17 25.19 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 116.221 1.934 . . . . 74.52 116.221 164.6 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.33 0.0 OUTLIER -78.63 157.21 28.73 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 120.238 1.381 . . . . 73.13 110.941 179.597 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.52 30.85 1.77 Allowed Glycine 0 N--CA 1.428 -1.889 0 C-N-CA 117.526 -2.273 . . . . 73.3 113.622 -151.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.75 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 6.9 t -49.07 132.69 19.04 Favored 'General case' 0 C--N 1.376 1.74 0 CA-C-O 122.062 0.934 . . . . 65.43 111.049 172.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -128.92 147.13 50.81 Favored 'General case' 0 C--O 1.246 0.914 0 CA-C-N 113.951 -1.477 . . . . 72.4 112.836 -170.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.63 144.91 24.72 Favored 'General case' 0 C--N 1.355 0.83 0 C-N-CA 126.83 2.052 . . . . 74.22 108.154 -156.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 70.91 62.28 0.18 Allowed 'General case' 0 N--CA 1.501 2.086 0 O-C-N 123.611 0.569 . . . . 74.51 112.473 173.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.95 -14.79 64.15 Favored Glycine 0 N--CA 1.472 1.036 0 N-CA-C 116.952 1.541 . . . . 73.33 116.952 173.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -123.11 119.74 31.19 Favored 'General case' 0 C--O 1.211 -0.942 0 N-CA-C 104.592 -2.373 . . . . 74.43 104.592 159.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.54 131.44 51.93 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 118.02 -1.472 . . . . 73.42 111.281 -177.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.75 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -171.33 70.69 0.05 OUTLIER 'General case' 0 C--O 1.199 -1.594 0 CA-C-O 117.981 -1.009 . . . . 72.41 110.589 -178.417 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.0 tpp85 -93.0 115.62 28.29 Favored 'General case' 0 CA--C 1.571 1.763 0 CA-C-N 121.572 1.987 . . . . 74.25 111.411 -172.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.04 116.09 48.76 Favored 'Isoleucine or valine' 0 C--N 1.361 1.079 0 N-CA-C 107.558 -1.275 . . . . 64.03 107.558 163.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.2 tp10 -134.46 138.66 44.93 Favored 'General case' 0 C--N 1.363 1.178 0 CA-C-N 119.576 1.08 . . . . 75.42 110.427 174.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.0 m -90.3 122.39 67.48 Favored Pre-proline 0 N--CA 1.439 -0.998 0 C-N-CA 120.016 -0.673 . . . . 71.51 110.579 170.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.505 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 75.5 Cg_endo -89.74 22.77 0.76 Allowed 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 121.887 1.725 . . . . 74.1 113.378 168.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.447 ' HD2' ' N ' ' A' ' 9' ' ' ARG . 0.8 OUTLIER -113.32 -16.84 12.43 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 120.009 -0.676 . . . . 70.34 112.417 175.426 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.6 m120 70.87 123.9 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 124.957 1.411 . . . . 71.42 110.271 -171.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.66 60.04 2.64 Favored 'General case' 0 C--N 1.365 1.259 0 CA-C-N 119.481 1.037 . . . . 75.22 113.123 -173.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.48 39.17 5.23 Favored 'General case' 0 C--N 1.366 1.313 0 C-N-CA 125.681 1.592 . . . . 62.33 110.393 178.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.417 ' HB3' ' O ' ' A' ' -1' ' ' SER . 19.3 mm-40 . . . . . 0 CA--C 1.552 1.051 0 C-N-CA 124.091 0.956 . . . . 65.53 112.958 170.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.511 0 N-CA-C 112.116 -0.394 . . . . 61.22 112.116 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 23.4 p -135.14 -9.6 2.27 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 122.748 0.419 . . . . 64.13 112.117 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -142.78 174.52 10.58 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.205 0.202 . . . . 72.25 110.826 178.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.465 ' SD ' ' HD3' ' A' ' 85' ' ' ARG . 30.6 ttp -164.1 87.65 0.5 Allowed 'General case' 0 C--N 1.345 0.408 0 O-C-N 123.621 0.576 . . . . 74.32 109.567 175.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 44.0 t 69.26 136.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 C-N-CA 125.467 1.507 . . . . 71.21 112.668 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.0 tt -130.93 -46.78 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.202 0 O-C-N 121.2 -0.937 . . . . 61.01 112.728 174.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.6 tpt180 -171.98 54.52 0.02 OUTLIER 'General case' 0 C--N 1.355 0.805 0 CA-C-N 119.21 0.914 . . . . 71.13 109.803 -173.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 68.96 92.59 0.08 Allowed 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 124.574 1.15 . . . . 74.34 110.88 177.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.1 t -121.38 -166.83 1.41 Allowed 'General case' 0 CA--C 1.551 0.995 0 O-C-N 121.094 -1.004 . . . . 72.45 110.573 -178.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.9 m -142.58 115.55 3.71 Favored 'Isoleucine or valine' 0 C--N 1.353 0.745 0 N-CA-C 106.637 -1.616 . . . . 70.21 106.637 175.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.68 122.88 29.22 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 122.017 -0.427 . . . . 74.22 112.092 -172.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.491 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -126.59 154.76 43.5 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.044 0.757 . . . . 73.43 113.044 -176.299 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.416 HD13 HG13 ' A' ' 63' ' ' ILE . 23.4 mt -116.79 141.17 36.07 Favored 'Isoleucine or valine' 0 C--O 1.254 1.31 0 CA-C-N 119.446 1.021 . . . . 75.34 108.637 179.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -101.71 116.99 33.96 Favored 'General case' 0 CA--C 1.572 1.797 0 O-C-N 125.991 2.057 . . . . 70.41 110.073 177.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.37 105.67 14.15 Favored 'Isoleucine or valine' 0 C--N 1.381 1.95 0 CA-C-N 119.348 0.977 . . . . 73.12 108.754 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -113.12 -175.66 19.36 Favored Glycine 0 CA--C 1.521 0.445 0 CA-C-O 118.504 -1.164 . . . . 73.33 112.991 176.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.7 m120 54.09 28.8 9.34 Favored 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 115.701 1.741 . . . . 74.1 115.701 170.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.3 mt -89.08 150.79 45.87 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 123.51 0.724 . . . . 73.54 111.629 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -59.35 130.73 37.21 Favored 'Trans proline' 0 CA--C 1.556 1.582 0 C-N-CA 123.095 2.53 . . . . 61.22 113.232 173.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.0 p 71.98 -5.11 1.79 Allowed 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 126.473 1.909 . . . . 71.22 114.525 168.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 71.54 129.8 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.062 1.345 . . . . 74.13 110.605 -173.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.9 m -91.68 119.78 39.61 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.443 0 N-CA-C 107.424 -1.324 . . . . 73.15 107.424 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.44 157.47 24.91 Favored 'General case' 0 C--N 1.381 1.972 0 O-C-N 120.263 -1.523 . . . . 64.02 109.991 -175.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.0 p -58.96 -34.25 71.58 Favored 'General case' 0 C--N 1.378 1.836 0 N-CA-C 115.835 1.791 . . . . 72.24 115.835 -174.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . 0.274 0.0 OUTLIER -60.75 -39.14 87.61 Favored 'General case' 0 CA--C 1.582 2.199 0 N-CA-C 115.477 1.658 . . . . 73.21 115.477 172.377 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -65.32 -50.47 65.54 Favored 'General case' 0 C--O 1.279 2.622 0 CA-C-N 119.87 1.214 . . . . 73.4 111.329 178.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.7 m -62.94 -43.75 99.19 Favored 'Isoleucine or valine' 0 C--N 1.376 1.759 0 O-C-N 123.546 0.529 . . . . 53.31 111.877 177.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.13 -50.16 67.54 Favored 'General case' 0 C--O 1.191 -2.015 0 CA-C-O 115.195 -2.336 . . . . 75.44 115.202 169.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.41 -56.63 7.81 Favored 'General case' 0 C--O 1.283 2.85 0 CA-C-N 123.257 2.753 . . . . 51.32 114.071 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -61.18 -44.56 97.1 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 117.903 -1.046 . . . . 64.3 111.71 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -74.59 -28.54 60.95 Favored 'General case' 0 C--O 1.209 -1.04 0 CA-C-N 120.857 1.662 . . . . 62.33 114.194 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . 0.379 0.0 OUTLIER -57.62 -37.88 74.03 Favored 'General case' 0 N--CA 1.526 3.353 0 CA-C-N 121.285 1.857 . . . . 74.33 114.252 164.025 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.417 ' HE2' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -56.6 -47.75 78.91 Favored 'General case' 0 N--CA 1.508 2.475 0 C-N-CA 116.194 -2.202 . . . . 64.3 110.319 167.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.486 ' HB3' ' HA ' ' A' ' 59' ' ' ALA . 35.2 m-85 -72.64 -39.47 67.16 Favored 'General case' 0 CA--C 1.564 1.505 0 CA-C-O 118.065 -0.969 . . . . 70.32 112.79 -166.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -150.11 176.07 28.91 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-N 119.965 1.257 . . . . 74.22 110.722 161.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 47.1 m-20 -83.58 101.14 11.26 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.249 2.024 . . . . 75.31 111.077 -176.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.91 134.41 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.108 0.48 . . . . 64.31 112.034 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.5 mp -102.77 -24.86 13.69 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 116.097 -0.501 . . . . 74.51 111.992 171.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.53 138.0 13.97 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 109.249 -0.648 . . . . 74.43 109.249 -173.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -140.27 108.73 5.86 Favored 'General case' 0 C--N 1.359 0.982 0 CA-C-N 118.727 0.694 . . . . 72.43 109.545 178.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -120.8 143.68 48.71 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 117.852 -1.539 . . . . 61.15 112.643 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -127.15 112.8 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 CA-C-O 121.452 0.644 . . . . 62.43 110.284 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.5 mttm -113.41 152.43 30.07 Favored 'General case' 0 CA--C 1.56 1.336 0 CA-C-O 118.018 -0.991 . . . . 73.23 108.874 -174.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.37 147.19 50.27 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-N 121.755 2.071 . . . . 70.51 109.061 -174.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.417 HG21 ' H ' ' A' ' 44' ' ' SER . 5.8 t -98.88 175.65 5.87 Favored 'General case' 0 CA--C 1.565 1.53 0 CA-C-N 120.816 1.644 . . . . 72.11 111.356 175.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.5 t -77.51 -8.99 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.387 0 C-N-CA 123.486 0.714 . . . . 71.32 112.115 -178.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.417 ' H ' HG21 ' A' ' 42' ' ' THR . 8.2 t -86.14 -0.8 56.53 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 121.773 -0.579 . . . . 54.03 110.753 -177.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.06 -7.46 66.81 Favored Glycine 0 CA--C 1.534 1.258 0 N-CA-C 114.977 0.751 . . . . 52.23 114.977 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.31 132.26 37.38 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 117.728 0.764 . . . . 73.32 108.952 170.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.88 145.35 44.68 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.022 -0.733 . . . . 51.21 109.022 -171.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -127.04 151.16 48.97 Favored 'General case' 0 C--N 1.363 1.16 0 CA-C-N 119.783 1.174 . . . . 74.53 112.0 -170.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -127.57 147.0 50.34 Favored 'General case' 0 C--N 1.351 0.642 0 CA-C-O 121.705 0.764 . . . . 70.05 111.831 175.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -132.69 113.31 12.84 Favored 'General case' 0 C--O 1.256 1.407 0 N-CA-C 105.392 -2.077 . . . . 73.33 105.392 -164.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 0.6 OUTLIER -126.38 108.91 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 C-N-CA 118.186 -1.406 . . . . 73.15 108.865 -170.525 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -106.27 106.0 16.3 Favored 'General case' 0 CA--C 1.549 0.905 0 O-C-N 124.6 1.187 . . . . 72.43 110.233 -173.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.19 146.6 39.0 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-O 118.681 -0.676 . . . . 74.21 112.766 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -57.46 -24.21 54.4 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 114.657 1.354 . . . . 72.25 114.657 166.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -114.09 113.42 24.7 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 119.603 1.092 . . . . 74.43 109.015 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.29 -43.68 32.37 Favored 'General case' 0 CA--C 1.554 1.103 0 N-CA-C 115.426 1.639 . . . . 72.43 115.426 172.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.305 0.0 OUTLIER -77.49 -29.57 52.66 Favored 'General case' 0 C--N 1.373 1.589 0 CA-C-N 121.117 1.78 . . . . 75.35 114.916 -167.831 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.17 -30.17 63.36 Favored 'General case' 0 CA--C 1.581 2.17 0 N-CA-C 116.353 1.983 . . . . 74.43 116.353 176.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.486 ' HA ' ' HB3' ' A' ' 31' ' ' TYR . . . -72.99 -19.28 61.24 Favored 'General case' 0 CA--C 1.585 2.302 0 CA-C-N 120.367 1.439 . . . . 44.13 111.993 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -48.58 -29.78 4.62 Favored 'General case' 0 CA--C 1.572 1.825 0 CA-C-O 116.97 -1.49 . . . . 53.34 114.325 170.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.556 ' O ' ' HB3' ' A' ' 65' ' ' GLU . 18.8 m-20 -51.88 -53.38 41.31 Favored 'General case' 0 C--N 1.398 2.708 0 CA-C-N 121.025 1.739 . . . . 62.32 111.571 164.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.02 -34.8 79.3 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-O 117.824 -1.084 . . . . 72.33 113.689 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.416 HG13 HD13 ' A' ' 10' ' ' ILE 0.281 0.0 OUTLIER -72.92 -35.93 50.34 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.685 0 C-N-CA 116.457 -2.097 . . . . 74.22 113.727 -178.741 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.61 -32.95 74.58 Favored 'General case' 0 C--N 1.362 1.143 0 CA-C-N 119.848 1.204 . . . . 73.52 113.678 163.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.556 ' HB3' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -83.38 -19.28 36.35 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 113.206 0.817 . . . . 74.41 113.206 -172.804 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -100.35 13.64 33.75 Favored 'General case' 0 CA--C 1.571 1.784 0 O-C-N 122.207 -0.308 . . . . 74.33 110.329 173.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.302 0.1 OUTLIER -77.02 161.94 27.93 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 118.422 0.555 . . . . 71.43 112.296 -167.463 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 119.85 28.41 1.89 Allowed Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 119.452 -1.356 . . . . 72.23 114.681 -155.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.691 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 0.8 OUTLIER -47.94 132.68 15.02 Favored 'General case' 0 C--N 1.377 1.768 0 C-N-CA 124.573 1.149 . . . . 75.3 109.811 179.238 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.455 ' H ' ' HA ' ' A' ' 77' ' ' ARG . 9.8 t0 -56.95 102.06 0.07 Allowed 'General case' 0 C--N 1.384 2.105 0 O-C-N 125.216 1.573 . . . . 74.42 112.362 -160.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -153.92 139.3 17.64 Favored 'General case' 0 N--CA 1.439 -0.998 0 O-C-N 125.252 1.595 . . . . 71.22 107.303 -178.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 67.32 54.12 0.73 Allowed 'General case' 0 N--CA 1.508 2.461 0 C-N-CA 123.501 0.72 . . . . 64.41 111.892 172.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.73 -9.06 32.01 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 117.893 1.917 . . . . 75.31 117.893 176.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -115.54 119.54 36.52 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.245 1.522 . . . . 70.44 107.993 -174.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.03 100.83 12.59 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 117.966 -1.016 . . . . 63.34 111.643 -167.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.691 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -162.49 103.95 1.08 Allowed 'General case' 0 C--O 1.158 -3.749 0 CA-C-O 117.081 -1.438 . . . . 74.03 107.935 170.498 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.455 ' HA ' ' H ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -92.67 109.9 21.33 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 123.533 2.879 . . . . 72.52 107.257 -170.031 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 88.4 t -128.38 117.21 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.548 0 CA-C-N 120.481 1.491 . . . . 63.22 108.573 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -150.22 135.53 18.02 Favored 'General case' 0 C--N 1.381 1.972 0 CA-C-N 120.339 1.427 . . . . 72.24 110.144 -174.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.0 m -77.93 122.27 85.29 Favored Pre-proline 0 C--N 1.36 1.052 0 CA-C-O 121.618 0.723 . . . . 73.43 110.892 161.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.491 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 72.2 Cg_endo -90.78 13.69 2.13 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.402 2.068 . . . . 72.4 113.362 165.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -102.41 -45.72 5.0 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.055 -0.72 . . . . 73.41 109.055 170.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 51.52 55.68 9.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 125.058 1.474 . . . . 63.22 110.302 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -165.31 175.87 8.83 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 121.471 -0.768 . . . . 71.33 109.725 -162.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.465 ' HD3' ' SD ' ' A' ' 1' ' ' MET . 49.3 ttt180 -120.72 147.65 45.01 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 108.609 -0.886 . . . . 74.34 108.609 172.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 . . . . . 0 C--O 1.246 0.887 0 N-CA-C 107.304 -1.369 . . . . 71.03 107.304 167.485 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.057 0 N-CA-C 111.138 -0.785 . . . . 52.4 111.138 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 83.4 p -153.16 136.46 15.74 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 112.441 0.534 . . . . 71.33 112.441 -176.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -130.86 -88.16 0.48 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.483 0.713 . . . . 71.21 110.602 173.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ptp -169.32 112.81 0.52 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.866 0.466 . . . . 71.52 111.168 -177.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 60.9 t -130.97 -46.11 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 O-C-N 122.15 -0.344 . . . . 73.24 110.989 169.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.7 tt -61.77 107.03 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 113.54 0.941 . . . . 64.24 113.54 -169.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.46 152.22 43.59 Favored 'General case' 0 C--N 1.353 0.722 0 CA-C-N 115.668 -0.696 . . . . 74.53 109.807 167.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 65.14 46.18 2.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 123.855 0.722 . . . . 74.44 111.359 175.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.3 t -154.8 164.46 38.78 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 116.155 -0.475 . . . . 73.42 109.985 -177.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.7 m -114.37 126.68 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 109.785 -0.45 . . . . 74.23 109.785 -177.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 t -84.96 124.21 31.41 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 122.252 -0.28 . . . . 63.23 111.725 -178.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -141.16 154.66 45.97 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 113.351 0.871 . . . . 75.51 113.351 -175.06 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.6 mt -116.65 141.72 33.45 Favored 'Isoleucine or valine' 0 C--O 1.26 1.644 0 N-CA-C 108.418 -0.956 . . . . 71.11 108.418 -179.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -100.7 118.02 35.97 Favored 'General case' 0 CA--C 1.566 1.568 0 O-C-N 125.775 1.922 . . . . 74.32 110.374 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.9 t -125.78 106.24 15.79 Favored 'Isoleucine or valine' 0 C--N 1.375 1.677 0 CA-C-N 119.849 1.204 . . . . 73.12 109.889 177.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.17 -178.07 20.9 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 118.582 -1.121 . . . . 54.43 111.818 174.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.5 m120 50.13 24.2 1.36 Allowed 'General case' 0 N--CA 1.509 2.489 0 N-CA-C 116.579 2.066 . . . . 63.2 116.579 172.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -89.18 123.93 66.01 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 123.401 0.681 . . . . 61.34 111.001 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -84.33 126.67 3.72 Favored 'Trans proline' 0 CA--C 1.559 1.74 0 C-N-CA 121.415 1.41 . . . . 62.33 112.855 174.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.1 m 33.42 60.55 0.47 Allowed 'General case' 0 C--N 1.386 2.154 0 C-N-CA 125.772 1.629 . . . . 55.53 114.271 174.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -109.58 -128.29 0.28 Allowed 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.65 -0.704 . . . . 73.31 109.671 -168.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.9 m -83.37 121.59 36.41 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.695 0 CA-C-N 118.384 0.538 . . . . 70.35 110.983 -174.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -81.43 165.56 21.17 Favored 'General case' 0 C--N 1.369 1.434 0 CA-C-O 117.571 -1.204 . . . . 72.14 109.134 176.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.6 p -47.79 -46.78 30.84 Favored 'General case' 0 C--N 1.382 2.008 0 N-CA-C 116.065 1.876 . . . . 63.24 116.065 -173.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.25 -42.03 96.69 Favored 'General case' 0 CA--C 1.577 2.0 0 N-CA-C 114.517 1.303 . . . . 71.43 114.517 178.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.352 0.6 OUTLIER -67.41 -27.24 66.91 Favored 'General case' 0 CA--C 1.565 1.543 0 CA-C-N 120.036 1.289 . . . . 61.41 112.958 172.783 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.433 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 2.3 t -71.11 -38.78 72.65 Favored 'Isoleucine or valine' 0 C--N 1.406 3.055 0 CA-C-N 120.266 1.394 . . . . 64.34 107.734 175.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.589 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -65.79 -56.82 9.94 Favored 'General case' 0 CA--C 1.555 1.138 0 CA-C-O 117.129 -1.415 . . . . 75.4 112.198 179.488 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.11 -54.92 19.69 Favored 'General case' 0 C--O 1.299 3.666 0 CA-C-N 121.739 2.063 . . . . 72.32 115.58 176.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.78 -37.83 80.18 Favored 'General case' 0 C--N 1.387 2.209 0 CA-C-O 118.126 -0.94 . . . . 53.25 112.136 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.433 ' HB2' ' O ' ' A' ' 24' ' ' VAL 0.256 63.4 m-85 -83.87 -21.9 31.82 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-O 115.832 -2.033 . . . . 72.22 114.188 178.312 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.589 ' HG3' ' O ' ' A' ' 25' ' ' GLU 0.372 10.6 mtp180 -61.95 -36.05 80.25 Favored 'General case' 0 N--CA 1.524 3.225 0 CA-C-N 122.689 2.495 . . . . 72.12 109.115 169.466 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.84 -45.86 89.06 Favored 'General case' 0 N--CA 1.509 2.52 0 C-N-CA 116.879 -1.929 . . . . 64.32 112.179 172.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.518 ' HB3' ' HA ' ' A' ' 59' ' ' ALA . 13.7 m-85 -71.83 -40.35 69.16 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 112.746 0.647 . . . . 75.01 112.746 -169.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -151.5 163.72 30.01 Favored Glycine 0 C--O 1.213 -1.184 0 CA-C-O 117.346 -1.808 . . . . 71.31 108.591 156.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -72.59 101.18 2.95 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 121.188 2.494 . . . . 44.42 111.402 -170.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.451 HD13 ' SG ' ' A' ' 37' ' ' CYS . 2.1 pp -73.81 142.41 14.91 Favored 'Isoleucine or valine' 0 C--N 1.359 0.983 0 C-N-CA 120.089 -0.645 . . . . 73.45 112.602 -174.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.1 mp -97.37 -45.5 6.44 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 115.912 -0.585 . . . . 74.32 112.131 174.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.05 152.99 38.34 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-N 118.697 0.681 . . . . 73.02 110.558 172.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.451 ' SG ' HD13 ' A' ' 34' ' ' ILE . 3.3 m -137.62 107.4 6.26 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 106.756 -1.572 . . . . 72.52 106.756 176.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -115.88 143.41 45.46 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 118.544 -1.263 . . . . 63.41 111.288 -175.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -123.62 113.14 36.05 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-O 121.27 0.557 . . . . 74.34 110.239 -173.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 48.1 mttm -116.76 146.14 43.02 Favored 'General case' 0 CA--C 1.563 1.445 0 CA-C-O 117.968 -1.015 . . . . 55.34 109.956 -173.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.42 146.31 50.13 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 121.508 1.958 . . . . 71.12 108.771 -170.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.1 t -99.33 167.41 10.67 Favored 'General case' 0 C--N 1.363 1.164 0 CA-C-N 120.358 1.435 . . . . 75.24 111.398 175.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.3 m -66.39 -5.32 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.472 0 N-CA-C 116.262 1.949 . . . . 75.43 116.262 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -98.83 4.81 47.64 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 119.507 1.049 . . . . 75.4 110.14 -172.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.37 -6.82 74.99 Favored Glycine 0 CA--C 1.543 1.781 0 N-CA-C 115.238 0.855 . . . . 62.22 115.238 -176.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -80.78 131.52 35.43 Favored 'General case' 0 CA--C 1.554 1.133 0 CA-C-N 118.267 1.034 . . . . 73.31 109.248 171.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.93 147.45 43.13 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-O 118.565 -0.731 . . . . 73.3 109.319 -171.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -129.57 151.62 49.99 Favored 'General case' 0 C--N 1.367 1.327 0 CA-C-N 119.541 1.064 . . . . 74.24 111.619 -173.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -134.29 144.01 48.08 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.919 0.866 . . . . 75.44 111.598 175.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -131.59 114.67 15.12 Favored 'General case' 0 C--O 1.265 1.88 0 N-CA-C 105.591 -2.003 . . . . 71.25 105.591 -159.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 0.3 OUTLIER -120.01 107.6 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 C-N-CA 119.271 -0.972 . . . . 75.02 109.713 -165.79 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -114.04 104.7 12.4 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.126 -0.488 . . . . 61.53 111.04 -169.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.402 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -114.12 160.73 18.62 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.831 1.048 . . . . 74.32 113.831 -177.035 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -73.09 -28.7 62.44 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 112.741 0.645 . . . . 61.41 112.741 167.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -113.8 112.42 23.37 Favored 'General case' 0 C--N 1.351 0.659 0 C-N-CA 118.571 -1.252 . . . . 63.13 109.277 176.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.34 -44.71 35.47 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 116.058 1.873 . . . . 72.44 116.058 170.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.97 -34.9 76.08 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 113.846 1.054 . . . . 73.32 113.846 -169.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -75.96 -32.64 59.6 Favored 'General case' 0 CA--C 1.586 2.358 0 N-CA-C 115.897 1.814 . . . . 64.44 115.897 176.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.518 ' HA ' ' HB3' ' A' ' 31' ' ' TYR . . . -64.93 -19.81 66.13 Favored 'General case' 0 CA--C 1.595 2.694 0 N-CA-C 114.884 1.439 . . . . 75.44 114.884 173.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -48.46 -31.83 6.89 Favored 'General case' 0 CA--C 1.578 2.055 0 N-CA-C 115.047 1.499 . . . . 74.1 115.047 171.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -51.21 -52.97 39.5 Favored 'General case' 0 N--CA 1.507 2.424 0 CA-C-N 119.915 1.234 . . . . 62.21 111.77 164.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.58 -31.32 71.95 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 117.13 -1.414 . . . . 73.21 114.023 175.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . 0.343 0.3 OUTLIER -73.59 -42.49 55.51 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.199 0 C-N-CA 115.578 -2.449 . . . . 74.51 113.895 177.612 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.16 -27.42 65.65 Favored 'General case' 0 CA--C 1.56 1.328 0 CA-C-N 120.158 1.345 . . . . 72.53 113.691 165.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -77.59 -29.31 51.91 Favored 'General case' 0 CA--C 1.549 0.937 0 O-C-N 121.31 -0.869 . . . . 73.13 112.45 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 43.0 mmtt -96.01 13.0 28.48 Favored 'General case' 0 CA--C 1.584 2.259 0 N-CA-C 112.861 0.689 . . . . 74.4 112.861 172.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.323 0.2 OUTLIER -76.23 164.97 25.54 Favored 'General case' 0 N--CA 1.51 2.534 0 CA-C-N 119.825 1.193 . . . . 74.4 111.922 -171.059 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.76 31.19 1.05 Allowed Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 118.652 -1.737 . . . . 74.14 114.801 -153.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.628 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 59.5 m -44.68 139.49 2.89 Favored 'General case' 0 C--N 1.393 2.492 0 CA-C-N 117.767 0.784 . . . . 74.03 111.852 171.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -58.05 99.79 0.05 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 O-C-N 125.038 1.461 . . . . 71.43 110.774 -169.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -155.63 139.29 16.05 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 125.551 1.54 . . . . 75.44 109.63 -175.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 66.06 51.39 1.31 Allowed 'General case' 0 N--CA 1.509 2.506 0 C-N-CA 123.148 0.579 . . . . 73.23 111.935 168.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.9 -11.01 36.84 Favored Glycine 0 CA--C 1.541 1.69 0 N-CA-C 117.456 1.742 . . . . 53.32 117.456 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -114.83 118.9 34.84 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 119.608 1.704 . . . . 74.51 108.84 -177.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.96 107.59 19.88 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 113.57 0.952 . . . . 70.32 113.57 -176.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.628 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -159.35 108.87 1.89 Allowed 'General case' 0 C--O 1.167 -3.261 0 N-CA-C 107.48 -1.304 . . . . 74.04 107.48 165.847 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 -90.79 107.58 19.28 Favored 'General case' 0 CA--C 1.554 1.098 0 CA-C-N 122.728 2.513 . . . . 72.03 108.028 -175.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.7 t -127.28 111.46 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 O-C-N 120.771 -1.206 . . . . 55.21 108.776 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -149.44 133.68 17.33 Favored 'General case' 0 C--O 1.257 1.475 0 CA-C-N 120.565 1.529 . . . . 64.32 110.615 -166.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.8 m -73.47 126.14 90.16 Favored Pre-proline 0 C--N 1.37 1.491 0 CA-C-O 121.363 0.601 . . . . 73.11 111.88 164.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -96.49 17.31 0.68 Allowed 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.367 2.711 . . . . 75.11 113.959 164.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -114.32 -26.38 8.02 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 120.574 -0.45 . . . . 75.32 112.063 176.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 54.94 73.79 0.39 Allowed 'General case' 0 CA--C 1.569 1.683 0 O-C-N 124.583 1.177 . . . . 72.44 113.43 -175.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 72.81 -99.41 0.03 OUTLIER 'General case' 0 C--N 1.369 1.431 0 C-N-CA 125.109 1.363 . . . . 53.53 112.838 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 14.1 ttt180 -167.9 26.63 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 109.052 -0.722 . . . . 75.31 109.052 -176.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.296 -1.335 . . . . 73.42 111.794 -171.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.935 0 N-CA-C 111.467 -0.653 . . . . 36.67 111.467 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 9.6 t -153.0 147.09 25.51 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 116.972 0.386 . . . . 75.12 110.61 176.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -136.04 158.84 43.44 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 109.251 -0.648 . . . . 73.15 109.251 177.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 mpp? -130.27 11.95 5.49 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.193 0.52 . . . . 72.33 110.748 173.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.7 m -121.3 -179.13 1.75 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 115.933 -0.576 . . . . 74.54 109.566 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.0 mt 71.73 101.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 O-C-N 124.752 1.282 . . . . 73.4 110.798 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.94 77.79 1.14 Allowed 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.343 0.592 . . . . 75.12 110.497 -175.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -167.07 -163.91 0.57 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.26 -1.336 . . . . 65.33 108.979 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.3 m 65.85 -159.42 0.27 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.925 0.89 . . . . 70.31 110.948 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.3 p -151.29 136.58 10.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 121.247 0.546 . . . . 73.45 110.642 177.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 t -80.88 123.52 28.35 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.508 -0.769 . . . . 74.35 110.188 178.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.551 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 0.3 OUTLIER -141.87 160.34 40.4 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 112.66 0.615 . . . . 73.21 112.66 -176.726 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.7 mt -113.64 136.9 48.59 Favored 'Isoleucine or valine' 0 C--O 1.246 0.911 0 N-CA-C 109.075 -0.713 . . . . 53.42 109.075 176.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -111.35 112.86 24.93 Favored 'General case' 0 C--N 1.354 0.761 0 O-C-N 124.619 1.2 . . . . 64.3 108.923 172.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 4.0 p -124.42 110.38 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-O 121.577 0.703 . . . . 73.0 111.422 175.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -117.62 159.24 14.22 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.918 -0.583 . . . . 64.11 112.458 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.1 m120 60.87 28.98 18.72 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.996 0.918 . . . . 70.25 111.925 175.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -85.04 137.46 37.5 Favored Pre-proline 0 C--O 1.239 0.528 0 CA-C-N 115.873 -0.603 . . . . 61.24 111.564 -172.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -69.23 126.92 14.26 Favored 'Trans proline' 0 C--N 1.36 1.142 0 C-N-CA 122.23 1.954 . . . . 71.11 112.055 174.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.6 t 52.23 92.24 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.96 0 O-C-N 124.672 1.233 . . . . 73.13 111.956 -173.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 34.0 p-80 -58.71 131.61 51.41 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.652 -0.703 . . . . 72.42 111.325 -177.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.3 m -72.45 133.54 31.58 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-N 115.079 -0.964 . . . . 72.43 111.525 -176.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.405 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -83.03 157.08 23.05 Favored 'General case' 0 C--O 1.212 -0.888 0 CA-C-N 114.968 -1.015 . . . . 64.4 110.541 -178.923 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.2 p -60.17 -31.42 70.1 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.097 1.517 . . . . 72.32 115.097 -166.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.63 -47.11 67.47 Favored 'General case' 0 C--O 1.249 1.058 0 CA-C-O 121.747 0.784 . . . . 52.24 110.673 176.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -66.62 -40.23 88.68 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 113.686 -1.597 . . . . 74.22 110.436 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.579 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 57.2 t -59.93 -46.73 93.62 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 O-C-N 123.899 0.749 . . . . 72.11 109.654 170.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.519 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 0.3 OUTLIER -58.92 -54.4 47.52 Favored 'General case' 0 C--O 1.204 -1.327 0 CA-C-O 118.667 -0.683 . . . . 72.35 111.326 -175.784 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.476 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 5.7 m-80 -79.97 -49.78 11.36 Favored 'General case' 0 C--O 1.278 2.564 0 N-CA-C 114.523 1.305 . . . . 74.44 114.523 -177.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -68.69 -35.54 77.33 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 120.407 -0.517 . . . . 54.42 109.961 -173.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.579 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 59.0 m-85 -85.31 -18.22 34.52 Favored 'General case' 0 CA--C 1.556 1.195 0 N-CA-C 113.671 0.989 . . . . 73.41 113.671 172.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.519 ' HB3' ' O ' ' A' ' 25' ' ' GLU . 2.3 ppt_? -64.85 -25.36 67.87 Favored 'General case' 0 N--CA 1.503 2.191 0 CA-C-N 120.387 1.448 . . . . 74.54 110.768 167.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.76 -30.95 57.84 Favored 'General case' 0 CA--C 1.565 1.523 0 O-C-N 123.455 0.472 . . . . 64.25 111.879 168.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.497 ' CD1' ' HA ' ' A' ' 28' ' ' PHE . 1.0 OUTLIER -74.9 -17.57 60.55 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.493 0.717 . . . . 63.0 111.659 -175.448 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 140.84 57.73 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 119.358 -1.401 . . . . 72.01 113.399 174.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 55.28 98.0 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 125.573 1.549 . . . . 74.43 113.302 173.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.91 124.54 36.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.295 -1.32 . . . . 70.43 110.993 -177.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -90.01 -42.68 11.0 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 114.898 -1.047 . . . . 72.15 109.744 175.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -144.34 139.43 28.5 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.842 -0.617 . . . . 65.32 110.693 -177.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 8.5 p -129.57 123.24 30.86 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.133 -0.485 . . . . 71.14 110.009 172.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -130.33 128.14 40.87 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 116.497 -0.319 . . . . 73.33 110.21 177.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.9 t -109.81 116.99 53.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 120.945 0.402 . . . . 74.52 109.925 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt -108.25 157.55 18.24 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.095 -0.502 . . . . 73.13 110.741 -177.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.98 147.98 52.68 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 122.248 -0.282 . . . . 64.1 110.401 173.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.1 t -101.16 165.28 11.38 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.81 -0.441 . . . . 71.22 109.81 171.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.5 t -74.52 -15.23 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 123.787 0.835 . . . . 64.04 110.797 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.9 m -75.56 -9.8 58.89 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.952 -0.567 . . . . 74.03 111.929 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.43 -4.31 47.49 Favored Glycine 0 C--N 1.342 0.912 0 C-N-CA 121.534 -0.365 . . . . 61.34 113.7 175.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -89.53 141.58 28.45 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.1 0.476 . . . . 61.33 111.37 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -106.23 149.6 26.71 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.614 -0.721 . . . . 61.41 110.041 176.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.462 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 2.1 m-85 -136.68 151.29 49.11 Favored 'General case' 0 C--O 1.223 -0.303 0 N-CA-C 109.25 -0.648 . . . . 74.35 109.25 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -127.35 139.61 52.75 Favored 'General case' 0 C--O 1.248 0.976 0 N-CA-C 109.528 -0.545 . . . . 51.23 109.528 169.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -120.53 115.44 23.44 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 106.717 -1.586 . . . . 72.55 106.717 -176.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -133.67 112.26 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 N-CA-C 113.787 1.032 . . . . 74.05 113.787 -166.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -90.84 114.76 27.26 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.531 0.567 . . . . 70.4 112.531 -173.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -110.24 161.94 15.1 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 115.967 -0.56 . . . . 73.21 110.713 176.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -83.09 -30.12 28.23 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.237 0.458 . . . . 70.12 112.237 174.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.48 125.65 49.4 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.836 0.827 . . . . 42.3 112.409 -176.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.53 -45.73 24.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 113.893 -1.503 . . . . 71.42 113.492 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -23.43 53.63 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.005 0.743 . . . . 70.5 113.005 -168.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -73.61 -34.01 64.84 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.786 0.803 . . . . 74.34 109.887 176.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.01 -27.74 61.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.708 -1.133 . . . . 72.45 112.658 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.56 -33.44 63.87 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.246 1.202 . . . . 72.11 114.246 -175.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.509 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 17.4 m-20 -70.99 -37.67 72.71 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.564 0.697 . . . . 75.32 112.711 177.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.479 ' O ' ' HG3' ' A' ' 65' ' ' GLU . . . -75.74 -36.08 60.01 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.736 0.779 . . . . 60.02 111.097 177.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.452 ' O ' ' HB3' ' A' ' 67' ' ' ASP . 0.4 OUTLIER -68.13 -31.83 53.42 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.231 0 CA-C-O 117.918 -1.039 . . . . 73.35 109.748 174.892 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.509 ' HG3' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -77.11 -20.68 55.34 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 120.201 1.364 . . . . 71.24 111.506 172.659 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.479 ' HG3' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -71.73 -27.47 63.02 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 119.438 -0.905 . . . . 64.45 111.394 170.565 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.42 13.9 19.03 Favored 'General case' 0 N--CA 1.511 2.622 0 N-CA-C 116.578 2.066 . . . . 72.25 116.578 167.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.452 ' HB3' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -73.3 158.21 35.55 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 124.663 1.185 . . . . 71.15 112.229 176.215 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.83 23.38 5.01 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 119.981 -1.104 . . . . 36.67 112.259 -159.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 15.8 p -57.22 134.52 56.0 Favored 'General case' 0 C--O 1.24 0.582 0 O-C-N 124.895 0.997 . . . . 54.33 113.125 -173.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.63 149.07 52.62 Favored 'General case' 0 C--O 1.257 1.462 0 CA-C-N 114.242 -1.345 . . . . 70.23 112.605 -170.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -143.81 145.61 32.48 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 112.504 -2.134 . . . . 70.33 110.778 -171.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 73.02 67.95 0.11 Allowed 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 122.569 1.176 . . . . 42.11 114.142 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.88 -11.2 57.5 Favored Glycine 0 C--N 1.333 0.414 0 CA-C-N 113.786 -1.552 . . . . 51.15 114.081 176.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -121.51 123.78 42.83 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.527 -1.286 . . . . 55.45 107.527 158.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.63 103.4 15.33 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 119.222 -0.418 . . . . 60.25 110.962 178.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 13.9 tp -165.41 70.93 0.15 Allowed 'General case' 0 C--O 1.206 -1.186 0 C-N-CA 119.937 -0.705 . . . . 54.33 112.261 177.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -96.76 111.4 23.58 Favored 'General case' 0 C--O 1.209 -1.075 0 O-C-N 119.834 -1.791 . . . . 74.25 109.701 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 t -129.17 119.64 49.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 107.492 -1.299 . . . . 74.34 107.492 170.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -148.16 141.95 25.69 Favored 'General case' 0 C--O 1.247 0.939 0 C-N-CA 119.81 -0.756 . . . . 53.21 111.289 176.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.444 HG11 ' CZ ' ' A' ' 82' ' ' PHE . 19.1 m -89.9 121.95 68.38 Favored Pre-proline 0 N--CA 1.438 -1.035 0 CA-C-N 114.75 -1.114 . . . . 72.44 110.194 166.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.551 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 72.2 Cg_endo -88.21 21.58 0.99 Allowed 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 121.89 1.727 . . . . 63.22 112.503 164.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.458 ' HD2' ' N ' ' A' ' 9' ' ' ARG . 0.2 OUTLIER -116.71 13.1 15.09 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 113.13 0.789 . . . . 74.24 113.13 179.504 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -76.94 78.9 3.5 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.925 0.393 . . . . 65.23 111.137 -171.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -173.95 23.51 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.28 -1.327 . . . . 64.24 109.909 -177.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 74.72 -56.2 0.64 Allowed 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.615 1.566 . . . . 70.23 112.546 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 . . . . . 0 C--O 1.252 1.212 0 N-CA-C 108.742 -0.836 . . . . 74.23 108.742 177.16 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.962 0 N-CA-C 112.263 -0.335 . . . . 51.31 112.263 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 39.5 t -141.55 127.87 19.87 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.65 0.262 . . . . 51.23 110.981 -177.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -152.32 152.5 32.19 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.302 0.641 . . . . 73.53 110.217 177.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 ptp -153.21 89.56 1.37 Allowed 'General case' 0 CA--C 1.547 0.838 0 CA-C-O 121.201 0.524 . . . . 74.1 111.532 174.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 42.6 t -126.82 147.47 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 109.103 -0.703 . . . . 75.05 109.103 174.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.4 tt -67.08 112.36 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 CA-C-O 121.92 0.867 . . . . 43.33 111.827 178.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.0 mtm-85 -152.02 133.8 14.82 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.196 -0.911 . . . . 75.25 109.717 174.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -92.93 99.77 12.35 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.873 0.844 . . . . 53.13 111.485 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.5 t -158.12 154.72 27.93 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 114.853 -1.067 . . . . 71.41 109.484 -177.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -105.23 117.35 50.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 109.263 -0.643 . . . . 72.14 109.263 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.4 p -83.39 128.03 34.17 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.07 -0.514 . . . . 60.32 112.328 -174.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.487 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 8.8 ptt180 -132.56 150.51 52.15 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.7 -0.682 . . . . 64.0 112.39 -171.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 34.2 mt -118.51 142.47 33.16 Favored 'Isoleucine or valine' 0 C--O 1.247 0.937 0 C-N-CA 122.963 0.505 . . . . 74.3 110.121 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -111.81 114.65 27.74 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 124.874 1.359 . . . . 73.32 109.466 175.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 2.7 p -123.27 108.04 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 CA-C-O 122.286 1.041 . . . . 61.11 111.799 175.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -118.66 164.12 13.03 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 114.998 -1.001 . . . . 75.43 113.821 -176.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 58.15 24.74 11.66 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.873 1.269 . . . . 70.3 113.588 170.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -90.25 150.35 42.96 Favored Pre-proline 0 CA--C 1.552 1.023 0 N-CA-C 111.47 0.174 . . . . 55.23 111.47 -174.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 75' ' ' LYS . 57.3 Cg_endo -75.8 150.76 35.21 Favored 'Trans proline' 0 C--N 1.364 1.374 0 C-N-CA 122.771 2.314 . . . . 51.1 113.268 -178.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.7 p 79.88 -21.79 0.31 Allowed 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 127.334 2.254 . . . . 75.24 112.687 -177.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 66.18 107.37 0.04 OUTLIER 'General case' 0 C--N 1.357 0.918 0 C-N-CA 125.236 1.415 . . . . 72.23 110.415 -171.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.9 p -83.04 128.4 38.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 CA-C-N 115.217 -0.902 . . . . 65.11 109.023 175.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 m -91.1 167.95 11.99 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.298 -0.865 . . . . 73.42 109.759 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.4 p -57.28 -39.83 76.5 Favored 'General case' 0 C--O 1.218 -0.605 0 O-C-N 123.892 0.745 . . . . 73.53 112.778 -175.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.4 -39.38 90.5 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.125 0.97 . . . . 71.34 112.78 178.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -75.2 -46.98 30.47 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 116.138 -0.483 . . . . 75.41 111.323 -171.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -67.5 -32.96 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 115.967 -0.56 . . . . 62.2 110.969 173.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -58.96 -44.94 91.58 Favored 'General case' 0 C--O 1.206 -1.231 0 CA-C-O 118.639 -0.696 . . . . 74.31 110.811 172.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.437 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 2.0 t-20 -70.67 -48.92 52.34 Favored 'General case' 0 C--O 1.279 2.647 0 CA-C-O 121.631 0.729 . . . . 70.42 111.336 -177.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -61.7 -42.71 99.3 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-N 114.003 -1.453 . . . . 55.12 111.063 -176.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -82.55 -26.04 32.8 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 117.823 -1.084 . . . . 73.45 112.511 178.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 26' ' ' ASN . 46.8 ptt85 -69.92 -33.06 71.66 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 119.327 0.967 . . . . 71.22 111.374 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.07 -26.57 66.8 Favored 'General case' 0 C--N 1.362 1.13 0 C-N-CA 118.796 -1.162 . . . . 62.44 111.541 -177.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.517 ' CD2' ' HB2' ' A' ' 62' ' ' ALA . 69.2 m-85 -92.89 -39.73 11.0 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 111.622 0.23 . . . . 74.1 111.622 178.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -153.39 133.52 4.02 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 111.647 -0.581 . . . . 45.2 111.647 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -64.74 118.09 8.44 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 113.447 0.906 . . . . 72.2 113.447 -168.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.68 139.45 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 114.686 -1.143 . . . . 73.31 111.278 -174.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.3 mp -102.12 -43.72 5.66 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.085 -0.961 . . . . 71.22 111.509 -176.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.92 132.98 20.32 Favored 'General case' 0 C--O 1.213 -0.842 0 N-CA-C 108.951 -0.759 . . . . 73.03 108.951 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.9 t -137.73 119.64 15.34 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 109.73 -0.47 . . . . 71.43 109.73 175.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -130.82 147.66 52.5 Favored 'General case' 0 C--O 1.22 -0.479 0 C-N-CA 120.592 -0.443 . . . . 54.24 111.315 -177.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.2 p -117.12 124.56 73.16 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 CA-C-O 121.535 0.683 . . . . 73.22 111.428 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.92 163.7 12.9 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.565 -0.743 . . . . 70.44 110.071 -178.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.76 150.92 52.1 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 122.001 -0.437 . . . . 75.24 110.9 172.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 15.3 t -100.32 169.47 9.09 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 110.072 -0.344 . . . . 64.22 110.072 172.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.6 t -74.91 -18.13 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.132 0 C-N-CA 123.79 0.836 . . . . 64.43 111.089 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.6 t -75.79 -12.87 60.26 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 122.866 0.467 . . . . 60.34 111.846 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.46 -3.56 43.21 Favored Glycine 0 C--N 1.34 0.783 0 C-N-CA 121.347 -0.454 . . . . 71.44 113.92 175.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.0 144.63 26.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.976 0.417 . . . . 74.44 110.556 176.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.74 147.9 41.6 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.013 -0.539 . . . . 74.35 110.263 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.455 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 0.9 OUTLIER -136.77 147.28 46.57 Favored 'General case' 0 C--O 1.217 -0.63 0 N-CA-C 109.411 -0.588 . . . . 74.33 109.411 -175.004 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -121.84 140.39 52.44 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 121.385 0.612 . . . . 74.3 109.91 176.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -113.62 118.09 33.42 Favored 'General case' 0 C--O 1.257 1.479 0 CA-C-N 113.633 -1.621 . . . . 71.33 107.833 -176.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.487 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 4.2 mp -118.25 110.07 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 O-C-N 123.607 0.567 . . . . 64.23 110.781 -174.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -115.52 105.06 12.36 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 121.834 0.826 . . . . 62.32 111.214 -171.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -114.11 171.58 7.52 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.137 1.162 . . . . 75.44 114.137 -177.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -75.28 -43.54 50.62 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 114.713 -1.13 . . . . 71.1 111.554 171.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -117.25 121.92 42.53 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 122.331 1.062 . . . . 74.43 112.078 -175.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.489 ' HB3' ' CE1' ' A' ' 82' ' ' PHE . . . -78.45 -43.53 26.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 112.883 -1.962 . . . . 61.53 113.99 -175.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -74.27 -25.86 59.86 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.39 0.885 . . . . 74.34 113.39 -169.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.481 ' HB3' ' O ' ' A' ' 31' ' ' TYR . 1.3 m-20 -80.75 -44.95 17.81 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.971 0.36 . . . . 53.13 111.971 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.48 -24.05 64.64 Favored 'General case' 0 C--O 1.251 1.147 0 C-N-CA 124.221 1.008 . . . . 36.76 111.747 176.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -53.3 -23.36 8.93 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.441 -1.254 . . . . 51.45 114.128 172.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -63.51 -47.05 83.29 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 118.823 0.738 . . . . 54.33 111.674 171.194 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.517 ' HB2' ' CD2' ' A' ' 31' ' ' TYR . . . -65.24 -39.92 93.33 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.938 -0.574 . . . . 61.42 110.24 174.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -66.81 -31.28 52.8 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 C-N-CA 120.28 -0.568 . . . . 36.76 111.381 177.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -80.21 -23.35 40.99 Favored 'General case' 0 C--N 1.351 0.631 0 N-CA-C 112.881 0.697 . . . . 73.54 112.881 176.875 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.454 ' HG2' ' HA ' ' A' ' 62' ' ' ALA . 10.2 pt-20 -81.52 -19.55 41.94 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 118.987 -1.085 . . . . 72.21 111.454 171.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' A' ' 62' ' ' ALA . 68.9 mmtt -92.36 -6.07 50.89 Favored 'General case' 0 CA--C 1.57 1.731 0 CA-C-N 118.451 0.569 . . . . 64.41 111.474 169.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -64.77 153.33 40.21 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 126.321 1.848 . . . . 71.21 112.746 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.71 23.82 4.88 Favored Glycine 0 C--N 1.343 0.942 0 C-N-CA 119.94 -1.124 . . . . 74.22 113.626 -163.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 24.5 p -58.7 133.1 55.63 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-O 122.196 0.998 . . . . 65.24 113.214 -169.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.37 149.13 49.61 Favored 'General case' 0 C--O 1.261 1.69 0 CA-C-N 114.09 -1.413 . . . . 62.35 112.907 -170.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -143.52 145.53 32.63 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 126.112 1.765 . . . . 75.34 111.224 -174.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 73.38 68.61 0.11 Allowed 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 114.554 1.316 . . . . 75.54 114.554 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.66 -10.99 59.37 Favored Glycine 0 N--CA 1.462 0.388 0 CA-C-N 114.188 -1.369 . . . . 73.21 113.778 175.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -120.51 122.6 40.98 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 107.065 -1.458 . . . . 64.51 107.065 155.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.463 ' O ' ' HD3' ' A' ' 16' ' ' PRO . 0.3 OUTLIER -95.08 102.39 14.2 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 117.961 -1.019 . . . . 74.32 110.286 178.573 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.534 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.3 OUTLIER -168.51 67.78 0.07 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 113.599 0.963 . . . . 71.24 113.599 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -95.85 111.1 23.16 Favored 'General case' 0 C--O 1.2 -1.529 0 CA-C-N 120.829 1.649 . . . . 73.32 110.157 -176.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.7 t -130.1 118.12 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 108.317 -0.994 . . . . 64.34 108.317 175.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -149.84 147.26 27.75 Favored 'General case' 0 C--O 1.255 1.345 0 C-N-CA 119.825 -0.75 . . . . 64.13 112.264 176.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.9 m -88.74 124.7 64.99 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 114.791 -1.095 . . . . 61.55 111.373 168.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.484 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 61.5 Cg_endo -87.08 12.03 3.08 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.132 1.888 . . . . 71.11 113.958 167.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.489 ' CE1' ' HB3' ' A' ' 56' ' ' ALA . 10.7 p90 -102.26 -25.79 13.55 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.847 0.684 . . . . 71.44 112.847 177.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.7 m120 55.97 70.43 0.64 Allowed 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.255 1.022 . . . . 73.42 113.198 -176.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 62.52 -173.11 0.15 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 125.169 1.388 . . . . 73.53 112.901 -177.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 7.5 ttt85 -100.64 75.21 1.72 Allowed 'General case' 0 C--N 1.334 -0.103 0 O-C-N 121.573 -0.705 . . . . 75.43 109.494 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 . . . . . 0 C--O 1.24 0.582 0 CA-C-O 117.656 -1.164 . . . . 71.35 110.233 -176.981 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.928 0 N-CA-C 111.714 -0.554 . . . . 54.44 111.714 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 66.5 m -110.46 -80.25 0.58 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 119.429 -0.32 . . . . 60.42 111.515 -178.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 66.73 90.32 0.09 Allowed 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 125.228 1.411 . . . . 75.22 111.305 -178.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpp? -104.54 160.65 14.77 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 116.449 -0.341 . . . . 70.12 110.368 -176.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 76.4 t 76.32 -63.29 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 C-N-CA 125.473 1.509 . . . . 75.2 111.616 177.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.7 mm 70.35 -87.3 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 125.331 1.452 . . . . 73.14 111.532 176.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -160.45 52.45 0.31 Allowed 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 118.556 0.616 . . . . 74.15 110.747 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 73.31 121.12 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 126.055 1.742 . . . . 71.22 112.043 176.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.5 163.66 38.52 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.518 -0.31 . . . . 73.31 111.651 -176.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.2 m -114.36 128.68 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 116.014 -0.539 . . . . 62.13 110.568 176.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.5 t -85.46 119.13 25.48 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.482 -0.326 . . . . 71.2 110.814 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 24.2 ptt180 -143.68 152.57 41.49 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-N 115.837 -0.62 . . . . 72.41 111.851 -176.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 52.9 mt -116.98 135.46 57.28 Favored 'Isoleucine or valine' 0 C--O 1.256 1.421 0 C-N-CA 122.924 0.489 . . . . 74.35 109.849 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -103.0 115.13 30.02 Favored 'General case' 0 C--N 1.362 1.142 0 O-C-N 125.644 1.84 . . . . 75.2 109.412 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.9 t -115.77 132.81 64.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 107.657 -1.238 . . . . 72.33 107.657 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -140.89 160.3 26.64 Favored Glycine 0 CA--C 1.519 0.301 0 N-CA-C 111.775 -0.53 . . . . 53.2 111.775 173.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 61.02 27.54 17.4 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.79 0.836 . . . . 71.41 112.105 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.29 125.77 73.53 Favored Pre-proline 0 C--O 1.237 0.413 0 N-CA-C 111.7 0.259 . . . . 63.04 111.7 -174.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.35 150.68 37.05 Favored 'Trans proline' 0 C--N 1.36 1.164 0 C-N-CA 121.794 1.662 . . . . 73.22 110.8 165.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.8 m -22.16 -83.13 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 125.629 1.83 . . . . 73.32 115.788 -163.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.2 t60 52.33 -91.86 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 124.996 1.319 . . . . 72.24 112.01 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.7 m -100.15 120.92 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-O 121.053 0.454 . . . . 71.33 110.775 176.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.488 ' O ' HG22 ' A' ' 24' ' ' VAL . 47.2 m -88.39 177.53 6.8 Favored 'General case' 0 C--O 1.193 -1.887 0 CA-C-O 117.575 -1.202 . . . . 75.22 107.844 170.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.7 m -49.67 -49.97 45.31 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 120.344 1.429 . . . . 72.14 114.391 -169.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -39.35 94.24 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.092 0.957 . . . . 75.25 111.697 177.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.83 -32.51 57.63 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 115.262 -0.881 . . . . 74.21 111.488 -177.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 20' ' ' SER . 47.8 t -62.82 -47.32 93.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 108.228 -1.027 . . . . 71.45 108.228 170.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.13 -51.19 67.24 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 124.422 1.076 . . . . 75.53 111.862 177.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -73.89 -43.85 57.19 Favored 'General case' 0 C--O 1.276 2.46 0 N-CA-C 112.564 0.579 . . . . 72.24 112.564 -174.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -57.78 -46.72 84.19 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 115.177 -0.919 . . . . 73.24 110.132 177.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -78.35 -25.4 46.34 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 117.956 -1.021 . . . . 75.14 112.29 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -72.42 -28.98 63.3 Favored 'General case' 0 C--N 1.358 0.971 0 CA-C-N 118.971 0.805 . . . . 74.24 112.468 -179.654 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.66 -31.16 70.95 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 118.612 -1.235 . . . . 74.45 111.445 176.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.51 ' O ' ' HB3' ' A' ' 58' ' ' ASP . 99.2 m-85 -87.94 -37.17 16.64 Favored 'General case' 0 C--O 1.219 -0.534 0 C-N-CA 121.193 -0.203 . . . . 62.32 111.174 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 29' ' ' ARG . . . -152.29 147.3 16.85 Favored Glycine 0 C--O 1.223 -0.589 0 N-CA-C 111.759 -0.536 . . . . 73.2 111.759 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -74.49 105.12 5.47 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 117.694 0.747 . . . . 75.22 112.937 -172.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.06 130.94 35.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 114.909 -1.041 . . . . 74.02 111.531 -175.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 56.2 mt -93.73 -47.9 6.56 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 114.418 -1.264 . . . . 74.14 111.083 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.07 144.09 31.46 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.234 0.54 . . . . 73.41 109.996 173.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.6 t -132.15 120.47 22.32 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.058 -0.719 . . . . 73.53 109.058 178.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -129.45 125.95 37.64 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 120.454 -0.498 . . . . 75.35 111.384 -174.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 75.9 t -107.94 121.29 60.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 122.642 0.377 . . . . 74.12 110.121 -177.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -108.69 157.49 18.49 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 116.297 -0.41 . . . . 73.12 110.713 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.22 147.59 52.61 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.416 0.15 . . . . 71.23 110.908 172.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.3 t -101.1 167.06 10.47 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 110.014 -0.365 . . . . 60.22 110.014 173.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.9 m -75.43 -11.02 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 123.81 0.844 . . . . 72.52 112.411 177.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -80.25 -11.65 59.7 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 122.629 0.372 . . . . 71.25 111.222 176.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.43 -2.04 46.42 Favored Glycine 0 C--N 1.34 0.786 0 C-N-CA 121.426 -0.416 . . . . 72.31 113.886 176.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.39 143.24 27.12 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.211 0.529 . . . . 74.31 111.596 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -105.56 150.28 25.51 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.157 -0.929 . . . . 65.14 110.673 178.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -134.5 150.1 50.76 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 108.767 -0.827 . . . . 73.12 108.767 -177.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -129.31 137.14 50.84 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.143 0.497 . . . . 72.14 110.631 174.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.94 120.05 37.24 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 108.576 -0.898 . . . . 73.42 108.576 175.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 3.2 mp -120.32 111.56 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 119.158 -1.017 . . . . 71.43 111.114 -174.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -113.45 108.0 16.61 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-O 120.813 0.339 . . . . 70.34 111.71 -172.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.28 170.51 8.24 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.269 -0.878 . . . . 60.54 111.954 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -78.85 -31.49 45.68 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 112.825 0.676 . . . . 74.42 112.825 175.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -120.35 125.01 46.95 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 122.241 1.019 . . . . 73.42 112.607 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.9 -46.01 25.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 113.99 -1.459 . . . . 71.51 113.931 -175.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.18 -25.1 54.86 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.641 0.978 . . . . 65.22 113.641 -165.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.51 ' HB3' ' O ' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -80.0 -35.52 37.29 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.627 0.727 . . . . 74.14 111.707 177.52 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.33 -18.61 59.97 Favored 'General case' 0 C--O 1.257 1.49 0 C-N-CA 124.577 1.151 . . . . 73.02 112.767 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -53.15 -26.42 16.86 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 114.626 -1.17 . . . . 74.33 113.134 170.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.411 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -69.32 -34.69 75.04 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.208 0.603 . . . . 74.24 111.697 172.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.604 ' O ' ' HD2' ' A' ' 66' ' ' LYS . . . -66.57 -48.75 68.63 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 110.425 -0.213 . . . . 70.02 110.425 171.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.46 -30.78 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 C-N-CA 120.296 -0.561 . . . . 64.14 111.002 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.475 ' HA ' ' HB2' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -79.18 -21.04 46.95 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 118.916 0.78 . . . . 74.43 112.777 171.865 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.88 -37.26 76.0 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 118.885 0.766 . . . . 73.41 110.581 171.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.604 ' HD2' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -100.13 12.67 36.42 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 118.284 -1.367 . . . . 63.41 114.28 174.488 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.475 ' HB2' ' HA ' ' A' ' 64' ' ' LYS . 21.0 t70 -51.54 152.83 2.51 Favored 'General case' 0 N--CA 1.506 2.368 0 C-N-CA 126.998 2.119 . . . . 61.24 114.442 170.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.3 25.35 3.82 Favored Glycine 0 C--N 1.35 1.332 0 C-N-CA 119.554 -1.308 . . . . 63.35 113.948 -165.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.609 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 8.6 p -58.48 133.49 55.84 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 122.393 1.092 . . . . 74.4 113.147 -173.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.94 144.46 47.46 Favored 'General case' 0 C--O 1.256 1.404 0 CA-C-N 113.771 -1.559 . . . . 73.23 113.48 -171.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -143.56 147.66 34.76 Favored 'General case' 0 CA--C 1.553 1.089 0 O-C-N 125.834 1.959 . . . . 72.0 110.83 -172.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 74.14 66.07 0.09 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 122.484 1.135 . . . . 70.42 113.463 174.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.74 -10.25 62.45 Favored Glycine 0 N--CA 1.461 0.304 0 CA-C-N 114.263 -1.335 . . . . 71.43 113.302 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -119.64 122.51 41.68 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.063 -1.458 . . . . 73.31 107.063 161.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.59 102.16 13.93 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 118.446 -0.788 . . . . 74.41 110.676 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.609 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -165.49 60.18 0.11 Allowed 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 113.304 0.853 . . . . 73.14 113.304 179.911 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.4 tpp85 -93.67 117.21 29.8 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 120.585 -1.322 . . . . 71.43 111.031 -171.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 66' ' ' LYS . 2.2 m -128.59 120.96 53.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.902 -1.045 . . . . 73.12 109.346 174.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -148.93 145.4 27.39 Favored 'General case' 0 C--O 1.255 1.351 0 CA-C-O 121.97 0.89 . . . . 61.03 112.503 -178.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.1 m -89.47 123.48 66.68 Favored Pre-proline 0 CA--C 1.546 0.792 0 CA-C-N 115.012 -0.995 . . . . 75.0 110.042 167.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.432 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 66.9 Cg_endo -88.79 4.3 5.47 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.162 1.908 . . . . 72.34 113.335 166.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -95.01 -32.29 13.21 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 119.062 -0.494 . . . . 74.34 111.983 176.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.8 t30 54.54 78.33 0.17 Allowed 'General case' 0 N--CA 1.486 1.342 0 O-C-N 124.564 1.165 . . . . 73.33 111.118 -174.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 60.69 -166.45 0.2 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 125.167 1.387 . . . . 51.34 112.364 -175.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -95.36 9.78 38.68 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.354 -0.841 . . . . 74.31 109.041 171.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 . . . . . 0 C--O 1.253 1.286 0 CA-C-N 115.207 -0.906 . . . . 73.23 109.728 -173.887 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.0 0 N-CA-C 111.894 -0.482 . . . . 63.01 111.894 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.22 178.16 7.48 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 122.664 0.386 . . . . 73.3 111.126 -177.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -146.44 74.26 1.35 Allowed 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 121.195 0.521 . . . . 60.25 111.561 -168.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.1 mtt -149.37 145.05 26.79 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.069 0.948 . . . . 73.43 109.41 169.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.3 t -122.81 7.45 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 CA-C-O 121.883 0.849 . . . . 75.04 109.698 178.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.2 mt -99.94 86.85 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 O-C-N 121.343 -0.848 . . . . 73.04 111.294 -175.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.439 ' HG2' ' H ' ' A' ' 5' ' ' GLU . 6.7 ttt180 175.09 172.55 0.25 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 125.144 1.378 . . . . 74.4 109.505 170.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.439 ' H ' ' HG2' ' A' ' 4' ' ' ARG . 68.9 tt0 -127.08 128.88 46.95 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.374 0.669 . . . . 73.41 109.816 175.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.2 t -163.18 161.37 24.97 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 110.183 -0.303 . . . . 71.22 110.183 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.5 t -109.02 122.46 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 109.931 -0.396 . . . . 74.32 109.931 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.524 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . 80.3 p -84.96 140.41 31.09 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 122.655 0.382 . . . . 74.31 111.257 178.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.474 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 0.9 OUTLIER -126.22 149.98 48.68 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 111.952 0.353 . . . . 71.23 111.952 -177.183 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.0 mp -131.96 134.74 59.57 Favored 'Isoleucine or valine' 0 C--O 1.247 0.927 0 C-N-CA 123.882 0.873 . . . . 70.42 109.208 -178.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -115.82 115.21 25.87 Favored 'General case' 0 C--O 1.242 0.676 0 O-C-N 124.029 0.831 . . . . 65.32 109.613 177.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 p -119.74 111.43 32.8 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.819 0 CA-C-O 121.431 0.634 . . . . 75.23 110.867 172.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -123.52 158.79 18.16 Favored Glycine 0 CA--C 1.52 0.372 0 CA-C-N 116.077 -0.511 . . . . 37.25 113.522 -175.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.7 m120 62.25 26.63 15.96 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.235 1.014 . . . . 62.14 111.648 175.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -82.57 125.11 76.84 Favored Pre-proline 0 CA--C 1.543 0.708 0 CA-C-O 120.878 0.37 . . . . 70.1 111.848 -170.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -86.45 125.99 2.59 Favored 'Trans proline' 0 C--N 1.363 1.326 0 C-N-CA 121.829 1.686 . . . . 73.11 113.081 175.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.8 m 26.01 62.82 0.07 Allowed 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 126.417 1.887 . . . . 74.01 114.887 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -110.4 -134.31 0.35 Allowed 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.611 -0.722 . . . . 74.54 109.091 -171.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.2 m -69.76 126.04 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 111.993 0.368 . . . . 75.44 111.993 174.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.9 m -83.84 173.47 11.23 Favored 'General case' 0 C--O 1.211 -0.938 0 N-CA-C 108.403 -0.962 . . . . 63.14 108.403 173.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.6 t -60.15 -37.39 79.98 Favored 'General case' 0 CA--C 1.557 1.219 0 CA-C-N 118.969 0.804 . . . . 64.21 112.905 -174.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -66.61 -44.96 80.67 Favored 'General case' 0 C--O 1.251 1.172 0 C-N-CA 123.066 0.547 . . . . 73.44 110.808 176.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -68.4 -34.37 75.9 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.096 -0.956 . . . . 72.23 110.679 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.646 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 74.3 t -60.45 -51.72 69.79 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.588 0 N-CA-C 108.969 -0.752 . . . . 72.04 108.969 171.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.412 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 25.2 tt0 -57.01 -53.82 53.76 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 118.873 -0.584 . . . . 74.11 111.61 -177.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -76.4 -52.04 10.66 Favored 'General case' 0 C--O 1.26 1.629 0 CA-C-N 118.63 0.65 . . . . 74.23 112.113 -172.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.84 -39.0 66.92 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 120.685 -0.406 . . . . 74.11 110.057 -172.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.646 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 4.4 m-85 -77.57 -23.02 50.08 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 118.094 -0.955 . . . . 73.54 111.5 177.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.482 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 10.1 ptt180 -72.29 -25.9 61.76 Favored 'General case' 0 C--N 1.374 1.632 0 CA-C-N 120.065 1.302 . . . . 73.04 110.876 170.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.69 -25.86 65.89 Favored 'General case' 0 CA--C 1.561 1.388 0 C-N-CA 120.105 -0.638 . . . . 64.21 111.337 175.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.464 ' CG ' ' HB3' ' A' ' 62' ' ' ALA . 98.4 m-85 -89.32 -35.21 16.24 Favored 'General case' 0 C--O 1.216 -0.676 0 N-CA-C 111.974 0.361 . . . . 65.35 111.974 174.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 29' ' ' ARG . . . -156.9 137.94 5.67 Favored Glycine 0 C--O 1.228 -0.236 0 C-N-CA 120.884 -0.674 . . . . 64.33 111.668 177.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -62.06 114.73 3.57 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.142 0.577 . . . . 71.3 112.133 -175.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.61 124.76 39.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.948 0.88 . . . . 74.5 112.119 -173.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.5 mp -97.62 -36.84 10.15 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.208 -1.36 . . . . 74.34 110.327 175.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -145.43 131.25 19.07 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 120.694 0.283 . . . . 51.4 111.069 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -122.09 121.28 36.59 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 110.043 -0.355 . . . . 52.43 110.043 175.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -131.03 125.63 33.77 Favored 'General case' 0 C--O 1.219 -0.535 0 C-N-CA 120.432 -0.507 . . . . 74.12 110.277 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.01 119.31 61.06 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 CA-C-O 121.955 0.883 . . . . 72.24 110.837 176.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -117.46 157.69 25.8 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.256 -0.883 . . . . 73.54 110.348 -177.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.39 151.22 51.12 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 122.088 -0.382 . . . . 71.25 110.537 173.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.9 t -101.34 164.53 11.73 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 110.119 -0.326 . . . . 74.34 110.119 172.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.6 m -75.63 -10.28 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.78 0.832 . . . . 71.31 112.511 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -78.65 -9.29 59.33 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 122.682 0.393 . . . . 65.11 110.879 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.66 -5.01 43.27 Favored Glycine 0 C--N 1.344 0.999 0 C-N-CA 121.179 -0.534 . . . . 70.31 113.827 176.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -89.38 143.0 27.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.972 0.415 . . . . 71.2 111.444 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -107.71 149.86 27.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.648 -0.705 . . . . 75.41 109.635 175.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -137.49 150.13 47.33 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.426 -0.583 . . . . 73.52 109.426 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -127.6 138.61 52.91 Favored 'General case' 0 C--O 1.253 1.271 0 CA-C-O 121.718 0.771 . . . . 70.13 109.344 170.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -116.47 120.61 39.33 Favored 'General case' 0 C--O 1.252 1.216 0 CA-C-N 113.688 -1.596 . . . . 73.4 107.509 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.87 126.84 73.25 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.67 0 CA-C-N 115.611 -0.722 . . . . 71.44 111.111 -170.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -115.51 114.73 25.39 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 122.331 -0.23 . . . . 75.33 111.539 -178.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -109.47 169.22 8.84 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.351 0.26 . . . . 73.03 110.884 176.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -81.59 -31.18 32.65 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.22 0.452 . . . . 74.42 112.22 169.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -119.29 125.49 49.21 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-O 122.107 0.956 . . . . 62.32 112.816 -172.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.39 -44.99 18.45 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 115.644 1.72 . . . . 73.11 115.644 -177.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.76 -24.76 56.08 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 113.457 0.91 . . . . 73.14 113.457 -167.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.73 -27.43 40.61 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 121.494 0.664 . . . . 73.43 111.272 175.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.84 -25.06 61.82 Favored 'General case' 0 C--O 1.249 1.036 0 C-N-CA 124.265 1.026 . . . . 64.53 112.065 174.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.64 -27.85 63.19 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.048 -0.978 . . . . 75.32 112.859 177.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -67.83 -41.74 82.54 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 122.751 0.421 . . . . 72.22 111.149 174.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.464 ' HB3' ' CG ' ' A' ' 31' ' ' TYR . . . -64.05 -44.95 90.91 Favored 'General case' 0 C--O 1.237 0.417 0 O-C-N 123.55 0.531 . . . . 72.42 111.213 175.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.474 HD12 HG21 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -70.15 -29.93 41.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 119.936 -0.706 . . . . 63.21 110.999 179.145 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.02 -26.44 53.78 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.674 1.125 . . . . 74.12 112.331 176.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -85.98 -18.0 33.77 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 118.621 -1.232 . . . . 75.31 112.524 173.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt -100.14 8.18 44.06 Favored 'General case' 0 CA--C 1.558 1.259 0 O-C-N 121.794 -0.566 . . . . 74.24 111.3 172.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -60.37 152.25 25.83 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 126.596 1.958 . . . . 73.23 111.228 173.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.81 25.07 3.76 Favored Glycine 0 C--N 1.349 1.277 0 C-N-CA 120.166 -1.016 . . . . 73.13 113.715 -160.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.595 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 12.8 t -59.13 132.65 54.66 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.644 0.735 . . . . 71.53 111.439 178.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -135.63 134.7 39.54 Favored 'General case' 0 C--O 1.252 1.214 0 CA-C-N 114.134 -1.394 . . . . 70.1 112.993 -172.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -142.93 148.03 36.25 Favored 'General case' 0 CA--C 1.548 0.886 0 O-C-N 125.658 1.849 . . . . 75.15 109.574 -175.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 75.66 65.86 0.06 Allowed 'General case' 0 N--CA 1.5 2.041 0 CA-C-O 122.828 1.299 . . . . 54.55 114.206 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.02 -10.98 62.2 Favored Glycine 0 C--O 1.227 -0.325 0 CA-C-N 113.579 -1.646 . . . . 41.51 114.174 172.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -121.68 123.99 43.19 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.274 -1.38 . . . . 70.31 107.274 162.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.94 104.77 16.81 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 118.483 -0.77 . . . . 73.22 111.41 -177.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.595 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.4 OUTLIER -166.73 64.31 0.09 Allowed 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 113.394 0.887 . . . . 64.1 113.394 178.48 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.479 ' HD3' ' SG ' ' A' ' 69' ' ' CYS . 0.0 OUTLIER -93.37 115.61 28.17 Favored 'General case' 0 C--O 1.212 -0.907 0 O-C-N 120.909 -1.12 . . . . 71.34 110.324 -173.94 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.5 t -128.25 117.85 46.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 107.757 -1.201 . . . . 62.23 107.757 168.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -151.73 140.97 21.38 Favored 'General case' 0 C--O 1.244 0.775 0 C-N-CA 119.833 -0.747 . . . . 72.42 112.309 -177.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.3 m -91.74 125.46 57.31 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 115.918 -0.583 . . . . 63.41 111.879 168.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.474 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 60.3 Cg_endo -84.59 13.5 2.73 Favored 'Trans proline' 0 CA--C 1.547 1.125 0 C-N-CA 122.363 2.042 . . . . 71.24 113.806 165.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.524 ' CD2' ' HB2' ' A' ' 8' ' ' SER . 1.8 p90 -101.66 -20.45 15.0 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.422 0.555 . . . . 74.33 112.191 176.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 65.78 -78.34 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 125.022 1.329 . . . . 61.41 112.661 -170.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -155.44 -176.52 5.99 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.158 0.436 . . . . 63.31 110.311 177.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -84.29 122.5 28.98 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.206 -0.665 . . . . 64.25 109.206 176.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 . . . . . 0 C--O 1.249 1.077 0 O-C-N 124.315 1.009 . . . . 61.3 110.705 -179.821 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.116 0 N-CA-C 112.227 -0.349 . . . . 72.43 112.227 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 16.6 p -156.88 104.57 2.13 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 121.158 0.504 . . . . 73.42 110.552 177.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . 0.427 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 0.9 OUTLIER -150.19 -173.48 4.45 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.94 -0.763 . . . . 74.35 108.94 179.242 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.427 ' SD ' ' HB3' ' A' ' 0' ' ' HIS . 2.8 mpt? 70.81 146.7 0.07 Allowed 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 124.631 1.173 . . . . 63.1 113.818 172.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.8 m -132.78 159.92 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 115.773 -0.649 . . . . 73.5 111.324 177.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.8 tt -149.41 143.43 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 109.174 -0.676 . . . . 73.14 109.174 175.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -125.8 10.18 7.68 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.391 0.515 . . . . 72.43 112.391 -178.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -130.75 21.52 5.03 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.94 0.4 . . . . 63.21 111.297 -176.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.3 t -129.99 157.01 43.5 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.27 0.557 . . . . 71.23 111.116 -177.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.5 t -110.2 104.45 17.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 114.912 -1.04 . . . . 65.32 109.322 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.45 121.2 28.67 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 112.704 0.631 . . . . 73.52 112.704 -178.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.452 ' HD2' ' CE2' ' A' ' 50' ' ' PHE . 0.6 OUTLIER -136.27 159.7 40.94 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 122.825 0.45 . . . . 63.41 111.21 -173.344 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.1 mt -117.38 142.88 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.118 0.967 . . . . 71.22 108.531 -178.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -112.26 111.18 21.88 Favored 'General case' 0 C--N 1.349 0.58 0 N-CA-C 109.786 -0.449 . . . . 74.24 109.786 -177.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.2 m -123.95 108.08 20.0 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-O 121.946 0.879 . . . . 72.31 111.29 175.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -133.69 168.94 23.01 Favored Glycine 0 CA--C 1.518 0.261 0 N-CA-C 114.873 0.709 . . . . 64.1 114.873 -176.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.8 m120 58.36 21.43 8.32 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.838 1.255 . . . . 53.42 112.071 176.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -90.88 149.78 40.86 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 112.338 0.495 . . . . 71.53 112.338 -167.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 75' ' ' LYS . 24.5 Cg_endo -65.02 137.57 53.2 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 123.144 2.563 . . . . 71.33 112.868 176.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.1 p 73.77 -41.73 0.5 Allowed 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 126.61 1.964 . . . . 65.44 111.692 -173.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 68.41 117.34 0.03 OUTLIER 'General case' 0 C--N 1.365 1.25 0 C-N-CA 125.7 1.6 . . . . 70.45 111.052 -177.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.8 m -69.71 128.84 33.69 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 CA-C-N 114.646 -1.161 . . . . 64.21 110.564 177.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.1 m -83.15 169.14 16.14 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 114.364 -1.289 . . . . 72.32 108.787 176.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.2 m -57.17 -41.87 80.08 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.654 0.612 . . . . 71.52 112.654 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -64.83 -47.68 77.1 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.154 0.581 . . . . 74.34 111.321 178.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -67.77 -44.28 77.82 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 114.646 -1.161 . . . . 75.22 111.037 -174.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.534 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 9.0 p -70.46 -34.93 59.77 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 CA-C-O 118.99 -0.529 . . . . 43.02 110.036 177.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -61.06 -52.7 63.85 Favored 'General case' 0 C--O 1.212 -0.888 0 CA-C-O 118.745 -0.645 . . . . 54.13 110.524 178.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -73.0 -51.11 19.48 Favored 'General case' 0 C--O 1.27 2.158 0 CA-C-N 118.12 0.418 . . . . 64.42 111.622 -174.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -69.22 -44.01 72.93 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 115.467 -0.788 . . . . 72.12 110.457 -173.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.534 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 0.7 OUTLIER -76.85 -25.13 52.81 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 118.676 -0.678 . . . . 75.15 111.534 179.32 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 2.7 ptt85 -72.44 -22.99 61.01 Favored 'General case' 0 C--N 1.365 1.257 0 CA-C-N 119.429 1.013 . . . . 75.33 111.834 174.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -29.71 70.45 Favored 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 119.543 -0.863 . . . . 72.32 111.421 170.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -88.77 -37.23 15.61 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.563 0.579 . . . . 71.34 112.563 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 29' ' ' ARG . . . -154.74 171.83 33.13 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.501 -0.857 . . . . 73.15 112.587 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -82.0 113.09 19.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.571 0.701 . . . . 65.51 111.998 -175.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.86 126.4 43.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 114.803 -1.089 . . . . 71.41 110.586 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 26.2 mt -94.86 -43.11 8.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.488 -1.233 . . . . 70.0 109.568 178.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.05 153.33 33.77 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.491 0.316 . . . . 70.15 110.479 170.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 13.4 p -126.92 124.76 40.26 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.785 -0.45 . . . . 63.2 109.785 173.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -129.68 125.94 37.17 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-N 115.974 -0.557 . . . . 71.43 111.093 -176.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 72.1 t -112.08 123.02 67.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-O 121.041 0.448 . . . . 62.21 111.176 -174.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.13 161.32 22.0 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.069 -0.514 . . . . 71.3 110.869 -174.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.5 152.02 51.85 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 122.457 -0.152 . . . . 73.54 111.004 172.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.4 t -100.62 169.39 9.08 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 109.973 -0.38 . . . . 71.42 109.973 169.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.3 t -75.3 -15.45 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 C-N-CA 123.715 0.806 . . . . 73.3 111.259 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.3 m -75.88 -7.56 54.8 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.107 0.563 . . . . 44.05 112.175 -179.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.76 -4.74 53.53 Favored Glycine 0 C--N 1.341 0.844 0 C-N-CA 121.345 -0.455 . . . . 62.12 113.308 176.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.75 138.38 31.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.832 0.348 . . . . 75.01 110.791 178.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.44 147.93 38.54 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.741 -0.663 . . . . 62.13 110.546 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -136.22 165.91 24.64 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.187 0.517 . . . . 73.13 109.96 -171.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -141.35 139.72 33.6 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-N 115.328 -0.851 . . . . 61.23 109.96 171.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.452 ' CE2' ' HD2' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -114.43 118.69 34.52 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 113.996 -1.456 . . . . 75.31 107.263 -179.655 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.76 112.77 36.44 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.531 0 C-N-CA 119.556 -0.858 . . . . 73.33 111.151 -171.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -88.58 106.98 18.66 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-N 116.545 -0.298 . . . . 74.54 110.233 -170.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -114.27 143.46 44.82 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.58 -0.736 . . . . 74.33 112.021 -174.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -83.06 -28.38 29.61 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 120.558 -0.457 . . . . 73.34 111.83 172.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.61 126.68 49.66 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.864 0.84 . . . . 62.33 112.402 -178.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.41 ' CB ' ' HB2' ' A' ' 85' ' ' ARG . . . -80.41 -45.4 17.73 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 114.19 1.181 . . . . 73.04 114.19 179.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -75.31 -25.17 57.64 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.963 0.727 . . . . 73.21 112.963 -167.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -80.13 -34.73 37.55 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.505 0.669 . . . . 71.14 109.841 175.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.67 -24.09 65.38 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.785 1.234 . . . . 38.7 112.511 172.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.01 -25.0 60.53 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 114.572 1.323 . . . . 38.7 114.572 -174.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.21 -44.93 78.35 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 118.881 0.764 . . . . 51.1 111.483 173.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.36 -43.38 98.96 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 115.79 -0.641 . . . . 71.43 110.822 173.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.434 HD11 ' O ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -68.21 -32.3 55.26 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.003 0 CA-C-O 118.852 -0.594 . . . . 72.34 111.359 -179.38 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.62 -26.24 41.21 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.384 0.993 . . . . 75.02 112.341 177.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -81.81 -20.68 38.57 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 119.486 -0.886 . . . . 73.53 111.458 175.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -99.39 0.01 41.87 Favored 'General case' 0 CA--C 1.569 1.706 0 C-N-CA 120.189 -0.605 . . . . 73.11 111.335 172.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 35.0 t70 -70.42 154.83 41.47 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 125.695 1.598 . . . . 64.52 111.425 177.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.53 25.11 4.44 Favored Glycine 0 C--N 1.346 1.133 0 C-N-CA 119.637 -1.268 . . . . 61.33 112.058 -159.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.684 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 8.2 t -57.22 131.56 50.36 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 124.496 0.762 . . . . 74.51 111.837 -171.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.63 146.74 46.36 Favored 'General case' 0 C--O 1.252 1.22 0 CA-C-N 114.23 -1.35 . . . . 72.42 113.404 -170.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -143.58 147.8 34.95 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 126.116 1.766 . . . . 74.24 109.807 -173.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 76.3 66.71 0.06 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 122.686 1.232 . . . . 62.4 113.381 173.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.05 -11.71 63.96 Favored Glycine 0 C--N 1.337 0.638 0 CA-C-N 113.729 -1.578 . . . . 70.02 113.313 177.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -119.2 122.09 41.2 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 106.841 -1.54 . . . . 73.35 106.841 163.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.404 ' O ' ' HD3' ' A' ' 16' ' ' PRO . 0.5 OUTLIER -94.78 105.16 17.08 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 117.954 -1.022 . . . . 73.15 111.075 178.531 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.684 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -165.65 64.7 0.11 Allowed 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 115.283 1.586 . . . . 74.42 115.283 179.319 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.502 ' HA ' ' SG ' ' A' ' 69' ' ' CYS . 0.1 OUTLIER -95.34 113.64 25.33 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 121.8 2.091 . . . . 75.12 111.555 -176.199 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 95.3 t -131.52 120.76 46.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 121.22 -0.925 . . . . 74.23 109.474 174.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -149.14 141.99 24.67 Favored 'General case' 0 C--O 1.258 1.525 0 N-CA-C 113.66 0.985 . . . . 74.01 113.66 173.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.3 m -89.76 126.95 56.06 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-N 114.033 -1.44 . . . . 72.35 109.645 159.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -84.24 16.96 1.81 Allowed 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.658 2.238 . . . . 72.2 112.44 170.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -86.33 -30.02 22.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.042 -0.981 . . . . 75.3 110.544 177.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 64.23 41.8 5.84 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 124.824 1.328 . . . . 74.11 110.768 -173.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 69.06 10.95 8.16 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 125.831 1.653 . . . . 74.14 113.001 -178.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.41 ' HB2' ' CB ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER 70.54 108.56 0.06 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 126.262 1.825 . . . . 74.31 111.759 -178.067 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.256 1.408 0 CA-C-N 114.497 -1.229 . . . . 64.33 110.354 170.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.958 0 CA-C-O 119.74 -0.478 . . . . 53.44 112.406 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 4.6 t 68.7 -168.47 0.18 Allowed 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 125.151 1.38 . . . . 73.54 111.344 178.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 65.13 38.03 6.3 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.422 1.089 . . . . 75.25 110.734 176.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt -135.48 138.22 42.93 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.593 -0.731 . . . . 61.21 110.334 -177.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.9 p -147.45 115.18 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 CA-C-O 121.882 0.849 . . . . 73.05 111.004 177.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.1 mp -127.41 127.78 69.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 115.566 -0.743 . . . . 73.52 109.344 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.54 165.14 12.31 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 110.067 -0.345 . . . . 72.5 110.067 174.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 66.68 -171.29 0.19 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.013 1.325 . . . . 71.13 110.499 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.0 t 64.6 -173.03 0.17 Allowed 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.769 1.227 . . . . 73.52 111.067 -177.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -128.75 134.74 63.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 109.51 -0.552 . . . . 73.52 109.51 177.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.3 p -83.89 138.15 33.32 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.915 -0.584 . . . . 73.25 112.029 -178.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.485 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -138.01 158.43 44.35 Favored 'General case' 0 C--O 1.211 -0.948 0 CA-C-N 115.911 -0.586 . . . . 73.41 111.956 -175.903 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.6 mt -117.9 141.66 35.9 Favored 'Isoleucine or valine' 0 C--O 1.254 1.335 0 N-CA-C 109.842 -0.429 . . . . 73.15 109.842 174.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -108.25 119.41 39.41 Favored 'General case' 0 C--O 1.246 0.875 0 O-C-N 124.653 1.221 . . . . 74.34 109.148 178.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 3.6 p -123.14 110.39 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-O 121.918 0.866 . . . . 75.34 111.328 174.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -115.36 166.57 12.22 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-N 115.072 -0.967 . . . . 55.14 113.126 177.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 55.76 30.25 15.35 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.427 1.091 . . . . 74.32 113.083 175.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -89.16 140.44 28.85 Favored Pre-proline 0 C--O 1.237 0.42 0 CA-C-N 116.341 -0.39 . . . . 73.05 111.773 -172.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -72.05 142.5 38.47 Favored 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 122.527 2.151 . . . . 70.42 112.254 174.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.0 p 77.64 -32.84 0.18 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 127.351 2.26 . . . . 71.23 113.201 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 69.34 120.29 0.03 OUTLIER 'General case' 0 C--N 1.365 1.26 0 C-N-CA 124.869 1.268 . . . . 74.42 110.513 -174.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.8 m -74.87 126.32 35.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 CA-C-O 121.508 0.671 . . . . 72.44 109.479 173.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.54 ' HB2' ' OD2' ' A' ' 23' ' ' ASP . 19.2 m -81.97 160.68 23.27 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.951 -1.129 . . . . 72.22 107.951 177.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.2 p -60.68 -32.43 71.65 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.42 0.896 . . . . 62.12 113.42 -168.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.19 -38.61 51.17 Favored 'General case' 0 C--O 1.253 1.243 0 C-N-CA 123.844 0.858 . . . . 73.43 111.127 -178.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.54 ' OD2' ' HB2' ' A' ' 20' ' ' SER . 51.8 m-20 -67.28 -48.67 67.0 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 114.676 -1.147 . . . . 71.43 110.205 -179.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.458 HG12 ' SG ' ' A' ' 37' ' ' CYS . 9.3 p -69.73 -29.91 42.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 CA-C-N 114.482 -1.235 . . . . 52.21 110.57 177.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -57.75 -53.17 61.24 Favored 'General case' 0 C--N 1.359 1.001 0 CA-C-O 118.812 -0.614 . . . . 72.43 111.188 170.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -67.22 -48.07 68.92 Favored 'General case' 0 C--O 1.295 3.463 0 CA-C-O 122.127 0.965 . . . . 73.52 111.87 -178.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -58.93 -47.78 83.81 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-N 113.777 -1.556 . . . . 62.31 109.945 -175.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.469 ' HA ' ' CD1' ' A' ' 31' ' ' TYR . 14.9 m-85 -81.99 -15.76 52.63 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.092 0.775 . . . . 65.34 113.092 -179.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 23.4 mtp180 -60.4 -35.35 75.56 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 118.149 0.431 . . . . 64.53 110.446 164.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.74 -30.22 70.63 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 119.487 -0.885 . . . . 72.21 112.954 168.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.473 ' OH ' ' HE3' ' A' ' 66' ' ' LYS . 1.1 m-85 -77.65 -11.27 59.85 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 113.247 0.832 . . . . 74.43 113.247 -171.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 141.28 38.18 0.09 OUTLIER Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.125 -1.036 . . . . 37.61 113.102 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 60.4 95.98 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.895 1.278 . . . . 63.01 112.933 174.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.17 132.63 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 115.774 -0.648 . . . . 64.25 110.701 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.33 -28.62 12.87 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.432 -0.803 . . . . 71.03 109.844 174.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -142.72 129.26 20.2 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.444 -0.343 . . . . 73.4 110.478 -173.098 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.458 ' SG ' HG12 ' A' ' 24' ' ' VAL . 0.9 OUTLIER -127.73 113.47 16.04 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.624 -0.509 . . . . 52.24 109.624 175.089 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -128.12 124.02 35.89 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 120.393 -0.523 . . . . 73.12 110.747 -178.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 87.2 t -99.6 128.97 50.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 116.114 -0.493 . . . . 75.33 110.346 -177.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.426 ' HB2' ' HB2' ' A' ' 48' ' ' PHE . 71.6 mmtt -106.54 137.02 45.3 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.628 -0.714 . . . . 74.2 109.731 -178.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -130.75 126.15 35.68 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.843 -0.343 . . . . 65.35 110.6 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.0 t -101.04 164.95 11.56 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 120.915 0.388 . . . . 65.52 111.078 177.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.9 t -75.51 -14.08 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 C-N-CA 124.133 0.973 . . . . 73.24 110.872 178.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.2 m -75.52 -11.59 60.06 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.184 0.594 . . . . 73.45 112.401 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.63 -3.32 56.15 Favored Glycine 0 C--N 1.343 0.955 0 C-N-CA 121.343 -0.456 . . . . 53.24 113.743 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.16 143.72 26.89 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.507 0.67 . . . . 63.44 111.285 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.58 142.81 33.98 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.175 -0.92 . . . . 71.45 109.257 177.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.471 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 7.9 m-85 -137.13 153.31 50.54 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.11 -0.7 . . . . 73.33 109.11 178.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -137.38 139.51 40.79 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-O 121.332 0.587 . . . . 53.2 109.636 170.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -116.35 117.81 31.0 Favored 'General case' 0 C--O 1.252 1.193 0 CA-C-N 113.803 -1.544 . . . . 72.04 106.929 -179.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.485 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 3.1 mp -127.16 112.92 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 119.715 -0.794 . . . . 60.41 111.99 -170.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -107.42 107.53 18.45 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.607 -0.724 . . . . 71.32 111.918 -171.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -112.51 167.34 10.53 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 115.039 -0.982 . . . . 74.53 112.977 -177.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -82.3 -25.27 34.13 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 113.39 0.885 . . . . 74.21 113.39 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.5 121.57 39.72 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.388 0.994 . . . . 70.11 112.421 177.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -81.47 -45.63 15.73 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.294 -1.321 . . . . 75.11 114.563 -177.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.21 -23.59 51.4 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 112.533 0.568 . . . . 74.12 112.533 -171.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -75.28 -26.99 59.2 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.863 0.84 . . . . 73.53 110.142 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.15 -27.14 67.06 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 114.711 -1.131 . . . . 75.51 112.602 175.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.37 -30.53 68.48 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 114.607 1.336 . . . . 53.53 114.607 -171.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.517 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -67.89 -44.18 77.61 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 122.135 0.969 . . . . 74.1 112.21 176.858 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.51 -31.54 57.74 Favored 'General case' 0 C--O 1.253 1.284 0 CA-C-O 122.604 1.192 . . . . 75.2 111.38 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.421 ' O ' ' HB3' ' A' ' 67' ' ' ASP . 0.4 OUTLIER -70.48 -30.6 43.44 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.465 0 CA-C-O 118.456 -0.783 . . . . 73.25 109.714 174.562 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.517 ' HG3' ' O ' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -77.6 -20.93 53.13 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 119.611 1.096 . . . . 63.1 111.551 170.234 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.78 -27.02 63.6 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-O 118.481 -0.771 . . . . 74.45 111.67 170.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.473 ' HE3' ' OH ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -113.42 13.47 18.96 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 116.405 2.002 . . . . 71.23 116.405 166.129 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -73.2 158.21 35.66 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 123.989 0.915 . . . . 72.43 112.539 174.662 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 112.72 24.84 4.79 Favored Glycine 0 C--N 1.345 1.036 0 C-N-CA 120.215 -0.993 . . . . 72.05 111.522 -160.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 6.2 p -57.81 132.41 53.25 Favored 'General case' 0 C--N 1.352 0.699 0 CA-C-O 122.392 1.091 . . . . 74.31 112.248 -168.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -134.14 149.27 51.05 Favored 'General case' 0 C--O 1.263 1.763 0 CA-C-N 113.521 -1.672 . . . . 73.13 112.383 -166.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -143.8 146.34 33.02 Favored 'General case' 0 CA--C 1.557 1.246 0 CA-C-N 112.733 -2.03 . . . . 64.31 109.477 -175.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 75.12 66.86 0.07 Allowed 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 124.706 1.202 . . . . 72.54 114.057 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.55 -11.93 59.68 Favored Glycine 0 N--CA 1.464 0.53 0 CA-C-N 113.605 -1.634 . . . . 72.34 113.796 173.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -118.91 119.64 34.95 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 105.717 -1.957 . . . . 72.14 105.717 157.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.94 103.52 15.48 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 118.975 -0.536 . . . . 75.52 111.17 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.469 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 12.0 tp -168.78 73.79 0.1 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 118.094 0.406 . . . . 71.22 111.323 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.75 109.04 21.86 Favored 'General case' 0 C--O 1.206 -1.228 0 O-C-N 120.202 -1.562 . . . . 73.14 109.008 -175.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.0 t -133.03 125.83 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 O-C-N 121.243 -0.911 . . . . 62.4 109.593 176.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -150.15 163.63 37.72 Favored 'General case' 0 C--O 1.26 1.606 0 CA-C-O 122.6 1.19 . . . . 75.4 113.131 169.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.1 m -87.14 123.39 70.14 Favored Pre-proline 0 CA--C 1.555 1.164 0 CA-C-N 112.649 -2.068 . . . . 64.21 109.047 165.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.452 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 56.5 Cg_endo -85.04 10.36 3.78 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 121.798 1.665 . . . . 74.31 113.941 167.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -102.87 -60.75 1.5 Allowed 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 112.099 0.407 . . . . 75.2 112.099 175.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.6 t30 54.01 30.39 11.74 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 126.047 1.739 . . . . 73.15 112.355 -173.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.91 127.28 10.67 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 112.399 0.518 . . . . 72.52 112.399 -175.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -171.73 142.97 1.62 Allowed 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.276 0.985 . . . . 75.13 110.797 174.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-N 114.769 -1.105 . . . . 74.12 108.281 168.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.746 0 CA-C-O 120.014 -0.326 . . . . 73.12 112.318 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 47.2 m 66.28 37.47 4.91 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.738 1.215 . . . . 74.44 114.24 170.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -146.59 159.98 42.74 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 122.548 0.339 . . . . 72.34 110.297 174.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.6 ptp -157.84 99.93 1.72 Allowed 'General case' 0 CA--C 1.547 0.858 0 O-C-N 123.824 0.703 . . . . 73.15 111.395 171.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.7 p -165.67 117.94 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.314 0 CA-C-O 121.112 0.482 . . . . 63.41 110.996 176.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.8 tt -162.11 130.34 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 CA-C-O 120.911 0.386 . . . . 54.33 110.892 174.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.8 mtt-85 -145.17 135.46 24.06 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.658 0.783 . . . . 73.01 109.894 172.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 61.6 19.34 10.33 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 124.647 1.179 . . . . 74.23 113.925 171.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.7 t -112.53 -7.77 13.88 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 111.417 0.154 . . . . 54.45 111.417 -173.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.7 m 59.05 138.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 C-N-CA 127.876 2.471 . . . . 71.45 115.254 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.3 m -85.36 119.77 26.1 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.077 -0.965 . . . . 74.14 110.382 176.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.609 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -140.56 156.29 46.34 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-N 115.654 -0.703 . . . . 74.5 112.147 -178.934 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.8 mt -113.43 137.91 44.88 Favored 'Isoleucine or valine' 0 C--O 1.258 1.534 0 N-CA-C 108.561 -0.903 . . . . 44.42 108.561 177.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -99.11 112.53 24.64 Favored 'General case' 0 C--N 1.363 1.196 0 O-C-N 126.456 2.347 . . . . 74.41 108.629 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.2 133.05 67.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 107.789 -1.189 . . . . 75.44 107.789 175.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -141.13 159.99 26.7 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 121.223 -0.513 . . . . 64.41 112.801 173.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.496 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 72.8 m-20 60.94 25.59 15.56 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.491 1.116 . . . . 51.12 112.953 171.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.58 146.62 44.58 Favored Pre-proline 0 CA--C 1.549 0.942 0 O-C-N 121.363 -0.836 . . . . 73.21 113.033 -163.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.28 151.7 43.71 Favored 'Trans proline' 0 C--N 1.361 1.234 0 C-N-CA 123.351 2.701 . . . . 61.14 113.407 174.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.5 p 74.6 -30.52 0.2 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 127.421 2.288 . . . . 73.03 113.422 -176.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 71.2 t60 67.47 106.12 0.05 OUTLIER 'General case' 0 C--N 1.359 0.999 0 C-N-CA 125.24 1.416 . . . . 75.41 110.872 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.7 m -82.59 131.06 34.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 CA-C-N 115.636 -0.711 . . . . 74.24 110.328 176.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.543 ' HB2' ' OD2' ' A' ' 23' ' ' ASP . 16.8 m -89.5 160.84 16.53 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-N 115.388 -0.824 . . . . 55.11 109.545 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.6 t -52.79 -43.37 65.83 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.932 0.893 . . . . 74.13 113.078 -174.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.08 -42.16 80.8 Favored 'General case' 0 C--O 1.25 1.085 0 C-N-CA 124.741 1.216 . . . . 73.01 112.36 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.543 ' OD2' ' HB2' ' A' ' 20' ' ' SER . 12.0 m-20 -66.72 -43.09 85.17 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.125 -0.943 . . . . 73.55 110.376 -178.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.474 ' CG1' HG12 ' A' ' 51' ' ' ILE . 39.1 t -64.19 -40.4 88.92 Favored 'Isoleucine or valine' 0 C--N 1.343 0.309 0 CA-C-N 115.082 -0.963 . . . . 71.02 110.088 174.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.497 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 10.9 tt0 -58.71 -49.95 75.71 Favored 'General case' 0 C--O 1.209 -1.049 0 CA-C-O 118.455 -0.783 . . . . 62.13 111.141 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.5 -46.43 22.48 Favored 'General case' 0 C--O 1.282 2.779 0 N-CA-C 113.686 0.995 . . . . 71.1 113.686 -178.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -59.32 -44.6 92.57 Favored 'General case' 0 C--N 1.36 1.037 0 CA-C-N 116.353 -0.385 . . . . 71.24 110.375 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 42.6 m-85 -80.62 -20.63 42.76 Favored 'General case' 0 C--O 1.211 -0.921 0 CA-C-O 117.929 -1.034 . . . . 74.15 112.869 176.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.497 ' HB3' ' O ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -66.61 -29.56 69.64 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 120.031 1.287 . . . . 74.41 111.671 172.544 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.86 -31.01 68.62 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 117.185 -1.806 . . . . 75.35 112.202 173.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.515 ' CD2' ' HB3' ' A' ' 62' ' ' ALA . 85.1 m-85 -87.36 -37.08 17.41 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.307 0.484 . . . . 73.04 112.307 -176.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -143.9 165.16 27.36 Favored Glycine 0 C--O 1.221 -0.669 0 N-CA-C 111.662 -0.575 . . . . 72.35 111.662 174.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -80.37 99.39 7.91 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 117.516 0.658 . . . . 63.12 110.579 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.84 132.57 31.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 121.884 0.849 . . . . 72.1 111.744 -171.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.0 mp -103.1 -38.44 7.3 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.212 -1.358 . . . . 74.51 111.371 -178.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.51 131.44 15.21 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 122.89 0.476 . . . . 45.21 110.487 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.8 m -121.26 124.33 44.36 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.836 -0.54 . . . . 75.31 110.667 171.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -128.44 132.86 48.44 Favored 'General case' 0 C--O 1.212 -0.911 0 CA-C-N 116.299 -0.41 . . . . 73.53 110.669 -178.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 p -119.19 120.15 62.93 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.173 0 CA-C-O 121.684 0.755 . . . . 43.43 111.077 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -108.56 157.84 18.11 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.703 -0.68 . . . . 74.53 110.625 -178.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.04 149.87 52.16 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 122.243 -0.285 . . . . 73.13 111.034 173.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.4 t -101.48 166.37 10.76 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 120.654 0.264 . . . . 63.44 110.339 172.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.9 t -75.32 -13.72 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 C-N-CA 124.224 1.01 . . . . 72.42 111.14 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.0 t -76.25 -12.42 60.08 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.063 0.545 . . . . 74.22 111.594 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.87 -3.7 41.79 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.25 -0.5 . . . . 75.04 113.667 177.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.99 152.74 21.52 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.064 0.459 . . . . 72.13 111.001 177.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.14 148.93 49.29 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.625 -0.716 . . . . 36.79 110.205 -177.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -134.61 149.41 50.57 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 109.458 -0.571 . . . . 64.4 109.458 -170.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -125.09 138.04 54.18 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.099 0.476 . . . . 54.1 110.648 174.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.52 118.65 34.35 Favored 'General case' 0 C--O 1.256 1.423 0 N-CA-C 107.975 -1.121 . . . . 74.25 107.975 173.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.609 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 3.7 mt -115.1 109.29 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 119.069 -1.052 . . . . 61.41 111.183 -174.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -109.09 104.88 14.15 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.975 0.893 . . . . 71.34 111.345 -171.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -117.58 171.88 7.72 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 114.693 -1.14 . . . . 75.44 113.315 -179.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -79.2 -37.07 39.15 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 114.908 -1.042 . . . . 74.54 111.618 168.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -116.19 117.55 30.35 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 122.179 0.99 . . . . 72.23 111.138 -171.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -84.31 -46.11 12.12 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 113.62 -1.627 . . . . 64.31 115.373 -174.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.8 tmm_? -75.07 -28.53 60.39 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 121.294 0.568 . . . . 63.2 111.913 -168.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -79.17 -25.86 42.76 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-O 121.469 0.652 . . . . 74.21 111.54 177.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.35 -23.76 61.18 Favored 'General case' 0 C--O 1.251 1.151 0 CA-C-O 122.291 1.043 . . . . 62.21 112.245 173.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.81 -22.25 23.79 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 114.593 -1.185 . . . . 73.21 113.856 173.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.469 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 0.4 OUTLIER -66.74 -43.04 85.24 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.82 0.819 . . . . 73.32 110.547 173.51 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.515 ' HB3' ' CD2' ' A' ' 31' ' ' TYR . . . -64.03 -43.02 96.86 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 114.696 -1.138 . . . . 72.35 110.659 173.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -66.82 -31.0 51.5 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.411 0 C-N-CA 120.202 -0.599 . . . . 64.41 111.477 178.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -80.18 -21.32 43.12 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.444 0.566 . . . . 72.41 112.172 176.927 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -85.38 -17.96 35.16 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 118.55 -1.26 . . . . 63.34 111.809 170.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 62' ' ' ALA . 67.4 mmtt -99.67 13.65 32.84 Favored 'General case' 0 CA--C 1.575 1.92 0 CA-C-O 121.622 0.725 . . . . 73.32 111.401 170.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -70.77 153.06 43.13 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 127.115 2.166 . . . . 72.4 114.329 -178.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 112.03 24.28 5.22 Favored Glycine 0 C--N 1.351 1.416 0 C-N-CA 120.268 -0.968 . . . . 72.1 114.53 -171.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 20.7 p -58.27 133.62 55.84 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 114.219 1.192 . . . . 73.24 114.219 -167.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.1 149.92 51.13 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-N 113.826 -1.534 . . . . 63.23 113.212 -168.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -143.5 149.38 37.42 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.442 1.897 . . . . 73.44 110.562 -171.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 74.34 64.87 0.08 Allowed 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 122.476 1.131 . . . . 72.14 113.466 174.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.94 -10.64 60.46 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 113.745 -1.57 . . . . 75.41 113.952 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -120.25 122.78 41.64 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.19 -1.411 . . . . 71.22 107.19 160.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.496 ' HB3' ' O ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -96.12 103.25 15.13 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 119.109 -0.472 . . . . 74.2 111.038 178.855 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 41.5 tp -162.29 69.84 0.28 Allowed 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 118.267 0.485 . . . . 71.23 112.01 177.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -97.86 113.14 24.88 Favored 'General case' 0 C--O 1.208 -1.097 0 O-C-N 119.451 -2.031 . . . . 74.45 109.703 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.8 t -130.1 120.48 49.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 107.893 -1.151 . . . . 62.3 107.893 171.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -149.01 141.33 24.12 Favored 'General case' 0 C--O 1.258 1.517 0 CA-C-O 123.075 1.417 . . . . 65.24 113.922 176.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.6 m -88.91 135.86 31.4 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 113.112 -1.858 . . . . 75.33 110.209 165.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -82.96 20.21 1.19 Allowed 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.19 1.927 . . . . 74.43 112.415 166.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -103.34 72.38 1.15 Allowed 'General case' 0 C--N 1.345 0.404 0 CA-C-O 121.828 0.823 . . . . 53.32 109.707 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -99.24 39.68 1.27 Allowed 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.838 -1.074 . . . . 71.5 109.128 177.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -169.49 39.12 0.03 OUTLIER 'General case' 0 C--O 1.238 0.484 0 CA-C-N 114.704 -1.135 . . . . 75.33 109.838 -174.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 7.3 tpt85 -134.75 1.89 3.11 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 112.168 0.433 . . . . 52.34 112.168 -171.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 . . . . . 0 C--O 1.255 1.352 0 CA-C-O 118.452 -0.785 . . . . 71.21 111.312 -178.223 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.197 0 N-CA-C 111.821 -0.512 . . . . 74.11 111.821 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 6.9 t -118.47 -178.01 3.43 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 110.186 -0.302 . . . . 64.24 110.186 -176.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -130.81 153.18 49.35 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 122.603 0.361 . . . . 74.23 111.254 -178.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -112.88 141.05 47.15 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.315 -0.402 . . . . 62.23 111.11 -178.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.7 t -119.84 128.93 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 116.344 -0.389 . . . . 43.12 110.128 -178.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.0 pp -116.72 165.77 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 120.633 0.254 . . . . 75.41 111.374 177.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -158.2 139.52 13.43 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.975 -0.557 . . . . 72.41 110.343 176.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 64.45 90.7 0.08 Allowed 'General case' 0 N--CA 1.481 1.08 0 O-C-N 124.985 1.428 . . . . 73.31 112.444 175.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.1 t -158.09 155.33 29.02 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.038 -0.528 . . . . 63.11 110.587 -177.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.5 m -109.15 138.09 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-O 120.826 0.346 . . . . 73.01 110.908 176.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.2 p -85.49 139.36 31.55 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.731 -0.213 . . . . 74.03 110.555 -178.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.496 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 0.3 OUTLIER -130.52 151.65 50.76 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.338 0.496 . . . . 60.31 112.338 -177.096 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.9 mp -121.13 132.33 70.8 Favored 'Isoleucine or valine' 0 C--O 1.247 0.95 0 N-CA-C 108.948 -0.76 . . . . 72.32 108.948 174.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -113.16 113.95 26.09 Favored 'General case' 0 C--O 1.244 0.813 0 O-C-N 124.21 0.944 . . . . 75.24 109.338 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 7.2 p -122.71 109.69 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 CA-C-O 122.503 1.144 . . . . 37.78 111.651 176.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -128.14 157.34 21.16 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-N 115.32 -0.855 . . . . 63.02 114.946 -174.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.427 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 15.3 m120 59.37 25.07 13.71 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.715 1.206 . . . . 70.14 111.944 175.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -88.37 151.2 48.23 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 112.511 0.559 . . . . 73.13 112.511 -167.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -64.43 144.2 84.7 Favored 'Trans proline' 0 C--N 1.364 1.382 0 C-N-CA 122.901 2.401 . . . . 74.34 112.227 172.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.5 p 73.53 -31.03 0.22 Allowed 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 127.316 2.246 . . . . 43.33 113.046 -176.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 64.78 86.74 0.12 Allowed 'General case' 0 C--N 1.361 1.071 0 C-N-CA 125.746 1.618 . . . . 74.31 110.156 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.2 p -69.18 133.74 31.35 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 CA-C-O 121.653 0.74 . . . . 75.13 110.521 -174.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.405 ' O ' HG22 ' A' ' 24' ' ' VAL . 25.5 m -90.46 169.33 11.14 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.358 -0.837 . . . . 54.54 110.207 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.3 p -61.82 -28.39 69.44 Favored 'General case' 0 C--O 1.21 -1.022 0 N-CA-C 113.509 0.929 . . . . 73.1 113.509 -175.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -71.85 -41.78 67.71 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 123.586 0.754 . . . . 62.14 111.852 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -73.68 -43.55 59.07 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.888 -0.597 . . . . 75.44 109.829 -172.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.405 HG22 ' O ' ' A' ' 20' ' ' SER . 2.2 m -68.62 -30.79 48.48 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.945 0 CA-C-O 118.179 -0.915 . . . . 75.14 111.175 170.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.0 -55.73 21.37 Favored 'General case' 0 C--O 1.195 -1.801 0 CA-C-O 118.003 -0.998 . . . . 72.53 109.094 172.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -73.84 -55.16 6.54 Favored 'General case' 0 C--O 1.276 2.462 0 C-N-CA 119.199 -1.001 . . . . 72.41 112.662 -175.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -76.64 -35.96 57.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.543 -0.753 . . . . 71.42 110.787 -168.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.31 -23.64 30.17 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 118.073 -0.965 . . . . 74.54 110.984 177.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.585 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 4.7 ptt85 -71.52 -22.94 61.71 Favored 'General case' 0 C--N 1.383 2.065 0 CA-C-N 120.193 1.36 . . . . 70.4 111.698 170.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.19 -33.5 67.54 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 119.005 -1.078 . . . . 63.21 110.91 169.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.511 ' CG ' ' HB3' ' A' ' 62' ' ' ALA . 90.0 m-85 -85.41 -38.02 19.16 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.327 0.492 . . . . 75.55 112.327 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.585 ' O ' ' HA ' ' A' ' 29' ' ' ARG . . . -152.62 143.9 10.86 Favored Glycine 0 C--O 1.22 -0.779 0 C-N-CA 121.045 -0.598 . . . . 64.32 111.67 178.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -66.9 117.73 9.4 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 123.718 0.305 . . . . 74.4 111.05 -172.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.36 122.92 35.55 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-O 122.045 0.926 . . . . 63.33 111.278 -174.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 50.0 mt -100.61 -36.19 9.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.937 -1.029 . . . . 62.42 109.431 177.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.84 139.39 21.58 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.682 -0.69 . . . . 74.4 109.545 -177.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 18.7 p -136.9 118.76 15.17 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.252 0.549 . . . . 74.32 110.497 173.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -129.26 144.83 51.37 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 115.589 -0.732 . . . . 44.25 109.623 -179.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 84.9 t -117.64 129.06 74.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 121.069 0.461 . . . . 74.34 110.365 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -106.08 135.32 47.75 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.117 -0.697 . . . . 71.32 109.117 -178.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.91 125.06 36.75 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.753 -0.379 . . . . 63.13 110.424 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.1 t -102.16 164.42 11.7 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.463 -0.335 . . . . 71.42 111.481 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.7 t -75.04 -13.46 15.35 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 C-N-CA 123.748 0.819 . . . . 75.14 110.913 178.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.8 t -75.65 -10.83 59.77 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.066 0.546 . . . . 65.43 111.542 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.42 -4.12 59.95 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 120.92 -0.657 . . . . 52.05 113.226 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.81 139.12 30.85 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.339 0.59 . . . . 74.44 111.135 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.84 142.12 35.29 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.274 -0.876 . . . . 37.78 109.54 177.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.43 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 8.8 m-85 -136.25 149.43 48.5 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.438 -0.949 . . . . 71.21 108.438 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -132.82 138.52 47.11 Favored 'General case' 0 C--O 1.248 1.012 0 N-CA-C 109.212 -0.662 . . . . 65.04 109.212 172.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -118.09 117.93 30.51 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.113 -1.403 . . . . 72.45 107.836 -176.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.94 112.51 27.59 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.468 0 C-N-CA 120.176 -0.609 . . . . 70.35 111.033 -171.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -98.51 114.52 26.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.922 0.391 . . . . 72.13 111.186 -176.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -107.88 166.37 10.76 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.511 -0.768 . . . . 61.23 111.451 -178.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -80.61 -35.08 34.56 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 120.318 -0.553 . . . . 74.51 110.921 172.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.71 124.28 45.84 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.929 0.871 . . . . 72.24 112.363 -171.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.53 -46.16 16.26 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 113.74 -1.573 . . . . 73.22 114.529 -176.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.59 -21.94 57.37 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 112.727 0.64 . . . . 74.12 112.727 -169.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.416 ' HB3' ' O ' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -78.57 -33.1 47.91 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 121.35 0.595 . . . . 73.2 110.807 174.852 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.96 -24.88 63.41 Favored 'General case' 0 C--O 1.25 1.083 0 C-N-CA 124.4 1.08 . . . . 62.14 112.162 174.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.65 -26.63 56.65 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.164 -0.926 . . . . 62.32 113.34 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.27 -39.2 78.53 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 117.84 0.291 . . . . 75.52 111.257 174.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.511 ' HB3' ' CG ' ' A' ' 31' ' ' TYR . . . -66.17 -42.54 88.82 Favored 'General case' 0 C--O 1.245 0.851 0 C-N-CA 122.844 0.457 . . . . 62.31 111.139 174.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.32 -29.05 37.6 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 119.771 -0.772 . . . . 73.03 111.024 178.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.96 -27.2 43.52 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.793 1.179 . . . . 73.33 112.438 174.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.49 -22.53 43.91 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 119.015 -1.074 . . . . 75.42 111.269 176.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -109.04 14.36 24.06 Favored 'General case' 0 CA--C 1.558 1.287 0 CA-C-O 121.35 0.595 . . . . 63.42 111.92 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -67.1 154.02 42.23 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 125.763 1.625 . . . . 71.34 110.902 169.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.15 21.75 5.81 Favored Glycine 0 C--N 1.343 0.931 0 C-N-CA 119.81 -1.186 . . . . 63.35 112.501 -162.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.657 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 14.3 p -59.81 132.03 52.72 Favored 'General case' 0 C--O 1.242 0.672 0 O-C-N 124.239 0.611 . . . . 62.01 111.888 -175.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.5 147.68 50.4 Favored 'General case' 0 C--O 1.254 1.315 0 CA-C-N 115.171 -0.922 . . . . 72.42 112.744 -169.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -143.16 146.34 33.63 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.335 1.854 . . . . 62.24 110.766 -173.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 74.16 67.56 0.09 Allowed 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 114.084 1.142 . . . . 75.32 114.084 177.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.67 -11.78 59.45 Favored Glycine 0 N--CA 1.462 0.415 0 CA-C-N 114.299 -1.319 . . . . 73.44 113.665 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -121.82 123.18 41.18 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.499 -1.297 . . . . 73.31 107.499 157.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.427 ' HB3' ' O ' ' A' ' 14' ' ' ASN . 0.3 OUTLIER -94.15 104.11 16.14 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 118.97 -0.538 . . . . 73.54 110.701 179.202 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.657 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -162.89 58.15 0.2 Allowed 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.438 1.273 . . . . 73.11 114.438 -175.228 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -95.27 113.83 25.55 Favored 'General case' 0 C--O 1.214 -0.774 0 CA-C-N 121.036 1.744 . . . . 73.4 110.838 -173.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.2 t -128.4 117.39 45.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 107.78 -1.192 . . . . 72.54 107.78 170.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -151.98 144.97 24.49 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.799 0.809 . . . . 74.03 111.625 176.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.7 m -89.06 124.83 64.1 Favored Pre-proline 0 C--N 1.317 -0.836 0 CA-C-N 115.81 -0.632 . . . . 71.42 111.077 170.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.496 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 57.8 Cg_endo -80.37 5.92 5.74 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.036 1.824 . . . . 74.42 114.047 169.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -87.37 -32.61 19.5 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 119.933 -0.707 . . . . 74.41 111.809 175.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 52.45 71.64 0.46 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.887 1.275 . . . . 74.42 112.27 -175.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 63.07 -173.29 0.16 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.045 1.338 . . . . 74.33 112.849 -176.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -79.01 -67.95 0.7 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.88 0.371 . . . . 63.41 111.006 177.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 . . . . . 0 C--O 1.256 1.418 0 CA-C-N 115.583 -0.735 . . . . 74.42 110.238 -174.278 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.86 0 N-CA-C 112.057 -0.417 . . . . 72.03 112.057 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 11.7 p -143.78 156.97 44.68 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.077 0.551 . . . . 64.24 109.93 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -143.96 120.77 11.25 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 110.243 -0.28 . . . . 75.11 110.243 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.3 mtt -135.08 171.51 14.32 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.665 0.269 . . . . 73.12 111.532 178.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 31.2 m -95.3 145.98 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 116.213 -0.449 . . . . 63.22 111.52 -178.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.4 pt -128.15 145.7 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 115.963 -0.562 . . . . 71.35 111.154 178.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 37.6 mtt85 -143.9 127.23 16.76 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 116.239 -0.437 . . . . 73.2 110.105 175.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 59.71 79.75 0.22 Allowed 'General case' 0 N--CA 1.481 1.115 0 O-C-N 125.322 1.639 . . . . 63.45 112.02 178.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -138.95 155.77 47.77 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.963 -0.562 . . . . 73.11 110.349 -176.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.5 t -111.26 105.14 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 116.033 -0.531 . . . . 73.35 110.24 -178.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.9 t -83.0 122.28 28.1 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.738 -0.665 . . . . 72.32 111.401 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.53 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 1.6 ptp180 -143.93 155.86 44.22 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 112.501 0.556 . . . . 63.42 112.501 -175.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 50' ' ' PHE . 6.7 mt -115.28 136.8 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 123.6 0.76 . . . . 74.54 109.896 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -105.63 117.6 34.44 Favored 'General case' 0 C--O 1.249 1.057 0 O-C-N 125.111 1.507 . . . . 63.54 109.728 177.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 59.4 t -119.68 109.51 26.46 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.055 0 CA-C-N 115.495 -0.775 . . . . 71.32 109.504 176.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -123.07 156.84 17.51 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.74 -0.743 . . . . 74.32 113.627 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.2 m120 59.11 32.42 22.12 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.029 0.932 . . . . 73.32 112.255 170.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -87.77 149.23 45.55 Favored Pre-proline 0 CA--C 1.543 0.707 0 N-CA-C 113.277 0.843 . . . . 74.21 113.277 -168.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -69.69 129.94 18.56 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 122.943 2.428 . . . . 73.24 112.647 172.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.7 p 48.3 101.62 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 125.949 1.7 . . . . 73.13 113.021 -169.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 38.0 p-80 -55.42 119.31 5.42 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.778 0.799 . . . . 65.52 112.218 -175.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.5 p -77.12 129.59 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 114.534 -1.212 . . . . 63.44 110.43 -175.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.3 m -83.6 165.75 18.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.401 -0.818 . . . . 73.02 110.207 -178.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 32.0 p -62.88 -28.2 69.88 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.723 0.809 . . . . 71.14 112.54 -174.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.06 -37.59 54.34 Favored 'General case' 0 C--O 1.253 1.249 0 CA-C-O 121.52 0.676 . . . . 75.14 110.809 -177.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -71.03 -44.42 65.86 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 114.652 -1.158 . . . . 75.03 110.564 -178.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.636 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 2.9 m -67.62 -31.52 52.86 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.872 0 CA-C-O 118.978 -0.534 . . . . 72.43 110.588 171.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.419 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 17.1 tt0 -58.41 -54.14 50.43 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 118.946 -0.55 . . . . 74.21 110.476 177.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -72.47 -54.02 10.47 Favored 'General case' 0 C--O 1.29 3.225 0 C-N-CA 119.829 -0.749 . . . . 52.14 112.512 -178.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -69.48 -44.58 70.86 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.676 -1.147 . . . . 74.21 109.689 -169.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.636 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 7.8 m-85 -77.95 -21.99 50.17 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-O 118.099 -0.953 . . . . 72.34 111.384 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.419 ' HB3' ' O ' ' A' ' 25' ' ' GLU . 3.6 ppt_? -68.44 -26.66 65.62 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 121.193 1.815 . . . . 71.25 111.402 171.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.48 -21.05 66.55 Favored 'General case' 0 CA--C 1.561 1.398 0 C-N-CA 118.304 -1.358 . . . . 71.52 112.442 169.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.434 ' OH ' ' HE3' ' A' ' 66' ' ' LYS . 5.2 m-30 -74.76 -37.22 62.52 Favored 'General case' 0 C--O 1.207 -1.173 0 N-CA-C 113.134 0.79 . . . . 73.04 113.134 -175.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 166.54 43.82 0.02 OUTLIER Glycine 0 N--CA 1.469 0.839 0 C-N-CA 118.943 -1.598 . . . . 64.11 114.061 -178.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.5 t30 62.05 99.28 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 125.217 1.407 . . . . 72.32 113.058 175.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.16 127.48 39.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 114.951 -1.022 . . . . 72.51 110.535 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -97.29 -32.25 12.0 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.536 -0.756 . . . . 73.35 109.932 176.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.01 132.15 15.38 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.001 -0.545 . . . . 62.52 109.697 -176.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.1 p -125.2 125.19 43.25 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 120.862 0.363 . . . . 64.31 110.041 172.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -129.41 130.99 46.67 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.825 -0.625 . . . . 73.31 110.144 -179.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.4 t -111.89 114.47 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.285 0.564 . . . . 72.53 110.035 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -107.12 139.93 40.76 Favored 'General case' 0 C--O 1.212 -0.915 0 CA-C-N 115.22 -0.9 . . . . 75.42 108.815 -178.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.83 148.22 52.54 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.313 0.96 . . . . 64.21 112.005 171.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.4 t -100.85 165.76 11.19 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 116.263 -0.426 . . . . 43.42 110.49 177.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.5 t -75.57 -11.47 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 C-N-CA 123.862 0.865 . . . . 73.23 110.937 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -76.46 -8.25 56.77 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 122.837 0.455 . . . . 65.41 111.63 178.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.83 -4.09 52.98 Favored Glycine 0 C--N 1.341 0.815 0 C-N-CA 121.248 -0.501 . . . . 54.21 112.869 175.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.89 135.24 33.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.994 0.426 . . . . 71.5 110.953 178.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.96 148.49 26.65 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.351 -0.841 . . . . 43.45 109.397 177.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.524 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 19.8 m-85 -136.13 153.21 51.35 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 123.641 0.588 . . . . 74.1 109.503 -176.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -136.0 137.86 41.66 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.997 -0.547 . . . . 74.14 109.62 174.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.435 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 0.4 OUTLIER -111.46 119.95 40.5 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 114.736 -1.12 . . . . 64.33 108.448 172.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.3 mp -123.87 113.92 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 119.997 -0.681 . . . . 71.52 111.145 -177.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -92.73 116.15 28.75 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.325 -0.852 . . . . 61.34 111.593 -169.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -109.84 152.94 25.11 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.782 1.03 . . . . 71.51 113.782 -177.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.41 -34.03 25.6 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 115.275 -0.875 . . . . 63.14 112.044 172.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -122.51 129.5 52.04 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.278 0.844 . . . . 74.41 113.278 -177.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.07 -45.99 31.32 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 113.98 -1.464 . . . . 63.1 114.339 -175.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.09 -25.23 52.05 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.324 0.861 . . . . 65.41 113.324 -170.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -76.47 -36.81 57.67 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.859 0.838 . . . . 72.32 109.331 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.65 -27.93 65.46 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 114.505 -1.225 . . . . 71.44 111.743 177.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.02 -35.45 69.28 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 114.227 1.195 . . . . 73.31 114.227 -176.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.545 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 0.5 OUTLIER -69.55 -40.51 76.79 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 122.122 0.963 . . . . 65.51 112.729 -179.437 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.544 ' O ' ' HG3' ' A' ' 65' ' ' GLU . . . -75.92 -36.48 59.39 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.674 -0.693 . . . . 73.2 110.598 178.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -68.83 -28.85 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 O-C-N 121.875 -0.516 . . . . 54.43 110.575 176.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.545 ' HG3' ' O ' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -78.86 -23.0 45.23 Favored 'General case' 0 C--N 1.354 0.803 0 CA-C-N 118.295 0.498 . . . . 71.21 111.833 169.874 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.544 ' HG3' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -69.45 -29.41 67.09 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 120.192 -0.603 . . . . 75.41 110.88 172.189 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.526 ' HD2' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -105.03 7.81 34.13 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 114.767 1.395 . . . . 74.52 114.767 169.033 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -70.1 152.9 43.81 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 123.444 0.698 . . . . 73.13 111.25 173.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.02 23.7 4.49 Favored Glycine 0 C--N 1.342 0.865 0 C-N-CA 119.532 -1.318 . . . . 73.3 112.327 -155.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.544 ' SG ' ' HA ' ' A' ' 77' ' ' ARG . 6.1 t -55.81 136.75 51.03 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.815 0.846 . . . . 65.43 112.059 -178.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -123.82 146.16 48.56 Favored 'General case' 0 C--O 1.249 1.056 0 CA-C-N 114.808 -1.087 . . . . 72.4 112.928 -169.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -142.61 145.78 33.87 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 112.14 -2.3 . . . . 74.22 110.298 -173.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 73.24 66.87 0.1 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 114.302 1.223 . . . . 74.51 114.302 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.67 -12.6 59.56 Favored Glycine 0 C--N 1.335 0.474 0 CA-C-N 114.148 -1.387 . . . . 73.33 114.258 171.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -123.22 120.49 33.31 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 106.483 -1.673 . . . . 74.43 106.483 157.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.1 116.08 28.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 119.579 -0.248 . . . . 73.42 111.319 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -157.91 81.33 0.86 Allowed 'General case' 0 C--O 1.208 -1.107 0 N-CA-C 112.356 0.502 . . . . 72.41 112.356 178.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.544 ' HA ' ' SG ' ' A' ' 69' ' ' CYS . 7.4 tpp85 -97.85 113.26 25.02 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.576 1.08 . . . . 74.25 110.165 -178.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -133.22 115.88 24.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.662 -0.699 . . . . 64.03 109.441 169.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.18 155.09 36.02 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-O 121.802 0.811 . . . . 75.42 112.724 175.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 31.0 m -90.6 123.38 65.37 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 114.824 -1.08 . . . . 71.51 110.764 166.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.53 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 73.8 Cg_endo -88.17 9.15 3.84 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 122.061 1.84 . . . . 74.1 112.576 164.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -97.05 -13.28 22.35 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 120.576 -0.45 . . . . 70.34 111.887 176.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.3 m120 67.75 127.92 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.29 0 O-C-N 124.872 1.358 . . . . 71.42 111.948 -172.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.22 61.3 5.39 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.15 -0.932 . . . . 75.22 113.069 -167.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.18 34.52 21.09 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.555 1.542 . . . . 62.33 111.726 -179.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 . . . . . 0 C--O 1.254 1.31 0 O-C-N 124.52 1.138 . . . . 65.53 112.34 174.745 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.541 0.597 0 N-CA-C 110.451 -0.203 . . . . 73.52 110.451 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.21 158.5 44.26 Favored 'General case' 0 N--CA 1.509 2.518 0 CA-C-O 118.666 -0.683 . . . . 63.41 112.163 -177.257 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.547 ' HB ' HD12 ' A' ' 51' ' ' ILE . 6.2 mt -117.66 143.0 29.37 Favored 'Isoleucine or valine' 0 C--N 1.371 1.518 0 N-CA-C 107.258 -1.386 . . . . 71.22 107.258 -176.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -104.95 113.23 26.7 Favored 'General case' 0 CA--C 1.564 1.499 0 CA-C-O 117.996 -1.002 . . . . 74.24 111.413 -176.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.526 HG12 HG13 ' A' ' 78' ' ' VAL . 14.2 m -127.24 107.45 16.85 Favored 'Isoleucine or valine' 0 C--N 1.376 1.728 0 CA-C-N 121.166 1.803 . . . . 62.42 110.309 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.511 ' H ' ' HG3' ' A' ' 77' ' ' ARG . . . -134.7 -179.05 16.1 Favored Glycine 0 N--CA 1.485 1.941 0 O-C-N 120.86 -1.15 . . . . 64.1 113.987 -174.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.4 m120 49.72 23.22 0.94 Allowed 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 113.875 1.065 . . . . 53.42 113.875 -178.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.648 HD23 ' H ' ' A' ' 15' ' ' LEU . 2.2 pt? -91.14 141.59 26.51 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.236 1.014 . . . . 71.53 110.561 -167.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -64.46 133.55 37.77 Favored 'Trans proline' 0 C--N 1.365 1.404 0 C-N-CA 122.367 2.045 . . . . 71.33 111.807 177.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.5 p 82.13 -39.67 0.11 Allowed 'General case' 0 C--N 1.379 1.859 0 C-N-CA 126.73 2.012 . . . . 65.44 112.053 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 73.7 t60 67.19 117.58 0.03 OUTLIER 'General case' 0 C--N 1.357 0.926 0 C-N-CA 125.278 1.431 . . . . 70.45 110.999 -173.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.474 ' H ' HD11 ' A' ' 15' ' ' LEU . 9.8 m -71.82 116.3 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.594 2.643 0 N-CA-C 107.312 -1.366 . . . . 64.21 107.312 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -79.25 155.8 28.4 Favored 'General case' 0 C--N 1.38 1.908 0 O-C-N 120.789 -1.194 . . . . 72.32 110.727 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 69.9 m -48.81 -43.34 38.19 Favored 'General case' 0 C--N 1.381 1.963 0 N-CA-C 115.911 1.819 . . . . 71.52 115.911 -173.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.99 -47.52 71.35 Favored 'General case' 0 CA--C 1.589 2.445 0 N-CA-C 113.865 1.061 . . . . 74.34 113.865 174.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -72.88 -35.97 67.25 Favored 'General case' 0 C--N 1.361 1.072 0 CA-C-O 119.089 -0.482 . . . . 75.22 112.286 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.511 ' O ' ' HB2' ' A' ' 28' ' ' PHE 0.262 1.7 p -69.41 -44.12 80.38 Favored 'Isoleucine or valine' 0 C--N 1.36 1.025 0 CA-C-O 118.107 -0.949 . . . . 43.02 110.683 176.619 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.488 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 22.1 tt0 -49.12 -60.44 2.79 Favored 'General case' 0 N--CA 1.507 2.405 0 CA-C-O 116.809 -1.567 . . . . 54.13 112.165 165.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -70.21 -61.82 1.63 Allowed 'General case' 0 C--O 1.303 3.912 0 CA-C-N 121.467 1.94 . . . . 64.42 114.417 -173.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -70.42 -34.34 72.39 Favored 'General case' 0 C--N 1.369 1.421 0 CA-C-O 117.111 -1.423 . . . . 72.12 112.622 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.511 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 1.2 m-85 -77.57 -35.82 52.7 Favored 'General case' 0 C--N 1.364 1.23 0 CA-C-N 121.939 2.154 . . . . 75.15 112.271 177.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.488 ' HB3' ' O ' ' A' ' 25' ' ' GLU . 5.2 ptt85 -53.21 -28.51 27.28 Favored 'General case' 0 N--CA 1.509 2.513 0 CA-C-O 115.87 -2.014 . . . . 75.33 115.338 166.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.63 -47.04 73.94 Favored 'General case' 0 N--CA 1.522 3.142 0 CA-C-N 123.485 2.857 . . . . 72.32 111.666 167.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.514 ' HB3' ' HA ' ' A' ' 59' ' ' ALA . 94.6 m-85 -76.39 -38.26 55.96 Favored 'General case' 0 CA--C 1.554 1.103 0 CA-C-O 118.302 -0.856 . . . . 71.22 112.532 -166.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -148.94 -175.43 21.39 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-N 120.001 1.273 . . . . 73.15 111.605 170.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -99.48 98.77 9.64 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 119.23 -0.988 . . . . 65.51 109.362 -166.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.49 134.6 29.17 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.409 0 N-CA-C 113.761 1.023 . . . . 71.41 113.761 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.46 -26.36 11.47 Favored 'General case' 0 CA--C 1.562 1.407 0 N-CA-C 110.092 -0.336 . . . . 70.0 110.092 172.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.8 pttm -153.92 153.82 32.72 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.528 0.731 . . . . 70.15 110.121 168.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -139.52 105.47 5.19 Favored 'General case' 0 C--N 1.356 0.873 0 N-CA-C 108.13 -1.063 . . . . 63.2 108.13 175.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -112.45 144.5 41.8 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 118.864 -1.135 . . . . 71.43 114.054 -176.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 69.4 t -97.09 113.93 32.75 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 N-CA-C 108.837 -0.801 . . . . 62.21 108.837 175.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -115.28 131.37 56.95 Favored 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 107.948 -1.13 . . . . 71.3 107.948 175.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.44 141.52 51.38 Favored 'General case' 0 CA--C 1.564 1.492 0 CA-C-N 121.8 2.091 . . . . 73.22 108.354 -170.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.585 HG23 ' H ' ' A' ' 44' ' ' SER . 6.4 t -100.81 173.51 6.48 Favored 'General case' 0 CA--C 1.565 1.539 0 CA-C-N 120.853 1.66 . . . . 71.42 111.977 -178.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.9 t -75.74 -9.3 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.305 0 C-N-CA 123.749 0.819 . . . . 73.3 112.377 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.585 ' H ' HG23 ' A' ' 42' ' ' THR . 0.8 OUTLIER -89.19 7.66 34.14 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 121.705 -0.622 . . . . 44.05 110.499 -175.984 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.54 -5.09 75.47 Favored Glycine 0 C--N 1.347 1.178 0 N-CA-C 115.436 0.934 . . . . 62.12 115.436 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.09 131.95 34.75 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 118.022 0.911 . . . . 75.01 110.031 176.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -105.63 146.26 29.93 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 109.393 -0.595 . . . . 62.13 109.393 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -129.3 148.75 51.25 Favored 'General case' 0 C--N 1.347 0.496 0 N-CA-C 108.942 -0.762 . . . . 73.13 108.942 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -121.29 135.57 55.09 Favored 'General case' 0 C--O 1.247 0.964 0 C-N-CA 119.855 -0.738 . . . . 61.23 110.257 168.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -108.92 122.15 46.62 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 114.048 -1.433 . . . . 71.34 108.229 -172.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.547 HD12 ' HB ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -126.92 108.6 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 C-N-CA 118.953 -1.099 . . . . 73.33 109.975 -165.071 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -89.27 103.99 16.57 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 120.508 -0.477 . . . . 74.54 110.905 -171.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -113.22 142.33 45.93 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 113.645 0.98 . . . . 74.33 113.645 -172.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -82.81 -34.5 26.94 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.742 -0.783 . . . . 72.12 112.565 172.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -117.75 120.25 37.38 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 108.991 -0.744 . . . . 62.33 108.991 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.528 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -77.87 -38.37 46.15 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 115.425 1.639 . . . . 73.04 115.425 167.011 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -60.21 -40.11 88.97 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 113.593 0.96 . . . . 73.21 113.593 -168.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -69.53 -49.18 56.87 Favored 'General case' 0 CA--C 1.582 2.18 0 N-CA-C 114.835 1.42 . . . . 71.14 114.835 169.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.514 ' HA ' ' HB3' ' A' ' 31' ' ' TYR . . . -52.76 -21.63 4.35 Favored 'General case' 0 CA--C 1.587 2.37 0 N-CA-C 115.541 1.682 . . . . 33.23 115.541 172.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.482 ' O ' ' HG3' ' A' ' 64' ' ' LYS . . . -47.01 -34.61 5.81 Favored 'General case' 0 CA--C 1.561 1.383 0 CA-C-O 116.269 -1.824 . . . . 32.05 114.565 173.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.426 ' O ' ' HB3' ' A' ' 65' ' ' GLU . 29.3 m-20 -52.5 -53.89 39.87 Favored 'General case' 0 N--CA 1.51 2.539 0 CA-C-N 121.517 1.962 . . . . 51.1 111.835 168.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.08 -43.54 95.11 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 118.504 0.593 . . . . 71.43 111.809 178.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.576 HD12 HG13 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -67.37 -39.61 83.06 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.415 0 C-N-CA 118.748 -1.181 . . . . 72.34 113.458 -174.454 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.492 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -65.92 -32.58 74.16 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.813 1.042 . . . . 75.02 113.813 167.492 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.426 ' HB3' ' O ' ' A' ' 61' ' ' ASP . 0.6 OUTLIER -76.95 -17.1 59.12 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.059 0.391 . . . . 73.53 111.196 -176.19 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt -109.78 12.01 24.18 Favored 'General case' 0 CA--C 1.577 1.984 0 CA-C-O 119.742 -0.171 . . . . 73.11 111.056 169.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.492 ' HB3' ' HA ' ' A' ' 64' ' ' LYS 0.373 0.0 OUTLIER -78.45 159.63 28.16 Favored 'General case' 0 N--CA 1.506 2.344 0 C-N-CA 123.664 0.786 . . . . 64.52 112.406 -176.028 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.55 29.55 2.24 Favored Glycine 0 N--CA 1.439 -1.166 0 CA-C-O 117.819 -1.545 . . . . 61.33 114.406 -161.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.81 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 18.2 t -49.63 126.16 13.03 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-N 118.314 1.057 . . . . 74.51 112.125 -175.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.53 145.47 47.08 Favored 'General case' 0 C--O 1.251 1.172 0 CA-C-N 113.208 -1.814 . . . . 72.42 112.464 -172.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -147.8 147.36 29.75 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 105.947 -1.872 . . . . 74.24 105.947 -168.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 72.35 63.03 0.12 Allowed 'General case' 0 N--CA 1.483 1.175 0 CA-C-O 122.347 1.07 . . . . 62.4 112.995 176.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 97.5 -13.92 63.77 Favored Glycine 0 N--CA 1.471 0.998 0 N-CA-C 116.632 1.413 . . . . 70.02 116.632 172.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -113.23 121.19 43.72 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 105.1 -2.185 . . . . 64.41 105.1 156.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.49 102.8 14.65 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 117.438 -1.268 . . . . 73.15 109.826 -173.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.81 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -162.94 72.53 0.32 Allowed 'General case' 0 N--CA 1.512 2.672 0 CA-C-N 121.328 1.876 . . . . 74.42 115.668 178.834 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.511 ' HG3' ' H ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -96.6 118.03 32.23 Favored 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 123.769 2.986 . . . . 63.54 111.702 -175.319 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.526 HG13 HG12 ' A' ' 12' ' ' VAL . 41.0 t -131.78 119.4 41.6 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.772 0 O-C-N 120.189 -1.569 . . . . 74.23 108.056 172.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -146.99 134.57 20.96 Favored 'General case' 0 C--N 1.384 2.107 0 CA-C-N 121.088 1.767 . . . . 74.01 112.841 -172.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.576 HG13 HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -93.12 126.54 50.62 Favored Pre-proline 0 N--CA 1.45 -0.467 0 CA-C-N 114.197 -1.365 . . . . 72.35 112.095 169.901 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -85.85 25.5 0.69 Allowed 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 122.147 1.898 . . . . 72.2 111.842 165.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.528 ' CD2' ' HB2' ' A' ' 56' ' ' ALA . 9.2 m-85 -110.95 -28.13 8.48 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 115.595 -0.73 . . . . 75.3 110.161 176.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 . . . . . 0 N--CA 1.489 1.506 0 O-C-N 124.75 1.281 . . . . 74.11 112.145 -172.77 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.546 0.821 0 N-CA-C 109.649 -0.5 . . . . 74.35 109.649 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.565 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -140.49 159.84 41.3 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 118.633 -0.698 . . . . 71.33 112.322 -178.783 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.708 HG12 HG12 ' A' ' 80' ' ' VAL . 4.5 mt -114.04 138.73 42.93 Favored 'Isoleucine or valine' 0 C--O 1.264 1.855 0 CA-C-N 119.927 1.24 . . . . 53.42 107.725 170.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -102.79 114.53 28.86 Favored 'General case' 0 CA--C 1.561 1.401 0 O-C-N 125.903 2.002 . . . . 64.3 109.399 172.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.419 HG23 HG22 ' A' ' 78' ' ' VAL . 2.1 p -125.58 106.04 15.62 Favored 'Isoleucine or valine' 0 C--N 1.37 1.475 0 CA-C-N 120.62 1.555 . . . . 73.0 109.322 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -115.31 168.32 12.57 Favored Glycine 0 C--N 1.354 1.549 0 C-N-CA 120.687 -0.768 . . . . 64.11 112.274 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.0 m120 50.79 24.92 1.91 Allowed 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 114.617 1.34 . . . . 64.04 114.617 -177.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.422 HD23 ' H ' ' A' ' 15' ' ' LEU . 1.9 pt? -75.69 136.2 70.96 Favored Pre-proline 0 C--O 1.239 0.522 0 C-N-CA 123.335 0.654 . . . . 61.24 110.709 178.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -73.71 126.35 10.71 Favored 'Trans proline' 0 CA--C 1.553 1.468 0 C-N-CA 121.422 1.414 . . . . 71.11 111.685 175.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.5 t 60.33 100.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.005 0.922 . . . . 51.3 111.129 -174.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 -64.79 132.9 50.79 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.086 -0.506 . . . . 72.42 111.789 -177.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.7 m -66.02 121.43 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.895 0 CA-C-N 114.557 -1.201 . . . . 61.31 109.614 -176.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.84 154.06 28.66 Favored 'General case' 0 C--N 1.377 1.768 0 CA-C-N 119.212 0.914 . . . . 64.4 110.576 -176.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.9 p -47.18 -48.09 23.88 Favored 'General case' 0 C--N 1.375 1.699 0 N-CA-C 116.036 1.865 . . . . 72.14 116.036 -174.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.19 -46.46 75.84 Favored 'General case' 0 C--O 1.285 2.93 0 N-CA-C 114.41 1.263 . . . . 52.24 114.41 175.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -64.34 -35.45 80.9 Favored 'General case' 0 C--N 1.372 1.545 0 CA-C-O 118.002 -0.999 . . . . 74.22 110.142 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.528 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 1.2 t -66.82 -44.43 89.11 Favored 'Isoleucine or valine' 0 C--N 1.385 2.139 0 CA-C-O 116.552 -1.689 . . . . 72.11 110.722 174.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.01 -56.15 24.17 Favored 'General case' 0 C--N 1.373 1.602 0 CA-C-N 120.641 1.564 . . . . 72.35 110.747 177.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.55 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 12.9 m-80 -81.33 -57.01 3.68 Favored 'General case' 0 C--O 1.294 3.418 0 CA-C-N 122.156 2.253 . . . . 74.44 116.364 -176.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -68.36 -26.99 65.86 Favored 'General case' 0 C--N 1.354 0.777 0 C-N-CA 119.566 -0.854 . . . . 54.42 111.218 -175.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.528 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 35.7 m-85 -90.98 -22.55 20.77 Favored 'General case' 0 CA--C 1.565 1.544 0 C-N-CA 118.337 -1.345 . . . . 73.41 114.222 173.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.55 ' HG3' ' O ' ' A' ' 26' ' ' ASN 0.259 2.5 ppt_? -54.27 -28.34 41.12 Favored 'General case' 0 N--CA 1.503 2.218 0 CA-C-N 120.161 1.346 . . . . 72.01 112.285 163.916 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.566 ' O ' ' HD2' ' A' ' 30' ' ' LYS 0.257 1.7 tptm -52.03 -28.63 17.88 Favored 'General case' 0 N--CA 1.518 2.946 0 C-N-CA 118.445 -1.302 . . . . 64.25 113.742 168.433 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -80.22 -44.17 20.18 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 120.023 1.283 . . . . 63.0 111.488 -166.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -169.24 44.28 0.21 Allowed Glycine 0 C--N 1.341 0.859 0 C-N-CA 117.712 -2.185 . . . . 72.01 114.45 162.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 60.38 87.33 0.09 Allowed 'General case' 0 C--N 1.359 1.005 0 C-N-CA 123.983 0.913 . . . . 53.02 109.9 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.467 HG22 ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -67.36 138.45 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-N 114.976 -1.011 . . . . 70.43 112.471 -178.325 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.419 ' H ' HD22 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -103.31 -26.49 12.92 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 109.63 -0.507 . . . . 72.15 109.63 173.115 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp -149.66 137.36 20.17 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-O 118.826 -0.606 . . . . 64.22 109.889 -173.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -140.84 110.06 6.22 Favored 'General case' 0 C--N 1.364 1.226 0 CA-C-N 119.564 1.075 . . . . 71.14 109.268 176.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -109.13 146.59 33.84 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 117.762 -1.575 . . . . 73.33 112.847 177.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.8 t -114.27 110.6 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 106.317 -1.735 . . . . 74.52 106.317 176.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.0 mttm -121.45 137.25 54.8 Favored 'General case' 0 CA--C 1.563 1.446 0 CA-C-O 118.909 -0.567 . . . . 64.12 110.301 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.97 143.92 50.9 Favored 'General case' 0 C--N 1.371 1.516 0 CA-C-N 120.437 1.471 . . . . 64.1 108.122 -168.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.632 HG23 ' H ' ' A' ' 44' ' ' SER . 6.4 t -99.98 172.1 7.43 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-N 120.683 1.583 . . . . 71.22 110.941 -178.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.8 t -75.37 -9.95 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.208 0 C-N-CA 123.502 0.721 . . . . 64.04 112.077 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.632 ' H ' HG23 ' A' ' 42' ' ' THR . 0.8 OUTLIER -89.27 7.57 34.85 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 121.735 -0.603 . . . . 74.03 110.24 -177.307 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.73 -4.63 78.43 Favored Glycine 0 CA--C 1.537 1.417 0 N-CA-C 115.952 1.141 . . . . 61.34 115.952 178.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.94 131.79 33.99 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 118.429 1.115 . . . . 61.33 109.903 176.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.93 146.89 28.4 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 108.606 -0.887 . . . . 61.41 108.606 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -127.49 146.84 50.36 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 119.211 -0.995 . . . . 70.23 108.555 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.417 ' HB3' HG13 ' A' ' 12' ' ' VAL . . . -121.4 139.08 53.91 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 119.486 -0.886 . . . . 51.23 110.295 172.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -125.28 117.14 23.15 Favored 'General case' 0 C--O 1.263 1.803 0 N-CA-C 106.864 -1.532 . . . . 72.55 106.864 -167.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.33 113.12 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 114.351 1.241 . . . . 74.05 114.351 -163.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -90.21 108.81 19.98 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 115.002 -0.999 . . . . 70.4 112.604 -171.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -108.51 155.61 20.43 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 112.145 0.424 . . . . 73.21 112.145 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -81.72 -26.36 34.66 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 113.809 1.04 . . . . 70.12 113.809 173.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.48 120.89 39.49 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 119.208 0.913 . . . . 42.3 110.328 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.91 -35.87 59.64 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 114.773 1.397 . . . . 71.42 114.773 172.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.27 0.0 OUTLIER -80.71 -30.0 36.38 Favored 'General case' 0 CA--C 1.564 1.5 0 CA-C-N 120.828 1.649 . . . . 70.5 113.435 -167.144 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -62.21 -50.57 71.27 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-N 118.85 0.75 . . . . 74.34 112.521 175.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.0 -25.53 21.53 Favored 'General case' 0 CA--C 1.57 1.712 0 N-CA-C 116.369 1.989 . . . . 64.4 116.369 177.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.73 -43.05 57.9 Favored 'General case' 0 CA--C 1.581 2.171 0 C-N-CA 125.482 1.513 . . . . 44.11 114.231 178.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -53.54 -48.14 69.34 Favored 'General case' 0 N--CA 1.518 2.944 0 CA-C-N 119.654 1.116 . . . . 75.32 113.771 169.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.635 ' O ' ' HD2' ' A' ' 66' ' ' LYS . . . -72.19 -32.91 67.25 Favored 'General case' 0 C--N 1.31 -1.131 0 O-C-N 120.786 -1.197 . . . . 60.02 111.777 179.056 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.722 HD12 HG13 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -73.33 -41.04 57.51 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.053 0 CA-C-O 117.247 -1.358 . . . . 73.35 112.141 -177.264 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.48 -34.0 70.41 Favored 'General case' 0 CA--C 1.557 1.219 0 CA-C-N 120.505 1.502 . . . . 71.24 114.285 161.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.54 -23.89 66.98 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 120.816 1.644 . . . . 64.45 112.773 175.317 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.635 ' HD2' ' O ' ' A' ' 62' ' ' ALA 0.283 0.0 OUTLIER -110.48 16.89 21.29 Favored 'General case' 0 N--CA 1.514 2.738 0 N-CA-C 117.1 2.259 . . . . 61.24 117.1 160.64 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.418 0.0 OUTLIER -79.72 160.03 26.41 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 120.016 1.28 . . . . 71.15 113.945 -176.381 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.14 29.33 2.38 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 119.095 -1.526 . . . . 32.51 114.593 -158.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.791 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -53.06 125.95 19.01 Favored 'General case' 0 C--N 1.37 1.472 0 CA-C-N 117.268 0.534 . . . . 53.15 111.19 -178.195 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -131.23 150.76 52.01 Favored 'General case' 0 C--O 1.259 1.6 0 CA-C-N 115.63 -0.713 . . . . 70.23 112.018 -174.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -147.59 146.66 29.47 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 127.872 2.469 . . . . 70.33 107.508 -168.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 73.22 62.54 0.1 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.975 0.893 . . . . 42.11 112.844 -176.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.44 -13.19 61.5 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 117.157 1.623 . . . . 51.15 117.157 169.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -112.79 122.23 47.04 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 106.947 -1.501 . . . . 55.45 106.947 154.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.93 103.52 15.39 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 117.719 -1.134 . . . . 60.25 109.433 -175.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.791 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 14.3 tp -165.92 66.97 0.11 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 120.651 1.569 . . . . 54.33 112.485 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -96.54 110.83 23.15 Favored 'General case' 0 CA--C 1.569 1.704 0 CA-C-N 122.584 2.447 . . . . 74.25 109.733 -173.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.518 ' H ' ' HB3' ' A' ' 69' ' ' CYS . 22.6 t -123.48 115.54 45.69 Favored 'Isoleucine or valine' 0 C--N 1.358 0.967 0 O-C-N 120.577 -1.327 . . . . 74.34 107.806 170.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -138.7 143.12 38.98 Favored 'General case' 0 C--O 1.254 1.298 0 CA-C-N 120.574 1.533 . . . . 53.21 111.317 176.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.722 HG13 HD12 ' A' ' 63' ' ' ILE . 8.8 m -88.01 122.28 70.12 Favored Pre-proline 0 N--CA 1.437 -1.11 0 CA-C-N 114.622 -1.172 . . . . 72.44 111.412 168.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.565 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 61.2 Cg_endo -91.76 32.98 0.29 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.67 2.247 . . . . 63.22 111.447 159.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.3 10.62 5.33 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 112.58 0.585 . . . . 71.1 112.58 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 t30 . . . . . 0 N--CA 1.493 1.719 0 O-C-N 123.174 0.296 . . . . 61.53 111.427 -167.69 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 p . . . . . 0 CA--C 1.54 0.594 0 N-CA-C 109.723 -0.473 . . . . 60.32 109.723 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.439 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 3.2 ptt180 -124.99 151.29 45.74 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 120.251 -0.58 . . . . 63.43 111.716 -170.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.683 HD12 ' HB ' ' A' ' 51' ' ' ILE . 7.7 mt -116.94 137.17 51.71 Favored 'Isoleucine or valine' 0 C--O 1.259 1.569 0 CA-C-N 120.041 1.291 . . . . 74.3 108.855 -175.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -106.05 113.71 27.41 Favored 'General case' 0 CA--C 1.574 1.876 0 O-C-N 125.903 2.002 . . . . 73.32 110.359 176.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.666 HG23 HG22 ' A' ' 78' ' ' VAL . 1.1 p -125.87 103.89 12.37 Favored 'Isoleucine or valine' 0 C--N 1.375 1.674 0 CA-C-N 120.194 1.361 . . . . 61.11 108.949 177.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -118.26 175.01 15.53 Favored Glycine 0 C--N 1.353 1.478 0 C-N-CA 120.652 -0.785 . . . . 75.43 113.354 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 51.34 29.11 4.8 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 115.697 1.74 . . . . 70.3 115.697 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.429 HD11 ' H ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -87.26 150.86 50.29 Favored Pre-proline 0 CA--C 1.555 1.15 0 CA-C-N 119.27 0.941 . . . . 55.23 110.406 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -82.94 128.86 5.23 Favored 'Trans proline' 0 CA--C 1.567 2.149 0 C-N-CA 120.8 1.0 . . . . 43.24 112.487 177.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.5 p 113.6 -29.16 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.631 0 C-N-CA 128.736 2.814 . . . . 62.41 111.045 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 68.17 105.28 0.05 Allowed 'General case' 0 C--N 1.358 0.949 0 C-N-CA 124.859 1.264 . . . . 72.23 110.285 -167.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.52 HG21 HG13 ' A' ' 24' ' ' VAL . 7.4 p -76.6 118.32 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.292 0 CA-C-N 114.874 -1.057 . . . . 62.54 108.936 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.9 m -82.23 160.0 23.09 Favored 'General case' 0 CA--C 1.559 1.303 0 CA-C-O 117.744 -1.122 . . . . 55.25 108.449 178.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.453 ' O ' ' HB3' ' A' ' 25' ' ' GLU . 5.6 p -50.64 -39.77 51.37 Favored 'General case' 0 C--N 1.378 1.834 0 N-CA-C 115.3 1.592 . . . . 73.53 115.3 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.34 -33.08 73.03 Favored 'General case' 0 CA--C 1.576 1.963 0 N-CA-C 115.51 1.67 . . . . 71.34 115.51 177.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -68.34 -54.11 19.57 Favored 'General case' 0 C--O 1.283 2.844 0 CA-C-N 119.719 1.145 . . . . 75.41 111.295 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.52 HG13 HG21 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -57.7 -54.04 36.82 Favored 'Isoleucine or valine' 0 C--N 1.368 1.398 0 O-C-N 124.573 1.17 . . . . 43.31 111.389 176.668 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.453 ' HB3' ' O ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -49.36 -46.79 47.57 Favored 'General case' 0 CA--C 1.566 1.559 0 CA-C-O 116.931 -1.509 . . . . 74.31 114.836 170.205 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -71.39 -55.58 7.68 Favored 'General case' 0 C--O 1.295 3.481 0 CA-C-N 122.525 2.42 . . . . 70.42 112.634 -177.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -57.77 -38.82 76.1 Favored 'General case' 0 C--N 1.396 2.598 0 CA-C-O 118.965 -0.541 . . . . 42.44 111.551 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -83.54 -35.61 24.66 Favored 'General case' 0 C--N 1.359 1.008 0 C-N-CA 118.564 -1.255 . . . . 73.45 113.277 -178.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.421 ' HB3' ' O ' ' A' ' 25' ' ' GLU . 20.4 ptt85 -52.27 -36.62 53.22 Favored 'General case' 0 N--CA 1.507 2.409 0 CA-C-O 117.923 -1.037 . . . . 71.22 112.099 171.034 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.476 ' HE2' ' CG ' ' A' ' 31' ' ' TYR 0.289 0.0 OUTLIER -71.92 -30.84 65.77 Favored 'General case' 0 C--N 1.374 1.653 0 C-N-CA 116.311 -2.156 . . . . 62.44 112.71 -173.322 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.494 ' CB ' ' HA ' ' A' ' 59' ' ' ALA . 54.4 m-85 -82.75 -46.27 13.35 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 112.169 0.433 . . . . 74.1 112.169 177.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -150.14 143.76 11.1 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 118.671 0.669 . . . . 45.2 112.217 169.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -63.18 117.96 7.28 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 113.331 0.863 . . . . 72.2 113.331 -166.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.44 140.98 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-N 115.539 -0.755 . . . . 73.31 111.525 174.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.0 mp -103.8 -24.35 13.32 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 119.538 -0.865 . . . . 71.22 112.91 170.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.33 135.4 12.98 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 108.632 -0.877 . . . . 73.03 108.632 -175.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 41.8 t -145.96 115.2 7.07 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 120.125 1.33 . . . . 71.43 110.396 174.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.09 150.2 50.58 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 119.56 -0.856 . . . . 45.35 111.947 -176.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -116.07 116.72 53.21 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.53 0 CA-C-O 121.45 0.643 . . . . 73.22 110.578 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.0 mttp -108.53 141.99 39.61 Favored 'General case' 0 CA--C 1.565 1.531 0 C-N-CA 125.698 1.599 . . . . 70.44 107.762 -170.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.79 142.65 50.65 Favored 'General case' 0 CA--C 1.57 1.729 0 CA-C-N 122.329 2.331 . . . . 75.24 109.567 -177.197 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.613 HG23 ' H ' ' A' ' 44' ' ' SER . 5.0 t -100.59 176.88 5.18 Favored 'General case' 0 CA--C 1.568 1.64 0 CA-C-N 120.957 1.708 . . . . 64.22 111.572 176.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.4 t -77.33 -9.5 12.55 Favored 'Isoleucine or valine' 0 C--N 1.373 1.623 0 C-N-CA 123.834 0.854 . . . . 64.43 112.698 -176.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.613 ' H ' HG23 ' A' ' 42' ' ' THR . 8.9 t -90.72 2.62 55.83 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 121.584 -0.698 . . . . 60.34 111.03 -173.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.18 -7.26 68.02 Favored Glycine 0 CA--C 1.537 1.414 0 N-CA-C 115.184 0.834 . . . . 71.44 115.184 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.35 132.5 37.43 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 117.886 0.843 . . . . 74.44 108.89 167.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.75 145.55 43.42 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.743 -0.836 . . . . 74.35 108.743 -173.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -128.57 150.3 50.26 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.836 0.743 . . . . 74.33 110.693 -168.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -129.5 146.81 51.29 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.394 0.616 . . . . 74.3 112.045 175.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -132.9 114.09 13.63 Favored 'General case' 0 C--O 1.263 1.764 0 N-CA-C 106.442 -1.688 . . . . 71.33 106.442 -158.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.683 ' HB ' HD12 ' A' ' 10' ' ' ILE . 0.3 OUTLIER -124.29 110.52 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.662 0 C-N-CA 118.493 -1.283 . . . . 43.55 109.491 -173.986 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -109.74 103.09 11.86 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.464 -1.244 . . . . 31.22 110.158 -174.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.615 ' CE2' ' HB3' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -111.43 161.44 16.12 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 115.306 -0.861 . . . . 63.33 113.241 -174.502 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.14 -42.0 69.75 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 112.281 0.474 . . . . 71.1 112.281 173.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -113.17 114.8 27.29 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 118.54 -1.264 . . . . 74.43 109.901 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.97 -21.8 56.58 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 115.902 1.816 . . . . 61.53 115.902 169.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.293 10.6 ptm180 -75.69 -40.96 54.95 Favored 'General case' 0 CA--C 1.567 1.601 0 CA-C-N 120.402 1.455 . . . . 74.34 114.364 -172.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -77.68 -36.33 51.35 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 117.064 2.246 . . . . 53.13 117.064 177.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.615 ' HB3' ' CE2' ' A' ' 53' ' ' PHE 0.303 . . -75.27 -14.6 60.52 Favored 'General case' 0 CA--C 1.584 2.252 0 CA-C-N 120.564 1.529 . . . . 32.0 112.266 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -44.88 -35.74 2.96 Favored 'General case' 0 CA--C 1.583 2.239 0 CA-C-N 114.159 -1.382 . . . . 51.45 114.24 161.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.471 ' O ' ' HB3' ' A' ' 65' ' ' GLU . 46.3 m-20 -52.98 -54.75 30.46 Favored 'General case' 0 N--CA 1.507 2.384 0 CA-C-N 120.822 1.646 . . . . 54.32 113.311 164.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.406 ' O ' ' HG2' ' A' ' 66' ' ' LYS . . . -57.09 -35.78 69.81 Favored 'General case' 0 N--CA 1.507 2.385 0 CA-C-N 119.533 1.06 . . . . 61.42 113.816 171.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.456 HD12 HG13 ' A' ' 80' ' ' VAL 0.251 0.2 OUTLIER -73.53 -45.33 51.8 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.419 0 C-N-CA 119.157 -1.017 . . . . 13.43 113.443 -177.437 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.486 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -56.6 -30.46 63.25 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 120.319 1.418 . . . . 73.54 114.495 162.403 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.471 ' HB3' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -79.7 -20.46 46.47 Favored 'General case' 0 CA--C 1.55 0.967 0 O-C-N 120.825 -1.172 . . . . 72.21 111.84 -178.133 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 62' ' ' ALA . 60.7 mmtt -98.35 9.54 42.82 Favored 'General case' 0 CA--C 1.598 2.804 0 CA-C-O 118.697 -0.668 . . . . 64.41 112.533 163.012 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.486 ' HB3' ' HA ' ' A' ' 64' ' ' LYS 0.408 0.0 OUTLIER -79.79 160.54 26.12 Favored 'General case' 0 N--CA 1.516 2.858 0 CA-C-N 120.475 1.489 . . . . 71.21 114.619 -173.165 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.83 30.64 2.11 Favored Glycine 0 N--CA 1.439 -1.116 0 C-N-CA 118.529 -1.796 . . . . 74.22 115.466 -164.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.732 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -51.09 124.67 11.97 Favored 'General case' 0 C--N 1.372 1.577 0 O-C-N 124.65 0.853 . . . . 65.24 112.391 -173.791 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -133.4 150.73 51.79 Favored 'General case' 0 C--O 1.255 1.377 0 CA-C-N 115.574 -0.739 . . . . 51.32 112.311 -176.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -147.77 145.67 28.89 Favored 'General case' 0 C--N 1.354 0.795 0 C-N-CA 127.305 2.242 . . . . 75.34 106.574 -169.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 74.01 63.44 0.08 Allowed 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 113.17 0.804 . . . . 75.54 113.17 -175.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.32 -12.95 63.37 Favored Glycine 0 N--CA 1.472 1.057 0 N-CA-C 116.757 1.463 . . . . 73.21 116.757 168.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -113.43 121.28 43.84 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 106.309 -1.738 . . . . 64.51 106.309 152.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.28 104.05 15.93 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 117.431 -1.271 . . . . 74.32 109.454 -176.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.732 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -168.63 69.82 0.08 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 120.422 1.464 . . . . 71.24 112.273 179.347 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -95.77 108.83 21.19 Favored 'General case' 0 C--N 1.369 1.448 0 CA-C-N 122.443 2.383 . . . . 73.32 109.375 -171.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.666 HG22 HG23 ' A' ' 12' ' ' VAL . 50.1 t -127.77 118.39 48.88 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.888 0 O-C-N 120.828 -1.17 . . . . 61.42 109.098 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -146.61 144.9 29.85 Favored 'General case' 0 C--O 1.269 2.093 0 CA-C-N 120.651 1.569 . . . . 64.13 110.512 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.456 HG13 HD12 ' A' ' 63' ' ' ILE . 29.6 m -89.4 124.45 64.4 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-N 115.447 -0.797 . . . . 45.31 111.842 166.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.439 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 66.8 Cg_endo -86.57 29.9 0.49 Allowed 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 123.023 2.482 . . . . 71.11 113.747 168.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -128.71 -27.42 2.58 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.354 0.502 . . . . 71.44 112.354 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 N--CA 1.492 1.655 0 C-N-CA 124.581 1.152 . . . . 73.42 113.286 -176.756 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.51 ' OG ' ' HB2' ' A' ' 56' ' ' ALA . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 121.157 0.503 . . . . 71.2 112.127 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.498 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 11.3 ptt180 -143.81 152.9 41.8 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 113.792 1.034 . . . . 60.43 113.792 -172.034 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.6 HG12 HG12 ' A' ' 80' ' ' VAL . 7.8 mt -115.31 135.35 55.56 Favored 'Isoleucine or valine' 0 C--N 1.375 1.693 0 CA-C-N 120.199 1.363 . . . . 74.35 107.995 177.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -99.56 122.04 42.05 Favored 'General case' 0 CA--C 1.572 1.796 0 O-C-N 125.43 1.706 . . . . 75.2 110.283 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.469 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 67.3 t -124.71 110.99 26.48 Favored 'Isoleucine or valine' 0 C--N 1.366 1.32 0 O-C-N 120.643 -1.286 . . . . 72.33 108.594 -178.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.33 162.97 12.42 Favored Glycine 0 C--N 1.341 0.823 0 C-N-CA 119.135 -1.507 . . . . 53.2 112.209 173.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 51.16 22.93 1.42 Allowed 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 116.379 1.992 . . . . 71.41 116.379 178.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.02 125.41 91.41 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 123.45 0.7 . . . . 63.04 111.054 169.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -91.34 123.35 0.78 Allowed 'Trans proline' 0 CA--C 1.556 1.586 0 C-N-CA 121.873 1.715 . . . . 73.22 111.495 169.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.5 m 34.75 -100.66 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 124.741 1.216 . . . . 73.32 114.03 -173.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.4 t60 53.26 -88.95 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 126.243 1.817 . . . . 72.24 112.408 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.2 m -98.18 117.03 42.4 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.863 0 C-N-CA 119.435 -0.906 . . . . 71.33 109.713 177.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.9 m -80.76 170.96 15.62 Favored 'General case' 0 C--N 1.387 2.234 0 CA-C-O 117.197 -1.383 . . . . 75.22 109.076 166.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.9 m -46.53 -49.46 18.57 Favored 'General case' 0 C--O 1.27 2.148 0 CA-C-N 120.134 1.334 . . . . 72.14 114.492 -173.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.71 -43.59 97.64 Favored 'General case' 0 CA--C 1.578 2.03 0 CA-C-N 115.271 -0.877 . . . . 62.35 113.277 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.511 10.7 m-20 -76.99 -18.94 57.88 Favored 'General case' 0 CA--C 1.559 1.309 0 CA-C-O 115.715 -2.088 . . . . 74.21 114.146 172.306 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.429 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 2.0 t -59.65 -44.57 93.76 Favored 'Isoleucine or valine' 0 C--N 1.424 3.83 0 CA-C-N 123.411 2.823 . . . . 71.45 108.281 163.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.48 -54.52 45.61 Favored 'General case' 0 C--N 1.376 1.731 0 CA-C-O 116.455 -1.736 . . . . 75.53 112.677 174.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -73.81 -54.39 8.11 Favored 'General case' 1 C--O 1.309 4.187 0 CA-C-N 122.369 2.349 . . . . 72.24 114.793 -174.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -58.21 -37.06 74.08 Favored 'General case' 0 C--N 1.383 2.063 0 CA-C-O 117.325 -1.322 . . . . 64.02 110.428 177.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.429 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 47.3 m-85 -84.46 -24.2 29.58 Favored 'General case' 0 C--N 1.373 1.629 0 C-N-CA 115.716 -2.393 . . . . 71.15 113.457 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.53 ' HA ' HG22 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -64.95 -30.79 71.8 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 117.286 -1.34 . . . . 74.24 114.055 175.534 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.447 ' HE2' ' CD1' ' A' ' 31' ' ' TYR 0.323 0.0 OUTLIER -72.82 -34.8 67.09 Favored 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 113.354 -3.338 . . . . 74.45 111.986 175.338 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.547 ' HB3' ' HA ' ' A' ' 59' ' ' ALA . 57.8 m-85 -76.79 -40.96 46.41 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-O 118.975 -0.536 . . . . 62.32 110.783 -169.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -140.21 165.21 26.06 Favored Glycine 0 C--N 1.341 0.812 0 CA-C-O 118.309 -1.273 . . . . 73.2 110.666 152.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -76.71 102.77 6.35 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-N 119.95 1.875 . . . . 75.22 110.45 -174.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.53 HG22 ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -71.32 136.73 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 113.824 1.046 . . . . 74.02 113.824 -176.113 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.4 mt -89.55 -49.02 6.92 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 113.266 0.839 . . . . 74.14 113.266 166.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.65 128.2 20.18 Favored 'General case' 0 CA--C 1.585 2.322 0 CA-C-N 120.077 1.308 . . . . 73.41 111.901 173.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 4.8 m -105.65 111.03 23.56 Favored 'General case' 0 C--N 1.388 2.259 0 N-CA-C 107.473 -1.306 . . . . 73.13 107.473 166.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -113.11 139.93 48.31 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 117.855 -1.538 . . . . 75.35 111.41 176.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 t -113.0 110.09 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 106.77 -1.567 . . . . 74.12 106.77 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.7 mmtt -107.08 142.4 36.8 Favored 'General case' 0 CA--C 1.556 1.181 0 CA-C-O 118.792 -0.623 . . . . 73.12 109.455 175.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.39 142.78 51.01 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 120.063 1.302 . . . . 61.05 108.384 -170.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.614 HG23 ' H ' ' A' ' 44' ' ' SER . 12.0 t -100.01 167.75 10.29 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 120.45 1.477 . . . . 55.41 111.42 -178.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.0 m -61.84 -7.5 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.746 0 N-CA-C 115.993 1.849 . . . . 72.52 115.993 175.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.614 ' H ' HG23 ' A' ' 42' ' ' THR . 8.1 t -98.05 7.57 46.11 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 119.36 0.982 . . . . 71.25 110.517 -174.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.25 -4.35 77.22 Favored Glycine 0 CA--C 1.544 1.887 0 N-CA-C 115.717 1.047 . . . . 72.31 115.717 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -83.37 134.75 34.88 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-N 117.954 0.877 . . . . 74.31 110.485 177.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.31 149.75 25.07 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.619 -0.882 . . . . 65.14 108.619 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -125.12 145.02 50.13 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 118.915 -1.114 . . . . 73.12 109.568 175.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.469 ' HB3' ' HB ' ' A' ' 12' ' ' VAL . . . -115.47 137.88 51.59 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.915 -0.402 . . . . 72.14 109.915 176.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.47 115.85 16.71 Favored 'General case' 0 C--O 1.256 1.446 0 N-CA-C 108.168 -1.049 . . . . 72.31 108.168 -173.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.498 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 0.2 OUTLIER -123.76 108.77 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 C-N-CA 118.358 -1.337 . . . . 71.43 110.827 -171.693 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 8' ' ' SER . 33.6 tt0 -102.81 108.34 19.53 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 115.147 -0.933 . . . . 70.34 110.92 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.411 ' HB3' ' HA ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -114.95 156.33 25.23 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 118.748 -0.644 . . . . 55.45 112.673 -179.151 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -59.29 -32.44 70.04 Favored 'General case' 0 N--CA 1.516 2.834 0 N-CA-C 112.937 0.717 . . . . 73.15 112.937 166.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -115.41 113.0 23.16 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 119.151 -1.02 . . . . 73.42 109.966 -177.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.514 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -77.33 -41.39 40.71 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 116.084 1.883 . . . . 71.51 116.084 170.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.26 6.5 ptt180 -75.78 -33.33 60.17 Favored 'General case' 0 CA--C 1.573 1.864 0 N-CA-C 114.516 1.302 . . . . 65.22 114.516 -168.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.43 -44.97 73.79 Favored 'General case' 0 N--CA 1.518 2.934 0 CA-C-N 120.737 1.608 . . . . 74.14 114.034 173.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.547 ' HA ' ' HB3' ' A' ' 31' ' ' TYR . . . -50.02 -21.08 1.11 Allowed 'General case' 0 CA--C 1.598 2.821 0 N-CA-C 117.281 2.326 . . . . 73.02 117.281 171.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.409 ' O ' ' HG3' ' A' ' 64' ' ' LYS . . . -49.14 -34.15 13.61 Favored 'General case' 0 CA--C 1.585 2.319 0 CA-C-O 117.645 -1.169 . . . . 74.33 113.797 167.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.411 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 2.6 m-20 -52.39 -45.06 65.68 Favored 'General case' 0 C--N 1.394 2.519 0 CA-C-N 120.171 1.35 . . . . 74.24 113.789 165.05 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.503 ' O ' ' HD2' ' A' ' 66' ' ' LYS . . . -60.48 -54.02 50.49 Favored 'General case' 0 C--O 1.258 1.53 0 O-C-N 121.907 -0.496 . . . . 70.02 111.212 172.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.868 HD12 HG13 ' A' ' 80' ' ' VAL 0.262 0.4 OUTLIER -62.5 -41.22 91.09 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 C-N-CA 117.465 -1.694 . . . . 64.14 113.786 -173.948 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.447 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -62.06 -34.85 77.04 Favored 'General case' 0 CA--C 1.557 1.215 0 N-CA-C 115.588 1.699 . . . . 74.43 115.588 167.854 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 62' ' ' ALA . 0.2 OUTLIER -65.64 -34.83 79.13 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 121.168 1.804 . . . . 73.41 111.268 176.957 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.503 ' HD2' ' O ' ' A' ' 62' ' ' ALA 0.258 0.0 OUTLIER -103.07 18.42 21.73 Favored 'General case' 0 CA--C 1.575 1.921 0 C-N-CA 118.432 -1.307 . . . . 63.41 114.149 173.946 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.447 ' HB3' ' HA ' ' A' ' 64' ' ' LYS 0.323 0.5 OUTLIER -71.37 162.79 28.86 Favored 'General case' 0 N--CA 1.508 2.435 0 CA-C-N 118.975 0.807 . . . . 61.24 112.88 -174.857 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 120.44 31.99 1.19 Allowed Glycine 0 N--CA 1.438 -1.218 0 C-N-CA 119.024 -1.56 . . . . 63.35 115.533 -162.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.773 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -51.51 125.09 13.62 Favored 'General case' 0 C--N 1.375 1.704 0 CA-C-N 118.1 0.95 . . . . 74.4 111.768 176.444 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -133.66 149.36 51.56 Favored 'General case' 0 C--O 1.255 1.363 0 CA-C-N 114.766 -1.106 . . . . 73.23 111.482 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -148.25 144.66 27.8 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 126.225 1.81 . . . . 71.51 106.746 -166.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 68.89 65.98 0.29 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 124.244 0.965 . . . . 70.42 113.162 177.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.9 -12.34 60.81 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 116.86 1.504 . . . . 71.43 116.86 173.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -118.85 121.9 41.09 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 105.929 -1.878 . . . . 73.31 105.929 154.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.97 102.52 14.61 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 117.553 -1.213 . . . . 74.41 109.874 -172.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.773 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -169.2 58.64 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 CA-C-N 120.572 1.533 . . . . 73.14 114.419 -175.14 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.1 tpp85 -90.99 112.25 24.06 Favored 'General case' 0 CA--C 1.571 1.767 0 CA-C-N 122.258 2.299 . . . . 64.45 109.945 -170.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.502 ' H ' ' HB3' ' A' ' 69' ' ' CYS . 0.9 OUTLIER -119.78 121.69 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 O-C-N 120.325 -1.484 . . . . 73.12 108.678 173.928 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -146.58 132.5 19.13 Favored 'General case' 0 C--N 1.361 1.091 0 CA-C-N 119.75 1.159 . . . . 61.03 110.791 -165.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.868 HG13 HD12 ' A' ' 63' ' ' ILE . 7.8 m -89.62 124.56 63.78 Favored Pre-proline 0 C--N 1.349 0.559 0 C-N-CA 119.817 -0.753 . . . . 73.34 111.569 167.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.436 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 87.8 Cg_endo -89.91 17.17 1.58 Allowed 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 122.48 2.12 . . . . 72.34 113.625 166.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.514 ' CE1' ' HB1' ' A' ' 56' ' ' ALA . 5.6 p90 -110.74 -32.01 7.0 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.039 0.385 . . . . 61.03 112.039 175.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.0 t30 . . . . . 0 N--CA 1.501 2.096 0 C-N-CA 124.574 1.15 . . . . 73.33 110.692 -176.938 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.439 -0.994 0 N-CA-C 108.115 -1.068 . . . . 74.31 108.115 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.523 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 0.2 OUTLIER -118.83 153.27 34.77 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 121.305 -0.872 . . . . 71.23 109.036 -177.407 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.5 mp -138.16 134.92 44.78 Favored 'Isoleucine or valine' 0 C--O 1.264 1.82 0 CA-C-N 119.811 1.187 . . . . 70.42 108.269 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -105.33 114.95 29.44 Favored 'General case' 0 CA--C 1.571 1.751 0 O-C-N 125.664 1.852 . . . . 65.32 110.407 177.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.575 HG23 HG22 ' A' ' 78' ' ' VAL . 2.0 p -123.84 104.41 14.07 Favored 'Isoleucine or valine' 0 C--N 1.369 1.432 0 CA-C-N 120.333 1.424 . . . . 75.23 108.079 178.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.446 ' H ' ' HG3' ' A' ' 77' ' ' ARG . . . -121.33 177.24 16.41 Favored Glycine 0 C--N 1.346 1.134 0 C-N-CA 120.362 -0.923 . . . . 21.54 112.722 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.6 m120 50.72 24.34 1.67 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 114.792 1.405 . . . . 62.14 114.792 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.635 HD23 ' H ' ' A' ' 15' ' ' LEU . 1.7 pt? -79.71 123.54 83.94 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 123.812 0.845 . . . . 70.1 110.6 -178.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -89.51 120.11 0.95 Allowed 'Trans proline' 0 CA--C 1.559 1.729 0 C-N-CA 121.053 1.168 . . . . 73.11 112.186 172.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.7 m 39.05 43.42 0.8 Allowed 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 124.989 1.316 . . . . 42.2 114.034 178.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.425 ' HB3' HD12 ' A' ' 15' ' ' LEU . 5.2 t-160 -95.11 -93.37 0.19 Allowed 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 119.418 -0.325 . . . . 74.54 110.64 -166.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.7 m -103.23 119.16 51.33 Favored 'Isoleucine or valine' 0 CA--C 1.596 2.745 0 CA-C-N 118.627 0.649 . . . . 75.44 109.943 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.75 155.17 25.62 Favored 'General case' 0 C--N 1.392 2.429 0 CA-C-N 120.888 1.676 . . . . 43.33 110.155 171.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.0 t -48.12 -48.8 33.76 Favored 'General case' 0 C--N 1.371 1.53 0 N-CA-C 115.477 1.658 . . . . 64.21 115.477 -173.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.94 -43.46 86.36 Favored 'General case' 0 CA--C 1.582 2.208 0 N-CA-C 114.206 1.187 . . . . 73.31 114.206 176.374 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.03 -30.2 70.22 Favored 'General case' 0 C--N 1.364 1.204 0 CA-C-O 117.397 -1.287 . . . . 72.23 111.223 173.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.537 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 1.6 t -66.78 -43.05 90.1 Favored 'Isoleucine or valine' 0 C--N 1.391 2.399 0 CA-C-O 116.633 -1.651 . . . . 72.04 110.021 171.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.518 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 4.3 tt0 -61.05 -55.01 37.7 Favored 'General case' 0 C--N 1.365 1.247 0 CA-C-N 121.476 1.944 . . . . 71.04 111.48 176.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -71.82 -59.26 2.84 Favored 'General case' 0 C--O 1.284 2.901 0 CA-C-N 121.21 1.823 . . . . 74.23 112.796 -176.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -71.12 -31.52 67.86 Favored 'General case' 0 C--N 1.364 1.21 0 CA-C-O 117.178 -1.391 . . . . 73.01 112.711 -176.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.537 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 5.1 m-85 -82.78 -29.01 29.94 Favored 'General case' 0 C--N 1.375 1.698 0 CA-C-N 122.057 2.208 . . . . 73.54 112.55 176.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.518 ' HB3' ' O ' ' A' ' 25' ' ' GLU . 2.9 ptt180 -54.27 -32.52 56.42 Favored 'General case' 0 C--N 1.379 1.884 0 CA-C-O 115.777 -2.059 . . . . 73.04 114.824 161.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.85 -48.06 73.38 Favored 'General case' 0 N--CA 1.518 2.965 0 CA-C-N 122.479 2.4 . . . . 64.21 111.674 167.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -75.71 -38.29 58.71 Favored 'General case' 0 C--O 1.213 -0.865 0 CA-C-O 118.639 -0.696 . . . . 65.35 111.803 -168.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -149.2 154.92 26.07 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 119.473 1.033 . . . . 64.33 111.148 168.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -77.22 105.19 8.17 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-N 118.075 0.937 . . . . 71.3 110.722 -175.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.739 HG13 ' SG ' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -73.61 132.83 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 N-CA-C 114.286 1.217 . . . . 74.5 114.286 -176.748 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 11.1 mp -108.67 -23.26 11.88 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.883 -1.053 . . . . 74.34 110.861 175.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 52' ' ' GLU . 8.1 tmtm? -152.2 131.66 12.97 Favored 'General case' 0 CA--C 1.565 1.52 0 N-CA-C 108.576 -0.898 . . . . 51.4 108.576 -172.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.739 ' SG ' HG13 ' A' ' 34' ' ' ILE . 19.5 m -139.48 110.39 6.81 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 107.251 -1.388 . . . . 52.43 107.251 175.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -122.3 127.67 50.13 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 117.563 -1.655 . . . . 74.12 110.635 176.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -117.88 112.86 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-O 121.841 0.829 . . . . 72.24 110.042 -178.003 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.3 mtmt -120.38 146.85 45.77 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 114.439 -1.255 . . . . 73.54 109.98 -170.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.11 145.98 49.68 Favored 'General case' 0 C--N 1.368 1.397 0 CA-C-N 120.68 1.582 . . . . 71.25 108.464 -172.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.627 HG23 ' H ' ' A' ' 44' ' ' SER . 4.0 t -99.79 167.09 10.76 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 121.129 1.786 . . . . 74.34 111.138 174.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.5 m -66.74 -3.7 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.575 0 N-CA-C 116.038 1.866 . . . . 71.31 116.038 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.627 ' H ' HG23 ' A' ' 42' ' ' THR . 10.2 t -98.27 7.22 46.54 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 119.253 0.933 . . . . 65.11 109.639 -171.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.78 -5.7 73.76 Favored Glycine 0 CA--C 1.54 1.606 0 N-CA-C 115.2 0.84 . . . . 70.31 115.2 -175.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.45 130.89 34.34 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 118.201 1.0 . . . . 71.2 109.578 175.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.28 146.94 39.81 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 108.854 -0.795 . . . . 72.22 108.854 -175.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -129.63 150.84 50.78 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.526 1.057 . . . . 73.52 110.754 -176.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -127.34 147.47 50.26 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-O 121.713 0.768 . . . . 70.13 111.572 171.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -132.74 118.58 19.24 Favored 'General case' 0 C--O 1.266 1.924 0 N-CA-C 106.367 -1.716 . . . . 73.4 106.367 -164.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.79 114.02 26.35 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.079 0 C-N-CA 120.09 -0.644 . . . . 71.44 109.885 -162.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.41 ' HB2' ' HB3' ' A' ' 36' ' ' LYS . 45.8 mt-10 -109.44 109.14 19.9 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 120.541 -0.464 . . . . 75.33 112.108 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -107.0 160.63 15.39 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 119.4 -0.333 . . . . 73.03 111.428 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -80.49 -25.99 38.47 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 113.514 0.931 . . . . 74.42 113.514 177.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -115.86 119.57 36.4 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.402 -0.592 . . . . 50.21 109.402 -178.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.6 -33.12 58.44 Favored 'General case' 0 CA--C 1.56 1.356 0 N-CA-C 117.024 2.231 . . . . 65.5 117.024 174.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.352 0.0 OUTLIER -79.58 -29.25 41.19 Favored 'General case' 0 C--N 1.377 1.78 0 CA-C-N 122.095 2.225 . . . . 73.14 114.448 -170.391 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.2 -31.14 60.82 Favored 'General case' 0 CA--C 1.586 2.363 0 CA-C-N 121.281 1.855 . . . . 73.43 115.955 171.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.47 -24.27 54.77 Favored 'General case' 0 CA--C 1.586 2.36 0 CA-C-N 120.563 1.528 . . . . 64.51 114.222 170.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.565 ' HA ' HG22 ' A' ' 63' ' ' ILE . . . -49.78 -37.81 31.48 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-O 116.608 -1.663 . . . . 75.32 113.958 173.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.585 ' O ' ' HB3' ' A' ' 65' ' ' GLU . 31.7 m-20 -54.09 -51.65 63.49 Favored 'General case' 0 C--N 1.395 2.56 0 CA-C-N 120.178 1.354 . . . . 72.22 112.066 169.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.59 -39.22 87.32 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 117.144 -1.408 . . . . 72.42 113.04 174.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.762 HD12 HG13 ' A' ' 80' ' ' VAL 0.305 0.6 OUTLIER -73.78 -45.97 48.45 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 116.601 -2.04 . . . . 63.21 113.348 -176.854 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.98 -34.49 59.95 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 114.368 1.247 . . . . 74.12 114.368 166.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.585 ' HB3' ' O ' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -83.05 -22.47 33.52 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-N 119.454 1.025 . . . . 75.31 112.158 -175.098 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -100.07 14.23 31.38 Favored 'General case' 0 CA--C 1.57 1.735 0 CA-C-O 118.981 -0.533 . . . . 74.24 110.866 174.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.361 0.0 OUTLIER -77.36 162.89 26.91 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 113.674 0.99 . . . . 73.23 113.674 -168.651 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.75 29.58 2.01 Favored Glycine 0 N--CA 1.437 -1.269 0 CA-C-O 117.886 -1.508 . . . . 73.13 115.007 -158.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.675 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 44.8 t -51.37 126.23 16.49 Favored 'General case' 0 C--N 1.383 2.041 0 CA-C-O 122.123 0.963 . . . . 63.03 110.317 170.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -135.17 143.0 46.23 Favored 'General case' 0 C--O 1.252 1.236 0 CA-C-N 113.282 -1.781 . . . . 70.1 111.705 -176.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -155.51 144.8 20.94 Favored 'General case' 0 C--N 1.348 0.541 0 N-CA-C 106.695 -1.594 . . . . 75.15 106.695 -164.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 71.11 65.64 0.16 Allowed 'General case' 0 N--CA 1.512 2.658 0 CA-C-O 121.608 0.718 . . . . 54.55 111.86 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.2 -13.68 63.03 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 116.995 1.558 . . . . 41.51 116.995 174.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -122.93 125.37 45.19 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 106.037 -1.838 . . . . 70.31 106.037 161.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.69 105.9 18.1 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 117.506 -1.235 . . . . 73.22 110.491 -172.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.675 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.3 OUTLIER -169.1 69.71 0.07 Allowed 'General case' 0 N--CA 1.505 2.31 0 CA-C-N 120.944 1.702 . . . . 62.42 113.688 179.327 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.446 ' HG3' ' H ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -92.35 118.09 30.56 Favored 'General case' 0 CA--C 1.576 1.961 0 CA-C-N 122.761 2.528 . . . . 71.34 111.604 -172.95 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.575 HG22 HG23 ' A' ' 12' ' ' VAL . 42.6 t -126.87 115.89 42.96 Favored 'Isoleucine or valine' 0 C--N 1.371 1.536 0 O-C-N 120.761 -1.212 . . . . 62.23 107.753 168.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -149.83 137.65 20.18 Favored 'General case' 0 C--N 1.37 1.483 0 CA-C-N 119.852 1.205 . . . . 65.01 111.651 -179.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.762 HG13 HD12 ' A' ' 63' ' ' ILE . 35.5 m -90.81 128.35 48.51 Favored Pre-proline 0 N--CA 1.445 -0.71 0 CA-C-N 115.317 -0.856 . . . . 63.41 110.389 170.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.523 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 43.8 Cg_endo -87.06 31.25 0.45 Allowed 'Trans proline' 0 CA--C 1.553 1.428 0 C-N-CA 122.198 1.932 . . . . 71.24 112.482 162.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -120.51 -30.67 4.48 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 111.483 0.179 . . . . 74.33 111.483 175.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 15.7 m120 . . . . . 0 N--CA 1.497 1.885 0 C-N-CA 126.156 1.782 . . . . 61.41 113.485 -174.34 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.426 ' CB ' ' HB2' ' A' ' 56' ' ' ALA . 0.3 OUTLIER . . . . . 0 CA--C 1.529 0.162 0 N-CA-C 110.043 -0.354 . . . . 73.25 110.043 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -126.13 152.95 45.25 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 117.519 -1.229 . . . . 73.41 110.61 -179.343 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 mt -115.56 143.98 24.22 Favored 'Isoleucine or valine' 0 C--O 1.255 1.342 0 CA-C-N 121.223 1.829 . . . . 64.01 108.692 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -106.32 120.85 42.94 Favored 'General case' 0 CA--C 1.564 1.504 0 O-C-N 124.157 0.91 . . . . 74.34 110.324 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.577 HG23 HG22 ' A' ' 78' ' ' VAL . 1.5 p -124.57 105.84 15.81 Favored 'Isoleucine or valine' 0 C--N 1.376 1.753 0 CA-C-N 120.457 1.48 . . . . 75.34 109.024 177.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' A' ' 77' ' ' ARG . . . -114.57 166.79 12.19 Favored Glycine 0 C--N 1.355 1.618 0 C-N-CA 120.339 -0.934 . . . . 55.14 113.453 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 50.12 24.24 1.36 Allowed 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 115.102 1.519 . . . . 74.32 115.102 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.48 ' H ' HD23 ' A' ' 15' ' ' LEU . 2.4 pt? -71.47 141.52 85.58 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 124.297 1.039 . . . . 73.05 110.717 175.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -72.98 141.47 33.16 Favored 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 121.411 1.407 . . . . 70.42 111.169 173.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.9 p 86.25 -34.16 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 126.36 1.864 . . . . 71.23 112.652 170.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 71.08 121.82 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.106 1.362 . . . . 74.42 111.188 -175.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.0 m -75.84 118.15 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.442 0 N-CA-C 107.43 -1.322 . . . . 72.44 107.43 176.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.37 157.32 27.65 Favored 'General case' 0 C--N 1.383 2.036 0 O-C-N 120.025 -1.672 . . . . 61.52 109.472 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.44 ' HA ' HG12 ' A' ' 24' ' ' VAL . 44.8 p -49.84 -37.61 31.43 Favored 'General case' 0 C--N 1.38 1.934 0 N-CA-C 116.123 1.897 . . . . 44.04 116.123 -173.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -38.97 75.98 Favored 'General case' 0 CA--C 1.595 2.678 0 N-CA-C 114.637 1.347 . . . . 73.43 114.637 176.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.5 -32.59 68.39 Favored 'General case' 0 C--N 1.374 1.655 0 CA-C-N 120.301 1.409 . . . . 71.43 110.596 176.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.606 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 7.5 p -75.46 -34.03 28.86 Favored 'Isoleucine or valine' 0 C--N 1.391 2.403 0 N-CA-C 108.663 -0.866 . . . . 52.21 108.663 178.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.5 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 0.5 OUTLIER -60.16 -55.63 31.45 Favored 'General case' 0 CA--C 1.576 1.967 0 CA-C-O 117.187 -1.387 . . . . 72.43 113.717 168.83 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -65.4 -58.88 4.78 Favored 'General case' 0 C--O 1.299 3.666 0 CA-C-N 121.654 2.025 . . . . 73.52 113.37 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -57.7 -44.95 86.23 Favored 'General case' 0 C--N 1.385 2.133 0 CA-C-O 117.902 -1.047 . . . . 62.31 112.075 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.606 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 3.1 m-85 -79.66 -17.22 54.23 Favored 'General case' 0 CA--C 1.568 1.671 0 CA-C-N 120.373 1.442 . . . . 65.34 114.121 -176.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.501 ' HA ' HG22 ' A' ' 34' ' ' ILE 0.322 70.3 mtp180 -60.33 -32.01 70.84 Favored 'General case' 0 N--CA 1.535 3.819 0 CA-C-N 122.022 2.192 . . . . 64.53 110.942 170.368 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.512 ' HD2' ' O ' ' A' ' 30' ' ' LYS 0.283 0.2 OUTLIER -58.51 -21.1 50.92 Favored 'General case' 0 N--CA 1.509 2.486 0 C-N-CA 117.805 -1.558 . . . . 72.21 114.109 175.006 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.512 ' HB3' ' HB2' ' A' ' 59' ' ' ALA . 1.5 m-85 -84.86 -27.53 26.64 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.37 -0.831 . . . . 74.43 110.306 -165.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 175.32 32.99 0.04 OUTLIER Glycine 0 N--CA 1.437 -1.275 0 CA-C-O 118.783 -1.009 . . . . 33.4 113.598 174.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.2 t30 57.27 80.72 0.16 Allowed 'General case' 0 C--N 1.357 0.914 0 C-N-CA 124.525 1.13 . . . . 63.01 110.641 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.501 HG22 ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -68.49 141.24 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 CA-C-N 114.935 -1.03 . . . . 64.25 113.6 -175.424 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.434 ' H ' HD22 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -107.39 -25.25 11.52 Favored 'General case' 0 C--N 1.375 1.686 0 N-CA-C 110.577 -0.157 . . . . 71.03 110.577 176.494 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.84 130.91 26.36 Favored 'General case' 0 CA--C 1.56 1.343 0 N-CA-C 108.896 -0.779 . . . . 73.4 108.896 -168.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -141.28 111.08 6.54 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.025 -0.732 . . . . 42.43 109.025 -175.104 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -129.04 143.28 50.82 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 117.802 -1.559 . . . . 60.42 113.483 -177.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.0 t -116.21 114.6 46.58 Favored 'Isoleucine or valine' 0 C--N 1.345 0.383 0 N-CA-C 108.737 -0.838 . . . . 75.33 108.737 176.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -107.12 130.41 54.7 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-O 118.601 -0.714 . . . . 74.2 109.618 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -106.15 128.04 53.63 Favored 'General case' 0 C--N 1.379 1.857 0 CA-C-N 120.519 1.509 . . . . 65.35 112.391 -174.022 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.638 HG23 ' H ' ' A' ' 44' ' ' SER . 1.4 t -90.76 160.0 16.02 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 119.139 -1.024 . . . . 51.44 111.187 170.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.0 t -76.29 -9.95 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.415 0 C-N-CA 123.698 0.799 . . . . 73.24 112.376 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.638 ' H ' HG23 ' A' ' 42' ' ' THR . 7.3 m -83.16 7.84 14.89 Favored 'General case' 0 CA--C 1.556 1.185 0 O-C-N 121.873 -0.517 . . . . 73.45 111.282 -177.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.31 -4.57 76.55 Favored Glycine 0 C--N 1.351 1.385 0 N-CA-C 115.563 0.985 . . . . 53.24 115.563 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.77 134.42 33.68 Favored 'General case' 0 CA--C 1.561 1.366 0 CA-C-N 118.01 0.905 . . . . 63.44 110.776 176.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -103.86 144.97 30.79 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 107.333 -1.358 . . . . 71.45 107.333 176.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -132.57 149.87 52.25 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.225 0.92 . . . . 45.3 108.562 175.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.401 ' HB3' ' CG1' ' A' ' 12' ' ' VAL . . . -117.79 137.0 53.03 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 119.071 -1.052 . . . . 41.34 111.391 170.038 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -106.12 118.85 37.69 Favored 'General case' 0 C--O 1.268 2.068 0 CA-C-N 113.92 -1.491 . . . . 72.04 107.762 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 0.3 OUTLIER -125.96 111.36 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.505 0 C-N-CA 119.066 -1.054 . . . . 60.41 111.905 -174.486 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.59 105.8 17.71 Favored 'General case' 0 CA--C 1.556 1.205 0 CA-C-N 115.643 -0.708 . . . . 71.32 111.474 -174.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 3.0 p90 -115.2 166.87 11.36 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 114.493 1.294 . . . . 74.53 114.493 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -80.8 -27.82 36.51 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 114.843 1.423 . . . . 74.21 114.843 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.35 118.6 32.69 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 120.011 1.278 . . . . 70.11 111.593 175.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.46 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -77.42 -34.33 54.7 Favored 'General case' 0 CA--C 1.552 1.023 0 N-CA-C 116.78 2.141 . . . . 75.11 116.78 172.121 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.267 0.0 OUTLIER -80.35 -29.33 37.94 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-N 121.879 2.127 . . . . 74.12 113.034 -170.538 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.22 -38.18 90.14 Favored 'General case' 0 N--CA 1.506 2.364 0 N-CA-C 114.067 1.136 . . . . 73.53 114.067 176.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.512 ' HB2' ' HB3' ' A' ' 31' ' ' TYR . . . -53.58 -22.45 8.51 Favored 'General case' 0 CA--C 1.561 1.383 0 N-CA-C 115.755 1.761 . . . . 75.51 115.755 173.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.93 -45.89 60.64 Favored 'General case' 0 CA--C 1.582 2.211 0 N-CA-C 114.807 1.41 . . . . 53.53 114.807 -178.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -50.66 -51.7 46.78 Favored 'General case' 0 N--CA 1.524 3.268 0 CA-C-N 119.745 1.157 . . . . 74.1 112.459 170.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.49 ' O ' ' HD2' ' A' ' 66' ' ' LYS . . . -75.05 -31.61 61.33 Favored 'General case' 0 CA--C 1.555 1.151 0 O-C-N 121.213 -0.929 . . . . 75.2 111.994 -176.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.492 HD11 HG12 ' A' ' 78' ' ' VAL 0.296 0.0 OUTLIER -73.63 -42.37 55.25 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.875 0 O-C-N 120.058 -1.651 . . . . 73.25 113.118 179.293 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.492 ' HD2' ' N ' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -55.72 -33.84 64.6 Favored 'General case' 0 CA--C 1.559 1.291 0 CA-C-N 120.383 1.447 . . . . 63.1 114.815 162.861 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.492 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -63.65 -32.62 74.15 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 120.058 1.299 . . . . 74.45 112.252 172.364 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.49 ' HD2' ' O ' ' A' ' 62' ' ' ALA 0.269 0.0 OUTLIER -105.0 16.72 25.42 Favored 'General case' 0 CA--C 1.581 2.151 0 C-N-CA 117.09 -1.844 . . . . 71.23 115.566 166.661 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.475 ' HB3' ' HA ' ' A' ' 64' ' ' LYS 0.363 0.0 OUTLIER -79.26 159.61 27.2 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-N 119.092 0.86 . . . . 72.43 112.845 -177.361 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.1 31.44 2.05 Favored Glycine 0 N--CA 1.436 -1.365 0 C-N-CA 118.202 -1.951 . . . . 72.05 113.866 -164.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.733 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -50.97 124.82 12.1 Favored 'General case' 0 C--N 1.374 1.631 0 O-C-N 124.449 0.735 . . . . 74.31 111.328 -173.86 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -133.79 150.79 51.45 Favored 'General case' 0 C--O 1.252 1.232 0 CA-C-N 115.044 -0.98 . . . . 73.13 110.735 -173.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -149.65 142.47 24.7 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 105.159 -2.163 . . . . 64.31 105.159 -170.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 73.52 66.1 0.1 Allowed 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 113.014 0.746 . . . . 72.54 113.014 -176.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.33 -14.0 61.23 Favored Glycine 0 N--CA 1.478 1.463 0 N-CA-C 117.187 1.635 . . . . 72.34 117.187 169.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 -114.55 120.29 39.71 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 105.349 -2.093 . . . . 52.43 105.349 149.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.56 101.84 13.52 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.587 -1.245 . . . . 75.52 108.747 -175.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.733 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 13.1 tp -172.0 70.54 0.04 OUTLIER 'General case' 0 C--N 1.387 2.207 0 CA-C-N 120.809 1.641 . . . . 71.22 112.599 -174.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.42 ' HB3' ' O ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -96.51 113.26 24.82 Favored 'General case' 0 CA--C 1.566 1.572 0 CA-C-N 122.375 2.352 . . . . 73.14 109.56 -174.257 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.577 HG22 HG23 ' A' ' 12' ' ' VAL . 13.9 t -128.71 118.03 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.481 0 O-C-N 120.286 -1.509 . . . . 41.11 109.381 174.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -134.48 135.58 42.54 Favored 'General case' 0 C--O 1.263 1.807 0 CA-C-N 119.475 1.034 . . . . 75.4 109.944 -175.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.8 m -72.41 123.81 89.99 Favored Pre-proline 0 CA--C 1.551 1.017 0 CA-C-N 115.753 -0.658 . . . . 63.44 110.288 159.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -92.09 23.06 0.6 Allowed 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.441 2.094 . . . . 74.31 112.663 168.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.46 ' CE1' ' HB1' ' A' ' 56' ' ' ALA . 8.8 p90 -121.9 -57.61 1.79 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 121.403 -0.119 . . . . 75.2 110.88 176.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.6 t30 . . . . . 0 N--CA 1.496 1.83 0 C-N-CA 125.58 1.552 . . . . 73.15 112.764 -175.272 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.7 m . . . . . 0 CA--C 1.547 0.841 0 CA-C-O 120.26 0.076 . . . . 74.14 110.979 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -140.65 160.04 40.89 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 113.682 0.993 . . . . 74.5 113.682 -177.069 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.561 HG12 HG12 ' A' ' 80' ' ' VAL . 10.2 mt -112.57 136.56 48.44 Favored 'Isoleucine or valine' 0 C--O 1.259 1.564 0 N-CA-C 106.866 -1.531 . . . . 44.42 106.866 177.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -92.92 115.06 27.77 Favored 'General case' 0 CA--C 1.565 1.541 0 O-C-N 125.815 1.947 . . . . 74.41 109.045 177.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.409 HG22 HG13 ' A' ' 78' ' ' VAL . 38.5 t -123.57 115.29 44.86 Favored 'Isoleucine or valine' 0 C--N 1.366 1.316 0 CA-C-N 119.922 1.237 . . . . 75.44 109.042 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -121.63 171.03 14.95 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 119.276 -1.44 . . . . 64.41 113.738 173.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 50.81 25.69 2.25 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 115.367 1.618 . . . . 51.12 115.367 176.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.444 HD11 ' H ' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -79.24 140.84 57.06 Favored Pre-proline 0 CA--C 1.551 1.006 0 CA-C-N 119.144 0.883 . . . . 73.21 112.257 -170.265 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -76.15 142.69 24.75 Favored 'Trans proline' 0 CA--C 1.552 1.378 0 C-N-CA 122.992 2.461 . . . . 61.14 112.176 173.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.1 p 88.53 -32.25 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 126.719 2.008 . . . . 71.42 111.955 175.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 82.5 t60 69.13 105.29 0.06 Allowed 'General case' 0 C--N 1.361 1.069 0 C-N-CA 124.924 1.29 . . . . 75.41 111.184 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.444 ' H ' HD11 ' A' ' 15' ' ' LEU . 7.8 m -77.99 117.8 23.88 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.849 0 N-CA-C 109.127 -0.694 . . . . 74.24 109.127 -176.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.8 154.92 29.51 Favored 'General case' 0 C--N 1.378 1.839 0 CA-C-O 118.165 -0.921 . . . . 41.43 111.028 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.0 t -49.42 -46.52 47.74 Favored 'General case' 0 C--N 1.38 1.893 0 N-CA-C 114.821 1.415 . . . . 42.51 114.821 -177.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . 0.314 0.0 OUTLIER -55.23 -43.29 74.41 Favored 'General case' 0 CA--C 1.588 2.414 0 N-CA-C 115.246 1.573 . . . . 72.54 115.246 172.809 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.92 -37.84 87.12 Favored 'General case' 0 C--N 1.378 1.812 0 CA-C-O 117.903 -1.046 . . . . 73.55 110.726 176.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.2 t -64.89 -43.75 96.28 Favored 'Isoleucine or valine' 0 C--N 1.403 2.931 0 CA-C-N 119.551 1.069 . . . . 70.45 110.657 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.62 -52.72 63.77 Favored 'General case' 0 C--N 1.378 1.818 0 CA-C-O 116.201 -1.857 . . . . 62.13 111.12 176.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.558 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 1.8 m-20 -77.54 -55.28 5.5 Favored 'General case' 0 C--O 1.3 3.72 0 CA-C-N 122.713 2.506 . . . . 71.1 116.576 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.474 ' O ' ' HD2' ' A' ' 31' ' ' TYR . 19.8 tt0 -59.93 -39.96 87.26 Favored 'General case' 0 C--N 1.371 1.522 0 CA-C-O 117.335 -1.317 . . . . 71.24 111.698 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . 0.263 73.9 m-85 -82.28 -21.64 36.09 Favored 'General case' 0 CA--C 1.575 1.909 0 CA-C-N 121.918 2.145 . . . . 74.15 113.986 174.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.558 ' HG3' ' O ' ' A' ' 26' ' ' ASN 0.269 0.0 OUTLIER -59.72 -28.45 67.35 Favored 'General case' 0 N--CA 1.531 3.583 0 CA-C-N 120.864 1.665 . . . . 71.13 112.719 169.627 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.402 ' HE2' ' CD1' ' A' ' 31' ' ' TYR 0.325 0.0 OUTLIER -76.1 -36.21 59.01 Favored 'General case' 0 N--CA 1.506 2.338 0 C-N-CA 114.518 -2.873 . . . . 74.22 113.216 170.305 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.56 ' HB3' ' HA ' ' A' ' 59' ' ' ALA . 20.8 m-85 -76.68 -43.85 36.13 Favored 'General case' 0 CA--C 1.564 1.481 0 N-CA-C 112.681 0.623 . . . . 53.41 112.681 -164.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -132.45 -175.93 14.19 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.557 -1.017 . . . . 72.35 110.557 151.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -87.01 98.13 11.1 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.839 1.82 . . . . 63.12 109.6 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.428 ' HA ' ' HB3' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -75.37 141.02 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 113.349 0.87 . . . . 72.1 113.349 -178.653 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 11.1 mp -108.67 -24.14 11.48 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 122.758 0.423 . . . . 74.51 110.246 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.62 139.42 15.19 Favored 'General case' 0 CA--C 1.58 2.102 0 C-N-CA 123.794 0.837 . . . . 45.21 110.41 -170.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.427 ' SG ' HG13 ' A' ' 34' ' ' ILE . 62.0 m -138.79 112.3 8.22 Favored 'General case' 0 N--CA 1.507 2.382 0 N-CA-C 107.622 -1.251 . . . . 75.31 107.622 177.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -118.32 136.98 53.39 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 116.454 -2.098 . . . . 73.53 111.746 175.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -123.83 111.8 30.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 121.893 0.854 . . . . 43.43 109.266 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -115.77 152.61 32.95 Favored 'General case' 0 CA--C 1.559 1.318 0 CA-C-N 114.848 -1.069 . . . . 74.53 109.428 -172.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.39 146.24 50.85 Favored 'General case' 0 CA--C 1.565 1.528 0 CA-C-N 120.945 1.702 . . . . 73.13 108.838 -172.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.613 HG23 ' H ' ' A' ' 44' ' ' SER . 5.3 t -100.7 175.43 5.65 Favored 'General case' 0 CA--C 1.563 1.474 0 CA-C-N 120.698 1.59 . . . . 52.23 110.852 174.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.4 t -78.67 -8.53 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 123.545 0.738 . . . . 72.42 112.411 -175.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.613 ' H ' HG23 ' A' ' 42' ' ' THR . 7.1 t -89.15 4.72 47.58 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 122.937 0.495 . . . . 74.22 110.27 -175.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.13 -7.25 64.19 Favored Glycine 0 CA--C 1.534 1.26 0 N-CA-C 114.921 0.728 . . . . 75.04 114.921 -178.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.06 130.85 35.95 Favored 'General case' 0 CA--C 1.556 1.187 0 CA-C-N 117.877 0.838 . . . . 72.13 109.724 172.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.16 146.03 42.61 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.057 -0.72 . . . . 32.44 109.057 -173.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -128.29 148.51 50.66 Favored 'General case' 0 C--N 1.36 1.037 0 CA-C-N 119.63 1.105 . . . . 63.44 111.483 -173.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -123.61 146.27 48.3 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.162 0.801 . . . . 54.1 113.162 169.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -132.97 115.26 14.97 Favored 'General case' 0 C--O 1.267 2.005 0 N-CA-C 105.596 -2.002 . . . . 74.25 105.596 -165.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 1.4 mp -120.54 110.19 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.497 0 C-N-CA 118.371 -1.331 . . . . 61.41 111.378 -169.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -105.37 104.0 13.64 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-O 121.35 0.595 . . . . 71.34 111.754 -173.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.428 ' HB3' ' HA ' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -117.55 168.75 10.12 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 114.123 1.157 . . . . 75.44 114.123 -179.404 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -81.35 -33.86 32.14 Favored 'General case' 0 C--N 1.367 1.34 0 N-CA-C 113.963 1.098 . . . . 74.54 113.963 175.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -111.41 116.03 30.25 Favored 'General case' 0 C--N 1.349 0.576 0 N-CA-C 107.386 -1.338 . . . . 44.53 107.386 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.418 ' HB1' ' CD2' ' A' ' 82' ' ' PHE . . . -81.75 -28.78 33.15 Favored 'General case' 0 C--N 1.355 0.808 0 N-CA-C 114.647 1.351 . . . . 64.31 114.647 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.2 tmm_? -76.54 -41.07 47.96 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 114.2 1.185 . . . . 63.2 114.2 -170.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -70.65 -31.33 68.22 Favored 'General case' 0 CA--C 1.583 2.226 0 CA-C-N 121.459 1.936 . . . . 74.21 115.381 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.56 ' HA ' ' HB3' ' A' ' 31' ' ' TYR . . . -57.59 -22.16 43.32 Favored 'General case' 0 CA--C 1.596 2.743 0 N-CA-C 116.697 2.11 . . . . 62.21 116.697 169.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.451 ' HA ' HG22 ' A' ' 63' ' ' ILE . . . -50.47 -28.63 8.71 Favored 'General case' 0 CA--C 1.573 1.858 0 N-CA-C 114.758 1.392 . . . . 73.21 114.758 172.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.401 ' O ' ' HB3' ' A' ' 65' ' ' GLU . 5.5 m-20 -51.64 -54.42 28.15 Favored 'General case' 0 N--CA 1.504 2.266 0 CA-C-N 120.235 1.38 . . . . 73.32 112.644 162.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.64 -33.29 75.3 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 121.054 -1.029 . . . . 72.35 112.79 174.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.822 HD12 HG13 ' A' ' 80' ' ' VAL 0.303 0.0 OUTLIER -71.42 -46.41 64.31 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.607 0 C-N-CA 116.616 -2.034 . . . . 64.41 113.016 -178.619 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.526 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -55.06 -32.7 62.11 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 114.706 1.373 . . . . 72.41 114.706 164.221 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.401 ' HB3' ' O ' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -82.51 -18.37 41.81 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.702 1.137 . . . . 63.34 112.413 -176.537 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -101.29 15.05 30.04 Favored 'General case' 0 CA--C 1.588 2.428 0 CA-C-O 119.413 -0.327 . . . . 73.32 111.653 166.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.526 ' HB3' ' HA ' ' A' ' 64' ' ' LYS 0.378 0.2 OUTLIER -77.86 163.87 25.67 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 115.629 1.715 . . . . 72.4 115.629 -166.861 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.74 30.14 2.26 Favored Glycine 0 N--CA 1.432 -1.601 0 CA-C-O 117.224 -1.876 . . . . 72.1 115.62 -170.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.869 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -52.01 123.33 10.19 Favored 'General case' 0 C--N 1.382 2.019 0 CA-C-N 118.307 1.053 . . . . 73.24 111.577 -169.864 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.2 151.79 51.5 Favored 'General case' 0 C--O 1.258 1.504 0 CA-C-N 114.53 -1.213 . . . . 63.23 111.996 -170.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -148.75 145.28 27.55 Favored 'General case' 0 C--N 1.361 1.108 0 C-N-CA 126.97 2.108 . . . . 73.44 107.036 -163.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 70.42 64.33 0.2 Allowed 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 114.098 1.147 . . . . 72.14 114.098 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.21 -13.96 61.42 Favored Glycine 0 N--CA 1.476 1.31 0 N-CA-C 116.523 1.369 . . . . 75.41 116.523 172.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -118.42 120.34 37.29 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 105.956 -1.868 . . . . 71.22 105.956 153.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.53 107.37 19.78 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 118.051 -0.976 . . . . 74.2 109.774 -178.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.869 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 22.1 tp -163.08 70.44 0.25 Allowed 'General case' 0 C--O 1.192 -1.955 0 CA-C-N 120.114 1.324 . . . . 54.14 111.201 178.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -101.3 110.8 22.87 Favored 'General case' 0 CA--C 1.556 1.203 0 CA-C-N 122.537 2.426 . . . . 74.45 110.213 -170.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.479 HG12 HG12 ' A' ' 63' ' ' ILE . 90.8 t -126.88 118.23 49.97 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.732 0 O-C-N 120.097 -1.627 . . . . 62.3 107.5 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -145.28 131.43 19.41 Favored 'General case' 0 C--N 1.386 2.194 0 CA-C-N 120.694 1.588 . . . . 65.24 111.741 -170.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.822 HG13 HD12 ' A' ' 63' ' ' ILE . 15.7 m -88.44 134.24 34.79 Favored Pre-proline 0 C--N 1.349 0.576 0 CA-C-N 115.696 -0.684 . . . . 75.33 112.534 165.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -82.7 38.19 0.72 Allowed 'Trans proline' 0 CA--C 1.548 1.197 0 C-N-CA 122.322 2.014 . . . . 74.43 111.347 161.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.418 ' CD2' ' HB1' ' A' ' 56' ' ' ALA . 10.3 m-85 -125.56 52.01 1.67 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.452 -0.944 . . . . 53.32 108.452 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 61.7 m-20 . . . . . 0 CA--C 1.549 0.937 0 CA-C-N 115.597 -0.729 . . . . 71.5 110.055 175.022 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.622 0 CA-C-O 119.368 -0.348 . . . . 72.4 110.19 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.475 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 0.3 OUTLIER -138.71 159.19 42.72 Favored 'General case' 0 N--CA 1.509 2.524 0 CA-C-N 118.618 0.645 . . . . 60.31 111.909 -173.519 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.461 ' HB ' HD12 ' A' ' 51' ' ' ILE . 5.2 mp -134.48 133.77 54.79 Favored 'Isoleucine or valine' 0 C--O 1.269 2.082 0 N-CA-C 107.84 -1.17 . . . . 72.32 107.84 -177.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -108.54 114.4 28.2 Favored 'General case' 0 CA--C 1.57 1.731 0 O-C-N 125.877 1.986 . . . . 75.24 110.061 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.508 HG23 HG22 ' A' ' 78' ' ' VAL . 2.6 p -123.43 104.76 14.72 Favored 'Isoleucine or valine' 0 C--N 1.372 1.563 0 CA-C-N 120.555 1.525 . . . . 32.44 108.915 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -128.9 169.63 20.28 Favored Glycine 0 C--N 1.364 2.103 0 C-N-CA 120.374 -0.917 . . . . 63.02 114.747 -174.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.5 m120 49.24 24.8 1.06 Allowed 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 114.037 1.125 . . . . 54.44 114.037 -175.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.595 ' H ' HD23 ' A' ' 15' ' ' LEU . 2.0 pt? -85.12 149.98 54.03 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 125.439 1.496 . . . . 71.05 111.775 -171.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -72.13 140.98 35.27 Favored 'Trans proline' 0 C--N 1.367 1.532 0 C-N-CA 121.925 1.75 . . . . 74.34 111.56 173.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.4 p 82.5 -34.38 0.09 Allowed 'General case' 0 C--N 1.386 2.177 0 C-N-CA 126.857 2.063 . . . . 43.33 111.483 177.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 45.7 m-70 64.21 84.77 0.14 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.509 1.523 . . . . 74.31 110.109 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.576 ' H ' HD11 ' A' ' 15' ' ' LEU . 5.5 p -59.88 120.49 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.517 0 O-C-N 124.095 0.872 . . . . 75.13 110.503 -176.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.0 m -80.98 156.69 25.81 Favored 'General case' 0 C--N 1.363 1.174 0 CA-C-O 118.204 -0.903 . . . . 44.03 108.931 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.7 p -48.98 -37.29 19.79 Favored 'General case' 0 C--N 1.375 1.7 0 N-CA-C 115.795 1.776 . . . . 50.43 115.795 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . 0.255 0.0 OUTLIER -56.1 -47.62 77.71 Favored 'General case' 0 CA--C 1.588 2.433 0 N-CA-C 113.948 1.092 . . . . 62.14 113.948 173.191 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.457 ' HB2' HG23 ' A' ' 19' ' ' VAL . 13.6 m-20 -62.68 -50.97 69.06 Favored 'General case' 0 C--O 1.266 1.945 0 C-N-CA 123.686 0.794 . . . . 75.44 112.238 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.693 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -59.92 -46.18 94.26 Favored 'Isoleucine or valine' 0 C--N 1.372 1.55 0 CA-C-O 118.527 -0.749 . . . . 74.55 111.795 175.643 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.555 ' O ' ' HB3' ' A' ' 29' ' ' ARG 0.281 0.7 OUTLIER -52.5 -51.14 60.98 Favored 'General case' 0 C--O 1.202 -1.405 0 CA-C-O 115.647 -2.12 . . . . 71.42 112.049 171.217 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -71.73 -62.93 1.24 Allowed 'General case' 1 C--O 1.305 4.016 0 CA-C-N 124.537 3.335 . . . . 72.41 114.123 -178.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -72.8 -29.85 63.59 Favored 'General case' 0 C--N 1.371 1.512 0 O-C-N 120.495 -1.378 . . . . 71.42 112.118 -173.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.693 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 6.8 m-85 -84.05 -31.93 25.12 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 117.374 -1.298 . . . . 74.54 112.582 177.044 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.555 ' HB3' ' O ' ' A' ' 25' ' ' GLU . 3.3 ptt85 -51.46 -29.33 15.87 Favored 'General case' 0 N--CA 1.508 2.46 0 CA-C-O 116.353 -1.784 . . . . 70.4 114.355 164.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.41 -48.16 71.94 Favored 'General case' 0 N--CA 1.514 2.765 0 C-N-CA 114.775 -2.77 . . . . 63.21 113.2 164.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -79.99 -40.32 28.18 Favored 'General case' 0 CA--C 1.563 1.477 0 CA-C-N 119.082 0.856 . . . . 75.55 112.058 -170.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 29' ' ' ARG . . . -137.18 156.9 23.62 Favored Glycine 0 C--N 1.357 1.716 0 CA-C-N 120.245 1.384 . . . . 64.32 112.249 167.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -84.47 109.92 18.26 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.045 -0.724 . . . . 74.4 109.045 -170.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.74 121.42 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 113.439 0.904 . . . . 63.33 113.439 -176.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.81 -17.83 14.9 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.9 -0.778 . . . . 54.4 108.9 170.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -156.47 128.86 7.57 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 109.071 -0.714 . . . . 74.4 109.071 -165.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.4 p -143.04 107.99 4.92 Favored 'General case' 0 C--N 1.362 1.118 0 CA-C-N 119.34 0.973 . . . . 73.11 108.957 174.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -116.78 146.84 42.57 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 118.524 -1.27 . . . . 44.25 111.994 178.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.6 t -108.85 121.45 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 108.308 -0.997 . . . . 74.34 108.308 177.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -120.56 130.96 54.44 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 109.151 -0.685 . . . . 71.32 109.151 -176.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -121.98 128.6 51.66 Favored 'General case' 0 C--N 1.372 1.55 0 C-N-CA 117.839 -1.544 . . . . 63.13 111.127 -165.225 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.576 HG23 ' H ' ' A' ' 44' ' ' SER . 2.6 t -100.09 159.36 15.16 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 118.168 -1.413 . . . . 71.42 112.436 177.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.8 t -73.99 -7.99 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.408 0 C-N-CA 123.868 0.867 . . . . 75.14 112.377 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.576 ' H ' HG23 ' A' ' 42' ' ' THR . 7.4 t -85.23 7.78 20.81 Favored 'General case' 0 CA--C 1.55 0.968 0 O-C-N 121.489 -0.757 . . . . 65.43 110.601 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.34 -5.96 70.46 Favored Glycine 0 CA--C 1.532 1.13 0 N-CA-C 115.241 0.856 . . . . 52.05 115.241 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.48 132.38 33.94 Favored 'General case' 0 CA--C 1.558 1.283 0 CA-C-N 118.078 0.939 . . . . 74.44 110.713 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.91 142.38 34.87 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 107.439 -1.319 . . . . 24.44 107.439 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -130.79 145.99 52.12 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 106.944 -1.502 . . . . 71.21 106.944 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -118.22 138.2 52.5 Favored 'General case' 0 C--O 1.253 1.248 0 C-N-CA 119.114 -1.034 . . . . 42.42 109.798 173.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -116.84 120.45 38.54 Favored 'General case' 0 C--O 1.252 1.207 0 CA-C-N 114.516 -1.22 . . . . 72.45 108.848 -169.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.461 HD12 ' HB ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -132.84 112.66 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 123.122 0.263 . . . . 70.35 110.581 -166.902 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -103.07 113.11 26.31 Favored 'General case' 0 CA--C 1.565 1.529 0 CA-C-N 118.554 0.615 . . . . 72.13 112.169 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -108.74 164.14 12.64 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 112.742 0.645 . . . . 61.23 112.742 -176.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -78.85 -39.64 34.8 Favored 'General case' 0 N--CA 1.51 2.532 0 N-CA-C 113.37 0.878 . . . . 74.51 113.37 174.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.95 117.7 32.79 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 118.96 0.8 . . . . 72.24 109.615 -177.079 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.494 ' HB1' ' CD1' ' A' ' 82' ' ' PHE . . . -75.79 -26.32 57.21 Favored 'General case' 0 CA--C 1.556 1.19 0 N-CA-C 115.022 1.49 . . . . 72.34 115.022 175.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.321 0.0 OUTLIER -79.57 -28.2 41.16 Favored 'General case' 0 CA--C 1.57 1.74 0 CA-C-N 121.649 2.022 . . . . 74.03 114.803 -176.7 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.02 -30.23 49.89 Favored 'General case' 0 CA--C 1.591 2.552 0 CA-C-N 121.837 2.108 . . . . 73.2 115.668 174.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.74 -24.33 21.78 Favored 'General case' 0 CA--C 1.597 2.787 0 CA-C-N 120.551 1.523 . . . . 62.14 114.615 166.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.647 ' HA ' HG22 ' A' ' 63' ' ' ILE . . . -48.41 -39.37 22.28 Favored 'General case' 0 CA--C 1.569 1.691 0 C-N-CA 125.368 1.467 . . . . 62.32 114.061 173.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.459 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 2.1 m-20 -53.76 -50.82 65.17 Favored 'General case' 0 C--N 1.382 2.005 0 CA-C-N 120.473 1.488 . . . . 75.52 112.771 169.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.09 -44.99 91.98 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 118.454 -0.784 . . . . 62.31 112.65 174.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.717 HD12 HG13 ' A' ' 80' ' ' VAL 0.254 2.3 tt -69.94 -50.04 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 117.247 -1.781 . . . . 73.03 112.504 -174.648 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.53 ' HG3' ' O ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -56.9 -26.33 58.84 Favored 'General case' 0 CA--C 1.561 1.399 0 N-CA-C 115.57 1.692 . . . . 73.33 115.57 167.741 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.47 -20.11 37.53 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 121.369 1.895 . . . . 75.42 111.03 179.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.5 mttt -110.21 16.72 21.57 Favored 'General case' 0 CA--C 1.578 2.023 0 O-C-N 122.304 -0.248 . . . . 52.51 111.318 176.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.32 0.1 OUTLIER -78.23 161.4 27.32 Favored 'General case' 0 C--N 1.377 1.772 0 N-CA-C 112.988 0.736 . . . . 71.34 112.988 -176.188 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.38 26.04 3.57 Favored Glycine 0 N--CA 1.434 -1.499 0 C-N-CA 119.226 -1.464 . . . . 63.35 113.574 -160.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.819 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -55.15 123.63 14.29 Favored 'General case' 0 C--N 1.365 1.28 0 CA-C-N 117.545 0.672 . . . . 62.01 110.317 -176.628 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -133.19 151.3 51.96 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-N 115.792 -0.64 . . . . 62.42 112.122 -169.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -149.12 144.19 26.48 Favored 'General case' 0 C--N 1.354 0.78 0 C-N-CA 126.764 2.026 . . . . 62.12 106.779 -165.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 71.43 64.37 0.15 Allowed 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 113.43 0.9 . . . . 75.32 113.43 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.66 -13.72 62.35 Favored Glycine 0 N--CA 1.47 0.951 0 N-CA-C 117.081 1.592 . . . . 73.44 117.081 172.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -119.23 119.4 33.99 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 106.079 -1.823 . . . . 73.31 106.079 153.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.99 102.9 14.74 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 118.732 -1.187 . . . . 73.54 108.05 -171.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.819 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -160.57 65.99 0.32 Allowed 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 116.796 -1.574 . . . . 73.11 115.171 -177.673 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.29 114.86 27.29 Favored 'General case' 0 CA--C 1.578 2.05 0 CA-C-N 124.109 3.141 . . . . 73.4 111.962 -172.082 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.508 HG22 HG23 ' A' ' 12' ' ' VAL . 21.9 t -120.28 116.57 50.67 Favored 'Isoleucine or valine' 0 C--N 1.363 1.17 0 O-C-N 119.752 -1.842 . . . . 34.25 107.793 165.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -142.95 142.06 31.58 Favored 'General case' 0 C--N 1.362 1.116 0 C-N-CA 117.193 -1.803 . . . . 73.54 111.622 168.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.717 HG13 HD12 ' A' ' 63' ' ' ILE . 25.9 m -82.96 127.15 70.65 Favored Pre-proline 0 N--CA 1.442 -0.828 0 CA-C-N 114.676 -1.147 . . . . 71.42 110.556 169.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.475 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 57.9 Cg_endo -85.5 25.32 0.7 Allowed 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 121.6 1.533 . . . . 74.42 112.341 164.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.494 ' CD1' ' HB1' ' A' ' 56' ' ' ALA . 1.5 p90 -105.3 -31.59 9.01 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 120.414 -0.514 . . . . 74.41 111.048 174.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 N--CA 1.489 1.485 0 C-N-CA 125.057 1.343 . . . . 74.42 113.26 -177.481 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.546 0.794 0 N-CA-C 109.625 -0.509 . . . . 72.32 109.625 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.506 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 4.9 ptt180 -140.59 157.53 45.34 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 118.837 -0.601 . . . . 63.42 112.394 -177.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.8 mt -118.15 135.17 59.42 Favored 'Isoleucine or valine' 0 C--N 1.368 1.41 0 CA-C-N 119.47 1.032 . . . . 74.54 109.075 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -105.97 118.54 36.86 Favored 'General case' 0 CA--C 1.568 1.661 0 O-C-N 125.281 1.613 . . . . 63.54 110.445 -177.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.456 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 47.3 t -124.2 107.52 18.76 Favored 'Isoleucine or valine' 0 C--N 1.373 1.619 0 CA-C-N 120.439 1.472 . . . . 71.32 109.287 -177.075 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.449 ' H ' ' HG3' ' A' ' 77' ' ' ARG . . . -120.18 163.93 13.88 Favored Glycine 0 C--N 1.344 1.021 0 C-N-CA 118.845 -1.645 . . . . 74.32 112.818 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.44 ' HB3' ' HB2' ' A' ' 75' ' ' LYS . 8.3 m120 50.45 26.89 2.53 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 114.772 1.397 . . . . 73.32 114.772 177.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.411 HD23 ' H ' ' A' ' 15' ' ' LEU . 0.9 OUTLIER -74.69 149.72 86.09 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.543 1.537 . . . . 74.21 111.415 -177.22 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -79.92 129.17 7.89 Favored 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 121.565 1.51 . . . . 73.24 111.27 176.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 96.7 p 57.55 102.56 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 124.647 1.179 . . . . 73.13 112.357 -171.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 32.0 p-80 -57.15 125.31 22.13 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.529 -0.76 . . . . 65.52 111.781 -177.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.513 HG23 ' HB2' ' A' ' 23' ' ' ASP . 2.9 p -77.61 119.29 26.01 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 CA-C-N 114.85 -1.068 . . . . 63.13 109.006 -176.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.0 m -79.4 157.37 27.6 Favored 'General case' 0 C--N 1.369 1.45 0 CA-C-O 117.955 -1.022 . . . . 73.02 108.581 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.8 p -48.97 -37.53 20.43 Favored 'General case' 0 C--N 1.375 1.698 0 N-CA-C 115.926 1.825 . . . . 71.14 115.926 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.584 ' H ' ' HD3' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -56.6 -40.72 75.79 Favored 'General case' 0 N--CA 1.507 2.381 0 N-CA-C 114.547 1.314 . . . . 75.14 114.547 172.692 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.513 ' HB2' HG23 ' A' ' 19' ' ' VAL . 7.5 m-20 -70.7 -45.93 64.07 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 118.955 0.798 . . . . 75.03 111.173 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.704 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 2.4 m -61.63 -49.75 83.07 Favored 'Isoleucine or valine' 0 C--N 1.372 1.572 0 N-CA-C 112.085 0.402 . . . . 72.43 112.085 174.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -50.09 -53.69 25.51 Favored 'General case' 0 CA--C 1.562 1.411 0 CA-C-O 116.528 -1.701 . . . . 74.21 113.226 171.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -73.09 -63.07 1.25 Allowed 'General case' 0 C--O 1.302 3.843 0 CA-C-N 122.901 2.591 . . . . 52.14 114.29 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -72.54 -30.79 64.76 Favored 'General case' 0 C--N 1.365 1.265 0 C-N-CA 119.031 -1.068 . . . . 74.21 111.172 -174.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.704 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 17.9 m-85 -85.85 -23.19 27.21 Favored 'General case' 0 CA--C 1.56 1.341 0 CA-C-N 119.536 1.062 . . . . 72.34 111.391 -178.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.434 ' HA ' HG22 ' A' ' 34' ' ' ILE 0.295 1.8 ppt_? -60.62 -24.5 65.56 Favored 'General case' 0 C--N 1.401 2.828 0 CA-C-N 120.602 1.546 . . . . 71.25 112.341 165.181 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . 0.297 0.0 OUTLIER -53.55 -30.77 43.47 Favored 'General case' 0 N--CA 1.508 2.466 0 C-N-CA 117.123 -1.831 . . . . 71.52 114.042 164.237 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -85.67 -49.47 7.96 Favored 'General case' 0 C--O 1.214 -0.793 0 CA-C-N 121.564 1.984 . . . . 73.04 112.279 -157.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -160.55 39.9 0.44 Allowed Glycine 0 C--N 1.355 1.613 0 C-N-CA 117.89 -2.1 . . . . 64.11 114.507 171.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.3 t30 69.33 93.78 0.08 Allowed 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 124.37 1.068 . . . . 72.32 111.435 173.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.434 HG22 ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -73.95 129.75 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-N 115.537 -0.756 . . . . 72.51 112.553 179.407 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.79 -21.73 12.54 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 109.553 -0.536 . . . . 73.35 109.553 174.272 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.22 131.63 15.67 Favored 'General case' 0 CA--C 1.561 1.394 0 N-CA-C 108.57 -0.9 . . . . 61.12 108.57 -173.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -138.55 110.59 7.28 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 120.126 1.33 . . . . 64.31 109.803 176.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -118.64 145.98 45.02 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 117.875 -1.53 . . . . 73.31 111.499 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 37.1 t -114.9 112.76 41.36 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 N-CA-C 107.623 -1.251 . . . . 71.22 107.623 172.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -114.7 129.83 56.74 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 114.825 -1.079 . . . . 75.42 108.739 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.09 144.52 51.48 Favored 'General case' 0 C--N 1.369 1.433 0 CA-C-N 121.004 1.729 . . . . 64.21 108.998 -171.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.49 HG23 ' H ' ' A' ' 44' ' ' SER . 8.8 t -99.06 170.99 8.32 Favored 'General case' 0 CA--C 1.558 1.288 0 CA-C-N 120.499 1.5 . . . . 30.13 111.738 -178.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.7 t -73.63 -7.07 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.368 0 C-N-CA 124.113 0.965 . . . . 73.23 112.577 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.49 ' H ' HG23 ' A' ' 42' ' ' THR . 8.5 t -85.41 8.36 19.19 Favored 'General case' 0 CA--C 1.55 0.965 0 O-C-N 121.59 -0.694 . . . . 65.41 111.04 -177.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.42 -4.89 75.73 Favored Glycine 0 C--N 1.351 1.4 0 N-CA-C 115.178 0.831 . . . . 54.21 115.178 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.19 131.27 34.24 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 117.726 0.763 . . . . 71.5 110.484 176.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -105.34 147.76 27.81 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 108.045 -1.094 . . . . 43.45 108.045 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -126.67 147.27 49.95 Favored 'General case' 0 C--N 1.352 0.7 0 C-N-CA 118.609 -1.236 . . . . 74.1 109.7 177.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.456 ' HB3' ' HB ' ' A' ' 12' ' ' VAL . . . -117.08 138.75 51.41 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 120.538 -0.465 . . . . 74.14 109.751 176.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.13 113.83 15.58 Favored 'General case' 0 C--O 1.261 1.662 0 N-CA-C 106.709 -1.589 . . . . 64.33 106.709 -175.239 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.44 ' N ' HD12 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -129.18 113.9 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 C-N-CA 118.699 -1.2 . . . . 71.52 109.72 -170.871 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -91.62 115.38 28.0 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 114.567 -1.197 . . . . 61.34 112.481 -172.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -109.39 159.58 16.89 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 114.279 1.214 . . . . 71.51 114.279 -177.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -82.04 -43.33 18.07 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 120.115 -0.634 . . . . 63.14 112.315 172.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.451 ' OD1' ' HD2' ' A' ' 57' ' ' ARG . 6.0 t0 -116.41 127.02 54.26 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 118.923 0.783 . . . . 74.41 110.896 -174.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.03 -22.21 53.38 Favored 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 115.548 1.684 . . . . 54.31 115.548 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.451 ' HD2' ' OD1' ' A' ' 55' ' ' ASP 0.289 0.0 OUTLIER -76.73 -41.32 45.47 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 121.939 2.154 . . . . 65.41 113.273 -173.191 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -62.69 -48.85 77.5 Favored 'General case' 0 N--CA 1.505 2.319 0 CA-C-N 120.217 1.371 . . . . 63.14 113.499 178.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.55 -24.62 33.25 Favored 'General case' 0 CA--C 1.567 1.596 0 N-CA-C 115.477 1.658 . . . . 71.44 115.477 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.401 ' O ' ' HG3' ' A' ' 64' ' ' LYS . . . -46.68 -44.37 18.55 Favored 'General case' 0 CA--C 1.576 1.967 0 C-N-CA 125.31 1.444 . . . . 73.31 114.025 173.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -51.83 -53.47 39.81 Favored 'General case' 0 N--CA 1.514 2.739 0 CA-C-N 119.523 1.056 . . . . 65.51 112.822 173.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.629 ' O ' ' HD2' ' A' ' 66' ' ' LYS . . . -75.67 -30.21 59.32 Favored 'General case' 0 C--N 1.31 -1.141 0 O-C-N 120.467 -1.396 . . . . 73.2 112.868 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 63' ' ' ILE 0.256 5.9 mm -68.78 -46.23 79.78 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.921 0 C-N-CA 118.174 -1.41 . . . . 54.43 111.915 179.205 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -56.94 -32.83 66.38 Favored 'General case' 0 CA--C 1.562 1.44 0 N-CA-C 115.155 1.539 . . . . 71.21 115.155 164.831 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -64.36 -28.39 69.66 Favored 'General case' 0 N--CA 1.507 2.377 0 CA-C-N 120.542 1.519 . . . . 75.41 113.201 173.12 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.629 ' HD2' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -107.41 15.17 25.19 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 116.221 1.934 . . . . 74.52 116.221 164.6 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.33 0.0 OUTLIER -78.63 157.21 28.73 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 120.238 1.381 . . . . 73.13 110.941 179.597 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.52 30.85 1.77 Allowed Glycine 0 N--CA 1.428 -1.889 0 C-N-CA 117.526 -2.273 . . . . 73.3 113.622 -151.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.739 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 6.9 t -49.07 132.69 19.04 Favored 'General case' 0 C--N 1.376 1.74 0 CA-C-O 122.062 0.934 . . . . 65.43 111.049 172.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.41 ' HB2' ' HB2' ' A' ' 76' ' ' LEU . 1.2 m-20 -128.92 147.13 50.81 Favored 'General case' 0 C--O 1.246 0.914 0 CA-C-N 113.951 -1.477 . . . . 72.4 112.836 -170.3 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.63 144.91 24.72 Favored 'General case' 0 C--N 1.355 0.83 0 C-N-CA 126.83 2.052 . . . . 74.22 108.154 -156.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 70.91 62.28 0.18 Allowed 'General case' 0 N--CA 1.501 2.086 0 O-C-N 123.611 0.569 . . . . 74.51 112.473 173.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.95 -14.79 64.15 Favored Glycine 0 N--CA 1.472 1.036 0 N-CA-C 116.952 1.541 . . . . 73.33 116.952 173.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -123.11 119.74 31.19 Favored 'General case' 0 C--O 1.211 -0.942 0 N-CA-C 104.592 -2.373 . . . . 74.43 104.592 159.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.44 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -104.54 131.44 51.93 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 118.02 -1.472 . . . . 73.42 111.281 -177.548 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.739 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -171.33 70.69 0.05 OUTLIER 'General case' 0 C--O 1.199 -1.594 0 CA-C-O 117.981 -1.009 . . . . 52.01 110.589 -178.417 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.449 ' HG3' ' H ' ' A' ' 13' ' ' GLY . 2.0 tpp85 -93.0 115.62 28.29 Favored 'General case' 0 CA--C 1.571 1.763 0 CA-C-N 121.572 1.987 . . . . 73.34 111.411 -172.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.04 116.09 48.76 Favored 'Isoleucine or valine' 0 C--N 1.361 1.079 0 N-CA-C 107.558 -1.275 . . . . 64.03 107.558 163.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.2 tp10 -134.46 138.66 44.93 Favored 'General case' 0 C--N 1.363 1.178 0 CA-C-N 119.576 1.08 . . . . 73.44 110.427 174.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.0 m -90.3 122.39 67.48 Favored Pre-proline 0 N--CA 1.439 -0.998 0 C-N-CA 120.016 -0.673 . . . . 71.51 110.579 170.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 75.5 Cg_endo -89.74 22.77 0.76 Allowed 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 121.887 1.725 . . . . 74.1 113.378 168.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.446 ' HD2' ' N ' ' A' ' 9' ' ' ARG . 0.8 OUTLIER -113.32 -16.84 12.43 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 120.009 -0.676 . . . . 70.34 112.417 175.426 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.6 m120 . . . . . 0 N--CA 1.49 1.545 0 O-C-N 124.957 1.411 . . . . 71.42 110.271 -171.13 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.548 0.877 0 N-CA-C 112.092 0.405 . . . . 74.22 112.092 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.499 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -126.59 154.76 43.5 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.044 0.757 . . . . 73.43 113.044 -176.299 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.776 HD13 HG13 ' A' ' 63' ' ' ILE . 23.4 mt -116.79 141.17 36.07 Favored 'Isoleucine or valine' 0 C--O 1.254 1.31 0 CA-C-N 119.446 1.021 . . . . 75.34 108.637 179.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -101.71 116.99 33.96 Favored 'General case' 0 CA--C 1.572 1.797 0 O-C-N 125.991 2.057 . . . . 70.41 110.073 177.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.491 ' CG1' HG22 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -127.37 105.67 14.15 Favored 'Isoleucine or valine' 0 C--N 1.381 1.95 0 CA-C-N 119.348 0.977 . . . . 73.12 108.754 179.843 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -113.12 -175.66 19.36 Favored Glycine 0 CA--C 1.521 0.445 0 CA-C-O 118.504 -1.164 . . . . 73.33 112.991 176.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.7 m120 54.09 28.8 9.34 Favored 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 115.701 1.741 . . . . 74.1 115.701 170.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.3 mt -89.08 150.79 45.87 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 123.51 0.724 . . . . 73.54 111.629 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -59.35 130.73 37.21 Favored 'Trans proline' 0 CA--C 1.556 1.582 0 C-N-CA 123.095 2.53 . . . . 61.22 113.232 173.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.0 p 71.98 -5.11 1.79 Allowed 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 126.473 1.909 . . . . 71.22 114.525 168.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 71.54 129.8 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.062 1.345 . . . . 74.13 110.605 -173.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.9 m -91.68 119.78 39.61 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.443 0 N-CA-C 107.424 -1.324 . . . . 73.15 107.424 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.44 157.47 24.91 Favored 'General case' 0 C--N 1.381 1.972 0 O-C-N 120.263 -1.523 . . . . 64.02 109.991 -175.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.0 p -58.96 -34.25 71.58 Favored 'General case' 0 C--N 1.378 1.836 0 N-CA-C 115.835 1.791 . . . . 64.42 115.835 -174.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.4 ' HA ' ' HG2' ' A' ' 25' ' ' GLU 0.274 0.0 OUTLIER -60.75 -39.14 87.61 Favored 'General case' 0 CA--C 1.582 2.199 0 N-CA-C 115.477 1.658 . . . . 73.21 115.477 172.377 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -65.32 -50.47 65.54 Favored 'General case' 0 C--O 1.279 2.622 0 CA-C-N 119.87 1.214 . . . . 73.4 111.329 178.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.7 m -62.94 -43.75 99.19 Favored 'Isoleucine or valine' 0 C--N 1.376 1.759 0 O-C-N 123.546 0.529 . . . . 53.31 111.877 177.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.4 ' HG2' ' HA ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -54.13 -50.16 67.54 Favored 'General case' 0 C--O 1.191 -2.015 0 CA-C-O 115.195 -2.336 . . . . 75.44 115.202 169.03 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -68.41 -56.63 7.81 Favored 'General case' 0 C--O 1.283 2.85 0 CA-C-N 123.257 2.753 . . . . 51.32 114.071 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -61.18 -44.56 97.1 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 117.903 -1.046 . . . . 64.3 111.71 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -74.59 -28.54 60.95 Favored 'General case' 0 C--O 1.209 -1.04 0 CA-C-N 120.857 1.662 . . . . 62.33 114.194 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.417 ' C ' ' HE ' ' A' ' 29' ' ' ARG 0.379 0.0 OUTLIER -57.62 -37.88 74.03 Favored 'General case' 0 N--CA 1.526 3.353 0 CA-C-N 121.285 1.857 . . . . 74.33 114.252 164.025 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.41 ' HE2' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -56.6 -47.75 78.91 Favored 'General case' 0 N--CA 1.508 2.475 0 C-N-CA 116.194 -2.202 . . . . 64.3 110.319 167.903 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.554 ' HB3' ' HA ' ' A' ' 59' ' ' ALA . 35.2 m-85 -72.64 -39.47 67.16 Favored 'General case' 0 CA--C 1.564 1.505 0 CA-C-O 118.065 -0.969 . . . . 70.32 112.79 -166.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -150.11 176.07 28.91 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-N 119.965 1.257 . . . . 74.22 110.722 161.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 47.1 m-20 -83.58 101.14 11.26 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.249 2.024 . . . . 75.31 111.077 -176.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.91 134.41 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.108 0.48 . . . . 64.31 112.034 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.5 mp -102.77 -24.86 13.69 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 116.097 -0.501 . . . . 74.51 111.992 171.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.53 138.0 13.97 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 109.249 -0.648 . . . . 74.43 109.249 -173.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -140.27 108.73 5.86 Favored 'General case' 0 C--N 1.359 0.982 0 CA-C-N 118.727 0.694 . . . . 72.43 109.545 178.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -120.8 143.68 48.71 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 117.852 -1.539 . . . . 61.15 112.643 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -127.15 112.8 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 CA-C-O 121.452 0.644 . . . . 62.43 110.284 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.5 mttm -113.41 152.43 30.07 Favored 'General case' 0 CA--C 1.56 1.336 0 CA-C-O 118.018 -0.991 . . . . 73.23 108.874 -174.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.37 147.19 50.27 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-N 121.755 2.071 . . . . 70.51 109.061 -174.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.682 HG23 ' H ' ' A' ' 44' ' ' SER . 5.8 t -98.88 175.65 5.87 Favored 'General case' 0 CA--C 1.565 1.53 0 CA-C-N 120.816 1.644 . . . . 72.11 111.356 175.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.5 t -77.51 -8.99 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.387 0 C-N-CA 123.486 0.714 . . . . 71.32 112.115 -178.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.682 ' H ' HG23 ' A' ' 42' ' ' THR . 8.2 t -86.14 -0.8 56.53 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 121.773 -0.579 . . . . 54.03 110.753 -177.004 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.06 -7.46 66.81 Favored Glycine 0 CA--C 1.534 1.258 0 N-CA-C 114.977 0.751 . . . . 52.23 114.977 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.31 132.26 37.38 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 117.728 0.764 . . . . 73.32 108.952 170.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.88 145.35 44.68 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.022 -0.733 . . . . 51.21 109.022 -171.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -127.04 151.16 48.97 Favored 'General case' 0 C--N 1.363 1.16 0 CA-C-N 119.783 1.174 . . . . 74.53 112.0 -170.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -127.57 147.0 50.34 Favored 'General case' 0 C--N 1.351 0.642 0 CA-C-O 121.705 0.764 . . . . 70.05 111.831 175.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -132.69 113.31 12.84 Favored 'General case' 0 C--O 1.256 1.407 0 N-CA-C 105.392 -2.077 . . . . 73.33 105.392 -164.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 0.6 OUTLIER -126.38 108.91 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 C-N-CA 118.186 -1.406 . . . . 73.15 108.865 -170.525 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -106.27 106.0 16.3 Favored 'General case' 0 CA--C 1.549 0.905 0 O-C-N 124.6 1.187 . . . . 72.43 110.233 -173.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.19 146.6 39.0 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-O 118.681 -0.676 . . . . 74.21 112.766 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -57.46 -24.21 54.4 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 114.657 1.354 . . . . 72.25 114.657 166.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -114.09 113.42 24.7 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 119.603 1.092 . . . . 74.34 109.015 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.29 -43.68 32.37 Favored 'General case' 0 CA--C 1.554 1.103 0 N-CA-C 115.426 1.639 . . . . 72.43 115.426 172.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.305 0.0 OUTLIER -77.49 -29.57 52.66 Favored 'General case' 0 C--N 1.373 1.589 0 CA-C-N 121.117 1.78 . . . . 75.35 114.916 -167.831 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.17 -30.17 63.36 Favored 'General case' 0 CA--C 1.581 2.17 0 N-CA-C 116.353 1.983 . . . . 74.43 116.353 176.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.554 ' HA ' ' HB3' ' A' ' 31' ' ' TYR . . . -72.99 -19.28 61.24 Favored 'General case' 0 CA--C 1.585 2.302 0 CA-C-N 120.367 1.439 . . . . 44.13 111.993 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -48.58 -29.78 4.62 Favored 'General case' 0 CA--C 1.572 1.825 0 CA-C-O 116.97 -1.49 . . . . 35.42 114.325 170.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.565 ' O ' ' HB3' ' A' ' 65' ' ' GLU . 18.8 m-20 -51.88 -53.38 41.31 Favored 'General case' 0 C--N 1.398 2.708 0 CA-C-N 121.025 1.739 . . . . 62.32 111.571 164.042 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.02 -34.8 79.3 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-O 117.824 -1.084 . . . . 72.33 113.689 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.776 HG13 HD13 ' A' ' 10' ' ' ILE 0.281 0.0 OUTLIER -72.92 -35.93 50.34 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.685 0 C-N-CA 116.457 -2.097 . . . . 74.22 113.727 -178.741 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.61 -32.95 74.58 Favored 'General case' 0 C--N 1.362 1.143 0 CA-C-N 119.848 1.204 . . . . 73.52 113.678 163.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.565 ' HB3' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -83.38 -19.28 36.35 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 113.206 0.817 . . . . 74.41 113.206 -172.804 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -100.35 13.64 33.75 Favored 'General case' 0 CA--C 1.571 1.784 0 O-C-N 122.207 -0.308 . . . . 74.33 110.329 173.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.302 0.1 OUTLIER -77.02 161.94 27.93 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 118.422 0.555 . . . . 71.43 112.296 -167.463 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 119.85 28.41 1.89 Allowed Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 119.452 -1.356 . . . . 72.23 114.681 -155.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.702 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 0.8 OUTLIER -47.94 132.68 15.02 Favored 'General case' 0 C--N 1.377 1.768 0 C-N-CA 124.573 1.149 . . . . 75.3 109.811 179.238 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -56.95 102.06 0.07 Allowed 'General case' 0 C--N 1.384 2.105 0 O-C-N 125.216 1.573 . . . . 73.23 112.362 -160.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -153.92 139.3 17.64 Favored 'General case' 0 N--CA 1.439 -0.998 0 O-C-N 125.252 1.595 . . . . 71.22 107.303 -178.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 67.32 54.12 0.73 Allowed 'General case' 0 N--CA 1.508 2.461 0 C-N-CA 123.501 0.72 . . . . 64.41 111.892 172.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.73 -9.06 32.01 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 117.893 1.917 . . . . 75.31 117.893 176.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -115.54 119.54 36.52 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.245 1.522 . . . . 70.44 107.993 -174.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.03 100.83 12.59 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 117.966 -1.016 . . . . 52.31 111.643 -167.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.702 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -162.49 103.95 1.08 Allowed 'General case' 0 C--O 1.158 -3.749 0 CA-C-O 117.081 -1.438 . . . . 74.03 107.935 170.498 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.67 109.9 21.33 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 123.533 2.879 . . . . 65.54 107.257 -170.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.491 HG22 ' CG1' ' A' ' 12' ' ' VAL . 88.4 t -128.38 117.21 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.548 0 CA-C-N 120.481 1.491 . . . . 63.22 108.573 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -150.22 135.53 18.02 Favored 'General case' 0 C--N 1.381 1.972 0 CA-C-N 120.339 1.427 . . . . 72.24 110.144 -174.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.679 HG13 HD12 ' A' ' 63' ' ' ILE . 19.0 m -77.93 122.27 85.29 Favored Pre-proline 0 C--N 1.36 1.052 0 CA-C-O 121.618 0.723 . . . . 55.24 110.892 161.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.499 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 72.2 Cg_endo -90.78 13.69 2.13 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.402 2.068 . . . . 60.15 113.362 165.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -102.41 -45.72 5.0 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.055 -0.72 . . . . 55.24 109.055 170.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 . . . . . 0 N--CA 1.492 1.668 0 O-C-N 125.058 1.474 . . . . 63.22 110.302 -178.2 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 111.725 0.268 . . . . 63.23 111.725 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.454 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -141.16 154.66 45.97 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 113.351 0.871 . . . . 75.51 113.351 -175.06 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.6 mt -116.65 141.72 33.45 Favored 'Isoleucine or valine' 0 C--O 1.26 1.644 0 N-CA-C 108.418 -0.956 . . . . 71.11 108.418 -179.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -100.7 118.02 35.97 Favored 'General case' 0 CA--C 1.566 1.568 0 O-C-N 125.775 1.922 . . . . 74.32 110.374 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.475 HG13 HG22 ' A' ' 78' ' ' VAL . 57.9 t -125.78 106.24 15.79 Favored 'Isoleucine or valine' 0 C--N 1.375 1.677 0 CA-C-N 119.849 1.204 . . . . 73.12 109.889 177.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.17 -178.07 20.9 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 118.582 -1.121 . . . . 54.43 111.818 174.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.5 m120 50.13 24.2 1.36 Allowed 'General case' 0 N--CA 1.509 2.489 0 N-CA-C 116.579 2.066 . . . . 63.2 116.579 172.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.616 HD12 ' HB3' ' A' ' 18' ' ' HIS . 2.4 pt? -89.18 123.93 66.01 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 123.401 0.681 . . . . 61.34 111.001 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -84.33 126.67 3.72 Favored 'Trans proline' 0 CA--C 1.559 1.74 0 C-N-CA 121.415 1.41 . . . . 62.33 112.855 174.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.1 m 33.42 60.55 0.47 Allowed 'General case' 0 C--N 1.386 2.154 0 C-N-CA 125.772 1.629 . . . . 55.53 114.271 174.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.616 ' HB3' HD12 ' A' ' 15' ' ' LEU . 7.3 t60 -109.58 -128.29 0.28 Allowed 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.65 -0.704 . . . . 73.31 109.671 -168.275 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.9 m -83.37 121.59 36.41 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.695 0 CA-C-N 118.384 0.538 . . . . 70.35 110.983 -174.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -81.43 165.56 21.17 Favored 'General case' 0 C--N 1.369 1.434 0 CA-C-O 117.571 -1.204 . . . . 72.14 109.134 176.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.6 p -47.79 -46.78 30.84 Favored 'General case' 0 C--N 1.382 2.008 0 N-CA-C 116.065 1.876 . . . . 63.24 116.065 -173.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.25 -42.03 96.69 Favored 'General case' 0 CA--C 1.577 2.0 0 N-CA-C 114.517 1.303 . . . . 65.55 114.517 178.115 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.352 0.6 OUTLIER -67.41 -27.24 66.91 Favored 'General case' 0 CA--C 1.565 1.543 0 CA-C-N 120.036 1.289 . . . . 61.41 112.958 172.783 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.441 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 2.3 t -71.11 -38.78 72.65 Favored 'Isoleucine or valine' 0 C--N 1.406 3.055 0 CA-C-N 120.266 1.394 . . . . 64.34 107.734 175.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.601 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -65.79 -56.82 9.94 Favored 'General case' 0 CA--C 1.555 1.138 0 CA-C-O 117.129 -1.415 . . . . 75.4 112.198 179.488 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.11 -54.92 19.69 Favored 'General case' 0 C--O 1.299 3.666 0 CA-C-N 121.739 2.063 . . . . 72.32 115.58 176.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.78 -37.83 80.18 Favored 'General case' 0 C--N 1.387 2.209 0 CA-C-O 118.126 -0.94 . . . . 53.25 112.136 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.441 ' HB2' ' O ' ' A' ' 24' ' ' VAL 0.256 63.4 m-85 -83.87 -21.9 31.82 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-O 115.832 -2.033 . . . . 72.22 114.188 178.312 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.601 ' HG3' ' O ' ' A' ' 25' ' ' GLU 0.372 10.6 mtp180 -61.95 -36.05 80.25 Favored 'General case' 0 N--CA 1.524 3.225 0 CA-C-N 122.689 2.495 . . . . 72.12 109.115 169.466 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.84 -45.86 89.06 Favored 'General case' 0 N--CA 1.509 2.52 0 C-N-CA 116.879 -1.929 . . . . 64.32 112.179 172.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.56 ' HB3' ' HA ' ' A' ' 59' ' ' ALA . 13.7 m-85 -71.83 -40.35 69.16 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 112.746 0.647 . . . . 75.01 112.746 -169.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -151.5 163.72 30.01 Favored Glycine 0 C--O 1.213 -1.184 0 CA-C-O 117.346 -1.808 . . . . 71.31 108.591 156.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -72.59 101.18 2.95 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 121.188 2.494 . . . . 44.42 111.402 -170.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.49 HG22 ' HB3' ' A' ' 53' ' ' PHE . 2.1 pp -73.81 142.41 14.91 Favored 'Isoleucine or valine' 0 C--N 1.359 0.983 0 C-N-CA 120.089 -0.645 . . . . 73.45 112.602 -174.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.1 mp -97.37 -45.5 6.44 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 115.912 -0.585 . . . . 74.21 112.131 174.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.05 152.99 38.34 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-N 118.697 0.681 . . . . 61.23 110.558 172.041 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 3.3 m -137.62 107.4 6.26 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 106.756 -1.572 . . . . 72.52 106.756 176.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -115.88 143.41 45.46 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 118.544 -1.263 . . . . 63.41 111.288 -175.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -123.62 113.14 36.05 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-O 121.27 0.557 . . . . 74.34 110.239 -173.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 48.1 mttm -116.76 146.14 43.02 Favored 'General case' 0 CA--C 1.563 1.445 0 CA-C-O 117.968 -1.015 . . . . 55.34 109.956 -173.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.42 146.31 50.13 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 121.508 1.958 . . . . 71.12 108.771 -170.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.601 HG23 ' H ' ' A' ' 44' ' ' SER . 5.1 t -99.33 167.41 10.67 Favored 'General case' 0 C--N 1.363 1.164 0 CA-C-N 120.358 1.435 . . . . 75.23 111.398 175.228 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.3 m -66.39 -5.32 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.472 0 N-CA-C 116.262 1.949 . . . . 75.43 116.262 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.601 ' H ' HG23 ' A' ' 42' ' ' THR . 0.8 OUTLIER -98.83 4.81 47.64 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 119.507 1.049 . . . . 75.4 110.14 -172.373 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.37 -6.82 74.99 Favored Glycine 0 CA--C 1.543 1.781 0 N-CA-C 115.238 0.855 . . . . 62.22 115.238 -176.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -80.78 131.52 35.43 Favored 'General case' 0 CA--C 1.554 1.133 0 CA-C-N 118.267 1.034 . . . . 73.31 109.248 171.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.93 147.45 43.13 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-O 118.565 -0.731 . . . . 73.3 109.319 -171.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -129.57 151.62 49.99 Favored 'General case' 0 C--N 1.367 1.327 0 CA-C-N 119.541 1.064 . . . . 70.24 111.619 -173.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -134.29 144.01 48.08 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.919 0.866 . . . . 75.44 111.598 175.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -131.59 114.67 15.12 Favored 'General case' 0 C--O 1.265 1.88 0 N-CA-C 105.591 -2.003 . . . . 71.25 105.591 -159.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 0.3 OUTLIER -120.01 107.6 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 C-N-CA 119.271 -0.972 . . . . 74.21 109.713 -165.79 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -114.04 104.7 12.4 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.126 -0.488 . . . . 61.53 111.04 -169.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.49 ' HB3' HG22 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -114.12 160.73 18.62 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.831 1.048 . . . . 74.32 113.831 -177.035 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -73.09 -28.7 62.44 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 112.741 0.645 . . . . 61.41 112.741 167.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -113.8 112.42 23.37 Favored 'General case' 0 C--N 1.351 0.659 0 C-N-CA 118.571 -1.252 . . . . 60.33 109.277 176.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.34 -44.71 35.47 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 116.058 1.873 . . . . 72.44 116.058 170.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.97 -34.9 76.08 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 113.846 1.054 . . . . 73.32 113.846 -169.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -75.96 -32.64 59.6 Favored 'General case' 0 CA--C 1.586 2.358 0 N-CA-C 115.897 1.814 . . . . 64.44 115.897 176.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.56 ' HA ' ' HB3' ' A' ' 31' ' ' TYR . . . -64.93 -19.81 66.13 Favored 'General case' 0 CA--C 1.595 2.694 0 N-CA-C 114.884 1.439 . . . . 75.44 114.884 173.573 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -48.46 -31.83 6.89 Favored 'General case' 0 CA--C 1.578 2.055 0 N-CA-C 115.047 1.499 . . . . 74.1 115.047 171.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.406 ' O ' ' HB3' ' A' ' 65' ' ' GLU . 14.9 m-20 -51.21 -52.97 39.5 Favored 'General case' 0 N--CA 1.507 2.424 0 CA-C-N 119.915 1.234 . . . . 62.21 111.77 164.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.58 -31.32 71.95 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 117.13 -1.414 . . . . 73.21 114.023 175.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . 0.343 0.3 OUTLIER -73.59 -42.49 55.51 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.199 0 C-N-CA 115.578 -2.449 . . . . 74.31 113.895 177.612 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.16 -27.42 65.65 Favored 'General case' 0 CA--C 1.56 1.328 0 CA-C-N 120.158 1.345 . . . . 72.53 113.691 165.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.406 ' HB3' ' O ' ' A' ' 61' ' ' ASP . 1.2 tt0 -77.59 -29.31 51.91 Favored 'General case' 0 CA--C 1.549 0.937 0 O-C-N 121.31 -0.869 . . . . 73.13 112.45 178.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 43.0 mmtt -96.01 13.0 28.48 Favored 'General case' 0 CA--C 1.584 2.259 0 N-CA-C 112.861 0.689 . . . . 74.4 112.861 172.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.323 0.2 OUTLIER -76.23 164.97 25.54 Favored 'General case' 0 N--CA 1.51 2.534 0 CA-C-N 119.825 1.193 . . . . 74.4 111.922 -171.059 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.76 31.19 1.05 Allowed Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 118.652 -1.737 . . . . 74.14 114.801 -153.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.647 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 59.5 m -44.68 139.49 2.89 Favored 'General case' 0 C--N 1.393 2.492 0 CA-C-N 117.767 0.784 . . . . 74.03 111.852 171.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.406 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 7.9 t0 -58.05 99.79 0.05 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 O-C-N 125.038 1.461 . . . . 71.43 110.774 -169.014 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -155.63 139.29 16.05 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 125.551 1.54 . . . . 75.44 109.63 -175.278 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 66.06 51.39 1.31 Allowed 'General case' 0 N--CA 1.509 2.506 0 C-N-CA 123.148 0.579 . . . . 73.23 111.935 168.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.9 -11.01 36.84 Favored Glycine 0 CA--C 1.541 1.69 0 N-CA-C 117.456 1.742 . . . . 53.32 117.456 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' A' ' 70' ' ' ASP . 8.8 t30 -114.83 118.9 34.84 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 119.608 1.704 . . . . 74.51 108.84 -177.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.96 107.59 19.88 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 113.57 0.952 . . . . 70.32 113.57 -176.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.647 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -159.35 108.87 1.89 Allowed 'General case' 0 C--O 1.167 -3.261 0 N-CA-C 107.48 -1.304 . . . . 74.04 107.48 165.847 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 -90.79 107.58 19.28 Favored 'General case' 0 CA--C 1.554 1.098 0 CA-C-N 122.728 2.513 . . . . 72.03 108.028 -175.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.475 HG22 HG13 ' A' ' 12' ' ' VAL . 57.7 t -127.28 111.46 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 O-C-N 120.771 -1.206 . . . . 55.21 108.776 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -149.44 133.68 17.33 Favored 'General case' 0 C--O 1.257 1.475 0 CA-C-N 120.565 1.529 . . . . 64.32 110.615 -166.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.8 m -73.47 126.14 90.16 Favored Pre-proline 0 C--N 1.37 1.491 0 CA-C-O 121.363 0.601 . . . . 73.11 111.88 164.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -96.49 17.31 0.68 Allowed 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.367 2.711 . . . . 53.3 113.959 164.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -114.32 -26.38 8.02 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 120.574 -0.45 . . . . 75.32 112.063 176.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 CA--C 1.569 1.683 0 O-C-N 124.583 1.177 . . . . 72.44 113.43 -175.998 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 t . . . . . 0 CA--C 1.548 0.878 0 N-CA-C 110.188 -0.301 . . . . 74.35 110.188 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.551 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 0.3 OUTLIER -141.87 160.34 40.4 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 112.66 0.615 . . . . 71.33 112.66 -176.726 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.797 HG12 HG12 ' A' ' 80' ' ' VAL . 3.7 mt -113.64 136.9 48.59 Favored 'Isoleucine or valine' 0 C--O 1.246 0.911 0 N-CA-C 109.075 -0.713 . . . . 53.42 109.075 176.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -111.35 112.86 24.93 Favored 'General case' 0 C--N 1.354 0.761 0 O-C-N 124.619 1.2 . . . . 64.3 108.923 172.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 4.0 p -124.42 110.38 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-O 121.577 0.703 . . . . 73.0 111.422 175.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -117.62 159.24 14.22 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.918 -0.583 . . . . 64.11 112.458 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.1 m120 60.87 28.98 18.72 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.996 0.918 . . . . 64.04 111.925 175.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.538 HD23 ' H ' ' A' ' 15' ' ' LEU . 2.1 pt? -85.04 137.46 37.5 Favored Pre-proline 0 C--O 1.239 0.528 0 CA-C-N 115.873 -0.603 . . . . 61.24 111.564 -172.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -69.23 126.92 14.26 Favored 'Trans proline' 0 C--N 1.36 1.142 0 C-N-CA 122.23 1.954 . . . . 71.11 112.055 174.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.6 t 52.23 92.24 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.96 0 O-C-N 124.672 1.233 . . . . 51.3 111.956 -173.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 34.0 p-80 -58.71 131.61 51.41 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.652 -0.703 . . . . 72.42 111.325 -177.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.3 m -72.45 133.54 31.58 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-N 115.079 -0.964 . . . . 61.31 111.525 -176.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.414 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -83.03 157.08 23.05 Favored 'General case' 0 C--O 1.212 -0.888 0 CA-C-N 114.968 -1.015 . . . . 64.4 110.541 -178.923 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.2 p -60.17 -31.42 70.1 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.097 1.517 . . . . 72.14 115.097 -166.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.63 -47.11 67.47 Favored 'General case' 0 C--O 1.249 1.058 0 CA-C-O 121.747 0.784 . . . . 52.24 110.673 176.313 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -66.62 -40.23 88.68 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 113.686 -1.597 . . . . 74.22 110.436 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.588 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 57.2 t -59.93 -46.73 93.62 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 O-C-N 123.899 0.749 . . . . 72.11 109.654 170.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.516 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 0.3 OUTLIER -58.92 -54.4 47.52 Favored 'General case' 0 C--O 1.204 -1.327 0 CA-C-O 118.667 -0.683 . . . . 72.35 111.326 -175.784 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.488 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 5.7 m-80 -79.97 -49.78 11.36 Favored 'General case' 0 C--O 1.278 2.564 0 N-CA-C 114.523 1.305 . . . . 74.44 114.523 -177.579 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -68.69 -35.54 77.33 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 120.407 -0.517 . . . . 54.42 109.961 -173.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.588 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 59.0 m-85 -85.31 -18.22 34.52 Favored 'General case' 0 CA--C 1.556 1.195 0 N-CA-C 113.671 0.989 . . . . 73.41 113.671 172.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.516 ' HB3' ' O ' ' A' ' 25' ' ' GLU . 2.3 ppt_? -64.85 -25.36 67.87 Favored 'General case' 0 N--CA 1.503 2.191 0 CA-C-N 120.387 1.448 . . . . 72.01 110.768 167.267 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.76 -30.95 57.84 Favored 'General case' 0 CA--C 1.565 1.523 0 O-C-N 123.455 0.472 . . . . 64.25 111.879 168.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.507 ' CD1' ' HA ' ' A' ' 28' ' ' PHE . 1.0 OUTLIER -74.9 -17.57 60.55 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.493 0.717 . . . . 63.0 111.659 -175.448 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 140.84 57.73 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 119.358 -1.401 . . . . 72.01 113.399 174.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 55.28 98.0 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 125.573 1.549 . . . . 53.02 113.302 173.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.91 124.54 36.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.295 -1.32 . . . . 70.43 110.993 -177.179 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -90.01 -42.68 11.0 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 114.898 -1.047 . . . . 72.15 109.744 175.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -144.34 139.43 28.5 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.842 -0.617 . . . . 64.22 110.693 -177.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 8.5 p -129.57 123.24 30.86 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.133 -0.485 . . . . 71.14 110.009 172.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -130.33 128.14 40.87 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 116.497 -0.319 . . . . 73.33 110.21 177.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.9 t -109.81 116.99 53.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 120.945 0.402 . . . . 74.52 109.925 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt -108.25 157.55 18.24 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.095 -0.502 . . . . 64.12 110.741 -177.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.98 147.98 52.68 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 122.248 -0.282 . . . . 64.1 110.401 173.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.1 t -101.16 165.28 11.38 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.81 -0.441 . . . . 71.22 109.81 171.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.5 t -74.52 -15.23 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 123.787 0.835 . . . . 64.04 110.797 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.9 m -75.56 -9.8 58.89 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.952 -0.567 . . . . 74.03 111.929 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.43 -4.31 47.49 Favored Glycine 0 C--N 1.342 0.912 0 C-N-CA 121.534 -0.365 . . . . 61.34 113.7 175.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -89.53 141.58 28.45 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.1 0.476 . . . . 61.33 111.37 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -106.23 149.6 26.71 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.614 -0.721 . . . . 61.41 110.041 176.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.435 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 2.1 m-85 -136.68 151.29 49.11 Favored 'General case' 0 C--O 1.223 -0.303 0 N-CA-C 109.25 -0.648 . . . . 70.23 109.25 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -127.35 139.61 52.75 Favored 'General case' 0 C--O 1.248 0.976 0 N-CA-C 109.528 -0.545 . . . . 51.23 109.528 169.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -120.53 115.44 23.44 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 106.717 -1.586 . . . . 72.55 106.717 -176.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -133.67 112.26 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 N-CA-C 113.787 1.032 . . . . 74.05 113.787 -166.083 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -90.84 114.76 27.26 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.531 0.567 . . . . 70.4 112.531 -173.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -110.24 161.94 15.1 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 115.967 -0.56 . . . . 73.21 110.713 176.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -83.09 -30.12 28.23 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.237 0.458 . . . . 70.12 112.237 174.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.48 125.65 49.4 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.836 0.827 . . . . 42.3 112.409 -176.254 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.53 -45.73 24.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 113.893 -1.503 . . . . 71.42 113.492 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -23.43 53.63 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.005 0.743 . . . . 70.5 113.005 -168.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -73.61 -34.01 64.84 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.786 0.803 . . . . 74.34 109.887 176.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.01 -27.74 61.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.708 -1.133 . . . . 64.4 112.658 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.56 -33.44 63.87 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.246 1.202 . . . . 44.11 114.246 -175.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.521 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 17.4 m-20 -70.99 -37.67 72.71 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.564 0.697 . . . . 75.32 112.711 177.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.49 ' O ' ' HG3' ' A' ' 65' ' ' GLU . . . -75.74 -36.08 60.01 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.736 0.779 . . . . 60.02 111.097 177.495 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.851 HG13 HG13 ' A' ' 80' ' ' VAL . 0.4 OUTLIER -68.13 -31.83 53.42 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.231 0 CA-C-O 117.918 -1.039 . . . . 73.35 109.748 174.892 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.521 ' HG3' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -77.11 -20.68 55.34 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 120.201 1.364 . . . . 71.24 111.506 172.659 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -71.73 -27.47 63.02 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 119.438 -0.905 . . . . 64.45 111.394 170.565 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.42 13.9 19.03 Favored 'General case' 0 N--CA 1.511 2.622 0 N-CA-C 116.578 2.066 . . . . 61.24 116.578 167.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.466 ' HB3' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -73.3 158.21 35.55 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 124.663 1.185 . . . . 71.15 112.229 176.215 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.83 23.38 5.01 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 119.981 -1.104 . . . . 32.51 112.259 -159.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 15.8 p -57.22 134.52 56.0 Favored 'General case' 0 C--O 1.24 0.582 0 O-C-N 124.895 0.997 . . . . 53.15 113.125 -173.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.63 149.07 52.62 Favored 'General case' 0 C--O 1.257 1.462 0 CA-C-N 114.242 -1.345 . . . . 70.23 112.605 -170.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -143.81 145.61 32.48 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 112.504 -2.134 . . . . 70.33 110.778 -171.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 73.02 67.95 0.11 Allowed 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 122.569 1.176 . . . . 42.11 114.142 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.88 -11.2 57.5 Favored Glycine 0 C--N 1.333 0.414 0 CA-C-N 113.786 -1.552 . . . . 51.15 114.081 176.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -121.51 123.78 42.83 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.527 -1.286 . . . . 55.45 107.527 158.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.63 103.4 15.33 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 119.222 -0.418 . . . . 60.25 110.962 178.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 13.9 tp -165.41 70.93 0.15 Allowed 'General case' 0 C--O 1.206 -1.186 0 C-N-CA 119.937 -0.705 . . . . 54.33 112.261 177.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -96.76 111.4 23.58 Favored 'General case' 0 C--O 1.209 -1.075 0 O-C-N 119.834 -1.791 . . . . 74.25 109.701 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 t -129.17 119.64 49.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 107.492 -1.299 . . . . 74.34 107.492 170.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -148.16 141.95 25.69 Favored 'General case' 0 C--O 1.247 0.939 0 C-N-CA 119.81 -0.756 . . . . 53.21 111.289 176.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.851 HG13 HG13 ' A' ' 63' ' ' ILE . 19.1 m -89.9 121.95 68.38 Favored Pre-proline 0 N--CA 1.438 -1.035 0 CA-C-N 114.75 -1.114 . . . . 72.44 110.194 166.114 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.551 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 72.2 Cg_endo -88.21 21.58 0.99 Allowed 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 121.89 1.727 . . . . 63.22 112.503 164.028 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.455 ' HD2' ' N ' ' A' ' 9' ' ' ARG . 0.2 OUTLIER -116.71 13.1 15.09 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 113.13 0.789 . . . . 71.1 113.13 179.504 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.3 t30 . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 120.925 0.393 . . . . 61.53 111.137 -171.563 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.4 p . . . . . 0 CA--C 1.538 0.5 0 N-CA-C 112.328 0.492 . . . . 60.32 112.328 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.518 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 8.8 ptt180 -132.56 150.51 52.15 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.7 -0.682 . . . . 63.43 112.39 -171.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 34.2 mt -118.51 142.47 33.16 Favored 'Isoleucine or valine' 0 C--O 1.247 0.937 0 C-N-CA 122.963 0.505 . . . . 74.3 110.121 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -111.81 114.65 27.74 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 124.874 1.359 . . . . 73.32 109.466 175.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 2.7 p -123.27 108.04 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 CA-C-O 122.286 1.041 . . . . 61.11 111.799 175.25 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 77' ' ' ARG . . . -118.66 164.12 13.03 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 114.998 -1.001 . . . . 75.43 113.821 -176.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 58.15 24.74 11.66 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.873 1.269 . . . . 70.3 113.588 170.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -90.25 150.35 42.96 Favored Pre-proline 0 CA--C 1.552 1.023 0 N-CA-C 111.47 0.174 . . . . 55.23 111.47 -174.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 75' ' ' LYS . 57.3 Cg_endo -75.8 150.76 35.21 Favored 'Trans proline' 0 C--N 1.364 1.374 0 C-N-CA 122.771 2.314 . . . . 43.24 113.268 -178.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.7 p 79.88 -21.79 0.31 Allowed 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 127.334 2.254 . . . . 62.41 112.687 -177.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 66.18 107.37 0.04 OUTLIER 'General case' 0 C--N 1.357 0.918 0 C-N-CA 125.236 1.415 . . . . 72.23 110.415 -171.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.402 HG21 HG13 ' A' ' 24' ' ' VAL . 9.9 p -83.04 128.4 38.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 CA-C-N 115.217 -0.902 . . . . 62.54 109.023 175.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 m -91.1 167.95 11.99 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.298 -0.865 . . . . 55.25 109.759 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.4 p -57.28 -39.83 76.5 Favored 'General case' 0 C--O 1.218 -0.605 0 O-C-N 123.892 0.745 . . . . 73.53 112.778 -175.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.4 -39.38 90.5 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.125 0.97 . . . . 71.34 112.78 178.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -75.2 -46.98 30.47 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 116.138 -0.483 . . . . 75.41 111.323 -171.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.402 HG13 HG21 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -67.5 -32.96 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 115.967 -0.56 . . . . 43.31 110.969 173.285 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -58.96 -44.94 91.58 Favored 'General case' 0 C--O 1.206 -1.231 0 CA-C-O 118.639 -0.696 . . . . 74.31 110.811 172.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.448 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 2.0 t-20 -70.67 -48.92 52.34 Favored 'General case' 0 C--O 1.279 2.647 0 CA-C-O 121.631 0.729 . . . . 70.42 111.336 -177.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -61.7 -42.71 99.3 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-N 114.003 -1.453 . . . . 42.44 111.063 -176.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -82.55 -26.04 32.8 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 117.823 -1.084 . . . . 73.45 112.511 178.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 26' ' ' ASN . 46.8 ptt85 -69.92 -33.06 71.66 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 119.327 0.967 . . . . 71.22 111.374 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.07 -26.57 66.8 Favored 'General case' 0 C--N 1.362 1.13 0 C-N-CA 118.796 -1.162 . . . . 62.44 111.541 -177.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.536 ' CD2' ' HB2' ' A' ' 62' ' ' ALA . 69.2 m-85 -92.89 -39.73 11.0 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 111.622 0.23 . . . . 74.1 111.622 178.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -153.39 133.52 4.02 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 111.647 -0.581 . . . . 45.2 111.647 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -64.74 118.09 8.44 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 113.447 0.906 . . . . 72.2 113.447 -168.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.68 139.45 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 114.686 -1.143 . . . . 73.31 111.278 -174.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.3 mp -102.12 -43.72 5.66 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.085 -0.961 . . . . 71.22 111.509 -176.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.92 132.98 20.32 Favored 'General case' 0 C--O 1.213 -0.842 0 N-CA-C 108.951 -0.759 . . . . 73.03 108.951 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.9 t -137.73 119.64 15.34 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 109.73 -0.47 . . . . 71.43 109.73 175.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -130.82 147.66 52.5 Favored 'General case' 0 C--O 1.22 -0.479 0 C-N-CA 120.592 -0.443 . . . . 45.35 111.315 -177.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.2 p -117.12 124.56 73.16 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 CA-C-O 121.535 0.683 . . . . 73.22 111.428 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.92 163.7 12.9 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.565 -0.743 . . . . 70.44 110.071 -178.393 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.76 150.92 52.1 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 122.001 -0.437 . . . . 75.24 110.9 172.08 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 15.3 t -100.32 169.47 9.09 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 110.072 -0.344 . . . . 64.22 110.072 172.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.6 t -74.91 -18.13 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.132 0 C-N-CA 123.79 0.836 . . . . 64.43 111.089 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.6 t -75.79 -12.87 60.26 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 122.866 0.467 . . . . 60.34 111.846 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.46 -3.56 43.21 Favored Glycine 0 C--N 1.34 0.783 0 C-N-CA 121.347 -0.454 . . . . 71.44 113.92 175.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.0 144.63 26.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.976 0.417 . . . . 74.44 110.556 176.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.74 147.9 41.6 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.013 -0.539 . . . . 74.35 110.263 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 0.9 OUTLIER -136.77 147.28 46.57 Favored 'General case' 0 C--O 1.217 -0.63 0 N-CA-C 109.411 -0.588 . . . . 74.33 109.411 -175.004 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -121.84 140.39 52.44 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 121.385 0.612 . . . . 74.3 109.91 176.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -113.62 118.09 33.42 Favored 'General case' 0 C--O 1.257 1.479 0 CA-C-N 113.633 -1.621 . . . . 71.33 107.833 -176.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.518 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 4.2 mp -118.25 110.07 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 O-C-N 123.607 0.567 . . . . 43.55 110.781 -174.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -115.52 105.06 12.36 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 121.834 0.826 . . . . 31.22 111.214 -171.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -114.11 171.58 7.52 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.137 1.162 . . . . 63.33 114.137 -177.347 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -75.28 -43.54 50.62 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 114.713 -1.13 . . . . 71.1 111.554 171.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -117.25 121.92 42.53 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 122.331 1.062 . . . . 74.43 112.078 -175.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.501 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -78.45 -43.53 26.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 112.883 -1.962 . . . . 61.53 113.99 -175.513 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -74.27 -25.86 59.86 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.39 0.885 . . . . 74.34 113.39 -169.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.488 ' HB3' ' O ' ' A' ' 31' ' ' TYR . 1.3 m-20 -80.75 -44.95 17.81 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.971 0.36 . . . . 53.13 111.971 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.48 -24.05 64.64 Favored 'General case' 0 C--O 1.251 1.147 0 C-N-CA 124.221 1.008 . . . . 32.0 111.747 176.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -53.3 -23.36 8.93 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.441 -1.254 . . . . 51.45 114.128 172.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.457 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -63.51 -47.05 83.29 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 118.823 0.738 . . . . 54.32 111.674 171.194 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.536 ' HB2' ' CD2' ' A' ' 31' ' ' TYR . . . -65.24 -39.92 93.33 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.938 -0.574 . . . . 61.42 110.24 174.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -66.81 -31.28 52.8 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 C-N-CA 120.28 -0.568 . . . . 13.43 111.381 177.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -80.21 -23.35 40.99 Favored 'General case' 0 C--N 1.351 0.631 0 N-CA-C 112.881 0.697 . . . . 73.54 112.881 176.875 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.495 ' HG2' ' HA ' ' A' ' 62' ' ' ALA . 10.2 pt-20 -81.52 -19.55 41.94 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 118.987 -1.085 . . . . 72.21 111.454 171.249 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 62' ' ' ALA . 68.9 mmtt -92.36 -6.07 50.89 Favored 'General case' 0 CA--C 1.57 1.731 0 CA-C-N 118.451 0.569 . . . . 64.41 111.474 169.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.43 ' HB2' ' HA ' ' A' ' 64' ' ' LYS . 38.3 t70 -64.77 153.33 40.21 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 126.321 1.848 . . . . 71.21 112.746 178.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.71 23.82 4.88 Favored Glycine 0 C--N 1.343 0.942 0 C-N-CA 119.94 -1.124 . . . . 74.22 113.626 -163.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 24.5 p -58.7 133.1 55.63 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-O 122.196 0.998 . . . . 65.24 113.214 -169.098 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.37 149.13 49.61 Favored 'General case' 0 C--O 1.261 1.69 0 CA-C-N 114.09 -1.413 . . . . 51.32 112.907 -170.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -143.52 145.53 32.63 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 126.112 1.765 . . . . 75.34 111.224 -174.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 73.38 68.61 0.11 Allowed 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 114.554 1.316 . . . . 75.54 114.554 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.66 -10.99 59.37 Favored Glycine 0 N--CA 1.462 0.388 0 CA-C-N 114.188 -1.369 . . . . 73.21 113.778 175.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -120.51 122.6 40.98 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 107.065 -1.458 . . . . 64.51 107.065 155.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.47 ' O ' ' HD3' ' A' ' 16' ' ' PRO . 0.3 OUTLIER -95.08 102.39 14.2 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 117.961 -1.019 . . . . 74.32 110.286 178.573 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.54 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.3 OUTLIER -168.51 67.78 0.07 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 113.599 0.963 . . . . 71.24 113.599 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.403 ' HB3' ' O ' ' A' ' 13' ' ' GLY . 23.8 tpt180 -95.85 111.1 23.16 Favored 'General case' 0 C--O 1.2 -1.529 0 CA-C-N 120.829 1.649 . . . . 73.32 110.157 -176.012 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.451 ' H ' ' HB3' ' A' ' 69' ' ' CYS . 2.7 t -130.1 118.12 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 108.317 -0.994 . . . . 61.42 108.317 175.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -149.84 147.26 27.75 Favored 'General case' 0 C--O 1.255 1.345 0 C-N-CA 119.825 -0.75 . . . . 64.13 112.264 176.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.9 m -88.74 124.7 64.99 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 114.791 -1.095 . . . . 45.31 111.373 168.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.49 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 61.5 Cg_endo -87.08 12.03 3.08 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.132 1.888 . . . . 71.11 113.958 167.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.501 ' CE1' ' HB1' ' A' ' 56' ' ' ALA . 10.7 p90 -102.26 -25.79 13.55 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.847 0.684 . . . . 71.44 112.847 177.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.7 m120 . . . . . 0 N--CA 1.488 1.472 0 C-N-CA 124.255 1.022 . . . . 73.42 113.198 -176.366 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 CA--C 1.538 0.493 0 CA-C-O 120.681 0.276 . . . . 71.2 110.814 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 24.2 ptt180 -143.68 152.57 41.49 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-N 115.837 -0.62 . . . . 60.43 111.851 -176.002 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 52.9 mt -116.98 135.46 57.28 Favored 'Isoleucine or valine' 0 C--O 1.256 1.421 0 C-N-CA 122.924 0.489 . . . . 74.35 109.849 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -103.0 115.13 30.02 Favored 'General case' 0 C--N 1.362 1.142 0 O-C-N 125.644 1.84 . . . . 75.2 109.412 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.9 t -115.77 132.81 64.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 107.657 -1.238 . . . . 72.33 107.657 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -140.89 160.3 26.64 Favored Glycine 0 CA--C 1.519 0.301 0 N-CA-C 111.775 -0.53 . . . . 53.2 111.775 173.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 61.02 27.54 17.4 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.79 0.836 . . . . 71.41 112.105 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.29 125.77 73.53 Favored Pre-proline 0 C--O 1.237 0.413 0 N-CA-C 111.7 0.259 . . . . 63.04 111.7 -174.137 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.35 150.68 37.05 Favored 'Trans proline' 0 C--N 1.36 1.164 0 C-N-CA 121.794 1.662 . . . . 73.22 110.8 165.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.8 m -22.16 -83.13 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 125.629 1.83 . . . . 73.32 115.788 -163.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.2 t60 52.33 -91.86 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 124.996 1.319 . . . . 72.24 112.01 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.7 m -100.15 120.92 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-O 121.053 0.454 . . . . 71.33 110.775 176.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.498 ' O ' HG23 ' A' ' 24' ' ' VAL . 47.2 m -88.39 177.53 6.8 Favored 'General case' 0 C--O 1.193 -1.887 0 CA-C-O 117.575 -1.202 . . . . 75.22 107.844 170.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.7 m -49.67 -49.97 45.31 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 120.344 1.429 . . . . 72.14 114.391 -169.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -39.35 94.24 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.092 0.957 . . . . 62.35 111.697 177.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.83 -32.51 57.63 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 115.262 -0.881 . . . . 74.21 111.488 -177.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 20' ' ' SER . 47.8 t -62.82 -47.32 93.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 108.228 -1.027 . . . . 71.45 108.228 170.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.13 -51.19 67.24 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 124.422 1.076 . . . . 75.53 111.862 177.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -73.89 -43.85 57.19 Favored 'General case' 0 C--O 1.276 2.46 0 N-CA-C 112.564 0.579 . . . . 72.24 112.564 -174.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -57.78 -46.72 84.19 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 115.177 -0.919 . . . . 64.02 110.132 177.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -78.35 -25.4 46.34 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 117.956 -1.021 . . . . 71.15 112.29 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -72.42 -28.98 63.3 Favored 'General case' 0 C--N 1.358 0.971 0 CA-C-N 118.971 0.805 . . . . 74.24 112.468 -179.654 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.66 -31.16 70.95 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 118.612 -1.235 . . . . 74.45 111.445 176.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.524 ' CD2' ' HB2' ' A' ' 62' ' ' ALA . 99.2 m-85 -87.94 -37.17 16.64 Favored 'General case' 0 C--O 1.219 -0.534 0 C-N-CA 121.193 -0.203 . . . . 62.32 111.174 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 29' ' ' ARG . . . -152.29 147.3 16.85 Favored Glycine 0 C--O 1.223 -0.589 0 N-CA-C 111.759 -0.536 . . . . 73.2 111.759 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -74.49 105.12 5.47 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 117.694 0.747 . . . . 75.22 112.937 -172.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.405 HG22 ' H ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -77.06 130.94 35.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 114.909 -1.041 . . . . 74.02 111.531 -175.537 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 56.2 mt -93.73 -47.9 6.56 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 114.418 -1.264 . . . . 74.14 111.083 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.447 ' HG3' ' HB3' ' A' ' 52' ' ' GLU . 0.1 OUTLIER -144.07 144.09 31.46 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.234 0.54 . . . . 73.41 109.996 173.811 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.6 t -132.15 120.47 22.32 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.058 -0.719 . . . . 73.13 109.058 178.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -129.45 125.95 37.64 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 120.454 -0.498 . . . . 75.35 111.384 -174.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 75.9 t -107.94 121.29 60.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 122.642 0.377 . . . . 74.12 110.121 -177.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -108.69 157.49 18.49 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 116.297 -0.41 . . . . 73.12 110.713 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.22 147.59 52.61 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.416 0.15 . . . . 61.05 110.908 172.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.3 t -101.1 167.06 10.47 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 110.014 -0.365 . . . . 55.41 110.014 173.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.9 m -75.43 -11.02 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 123.81 0.844 . . . . 72.52 112.411 177.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -80.25 -11.65 59.7 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 122.629 0.372 . . . . 71.25 111.222 176.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.43 -2.04 46.42 Favored Glycine 0 C--N 1.34 0.786 0 C-N-CA 121.426 -0.416 . . . . 72.31 113.886 176.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.39 143.24 27.12 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.211 0.529 . . . . 74.31 111.596 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -105.56 150.28 25.51 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.157 -0.929 . . . . 65.14 110.673 178.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -134.5 150.1 50.76 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 108.767 -0.827 . . . . 73.12 108.767 -177.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -129.31 137.14 50.84 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.143 0.497 . . . . 72.14 110.631 174.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.94 120.05 37.24 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 108.576 -0.898 . . . . 72.31 108.576 175.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 3.2 mp -120.32 111.56 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 119.158 -1.017 . . . . 71.43 111.114 -174.429 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.447 ' HB3' ' HG3' ' A' ' 36' ' ' LYS . 32.0 tt0 -113.45 108.0 16.61 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-O 120.813 0.339 . . . . 70.34 111.71 -172.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.28 170.51 8.24 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.269 -0.878 . . . . 55.45 111.954 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -78.85 -31.49 45.68 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 112.825 0.676 . . . . 73.15 112.825 175.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -120.35 125.01 46.95 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 122.241 1.019 . . . . 73.42 112.607 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.9 -46.01 25.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 113.99 -1.459 . . . . 71.51 113.931 -175.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.402 ' H ' ' HG2' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -76.18 -25.1 54.86 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.641 0.978 . . . . 65.22 113.641 -165.992 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.518 ' HB3' ' O ' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -80.0 -35.52 37.29 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.627 0.727 . . . . 74.14 111.707 177.52 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.33 -18.61 59.97 Favored 'General case' 0 C--O 1.257 1.49 0 C-N-CA 124.577 1.151 . . . . 73.02 112.767 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -53.15 -26.42 16.86 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 114.626 -1.17 . . . . 74.33 113.134 170.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.413 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -69.32 -34.69 75.04 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.208 0.603 . . . . 74.24 111.697 172.977 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.617 ' O ' ' HD2' ' A' ' 66' ' ' LYS . . . -66.57 -48.75 68.63 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 110.425 -0.213 . . . . 70.02 110.425 171.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.46 -30.78 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 C-N-CA 120.296 -0.561 . . . . 64.14 111.002 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.546 ' HA ' ' HB2' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -79.18 -21.04 46.95 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 118.916 0.78 . . . . 74.43 112.777 171.865 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.88 -37.26 76.0 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 118.885 0.766 . . . . 73.41 110.581 171.307 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.617 ' HD2' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -100.13 12.67 36.42 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 118.284 -1.367 . . . . 63.41 114.28 174.488 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.546 ' HB2' ' HA ' ' A' ' 64' ' ' LYS . 21.0 t70 -51.54 152.83 2.51 Favored 'General case' 0 N--CA 1.506 2.368 0 C-N-CA 126.998 2.119 . . . . 61.24 114.442 170.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.3 25.35 3.82 Favored Glycine 0 C--N 1.35 1.332 0 C-N-CA 119.554 -1.308 . . . . 63.35 113.948 -165.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.611 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 8.6 p -58.48 133.49 55.84 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 122.393 1.092 . . . . 74.4 113.147 -173.281 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.94 144.46 47.46 Favored 'General case' 0 C--O 1.256 1.404 0 CA-C-N 113.771 -1.559 . . . . 73.23 113.48 -171.084 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -143.56 147.66 34.76 Favored 'General case' 0 CA--C 1.553 1.089 0 O-C-N 125.834 1.959 . . . . 71.51 110.83 -172.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 74.14 66.07 0.09 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 122.484 1.135 . . . . 70.42 113.463 174.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.74 -10.25 62.45 Favored Glycine 0 N--CA 1.461 0.304 0 CA-C-N 114.263 -1.335 . . . . 71.43 113.302 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -119.64 122.51 41.68 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.063 -1.458 . . . . 73.31 107.063 161.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.59 102.16 13.93 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 118.446 -0.788 . . . . 74.41 110.676 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.611 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -165.49 60.18 0.11 Allowed 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 113.304 0.853 . . . . 73.14 113.304 179.911 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.4 tpp85 -93.67 117.21 29.8 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 120.585 -1.322 . . . . 64.45 111.031 -171.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.509 HG21 ' O ' ' A' ' 66' ' ' LYS . 2.2 m -128.59 120.96 53.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.902 -1.045 . . . . 73.12 109.346 174.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -148.93 145.4 27.39 Favored 'General case' 0 C--O 1.255 1.351 0 CA-C-O 121.97 0.89 . . . . 61.03 112.503 -178.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.1 m -89.47 123.48 66.68 Favored Pre-proline 0 CA--C 1.546 0.792 0 CA-C-N 115.012 -0.995 . . . . 73.34 110.042 167.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.438 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 66.9 Cg_endo -88.79 4.3 5.47 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.162 1.908 . . . . 72.34 113.335 166.085 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -95.01 -32.29 13.21 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 119.062 -0.494 . . . . 61.03 111.983 176.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.8 t30 . . . . . 0 N--CA 1.486 1.342 0 O-C-N 124.564 1.165 . . . . 73.33 111.118 -174.242 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.535 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . 80.3 p . . . . . 0 CA--C 1.546 0.817 0 N-CA-C 111.257 0.095 . . . . 74.31 111.257 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.469 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 0.9 OUTLIER -126.22 149.98 48.68 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 111.952 0.353 . . . . 71.23 111.952 -177.183 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.0 mp -131.96 134.74 59.57 Favored 'Isoleucine or valine' 0 C--O 1.247 0.927 0 C-N-CA 123.882 0.873 . . . . 70.42 109.208 -178.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -115.82 115.21 25.87 Favored 'General case' 0 C--O 1.242 0.676 0 O-C-N 124.029 0.831 . . . . 65.32 109.613 177.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.447 HG23 HG22 ' A' ' 78' ' ' VAL . 3.4 p -119.74 111.43 32.8 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.819 0 CA-C-O 121.431 0.634 . . . . 75.23 110.867 172.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -123.52 158.79 18.16 Favored Glycine 0 CA--C 1.52 0.372 0 CA-C-N 116.077 -0.511 . . . . 21.54 113.522 -175.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.7 m120 62.25 26.63 15.96 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.235 1.014 . . . . 62.14 111.648 175.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.618 HD23 ' H ' ' A' ' 15' ' ' LEU . 1.5 pt? -82.57 125.11 76.84 Favored Pre-proline 0 CA--C 1.543 0.708 0 CA-C-O 120.878 0.37 . . . . 70.1 111.848 -170.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -86.45 125.99 2.59 Favored 'Trans proline' 0 C--N 1.363 1.326 0 C-N-CA 121.829 1.686 . . . . 73.11 113.081 175.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.8 m 26.01 62.82 0.07 Allowed 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 126.417 1.887 . . . . 42.2 114.887 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.475 ' HB3' HD12 ' A' ' 15' ' ' LEU . 0.5 OUTLIER -110.4 -134.31 0.35 Allowed 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.611 -0.722 . . . . 74.54 109.091 -171.493 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.2 m -69.76 126.04 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 111.993 0.368 . . . . 75.44 111.993 174.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.9 m -83.84 173.47 11.23 Favored 'General case' 0 C--O 1.211 -0.938 0 N-CA-C 108.403 -0.962 . . . . 43.33 108.403 173.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.6 t -60.15 -37.39 79.98 Favored 'General case' 0 CA--C 1.557 1.219 0 CA-C-N 118.969 0.804 . . . . 64.21 112.905 -174.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -66.61 -44.96 80.67 Favored 'General case' 0 C--O 1.251 1.172 0 C-N-CA 123.066 0.547 . . . . 73.31 110.808 176.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -68.4 -34.37 75.9 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.096 -0.956 . . . . 72.23 110.679 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.659 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 74.3 t -60.45 -51.72 69.79 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.588 0 N-CA-C 108.969 -0.752 . . . . 72.04 108.969 171.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.409 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 25.2 tt0 -57.01 -53.82 53.76 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 118.873 -0.584 . . . . 71.04 111.61 -177.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -76.4 -52.04 10.66 Favored 'General case' 0 C--O 1.26 1.629 0 CA-C-N 118.63 0.65 . . . . 74.23 112.113 -172.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.84 -39.0 66.92 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 120.685 -0.406 . . . . 73.01 110.057 -172.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.659 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 4.4 m-85 -77.57 -23.02 50.08 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 118.094 -0.955 . . . . 73.54 111.5 177.193 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 10.1 ptt180 -72.29 -25.9 61.76 Favored 'General case' 0 C--N 1.374 1.632 0 CA-C-N 120.065 1.302 . . . . 73.04 110.876 170.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.69 -25.86 65.89 Favored 'General case' 0 CA--C 1.561 1.388 0 C-N-CA 120.105 -0.638 . . . . 64.21 111.337 175.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.479 ' CG ' ' HB2' ' A' ' 62' ' ' ALA . 98.4 m-85 -89.32 -35.21 16.24 Favored 'General case' 0 C--O 1.216 -0.676 0 N-CA-C 111.974 0.361 . . . . 65.35 111.974 174.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 29' ' ' ARG . . . -156.9 137.94 5.67 Favored Glycine 0 C--O 1.228 -0.236 0 C-N-CA 120.884 -0.674 . . . . 64.33 111.668 177.141 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -62.06 114.73 3.57 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.142 0.577 . . . . 71.3 112.133 -175.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.61 124.76 39.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.948 0.88 . . . . 74.5 112.119 -173.367 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.5 mp -97.62 -36.84 10.15 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.208 -1.36 . . . . 74.34 110.327 175.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -145.43 131.25 19.07 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 120.694 0.283 . . . . 51.4 111.069 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -122.09 121.28 36.59 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 110.043 -0.355 . . . . 52.43 110.043 175.014 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -131.03 125.63 33.77 Favored 'General case' 0 C--O 1.219 -0.535 0 C-N-CA 120.432 -0.507 . . . . 74.12 110.277 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.01 119.31 61.06 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 CA-C-O 121.955 0.883 . . . . 72.24 110.837 176.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -117.46 157.69 25.8 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.256 -0.883 . . . . 73.54 110.348 -177.07 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.39 151.22 51.12 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 122.088 -0.382 . . . . 71.25 110.537 173.335 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.9 t -101.34 164.53 11.73 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 110.119 -0.326 . . . . 74.34 110.119 172.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.6 m -75.63 -10.28 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.78 0.832 . . . . 71.31 112.511 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -78.65 -9.29 59.33 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 122.682 0.393 . . . . 65.11 110.879 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.66 -5.01 43.27 Favored Glycine 0 C--N 1.344 0.999 0 C-N-CA 121.179 -0.534 . . . . 70.31 113.827 176.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -89.38 143.0 27.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.972 0.415 . . . . 71.2 111.444 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -107.71 149.86 27.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.648 -0.705 . . . . 72.22 109.635 175.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -137.49 150.13 47.33 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.426 -0.583 . . . . 73.52 109.426 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -127.6 138.61 52.91 Favored 'General case' 0 C--O 1.253 1.271 0 CA-C-O 121.718 0.771 . . . . 70.13 109.344 170.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -116.47 120.61 39.33 Favored 'General case' 0 C--O 1.252 1.216 0 CA-C-N 113.688 -1.596 . . . . 73.4 107.509 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.87 126.84 73.25 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.67 0 CA-C-N 115.611 -0.722 . . . . 71.44 111.111 -170.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -115.51 114.73 25.39 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 122.331 -0.23 . . . . 75.33 111.539 -178.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -109.47 169.22 8.84 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.351 0.26 . . . . 73.03 110.884 176.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -81.59 -31.18 32.65 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.22 0.452 . . . . 74.42 112.22 169.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -119.29 125.49 49.21 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-O 122.107 0.956 . . . . 50.21 112.816 -172.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.39 -44.99 18.45 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 115.644 1.72 . . . . 65.5 115.644 -177.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.76 -24.76 56.08 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 113.457 0.91 . . . . 73.14 113.457 -167.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.73 -27.43 40.61 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 121.494 0.664 . . . . 73.43 111.272 175.119 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.84 -25.06 61.82 Favored 'General case' 0 C--O 1.249 1.036 0 C-N-CA 124.265 1.026 . . . . 64.51 112.065 174.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.527 ' HA ' HG22 ' A' ' 63' ' ' ILE . . . -57.64 -27.85 63.19 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.048 -0.978 . . . . 75.32 112.859 177.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -67.83 -41.74 82.54 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 122.751 0.421 . . . . 72.22 111.149 174.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.479 ' HB2' ' CG ' ' A' ' 31' ' ' TYR . . . -64.05 -44.95 90.91 Favored 'General case' 0 C--O 1.237 0.417 0 O-C-N 123.55 0.531 . . . . 72.42 111.213 175.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.778 HG13 HG13 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -70.15 -29.93 41.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 119.936 -0.706 . . . . 63.21 110.999 179.145 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.02 -26.44 53.78 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.674 1.125 . . . . 74.12 112.331 176.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -85.98 -18.0 33.77 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 118.621 -1.232 . . . . 75.31 112.524 173.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt -100.14 8.18 44.06 Favored 'General case' 0 CA--C 1.558 1.259 0 O-C-N 121.794 -0.566 . . . . 74.24 111.3 172.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -60.37 152.25 25.83 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 126.596 1.958 . . . . 73.23 111.228 173.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.81 25.07 3.76 Favored Glycine 0 C--N 1.349 1.277 0 C-N-CA 120.166 -1.016 . . . . 73.13 113.715 -160.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.614 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 12.8 t -59.13 132.65 54.66 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.644 0.735 . . . . 63.03 111.439 178.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -135.63 134.7 39.54 Favored 'General case' 0 C--O 1.252 1.214 0 CA-C-N 114.134 -1.394 . . . . 70.1 112.993 -172.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -142.93 148.03 36.25 Favored 'General case' 0 CA--C 1.548 0.886 0 O-C-N 125.658 1.849 . . . . 75.15 109.574 -175.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 75.66 65.86 0.06 Allowed 'General case' 0 N--CA 1.5 2.041 0 CA-C-O 122.828 1.299 . . . . 54.55 114.206 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.02 -10.98 62.2 Favored Glycine 0 C--O 1.227 -0.325 0 CA-C-N 113.579 -1.646 . . . . 41.51 114.174 172.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -121.68 123.99 43.19 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.274 -1.38 . . . . 70.31 107.274 162.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.94 104.77 16.81 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 118.483 -0.77 . . . . 73.22 111.41 -177.01 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.614 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.4 OUTLIER -166.73 64.31 0.09 Allowed 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 113.394 0.887 . . . . 62.42 113.394 178.48 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.48 ' HD3' ' SG ' ' A' ' 69' ' ' CYS . 0.0 OUTLIER -93.37 115.61 28.17 Favored 'General case' 0 C--O 1.212 -0.907 0 O-C-N 120.909 -1.12 . . . . 71.34 110.324 -173.94 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.447 HG22 HG23 ' A' ' 12' ' ' VAL . 5.5 t -128.25 117.85 46.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 107.757 -1.201 . . . . 62.23 107.757 168.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -151.73 140.97 21.38 Favored 'General case' 0 C--O 1.244 0.775 0 C-N-CA 119.833 -0.747 . . . . 65.01 112.309 -177.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.778 HG13 HG13 ' A' ' 63' ' ' ILE . 15.3 m -91.74 125.46 57.31 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 115.918 -0.583 . . . . 63.41 111.879 168.356 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.469 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 60.3 Cg_endo -84.59 13.5 2.73 Favored 'Trans proline' 0 CA--C 1.547 1.125 0 C-N-CA 122.363 2.042 . . . . 71.24 113.806 165.465 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.535 ' CD2' ' HB2' ' A' ' 8' ' ' SER . 1.8 p90 -101.66 -20.45 15.0 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.422 0.555 . . . . 74.33 112.191 176.317 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 . . . . . 0 N--CA 1.494 1.729 0 C-N-CA 125.022 1.329 . . . . 61.41 112.661 -170.09 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.547 0.858 0 N-CA-C 112.704 0.631 . . . . 73.52 112.704 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.46 ' HD2' ' CE2' ' A' ' 50' ' ' PHE . 0.6 OUTLIER -136.27 159.7 40.94 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 122.825 0.45 . . . . 63.41 111.21 -173.344 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.1 mt -117.38 142.88 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.118 0.967 . . . . 71.22 108.531 -178.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -112.26 111.18 21.88 Favored 'General case' 0 C--N 1.349 0.58 0 N-CA-C 109.786 -0.449 . . . . 74.24 109.786 -177.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.685 HG12 HG13 ' A' ' 78' ' ' VAL . 26.2 m -123.95 108.08 20.0 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-O 121.946 0.879 . . . . 62.42 111.29 175.053 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -133.69 168.94 23.01 Favored Glycine 0 CA--C 1.518 0.261 0 N-CA-C 114.873 0.709 . . . . 64.1 114.873 -176.039 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.8 m120 58.36 21.43 8.32 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.838 1.255 . . . . 53.42 112.071 176.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.444 HD23 ' H ' ' A' ' 15' ' ' LEU . 1.2 pt? -90.88 149.78 40.86 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 112.338 0.495 . . . . 71.53 112.338 -167.116 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 75' ' ' LYS . 24.5 Cg_endo -65.02 137.57 53.2 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 123.144 2.563 . . . . 71.33 112.868 176.223 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.1 p 73.77 -41.73 0.5 Allowed 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 126.61 1.964 . . . . 65.44 111.692 -173.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 68.41 117.34 0.03 OUTLIER 'General case' 0 C--N 1.365 1.25 0 C-N-CA 125.7 1.6 . . . . 70.45 111.052 -177.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.8 m -69.71 128.84 33.69 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 CA-C-N 114.646 -1.161 . . . . 64.21 110.564 177.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.1 m -83.15 169.14 16.14 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 114.364 -1.289 . . . . 72.32 108.787 176.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.2 m -57.17 -41.87 80.08 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.654 0.612 . . . . 71.52 112.654 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -64.83 -47.68 77.1 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.154 0.581 . . . . 74.34 111.321 178.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -67.77 -44.28 77.82 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 114.646 -1.161 . . . . 75.22 111.037 -174.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.562 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 9.0 p -70.46 -34.93 59.77 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 CA-C-O 118.99 -0.529 . . . . 43.02 110.036 177.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -61.06 -52.7 63.85 Favored 'General case' 0 C--O 1.212 -0.888 0 CA-C-O 118.745 -0.645 . . . . 54.13 110.524 178.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -73.0 -51.11 19.48 Favored 'General case' 0 C--O 1.27 2.158 0 CA-C-N 118.12 0.418 . . . . 64.42 111.622 -174.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -69.22 -44.01 72.93 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 115.467 -0.788 . . . . 72.12 110.457 -173.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.562 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 0.7 OUTLIER -76.85 -25.13 52.81 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 118.676 -0.678 . . . . 75.15 111.534 179.32 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.7 ptt85 -72.44 -22.99 61.01 Favored 'General case' 0 C--N 1.365 1.257 0 CA-C-N 119.429 1.013 . . . . 75.33 111.834 174.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -29.71 70.45 Favored 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 119.543 -0.863 . . . . 72.32 111.421 170.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -88.77 -37.23 15.61 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.563 0.579 . . . . 71.22 112.563 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -154.74 171.83 33.13 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.501 -0.857 . . . . 73.15 112.587 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -82.0 113.09 19.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.571 0.701 . . . . 65.51 111.998 -175.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.86 126.4 43.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 114.803 -1.089 . . . . 71.41 110.586 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 26.2 mt -94.86 -43.11 8.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.488 -1.233 . . . . 70.0 109.568 178.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.05 153.33 33.77 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.491 0.316 . . . . 70.15 110.479 170.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 13.4 p -126.92 124.76 40.26 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.785 -0.45 . . . . 63.2 109.785 173.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -129.68 125.94 37.17 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-N 115.974 -0.557 . . . . 71.43 111.093 -176.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 72.1 t -112.08 123.02 67.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-O 121.041 0.448 . . . . 62.21 111.176 -174.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.13 161.32 22.0 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.069 -0.514 . . . . 71.3 110.869 -174.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.5 152.02 51.85 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 122.457 -0.152 . . . . 73.22 111.004 172.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.4 t -100.62 169.39 9.08 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 109.973 -0.38 . . . . 71.42 109.973 169.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.3 t -75.3 -15.45 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 C-N-CA 123.715 0.806 . . . . 73.3 111.259 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.3 m -75.88 -7.56 54.8 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.107 0.563 . . . . 44.05 112.175 -179.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.76 -4.74 53.53 Favored Glycine 0 C--N 1.341 0.844 0 C-N-CA 121.345 -0.455 . . . . 62.12 113.308 176.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.75 138.38 31.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.832 0.348 . . . . 75.01 110.791 178.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.44 147.93 38.54 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.741 -0.663 . . . . 62.13 110.546 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -136.22 165.91 24.64 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.187 0.517 . . . . 73.13 109.96 -171.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -141.35 139.72 33.6 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-N 115.328 -0.851 . . . . 61.23 109.96 171.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.46 ' CE2' ' HD2' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -114.43 118.69 34.52 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 113.996 -1.456 . . . . 71.34 107.263 -179.655 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.76 112.77 36.44 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.531 0 C-N-CA 119.556 -0.858 . . . . 73.33 111.151 -171.104 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -88.58 106.98 18.66 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-N 116.545 -0.298 . . . . 74.54 110.233 -170.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -114.27 143.46 44.82 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.58 -0.736 . . . . 74.33 112.021 -174.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -83.06 -28.38 29.61 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 120.558 -0.457 . . . . 72.12 111.83 172.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.61 126.68 49.66 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.864 0.84 . . . . 62.33 112.402 -178.571 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.41 -45.4 17.73 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 114.19 1.181 . . . . 73.04 114.19 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -75.31 -25.17 57.64 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.963 0.727 . . . . 73.21 112.963 -167.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -80.13 -34.73 37.55 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.505 0.669 . . . . 71.14 109.841 175.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.67 -24.09 65.38 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.785 1.234 . . . . 33.23 112.511 172.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.44 ' HA ' HG22 ' A' ' 63' ' ' ILE . . . -58.01 -25.0 60.53 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 114.572 1.323 . . . . 32.05 114.572 -174.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.21 -44.93 78.35 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 118.881 0.764 . . . . 51.1 111.483 173.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.36 -43.38 98.96 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 115.79 -0.641 . . . . 71.43 110.822 173.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.646 HG13 HG13 ' A' ' 80' ' ' VAL . 0.4 OUTLIER -68.21 -32.3 55.26 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.003 0 CA-C-O 118.852 -0.594 . . . . 72.34 111.359 -179.38 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.62 -26.24 41.21 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.384 0.993 . . . . 75.02 112.341 177.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -81.81 -20.68 38.57 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 119.486 -0.886 . . . . 73.53 111.458 175.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.674 ' HB2' HG11 ' A' ' 78' ' ' VAL . 69.5 mmtt -99.39 0.01 41.87 Favored 'General case' 0 CA--C 1.569 1.706 0 C-N-CA 120.189 -0.605 . . . . 73.11 111.335 172.525 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 35.0 t70 -70.42 154.83 41.47 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 125.695 1.598 . . . . 64.52 111.425 177.192 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.53 25.11 4.44 Favored Glycine 0 C--N 1.346 1.133 0 C-N-CA 119.637 -1.268 . . . . 61.33 112.058 -159.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.701 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 8.2 t -57.22 131.56 50.36 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 124.496 0.762 . . . . 74.51 111.837 -171.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.63 146.74 46.36 Favored 'General case' 0 C--O 1.252 1.22 0 CA-C-N 114.23 -1.35 . . . . 72.42 113.404 -170.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -143.58 147.8 34.95 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 126.116 1.766 . . . . 74.24 109.807 -173.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 76.3 66.71 0.06 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 122.686 1.232 . . . . 62.4 113.381 173.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.05 -11.71 63.96 Favored Glycine 0 C--N 1.337 0.638 0 CA-C-N 113.729 -1.578 . . . . 70.02 113.313 177.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -119.2 122.09 41.2 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 106.841 -1.54 . . . . 64.41 106.841 163.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.422 ' O ' ' HD3' ' A' ' 16' ' ' PRO . 0.5 OUTLIER -94.78 105.16 17.08 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 117.954 -1.022 . . . . 73.15 111.075 178.531 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.701 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -165.65 64.7 0.11 Allowed 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 115.283 1.586 . . . . 74.42 115.283 179.319 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.518 ' HA ' ' SG ' ' A' ' 69' ' ' CYS . 0.1 OUTLIER -95.34 113.64 25.33 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 121.8 2.091 . . . . 63.54 111.555 -176.199 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.685 HG13 HG12 ' A' ' 12' ' ' VAL . 95.3 t -131.52 120.76 46.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 121.22 -0.925 . . . . 74.23 109.474 174.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.498 ' HA ' HD11 ' A' ' 63' ' ' ILE . 0.5 OUTLIER -149.14 141.99 24.67 Favored 'General case' 0 C--O 1.258 1.525 0 N-CA-C 113.66 0.985 . . . . 74.01 113.66 173.444 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.646 HG13 HG13 ' A' ' 63' ' ' ILE . 2.3 m -89.76 126.95 56.06 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-N 114.033 -1.44 . . . . 72.35 109.645 159.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -84.24 16.96 1.81 Allowed 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.658 2.238 . . . . 72.2 112.44 170.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -86.33 -30.02 22.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.042 -0.981 . . . . 75.3 110.544 177.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 . . . . . 0 N--CA 1.482 1.142 0 O-C-N 124.824 1.328 . . . . 74.11 110.768 -173.281 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.3 p . . . . . 0 CA--C 1.53 0.194 0 N-CA-C 112.029 0.381 . . . . 73.25 112.029 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -138.01 158.43 44.35 Favored 'General case' 0 C--O 1.211 -0.948 0 CA-C-N 115.911 -0.586 . . . . 73.41 111.956 -175.903 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.6 mt -117.9 141.66 35.9 Favored 'Isoleucine or valine' 0 C--O 1.254 1.335 0 N-CA-C 109.842 -0.429 . . . . 64.01 109.842 174.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -108.25 119.41 39.41 Favored 'General case' 0 C--O 1.246 0.875 0 O-C-N 124.653 1.221 . . . . 74.34 109.148 178.029 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.5 ' HB ' HG13 ' A' ' 78' ' ' VAL . 3.6 p -123.14 110.39 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-O 121.918 0.866 . . . . 75.34 111.328 174.181 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -115.36 166.57 12.22 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-N 115.072 -0.967 . . . . 55.14 113.126 177.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 55.76 30.25 15.35 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.427 1.091 . . . . 74.32 113.083 175.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.494 HD23 ' H ' ' A' ' 15' ' ' LEU . 2.3 pt? -89.16 140.44 28.85 Favored Pre-proline 0 C--O 1.237 0.42 0 CA-C-N 116.341 -0.39 . . . . 73.05 111.773 -172.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -72.05 142.5 38.47 Favored 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 122.527 2.151 . . . . 70.42 112.254 174.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.0 p 77.64 -32.84 0.18 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 127.351 2.26 . . . . 71.23 113.201 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 69.34 120.29 0.03 OUTLIER 'General case' 0 C--N 1.365 1.26 0 C-N-CA 124.869 1.268 . . . . 74.42 110.513 -174.162 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.442 ' H ' HD11 ' A' ' 15' ' ' LEU . 22.8 m -74.87 126.32 35.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 CA-C-O 121.508 0.671 . . . . 72.44 109.479 173.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.524 ' HB2' ' OD2' ' A' ' 23' ' ' ASP . 19.2 m -81.97 160.68 23.27 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.951 -1.129 . . . . 61.52 107.951 177.412 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.2 p -60.68 -32.43 71.65 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.42 0.896 . . . . 44.04 113.42 -168.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.19 -38.61 51.17 Favored 'General case' 0 C--O 1.253 1.243 0 C-N-CA 123.844 0.858 . . . . 73.43 111.127 -178.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.524 ' OD2' ' HB2' ' A' ' 20' ' ' SER . 51.8 m-20 -67.28 -48.67 67.0 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 114.676 -1.147 . . . . 71.43 110.205 -179.011 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.463 HG13 ' SG ' ' A' ' 37' ' ' CYS . 9.3 p -69.73 -29.91 42.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 CA-C-N 114.482 -1.235 . . . . 52.21 110.57 177.197 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -57.75 -53.17 61.24 Favored 'General case' 0 C--N 1.359 1.001 0 CA-C-O 118.812 -0.614 . . . . 72.43 111.188 170.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -67.22 -48.07 68.92 Favored 'General case' 0 C--O 1.295 3.463 0 CA-C-O 122.127 0.965 . . . . 73.52 111.87 -178.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -58.93 -47.78 83.81 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-N 113.777 -1.556 . . . . 62.31 109.945 -175.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.475 ' HA ' ' CD1' ' A' ' 31' ' ' TYR . 14.9 m-85 -81.99 -15.76 52.63 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.092 0.775 . . . . 65.34 113.092 -179.026 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 23.4 mtp180 -60.4 -35.35 75.56 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 118.149 0.431 . . . . 64.53 110.446 164.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.74 -30.22 70.63 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 119.487 -0.885 . . . . 72.21 112.954 168.317 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.475 ' CD1' ' HA ' ' A' ' 28' ' ' PHE . 1.1 m-85 -77.65 -11.27 59.85 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 113.247 0.832 . . . . 74.43 113.247 -171.326 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 141.28 38.18 0.09 OUTLIER Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.125 -1.036 . . . . 33.4 113.102 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 60.4 95.98 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.895 1.278 . . . . 63.01 112.933 174.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.17 132.63 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 115.774 -0.648 . . . . 64.25 110.701 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.33 -28.62 12.87 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.432 -0.803 . . . . 71.03 109.844 174.598 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -142.72 129.26 20.2 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.444 -0.343 . . . . 73.4 110.478 -173.098 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.463 ' SG ' HG13 ' A' ' 24' ' ' VAL . 0.9 OUTLIER -127.73 113.47 16.04 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.624 -0.509 . . . . 42.43 109.624 175.089 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -128.12 124.02 35.89 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 120.393 -0.523 . . . . 60.42 110.747 -178.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 87.2 t -99.6 128.97 50.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 116.114 -0.493 . . . . 75.33 110.346 -177.139 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.467 ' HB2' ' HB2' ' A' ' 48' ' ' PHE . 71.6 mmtt -106.54 137.02 45.3 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.628 -0.714 . . . . 74.2 109.731 -178.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -130.75 126.15 35.68 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.843 -0.343 . . . . 65.35 110.6 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.0 t -101.04 164.95 11.56 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 120.915 0.388 . . . . 51.44 111.078 177.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.9 t -75.51 -14.08 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 C-N-CA 124.133 0.973 . . . . 73.24 110.872 178.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.2 m -75.52 -11.59 60.06 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.184 0.594 . . . . 73.45 112.401 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.63 -3.32 56.15 Favored Glycine 0 C--N 1.343 0.955 0 C-N-CA 121.343 -0.456 . . . . 53.24 113.743 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.16 143.72 26.89 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.507 0.67 . . . . 63.44 111.285 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.58 142.81 33.98 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.175 -0.92 . . . . 71.45 109.257 177.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.467 ' HB2' ' HB2' ' A' ' 40' ' ' LYS . 7.9 m-85 -137.13 153.31 50.54 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.11 -0.7 . . . . 45.3 109.11 178.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -137.38 139.51 40.79 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-O 121.332 0.587 . . . . 41.34 109.636 170.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -116.35 117.81 31.0 Favored 'General case' 0 C--O 1.252 1.193 0 CA-C-N 113.803 -1.544 . . . . 72.04 106.929 -179.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 3.1 mp -127.16 112.92 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 119.715 -0.794 . . . . 60.41 111.99 -170.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -107.42 107.53 18.45 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.607 -0.724 . . . . 71.32 111.918 -171.311 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -112.51 167.34 10.53 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 115.039 -0.982 . . . . 74.53 112.977 -177.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -82.3 -25.27 34.13 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 113.39 0.885 . . . . 74.21 113.39 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.5 121.57 39.72 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.388 0.994 . . . . 70.11 112.421 177.613 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.442 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -81.47 -45.63 15.73 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.294 -1.321 . . . . 75.11 114.563 -177.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.21 -23.59 51.4 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 112.533 0.568 . . . . 74.12 112.533 -171.305 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -75.28 -26.99 59.2 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.863 0.84 . . . . 73.53 110.142 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.15 -27.14 67.06 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 114.711 -1.131 . . . . 75.51 112.602 175.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.424 ' HA ' HG22 ' A' ' 63' ' ' ILE . . . -59.37 -30.53 68.48 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 114.607 1.336 . . . . 53.53 114.607 -171.035 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.517 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -67.89 -44.18 77.61 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 122.135 0.969 . . . . 74.1 112.21 176.858 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.51 -31.54 57.74 Favored 'General case' 0 C--O 1.253 1.284 0 CA-C-O 122.604 1.192 . . . . 75.2 111.38 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.433 ' O ' ' HB3' ' A' ' 67' ' ' ASP . 0.4 OUTLIER -70.48 -30.6 43.44 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.465 0 CA-C-O 118.456 -0.783 . . . . 73.25 109.714 174.562 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.517 ' HG3' ' O ' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -77.6 -20.93 53.13 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 119.611 1.096 . . . . 63.1 111.551 170.234 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.78 -27.02 63.6 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-O 118.481 -0.771 . . . . 74.45 111.67 170.03 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.469 ' HE3' ' OH ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -113.42 13.47 18.96 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 116.405 2.002 . . . . 71.23 116.405 166.129 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.433 ' HB3' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -73.2 158.21 35.66 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 123.989 0.915 . . . . 72.43 112.539 174.662 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 112.72 24.84 4.79 Favored Glycine 0 C--N 1.345 1.036 0 C-N-CA 120.215 -0.993 . . . . 72.05 111.522 -160.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 6.2 p -57.81 132.41 53.25 Favored 'General case' 0 C--N 1.352 0.699 0 CA-C-O 122.392 1.091 . . . . 74.31 112.248 -168.287 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -134.14 149.27 51.05 Favored 'General case' 0 C--O 1.263 1.763 0 CA-C-N 113.521 -1.672 . . . . 73.13 112.383 -166.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -143.8 146.34 33.02 Favored 'General case' 0 CA--C 1.557 1.246 0 CA-C-N 112.733 -2.03 . . . . 64.31 109.477 -175.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 75.12 66.86 0.07 Allowed 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 124.706 1.202 . . . . 72.54 114.057 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.55 -11.93 59.68 Favored Glycine 0 N--CA 1.464 0.53 0 CA-C-N 113.605 -1.634 . . . . 72.34 113.796 173.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -118.91 119.64 34.95 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 105.717 -1.957 . . . . 52.43 105.717 157.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.94 103.52 15.48 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 118.975 -0.536 . . . . 75.52 111.17 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 12.0 tp -168.78 73.79 0.1 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 118.094 0.406 . . . . 71.22 111.323 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.75 109.04 21.86 Favored 'General case' 0 C--O 1.206 -1.228 0 O-C-N 120.202 -1.562 . . . . 73.14 109.008 -175.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.5 HG13 ' HB ' ' A' ' 12' ' ' VAL . 2.0 t -133.03 125.83 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 O-C-N 121.243 -0.911 . . . . 41.11 109.593 176.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -150.15 163.63 37.72 Favored 'General case' 0 C--O 1.26 1.606 0 CA-C-O 122.6 1.19 . . . . 75.4 113.131 169.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.1 m -87.14 123.39 70.14 Favored Pre-proline 0 CA--C 1.555 1.164 0 CA-C-N 112.649 -2.068 . . . . 63.44 109.047 165.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.458 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 56.5 Cg_endo -85.04 10.36 3.78 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 121.798 1.665 . . . . 74.31 113.941 167.484 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.442 ' CE1' ' HB1' ' A' ' 56' ' ' ALA . 17.5 p90 -102.87 -60.75 1.5 Allowed 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 112.099 0.407 . . . . 75.2 112.099 175.237 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.6 t30 . . . . . 0 N--CA 1.487 1.418 0 C-N-CA 126.047 1.739 . . . . 73.15 112.355 -173.691 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' A' ' 52' ' ' GLU . 75.3 m . . . . . 0 N--CA 1.452 -0.348 0 CA-C-O 121.018 0.437 . . . . 74.14 110.382 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.611 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -140.56 156.29 46.34 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-N 115.654 -0.703 . . . . 74.5 112.147 -178.934 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.576 ' HB ' HD12 ' A' ' 51' ' ' ILE . 43.8 mt -113.43 137.91 44.88 Favored 'Isoleucine or valine' 0 C--O 1.258 1.534 0 N-CA-C 108.561 -0.903 . . . . 44.42 108.561 177.274 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -99.11 112.53 24.64 Favored 'General case' 0 C--N 1.363 1.196 0 O-C-N 126.456 2.347 . . . . 74.41 108.629 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.2 133.05 67.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 107.789 -1.189 . . . . 75.44 107.789 175.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -141.13 159.99 26.7 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 121.223 -0.513 . . . . 64.41 112.801 173.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.502 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 72.8 m-20 60.94 25.59 15.56 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.491 1.116 . . . . 51.12 112.953 171.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.424 HD11 HG22 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -85.58 146.62 44.58 Favored Pre-proline 0 CA--C 1.549 0.942 0 O-C-N 121.363 -0.836 . . . . 73.21 113.033 -163.215 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.28 151.7 43.71 Favored 'Trans proline' 0 C--N 1.361 1.234 0 C-N-CA 123.351 2.701 . . . . 61.14 113.407 174.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.5 p 74.6 -30.52 0.2 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 127.421 2.288 . . . . 71.42 113.422 -176.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 71.2 t60 67.47 106.12 0.05 OUTLIER 'General case' 0 C--N 1.359 0.999 0 C-N-CA 125.24 1.416 . . . . 75.41 110.872 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.424 HG22 HD11 ' A' ' 15' ' ' LEU . 7.7 m -82.59 131.06 34.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 CA-C-N 115.636 -0.711 . . . . 74.24 110.328 176.12 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.54 ' HB2' ' OD2' ' A' ' 23' ' ' ASP . 16.8 m -89.5 160.84 16.53 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-N 115.388 -0.824 . . . . 41.43 109.545 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.6 t -52.79 -43.37 65.83 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.932 0.893 . . . . 42.51 113.078 -174.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.08 -42.16 80.8 Favored 'General case' 0 C--O 1.25 1.085 0 C-N-CA 124.741 1.216 . . . . 72.54 112.36 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.54 ' OD2' ' HB2' ' A' ' 20' ' ' SER . 12.0 m-20 -66.72 -43.09 85.17 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.125 -0.943 . . . . 73.55 110.376 -178.251 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.496 ' CG1' HG12 ' A' ' 51' ' ' ILE . 39.1 t -64.19 -40.4 88.92 Favored 'Isoleucine or valine' 0 C--N 1.343 0.309 0 CA-C-N 115.082 -0.963 . . . . 70.45 110.088 174.089 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.504 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 10.9 tt0 -58.71 -49.95 75.71 Favored 'General case' 0 C--O 1.209 -1.049 0 CA-C-O 118.455 -0.783 . . . . 62.13 111.141 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.5 -46.43 22.48 Favored 'General case' 0 C--O 1.282 2.779 0 N-CA-C 113.686 0.995 . . . . 71.1 113.686 -178.366 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -59.32 -44.6 92.57 Favored 'General case' 0 C--N 1.36 1.037 0 CA-C-N 116.353 -0.385 . . . . 71.24 110.375 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.456 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 42.6 m-85 -80.62 -20.63 42.76 Favored 'General case' 0 C--O 1.211 -0.921 0 CA-C-O 117.929 -1.034 . . . . 74.15 112.869 176.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.504 ' HB3' ' O ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -66.61 -29.56 69.64 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 120.031 1.287 . . . . 71.13 111.671 172.544 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.86 -31.01 68.62 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 117.185 -1.806 . . . . 74.22 112.202 173.406 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.488 ' CD2' ' HB2' ' A' ' 62' ' ' ALA . 85.1 m-85 -87.36 -37.08 17.41 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.307 0.484 . . . . 53.41 112.307 -176.143 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -143.9 165.16 27.36 Favored Glycine 0 C--O 1.221 -0.669 0 N-CA-C 111.662 -0.575 . . . . 72.35 111.662 174.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -80.37 99.39 7.91 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 117.516 0.658 . . . . 63.12 110.579 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.84 132.57 31.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 121.884 0.849 . . . . 72.1 111.744 -171.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.0 mp -103.1 -38.44 7.3 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.212 -1.358 . . . . 74.51 111.371 -178.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.51 131.44 15.21 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 122.89 0.476 . . . . 45.21 110.487 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.8 m -121.26 124.33 44.36 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.836 -0.54 . . . . 75.31 110.667 171.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -128.44 132.86 48.44 Favored 'General case' 0 C--O 1.212 -0.911 0 CA-C-N 116.299 -0.41 . . . . 73.53 110.669 -178.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 p -119.19 120.15 62.93 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.173 0 CA-C-O 121.684 0.755 . . . . 43.43 111.077 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -108.56 157.84 18.11 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.703 -0.68 . . . . 74.53 110.625 -178.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.04 149.87 52.16 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 122.243 -0.285 . . . . 73.13 111.034 173.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.4 t -101.48 166.37 10.76 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 120.654 0.264 . . . . 52.23 110.339 172.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.9 t -75.32 -13.72 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 C-N-CA 124.224 1.01 . . . . 72.42 111.14 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.0 t -76.25 -12.42 60.08 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.063 0.545 . . . . 74.22 111.594 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.87 -3.7 41.79 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.25 -0.5 . . . . 75.04 113.667 177.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.99 152.74 21.52 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.064 0.459 . . . . 72.13 111.001 177.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.14 148.93 49.29 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.625 -0.716 . . . . 32.44 110.205 -177.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -134.61 149.41 50.57 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 109.458 -0.571 . . . . 63.44 109.458 -170.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -125.09 138.04 54.18 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.099 0.476 . . . . 54.1 110.648 174.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.52 118.65 34.35 Favored 'General case' 0 C--O 1.256 1.423 0 N-CA-C 107.975 -1.121 . . . . 74.25 107.975 173.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.611 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 3.7 mt -115.1 109.29 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 119.069 -1.052 . . . . 61.41 111.183 -174.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 8' ' ' SER . 34.1 tt0 -109.09 104.88 14.15 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.975 0.893 . . . . 71.34 111.345 -171.227 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -117.58 171.88 7.72 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 114.693 -1.14 . . . . 75.44 113.315 -179.38 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -79.2 -37.07 39.15 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 114.908 -1.042 . . . . 74.54 111.618 168.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -116.19 117.55 30.35 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 122.179 0.99 . . . . 44.53 111.138 -171.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -84.31 -46.11 12.12 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 113.62 -1.627 . . . . 64.31 115.373 -174.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.8 tmm_? -75.07 -28.53 60.39 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 121.294 0.568 . . . . 63.2 111.913 -168.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -79.17 -25.86 42.76 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-O 121.469 0.652 . . . . 74.21 111.54 177.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.35 -23.76 61.18 Favored 'General case' 0 C--O 1.251 1.151 0 CA-C-O 122.291 1.043 . . . . 62.21 112.245 173.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.81 -22.25 23.79 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 114.593 -1.185 . . . . 73.21 113.856 173.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.473 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 0.4 OUTLIER -66.74 -43.04 85.24 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.82 0.819 . . . . 73.32 110.547 173.51 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.488 ' HB2' ' CD2' ' A' ' 31' ' ' TYR . . . -64.03 -43.02 96.86 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 114.696 -1.138 . . . . 72.35 110.659 173.056 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.794 HG13 HG13 ' A' ' 80' ' ' VAL . 0.3 OUTLIER -66.82 -31.0 51.5 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.411 0 C-N-CA 120.202 -0.599 . . . . 64.41 111.477 178.143 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -80.18 -21.32 43.12 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.444 0.566 . . . . 72.41 112.172 176.927 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.409 ' HG2' ' HA ' ' A' ' 62' ' ' ALA . 15.7 pt-20 -85.38 -17.96 35.16 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 118.55 -1.26 . . . . 63.34 111.809 170.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 62' ' ' ALA . 67.4 mmtt -99.67 13.65 32.84 Favored 'General case' 0 CA--C 1.575 1.92 0 CA-C-O 121.622 0.725 . . . . 73.32 111.401 170.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -70.77 153.06 43.13 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 127.115 2.166 . . . . 72.4 114.329 -178.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 112.03 24.28 5.22 Favored Glycine 0 C--N 1.351 1.416 0 C-N-CA 120.268 -0.968 . . . . 72.1 114.53 -171.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 20.7 p -58.27 133.62 55.84 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 114.219 1.192 . . . . 73.24 114.219 -167.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.1 149.92 51.13 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-N 113.826 -1.534 . . . . 63.23 113.212 -168.111 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -143.5 149.38 37.42 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.442 1.897 . . . . 73.44 110.562 -171.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 74.34 64.87 0.08 Allowed 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 122.476 1.131 . . . . 72.14 113.466 174.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.94 -10.64 60.46 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 113.745 -1.57 . . . . 75.41 113.952 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -120.25 122.78 41.64 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.19 -1.411 . . . . 71.22 107.19 160.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.502 ' HB3' ' O ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -96.12 103.25 15.13 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 119.109 -0.472 . . . . 74.2 111.038 178.855 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 41.5 tp -162.29 69.84 0.28 Allowed 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 118.267 0.485 . . . . 54.14 112.01 177.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -97.86 113.14 24.88 Favored 'General case' 0 C--O 1.208 -1.097 0 O-C-N 119.451 -2.031 . . . . 74.45 109.703 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.8 t -130.1 120.48 49.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 107.893 -1.151 . . . . 62.3 107.893 171.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -149.01 141.33 24.12 Favored 'General case' 0 C--O 1.258 1.517 0 CA-C-O 123.075 1.417 . . . . 65.24 113.922 176.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.794 HG13 HG13 ' A' ' 63' ' ' ILE . 16.6 m -88.91 135.86 31.4 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 113.112 -1.858 . . . . 75.33 110.209 165.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -82.96 20.21 1.19 Allowed 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.19 1.927 . . . . 74.43 112.415 166.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -103.34 72.38 1.15 Allowed 'General case' 0 C--N 1.345 0.404 0 CA-C-O 121.828 0.823 . . . . 53.32 109.707 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 . . . . . 0 C--N 1.313 -1.006 0 CA-C-N 114.838 -1.074 . . . . 71.5 109.128 177.387 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.2 p . . . . . 0 CA--C 1.54 0.558 0 N-CA-C 110.555 -0.165 . . . . 72.4 110.555 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.491 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 0.3 OUTLIER -130.52 151.65 50.76 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.338 0.496 . . . . 60.31 112.338 -177.096 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.493 HG13 HG12 ' A' ' 80' ' ' VAL . 4.9 mp -121.13 132.33 70.8 Favored 'Isoleucine or valine' 0 C--O 1.247 0.95 0 N-CA-C 108.948 -0.76 . . . . 72.32 108.948 174.265 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -113.16 113.95 26.09 Favored 'General case' 0 C--O 1.244 0.813 0 O-C-N 124.21 0.944 . . . . 75.24 109.338 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 7.2 p -122.71 109.69 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 CA-C-O 122.503 1.144 . . . . 32.44 111.651 176.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -128.14 157.34 21.16 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-N 115.32 -0.855 . . . . 63.02 114.946 -174.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.435 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 15.3 m120 59.37 25.07 13.71 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.715 1.206 . . . . 54.44 111.944 175.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.467 HD23 ' H ' ' A' ' 15' ' ' LEU . 1.7 pt? -88.37 151.2 48.23 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 112.511 0.559 . . . . 71.05 112.511 -167.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -64.43 144.2 84.7 Favored 'Trans proline' 0 C--N 1.364 1.382 0 C-N-CA 122.901 2.401 . . . . 74.34 112.227 172.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.5 p 73.53 -31.03 0.22 Allowed 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 127.316 2.246 . . . . 43.33 113.046 -176.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 64.78 86.74 0.12 Allowed 'General case' 0 C--N 1.361 1.071 0 C-N-CA 125.746 1.618 . . . . 74.31 110.156 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.433 ' H ' HD11 ' A' ' 15' ' ' LEU . 8.2 p -69.18 133.74 31.35 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 CA-C-O 121.653 0.74 . . . . 75.13 110.521 -174.084 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.429 ' O ' HG22 ' A' ' 24' ' ' VAL . 25.5 m -90.46 169.33 11.14 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.358 -0.837 . . . . 44.03 110.207 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.3 p -61.82 -28.39 69.44 Favored 'General case' 0 C--O 1.21 -1.022 0 N-CA-C 113.509 0.929 . . . . 50.43 113.509 -175.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -71.85 -41.78 67.71 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 123.586 0.754 . . . . 62.14 111.852 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -73.68 -43.55 59.07 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.888 -0.597 . . . . 75.44 109.829 -172.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 20' ' ' SER . 2.2 m -68.62 -30.79 48.48 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.945 0 CA-C-O 118.179 -0.915 . . . . 74.55 111.175 170.338 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.0 -55.73 21.37 Favored 'General case' 0 C--O 1.195 -1.801 0 CA-C-O 118.003 -0.998 . . . . 71.42 109.094 172.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -73.84 -55.16 6.54 Favored 'General case' 0 C--O 1.276 2.462 0 C-N-CA 119.199 -1.001 . . . . 72.41 112.662 -175.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -76.64 -35.96 57.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.543 -0.753 . . . . 71.42 110.787 -168.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.31 -23.64 30.17 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 118.073 -0.965 . . . . 74.54 110.984 177.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.557 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 4.7 ptt85 -71.52 -22.94 61.71 Favored 'General case' 0 C--N 1.383 2.065 0 CA-C-N 120.193 1.36 . . . . 70.4 111.698 170.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.19 -33.5 67.54 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 119.005 -1.078 . . . . 63.21 110.91 169.196 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.514 ' CG ' ' HB2' ' A' ' 62' ' ' ALA . 90.0 m-85 -85.41 -38.02 19.16 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.327 0.492 . . . . 75.55 112.327 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' A' ' 29' ' ' ARG . . . -152.62 143.9 10.86 Favored Glycine 0 C--O 1.22 -0.779 0 C-N-CA 121.045 -0.598 . . . . 64.32 111.67 178.233 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -66.9 117.73 9.4 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 123.718 0.305 . . . . 74.4 111.05 -172.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.36 122.92 35.55 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-O 122.045 0.926 . . . . 63.33 111.278 -174.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 50.0 mt -100.61 -36.19 9.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.937 -1.029 . . . . 54.4 109.431 177.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.84 139.39 21.58 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.682 -0.69 . . . . 74.4 109.545 -177.251 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 18.7 p -136.9 118.76 15.17 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.252 0.549 . . . . 73.11 110.497 173.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -129.26 144.83 51.37 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 115.589 -0.732 . . . . 44.25 109.623 -179.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 84.9 t -117.64 129.06 74.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 121.069 0.461 . . . . 74.34 110.365 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -106.08 135.32 47.75 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.117 -0.697 . . . . 71.32 109.117 -178.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.91 125.06 36.75 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.753 -0.379 . . . . 63.13 110.424 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.1 t -102.16 164.42 11.7 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.463 -0.335 . . . . 71.42 111.481 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.7 t -75.04 -13.46 15.35 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 C-N-CA 123.748 0.819 . . . . 75.14 110.913 178.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.8 t -75.65 -10.83 59.77 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.066 0.546 . . . . 65.43 111.542 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.42 -4.12 59.95 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 120.92 -0.657 . . . . 52.05 113.226 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.81 139.12 30.85 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.339 0.59 . . . . 74.44 111.135 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.84 142.12 35.29 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.274 -0.876 . . . . 24.44 109.54 177.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 8.8 m-85 -136.25 149.43 48.5 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.438 -0.949 . . . . 71.21 108.438 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -132.82 138.52 47.11 Favored 'General case' 0 C--O 1.248 1.012 0 N-CA-C 109.212 -0.662 . . . . 42.42 109.212 172.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -118.09 117.93 30.51 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.113 -1.403 . . . . 72.45 107.836 -176.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.94 112.51 27.59 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.468 0 C-N-CA 120.176 -0.609 . . . . 70.35 111.033 -171.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -98.51 114.52 26.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.922 0.391 . . . . 72.13 111.186 -176.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -107.88 166.37 10.76 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.511 -0.768 . . . . 61.23 111.451 -178.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -80.61 -35.08 34.56 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 120.318 -0.553 . . . . 74.51 110.921 172.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.71 124.28 45.84 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.929 0.871 . . . . 72.24 112.363 -171.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.53 -46.16 16.26 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 113.74 -1.573 . . . . 72.34 114.529 -176.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.59 -21.94 57.37 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 112.727 0.64 . . . . 74.03 112.727 -169.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.419 ' HB3' ' O ' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -78.57 -33.1 47.91 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 121.35 0.595 . . . . 73.2 110.807 174.852 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.96 -24.88 63.41 Favored 'General case' 0 C--O 1.25 1.083 0 C-N-CA 124.4 1.08 . . . . 62.14 112.162 174.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.557 ' HA ' HG22 ' A' ' 63' ' ' ILE . . . -56.65 -26.63 56.65 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.164 -0.926 . . . . 62.32 113.34 178.449 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.43 ' HA ' ' HG3' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -69.27 -39.2 78.53 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 117.84 0.291 . . . . 75.52 111.257 174.734 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.514 ' HB2' ' CG ' ' A' ' 31' ' ' TYR . . . -66.17 -42.54 88.82 Favored 'General case' 0 C--O 1.245 0.851 0 C-N-CA 122.844 0.457 . . . . 62.31 111.139 174.471 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.778 HG13 HG13 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -70.32 -29.05 37.6 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 119.771 -0.772 . . . . 73.03 111.024 178.766 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.43 ' HG3' ' HA ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -78.96 -27.2 43.52 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.793 1.179 . . . . 73.33 112.438 174.811 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.49 -22.53 43.91 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 119.015 -1.074 . . . . 75.42 111.269 176.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -109.04 14.36 24.06 Favored 'General case' 0 CA--C 1.558 1.287 0 CA-C-O 121.35 0.595 . . . . 52.51 111.92 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -67.1 154.02 42.23 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 125.763 1.625 . . . . 71.34 110.902 169.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.15 21.75 5.81 Favored Glycine 0 C--N 1.343 0.931 0 C-N-CA 119.81 -1.186 . . . . 63.35 112.501 -162.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.67 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 14.3 p -59.81 132.03 52.72 Favored 'General case' 0 C--O 1.242 0.672 0 O-C-N 124.239 0.611 . . . . 62.01 111.888 -175.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.5 147.68 50.4 Favored 'General case' 0 C--O 1.254 1.315 0 CA-C-N 115.171 -0.922 . . . . 62.42 112.744 -169.363 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -143.16 146.34 33.63 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.335 1.854 . . . . 62.12 110.766 -173.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 74.16 67.56 0.09 Allowed 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 114.084 1.142 . . . . 75.32 114.084 177.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.67 -11.78 59.45 Favored Glycine 0 N--CA 1.462 0.415 0 CA-C-N 114.299 -1.319 . . . . 73.44 113.665 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -121.82 123.18 41.18 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.499 -1.297 . . . . 73.31 107.499 157.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.435 ' HB3' ' O ' ' A' ' 14' ' ' ASN . 0.3 OUTLIER -94.15 104.11 16.14 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 118.97 -0.538 . . . . 73.54 110.701 179.202 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.67 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -162.89 58.15 0.2 Allowed 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.438 1.273 . . . . 73.11 114.438 -175.228 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -95.27 113.83 25.55 Favored 'General case' 0 C--O 1.214 -0.774 0 CA-C-N 121.036 1.744 . . . . 73.4 110.838 -173.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.2 t -128.4 117.39 45.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 107.78 -1.192 . . . . 34.25 107.78 170.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.563 ' HA ' HD11 ' A' ' 63' ' ' ILE . 32.6 tt0 -151.98 144.97 24.49 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.799 0.809 . . . . 73.54 111.625 176.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.778 HG13 HG13 ' A' ' 63' ' ' ILE . 18.7 m -89.06 124.83 64.1 Favored Pre-proline 0 C--N 1.317 -0.836 0 CA-C-N 115.81 -0.632 . . . . 71.42 111.077 170.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.491 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 57.8 Cg_endo -80.37 5.92 5.74 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.036 1.824 . . . . 74.42 114.047 169.262 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -87.37 -32.61 19.5 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 119.933 -0.707 . . . . 74.41 111.809 175.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 N--CA 1.486 1.356 0 C-N-CA 124.887 1.275 . . . . 74.42 112.27 -175.744 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.9 t . . . . . 0 CA--C 1.548 0.881 0 CA-C-O 120.417 0.151 . . . . 72.32 111.401 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.528 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 1.6 ptp180 -143.93 155.86 44.22 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 112.501 0.556 . . . . 63.42 112.501 -175.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.675 HG12 HG12 ' A' ' 80' ' ' VAL . 6.7 mt -115.28 136.8 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 123.6 0.76 . . . . 74.54 109.896 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -105.63 117.6 34.44 Favored 'General case' 0 C--O 1.249 1.057 0 O-C-N 125.111 1.507 . . . . 63.54 109.728 177.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.517 HG12 HD22 ' A' ' 15' ' ' LEU . 59.4 t -119.68 109.51 26.46 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.055 0 CA-C-N 115.495 -0.775 . . . . 71.32 109.504 176.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -123.07 156.84 17.51 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.74 -0.743 . . . . 74.32 113.627 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.2 m120 59.11 32.42 22.12 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.029 0.932 . . . . 73.32 112.255 170.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.517 HD22 HG12 ' A' ' 12' ' ' VAL . 1.3 pt? -87.77 149.23 45.55 Favored Pre-proline 0 CA--C 1.543 0.707 0 N-CA-C 113.277 0.843 . . . . 74.21 113.277 -168.398 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -69.69 129.94 18.56 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 122.943 2.428 . . . . 73.24 112.647 172.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.7 p 48.3 101.62 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 125.949 1.7 . . . . 73.13 113.021 -169.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 38.0 p-80 -55.42 119.31 5.42 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.778 0.799 . . . . 65.52 112.218 -175.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.5 p -77.12 129.59 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 114.534 -1.212 . . . . 63.13 110.43 -175.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.3 m -83.6 165.75 18.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.401 -0.818 . . . . 73.02 110.207 -178.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 32.0 p -62.88 -28.2 69.88 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.723 0.809 . . . . 71.14 112.54 -174.486 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.06 -37.59 54.34 Favored 'General case' 0 C--O 1.253 1.249 0 CA-C-O 121.52 0.676 . . . . 75.14 110.809 -177.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -71.03 -44.42 65.86 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 114.652 -1.158 . . . . 75.03 110.564 -178.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.644 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 2.9 m -67.62 -31.52 52.86 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.872 0 CA-C-O 118.978 -0.534 . . . . 72.43 110.588 171.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 21' ' ' SER . 17.1 tt0 -58.41 -54.14 50.43 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 118.946 -0.55 . . . . 74.21 110.476 177.049 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -72.47 -54.02 10.47 Favored 'General case' 0 C--O 1.29 3.225 0 C-N-CA 119.829 -0.749 . . . . 52.14 112.512 -178.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -69.48 -44.58 70.86 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.676 -1.147 . . . . 74.21 109.689 -169.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.644 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 7.8 m-85 -77.95 -21.99 50.17 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-O 118.099 -0.953 . . . . 72.34 111.384 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.419 ' HB3' ' O ' ' A' ' 25' ' ' GLU . 3.6 ppt_? -68.44 -26.66 65.62 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 121.193 1.815 . . . . 71.25 111.402 171.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.48 -21.05 66.55 Favored 'General case' 0 CA--C 1.561 1.398 0 C-N-CA 118.304 -1.358 . . . . 71.52 112.442 169.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.437 ' OH ' ' HE3' ' A' ' 66' ' ' LYS . 5.2 m-30 -74.76 -37.22 62.52 Favored 'General case' 0 C--O 1.207 -1.173 0 N-CA-C 113.134 0.79 . . . . 73.04 113.134 -175.137 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 166.54 43.82 0.02 OUTLIER Glycine 0 N--CA 1.469 0.839 0 C-N-CA 118.943 -1.598 . . . . 64.11 114.061 -178.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.5 t30 62.05 99.28 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 125.217 1.407 . . . . 72.32 113.058 175.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.16 127.48 39.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 114.951 -1.022 . . . . 72.51 110.535 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -97.29 -32.25 12.0 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.536 -0.756 . . . . 73.35 109.932 176.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.01 132.15 15.38 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.001 -0.545 . . . . 61.12 109.697 -176.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.1 p -125.2 125.19 43.25 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 120.862 0.363 . . . . 64.31 110.041 172.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -129.41 130.99 46.67 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.825 -0.625 . . . . 73.31 110.144 -179.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.4 t -111.89 114.47 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.285 0.564 . . . . 71.22 110.035 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -107.12 139.93 40.76 Favored 'General case' 0 C--O 1.212 -0.915 0 CA-C-N 115.22 -0.9 . . . . 75.42 108.815 -178.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.83 148.22 52.54 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.313 0.96 . . . . 64.21 112.005 171.23 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.4 t -100.85 165.76 11.19 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 116.263 -0.426 . . . . 30.13 110.49 177.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.5 t -75.57 -11.47 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 C-N-CA 123.862 0.865 . . . . 73.23 110.937 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -76.46 -8.25 56.77 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 122.837 0.455 . . . . 65.41 111.63 178.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.83 -4.09 52.98 Favored Glycine 0 C--N 1.341 0.815 0 C-N-CA 121.248 -0.501 . . . . 54.21 112.869 175.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.89 135.24 33.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.994 0.426 . . . . 71.5 110.953 178.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.96 148.49 26.65 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.351 -0.841 . . . . 43.45 109.397 177.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.5 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 19.8 m-85 -136.13 153.21 51.35 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 123.641 0.588 . . . . 74.1 109.503 -176.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -136.0 137.86 41.66 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.997 -0.547 . . . . 74.14 109.62 174.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.44 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 0.4 OUTLIER -111.46 119.95 40.5 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 114.736 -1.12 . . . . 64.33 108.448 172.986 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.3 mp -123.87 113.92 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 119.997 -0.681 . . . . 71.52 111.145 -177.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -92.73 116.15 28.75 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.325 -0.852 . . . . 61.34 111.593 -169.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -109.84 152.94 25.11 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.782 1.03 . . . . 71.51 113.782 -177.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.41 -34.03 25.6 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 115.275 -0.875 . . . . 63.14 112.044 172.24 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -122.51 129.5 52.04 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.278 0.844 . . . . 74.41 113.278 -177.355 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.07 -45.99 31.32 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 113.98 -1.464 . . . . 54.31 114.339 -175.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.09 -25.23 52.05 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.324 0.861 . . . . 65.41 113.324 -170.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -76.47 -36.81 57.67 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.859 0.838 . . . . 63.14 109.331 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.65 -27.93 65.46 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 114.505 -1.225 . . . . 71.44 111.743 177.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.02 -35.45 69.28 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 114.227 1.195 . . . . 73.31 114.227 -176.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.556 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 0.5 OUTLIER -69.55 -40.51 76.79 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 122.122 0.963 . . . . 65.51 112.729 -179.437 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.553 ' O ' ' HG3' ' A' ' 65' ' ' GLU . . . -75.92 -36.48 59.39 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.674 -0.693 . . . . 73.2 110.598 178.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.58 HG13 HG13 ' A' ' 80' ' ' VAL . 0.4 OUTLIER -68.83 -28.85 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 O-C-N 121.875 -0.516 . . . . 54.43 110.575 176.659 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.556 ' HG3' ' O ' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -78.86 -23.0 45.23 Favored 'General case' 0 C--N 1.354 0.803 0 CA-C-N 118.295 0.498 . . . . 71.21 111.833 169.874 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.553 ' HG3' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -69.45 -29.41 67.09 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 120.192 -0.603 . . . . 75.41 110.88 172.189 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.621 ' HG3' HG11 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -105.03 7.81 34.13 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 114.767 1.395 . . . . 74.52 114.767 169.033 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -70.1 152.9 43.81 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 123.444 0.698 . . . . 73.13 111.25 173.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.02 23.7 4.49 Favored Glycine 0 C--N 1.342 0.865 0 C-N-CA 119.532 -1.318 . . . . 73.3 112.327 -155.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.556 ' SG ' ' HA ' ' A' ' 77' ' ' ARG . 6.1 t -55.81 136.75 51.03 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.815 0.846 . . . . 65.43 112.059 -178.147 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -123.82 146.16 48.56 Favored 'General case' 0 C--O 1.249 1.056 0 CA-C-N 114.808 -1.087 . . . . 72.4 112.928 -169.058 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -142.61 145.78 33.87 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 112.14 -2.3 . . . . 74.22 110.298 -173.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 73.24 66.87 0.1 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 114.302 1.223 . . . . 74.51 114.302 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.67 -12.6 59.56 Favored Glycine 0 C--N 1.335 0.474 0 CA-C-N 114.148 -1.387 . . . . 73.33 114.258 171.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -123.22 120.49 33.31 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 106.483 -1.673 . . . . 74.43 106.483 157.362 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.1 116.08 28.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 119.579 -0.248 . . . . 73.42 111.319 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -157.91 81.33 0.86 Allowed 'General case' 0 C--O 1.208 -1.107 0 N-CA-C 112.356 0.502 . . . . 52.01 112.356 178.173 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.556 ' HA ' ' SG ' ' A' ' 69' ' ' CYS . 7.4 tpp85 -97.85 113.26 25.02 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.576 1.08 . . . . 73.34 110.165 -178.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.621 HG11 ' HG3' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -133.22 115.88 24.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.662 -0.699 . . . . 64.03 109.441 169.743 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.18 155.09 36.02 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-O 121.802 0.811 . . . . 73.44 112.724 175.537 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.675 HG12 HG12 ' A' ' 10' ' ' ILE . 31.0 m -90.6 123.38 65.37 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 114.824 -1.08 . . . . 71.51 110.764 166.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.528 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 73.8 Cg_endo -88.17 9.15 3.84 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 122.061 1.84 . . . . 74.1 112.576 164.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -97.05 -13.28 22.35 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 120.576 -0.45 . . . . 70.34 111.887 176.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.3 m120 . . . . . 0 N--CA 1.485 1.29 0 O-C-N 124.872 1.358 . . . . 71.42 111.948 -172.484 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.045 0 N-CA-C 111.911 -0.476 . . . . 72.43 111.911 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 13.9 p -158.4 101.43 1.7 Allowed 'General case' 0 C--O 1.242 0.669 0 CA-C-O 121.192 0.52 . . . . 73.42 110.931 178.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 0' ' ' HIS . . . . . 0.532 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 0.8 OUTLIER -149.07 -174.54 4.67 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 118.791 -0.623 . . . . 74.35 109.407 179.309 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.532 ' SD ' ' HB3' ' A' ' 0' ' ' HIS . 2.7 mpt? 70.75 148.3 0.08 Allowed 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 124.96 1.304 . . . . 63.1 113.743 172.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.0 m -134.34 162.37 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 115.643 -0.708 . . . . 73.5 111.058 177.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.1 tt -153.69 121.24 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 CA-C-O 120.906 0.384 . . . . 73.14 110.664 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -114.56 46.52 1.37 Allowed 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.837 -0.539 . . . . 72.43 112.368 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -157.87 21.24 0.26 Allowed 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 109.866 -0.42 . . . . 63.21 109.866 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.6 t -127.43 178.68 5.92 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.991 -0.443 . . . . 71.23 110.108 -177.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -133.53 105.29 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.915 0 N-CA-C 107.158 -1.423 . . . . 65.32 107.158 177.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.65 119.57 27.04 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.163 -0.926 . . . . 73.52 110.451 -174.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.21 158.5 44.26 Favored 'General case' 0 N--CA 1.509 2.518 0 CA-C-O 118.666 -0.683 . . . . 63.41 112.163 -177.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.547 ' HB ' HD12 ' A' ' 51' ' ' ILE . 6.2 mt -117.66 143.0 29.37 Favored 'Isoleucine or valine' 0 C--N 1.371 1.518 0 N-CA-C 107.258 -1.386 . . . . 71.22 107.258 -176.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -104.95 113.23 26.7 Favored 'General case' 0 CA--C 1.564 1.499 0 CA-C-O 117.996 -1.002 . . . . 74.24 111.413 -176.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.526 HG12 HG13 ' A' ' 78' ' ' VAL . 14.2 m -127.24 107.45 16.85 Favored 'Isoleucine or valine' 0 C--N 1.376 1.728 0 CA-C-N 121.166 1.803 . . . . 62.42 110.309 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.511 ' H ' ' HG3' ' A' ' 77' ' ' ARG . . . -134.7 -179.05 16.1 Favored Glycine 0 N--CA 1.485 1.941 0 O-C-N 120.86 -1.15 . . . . 64.1 113.987 -174.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.4 m120 49.72 23.22 0.94 Allowed 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 113.875 1.065 . . . . 53.42 113.875 -178.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.648 HD23 ' H ' ' A' ' 15' ' ' LEU . 2.2 pt? -91.14 141.59 26.51 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.236 1.014 . . . . 71.53 110.561 -167.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -64.46 133.55 37.77 Favored 'Trans proline' 0 C--N 1.365 1.404 0 C-N-CA 122.367 2.045 . . . . 71.33 111.807 177.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.5 p 82.13 -39.67 0.11 Allowed 'General case' 0 C--N 1.379 1.859 0 C-N-CA 126.73 2.012 . . . . 65.44 112.053 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 73.7 t60 67.19 117.58 0.03 OUTLIER 'General case' 0 C--N 1.357 0.926 0 C-N-CA 125.278 1.431 . . . . 70.45 110.999 -173.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.474 ' H ' HD11 ' A' ' 15' ' ' LEU . 9.8 m -71.82 116.3 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.594 2.643 0 N-CA-C 107.312 -1.366 . . . . 64.21 107.312 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -79.25 155.8 28.4 Favored 'General case' 0 C--N 1.38 1.908 0 O-C-N 120.789 -1.194 . . . . 72.32 110.727 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 69.9 m -48.81 -43.34 38.19 Favored 'General case' 0 C--N 1.381 1.963 0 N-CA-C 115.911 1.819 . . . . 71.52 115.911 -173.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.99 -47.52 71.35 Favored 'General case' 0 CA--C 1.589 2.445 0 N-CA-C 113.865 1.061 . . . . 74.34 113.865 174.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -72.88 -35.97 67.25 Favored 'General case' 0 C--N 1.361 1.072 0 CA-C-O 119.089 -0.482 . . . . 75.22 112.286 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.511 ' O ' ' HB2' ' A' ' 28' ' ' PHE 0.262 1.7 p -69.41 -44.12 80.38 Favored 'Isoleucine or valine' 0 C--N 1.36 1.025 0 CA-C-O 118.107 -0.949 . . . . 43.02 110.683 176.619 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.488 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 22.1 tt0 -49.12 -60.44 2.79 Favored 'General case' 0 N--CA 1.507 2.405 0 CA-C-O 116.809 -1.567 . . . . 54.13 112.165 165.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -70.21 -61.82 1.63 Allowed 'General case' 0 C--O 1.303 3.912 0 CA-C-N 121.467 1.94 . . . . 64.42 114.417 -173.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -70.42 -34.34 72.39 Favored 'General case' 0 C--N 1.369 1.421 0 CA-C-O 117.111 -1.423 . . . . 72.12 112.622 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.511 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 1.2 m-85 -77.57 -35.82 52.7 Favored 'General case' 0 C--N 1.364 1.23 0 CA-C-N 121.939 2.154 . . . . 75.15 112.271 177.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.488 ' HB3' ' O ' ' A' ' 25' ' ' GLU . 5.2 ptt85 -53.21 -28.51 27.28 Favored 'General case' 0 N--CA 1.509 2.513 0 CA-C-O 115.87 -2.014 . . . . 75.33 115.338 166.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.63 -47.04 73.94 Favored 'General case' 0 N--CA 1.522 3.142 0 CA-C-N 123.485 2.857 . . . . 72.32 111.666 167.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.514 ' HB3' ' HA ' ' A' ' 59' ' ' ALA . 94.6 m-85 -76.39 -38.26 55.96 Favored 'General case' 0 CA--C 1.554 1.103 0 CA-C-O 118.302 -0.856 . . . . 71.22 112.532 -166.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -148.94 -175.43 21.39 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-N 120.001 1.273 . . . . 73.15 111.605 170.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -99.48 98.77 9.64 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 119.23 -0.988 . . . . 65.51 109.362 -166.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.49 134.6 29.17 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.409 0 N-CA-C 113.761 1.023 . . . . 71.41 113.761 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.46 -26.36 11.47 Favored 'General case' 0 CA--C 1.562 1.407 0 N-CA-C 110.092 -0.336 . . . . 70.0 110.092 172.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.8 pttm -153.92 153.82 32.72 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.528 0.731 . . . . 70.15 110.121 168.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -139.52 105.47 5.19 Favored 'General case' 0 C--N 1.356 0.873 0 N-CA-C 108.13 -1.063 . . . . 63.2 108.13 175.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -112.45 144.5 41.8 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 118.864 -1.135 . . . . 71.43 114.054 -176.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 69.4 t -97.09 113.93 32.75 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 N-CA-C 108.837 -0.801 . . . . 62.21 108.837 175.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -115.28 131.37 56.95 Favored 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 107.948 -1.13 . . . . 71.3 107.948 175.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.44 141.52 51.38 Favored 'General case' 0 CA--C 1.564 1.492 0 CA-C-N 121.8 2.091 . . . . 73.22 108.354 -170.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.585 HG23 ' H ' ' A' ' 44' ' ' SER . 6.4 t -100.81 173.51 6.48 Favored 'General case' 0 CA--C 1.565 1.539 0 CA-C-N 120.853 1.66 . . . . 71.42 111.977 -178.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.9 t -75.74 -9.3 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.305 0 C-N-CA 123.749 0.819 . . . . 73.3 112.377 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.585 ' H ' HG23 ' A' ' 42' ' ' THR . 0.8 OUTLIER -89.19 7.66 34.14 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 121.705 -0.622 . . . . 44.05 110.499 -175.984 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.54 -5.09 75.47 Favored Glycine 0 C--N 1.347 1.178 0 N-CA-C 115.436 0.934 . . . . 62.12 115.436 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.09 131.95 34.75 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 118.022 0.911 . . . . 75.01 110.031 176.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -105.63 146.26 29.93 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 109.393 -0.595 . . . . 62.13 109.393 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -129.3 148.75 51.25 Favored 'General case' 0 C--N 1.347 0.496 0 N-CA-C 108.942 -0.762 . . . . 73.13 108.942 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -121.29 135.57 55.09 Favored 'General case' 0 C--O 1.247 0.964 0 C-N-CA 119.855 -0.738 . . . . 61.23 110.257 168.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -108.92 122.15 46.62 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 114.048 -1.433 . . . . 71.34 108.229 -172.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.547 HD12 ' HB ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -126.92 108.6 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 C-N-CA 118.953 -1.099 . . . . 73.33 109.975 -165.071 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -89.27 103.99 16.57 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 120.508 -0.477 . . . . 74.54 110.905 -171.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -113.22 142.33 45.93 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 113.645 0.98 . . . . 74.33 113.645 -172.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -82.81 -34.5 26.94 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.742 -0.783 . . . . 72.12 112.565 172.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -117.75 120.25 37.38 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 108.991 -0.744 . . . . 62.33 108.991 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.528 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -77.87 -38.37 46.15 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 115.425 1.639 . . . . 73.04 115.425 167.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -60.21 -40.11 88.97 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 113.593 0.96 . . . . 73.21 113.593 -168.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -69.53 -49.18 56.87 Favored 'General case' 0 CA--C 1.582 2.18 0 N-CA-C 114.835 1.42 . . . . 71.14 114.835 169.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.514 ' HA ' ' HB3' ' A' ' 31' ' ' TYR . . . -52.76 -21.63 4.35 Favored 'General case' 0 CA--C 1.587 2.37 0 N-CA-C 115.541 1.682 . . . . 33.23 115.541 172.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.482 ' O ' ' HG3' ' A' ' 64' ' ' LYS . . . -47.01 -34.61 5.81 Favored 'General case' 0 CA--C 1.561 1.383 0 CA-C-O 116.269 -1.824 . . . . 32.05 114.565 173.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.426 ' O ' ' HB3' ' A' ' 65' ' ' GLU . 29.3 m-20 -52.5 -53.89 39.87 Favored 'General case' 0 N--CA 1.51 2.539 0 CA-C-N 121.517 1.962 . . . . 51.1 111.835 168.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.08 -43.54 95.11 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 118.504 0.593 . . . . 71.43 111.809 178.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.576 HD12 HG13 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -67.37 -39.61 83.06 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.415 0 C-N-CA 118.748 -1.181 . . . . 72.34 113.458 -174.454 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.492 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -65.92 -32.58 74.16 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.813 1.042 . . . . 75.02 113.813 167.492 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.426 ' HB3' ' O ' ' A' ' 61' ' ' ASP . 0.6 OUTLIER -76.95 -17.1 59.12 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.059 0.391 . . . . 73.53 111.196 -176.19 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt -109.78 12.01 24.18 Favored 'General case' 0 CA--C 1.577 1.984 0 CA-C-O 119.742 -0.171 . . . . 73.11 111.056 169.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.492 ' HB3' ' HA ' ' A' ' 64' ' ' LYS 0.373 0.0 OUTLIER -78.45 159.63 28.16 Favored 'General case' 0 N--CA 1.506 2.344 0 C-N-CA 123.664 0.786 . . . . 64.52 112.406 -176.028 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.55 29.55 2.24 Favored Glycine 0 N--CA 1.439 -1.166 0 CA-C-O 117.819 -1.545 . . . . 61.33 114.406 -161.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.81 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 18.2 t -49.63 126.16 13.03 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-N 118.314 1.057 . . . . 74.51 112.125 -175.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.53 145.47 47.08 Favored 'General case' 0 C--O 1.251 1.172 0 CA-C-N 113.208 -1.814 . . . . 72.42 112.464 -172.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -147.8 147.36 29.75 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 105.947 -1.872 . . . . 74.24 105.947 -168.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 72.35 63.03 0.12 Allowed 'General case' 0 N--CA 1.483 1.175 0 CA-C-O 122.347 1.07 . . . . 62.4 112.995 176.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 97.5 -13.92 63.77 Favored Glycine 0 N--CA 1.471 0.998 0 N-CA-C 116.632 1.413 . . . . 70.02 116.632 172.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -113.23 121.19 43.72 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 105.1 -2.185 . . . . 64.41 105.1 156.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.49 102.8 14.65 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 117.438 -1.268 . . . . 73.15 109.826 -173.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.81 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -162.94 72.53 0.32 Allowed 'General case' 0 N--CA 1.512 2.672 0 CA-C-N 121.328 1.876 . . . . 74.42 115.668 178.834 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.511 ' HG3' ' H ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -96.6 118.03 32.23 Favored 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 123.769 2.986 . . . . 63.54 111.702 -175.319 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.526 HG13 HG12 ' A' ' 12' ' ' VAL . 41.0 t -131.78 119.4 41.6 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.772 0 O-C-N 120.189 -1.569 . . . . 74.23 108.056 172.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -146.99 134.57 20.96 Favored 'General case' 0 C--N 1.384 2.107 0 CA-C-N 121.088 1.767 . . . . 74.01 112.841 -172.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.576 HG13 HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -93.12 126.54 50.62 Favored Pre-proline 0 N--CA 1.45 -0.467 0 CA-C-N 114.197 -1.365 . . . . 72.35 112.095 169.901 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -85.85 25.5 0.69 Allowed 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 122.147 1.898 . . . . 72.2 111.842 165.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.528 ' CD2' ' HB2' ' A' ' 56' ' ' ALA . 9.2 m-85 -110.95 -28.13 8.48 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 115.595 -0.73 . . . . 75.3 110.161 176.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 53.77 54.4 9.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 124.75 1.281 . . . . 74.11 112.145 -172.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 68.96 -3.44 1.47 Allowed 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 125.224 1.41 . . . . 74.14 114.135 -175.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 76.12 133.76 0.05 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 125.281 1.613 . . . . 74.31 110.047 -173.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 . . . . . 0 C--O 1.25 1.082 0 CA-C-N 115.575 -0.739 . . . . 64.33 109.055 -175.891 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.84 0 N-CA-C 111.651 -0.58 . . . . 35.11 111.651 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 8.7 t -155.76 145.46 21.2 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 110.13 -0.322 . . . . 72.44 110.13 176.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -137.25 156.53 48.17 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.684 -0.858 . . . . 73.15 108.684 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 mpp? -127.92 14.24 6.85 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.128 0.49 . . . . 72.33 110.832 174.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.6 m -123.72 -173.89 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 109.33 -0.619 . . . . 74.54 109.33 -177.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 55.4 mt 69.89 77.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 O-C-N 124.415 1.072 . . . . 73.4 109.642 177.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.28 88.56 6.52 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-N 115.592 -0.731 . . . . 75.12 110.387 177.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 175.94 173.21 0.34 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.29 1.036 . . . . 62.41 108.713 -172.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.0 m 75.32 -157.67 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.403 1.081 . . . . 54.44 110.386 -178.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.0 p -153.5 135.48 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-O 120.997 0.427 . . . . 73.45 109.889 -175.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.23 128.11 34.21 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.924 -0.58 . . . . 74.35 109.649 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.565 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -140.49 159.84 41.3 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 118.633 -0.698 . . . . 71.33 112.322 -178.783 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.708 HG12 HG12 ' A' ' 80' ' ' VAL . 4.5 mt -114.04 138.73 42.93 Favored 'Isoleucine or valine' 0 C--O 1.264 1.855 0 CA-C-N 119.927 1.24 . . . . 53.42 107.725 170.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -102.79 114.53 28.86 Favored 'General case' 0 CA--C 1.561 1.401 0 O-C-N 125.903 2.002 . . . . 64.3 109.399 172.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.419 HG23 HG22 ' A' ' 78' ' ' VAL . 2.1 p -125.58 106.04 15.62 Favored 'Isoleucine or valine' 0 C--N 1.37 1.475 0 CA-C-N 120.62 1.555 . . . . 73.0 109.322 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -115.31 168.32 12.57 Favored Glycine 0 C--N 1.354 1.549 0 C-N-CA 120.687 -0.768 . . . . 64.11 112.274 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.0 m120 50.79 24.92 1.91 Allowed 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 114.617 1.34 . . . . 64.04 114.617 -177.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.422 HD23 ' H ' ' A' ' 15' ' ' LEU . 1.9 pt? -75.69 136.2 70.96 Favored Pre-proline 0 C--O 1.239 0.522 0 C-N-CA 123.335 0.654 . . . . 61.24 110.709 178.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -73.71 126.35 10.71 Favored 'Trans proline' 0 CA--C 1.553 1.468 0 C-N-CA 121.422 1.414 . . . . 71.11 111.685 175.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.5 t 60.33 100.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.005 0.922 . . . . 51.3 111.129 -174.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 -64.79 132.9 50.79 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.086 -0.506 . . . . 72.42 111.789 -177.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.7 m -66.02 121.43 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.895 0 CA-C-N 114.557 -1.201 . . . . 61.31 109.614 -176.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.84 154.06 28.66 Favored 'General case' 0 C--N 1.377 1.768 0 CA-C-N 119.212 0.914 . . . . 64.4 110.576 -176.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.9 p -47.18 -48.09 23.88 Favored 'General case' 0 C--N 1.375 1.699 0 N-CA-C 116.036 1.865 . . . . 72.14 116.036 -174.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.19 -46.46 75.84 Favored 'General case' 0 C--O 1.285 2.93 0 N-CA-C 114.41 1.263 . . . . 52.24 114.41 175.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -64.34 -35.45 80.9 Favored 'General case' 0 C--N 1.372 1.545 0 CA-C-O 118.002 -0.999 . . . . 74.22 110.142 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.528 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 1.2 t -66.82 -44.43 89.11 Favored 'Isoleucine or valine' 0 C--N 1.385 2.139 0 CA-C-O 116.552 -1.689 . . . . 72.11 110.722 174.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.01 -56.15 24.17 Favored 'General case' 0 C--N 1.373 1.602 0 CA-C-N 120.641 1.564 . . . . 72.35 110.747 177.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.55 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 12.9 m-80 -81.33 -57.01 3.68 Favored 'General case' 0 C--O 1.294 3.418 0 CA-C-N 122.156 2.253 . . . . 74.44 116.364 -176.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -68.36 -26.99 65.86 Favored 'General case' 0 C--N 1.354 0.777 0 C-N-CA 119.566 -0.854 . . . . 54.42 111.218 -175.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.528 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 35.7 m-85 -90.98 -22.55 20.77 Favored 'General case' 0 CA--C 1.565 1.544 0 C-N-CA 118.337 -1.345 . . . . 73.41 114.222 173.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.55 ' HG3' ' O ' ' A' ' 26' ' ' ASN 0.259 2.5 ppt_? -54.27 -28.34 41.12 Favored 'General case' 0 N--CA 1.503 2.218 0 CA-C-N 120.161 1.346 . . . . 72.01 112.285 163.916 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.566 ' O ' ' HD2' ' A' ' 30' ' ' LYS 0.257 1.7 tptm -52.03 -28.63 17.88 Favored 'General case' 0 N--CA 1.518 2.946 0 C-N-CA 118.445 -1.302 . . . . 64.25 113.742 168.433 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -80.22 -44.17 20.18 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 120.023 1.283 . . . . 63.0 111.488 -166.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -169.24 44.28 0.21 Allowed Glycine 0 C--N 1.341 0.859 0 C-N-CA 117.712 -2.185 . . . . 72.01 114.45 162.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 60.38 87.33 0.09 Allowed 'General case' 0 C--N 1.359 1.005 0 C-N-CA 123.983 0.913 . . . . 53.02 109.9 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.467 HG22 ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -67.36 138.45 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-N 114.976 -1.011 . . . . 70.43 112.471 -178.325 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.419 ' H ' HD22 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -103.31 -26.49 12.92 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 109.63 -0.507 . . . . 72.15 109.63 173.115 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp -149.66 137.36 20.17 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-O 118.826 -0.606 . . . . 64.22 109.889 -173.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -140.84 110.06 6.22 Favored 'General case' 0 C--N 1.364 1.226 0 CA-C-N 119.564 1.075 . . . . 71.14 109.268 176.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -109.13 146.59 33.84 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 117.762 -1.575 . . . . 73.33 112.847 177.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.8 t -114.27 110.6 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 106.317 -1.735 . . . . 74.52 106.317 176.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.0 mttm -121.45 137.25 54.8 Favored 'General case' 0 CA--C 1.563 1.446 0 CA-C-O 118.909 -0.567 . . . . 64.12 110.301 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.97 143.92 50.9 Favored 'General case' 0 C--N 1.371 1.516 0 CA-C-N 120.437 1.471 . . . . 64.1 108.122 -168.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.632 HG23 ' H ' ' A' ' 44' ' ' SER . 6.4 t -99.98 172.1 7.43 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-N 120.683 1.583 . . . . 71.22 110.941 -178.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.8 t -75.37 -9.95 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.208 0 C-N-CA 123.502 0.721 . . . . 64.04 112.077 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.632 ' H ' HG23 ' A' ' 42' ' ' THR . 0.8 OUTLIER -89.27 7.57 34.85 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 121.735 -0.603 . . . . 74.03 110.24 -177.307 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.73 -4.63 78.43 Favored Glycine 0 CA--C 1.537 1.417 0 N-CA-C 115.952 1.141 . . . . 61.34 115.952 178.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.94 131.79 33.99 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 118.429 1.115 . . . . 61.33 109.903 176.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.93 146.89 28.4 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 108.606 -0.887 . . . . 61.41 108.606 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -127.49 146.84 50.36 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 119.211 -0.995 . . . . 70.23 108.555 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.417 ' HB3' HG13 ' A' ' 12' ' ' VAL . . . -121.4 139.08 53.91 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 119.486 -0.886 . . . . 51.23 110.295 172.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -125.28 117.14 23.15 Favored 'General case' 0 C--O 1.263 1.803 0 N-CA-C 106.864 -1.532 . . . . 72.55 106.864 -167.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.33 113.12 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 114.351 1.241 . . . . 74.05 114.351 -163.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -90.21 108.81 19.98 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 115.002 -0.999 . . . . 70.4 112.604 -171.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -108.51 155.61 20.43 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 112.145 0.424 . . . . 73.21 112.145 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -81.72 -26.36 34.66 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 113.809 1.04 . . . . 70.12 113.809 173.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.48 120.89 39.49 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 119.208 0.913 . . . . 42.3 110.328 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.91 -35.87 59.64 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 114.773 1.397 . . . . 71.42 114.773 172.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.27 0.0 OUTLIER -80.71 -30.0 36.38 Favored 'General case' 0 CA--C 1.564 1.5 0 CA-C-N 120.828 1.649 . . . . 70.5 113.435 -167.144 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -62.21 -50.57 71.27 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-N 118.85 0.75 . . . . 74.34 112.521 175.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.0 -25.53 21.53 Favored 'General case' 0 CA--C 1.57 1.712 0 N-CA-C 116.369 1.989 . . . . 64.4 116.369 177.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.73 -43.05 57.9 Favored 'General case' 0 CA--C 1.581 2.171 0 C-N-CA 125.482 1.513 . . . . 44.11 114.231 178.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -53.54 -48.14 69.34 Favored 'General case' 0 N--CA 1.518 2.944 0 CA-C-N 119.654 1.116 . . . . 75.32 113.771 169.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.635 ' O ' ' HD2' ' A' ' 66' ' ' LYS . . . -72.19 -32.91 67.25 Favored 'General case' 0 C--N 1.31 -1.131 0 O-C-N 120.786 -1.197 . . . . 60.02 111.777 179.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.722 HD12 HG13 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -73.33 -41.04 57.51 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.053 0 CA-C-O 117.247 -1.358 . . . . 73.35 112.141 -177.264 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.48 -34.0 70.41 Favored 'General case' 0 CA--C 1.557 1.219 0 CA-C-N 120.505 1.502 . . . . 71.24 114.285 161.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.54 -23.89 66.98 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 120.816 1.644 . . . . 64.45 112.773 175.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.635 ' HD2' ' O ' ' A' ' 62' ' ' ALA 0.283 0.0 OUTLIER -110.48 16.89 21.29 Favored 'General case' 0 N--CA 1.514 2.738 0 N-CA-C 117.1 2.259 . . . . 61.24 117.1 160.64 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.418 0.0 OUTLIER -79.72 160.03 26.41 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 120.016 1.28 . . . . 71.15 113.945 -176.381 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.14 29.33 2.38 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 119.095 -1.526 . . . . 32.51 114.593 -158.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.791 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -53.06 125.95 19.01 Favored 'General case' 0 C--N 1.37 1.472 0 CA-C-N 117.268 0.534 . . . . 53.15 111.19 -178.195 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -131.23 150.76 52.01 Favored 'General case' 0 C--O 1.259 1.6 0 CA-C-N 115.63 -0.713 . . . . 70.23 112.018 -174.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -147.59 146.66 29.47 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 127.872 2.469 . . . . 70.33 107.508 -168.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 73.22 62.54 0.1 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.975 0.893 . . . . 42.11 112.844 -176.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.44 -13.19 61.5 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 117.157 1.623 . . . . 51.15 117.157 169.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -112.79 122.23 47.04 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 106.947 -1.501 . . . . 55.45 106.947 154.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.93 103.52 15.39 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 117.719 -1.134 . . . . 60.25 109.433 -175.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.791 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 14.3 tp -165.92 66.97 0.11 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 120.651 1.569 . . . . 54.33 112.485 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -96.54 110.83 23.15 Favored 'General case' 0 CA--C 1.569 1.704 0 CA-C-N 122.584 2.447 . . . . 74.25 109.733 -173.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.518 ' H ' ' HB3' ' A' ' 69' ' ' CYS . 22.6 t -123.48 115.54 45.69 Favored 'Isoleucine or valine' 0 C--N 1.358 0.967 0 O-C-N 120.577 -1.327 . . . . 74.34 107.806 170.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -138.7 143.12 38.98 Favored 'General case' 0 C--O 1.254 1.298 0 CA-C-N 120.574 1.533 . . . . 53.21 111.317 176.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.722 HG13 HD12 ' A' ' 63' ' ' ILE . 8.8 m -88.01 122.28 70.12 Favored Pre-proline 0 N--CA 1.437 -1.11 0 CA-C-N 114.622 -1.172 . . . . 72.44 111.412 168.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.565 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 61.2 Cg_endo -91.76 32.98 0.29 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.67 2.247 . . . . 63.22 111.447 159.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.3 10.62 5.33 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 112.58 0.585 . . . . 71.1 112.58 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -79.31 69.92 5.62 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 123.174 0.296 . . . . 61.53 111.427 -167.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -170.44 40.11 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.014 0.926 . . . . 64.24 109.785 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.5 ttt-85 67.04 -75.28 0.06 Allowed 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 125.805 1.642 . . . . 70.23 113.879 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 . . . . . 0 C--O 1.25 1.125 0 N-CA-C 108.715 -0.846 . . . . 74.23 108.715 171.333 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.932 0 N-CA-C 111.949 -0.46 . . . . 51.31 111.949 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 48.0 t -144.24 124.41 13.71 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.445 0.298 . . . . 51.23 111.036 -177.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -152.7 151.42 30.53 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.339 0.656 . . . . 73.53 110.551 177.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 ptp -152.46 94.99 1.97 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.18 0.592 . . . . 74.1 111.628 175.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.9 t -130.31 151.13 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 109.125 -0.694 . . . . 75.05 109.125 176.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.5 tt -70.44 98.34 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.131 0 CA-C-O 121.636 0.731 . . . . 43.33 111.448 175.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.0 mtm-85 -135.48 151.89 50.82 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 109.322 -0.621 . . . . 75.25 109.322 167.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -112.76 100.05 8.39 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 121.028 -0.269 . . . . 53.13 110.985 -170.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.4 t -153.43 -170.29 3.55 Favored 'General case' 0 CA--C 1.556 1.202 0 N-CA-C 108.919 -0.771 . . . . 71.41 108.919 -174.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.57 114.77 18.66 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.885 0 N-CA-C 107.114 -1.439 . . . . 71.23 107.114 175.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 p -83.64 124.03 30.4 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 114.195 -1.366 . . . . 60.32 109.723 -173.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.439 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 3.2 ptt180 -124.99 151.29 45.74 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 120.251 -0.58 . . . . 63.43 111.716 -170.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.683 HD12 ' HB ' ' A' ' 51' ' ' ILE . 7.7 mt -116.94 137.17 51.71 Favored 'Isoleucine or valine' 0 C--O 1.259 1.569 0 CA-C-N 120.041 1.291 . . . . 74.3 108.855 -175.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -106.05 113.71 27.41 Favored 'General case' 0 CA--C 1.574 1.876 0 O-C-N 125.903 2.002 . . . . 73.32 110.359 176.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.666 HG23 HG22 ' A' ' 78' ' ' VAL . 1.1 p -125.87 103.89 12.37 Favored 'Isoleucine or valine' 0 C--N 1.375 1.674 0 CA-C-N 120.194 1.361 . . . . 61.11 108.949 177.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -118.26 175.01 15.53 Favored Glycine 0 C--N 1.353 1.478 0 C-N-CA 120.652 -0.785 . . . . 75.43 113.354 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 51.34 29.11 4.8 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 115.697 1.74 . . . . 70.3 115.697 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.429 HD11 ' H ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -87.26 150.86 50.29 Favored Pre-proline 0 CA--C 1.555 1.15 0 CA-C-N 119.27 0.941 . . . . 55.23 110.406 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -82.94 128.86 5.23 Favored 'Trans proline' 0 CA--C 1.567 2.149 0 C-N-CA 120.8 1.0 . . . . 43.24 112.487 177.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.5 p 113.6 -29.16 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.631 0 C-N-CA 128.736 2.814 . . . . 62.41 111.045 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 68.17 105.28 0.05 Allowed 'General case' 0 C--N 1.358 0.949 0 C-N-CA 124.859 1.264 . . . . 72.23 110.285 -167.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.52 HG21 HG13 ' A' ' 24' ' ' VAL . 7.4 p -76.6 118.32 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.292 0 CA-C-N 114.874 -1.057 . . . . 62.54 108.936 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.9 m -82.23 160.0 23.09 Favored 'General case' 0 CA--C 1.559 1.303 0 CA-C-O 117.744 -1.122 . . . . 55.25 108.449 178.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.453 ' O ' ' HB3' ' A' ' 25' ' ' GLU . 5.6 p -50.64 -39.77 51.37 Favored 'General case' 0 C--N 1.378 1.834 0 N-CA-C 115.3 1.592 . . . . 73.53 115.3 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.34 -33.08 73.03 Favored 'General case' 0 CA--C 1.576 1.963 0 N-CA-C 115.51 1.67 . . . . 71.34 115.51 177.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -68.34 -54.11 19.57 Favored 'General case' 0 C--O 1.283 2.844 0 CA-C-N 119.719 1.145 . . . . 75.41 111.295 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.52 HG13 HG21 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -57.7 -54.04 36.82 Favored 'Isoleucine or valine' 0 C--N 1.368 1.398 0 O-C-N 124.573 1.17 . . . . 43.31 111.389 176.668 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.453 ' HB3' ' O ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -49.36 -46.79 47.57 Favored 'General case' 0 CA--C 1.566 1.559 0 CA-C-O 116.931 -1.509 . . . . 74.31 114.836 170.205 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -71.39 -55.58 7.68 Favored 'General case' 0 C--O 1.295 3.481 0 CA-C-N 122.525 2.42 . . . . 70.42 112.634 -177.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -57.77 -38.82 76.1 Favored 'General case' 0 C--N 1.396 2.598 0 CA-C-O 118.965 -0.541 . . . . 42.44 111.551 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -83.54 -35.61 24.66 Favored 'General case' 0 C--N 1.359 1.008 0 C-N-CA 118.564 -1.255 . . . . 73.45 113.277 -178.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.421 ' HB3' ' O ' ' A' ' 25' ' ' GLU . 20.4 ptt85 -52.27 -36.62 53.22 Favored 'General case' 0 N--CA 1.507 2.409 0 CA-C-O 117.923 -1.037 . . . . 71.22 112.099 171.034 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.476 ' HE2' ' CG ' ' A' ' 31' ' ' TYR 0.289 0.0 OUTLIER -71.92 -30.84 65.77 Favored 'General case' 0 C--N 1.374 1.653 0 C-N-CA 116.311 -2.156 . . . . 62.44 112.71 -173.322 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.494 ' CB ' ' HA ' ' A' ' 59' ' ' ALA . 54.4 m-85 -82.75 -46.27 13.35 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 112.169 0.433 . . . . 74.1 112.169 177.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -150.14 143.76 11.1 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 118.671 0.669 . . . . 45.2 112.217 169.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -63.18 117.96 7.28 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 113.331 0.863 . . . . 72.2 113.331 -166.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.44 140.98 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-N 115.539 -0.755 . . . . 73.31 111.525 174.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.0 mp -103.8 -24.35 13.32 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 119.538 -0.865 . . . . 71.22 112.91 170.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.33 135.4 12.98 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 108.632 -0.877 . . . . 73.03 108.632 -175.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 41.8 t -145.96 115.2 7.07 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 120.125 1.33 . . . . 71.43 110.396 174.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.09 150.2 50.58 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 119.56 -0.856 . . . . 45.35 111.947 -176.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -116.07 116.72 53.21 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.53 0 CA-C-O 121.45 0.643 . . . . 73.22 110.578 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.0 mttp -108.53 141.99 39.61 Favored 'General case' 0 CA--C 1.565 1.531 0 C-N-CA 125.698 1.599 . . . . 70.44 107.762 -170.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.79 142.65 50.65 Favored 'General case' 0 CA--C 1.57 1.729 0 CA-C-N 122.329 2.331 . . . . 75.24 109.567 -177.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.613 HG23 ' H ' ' A' ' 44' ' ' SER . 5.0 t -100.59 176.88 5.18 Favored 'General case' 0 CA--C 1.568 1.64 0 CA-C-N 120.957 1.708 . . . . 64.22 111.572 176.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.4 t -77.33 -9.5 12.55 Favored 'Isoleucine or valine' 0 C--N 1.373 1.623 0 C-N-CA 123.834 0.854 . . . . 64.43 112.698 -176.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.613 ' H ' HG23 ' A' ' 42' ' ' THR . 8.9 t -90.72 2.62 55.83 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 121.584 -0.698 . . . . 60.34 111.03 -173.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.18 -7.26 68.02 Favored Glycine 0 CA--C 1.537 1.414 0 N-CA-C 115.184 0.834 . . . . 71.44 115.184 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.35 132.5 37.43 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 117.886 0.843 . . . . 74.44 108.89 167.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.75 145.55 43.42 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.743 -0.836 . . . . 74.35 108.743 -173.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -128.57 150.3 50.26 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.836 0.743 . . . . 74.33 110.693 -168.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -129.5 146.81 51.29 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.394 0.616 . . . . 74.3 112.045 175.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -132.9 114.09 13.63 Favored 'General case' 0 C--O 1.263 1.764 0 N-CA-C 106.442 -1.688 . . . . 71.33 106.442 -158.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.683 ' HB ' HD12 ' A' ' 10' ' ' ILE . 0.3 OUTLIER -124.29 110.52 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.662 0 C-N-CA 118.493 -1.283 . . . . 43.55 109.491 -173.986 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -109.74 103.09 11.86 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.464 -1.244 . . . . 31.22 110.158 -174.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.615 ' CE2' ' HB3' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -111.43 161.44 16.12 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 115.306 -0.861 . . . . 63.33 113.241 -174.502 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.14 -42.0 69.75 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 112.281 0.474 . . . . 71.1 112.281 173.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -113.17 114.8 27.29 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 118.54 -1.264 . . . . 74.43 109.901 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.97 -21.8 56.58 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 115.902 1.816 . . . . 61.53 115.902 169.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.293 10.6 ptm180 -75.69 -40.96 54.95 Favored 'General case' 0 CA--C 1.567 1.601 0 CA-C-N 120.402 1.455 . . . . 74.34 114.364 -172.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -77.68 -36.33 51.35 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 117.064 2.246 . . . . 53.13 117.064 177.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.615 ' HB3' ' CE2' ' A' ' 53' ' ' PHE 0.303 . . -75.27 -14.6 60.52 Favored 'General case' 0 CA--C 1.584 2.252 0 CA-C-N 120.564 1.529 . . . . 32.0 112.266 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -44.88 -35.74 2.96 Favored 'General case' 0 CA--C 1.583 2.239 0 CA-C-N 114.159 -1.382 . . . . 51.45 114.24 161.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.471 ' O ' ' HB3' ' A' ' 65' ' ' GLU . 46.3 m-20 -52.98 -54.75 30.46 Favored 'General case' 0 N--CA 1.507 2.384 0 CA-C-N 120.822 1.646 . . . . 54.32 113.311 164.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.406 ' O ' ' HG2' ' A' ' 66' ' ' LYS . . . -57.09 -35.78 69.81 Favored 'General case' 0 N--CA 1.507 2.385 0 CA-C-N 119.533 1.06 . . . . 61.42 113.816 171.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.456 HD12 HG13 ' A' ' 80' ' ' VAL 0.251 0.2 OUTLIER -73.53 -45.33 51.8 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.419 0 C-N-CA 119.157 -1.017 . . . . 13.43 113.443 -177.437 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.486 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -56.6 -30.46 63.25 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 120.319 1.418 . . . . 73.54 114.495 162.403 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.471 ' HB3' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -79.7 -20.46 46.47 Favored 'General case' 0 CA--C 1.55 0.967 0 O-C-N 120.825 -1.172 . . . . 72.21 111.84 -178.133 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 62' ' ' ALA . 60.7 mmtt -98.35 9.54 42.82 Favored 'General case' 0 CA--C 1.598 2.804 0 CA-C-O 118.697 -0.668 . . . . 64.41 112.533 163.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.486 ' HB3' ' HA ' ' A' ' 64' ' ' LYS 0.408 0.0 OUTLIER -79.79 160.54 26.12 Favored 'General case' 0 N--CA 1.516 2.858 0 CA-C-N 120.475 1.489 . . . . 71.21 114.619 -173.165 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.83 30.64 2.11 Favored Glycine 0 N--CA 1.439 -1.116 0 C-N-CA 118.529 -1.796 . . . . 74.22 115.466 -164.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.732 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -51.09 124.67 11.97 Favored 'General case' 0 C--N 1.372 1.577 0 O-C-N 124.65 0.853 . . . . 65.24 112.391 -173.791 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -133.4 150.73 51.79 Favored 'General case' 0 C--O 1.255 1.377 0 CA-C-N 115.574 -0.739 . . . . 51.32 112.311 -176.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -147.77 145.67 28.89 Favored 'General case' 0 C--N 1.354 0.795 0 C-N-CA 127.305 2.242 . . . . 75.34 106.574 -169.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 74.01 63.44 0.08 Allowed 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 113.17 0.804 . . . . 75.54 113.17 -175.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.32 -12.95 63.37 Favored Glycine 0 N--CA 1.472 1.057 0 N-CA-C 116.757 1.463 . . . . 73.21 116.757 168.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -113.43 121.28 43.84 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 106.309 -1.738 . . . . 64.51 106.309 152.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.28 104.05 15.93 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 117.431 -1.271 . . . . 74.32 109.454 -176.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.732 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -168.63 69.82 0.08 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 120.422 1.464 . . . . 71.24 112.273 179.347 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -95.77 108.83 21.19 Favored 'General case' 0 C--N 1.369 1.448 0 CA-C-N 122.443 2.383 . . . . 73.32 109.375 -171.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.666 HG22 HG23 ' A' ' 12' ' ' VAL . 50.1 t -127.77 118.39 48.88 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.888 0 O-C-N 120.828 -1.17 . . . . 61.42 109.098 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -146.61 144.9 29.85 Favored 'General case' 0 C--O 1.269 2.093 0 CA-C-N 120.651 1.569 . . . . 64.13 110.512 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.456 HG13 HD12 ' A' ' 63' ' ' ILE . 29.6 m -89.4 124.45 64.4 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-N 115.447 -0.797 . . . . 45.31 111.842 166.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.439 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 66.8 Cg_endo -86.57 29.9 0.49 Allowed 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 123.023 2.482 . . . . 71.11 113.747 168.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -128.71 -27.42 2.58 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.354 0.502 . . . . 71.44 112.354 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 57.26 77.53 0.27 Allowed 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 124.581 1.152 . . . . 73.42 113.286 -176.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 63.79 -148.19 0.31 Allowed 'General case' 0 C--N 1.373 1.609 0 C-N-CA 123.899 0.879 . . . . 41.34 110.619 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 7.8 ttt85 -129.41 86.89 2.47 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 121.008 -1.057 . . . . 75.43 110.075 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 . . . . . 0 C--N 1.356 0.849 0 CA-C-O 118.427 -0.796 . . . . 71.35 109.703 -165.624 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.896 0 N-CA-C 112.013 -0.435 . . . . 54.44 112.013 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 40.2 m -112.37 -83.91 0.58 Allowed 'General case' 0 C--O 1.219 -0.525 0 CA-C-O 118.717 -0.659 . . . . 60.42 111.489 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 68.76 92.01 0.09 Allowed 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 125.499 1.52 . . . . 73.42 110.334 -177.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpp? -102.92 159.12 15.78 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 120.836 -0.346 . . . . 70.12 110.353 -176.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 66.2 t 77.2 -63.24 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 C-N-CA 125.813 1.645 . . . . 75.2 111.615 176.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.617 HG22 ' HD2' ' A' ' 4' ' ' ARG . 2.8 mm 69.31 -67.18 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 126.816 2.047 . . . . 73.14 112.121 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.617 ' HD2' HG22 ' A' ' 3' ' ' ILE . 2.5 ptm180 -177.18 39.11 0.01 OUTLIER 'General case' 0 C--N 1.366 1.302 0 CA-C-N 119.061 0.846 . . . . 74.15 110.508 -169.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 78.87 121.73 0.05 OUTLIER 'General case' 0 N--CA 1.506 2.338 0 C-N-CA 125.962 1.705 . . . . 71.22 110.727 173.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.4 t -151.5 166.41 31.2 Favored 'General case' 0 CA--C 1.549 0.922 0 O-C-N 120.956 -1.09 . . . . 73.31 110.946 -174.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.3 m -115.0 119.94 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-O 121.22 0.534 . . . . 62.13 110.279 177.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.51 ' OG ' ' HB2' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -86.1 121.06 28.17 Favored 'General case' 0 C--O 1.249 1.072 0 CA-C-O 121.157 0.503 . . . . 71.2 112.127 -176.205 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.498 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 11.3 ptt180 -143.81 152.9 41.8 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 113.792 1.034 . . . . 60.43 113.792 -172.034 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.6 HG12 HG12 ' A' ' 80' ' ' VAL . 7.8 mt -115.31 135.35 55.56 Favored 'Isoleucine or valine' 0 C--N 1.375 1.693 0 CA-C-N 120.199 1.363 . . . . 74.35 107.995 177.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -99.56 122.04 42.05 Favored 'General case' 0 CA--C 1.572 1.796 0 O-C-N 125.43 1.706 . . . . 75.2 110.283 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.469 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 67.3 t -124.71 110.99 26.48 Favored 'Isoleucine or valine' 0 C--N 1.366 1.32 0 O-C-N 120.643 -1.286 . . . . 72.33 108.594 -178.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.33 162.97 12.42 Favored Glycine 0 C--N 1.341 0.823 0 C-N-CA 119.135 -1.507 . . . . 53.2 112.209 173.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 51.16 22.93 1.42 Allowed 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 116.379 1.992 . . . . 71.41 116.379 178.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.02 125.41 91.41 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 123.45 0.7 . . . . 63.04 111.054 169.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -91.34 123.35 0.78 Allowed 'Trans proline' 0 CA--C 1.556 1.586 0 C-N-CA 121.873 1.715 . . . . 73.22 111.495 169.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.5 m 34.75 -100.66 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 124.741 1.216 . . . . 73.32 114.03 -173.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.4 t60 53.26 -88.95 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 126.243 1.817 . . . . 72.24 112.408 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.2 m -98.18 117.03 42.4 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.863 0 C-N-CA 119.435 -0.906 . . . . 71.33 109.713 177.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.9 m -80.76 170.96 15.62 Favored 'General case' 0 C--N 1.387 2.234 0 CA-C-O 117.197 -1.383 . . . . 75.22 109.076 166.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.9 m -46.53 -49.46 18.57 Favored 'General case' 0 C--O 1.27 2.148 0 CA-C-N 120.134 1.334 . . . . 72.14 114.492 -173.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.71 -43.59 97.64 Favored 'General case' 0 CA--C 1.578 2.03 0 CA-C-N 115.271 -0.877 . . . . 62.35 113.277 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.511 10.7 m-20 -76.99 -18.94 57.88 Favored 'General case' 0 CA--C 1.559 1.309 0 CA-C-O 115.715 -2.088 . . . . 74.21 114.146 172.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.429 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 2.0 t -59.65 -44.57 93.76 Favored 'Isoleucine or valine' 0 C--N 1.424 3.83 0 CA-C-N 123.411 2.823 . . . . 71.45 108.281 163.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.48 -54.52 45.61 Favored 'General case' 0 C--N 1.376 1.731 0 CA-C-O 116.455 -1.736 . . . . 75.53 112.677 174.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -73.81 -54.39 8.11 Favored 'General case' 1 C--O 1.309 4.187 0 CA-C-N 122.369 2.349 . . . . 72.24 114.793 -174.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -58.21 -37.06 74.08 Favored 'General case' 0 C--N 1.383 2.063 0 CA-C-O 117.325 -1.322 . . . . 64.02 110.428 177.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.429 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 47.3 m-85 -84.46 -24.2 29.58 Favored 'General case' 0 C--N 1.373 1.629 0 C-N-CA 115.716 -2.393 . . . . 71.15 113.457 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.53 ' HA ' HG22 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -64.95 -30.79 71.8 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 117.286 -1.34 . . . . 74.24 114.055 175.534 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.447 ' HE2' ' CD1' ' A' ' 31' ' ' TYR 0.323 0.0 OUTLIER -72.82 -34.8 67.09 Favored 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 113.354 -3.338 . . . . 74.45 111.986 175.338 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.547 ' HB3' ' HA ' ' A' ' 59' ' ' ALA . 57.8 m-85 -76.79 -40.96 46.41 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-O 118.975 -0.536 . . . . 62.32 110.783 -169.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -140.21 165.21 26.06 Favored Glycine 0 C--N 1.341 0.812 0 CA-C-O 118.309 -1.273 . . . . 73.2 110.666 152.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -76.71 102.77 6.35 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-N 119.95 1.875 . . . . 75.22 110.45 -174.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.53 HG22 ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -71.32 136.73 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 113.824 1.046 . . . . 74.02 113.824 -176.113 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.4 mt -89.55 -49.02 6.92 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 113.266 0.839 . . . . 74.14 113.266 166.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.65 128.2 20.18 Favored 'General case' 0 CA--C 1.585 2.322 0 CA-C-N 120.077 1.308 . . . . 73.41 111.901 173.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 4.8 m -105.65 111.03 23.56 Favored 'General case' 0 C--N 1.388 2.259 0 N-CA-C 107.473 -1.306 . . . . 73.13 107.473 166.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -113.11 139.93 48.31 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 117.855 -1.538 . . . . 75.35 111.41 176.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 t -113.0 110.09 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 106.77 -1.567 . . . . 74.12 106.77 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.7 mmtt -107.08 142.4 36.8 Favored 'General case' 0 CA--C 1.556 1.181 0 CA-C-O 118.792 -0.623 . . . . 73.12 109.455 175.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.39 142.78 51.01 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 120.063 1.302 . . . . 61.05 108.384 -170.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.614 HG23 ' H ' ' A' ' 44' ' ' SER . 12.0 t -100.01 167.75 10.29 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 120.45 1.477 . . . . 55.41 111.42 -178.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.0 m -61.84 -7.5 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.746 0 N-CA-C 115.993 1.849 . . . . 72.52 115.993 175.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.614 ' H ' HG23 ' A' ' 42' ' ' THR . 8.1 t -98.05 7.57 46.11 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 119.36 0.982 . . . . 71.25 110.517 -174.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.25 -4.35 77.22 Favored Glycine 0 CA--C 1.544 1.887 0 N-CA-C 115.717 1.047 . . . . 72.31 115.717 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -83.37 134.75 34.88 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-N 117.954 0.877 . . . . 74.31 110.485 177.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.31 149.75 25.07 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.619 -0.882 . . . . 65.14 108.619 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -125.12 145.02 50.13 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 118.915 -1.114 . . . . 73.12 109.568 175.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.469 ' HB3' ' HB ' ' A' ' 12' ' ' VAL . . . -115.47 137.88 51.59 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.915 -0.402 . . . . 72.14 109.915 176.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.47 115.85 16.71 Favored 'General case' 0 C--O 1.256 1.446 0 N-CA-C 108.168 -1.049 . . . . 72.31 108.168 -173.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.498 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 0.2 OUTLIER -123.76 108.77 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 C-N-CA 118.358 -1.337 . . . . 71.43 110.827 -171.693 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 8' ' ' SER . 33.6 tt0 -102.81 108.34 19.53 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 115.147 -0.933 . . . . 70.34 110.92 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.411 ' HB3' ' HA ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -114.95 156.33 25.23 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 118.748 -0.644 . . . . 55.45 112.673 -179.151 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -59.29 -32.44 70.04 Favored 'General case' 0 N--CA 1.516 2.834 0 N-CA-C 112.937 0.717 . . . . 73.15 112.937 166.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -115.41 113.0 23.16 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 119.151 -1.02 . . . . 73.42 109.966 -177.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.514 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -77.33 -41.39 40.71 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 116.084 1.883 . . . . 71.51 116.084 170.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.26 6.5 ptt180 -75.78 -33.33 60.17 Favored 'General case' 0 CA--C 1.573 1.864 0 N-CA-C 114.516 1.302 . . . . 65.22 114.516 -168.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.43 -44.97 73.79 Favored 'General case' 0 N--CA 1.518 2.934 0 CA-C-N 120.737 1.608 . . . . 74.14 114.034 173.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.547 ' HA ' ' HB3' ' A' ' 31' ' ' TYR . . . -50.02 -21.08 1.11 Allowed 'General case' 0 CA--C 1.598 2.821 0 N-CA-C 117.281 2.326 . . . . 73.02 117.281 171.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.409 ' O ' ' HG3' ' A' ' 64' ' ' LYS . . . -49.14 -34.15 13.61 Favored 'General case' 0 CA--C 1.585 2.319 0 CA-C-O 117.645 -1.169 . . . . 74.33 113.797 167.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.411 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 2.6 m-20 -52.39 -45.06 65.68 Favored 'General case' 0 C--N 1.394 2.519 0 CA-C-N 120.171 1.35 . . . . 74.24 113.789 165.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.503 ' O ' ' HD2' ' A' ' 66' ' ' LYS . . . -60.48 -54.02 50.49 Favored 'General case' 0 C--O 1.258 1.53 0 O-C-N 121.907 -0.496 . . . . 70.02 111.212 172.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.868 HD12 HG13 ' A' ' 80' ' ' VAL 0.262 0.4 OUTLIER -62.5 -41.22 91.09 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 C-N-CA 117.465 -1.694 . . . . 64.14 113.786 -173.948 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.447 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -62.06 -34.85 77.04 Favored 'General case' 0 CA--C 1.557 1.215 0 N-CA-C 115.588 1.699 . . . . 74.43 115.588 167.854 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 62' ' ' ALA . 0.2 OUTLIER -65.64 -34.83 79.13 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 121.168 1.804 . . . . 73.41 111.268 176.957 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.503 ' HD2' ' O ' ' A' ' 62' ' ' ALA 0.258 0.0 OUTLIER -103.07 18.42 21.73 Favored 'General case' 0 CA--C 1.575 1.921 0 C-N-CA 118.432 -1.307 . . . . 63.41 114.149 173.946 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.447 ' HB3' ' HA ' ' A' ' 64' ' ' LYS 0.323 0.5 OUTLIER -71.37 162.79 28.86 Favored 'General case' 0 N--CA 1.508 2.435 0 CA-C-N 118.975 0.807 . . . . 61.24 112.88 -174.857 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 120.44 31.99 1.19 Allowed Glycine 0 N--CA 1.438 -1.218 0 C-N-CA 119.024 -1.56 . . . . 63.35 115.533 -162.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.773 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -51.51 125.09 13.62 Favored 'General case' 0 C--N 1.375 1.704 0 CA-C-N 118.1 0.95 . . . . 74.4 111.768 176.444 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -133.66 149.36 51.56 Favored 'General case' 0 C--O 1.255 1.363 0 CA-C-N 114.766 -1.106 . . . . 73.23 111.482 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -148.25 144.66 27.8 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 126.225 1.81 . . . . 71.51 106.746 -166.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 68.89 65.98 0.29 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 124.244 0.965 . . . . 70.42 113.162 177.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.9 -12.34 60.81 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 116.86 1.504 . . . . 71.43 116.86 173.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -118.85 121.9 41.09 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 105.929 -1.878 . . . . 73.31 105.929 154.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.97 102.52 14.61 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 117.553 -1.213 . . . . 74.41 109.874 -172.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.773 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -169.2 58.64 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 CA-C-N 120.572 1.533 . . . . 73.14 114.419 -175.14 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.1 tpp85 -90.99 112.25 24.06 Favored 'General case' 0 CA--C 1.571 1.767 0 CA-C-N 122.258 2.299 . . . . 64.45 109.945 -170.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.502 ' H ' ' HB3' ' A' ' 69' ' ' CYS . 0.9 OUTLIER -119.78 121.69 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 O-C-N 120.325 -1.484 . . . . 73.12 108.678 173.928 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -146.58 132.5 19.13 Favored 'General case' 0 C--N 1.361 1.091 0 CA-C-N 119.75 1.159 . . . . 61.03 110.791 -165.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.868 HG13 HD12 ' A' ' 63' ' ' ILE . 7.8 m -89.62 124.56 63.78 Favored Pre-proline 0 C--N 1.349 0.559 0 C-N-CA 119.817 -0.753 . . . . 73.34 111.569 167.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.436 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 87.8 Cg_endo -89.91 17.17 1.58 Allowed 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 122.48 2.12 . . . . 72.34 113.625 166.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.514 ' CE1' ' HB1' ' A' ' 56' ' ' ALA . 5.6 p90 -110.74 -32.01 7.0 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.039 0.385 . . . . 61.03 112.039 175.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.0 t30 59.65 73.51 0.48 Allowed 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 124.574 1.15 . . . . 73.33 110.692 -176.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 59.62 -156.79 0.34 Allowed 'General case' 0 C--N 1.379 1.851 0 C-N-CA 124.066 0.946 . . . . 45.44 111.371 -178.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -118.29 71.66 0.84 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.806 -1.184 . . . . 74.31 109.003 176.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 . . . . . 0 C--O 1.251 1.177 0 N-CA-C 107.629 -1.248 . . . . 73.23 107.629 -153.633 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.141 0 N-CA-C 111.86 -0.496 . . . . 63.01 111.86 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.08 -176.69 4.15 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 110.19 -0.3 . . . . 71.53 110.19 -177.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -152.27 78.82 1.23 Allowed 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 120.906 0.384 . . . . 60.25 111.08 -171.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 mtt -156.64 139.31 15.08 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.361 1.064 . . . . 73.43 109.345 171.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.2 t -129.35 49.62 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-O 122.357 1.075 . . . . 75.04 108.857 173.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.9 mt -126.54 63.65 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 O-C-N 121.389 -0.819 . . . . 73.04 109.2 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -167.57 -160.57 0.36 Allowed 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 109.438 -0.579 . . . . 74.4 109.438 171.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -166.3 133.72 2.71 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 107.85 -1.167 . . . . 73.41 107.85 -170.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.0 t -169.23 -164.77 0.48 Allowed 'General case' 0 CA--C 1.562 1.439 0 N-CA-C 109.26 -0.644 . . . . 71.22 109.26 -178.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.24 127.52 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 108.448 -0.945 . . . . 74.32 108.448 170.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.1 p -83.72 130.03 34.95 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 114.769 -1.105 . . . . 74.31 108.115 173.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.523 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 0.2 OUTLIER -118.83 153.27 34.77 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 121.305 -0.872 . . . . 71.23 109.036 -177.407 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.5 mp -138.16 134.92 44.78 Favored 'Isoleucine or valine' 0 C--O 1.264 1.82 0 CA-C-N 119.811 1.187 . . . . 70.42 108.269 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -105.33 114.95 29.44 Favored 'General case' 0 CA--C 1.571 1.751 0 O-C-N 125.664 1.852 . . . . 65.32 110.407 177.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.575 HG23 HG22 ' A' ' 78' ' ' VAL . 2.0 p -123.84 104.41 14.07 Favored 'Isoleucine or valine' 0 C--N 1.369 1.432 0 CA-C-N 120.333 1.424 . . . . 75.23 108.079 178.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.446 ' H ' ' HG3' ' A' ' 77' ' ' ARG . . . -121.33 177.24 16.41 Favored Glycine 0 C--N 1.346 1.134 0 C-N-CA 120.362 -0.923 . . . . 21.54 112.722 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.6 m120 50.72 24.34 1.67 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 114.792 1.405 . . . . 62.14 114.792 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.635 HD23 ' H ' ' A' ' 15' ' ' LEU . 1.7 pt? -79.71 123.54 83.94 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 123.812 0.845 . . . . 70.1 110.6 -178.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -89.51 120.11 0.95 Allowed 'Trans proline' 0 CA--C 1.559 1.729 0 C-N-CA 121.053 1.168 . . . . 73.11 112.186 172.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.7 m 39.05 43.42 0.8 Allowed 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 124.989 1.316 . . . . 42.2 114.034 178.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.425 ' HB3' HD12 ' A' ' 15' ' ' LEU . 5.2 t-160 -95.11 -93.37 0.19 Allowed 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 119.418 -0.325 . . . . 74.54 110.64 -166.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.7 m -103.23 119.16 51.33 Favored 'Isoleucine or valine' 0 CA--C 1.596 2.745 0 CA-C-N 118.627 0.649 . . . . 75.44 109.943 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.75 155.17 25.62 Favored 'General case' 0 C--N 1.392 2.429 0 CA-C-N 120.888 1.676 . . . . 43.33 110.155 171.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.0 t -48.12 -48.8 33.76 Favored 'General case' 0 C--N 1.371 1.53 0 N-CA-C 115.477 1.658 . . . . 64.21 115.477 -173.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.94 -43.46 86.36 Favored 'General case' 0 CA--C 1.582 2.208 0 N-CA-C 114.206 1.187 . . . . 73.31 114.206 176.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.03 -30.2 70.22 Favored 'General case' 0 C--N 1.364 1.204 0 CA-C-O 117.397 -1.287 . . . . 72.23 111.223 173.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.537 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 1.6 t -66.78 -43.05 90.1 Favored 'Isoleucine or valine' 0 C--N 1.391 2.399 0 CA-C-O 116.633 -1.651 . . . . 72.04 110.021 171.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.518 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 4.3 tt0 -61.05 -55.01 37.7 Favored 'General case' 0 C--N 1.365 1.247 0 CA-C-N 121.476 1.944 . . . . 71.04 111.48 176.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -71.82 -59.26 2.84 Favored 'General case' 0 C--O 1.284 2.901 0 CA-C-N 121.21 1.823 . . . . 74.23 112.796 -176.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -71.12 -31.52 67.86 Favored 'General case' 0 C--N 1.364 1.21 0 CA-C-O 117.178 -1.391 . . . . 73.01 112.711 -176.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.537 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 5.1 m-85 -82.78 -29.01 29.94 Favored 'General case' 0 C--N 1.375 1.698 0 CA-C-N 122.057 2.208 . . . . 73.54 112.55 176.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.518 ' HB3' ' O ' ' A' ' 25' ' ' GLU . 2.9 ptt180 -54.27 -32.52 56.42 Favored 'General case' 0 C--N 1.379 1.884 0 CA-C-O 115.777 -2.059 . . . . 73.04 114.824 161.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.85 -48.06 73.38 Favored 'General case' 0 N--CA 1.518 2.965 0 CA-C-N 122.479 2.4 . . . . 64.21 111.674 167.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -75.71 -38.29 58.71 Favored 'General case' 0 C--O 1.213 -0.865 0 CA-C-O 118.639 -0.696 . . . . 65.35 111.803 -168.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -149.2 154.92 26.07 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 119.473 1.033 . . . . 64.33 111.148 168.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -77.22 105.19 8.17 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-N 118.075 0.937 . . . . 71.3 110.722 -175.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.739 HG13 ' SG ' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -73.61 132.83 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 N-CA-C 114.286 1.217 . . . . 74.5 114.286 -176.748 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 11.1 mp -108.67 -23.26 11.88 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.883 -1.053 . . . . 74.34 110.861 175.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 52' ' ' GLU . 8.1 tmtm? -152.2 131.66 12.97 Favored 'General case' 0 CA--C 1.565 1.52 0 N-CA-C 108.576 -0.898 . . . . 51.4 108.576 -172.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.739 ' SG ' HG13 ' A' ' 34' ' ' ILE . 19.5 m -139.48 110.39 6.81 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 107.251 -1.388 . . . . 52.43 107.251 175.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -122.3 127.67 50.13 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 117.563 -1.655 . . . . 74.12 110.635 176.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -117.88 112.86 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-O 121.841 0.829 . . . . 72.24 110.042 -178.003 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.3 mtmt -120.38 146.85 45.77 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 114.439 -1.255 . . . . 73.54 109.98 -170.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.11 145.98 49.68 Favored 'General case' 0 C--N 1.368 1.397 0 CA-C-N 120.68 1.582 . . . . 71.25 108.464 -172.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.627 HG23 ' H ' ' A' ' 44' ' ' SER . 4.0 t -99.79 167.09 10.76 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 121.129 1.786 . . . . 74.34 111.138 174.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.5 m -66.74 -3.7 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.575 0 N-CA-C 116.038 1.866 . . . . 71.31 116.038 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.627 ' H ' HG23 ' A' ' 42' ' ' THR . 10.2 t -98.27 7.22 46.54 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 119.253 0.933 . . . . 65.11 109.639 -171.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.78 -5.7 73.76 Favored Glycine 0 CA--C 1.54 1.606 0 N-CA-C 115.2 0.84 . . . . 70.31 115.2 -175.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.45 130.89 34.34 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 118.201 1.0 . . . . 71.2 109.578 175.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.28 146.94 39.81 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 108.854 -0.795 . . . . 72.22 108.854 -175.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -129.63 150.84 50.78 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.526 1.057 . . . . 73.52 110.754 -176.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -127.34 147.47 50.26 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-O 121.713 0.768 . . . . 70.13 111.572 171.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -132.74 118.58 19.24 Favored 'General case' 0 C--O 1.266 1.924 0 N-CA-C 106.367 -1.716 . . . . 73.4 106.367 -164.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.79 114.02 26.35 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.079 0 C-N-CA 120.09 -0.644 . . . . 71.44 109.885 -162.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.41 ' HB2' ' HB3' ' A' ' 36' ' ' LYS . 45.8 mt-10 -109.44 109.14 19.9 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 120.541 -0.464 . . . . 75.33 112.108 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -107.0 160.63 15.39 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 119.4 -0.333 . . . . 73.03 111.428 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -80.49 -25.99 38.47 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 113.514 0.931 . . . . 74.42 113.514 177.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -115.86 119.57 36.4 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.402 -0.592 . . . . 50.21 109.402 -178.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.6 -33.12 58.44 Favored 'General case' 0 CA--C 1.56 1.356 0 N-CA-C 117.024 2.231 . . . . 65.5 117.024 174.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.352 0.0 OUTLIER -79.58 -29.25 41.19 Favored 'General case' 0 C--N 1.377 1.78 0 CA-C-N 122.095 2.225 . . . . 73.14 114.448 -170.391 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.2 -31.14 60.82 Favored 'General case' 0 CA--C 1.586 2.363 0 CA-C-N 121.281 1.855 . . . . 73.43 115.955 171.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.47 -24.27 54.77 Favored 'General case' 0 CA--C 1.586 2.36 0 CA-C-N 120.563 1.528 . . . . 64.51 114.222 170.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.565 ' HA ' HG22 ' A' ' 63' ' ' ILE . . . -49.78 -37.81 31.48 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-O 116.608 -1.663 . . . . 75.32 113.958 173.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.585 ' O ' ' HB3' ' A' ' 65' ' ' GLU . 31.7 m-20 -54.09 -51.65 63.49 Favored 'General case' 0 C--N 1.395 2.56 0 CA-C-N 120.178 1.354 . . . . 72.22 112.066 169.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.59 -39.22 87.32 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 117.144 -1.408 . . . . 72.42 113.04 174.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.762 HD12 HG13 ' A' ' 80' ' ' VAL 0.305 0.6 OUTLIER -73.78 -45.97 48.45 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 116.601 -2.04 . . . . 63.21 113.348 -176.854 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.98 -34.49 59.95 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 114.368 1.247 . . . . 74.12 114.368 166.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.585 ' HB3' ' O ' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -83.05 -22.47 33.52 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-N 119.454 1.025 . . . . 75.31 112.158 -175.098 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -100.07 14.23 31.38 Favored 'General case' 0 CA--C 1.57 1.735 0 CA-C-O 118.981 -0.533 . . . . 74.24 110.866 174.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.361 0.0 OUTLIER -77.36 162.89 26.91 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 113.674 0.99 . . . . 73.23 113.674 -168.651 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.75 29.58 2.01 Favored Glycine 0 N--CA 1.437 -1.269 0 CA-C-O 117.886 -1.508 . . . . 73.13 115.007 -158.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.675 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 44.8 t -51.37 126.23 16.49 Favored 'General case' 0 C--N 1.383 2.041 0 CA-C-O 122.123 0.963 . . . . 63.03 110.317 170.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -135.17 143.0 46.23 Favored 'General case' 0 C--O 1.252 1.236 0 CA-C-N 113.282 -1.781 . . . . 70.1 111.705 -176.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -155.51 144.8 20.94 Favored 'General case' 0 C--N 1.348 0.541 0 N-CA-C 106.695 -1.594 . . . . 75.15 106.695 -164.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 71.11 65.64 0.16 Allowed 'General case' 0 N--CA 1.512 2.658 0 CA-C-O 121.608 0.718 . . . . 54.55 111.86 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.2 -13.68 63.03 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 116.995 1.558 . . . . 41.51 116.995 174.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -122.93 125.37 45.19 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 106.037 -1.838 . . . . 70.31 106.037 161.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.69 105.9 18.1 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 117.506 -1.235 . . . . 73.22 110.491 -172.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.675 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.3 OUTLIER -169.1 69.71 0.07 Allowed 'General case' 0 N--CA 1.505 2.31 0 CA-C-N 120.944 1.702 . . . . 62.42 113.688 179.327 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.446 ' HG3' ' H ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -92.35 118.09 30.56 Favored 'General case' 0 CA--C 1.576 1.961 0 CA-C-N 122.761 2.528 . . . . 71.34 111.604 -172.95 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.575 HG22 HG23 ' A' ' 12' ' ' VAL . 42.6 t -126.87 115.89 42.96 Favored 'Isoleucine or valine' 0 C--N 1.371 1.536 0 O-C-N 120.761 -1.212 . . . . 62.23 107.753 168.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -149.83 137.65 20.18 Favored 'General case' 0 C--N 1.37 1.483 0 CA-C-N 119.852 1.205 . . . . 65.01 111.651 -179.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.762 HG13 HD12 ' A' ' 63' ' ' ILE . 35.5 m -90.81 128.35 48.51 Favored Pre-proline 0 N--CA 1.445 -0.71 0 CA-C-N 115.317 -0.856 . . . . 63.41 110.389 170.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.523 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 43.8 Cg_endo -87.06 31.25 0.45 Allowed 'Trans proline' 0 CA--C 1.553 1.428 0 C-N-CA 122.198 1.932 . . . . 71.24 112.482 162.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -120.51 -30.67 4.48 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 111.483 0.179 . . . . 74.33 111.483 175.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 15.7 m120 69.93 -54.25 0.61 Allowed 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 126.156 1.782 . . . . 61.41 113.485 -174.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -175.11 -177.95 1.13 Allowed 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 107.862 -1.162 . . . . 63.31 107.862 -176.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -88.01 155.34 19.87 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 108.354 -0.98 . . . . 64.25 108.354 175.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 . . . . . 0 C--O 1.252 1.188 0 CA-C-O 118.144 -0.931 . . . . 61.3 108.771 -178.633 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.015 0 CA-C-O 119.465 -0.631 . . . . 53.44 112.322 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 4.9 t 70.27 -168.91 0.16 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.05 1.34 . . . . 73.54 111.039 178.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 14.0 t-160 65.77 38.84 5.02 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.435 1.094 . . . . 75.25 110.838 175.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 mtt -136.23 137.71 41.09 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.567 -0.742 . . . . 51.34 109.944 -177.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.3 p -146.82 115.51 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 CA-C-O 122.008 0.909 . . . . 73.05 110.796 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.1 mt -131.3 122.96 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 115.323 -0.853 . . . . 73.52 109.301 -174.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.46 159.74 14.8 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 119.038 -0.506 . . . . 72.5 109.878 176.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 74.38 163.41 0.27 Allowed 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 124.586 1.155 . . . . 71.13 109.391 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.8 t 83.78 -166.28 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 124.564 1.146 . . . . 73.52 108.361 175.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.71 135.88 59.39 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 CA-C-O 121.345 0.593 . . . . 73.52 110.143 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.426 ' CB ' ' HB2' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -81.41 127.88 33.25 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.263 -1.335 . . . . 73.25 110.043 176.797 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -126.13 152.95 45.25 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 117.519 -1.229 . . . . 73.41 110.61 -179.343 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 mt -115.56 143.98 24.22 Favored 'Isoleucine or valine' 0 C--O 1.255 1.342 0 CA-C-N 121.223 1.829 . . . . 64.01 108.692 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -106.32 120.85 42.94 Favored 'General case' 0 CA--C 1.564 1.504 0 O-C-N 124.157 0.91 . . . . 74.34 110.324 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.577 HG23 HG22 ' A' ' 78' ' ' VAL . 1.5 p -124.57 105.84 15.81 Favored 'Isoleucine or valine' 0 C--N 1.376 1.753 0 CA-C-N 120.457 1.48 . . . . 75.34 109.024 177.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' A' ' 77' ' ' ARG . . . -114.57 166.79 12.19 Favored Glycine 0 C--N 1.355 1.618 0 C-N-CA 120.339 -0.934 . . . . 55.14 113.453 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 50.12 24.24 1.36 Allowed 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 115.102 1.519 . . . . 74.32 115.102 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.48 ' H ' HD23 ' A' ' 15' ' ' LEU . 2.4 pt? -71.47 141.52 85.58 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 124.297 1.039 . . . . 73.05 110.717 175.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -72.98 141.47 33.16 Favored 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 121.411 1.407 . . . . 70.42 111.169 173.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.9 p 86.25 -34.16 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 126.36 1.864 . . . . 71.23 112.652 170.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 71.08 121.82 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.106 1.362 . . . . 74.42 111.188 -175.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.0 m -75.84 118.15 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.442 0 N-CA-C 107.43 -1.322 . . . . 72.44 107.43 176.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.37 157.32 27.65 Favored 'General case' 0 C--N 1.383 2.036 0 O-C-N 120.025 -1.672 . . . . 61.52 109.472 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.44 ' HA ' HG12 ' A' ' 24' ' ' VAL . 44.8 p -49.84 -37.61 31.43 Favored 'General case' 0 C--N 1.38 1.934 0 N-CA-C 116.123 1.897 . . . . 44.04 116.123 -173.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -38.97 75.98 Favored 'General case' 0 CA--C 1.595 2.678 0 N-CA-C 114.637 1.347 . . . . 73.43 114.637 176.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.5 -32.59 68.39 Favored 'General case' 0 C--N 1.374 1.655 0 CA-C-N 120.301 1.409 . . . . 71.43 110.596 176.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.606 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 7.5 p -75.46 -34.03 28.86 Favored 'Isoleucine or valine' 0 C--N 1.391 2.403 0 N-CA-C 108.663 -0.866 . . . . 52.21 108.663 178.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.5 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 0.5 OUTLIER -60.16 -55.63 31.45 Favored 'General case' 0 CA--C 1.576 1.967 0 CA-C-O 117.187 -1.387 . . . . 72.43 113.717 168.83 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -65.4 -58.88 4.78 Favored 'General case' 0 C--O 1.299 3.666 0 CA-C-N 121.654 2.025 . . . . 73.52 113.37 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -57.7 -44.95 86.23 Favored 'General case' 0 C--N 1.385 2.133 0 CA-C-O 117.902 -1.047 . . . . 62.31 112.075 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.606 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 3.1 m-85 -79.66 -17.22 54.23 Favored 'General case' 0 CA--C 1.568 1.671 0 CA-C-N 120.373 1.442 . . . . 65.34 114.121 -176.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.501 ' HA ' HG22 ' A' ' 34' ' ' ILE 0.322 70.3 mtp180 -60.33 -32.01 70.84 Favored 'General case' 0 N--CA 1.535 3.819 0 CA-C-N 122.022 2.192 . . . . 64.53 110.942 170.368 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.512 ' HD2' ' O ' ' A' ' 30' ' ' LYS 0.283 0.2 OUTLIER -58.51 -21.1 50.92 Favored 'General case' 0 N--CA 1.509 2.486 0 C-N-CA 117.805 -1.558 . . . . 72.21 114.109 175.006 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.512 ' HB3' ' HB2' ' A' ' 59' ' ' ALA . 1.5 m-85 -84.86 -27.53 26.64 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.37 -0.831 . . . . 74.43 110.306 -165.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 175.32 32.99 0.04 OUTLIER Glycine 0 N--CA 1.437 -1.275 0 CA-C-O 118.783 -1.009 . . . . 33.4 113.598 174.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.2 t30 57.27 80.72 0.16 Allowed 'General case' 0 C--N 1.357 0.914 0 C-N-CA 124.525 1.13 . . . . 63.01 110.641 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.501 HG22 ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -68.49 141.24 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 CA-C-N 114.935 -1.03 . . . . 64.25 113.6 -175.424 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.434 ' H ' HD22 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -107.39 -25.25 11.52 Favored 'General case' 0 C--N 1.375 1.686 0 N-CA-C 110.577 -0.157 . . . . 71.03 110.577 176.494 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.84 130.91 26.36 Favored 'General case' 0 CA--C 1.56 1.343 0 N-CA-C 108.896 -0.779 . . . . 73.4 108.896 -168.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -141.28 111.08 6.54 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.025 -0.732 . . . . 42.43 109.025 -175.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -129.04 143.28 50.82 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 117.802 -1.559 . . . . 60.42 113.483 -177.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.0 t -116.21 114.6 46.58 Favored 'Isoleucine or valine' 0 C--N 1.345 0.383 0 N-CA-C 108.737 -0.838 . . . . 75.33 108.737 176.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -107.12 130.41 54.7 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-O 118.601 -0.714 . . . . 74.2 109.618 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -106.15 128.04 53.63 Favored 'General case' 0 C--N 1.379 1.857 0 CA-C-N 120.519 1.509 . . . . 65.35 112.391 -174.022 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.638 HG23 ' H ' ' A' ' 44' ' ' SER . 1.4 t -90.76 160.0 16.02 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 119.139 -1.024 . . . . 51.44 111.187 170.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.0 t -76.29 -9.95 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.415 0 C-N-CA 123.698 0.799 . . . . 73.24 112.376 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.638 ' H ' HG23 ' A' ' 42' ' ' THR . 7.3 m -83.16 7.84 14.89 Favored 'General case' 0 CA--C 1.556 1.185 0 O-C-N 121.873 -0.517 . . . . 73.45 111.282 -177.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.31 -4.57 76.55 Favored Glycine 0 C--N 1.351 1.385 0 N-CA-C 115.563 0.985 . . . . 53.24 115.563 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.77 134.42 33.68 Favored 'General case' 0 CA--C 1.561 1.366 0 CA-C-N 118.01 0.905 . . . . 63.44 110.776 176.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -103.86 144.97 30.79 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 107.333 -1.358 . . . . 71.45 107.333 176.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -132.57 149.87 52.25 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.225 0.92 . . . . 45.3 108.562 175.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.401 ' HB3' ' CG1' ' A' ' 12' ' ' VAL . . . -117.79 137.0 53.03 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 119.071 -1.052 . . . . 41.34 111.391 170.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -106.12 118.85 37.69 Favored 'General case' 0 C--O 1.268 2.068 0 CA-C-N 113.92 -1.491 . . . . 72.04 107.762 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 0.3 OUTLIER -125.96 111.36 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.505 0 C-N-CA 119.066 -1.054 . . . . 60.41 111.905 -174.486 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.59 105.8 17.71 Favored 'General case' 0 CA--C 1.556 1.205 0 CA-C-N 115.643 -0.708 . . . . 71.32 111.474 -174.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 3.0 p90 -115.2 166.87 11.36 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 114.493 1.294 . . . . 74.53 114.493 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -80.8 -27.82 36.51 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 114.843 1.423 . . . . 74.21 114.843 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.35 118.6 32.69 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 120.011 1.278 . . . . 70.11 111.593 175.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.46 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -77.42 -34.33 54.7 Favored 'General case' 0 CA--C 1.552 1.023 0 N-CA-C 116.78 2.141 . . . . 75.11 116.78 172.121 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.267 0.0 OUTLIER -80.35 -29.33 37.94 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-N 121.879 2.127 . . . . 74.12 113.034 -170.538 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.22 -38.18 90.14 Favored 'General case' 0 N--CA 1.506 2.364 0 N-CA-C 114.067 1.136 . . . . 73.53 114.067 176.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.512 ' HB2' ' HB3' ' A' ' 31' ' ' TYR . . . -53.58 -22.45 8.51 Favored 'General case' 0 CA--C 1.561 1.383 0 N-CA-C 115.755 1.761 . . . . 75.51 115.755 173.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.93 -45.89 60.64 Favored 'General case' 0 CA--C 1.582 2.211 0 N-CA-C 114.807 1.41 . . . . 53.53 114.807 -178.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -50.66 -51.7 46.78 Favored 'General case' 0 N--CA 1.524 3.268 0 CA-C-N 119.745 1.157 . . . . 74.1 112.459 170.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.49 ' O ' ' HD2' ' A' ' 66' ' ' LYS . . . -75.05 -31.61 61.33 Favored 'General case' 0 CA--C 1.555 1.151 0 O-C-N 121.213 -0.929 . . . . 75.2 111.994 -176.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.492 HD11 HG12 ' A' ' 78' ' ' VAL 0.296 0.0 OUTLIER -73.63 -42.37 55.25 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.875 0 O-C-N 120.058 -1.651 . . . . 73.25 113.118 179.293 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.492 ' HD2' ' N ' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -55.72 -33.84 64.6 Favored 'General case' 0 CA--C 1.559 1.291 0 CA-C-N 120.383 1.447 . . . . 63.1 114.815 162.861 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.492 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -63.65 -32.62 74.15 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 120.058 1.299 . . . . 74.45 112.252 172.364 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.49 ' HD2' ' O ' ' A' ' 62' ' ' ALA 0.269 0.0 OUTLIER -105.0 16.72 25.42 Favored 'General case' 0 CA--C 1.581 2.151 0 C-N-CA 117.09 -1.844 . . . . 71.23 115.566 166.661 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.475 ' HB3' ' HA ' ' A' ' 64' ' ' LYS 0.363 0.0 OUTLIER -79.26 159.61 27.2 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-N 119.092 0.86 . . . . 72.43 112.845 -177.361 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.1 31.44 2.05 Favored Glycine 0 N--CA 1.436 -1.365 0 C-N-CA 118.202 -1.951 . . . . 72.05 113.866 -164.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.733 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -50.97 124.82 12.1 Favored 'General case' 0 C--N 1.374 1.631 0 O-C-N 124.449 0.735 . . . . 74.31 111.328 -173.86 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -133.79 150.79 51.45 Favored 'General case' 0 C--O 1.252 1.232 0 CA-C-N 115.044 -0.98 . . . . 73.13 110.735 -173.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -149.65 142.47 24.7 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 105.159 -2.163 . . . . 64.31 105.159 -170.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 73.52 66.1 0.1 Allowed 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 113.014 0.746 . . . . 72.54 113.014 -176.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.33 -14.0 61.23 Favored Glycine 0 N--CA 1.478 1.463 0 N-CA-C 117.187 1.635 . . . . 72.34 117.187 169.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 -114.55 120.29 39.71 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 105.349 -2.093 . . . . 52.43 105.349 149.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.56 101.84 13.52 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.587 -1.245 . . . . 75.52 108.747 -175.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.733 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 13.1 tp -172.0 70.54 0.04 OUTLIER 'General case' 0 C--N 1.387 2.207 0 CA-C-N 120.809 1.641 . . . . 71.22 112.599 -174.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.42 ' HB3' ' O ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -96.51 113.26 24.82 Favored 'General case' 0 CA--C 1.566 1.572 0 CA-C-N 122.375 2.352 . . . . 73.14 109.56 -174.257 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.577 HG22 HG23 ' A' ' 12' ' ' VAL . 13.9 t -128.71 118.03 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.481 0 O-C-N 120.286 -1.509 . . . . 41.11 109.381 174.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -134.48 135.58 42.54 Favored 'General case' 0 C--O 1.263 1.807 0 CA-C-N 119.475 1.034 . . . . 75.4 109.944 -175.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.8 m -72.41 123.81 89.99 Favored Pre-proline 0 CA--C 1.551 1.017 0 CA-C-N 115.753 -0.658 . . . . 63.44 110.288 159.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -92.09 23.06 0.6 Allowed 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.441 2.094 . . . . 74.31 112.663 168.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.46 ' CE1' ' HB1' ' A' ' 56' ' ' ALA . 8.8 p90 -121.9 -57.61 1.79 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 121.403 -0.119 . . . . 75.2 110.88 176.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 48.69 43.9 21.03 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 125.58 1.552 . . . . 73.15 112.764 -175.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -161.16 143.84 12.49 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 121.182 -0.949 . . . . 72.52 111.053 -171.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 168.9 150.55 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 C-N-CA 124.739 1.216 . . . . 75.13 109.436 -178.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 C--O 1.249 1.075 0 N-CA-C 107.234 -1.395 . . . . 72.13 107.234 167.161 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.16 0 CA-C-O 120.012 -0.326 . . . . 73.12 112.456 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 42.3 m 64.65 39.71 6.32 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.727 1.211 . . . . 74.44 114.167 170.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -148.12 160.98 42.33 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 109.873 -0.417 . . . . 72.34 109.873 174.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.5 ptp -160.93 97.12 1.14 Allowed 'General case' 0 N--CA 1.478 0.944 0 O-C-N 123.879 0.737 . . . . 73.15 111.188 173.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.7 p -163.59 113.41 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.197 0 CA-C-O 121.378 0.609 . . . . 63.41 110.948 177.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.3 tt -163.31 124.73 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.231 0 O-C-N 122.127 -0.358 . . . . 54.33 111.149 177.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -141.28 136.31 31.49 Favored 'General case' 0 C--N 1.355 0.808 0 N-CA-C 107.695 -1.224 . . . . 65.05 107.695 171.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 73.26 5.29 5.04 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 123.882 0.739 . . . . 74.23 112.71 167.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.9 t -99.46 -12.13 20.48 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.947 -0.47 . . . . 54.45 112.072 -171.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . 0.298 3.4 m 64.14 116.5 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.476 0 C-N-CA 126.751 2.02 . . . . 71.45 113.475 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.7 m -74.68 119.82 19.38 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.941 -0.572 . . . . 74.14 110.979 -177.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -140.65 160.04 40.89 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 113.682 0.993 . . . . 74.5 113.682 -177.069 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.561 HG12 HG12 ' A' ' 80' ' ' VAL . 10.2 mt -112.57 136.56 48.44 Favored 'Isoleucine or valine' 0 C--O 1.259 1.564 0 N-CA-C 106.866 -1.531 . . . . 44.42 106.866 177.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -92.92 115.06 27.77 Favored 'General case' 0 CA--C 1.565 1.541 0 O-C-N 125.815 1.947 . . . . 74.41 109.045 177.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.409 HG22 HG13 ' A' ' 78' ' ' VAL . 38.5 t -123.57 115.29 44.86 Favored 'Isoleucine or valine' 0 C--N 1.366 1.316 0 CA-C-N 119.922 1.237 . . . . 75.44 109.042 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -121.63 171.03 14.95 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 119.276 -1.44 . . . . 64.41 113.738 173.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 50.81 25.69 2.25 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 115.367 1.618 . . . . 51.12 115.367 176.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.444 HD11 ' H ' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -79.24 140.84 57.06 Favored Pre-proline 0 CA--C 1.551 1.006 0 CA-C-N 119.144 0.883 . . . . 73.21 112.257 -170.265 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -76.15 142.69 24.75 Favored 'Trans proline' 0 CA--C 1.552 1.378 0 C-N-CA 122.992 2.461 . . . . 61.14 112.176 173.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.1 p 88.53 -32.25 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 126.719 2.008 . . . . 71.42 111.955 175.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 82.5 t60 69.13 105.29 0.06 Allowed 'General case' 0 C--N 1.361 1.069 0 C-N-CA 124.924 1.29 . . . . 75.41 111.184 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.444 ' H ' HD11 ' A' ' 15' ' ' LEU . 7.8 m -77.99 117.8 23.88 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.849 0 N-CA-C 109.127 -0.694 . . . . 74.24 109.127 -176.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.8 154.92 29.51 Favored 'General case' 0 C--N 1.378 1.839 0 CA-C-O 118.165 -0.921 . . . . 41.43 111.028 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.0 t -49.42 -46.52 47.74 Favored 'General case' 0 C--N 1.38 1.893 0 N-CA-C 114.821 1.415 . . . . 42.51 114.821 -177.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . 0.314 0.0 OUTLIER -55.23 -43.29 74.41 Favored 'General case' 0 CA--C 1.588 2.414 0 N-CA-C 115.246 1.573 . . . . 72.54 115.246 172.809 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.92 -37.84 87.12 Favored 'General case' 0 C--N 1.378 1.812 0 CA-C-O 117.903 -1.046 . . . . 73.55 110.726 176.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.2 t -64.89 -43.75 96.28 Favored 'Isoleucine or valine' 0 C--N 1.403 2.931 0 CA-C-N 119.551 1.069 . . . . 70.45 110.657 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.62 -52.72 63.77 Favored 'General case' 0 C--N 1.378 1.818 0 CA-C-O 116.201 -1.857 . . . . 62.13 111.12 176.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.558 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 1.8 m-20 -77.54 -55.28 5.5 Favored 'General case' 0 C--O 1.3 3.72 0 CA-C-N 122.713 2.506 . . . . 71.1 116.576 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.474 ' O ' ' HD2' ' A' ' 31' ' ' TYR . 19.8 tt0 -59.93 -39.96 87.26 Favored 'General case' 0 C--N 1.371 1.522 0 CA-C-O 117.335 -1.317 . . . . 71.24 111.698 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . 0.263 73.9 m-85 -82.28 -21.64 36.09 Favored 'General case' 0 CA--C 1.575 1.909 0 CA-C-N 121.918 2.145 . . . . 74.15 113.986 174.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.558 ' HG3' ' O ' ' A' ' 26' ' ' ASN 0.269 0.0 OUTLIER -59.72 -28.45 67.35 Favored 'General case' 0 N--CA 1.531 3.583 0 CA-C-N 120.864 1.665 . . . . 71.13 112.719 169.627 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.402 ' HE2' ' CD1' ' A' ' 31' ' ' TYR 0.325 0.0 OUTLIER -76.1 -36.21 59.01 Favored 'General case' 0 N--CA 1.506 2.338 0 C-N-CA 114.518 -2.873 . . . . 74.22 113.216 170.305 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.56 ' HB3' ' HA ' ' A' ' 59' ' ' ALA . 20.8 m-85 -76.68 -43.85 36.13 Favored 'General case' 0 CA--C 1.564 1.481 0 N-CA-C 112.681 0.623 . . . . 53.41 112.681 -164.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -132.45 -175.93 14.19 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.557 -1.017 . . . . 72.35 110.557 151.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -87.01 98.13 11.1 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.839 1.82 . . . . 63.12 109.6 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.428 ' HA ' ' HB3' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -75.37 141.02 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 113.349 0.87 . . . . 72.1 113.349 -178.653 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 11.1 mp -108.67 -24.14 11.48 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 122.758 0.423 . . . . 74.51 110.246 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.62 139.42 15.19 Favored 'General case' 0 CA--C 1.58 2.102 0 C-N-CA 123.794 0.837 . . . . 45.21 110.41 -170.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.427 ' SG ' HG13 ' A' ' 34' ' ' ILE . 62.0 m -138.79 112.3 8.22 Favored 'General case' 0 N--CA 1.507 2.382 0 N-CA-C 107.622 -1.251 . . . . 75.31 107.622 177.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -118.32 136.98 53.39 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 116.454 -2.098 . . . . 73.53 111.746 175.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -123.83 111.8 30.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 121.893 0.854 . . . . 43.43 109.266 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -115.77 152.61 32.95 Favored 'General case' 0 CA--C 1.559 1.318 0 CA-C-N 114.848 -1.069 . . . . 74.53 109.428 -172.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.39 146.24 50.85 Favored 'General case' 0 CA--C 1.565 1.528 0 CA-C-N 120.945 1.702 . . . . 73.13 108.838 -172.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.613 HG23 ' H ' ' A' ' 44' ' ' SER . 5.3 t -100.7 175.43 5.65 Favored 'General case' 0 CA--C 1.563 1.474 0 CA-C-N 120.698 1.59 . . . . 52.23 110.852 174.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.4 t -78.67 -8.53 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 123.545 0.738 . . . . 72.42 112.411 -175.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.613 ' H ' HG23 ' A' ' 42' ' ' THR . 7.1 t -89.15 4.72 47.58 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 122.937 0.495 . . . . 74.22 110.27 -175.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.13 -7.25 64.19 Favored Glycine 0 CA--C 1.534 1.26 0 N-CA-C 114.921 0.728 . . . . 75.04 114.921 -178.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.06 130.85 35.95 Favored 'General case' 0 CA--C 1.556 1.187 0 CA-C-N 117.877 0.838 . . . . 72.13 109.724 172.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.16 146.03 42.61 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.057 -0.72 . . . . 32.44 109.057 -173.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -128.29 148.51 50.66 Favored 'General case' 0 C--N 1.36 1.037 0 CA-C-N 119.63 1.105 . . . . 63.44 111.483 -173.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -123.61 146.27 48.3 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.162 0.801 . . . . 54.1 113.162 169.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -132.97 115.26 14.97 Favored 'General case' 0 C--O 1.267 2.005 0 N-CA-C 105.596 -2.002 . . . . 74.25 105.596 -165.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 1.4 mp -120.54 110.19 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.497 0 C-N-CA 118.371 -1.331 . . . . 61.41 111.378 -169.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -105.37 104.0 13.64 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-O 121.35 0.595 . . . . 71.34 111.754 -173.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.428 ' HB3' ' HA ' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -117.55 168.75 10.12 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 114.123 1.157 . . . . 75.44 114.123 -179.404 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -81.35 -33.86 32.14 Favored 'General case' 0 C--N 1.367 1.34 0 N-CA-C 113.963 1.098 . . . . 74.54 113.963 175.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -111.41 116.03 30.25 Favored 'General case' 0 C--N 1.349 0.576 0 N-CA-C 107.386 -1.338 . . . . 44.53 107.386 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.499 ' HB3' ' HE ' ' A' ' 85' ' ' ARG . . . -81.75 -28.78 33.15 Favored 'General case' 0 C--N 1.355 0.808 0 N-CA-C 114.647 1.351 . . . . 64.31 114.647 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.2 tmm_? -76.54 -41.07 47.96 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 114.2 1.185 . . . . 63.2 114.2 -170.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -70.65 -31.33 68.22 Favored 'General case' 0 CA--C 1.583 2.226 0 CA-C-N 121.459 1.936 . . . . 74.21 115.381 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.56 ' HA ' ' HB3' ' A' ' 31' ' ' TYR . . . -57.59 -22.16 43.32 Favored 'General case' 0 CA--C 1.596 2.743 0 N-CA-C 116.697 2.11 . . . . 62.21 116.697 169.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.451 ' HA ' HG22 ' A' ' 63' ' ' ILE . . . -50.47 -28.63 8.71 Favored 'General case' 0 CA--C 1.573 1.858 0 N-CA-C 114.758 1.392 . . . . 73.21 114.758 172.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.401 ' O ' ' HB3' ' A' ' 65' ' ' GLU . 5.5 m-20 -51.64 -54.42 28.15 Favored 'General case' 0 N--CA 1.504 2.266 0 CA-C-N 120.235 1.38 . . . . 73.32 112.644 162.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.64 -33.29 75.3 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 121.054 -1.029 . . . . 72.35 112.79 174.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.822 HD12 HG13 ' A' ' 80' ' ' VAL 0.303 0.0 OUTLIER -71.42 -46.41 64.31 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.607 0 C-N-CA 116.616 -2.034 . . . . 64.41 113.016 -178.619 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.526 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -55.06 -32.7 62.11 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 114.706 1.373 . . . . 72.41 114.706 164.221 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.401 ' HB3' ' O ' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -82.51 -18.37 41.81 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.702 1.137 . . . . 63.34 112.413 -176.537 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -101.29 15.05 30.04 Favored 'General case' 0 CA--C 1.588 2.428 0 CA-C-O 119.413 -0.327 . . . . 73.32 111.653 166.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.526 ' HB3' ' HA ' ' A' ' 64' ' ' LYS 0.378 0.2 OUTLIER -77.86 163.87 25.67 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 115.629 1.715 . . . . 72.4 115.629 -166.861 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.74 30.14 2.26 Favored Glycine 0 N--CA 1.432 -1.601 0 CA-C-O 117.224 -1.876 . . . . 72.1 115.62 -170.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.869 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -52.01 123.33 10.19 Favored 'General case' 0 C--N 1.382 2.019 0 CA-C-N 118.307 1.053 . . . . 73.24 111.577 -169.864 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.2 151.79 51.5 Favored 'General case' 0 C--O 1.258 1.504 0 CA-C-N 114.53 -1.213 . . . . 63.23 111.996 -170.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -148.75 145.28 27.55 Favored 'General case' 0 C--N 1.361 1.108 0 C-N-CA 126.97 2.108 . . . . 73.44 107.036 -163.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 70.42 64.33 0.2 Allowed 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 114.098 1.147 . . . . 72.14 114.098 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.21 -13.96 61.42 Favored Glycine 0 N--CA 1.476 1.31 0 N-CA-C 116.523 1.369 . . . . 75.41 116.523 172.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -118.42 120.34 37.29 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 105.956 -1.868 . . . . 71.22 105.956 153.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.53 107.37 19.78 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 118.051 -0.976 . . . . 74.2 109.774 -178.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.869 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 22.1 tp -163.08 70.44 0.25 Allowed 'General case' 0 C--O 1.192 -1.955 0 CA-C-N 120.114 1.324 . . . . 54.14 111.201 178.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -101.3 110.8 22.87 Favored 'General case' 0 CA--C 1.556 1.203 0 CA-C-N 122.537 2.426 . . . . 74.45 110.213 -170.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.479 HG12 HG12 ' A' ' 63' ' ' ILE . 90.8 t -126.88 118.23 49.97 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.732 0 O-C-N 120.097 -1.627 . . . . 62.3 107.5 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -145.28 131.43 19.41 Favored 'General case' 0 C--N 1.386 2.194 0 CA-C-N 120.694 1.588 . . . . 65.24 111.741 -170.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.822 HG13 HD12 ' A' ' 63' ' ' ILE . 15.7 m -88.44 134.24 34.79 Favored Pre-proline 0 C--N 1.349 0.576 0 CA-C-N 115.696 -0.684 . . . . 75.33 112.534 165.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -82.7 38.19 0.72 Allowed 'Trans proline' 0 CA--C 1.548 1.197 0 C-N-CA 122.322 2.014 . . . . 74.43 111.347 161.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.418 ' CD2' ' HB1' ' A' ' 56' ' ' ALA . 10.3 m-85 -125.56 52.01 1.67 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.452 -0.944 . . . . 53.32 108.452 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 61.7 m-20 -84.45 46.16 1.2 Allowed 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 115.597 -0.729 . . . . 71.5 110.055 175.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -170.16 33.4 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.628 1.171 . . . . 75.33 110.501 -172.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.499 ' HE ' ' HB3' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -144.5 43.48 1.39 Allowed 'General case' 0 N--CA 1.481 1.087 0 O-C-N 122.232 -0.292 . . . . 52.34 111.054 178.437 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.252 1.189 0 CA-C-O 118.419 -0.801 . . . . 71.21 109.992 177.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.077 0 N-CA-C 111.685 -0.566 . . . . 74.11 111.685 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 6.0 t -116.16 -178.32 3.38 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 110.248 -0.279 . . . . 64.24 110.248 -176.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -131.01 154.02 48.62 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 122.524 0.33 . . . . 74.23 111.343 -177.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -113.19 143.74 43.88 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.115 -0.493 . . . . 62.23 111.112 -177.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.4 t -119.88 127.17 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 116.372 -0.377 . . . . 43.12 110.325 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.1 pt -115.07 145.03 21.33 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 N-CA-C 109.756 -0.461 . . . . 75.41 109.756 176.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -135.95 142.54 44.61 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-O 118.485 -0.769 . . . . 72.41 110.893 169.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 68.34 84.08 0.15 Allowed 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 124.433 1.093 . . . . 73.31 111.202 171.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.0 t -145.32 165.14 29.3 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.424 -0.798 . . . . 63.11 110.918 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.7 m -114.72 126.37 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 108.857 -0.794 . . . . 73.01 108.857 176.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.13 137.45 34.07 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 119.368 -0.348 . . . . 72.4 110.19 -177.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.475 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 0.3 OUTLIER -138.71 159.19 42.72 Favored 'General case' 0 N--CA 1.509 2.524 0 CA-C-N 118.618 0.645 . . . . 60.31 111.909 -173.519 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.461 ' HB ' HD12 ' A' ' 51' ' ' ILE . 5.2 mp -134.48 133.77 54.79 Favored 'Isoleucine or valine' 0 C--O 1.269 2.082 0 N-CA-C 107.84 -1.17 . . . . 72.32 107.84 -177.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -108.54 114.4 28.2 Favored 'General case' 0 CA--C 1.57 1.731 0 O-C-N 125.877 1.986 . . . . 75.24 110.061 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.508 HG23 HG22 ' A' ' 78' ' ' VAL . 2.6 p -123.43 104.76 14.72 Favored 'Isoleucine or valine' 0 C--N 1.372 1.563 0 CA-C-N 120.555 1.525 . . . . 32.44 108.915 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -128.9 169.63 20.28 Favored Glycine 0 C--N 1.364 2.103 0 C-N-CA 120.374 -0.917 . . . . 63.02 114.747 -174.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.5 m120 49.24 24.8 1.06 Allowed 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 114.037 1.125 . . . . 54.44 114.037 -175.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.595 ' H ' HD23 ' A' ' 15' ' ' LEU . 2.0 pt? -85.12 149.98 54.03 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 125.439 1.496 . . . . 71.05 111.775 -171.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -72.13 140.98 35.27 Favored 'Trans proline' 0 C--N 1.367 1.532 0 C-N-CA 121.925 1.75 . . . . 74.34 111.56 173.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.4 p 82.5 -34.38 0.09 Allowed 'General case' 0 C--N 1.386 2.177 0 C-N-CA 126.857 2.063 . . . . 43.33 111.483 177.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 45.7 m-70 64.21 84.77 0.14 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.509 1.523 . . . . 74.31 110.109 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.576 ' H ' HD11 ' A' ' 15' ' ' LEU . 5.5 p -59.88 120.49 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.517 0 O-C-N 124.095 0.872 . . . . 75.13 110.503 -176.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.0 m -80.98 156.69 25.81 Favored 'General case' 0 C--N 1.363 1.174 0 CA-C-O 118.204 -0.903 . . . . 44.03 108.931 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.7 p -48.98 -37.29 19.79 Favored 'General case' 0 C--N 1.375 1.7 0 N-CA-C 115.795 1.776 . . . . 50.43 115.795 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . 0.255 0.0 OUTLIER -56.1 -47.62 77.71 Favored 'General case' 0 CA--C 1.588 2.433 0 N-CA-C 113.948 1.092 . . . . 62.14 113.948 173.191 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.457 ' HB2' HG23 ' A' ' 19' ' ' VAL . 13.6 m-20 -62.68 -50.97 69.06 Favored 'General case' 0 C--O 1.266 1.945 0 C-N-CA 123.686 0.794 . . . . 75.44 112.238 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.693 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -59.92 -46.18 94.26 Favored 'Isoleucine or valine' 0 C--N 1.372 1.55 0 CA-C-O 118.527 -0.749 . . . . 74.55 111.795 175.643 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.555 ' O ' ' HB3' ' A' ' 29' ' ' ARG 0.281 0.7 OUTLIER -52.5 -51.14 60.98 Favored 'General case' 0 C--O 1.202 -1.405 0 CA-C-O 115.647 -2.12 . . . . 71.42 112.049 171.217 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -71.73 -62.93 1.24 Allowed 'General case' 1 C--O 1.305 4.016 0 CA-C-N 124.537 3.335 . . . . 72.41 114.123 -178.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -72.8 -29.85 63.59 Favored 'General case' 0 C--N 1.371 1.512 0 O-C-N 120.495 -1.378 . . . . 71.42 112.118 -173.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.693 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 6.8 m-85 -84.05 -31.93 25.12 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 117.374 -1.298 . . . . 74.54 112.582 177.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.555 ' HB3' ' O ' ' A' ' 25' ' ' GLU . 3.3 ptt85 -51.46 -29.33 15.87 Favored 'General case' 0 N--CA 1.508 2.46 0 CA-C-O 116.353 -1.784 . . . . 70.4 114.355 164.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.41 -48.16 71.94 Favored 'General case' 0 N--CA 1.514 2.765 0 C-N-CA 114.775 -2.77 . . . . 63.21 113.2 164.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -79.99 -40.32 28.18 Favored 'General case' 0 CA--C 1.563 1.477 0 CA-C-N 119.082 0.856 . . . . 75.55 112.058 -170.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 29' ' ' ARG . . . -137.18 156.9 23.62 Favored Glycine 0 C--N 1.357 1.716 0 CA-C-N 120.245 1.384 . . . . 64.32 112.249 167.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -84.47 109.92 18.26 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.045 -0.724 . . . . 74.4 109.045 -170.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.74 121.42 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 113.439 0.904 . . . . 63.33 113.439 -176.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.81 -17.83 14.9 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.9 -0.778 . . . . 54.4 108.9 170.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -156.47 128.86 7.57 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 109.071 -0.714 . . . . 74.4 109.071 -165.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.4 p -143.04 107.99 4.92 Favored 'General case' 0 C--N 1.362 1.118 0 CA-C-N 119.34 0.973 . . . . 73.11 108.957 174.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -116.78 146.84 42.57 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 118.524 -1.27 . . . . 44.25 111.994 178.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.6 t -108.85 121.45 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 108.308 -0.997 . . . . 74.34 108.308 177.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -120.56 130.96 54.44 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 109.151 -0.685 . . . . 71.32 109.151 -176.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -121.98 128.6 51.66 Favored 'General case' 0 C--N 1.372 1.55 0 C-N-CA 117.839 -1.544 . . . . 63.13 111.127 -165.225 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.576 HG23 ' H ' ' A' ' 44' ' ' SER . 2.6 t -100.09 159.36 15.16 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 118.168 -1.413 . . . . 71.42 112.436 177.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.8 t -73.99 -7.99 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.408 0 C-N-CA 123.868 0.867 . . . . 75.14 112.377 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.576 ' H ' HG23 ' A' ' 42' ' ' THR . 7.4 t -85.23 7.78 20.81 Favored 'General case' 0 CA--C 1.55 0.968 0 O-C-N 121.489 -0.757 . . . . 65.43 110.601 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.34 -5.96 70.46 Favored Glycine 0 CA--C 1.532 1.13 0 N-CA-C 115.241 0.856 . . . . 52.05 115.241 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.48 132.38 33.94 Favored 'General case' 0 CA--C 1.558 1.283 0 CA-C-N 118.078 0.939 . . . . 74.44 110.713 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.91 142.38 34.87 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 107.439 -1.319 . . . . 24.44 107.439 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -130.79 145.99 52.12 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 106.944 -1.502 . . . . 71.21 106.944 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -118.22 138.2 52.5 Favored 'General case' 0 C--O 1.253 1.248 0 C-N-CA 119.114 -1.034 . . . . 42.42 109.798 173.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -116.84 120.45 38.54 Favored 'General case' 0 C--O 1.252 1.207 0 CA-C-N 114.516 -1.22 . . . . 72.45 108.848 -169.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.461 HD12 ' HB ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -132.84 112.66 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 123.122 0.263 . . . . 70.35 110.581 -166.902 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -103.07 113.11 26.31 Favored 'General case' 0 CA--C 1.565 1.529 0 CA-C-N 118.554 0.615 . . . . 72.13 112.169 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -108.74 164.14 12.64 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 112.742 0.645 . . . . 61.23 112.742 -176.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -78.85 -39.64 34.8 Favored 'General case' 0 N--CA 1.51 2.532 0 N-CA-C 113.37 0.878 . . . . 74.51 113.37 174.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.95 117.7 32.79 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 118.96 0.8 . . . . 72.24 109.615 -177.079 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.494 ' HB1' ' CD1' ' A' ' 82' ' ' PHE . . . -75.79 -26.32 57.21 Favored 'General case' 0 CA--C 1.556 1.19 0 N-CA-C 115.022 1.49 . . . . 72.34 115.022 175.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.321 0.0 OUTLIER -79.57 -28.2 41.16 Favored 'General case' 0 CA--C 1.57 1.74 0 CA-C-N 121.649 2.022 . . . . 74.03 114.803 -176.7 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.02 -30.23 49.89 Favored 'General case' 0 CA--C 1.591 2.552 0 CA-C-N 121.837 2.108 . . . . 73.2 115.668 174.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.74 -24.33 21.78 Favored 'General case' 0 CA--C 1.597 2.787 0 CA-C-N 120.551 1.523 . . . . 62.14 114.615 166.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.647 ' HA ' HG22 ' A' ' 63' ' ' ILE . . . -48.41 -39.37 22.28 Favored 'General case' 0 CA--C 1.569 1.691 0 C-N-CA 125.368 1.467 . . . . 62.32 114.061 173.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.459 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 2.1 m-20 -53.76 -50.82 65.17 Favored 'General case' 0 C--N 1.382 2.005 0 CA-C-N 120.473 1.488 . . . . 75.52 112.771 169.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.09 -44.99 91.98 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 118.454 -0.784 . . . . 62.31 112.65 174.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.717 HD12 HG13 ' A' ' 80' ' ' VAL 0.254 2.3 tt -69.94 -50.04 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 117.247 -1.781 . . . . 73.03 112.504 -174.648 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.53 ' HG3' ' O ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -56.9 -26.33 58.84 Favored 'General case' 0 CA--C 1.561 1.399 0 N-CA-C 115.57 1.692 . . . . 73.33 115.57 167.741 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.47 -20.11 37.53 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 121.369 1.895 . . . . 75.42 111.03 179.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.5 mttt -110.21 16.72 21.57 Favored 'General case' 0 CA--C 1.578 2.023 0 O-C-N 122.304 -0.248 . . . . 52.51 111.318 176.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.32 0.1 OUTLIER -78.23 161.4 27.32 Favored 'General case' 0 C--N 1.377 1.772 0 N-CA-C 112.988 0.736 . . . . 71.34 112.988 -176.188 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.38 26.04 3.57 Favored Glycine 0 N--CA 1.434 -1.499 0 C-N-CA 119.226 -1.464 . . . . 63.35 113.574 -160.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.819 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -55.15 123.63 14.29 Favored 'General case' 0 C--N 1.365 1.28 0 CA-C-N 117.545 0.672 . . . . 62.01 110.317 -176.628 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -133.19 151.3 51.96 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-N 115.792 -0.64 . . . . 62.42 112.122 -169.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -149.12 144.19 26.48 Favored 'General case' 0 C--N 1.354 0.78 0 C-N-CA 126.764 2.026 . . . . 62.12 106.779 -165.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 71.43 64.37 0.15 Allowed 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 113.43 0.9 . . . . 75.32 113.43 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.66 -13.72 62.35 Favored Glycine 0 N--CA 1.47 0.951 0 N-CA-C 117.081 1.592 . . . . 73.44 117.081 172.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -119.23 119.4 33.99 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 106.079 -1.823 . . . . 73.31 106.079 153.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.99 102.9 14.74 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 118.732 -1.187 . . . . 73.54 108.05 -171.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.819 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -160.57 65.99 0.32 Allowed 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 116.796 -1.574 . . . . 73.11 115.171 -177.673 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.29 114.86 27.29 Favored 'General case' 0 CA--C 1.578 2.05 0 CA-C-N 124.109 3.141 . . . . 73.4 111.962 -172.082 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.508 HG22 HG23 ' A' ' 12' ' ' VAL . 21.9 t -120.28 116.57 50.67 Favored 'Isoleucine or valine' 0 C--N 1.363 1.17 0 O-C-N 119.752 -1.842 . . . . 34.25 107.793 165.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -142.95 142.06 31.58 Favored 'General case' 0 C--N 1.362 1.116 0 C-N-CA 117.193 -1.803 . . . . 73.54 111.622 168.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.717 HG13 HD12 ' A' ' 63' ' ' ILE . 25.9 m -82.96 127.15 70.65 Favored Pre-proline 0 N--CA 1.442 -0.828 0 CA-C-N 114.676 -1.147 . . . . 71.42 110.556 169.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.475 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 57.9 Cg_endo -85.5 25.32 0.7 Allowed 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 121.6 1.533 . . . . 74.42 112.341 164.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.494 ' CD1' ' HB1' ' A' ' 56' ' ' ALA . 1.5 p90 -105.3 -31.59 9.01 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 120.414 -0.514 . . . . 74.41 111.048 174.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 50.7 69.98 0.57 Allowed 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 125.057 1.343 . . . . 74.42 113.26 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 66.47 -157.4 0.25 Allowed 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 124.247 1.019 . . . . 63.14 111.754 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -96.13 -83.7 0.37 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 118.996 0.816 . . . . 63.41 110.254 -172.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 . . . . . 0 C--O 1.256 1.419 0 CA-C-O 118.704 -0.665 . . . . 74.42 109.816 177.684 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.97 0 N-CA-C 112.206 -0.358 . . . . 72.03 112.206 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -1' ' ' SER . . . . . 0.424 ' O ' ' HB3' ' A' ' 86' ' ' GLU . 6.6 p -145.73 159.48 43.11 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 123.041 0.536 . . . . 64.24 109.588 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 47.7 m80 -145.45 121.57 10.78 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 110.033 -0.358 . . . . 75.11 110.033 177.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.3 mtt -135.97 173.49 11.65 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.269 0.228 . . . . 73.12 111.458 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.7 m -97.51 143.54 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 116.307 -0.406 . . . . 25.32 111.737 -177.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.2 pt -127.68 132.53 68.95 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.261 0 CA-C-N 115.796 -0.638 . . . . 71.35 109.667 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 52.9 mtt85 -133.37 123.53 25.55 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-O 117.944 -1.027 . . . . 73.2 108.448 173.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 76.24 72.83 0.08 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 124.141 0.901 . . . . 63.45 110.206 170.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.4 t -140.95 166.35 25.01 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.509 -0.745 . . . . 73.11 110.248 -176.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.08 110.87 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 121.04 0.448 . . . . 73.35 109.943 177.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.79 124.52 31.0 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 115.363 -0.835 . . . . 72.32 109.625 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.506 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 4.9 ptt180 -140.59 157.53 45.34 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 118.837 -0.601 . . . . 63.42 112.394 -177.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.8 mt -118.15 135.17 59.42 Favored 'Isoleucine or valine' 0 C--N 1.368 1.41 0 CA-C-N 119.47 1.032 . . . . 74.54 109.075 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -105.97 118.54 36.86 Favored 'General case' 0 CA--C 1.568 1.661 0 O-C-N 125.281 1.613 . . . . 63.54 110.445 -177.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.456 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 47.3 t -124.2 107.52 18.76 Favored 'Isoleucine or valine' 0 C--N 1.373 1.619 0 CA-C-N 120.439 1.472 . . . . 71.32 109.287 -177.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.449 ' H ' ' HG3' ' A' ' 77' ' ' ARG . . . -120.18 163.93 13.88 Favored Glycine 0 C--N 1.344 1.021 0 C-N-CA 118.845 -1.645 . . . . 74.32 112.818 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.44 ' HB3' ' HB2' ' A' ' 75' ' ' LYS . 8.3 m120 50.45 26.89 2.53 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 114.772 1.397 . . . . 73.32 114.772 177.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.411 HD23 ' H ' ' A' ' 15' ' ' LEU . 0.9 OUTLIER -74.69 149.72 86.09 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.543 1.537 . . . . 74.21 111.415 -177.22 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -79.92 129.17 7.89 Favored 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 121.565 1.51 . . . . 73.24 111.27 176.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 96.7 p 57.55 102.56 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 124.647 1.179 . . . . 73.13 112.357 -171.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 32.0 p-80 -57.15 125.31 22.13 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.529 -0.76 . . . . 65.52 111.781 -177.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.513 HG23 ' HB2' ' A' ' 23' ' ' ASP . 2.9 p -77.61 119.29 26.01 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 CA-C-N 114.85 -1.068 . . . . 63.13 109.006 -176.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.0 m -79.4 157.37 27.6 Favored 'General case' 0 C--N 1.369 1.45 0 CA-C-O 117.955 -1.022 . . . . 73.02 108.581 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.8 p -48.97 -37.53 20.43 Favored 'General case' 0 C--N 1.375 1.698 0 N-CA-C 115.926 1.825 . . . . 71.14 115.926 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.584 ' H ' ' HD3' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -56.6 -40.72 75.79 Favored 'General case' 0 N--CA 1.507 2.381 0 N-CA-C 114.547 1.314 . . . . 75.14 114.547 172.692 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.513 ' HB2' HG23 ' A' ' 19' ' ' VAL . 7.5 m-20 -70.7 -45.93 64.07 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 118.955 0.798 . . . . 75.03 111.173 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.704 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 2.4 m -61.63 -49.75 83.07 Favored 'Isoleucine or valine' 0 C--N 1.372 1.572 0 N-CA-C 112.085 0.402 . . . . 72.43 112.085 174.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -50.09 -53.69 25.51 Favored 'General case' 0 CA--C 1.562 1.411 0 CA-C-O 116.528 -1.701 . . . . 74.21 113.226 171.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -73.09 -63.07 1.25 Allowed 'General case' 0 C--O 1.302 3.843 0 CA-C-N 122.901 2.591 . . . . 52.14 114.29 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -72.54 -30.79 64.76 Favored 'General case' 0 C--N 1.365 1.265 0 C-N-CA 119.031 -1.068 . . . . 74.21 111.172 -174.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.704 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 17.9 m-85 -85.85 -23.19 27.21 Favored 'General case' 0 CA--C 1.56 1.341 0 CA-C-N 119.536 1.062 . . . . 72.34 111.391 -178.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.434 ' HA ' HG22 ' A' ' 34' ' ' ILE 0.295 1.8 ppt_? -60.62 -24.5 65.56 Favored 'General case' 0 C--N 1.401 2.828 0 CA-C-N 120.602 1.546 . . . . 71.25 112.341 165.181 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . 0.297 0.0 OUTLIER -53.55 -30.77 43.47 Favored 'General case' 0 N--CA 1.508 2.466 0 C-N-CA 117.123 -1.831 . . . . 71.52 114.042 164.237 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -85.67 -49.47 7.96 Favored 'General case' 0 C--O 1.214 -0.793 0 CA-C-N 121.564 1.984 . . . . 73.04 112.279 -157.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -160.55 39.9 0.44 Allowed Glycine 0 C--N 1.355 1.613 0 C-N-CA 117.89 -2.1 . . . . 64.11 114.507 171.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.3 t30 69.33 93.78 0.08 Allowed 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 124.37 1.068 . . . . 72.32 111.435 173.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.434 HG22 ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -73.95 129.75 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-N 115.537 -0.756 . . . . 72.51 112.553 179.407 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.79 -21.73 12.54 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 109.553 -0.536 . . . . 73.35 109.553 174.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.22 131.63 15.67 Favored 'General case' 0 CA--C 1.561 1.394 0 N-CA-C 108.57 -0.9 . . . . 61.12 108.57 -173.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -138.55 110.59 7.28 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 120.126 1.33 . . . . 64.31 109.803 176.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -118.64 145.98 45.02 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 117.875 -1.53 . . . . 73.31 111.499 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 37.1 t -114.9 112.76 41.36 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 N-CA-C 107.623 -1.251 . . . . 71.22 107.623 172.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -114.7 129.83 56.74 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 114.825 -1.079 . . . . 75.42 108.739 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.09 144.52 51.48 Favored 'General case' 0 C--N 1.369 1.433 0 CA-C-N 121.004 1.729 . . . . 64.21 108.998 -171.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.49 HG23 ' H ' ' A' ' 44' ' ' SER . 8.8 t -99.06 170.99 8.32 Favored 'General case' 0 CA--C 1.558 1.288 0 CA-C-N 120.499 1.5 . . . . 30.13 111.738 -178.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.7 t -73.63 -7.07 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.368 0 C-N-CA 124.113 0.965 . . . . 73.23 112.577 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.49 ' H ' HG23 ' A' ' 42' ' ' THR . 8.5 t -85.41 8.36 19.19 Favored 'General case' 0 CA--C 1.55 0.965 0 O-C-N 121.59 -0.694 . . . . 65.41 111.04 -177.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.42 -4.89 75.73 Favored Glycine 0 C--N 1.351 1.4 0 N-CA-C 115.178 0.831 . . . . 54.21 115.178 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.19 131.27 34.24 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 117.726 0.763 . . . . 71.5 110.484 176.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -105.34 147.76 27.81 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 108.045 -1.094 . . . . 43.45 108.045 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -126.67 147.27 49.95 Favored 'General case' 0 C--N 1.352 0.7 0 C-N-CA 118.609 -1.236 . . . . 74.1 109.7 177.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.456 ' HB3' ' HB ' ' A' ' 12' ' ' VAL . . . -117.08 138.75 51.41 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 120.538 -0.465 . . . . 74.14 109.751 176.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.13 113.83 15.58 Favored 'General case' 0 C--O 1.261 1.662 0 N-CA-C 106.709 -1.589 . . . . 64.33 106.709 -175.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.44 ' N ' HD12 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -129.18 113.9 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 C-N-CA 118.699 -1.2 . . . . 71.52 109.72 -170.871 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -91.62 115.38 28.0 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 114.567 -1.197 . . . . 61.34 112.481 -172.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -109.39 159.58 16.89 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 114.279 1.214 . . . . 71.51 114.279 -177.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -82.04 -43.33 18.07 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 120.115 -0.634 . . . . 63.14 112.315 172.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.451 ' OD1' ' HD2' ' A' ' 57' ' ' ARG . 6.0 t0 -116.41 127.02 54.26 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 118.923 0.783 . . . . 74.41 110.896 -174.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.03 -22.21 53.38 Favored 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 115.548 1.684 . . . . 54.31 115.548 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.451 ' HD2' ' OD1' ' A' ' 55' ' ' ASP 0.289 0.0 OUTLIER -76.73 -41.32 45.47 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 121.939 2.154 . . . . 65.41 113.273 -173.191 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -62.69 -48.85 77.5 Favored 'General case' 0 N--CA 1.505 2.319 0 CA-C-N 120.217 1.371 . . . . 63.14 113.499 178.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.55 -24.62 33.25 Favored 'General case' 0 CA--C 1.567 1.596 0 N-CA-C 115.477 1.658 . . . . 71.44 115.477 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.401 ' O ' ' HG3' ' A' ' 64' ' ' LYS . . . -46.68 -44.37 18.55 Favored 'General case' 0 CA--C 1.576 1.967 0 C-N-CA 125.31 1.444 . . . . 73.31 114.025 173.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -51.83 -53.47 39.81 Favored 'General case' 0 N--CA 1.514 2.739 0 CA-C-N 119.523 1.056 . . . . 65.51 112.822 173.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.629 ' O ' ' HD2' ' A' ' 66' ' ' LYS . . . -75.67 -30.21 59.32 Favored 'General case' 0 C--N 1.31 -1.141 0 O-C-N 120.467 -1.396 . . . . 73.2 112.868 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 63' ' ' ILE 0.256 5.9 mm -68.78 -46.23 79.78 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.921 0 C-N-CA 118.174 -1.41 . . . . 54.43 111.915 179.205 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -56.94 -32.83 66.38 Favored 'General case' 0 CA--C 1.562 1.44 0 N-CA-C 115.155 1.539 . . . . 71.21 115.155 164.831 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -64.36 -28.39 69.66 Favored 'General case' 0 N--CA 1.507 2.377 0 CA-C-N 120.542 1.519 . . . . 75.41 113.201 173.12 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.629 ' HD2' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -107.41 15.17 25.19 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 116.221 1.934 . . . . 74.52 116.221 164.6 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.33 0.0 OUTLIER -78.63 157.21 28.73 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 120.238 1.381 . . . . 73.13 110.941 179.597 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.52 30.85 1.77 Allowed Glycine 0 N--CA 1.428 -1.889 0 C-N-CA 117.526 -2.273 . . . . 73.3 113.622 -151.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.739 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 6.9 t -49.07 132.69 19.04 Favored 'General case' 0 C--N 1.376 1.74 0 CA-C-O 122.062 0.934 . . . . 65.43 111.049 172.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.41 ' HB2' ' HB2' ' A' ' 76' ' ' LEU . 1.2 m-20 -128.92 147.13 50.81 Favored 'General case' 0 C--O 1.246 0.914 0 CA-C-N 113.951 -1.477 . . . . 72.4 112.836 -170.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.63 144.91 24.72 Favored 'General case' 0 C--N 1.355 0.83 0 C-N-CA 126.83 2.052 . . . . 74.22 108.154 -156.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 70.91 62.28 0.18 Allowed 'General case' 0 N--CA 1.501 2.086 0 O-C-N 123.611 0.569 . . . . 74.51 112.473 173.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.95 -14.79 64.15 Favored Glycine 0 N--CA 1.472 1.036 0 N-CA-C 116.952 1.541 . . . . 73.33 116.952 173.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -123.11 119.74 31.19 Favored 'General case' 0 C--O 1.211 -0.942 0 N-CA-C 104.592 -2.373 . . . . 74.43 104.592 159.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.44 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -104.54 131.44 51.93 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 118.02 -1.472 . . . . 73.42 111.281 -177.548 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.739 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -171.33 70.69 0.05 OUTLIER 'General case' 0 C--O 1.199 -1.594 0 CA-C-O 117.981 -1.009 . . . . 52.01 110.589 -178.417 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.449 ' HG3' ' H ' ' A' ' 13' ' ' GLY . 2.0 tpp85 -93.0 115.62 28.29 Favored 'General case' 0 CA--C 1.571 1.763 0 CA-C-N 121.572 1.987 . . . . 73.34 111.411 -172.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.04 116.09 48.76 Favored 'Isoleucine or valine' 0 C--N 1.361 1.079 0 N-CA-C 107.558 -1.275 . . . . 64.03 107.558 163.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.2 tp10 -134.46 138.66 44.93 Favored 'General case' 0 C--N 1.363 1.178 0 CA-C-N 119.576 1.08 . . . . 73.44 110.427 174.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.0 m -90.3 122.39 67.48 Favored Pre-proline 0 N--CA 1.439 -0.998 0 C-N-CA 120.016 -0.673 . . . . 71.51 110.579 170.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 75.5 Cg_endo -89.74 22.77 0.76 Allowed 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 121.887 1.725 . . . . 74.1 113.378 168.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.446 ' HD2' ' N ' ' A' ' 9' ' ' ARG . 0.8 OUTLIER -113.32 -16.84 12.43 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 120.009 -0.676 . . . . 70.34 112.417 175.426 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.6 m120 70.87 123.9 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 124.957 1.411 . . . . 71.42 110.271 -171.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.66 60.04 2.64 Favored 'General case' 0 C--N 1.365 1.259 0 CA-C-N 119.481 1.037 . . . . 75.22 113.123 -173.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.48 39.17 5.23 Favored 'General case' 0 C--N 1.366 1.313 0 C-N-CA 125.681 1.592 . . . . 62.33 110.393 178.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.424 ' HB3' ' O ' ' A' ' -1' ' ' SER . 19.3 mm-40 . . . . . 0 CA--C 1.552 1.051 0 C-N-CA 124.091 0.956 . . . . 65.53 112.958 170.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.511 0 N-CA-C 112.116 -0.394 . . . . 61.22 112.116 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 23.4 p -135.14 -9.6 2.27 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 122.748 0.419 . . . . 64.13 112.117 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -142.78 174.52 10.58 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.205 0.202 . . . . 72.25 110.826 178.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.476 ' SD ' ' HD3' ' A' ' 85' ' ' ARG . 30.6 ttp -164.1 87.65 0.5 Allowed 'General case' 0 C--N 1.345 0.408 0 O-C-N 123.621 0.576 . . . . 74.32 109.567 175.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 44.0 t 69.26 136.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 C-N-CA 125.467 1.507 . . . . 71.21 112.668 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.0 tt -130.93 -46.78 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.202 0 O-C-N 121.2 -0.937 . . . . 61.01 112.728 174.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.6 tpt180 -171.98 54.52 0.02 OUTLIER 'General case' 0 C--N 1.355 0.805 0 CA-C-N 119.21 0.914 . . . . 71.13 109.803 -173.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 68.96 92.59 0.08 Allowed 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 124.574 1.15 . . . . 74.34 110.88 177.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.1 t -121.38 -166.83 1.41 Allowed 'General case' 0 CA--C 1.551 0.995 0 O-C-N 121.094 -1.004 . . . . 64.14 110.573 -178.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.9 m -142.58 115.55 3.71 Favored 'Isoleucine or valine' 0 C--N 1.353 0.745 0 N-CA-C 106.637 -1.616 . . . . 70.21 106.637 175.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.68 122.88 29.22 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 122.017 -0.427 . . . . 74.22 112.092 -172.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.499 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -126.59 154.76 43.5 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.044 0.757 . . . . 73.43 113.044 -176.299 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.776 HD13 HG13 ' A' ' 63' ' ' ILE . 23.4 mt -116.79 141.17 36.07 Favored 'Isoleucine or valine' 0 C--O 1.254 1.31 0 CA-C-N 119.446 1.021 . . . . 75.34 108.637 179.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -101.71 116.99 33.96 Favored 'General case' 0 CA--C 1.572 1.797 0 O-C-N 125.991 2.057 . . . . 70.41 110.073 177.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.491 ' CG1' HG22 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -127.37 105.67 14.15 Favored 'Isoleucine or valine' 0 C--N 1.381 1.95 0 CA-C-N 119.348 0.977 . . . . 73.12 108.754 179.843 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -113.12 -175.66 19.36 Favored Glycine 0 CA--C 1.521 0.445 0 CA-C-O 118.504 -1.164 . . . . 73.33 112.991 176.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.7 m120 54.09 28.8 9.34 Favored 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 115.701 1.741 . . . . 74.1 115.701 170.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.3 mt -89.08 150.79 45.87 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 123.51 0.724 . . . . 73.54 111.629 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -59.35 130.73 37.21 Favored 'Trans proline' 0 CA--C 1.556 1.582 0 C-N-CA 123.095 2.53 . . . . 61.22 113.232 173.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.0 p 71.98 -5.11 1.79 Allowed 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 126.473 1.909 . . . . 71.22 114.525 168.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 71.54 129.8 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.062 1.345 . . . . 74.13 110.605 -173.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.9 m -91.68 119.78 39.61 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.443 0 N-CA-C 107.424 -1.324 . . . . 73.15 107.424 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.44 157.47 24.91 Favored 'General case' 0 C--N 1.381 1.972 0 O-C-N 120.263 -1.523 . . . . 64.02 109.991 -175.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.0 p -58.96 -34.25 71.58 Favored 'General case' 0 C--N 1.378 1.836 0 N-CA-C 115.835 1.791 . . . . 64.42 115.835 -174.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.4 ' HA ' ' HG2' ' A' ' 25' ' ' GLU 0.274 0.0 OUTLIER -60.75 -39.14 87.61 Favored 'General case' 0 CA--C 1.582 2.199 0 N-CA-C 115.477 1.658 . . . . 73.21 115.477 172.377 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -65.32 -50.47 65.54 Favored 'General case' 0 C--O 1.279 2.622 0 CA-C-N 119.87 1.214 . . . . 73.4 111.329 178.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.7 m -62.94 -43.75 99.19 Favored 'Isoleucine or valine' 0 C--N 1.376 1.759 0 O-C-N 123.546 0.529 . . . . 53.31 111.877 177.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.4 ' HG2' ' HA ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -54.13 -50.16 67.54 Favored 'General case' 0 C--O 1.191 -2.015 0 CA-C-O 115.195 -2.336 . . . . 75.44 115.202 169.03 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -68.41 -56.63 7.81 Favored 'General case' 0 C--O 1.283 2.85 0 CA-C-N 123.257 2.753 . . . . 51.32 114.071 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -61.18 -44.56 97.1 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 117.903 -1.046 . . . . 64.3 111.71 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -74.59 -28.54 60.95 Favored 'General case' 0 C--O 1.209 -1.04 0 CA-C-N 120.857 1.662 . . . . 62.33 114.194 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.417 ' C ' ' HE ' ' A' ' 29' ' ' ARG 0.379 0.0 OUTLIER -57.62 -37.88 74.03 Favored 'General case' 0 N--CA 1.526 3.353 0 CA-C-N 121.285 1.857 . . . . 74.33 114.252 164.025 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.41 ' HE2' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -56.6 -47.75 78.91 Favored 'General case' 0 N--CA 1.508 2.475 0 C-N-CA 116.194 -2.202 . . . . 64.3 110.319 167.903 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.554 ' HB3' ' HA ' ' A' ' 59' ' ' ALA . 35.2 m-85 -72.64 -39.47 67.16 Favored 'General case' 0 CA--C 1.564 1.505 0 CA-C-O 118.065 -0.969 . . . . 70.32 112.79 -166.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -150.11 176.07 28.91 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-N 119.965 1.257 . . . . 74.22 110.722 161.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 47.1 m-20 -83.58 101.14 11.26 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.249 2.024 . . . . 75.31 111.077 -176.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.91 134.41 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.108 0.48 . . . . 64.31 112.034 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.5 mp -102.77 -24.86 13.69 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 116.097 -0.501 . . . . 74.51 111.992 171.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.53 138.0 13.97 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 109.249 -0.648 . . . . 74.43 109.249 -173.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -140.27 108.73 5.86 Favored 'General case' 0 C--N 1.359 0.982 0 CA-C-N 118.727 0.694 . . . . 72.43 109.545 178.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -120.8 143.68 48.71 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 117.852 -1.539 . . . . 61.15 112.643 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -127.15 112.8 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 CA-C-O 121.452 0.644 . . . . 62.43 110.284 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.5 mttm -113.41 152.43 30.07 Favored 'General case' 0 CA--C 1.56 1.336 0 CA-C-O 118.018 -0.991 . . . . 73.23 108.874 -174.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.37 147.19 50.27 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-N 121.755 2.071 . . . . 70.51 109.061 -174.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.682 HG23 ' H ' ' A' ' 44' ' ' SER . 5.8 t -98.88 175.65 5.87 Favored 'General case' 0 CA--C 1.565 1.53 0 CA-C-N 120.816 1.644 . . . . 72.11 111.356 175.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.5 t -77.51 -8.99 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.387 0 C-N-CA 123.486 0.714 . . . . 71.32 112.115 -178.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.682 ' H ' HG23 ' A' ' 42' ' ' THR . 8.2 t -86.14 -0.8 56.53 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 121.773 -0.579 . . . . 54.03 110.753 -177.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.06 -7.46 66.81 Favored Glycine 0 CA--C 1.534 1.258 0 N-CA-C 114.977 0.751 . . . . 52.23 114.977 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.31 132.26 37.38 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 117.728 0.764 . . . . 73.32 108.952 170.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.88 145.35 44.68 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.022 -0.733 . . . . 51.21 109.022 -171.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -127.04 151.16 48.97 Favored 'General case' 0 C--N 1.363 1.16 0 CA-C-N 119.783 1.174 . . . . 74.53 112.0 -170.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -127.57 147.0 50.34 Favored 'General case' 0 C--N 1.351 0.642 0 CA-C-O 121.705 0.764 . . . . 70.05 111.831 175.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -132.69 113.31 12.84 Favored 'General case' 0 C--O 1.256 1.407 0 N-CA-C 105.392 -2.077 . . . . 73.33 105.392 -164.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 0.6 OUTLIER -126.38 108.91 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 C-N-CA 118.186 -1.406 . . . . 73.15 108.865 -170.525 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -106.27 106.0 16.3 Favored 'General case' 0 CA--C 1.549 0.905 0 O-C-N 124.6 1.187 . . . . 72.43 110.233 -173.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.19 146.6 39.0 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-O 118.681 -0.676 . . . . 74.21 112.766 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -57.46 -24.21 54.4 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 114.657 1.354 . . . . 72.25 114.657 166.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -114.09 113.42 24.7 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 119.603 1.092 . . . . 74.34 109.015 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.29 -43.68 32.37 Favored 'General case' 0 CA--C 1.554 1.103 0 N-CA-C 115.426 1.639 . . . . 72.43 115.426 172.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.305 0.0 OUTLIER -77.49 -29.57 52.66 Favored 'General case' 0 C--N 1.373 1.589 0 CA-C-N 121.117 1.78 . . . . 75.35 114.916 -167.831 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.17 -30.17 63.36 Favored 'General case' 0 CA--C 1.581 2.17 0 N-CA-C 116.353 1.983 . . . . 74.43 116.353 176.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.554 ' HA ' ' HB3' ' A' ' 31' ' ' TYR . . . -72.99 -19.28 61.24 Favored 'General case' 0 CA--C 1.585 2.302 0 CA-C-N 120.367 1.439 . . . . 44.13 111.993 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -48.58 -29.78 4.62 Favored 'General case' 0 CA--C 1.572 1.825 0 CA-C-O 116.97 -1.49 . . . . 35.42 114.325 170.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.565 ' O ' ' HB3' ' A' ' 65' ' ' GLU . 18.8 m-20 -51.88 -53.38 41.31 Favored 'General case' 0 C--N 1.398 2.708 0 CA-C-N 121.025 1.739 . . . . 62.32 111.571 164.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.02 -34.8 79.3 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-O 117.824 -1.084 . . . . 72.33 113.689 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.776 HG13 HD13 ' A' ' 10' ' ' ILE 0.281 0.0 OUTLIER -72.92 -35.93 50.34 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.685 0 C-N-CA 116.457 -2.097 . . . . 74.22 113.727 -178.741 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.61 -32.95 74.58 Favored 'General case' 0 C--N 1.362 1.143 0 CA-C-N 119.848 1.204 . . . . 73.52 113.678 163.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.565 ' HB3' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -83.38 -19.28 36.35 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 113.206 0.817 . . . . 74.41 113.206 -172.804 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -100.35 13.64 33.75 Favored 'General case' 0 CA--C 1.571 1.784 0 O-C-N 122.207 -0.308 . . . . 74.33 110.329 173.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.302 0.1 OUTLIER -77.02 161.94 27.93 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 118.422 0.555 . . . . 71.43 112.296 -167.463 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 119.85 28.41 1.89 Allowed Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 119.452 -1.356 . . . . 72.23 114.681 -155.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.702 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 0.8 OUTLIER -47.94 132.68 15.02 Favored 'General case' 0 C--N 1.377 1.768 0 C-N-CA 124.573 1.149 . . . . 75.3 109.811 179.238 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -56.95 102.06 0.07 Allowed 'General case' 0 C--N 1.384 2.105 0 O-C-N 125.216 1.573 . . . . 73.23 112.362 -160.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -153.92 139.3 17.64 Favored 'General case' 0 N--CA 1.439 -0.998 0 O-C-N 125.252 1.595 . . . . 71.22 107.303 -178.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 67.32 54.12 0.73 Allowed 'General case' 0 N--CA 1.508 2.461 0 C-N-CA 123.501 0.72 . . . . 64.41 111.892 172.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.73 -9.06 32.01 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 117.893 1.917 . . . . 75.31 117.893 176.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -115.54 119.54 36.52 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.245 1.522 . . . . 70.44 107.993 -174.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.03 100.83 12.59 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 117.966 -1.016 . . . . 52.31 111.643 -167.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.702 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -162.49 103.95 1.08 Allowed 'General case' 0 C--O 1.158 -3.749 0 CA-C-O 117.081 -1.438 . . . . 74.03 107.935 170.498 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.67 109.9 21.33 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 123.533 2.879 . . . . 65.54 107.257 -170.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.491 HG22 ' CG1' ' A' ' 12' ' ' VAL . 88.4 t -128.38 117.21 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.548 0 CA-C-N 120.481 1.491 . . . . 63.22 108.573 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -150.22 135.53 18.02 Favored 'General case' 0 C--N 1.381 1.972 0 CA-C-N 120.339 1.427 . . . . 72.24 110.144 -174.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.679 HG13 HD12 ' A' ' 63' ' ' ILE . 19.0 m -77.93 122.27 85.29 Favored Pre-proline 0 C--N 1.36 1.052 0 CA-C-O 121.618 0.723 . . . . 55.24 110.892 161.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.499 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 72.2 Cg_endo -90.78 13.69 2.13 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.402 2.068 . . . . 60.15 113.362 165.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -102.41 -45.72 5.0 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.055 -0.72 . . . . 55.24 109.055 170.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 51.52 55.68 9.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 125.058 1.474 . . . . 63.22 110.302 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -165.31 175.87 8.83 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 121.471 -0.768 . . . . 71.33 109.725 -162.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.476 ' HD3' ' SD ' ' A' ' 1' ' ' MET . 49.3 ttt180 -120.72 147.65 45.01 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 108.609 -0.886 . . . . 74.34 108.609 172.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 . . . . . 0 C--O 1.246 0.887 0 N-CA-C 107.304 -1.369 . . . . 71.03 107.304 167.485 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.057 0 N-CA-C 111.138 -0.785 . . . . 52.4 111.138 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 83.4 p -153.16 136.46 15.74 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 112.441 0.534 . . . . 63.53 112.441 -176.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -130.86 -88.16 0.48 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.483 0.713 . . . . 71.21 110.602 173.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ptp -169.32 112.81 0.52 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.866 0.466 . . . . 71.52 111.168 -177.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 60.9 t -130.97 -46.11 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 O-C-N 122.15 -0.344 . . . . 73.24 110.989 169.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.7 tt -61.77 107.03 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 113.54 0.941 . . . . 64.24 113.54 -169.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.46 152.22 43.59 Favored 'General case' 0 C--N 1.353 0.722 0 CA-C-N 115.668 -0.696 . . . . 74.53 109.807 167.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 65.14 46.18 2.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 123.855 0.722 . . . . 74.44 111.359 175.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.3 t -154.8 164.46 38.78 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 116.155 -0.475 . . . . 73.42 109.985 -177.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.7 m -114.37 126.68 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 109.785 -0.45 . . . . 74.23 109.785 -177.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 t -84.96 124.21 31.41 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 122.252 -0.28 . . . . 63.23 111.725 -178.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.454 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -141.16 154.66 45.97 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 113.351 0.871 . . . . 75.51 113.351 -175.06 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.6 mt -116.65 141.72 33.45 Favored 'Isoleucine or valine' 0 C--O 1.26 1.644 0 N-CA-C 108.418 -0.956 . . . . 71.11 108.418 -179.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -100.7 118.02 35.97 Favored 'General case' 0 CA--C 1.566 1.568 0 O-C-N 125.775 1.922 . . . . 74.32 110.374 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.475 HG13 HG22 ' A' ' 78' ' ' VAL . 57.9 t -125.78 106.24 15.79 Favored 'Isoleucine or valine' 0 C--N 1.375 1.677 0 CA-C-N 119.849 1.204 . . . . 73.12 109.889 177.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.17 -178.07 20.9 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 118.582 -1.121 . . . . 54.43 111.818 174.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.5 m120 50.13 24.2 1.36 Allowed 'General case' 0 N--CA 1.509 2.489 0 N-CA-C 116.579 2.066 . . . . 63.2 116.579 172.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.616 HD12 ' HB3' ' A' ' 18' ' ' HIS . 2.4 pt? -89.18 123.93 66.01 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 123.401 0.681 . . . . 61.34 111.001 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -84.33 126.67 3.72 Favored 'Trans proline' 0 CA--C 1.559 1.74 0 C-N-CA 121.415 1.41 . . . . 62.33 112.855 174.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.1 m 33.42 60.55 0.47 Allowed 'General case' 0 C--N 1.386 2.154 0 C-N-CA 125.772 1.629 . . . . 55.53 114.271 174.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.616 ' HB3' HD12 ' A' ' 15' ' ' LEU . 7.3 t60 -109.58 -128.29 0.28 Allowed 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.65 -0.704 . . . . 73.31 109.671 -168.275 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.9 m -83.37 121.59 36.41 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.695 0 CA-C-N 118.384 0.538 . . . . 70.35 110.983 -174.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -81.43 165.56 21.17 Favored 'General case' 0 C--N 1.369 1.434 0 CA-C-O 117.571 -1.204 . . . . 72.14 109.134 176.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.6 p -47.79 -46.78 30.84 Favored 'General case' 0 C--N 1.382 2.008 0 N-CA-C 116.065 1.876 . . . . 63.24 116.065 -173.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.25 -42.03 96.69 Favored 'General case' 0 CA--C 1.577 2.0 0 N-CA-C 114.517 1.303 . . . . 65.55 114.517 178.115 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.352 0.6 OUTLIER -67.41 -27.24 66.91 Favored 'General case' 0 CA--C 1.565 1.543 0 CA-C-N 120.036 1.289 . . . . 61.41 112.958 172.783 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.441 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 2.3 t -71.11 -38.78 72.65 Favored 'Isoleucine or valine' 0 C--N 1.406 3.055 0 CA-C-N 120.266 1.394 . . . . 64.34 107.734 175.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.601 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -65.79 -56.82 9.94 Favored 'General case' 0 CA--C 1.555 1.138 0 CA-C-O 117.129 -1.415 . . . . 75.4 112.198 179.488 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.11 -54.92 19.69 Favored 'General case' 0 C--O 1.299 3.666 0 CA-C-N 121.739 2.063 . . . . 72.32 115.58 176.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.78 -37.83 80.18 Favored 'General case' 0 C--N 1.387 2.209 0 CA-C-O 118.126 -0.94 . . . . 53.25 112.136 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.441 ' HB2' ' O ' ' A' ' 24' ' ' VAL 0.256 63.4 m-85 -83.87 -21.9 31.82 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-O 115.832 -2.033 . . . . 72.22 114.188 178.312 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.601 ' HG3' ' O ' ' A' ' 25' ' ' GLU 0.372 10.6 mtp180 -61.95 -36.05 80.25 Favored 'General case' 0 N--CA 1.524 3.225 0 CA-C-N 122.689 2.495 . . . . 72.12 109.115 169.466 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.84 -45.86 89.06 Favored 'General case' 0 N--CA 1.509 2.52 0 C-N-CA 116.879 -1.929 . . . . 64.32 112.179 172.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.56 ' HB3' ' HA ' ' A' ' 59' ' ' ALA . 13.7 m-85 -71.83 -40.35 69.16 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 112.746 0.647 . . . . 75.01 112.746 -169.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -151.5 163.72 30.01 Favored Glycine 0 C--O 1.213 -1.184 0 CA-C-O 117.346 -1.808 . . . . 71.31 108.591 156.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -72.59 101.18 2.95 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 121.188 2.494 . . . . 44.42 111.402 -170.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.49 HG22 ' HB3' ' A' ' 53' ' ' PHE . 2.1 pp -73.81 142.41 14.91 Favored 'Isoleucine or valine' 0 C--N 1.359 0.983 0 C-N-CA 120.089 -0.645 . . . . 73.45 112.602 -174.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.1 mp -97.37 -45.5 6.44 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 115.912 -0.585 . . . . 74.21 112.131 174.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.05 152.99 38.34 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-N 118.697 0.681 . . . . 61.23 110.558 172.041 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 3.3 m -137.62 107.4 6.26 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 106.756 -1.572 . . . . 72.52 106.756 176.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -115.88 143.41 45.46 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 118.544 -1.263 . . . . 63.41 111.288 -175.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -123.62 113.14 36.05 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-O 121.27 0.557 . . . . 74.34 110.239 -173.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 48.1 mttm -116.76 146.14 43.02 Favored 'General case' 0 CA--C 1.563 1.445 0 CA-C-O 117.968 -1.015 . . . . 55.34 109.956 -173.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.42 146.31 50.13 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 121.508 1.958 . . . . 71.12 108.771 -170.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.601 HG23 ' H ' ' A' ' 44' ' ' SER . 5.1 t -99.33 167.41 10.67 Favored 'General case' 0 C--N 1.363 1.164 0 CA-C-N 120.358 1.435 . . . . 75.23 111.398 175.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.3 m -66.39 -5.32 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.472 0 N-CA-C 116.262 1.949 . . . . 75.43 116.262 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.601 ' H ' HG23 ' A' ' 42' ' ' THR . 0.8 OUTLIER -98.83 4.81 47.64 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 119.507 1.049 . . . . 75.4 110.14 -172.373 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.37 -6.82 74.99 Favored Glycine 0 CA--C 1.543 1.781 0 N-CA-C 115.238 0.855 . . . . 62.22 115.238 -176.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -80.78 131.52 35.43 Favored 'General case' 0 CA--C 1.554 1.133 0 CA-C-N 118.267 1.034 . . . . 73.31 109.248 171.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.93 147.45 43.13 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-O 118.565 -0.731 . . . . 73.3 109.319 -171.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -129.57 151.62 49.99 Favored 'General case' 0 C--N 1.367 1.327 0 CA-C-N 119.541 1.064 . . . . 70.24 111.619 -173.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -134.29 144.01 48.08 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.919 0.866 . . . . 75.44 111.598 175.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -131.59 114.67 15.12 Favored 'General case' 0 C--O 1.265 1.88 0 N-CA-C 105.591 -2.003 . . . . 71.25 105.591 -159.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 0.3 OUTLIER -120.01 107.6 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 C-N-CA 119.271 -0.972 . . . . 74.21 109.713 -165.79 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -114.04 104.7 12.4 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.126 -0.488 . . . . 61.53 111.04 -169.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.49 ' HB3' HG22 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -114.12 160.73 18.62 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.831 1.048 . . . . 74.32 113.831 -177.035 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -73.09 -28.7 62.44 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 112.741 0.645 . . . . 61.41 112.741 167.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -113.8 112.42 23.37 Favored 'General case' 0 C--N 1.351 0.659 0 C-N-CA 118.571 -1.252 . . . . 60.33 109.277 176.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.34 -44.71 35.47 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 116.058 1.873 . . . . 72.44 116.058 170.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.97 -34.9 76.08 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 113.846 1.054 . . . . 73.32 113.846 -169.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -75.96 -32.64 59.6 Favored 'General case' 0 CA--C 1.586 2.358 0 N-CA-C 115.897 1.814 . . . . 64.44 115.897 176.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.56 ' HA ' ' HB3' ' A' ' 31' ' ' TYR . . . -64.93 -19.81 66.13 Favored 'General case' 0 CA--C 1.595 2.694 0 N-CA-C 114.884 1.439 . . . . 75.44 114.884 173.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -48.46 -31.83 6.89 Favored 'General case' 0 CA--C 1.578 2.055 0 N-CA-C 115.047 1.499 . . . . 74.1 115.047 171.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.406 ' O ' ' HB3' ' A' ' 65' ' ' GLU . 14.9 m-20 -51.21 -52.97 39.5 Favored 'General case' 0 N--CA 1.507 2.424 0 CA-C-N 119.915 1.234 . . . . 62.21 111.77 164.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.58 -31.32 71.95 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 117.13 -1.414 . . . . 73.21 114.023 175.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . 0.343 0.3 OUTLIER -73.59 -42.49 55.51 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.199 0 C-N-CA 115.578 -2.449 . . . . 74.31 113.895 177.612 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.16 -27.42 65.65 Favored 'General case' 0 CA--C 1.56 1.328 0 CA-C-N 120.158 1.345 . . . . 72.53 113.691 165.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.406 ' HB3' ' O ' ' A' ' 61' ' ' ASP . 1.2 tt0 -77.59 -29.31 51.91 Favored 'General case' 0 CA--C 1.549 0.937 0 O-C-N 121.31 -0.869 . . . . 73.13 112.45 178.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 43.0 mmtt -96.01 13.0 28.48 Favored 'General case' 0 CA--C 1.584 2.259 0 N-CA-C 112.861 0.689 . . . . 74.4 112.861 172.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.323 0.2 OUTLIER -76.23 164.97 25.54 Favored 'General case' 0 N--CA 1.51 2.534 0 CA-C-N 119.825 1.193 . . . . 74.4 111.922 -171.059 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.76 31.19 1.05 Allowed Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 118.652 -1.737 . . . . 74.14 114.801 -153.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.647 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 59.5 m -44.68 139.49 2.89 Favored 'General case' 0 C--N 1.393 2.492 0 CA-C-N 117.767 0.784 . . . . 74.03 111.852 171.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.406 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 7.9 t0 -58.05 99.79 0.05 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 O-C-N 125.038 1.461 . . . . 71.43 110.774 -169.014 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -155.63 139.29 16.05 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 125.551 1.54 . . . . 75.44 109.63 -175.278 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 66.06 51.39 1.31 Allowed 'General case' 0 N--CA 1.509 2.506 0 C-N-CA 123.148 0.579 . . . . 73.23 111.935 168.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.9 -11.01 36.84 Favored Glycine 0 CA--C 1.541 1.69 0 N-CA-C 117.456 1.742 . . . . 53.32 117.456 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' A' ' 70' ' ' ASP . 8.8 t30 -114.83 118.9 34.84 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 119.608 1.704 . . . . 74.51 108.84 -177.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.96 107.59 19.88 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 113.57 0.952 . . . . 70.32 113.57 -176.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.647 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -159.35 108.87 1.89 Allowed 'General case' 0 C--O 1.167 -3.261 0 N-CA-C 107.48 -1.304 . . . . 74.04 107.48 165.847 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 -90.79 107.58 19.28 Favored 'General case' 0 CA--C 1.554 1.098 0 CA-C-N 122.728 2.513 . . . . 72.03 108.028 -175.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.475 HG22 HG13 ' A' ' 12' ' ' VAL . 57.7 t -127.28 111.46 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 O-C-N 120.771 -1.206 . . . . 55.21 108.776 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -149.44 133.68 17.33 Favored 'General case' 0 C--O 1.257 1.475 0 CA-C-N 120.565 1.529 . . . . 64.32 110.615 -166.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.8 m -73.47 126.14 90.16 Favored Pre-proline 0 C--N 1.37 1.491 0 CA-C-O 121.363 0.601 . . . . 73.11 111.88 164.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -96.49 17.31 0.68 Allowed 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.367 2.711 . . . . 53.3 113.959 164.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -114.32 -26.38 8.02 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 120.574 -0.45 . . . . 75.32 112.063 176.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 54.94 73.79 0.39 Allowed 'General case' 0 CA--C 1.569 1.683 0 O-C-N 124.583 1.177 . . . . 72.44 113.43 -175.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 72.81 -99.41 0.03 OUTLIER 'General case' 0 C--N 1.369 1.431 0 C-N-CA 125.109 1.363 . . . . 53.53 112.838 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 14.1 ttt180 -167.9 26.63 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 109.052 -0.722 . . . . 75.31 109.052 -176.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.296 -1.335 . . . . 73.42 111.794 -171.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.935 0 N-CA-C 111.467 -0.653 . . . . 35.11 111.467 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -1' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 84' ' ' ALA . 9.6 t -153.0 147.09 25.51 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 116.972 0.386 . . . . 72.44 110.61 176.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -136.04 158.84 43.44 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 109.251 -0.648 . . . . 73.15 109.251 177.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 mpp? -130.27 11.95 5.49 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.193 0.52 . . . . 72.33 110.748 173.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.7 m -121.3 -179.13 1.75 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 115.933 -0.576 . . . . 74.54 109.566 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.0 mt 71.73 101.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 O-C-N 124.752 1.282 . . . . 73.4 110.798 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.94 77.79 1.14 Allowed 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.343 0.592 . . . . 75.12 110.497 -175.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -167.07 -163.91 0.57 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.26 -1.336 . . . . 62.41 108.979 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.3 m 65.85 -159.42 0.27 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.925 0.89 . . . . 54.44 110.948 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.3 p -151.29 136.58 10.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 121.247 0.546 . . . . 73.45 110.642 177.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 t -80.88 123.52 28.35 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.508 -0.769 . . . . 74.35 110.188 178.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.551 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 0.3 OUTLIER -141.87 160.34 40.4 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 112.66 0.615 . . . . 71.33 112.66 -176.726 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.797 HG12 HG12 ' A' ' 80' ' ' VAL . 3.7 mt -113.64 136.9 48.59 Favored 'Isoleucine or valine' 0 C--O 1.246 0.911 0 N-CA-C 109.075 -0.713 . . . . 53.42 109.075 176.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -111.35 112.86 24.93 Favored 'General case' 0 C--N 1.354 0.761 0 O-C-N 124.619 1.2 . . . . 64.3 108.923 172.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 4.0 p -124.42 110.38 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-O 121.577 0.703 . . . . 73.0 111.422 175.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -117.62 159.24 14.22 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.918 -0.583 . . . . 64.11 112.458 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.1 m120 60.87 28.98 18.72 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.996 0.918 . . . . 64.04 111.925 175.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.538 HD23 ' H ' ' A' ' 15' ' ' LEU . 2.1 pt? -85.04 137.46 37.5 Favored Pre-proline 0 C--O 1.239 0.528 0 CA-C-N 115.873 -0.603 . . . . 61.24 111.564 -172.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -69.23 126.92 14.26 Favored 'Trans proline' 0 C--N 1.36 1.142 0 C-N-CA 122.23 1.954 . . . . 71.11 112.055 174.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.6 t 52.23 92.24 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.96 0 O-C-N 124.672 1.233 . . . . 51.3 111.956 -173.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 34.0 p-80 -58.71 131.61 51.41 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.652 -0.703 . . . . 72.42 111.325 -177.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.3 m -72.45 133.54 31.58 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-N 115.079 -0.964 . . . . 61.31 111.525 -176.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.414 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -83.03 157.08 23.05 Favored 'General case' 0 C--O 1.212 -0.888 0 CA-C-N 114.968 -1.015 . . . . 64.4 110.541 -178.923 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.2 p -60.17 -31.42 70.1 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.097 1.517 . . . . 72.14 115.097 -166.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.63 -47.11 67.47 Favored 'General case' 0 C--O 1.249 1.058 0 CA-C-O 121.747 0.784 . . . . 52.24 110.673 176.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -66.62 -40.23 88.68 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 113.686 -1.597 . . . . 74.22 110.436 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.588 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 57.2 t -59.93 -46.73 93.62 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 O-C-N 123.899 0.749 . . . . 72.11 109.654 170.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.516 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 0.3 OUTLIER -58.92 -54.4 47.52 Favored 'General case' 0 C--O 1.204 -1.327 0 CA-C-O 118.667 -0.683 . . . . 72.35 111.326 -175.784 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.488 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 5.7 m-80 -79.97 -49.78 11.36 Favored 'General case' 0 C--O 1.278 2.564 0 N-CA-C 114.523 1.305 . . . . 74.44 114.523 -177.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -68.69 -35.54 77.33 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 120.407 -0.517 . . . . 54.42 109.961 -173.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.588 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 59.0 m-85 -85.31 -18.22 34.52 Favored 'General case' 0 CA--C 1.556 1.195 0 N-CA-C 113.671 0.989 . . . . 73.41 113.671 172.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.516 ' HB3' ' O ' ' A' ' 25' ' ' GLU . 2.3 ppt_? -64.85 -25.36 67.87 Favored 'General case' 0 N--CA 1.503 2.191 0 CA-C-N 120.387 1.448 . . . . 72.01 110.768 167.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.76 -30.95 57.84 Favored 'General case' 0 CA--C 1.565 1.523 0 O-C-N 123.455 0.472 . . . . 64.25 111.879 168.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.507 ' CD1' ' HA ' ' A' ' 28' ' ' PHE . 1.0 OUTLIER -74.9 -17.57 60.55 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.493 0.717 . . . . 63.0 111.659 -175.448 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 140.84 57.73 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 119.358 -1.401 . . . . 72.01 113.399 174.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 55.28 98.0 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 125.573 1.549 . . . . 53.02 113.302 173.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.91 124.54 36.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.295 -1.32 . . . . 70.43 110.993 -177.179 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -90.01 -42.68 11.0 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 114.898 -1.047 . . . . 72.15 109.744 175.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -144.34 139.43 28.5 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.842 -0.617 . . . . 64.22 110.693 -177.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 8.5 p -129.57 123.24 30.86 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.133 -0.485 . . . . 71.14 110.009 172.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -130.33 128.14 40.87 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 116.497 -0.319 . . . . 73.33 110.21 177.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.9 t -109.81 116.99 53.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 120.945 0.402 . . . . 74.52 109.925 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt -108.25 157.55 18.24 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.095 -0.502 . . . . 64.12 110.741 -177.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.98 147.98 52.68 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 122.248 -0.282 . . . . 64.1 110.401 173.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.1 t -101.16 165.28 11.38 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.81 -0.441 . . . . 71.22 109.81 171.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.5 t -74.52 -15.23 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 123.787 0.835 . . . . 64.04 110.797 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.9 m -75.56 -9.8 58.89 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.952 -0.567 . . . . 74.03 111.929 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.43 -4.31 47.49 Favored Glycine 0 C--N 1.342 0.912 0 C-N-CA 121.534 -0.365 . . . . 61.34 113.7 175.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -89.53 141.58 28.45 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.1 0.476 . . . . 61.33 111.37 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -106.23 149.6 26.71 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.614 -0.721 . . . . 61.41 110.041 176.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.435 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 2.1 m-85 -136.68 151.29 49.11 Favored 'General case' 0 C--O 1.223 -0.303 0 N-CA-C 109.25 -0.648 . . . . 70.23 109.25 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -127.35 139.61 52.75 Favored 'General case' 0 C--O 1.248 0.976 0 N-CA-C 109.528 -0.545 . . . . 51.23 109.528 169.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -120.53 115.44 23.44 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 106.717 -1.586 . . . . 72.55 106.717 -176.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -133.67 112.26 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 N-CA-C 113.787 1.032 . . . . 74.05 113.787 -166.083 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -90.84 114.76 27.26 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.531 0.567 . . . . 70.4 112.531 -173.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -110.24 161.94 15.1 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 115.967 -0.56 . . . . 73.21 110.713 176.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -83.09 -30.12 28.23 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.237 0.458 . . . . 70.12 112.237 174.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.48 125.65 49.4 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.836 0.827 . . . . 42.3 112.409 -176.254 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.53 -45.73 24.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 113.893 -1.503 . . . . 71.42 113.492 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -23.43 53.63 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.005 0.743 . . . . 70.5 113.005 -168.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -73.61 -34.01 64.84 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.786 0.803 . . . . 74.34 109.887 176.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.01 -27.74 61.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.708 -1.133 . . . . 64.4 112.658 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.56 -33.44 63.87 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.246 1.202 . . . . 44.11 114.246 -175.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.521 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 17.4 m-20 -70.99 -37.67 72.71 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.564 0.697 . . . . 75.32 112.711 177.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.49 ' O ' ' HG3' ' A' ' 65' ' ' GLU . . . -75.74 -36.08 60.01 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.736 0.779 . . . . 60.02 111.097 177.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.851 HG13 HG13 ' A' ' 80' ' ' VAL . 0.4 OUTLIER -68.13 -31.83 53.42 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.231 0 CA-C-O 117.918 -1.039 . . . . 73.35 109.748 174.892 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.521 ' HG3' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -77.11 -20.68 55.34 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 120.201 1.364 . . . . 71.24 111.506 172.659 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -71.73 -27.47 63.02 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 119.438 -0.905 . . . . 64.45 111.394 170.565 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.42 13.9 19.03 Favored 'General case' 0 N--CA 1.511 2.622 0 N-CA-C 116.578 2.066 . . . . 61.24 116.578 167.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.466 ' HB3' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -73.3 158.21 35.55 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 124.663 1.185 . . . . 71.15 112.229 176.215 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.83 23.38 5.01 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 119.981 -1.104 . . . . 32.51 112.259 -159.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 15.8 p -57.22 134.52 56.0 Favored 'General case' 0 C--O 1.24 0.582 0 O-C-N 124.895 0.997 . . . . 53.15 113.125 -173.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.63 149.07 52.62 Favored 'General case' 0 C--O 1.257 1.462 0 CA-C-N 114.242 -1.345 . . . . 70.23 112.605 -170.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -143.81 145.61 32.48 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 112.504 -2.134 . . . . 70.33 110.778 -171.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 73.02 67.95 0.11 Allowed 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 122.569 1.176 . . . . 42.11 114.142 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.88 -11.2 57.5 Favored Glycine 0 C--N 1.333 0.414 0 CA-C-N 113.786 -1.552 . . . . 51.15 114.081 176.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -121.51 123.78 42.83 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.527 -1.286 . . . . 55.45 107.527 158.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.63 103.4 15.33 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 119.222 -0.418 . . . . 60.25 110.962 178.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 13.9 tp -165.41 70.93 0.15 Allowed 'General case' 0 C--O 1.206 -1.186 0 C-N-CA 119.937 -0.705 . . . . 54.33 112.261 177.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -96.76 111.4 23.58 Favored 'General case' 0 C--O 1.209 -1.075 0 O-C-N 119.834 -1.791 . . . . 74.25 109.701 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 t -129.17 119.64 49.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 107.492 -1.299 . . . . 74.34 107.492 170.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -148.16 141.95 25.69 Favored 'General case' 0 C--O 1.247 0.939 0 C-N-CA 119.81 -0.756 . . . . 53.21 111.289 176.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.851 HG13 HG13 ' A' ' 63' ' ' ILE . 19.1 m -89.9 121.95 68.38 Favored Pre-proline 0 N--CA 1.438 -1.035 0 CA-C-N 114.75 -1.114 . . . . 72.44 110.194 166.114 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.551 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 72.2 Cg_endo -88.21 21.58 0.99 Allowed 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 121.89 1.727 . . . . 63.22 112.503 164.028 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.455 ' HD2' ' N ' ' A' ' 9' ' ' ARG . 0.2 OUTLIER -116.71 13.1 15.09 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 113.13 0.789 . . . . 71.1 113.13 179.504 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -76.94 78.9 3.5 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.925 0.393 . . . . 61.53 111.137 -171.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' ' -1' ' ' SER . . . -173.95 23.51 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.28 -1.327 . . . . 64.24 109.909 -177.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 74.72 -56.2 0.64 Allowed 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.615 1.566 . . . . 70.23 112.546 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 . . . . . 0 C--O 1.252 1.212 0 N-CA-C 108.742 -0.836 . . . . 74.23 108.742 177.16 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.962 0 N-CA-C 112.263 -0.335 . . . . 51.31 112.263 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 39.5 t -141.55 127.87 19.87 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.65 0.262 . . . . 51.23 110.981 -177.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -152.32 152.5 32.19 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.302 0.641 . . . . 73.53 110.217 177.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 ptp -153.21 89.56 1.37 Allowed 'General case' 0 CA--C 1.547 0.838 0 CA-C-O 121.201 0.524 . . . . 74.1 111.532 174.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 42.6 t -126.82 147.47 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 109.103 -0.703 . . . . 75.05 109.103 174.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.4 tt -67.08 112.36 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 CA-C-O 121.92 0.867 . . . . 43.33 111.827 178.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.0 mtm-85 -152.02 133.8 14.82 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.196 -0.911 . . . . 75.25 109.717 174.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -92.93 99.77 12.35 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.873 0.844 . . . . 53.13 111.485 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.5 t -158.12 154.72 27.93 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 114.853 -1.067 . . . . 71.41 109.484 -177.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -105.23 117.35 50.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 109.263 -0.643 . . . . 71.23 109.263 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.4 p -83.39 128.03 34.17 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.07 -0.514 . . . . 60.32 112.328 -174.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.518 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 8.8 ptt180 -132.56 150.51 52.15 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.7 -0.682 . . . . 63.43 112.39 -171.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 34.2 mt -118.51 142.47 33.16 Favored 'Isoleucine or valine' 0 C--O 1.247 0.937 0 C-N-CA 122.963 0.505 . . . . 74.3 110.121 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -111.81 114.65 27.74 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 124.874 1.359 . . . . 73.32 109.466 175.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 2.7 p -123.27 108.04 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 CA-C-O 122.286 1.041 . . . . 61.11 111.799 175.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 77' ' ' ARG . . . -118.66 164.12 13.03 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 114.998 -1.001 . . . . 75.43 113.821 -176.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 58.15 24.74 11.66 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.873 1.269 . . . . 70.3 113.588 170.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -90.25 150.35 42.96 Favored Pre-proline 0 CA--C 1.552 1.023 0 N-CA-C 111.47 0.174 . . . . 55.23 111.47 -174.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 75' ' ' LYS . 57.3 Cg_endo -75.8 150.76 35.21 Favored 'Trans proline' 0 C--N 1.364 1.374 0 C-N-CA 122.771 2.314 . . . . 43.24 113.268 -178.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.7 p 79.88 -21.79 0.31 Allowed 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 127.334 2.254 . . . . 62.41 112.687 -177.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 66.18 107.37 0.04 OUTLIER 'General case' 0 C--N 1.357 0.918 0 C-N-CA 125.236 1.415 . . . . 72.23 110.415 -171.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.402 HG21 HG13 ' A' ' 24' ' ' VAL . 9.9 p -83.04 128.4 38.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 CA-C-N 115.217 -0.902 . . . . 62.54 109.023 175.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 m -91.1 167.95 11.99 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.298 -0.865 . . . . 55.25 109.759 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.4 p -57.28 -39.83 76.5 Favored 'General case' 0 C--O 1.218 -0.605 0 O-C-N 123.892 0.745 . . . . 73.53 112.778 -175.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.4 -39.38 90.5 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.125 0.97 . . . . 71.34 112.78 178.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -75.2 -46.98 30.47 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 116.138 -0.483 . . . . 75.41 111.323 -171.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.402 HG13 HG21 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -67.5 -32.96 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 115.967 -0.56 . . . . 43.31 110.969 173.285 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -58.96 -44.94 91.58 Favored 'General case' 0 C--O 1.206 -1.231 0 CA-C-O 118.639 -0.696 . . . . 74.31 110.811 172.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.448 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 2.0 t-20 -70.67 -48.92 52.34 Favored 'General case' 0 C--O 1.279 2.647 0 CA-C-O 121.631 0.729 . . . . 70.42 111.336 -177.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -61.7 -42.71 99.3 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-N 114.003 -1.453 . . . . 42.44 111.063 -176.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -82.55 -26.04 32.8 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 117.823 -1.084 . . . . 73.45 112.511 178.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 26' ' ' ASN . 46.8 ptt85 -69.92 -33.06 71.66 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 119.327 0.967 . . . . 71.22 111.374 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.07 -26.57 66.8 Favored 'General case' 0 C--N 1.362 1.13 0 C-N-CA 118.796 -1.162 . . . . 62.44 111.541 -177.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.536 ' CD2' ' HB2' ' A' ' 62' ' ' ALA . 69.2 m-85 -92.89 -39.73 11.0 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 111.622 0.23 . . . . 74.1 111.622 178.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -153.39 133.52 4.02 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 111.647 -0.581 . . . . 45.2 111.647 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -64.74 118.09 8.44 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 113.447 0.906 . . . . 72.2 113.447 -168.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.68 139.45 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 114.686 -1.143 . . . . 73.31 111.278 -174.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.3 mp -102.12 -43.72 5.66 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.085 -0.961 . . . . 71.22 111.509 -176.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.92 132.98 20.32 Favored 'General case' 0 C--O 1.213 -0.842 0 N-CA-C 108.951 -0.759 . . . . 73.03 108.951 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.9 t -137.73 119.64 15.34 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 109.73 -0.47 . . . . 71.43 109.73 175.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -130.82 147.66 52.5 Favored 'General case' 0 C--O 1.22 -0.479 0 C-N-CA 120.592 -0.443 . . . . 45.35 111.315 -177.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.2 p -117.12 124.56 73.16 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 CA-C-O 121.535 0.683 . . . . 73.22 111.428 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.92 163.7 12.9 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.565 -0.743 . . . . 70.44 110.071 -178.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.76 150.92 52.1 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 122.001 -0.437 . . . . 75.24 110.9 172.08 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 15.3 t -100.32 169.47 9.09 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 110.072 -0.344 . . . . 64.22 110.072 172.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.6 t -74.91 -18.13 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.132 0 C-N-CA 123.79 0.836 . . . . 64.43 111.089 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.6 t -75.79 -12.87 60.26 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 122.866 0.467 . . . . 60.34 111.846 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.46 -3.56 43.21 Favored Glycine 0 C--N 1.34 0.783 0 C-N-CA 121.347 -0.454 . . . . 71.44 113.92 175.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.0 144.63 26.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.976 0.417 . . . . 74.44 110.556 176.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.74 147.9 41.6 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.013 -0.539 . . . . 74.35 110.263 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 0.9 OUTLIER -136.77 147.28 46.57 Favored 'General case' 0 C--O 1.217 -0.63 0 N-CA-C 109.411 -0.588 . . . . 74.33 109.411 -175.004 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -121.84 140.39 52.44 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 121.385 0.612 . . . . 74.3 109.91 176.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -113.62 118.09 33.42 Favored 'General case' 0 C--O 1.257 1.479 0 CA-C-N 113.633 -1.621 . . . . 71.33 107.833 -176.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.518 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 4.2 mp -118.25 110.07 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 O-C-N 123.607 0.567 . . . . 43.55 110.781 -174.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -115.52 105.06 12.36 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 121.834 0.826 . . . . 31.22 111.214 -171.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -114.11 171.58 7.52 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.137 1.162 . . . . 63.33 114.137 -177.347 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -75.28 -43.54 50.62 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 114.713 -1.13 . . . . 71.1 111.554 171.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -117.25 121.92 42.53 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 122.331 1.062 . . . . 74.43 112.078 -175.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.643 ' HB3' ' HB2' ' A' ' 85' ' ' ARG . . . -78.45 -43.53 26.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 112.883 -1.962 . . . . 61.53 113.99 -175.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -74.27 -25.86 59.86 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.39 0.885 . . . . 74.34 113.39 -169.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.488 ' HB3' ' O ' ' A' ' 31' ' ' TYR . 1.3 m-20 -80.75 -44.95 17.81 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.971 0.36 . . . . 53.13 111.971 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.48 -24.05 64.64 Favored 'General case' 0 C--O 1.251 1.147 0 C-N-CA 124.221 1.008 . . . . 32.0 111.747 176.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -53.3 -23.36 8.93 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.441 -1.254 . . . . 51.45 114.128 172.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.457 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -63.51 -47.05 83.29 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 118.823 0.738 . . . . 54.32 111.674 171.194 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.536 ' HB2' ' CD2' ' A' ' 31' ' ' TYR . . . -65.24 -39.92 93.33 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.938 -0.574 . . . . 61.42 110.24 174.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -66.81 -31.28 52.8 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 C-N-CA 120.28 -0.568 . . . . 13.43 111.381 177.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -80.21 -23.35 40.99 Favored 'General case' 0 C--N 1.351 0.631 0 N-CA-C 112.881 0.697 . . . . 73.54 112.881 176.875 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.495 ' HG2' ' HA ' ' A' ' 62' ' ' ALA . 10.2 pt-20 -81.52 -19.55 41.94 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 118.987 -1.085 . . . . 72.21 111.454 171.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 62' ' ' ALA . 68.9 mmtt -92.36 -6.07 50.89 Favored 'General case' 0 CA--C 1.57 1.731 0 CA-C-N 118.451 0.569 . . . . 64.41 111.474 169.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.43 ' HB2' ' HA ' ' A' ' 64' ' ' LYS . 38.3 t70 -64.77 153.33 40.21 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 126.321 1.848 . . . . 71.21 112.746 178.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.71 23.82 4.88 Favored Glycine 0 C--N 1.343 0.942 0 C-N-CA 119.94 -1.124 . . . . 74.22 113.626 -163.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 24.5 p -58.7 133.1 55.63 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-O 122.196 0.998 . . . . 65.24 113.214 -169.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.37 149.13 49.61 Favored 'General case' 0 C--O 1.261 1.69 0 CA-C-N 114.09 -1.413 . . . . 51.32 112.907 -170.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -143.52 145.53 32.63 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 126.112 1.765 . . . . 75.34 111.224 -174.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 73.38 68.61 0.11 Allowed 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 114.554 1.316 . . . . 75.54 114.554 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.66 -10.99 59.37 Favored Glycine 0 N--CA 1.462 0.388 0 CA-C-N 114.188 -1.369 . . . . 73.21 113.778 175.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -120.51 122.6 40.98 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 107.065 -1.458 . . . . 64.51 107.065 155.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.47 ' O ' ' HD3' ' A' ' 16' ' ' PRO . 0.3 OUTLIER -95.08 102.39 14.2 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 117.961 -1.019 . . . . 74.32 110.286 178.573 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.54 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.3 OUTLIER -168.51 67.78 0.07 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 113.599 0.963 . . . . 71.24 113.599 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.403 ' HB3' ' O ' ' A' ' 13' ' ' GLY . 23.8 tpt180 -95.85 111.1 23.16 Favored 'General case' 0 C--O 1.2 -1.529 0 CA-C-N 120.829 1.649 . . . . 73.32 110.157 -176.012 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.451 ' H ' ' HB3' ' A' ' 69' ' ' CYS . 2.7 t -130.1 118.12 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 108.317 -0.994 . . . . 61.42 108.317 175.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -149.84 147.26 27.75 Favored 'General case' 0 C--O 1.255 1.345 0 C-N-CA 119.825 -0.75 . . . . 64.13 112.264 176.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.9 m -88.74 124.7 64.99 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 114.791 -1.095 . . . . 45.31 111.373 168.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.49 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 61.5 Cg_endo -87.08 12.03 3.08 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.132 1.888 . . . . 71.11 113.958 167.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.501 ' CE1' ' HB1' ' A' ' 56' ' ' ALA . 10.7 p90 -102.26 -25.79 13.55 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.847 0.684 . . . . 71.44 112.847 177.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.7 m120 55.97 70.43 0.64 Allowed 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.255 1.022 . . . . 73.42 113.198 -176.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 62.52 -173.11 0.15 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 125.169 1.388 . . . . 41.34 112.901 -177.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.643 ' HB2' ' HB3' ' A' ' 56' ' ' ALA . 7.5 ttt85 -100.64 75.21 1.72 Allowed 'General case' 0 C--N 1.334 -0.103 0 O-C-N 121.573 -0.705 . . . . 75.43 109.494 178.022 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 . . . . . 0 C--O 1.24 0.582 0 CA-C-O 117.656 -1.164 . . . . 71.35 110.233 -176.981 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.928 0 N-CA-C 111.714 -0.554 . . . . 54.44 111.714 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 66.5 m -110.46 -80.25 0.58 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 119.429 -0.32 . . . . 60.42 111.515 -178.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 66.73 90.32 0.09 Allowed 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 125.228 1.411 . . . . 73.42 111.305 -178.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpp? -104.54 160.65 14.77 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 116.449 -0.341 . . . . 70.12 110.368 -176.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 76.4 t 76.32 -63.29 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 C-N-CA 125.473 1.509 . . . . 75.2 111.616 177.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.7 mm 70.35 -87.3 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 125.331 1.452 . . . . 73.14 111.532 176.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -160.45 52.45 0.31 Allowed 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 118.556 0.616 . . . . 74.15 110.747 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 73.31 121.12 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 126.055 1.742 . . . . 71.22 112.043 176.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.5 163.66 38.52 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.518 -0.31 . . . . 73.31 111.651 -176.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.2 m -114.36 128.68 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 116.014 -0.539 . . . . 62.13 110.568 176.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.5 t -85.46 119.13 25.48 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.482 -0.326 . . . . 71.2 110.814 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 24.2 ptt180 -143.68 152.57 41.49 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-N 115.837 -0.62 . . . . 60.43 111.851 -176.002 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 52.9 mt -116.98 135.46 57.28 Favored 'Isoleucine or valine' 0 C--O 1.256 1.421 0 C-N-CA 122.924 0.489 . . . . 74.35 109.849 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -103.0 115.13 30.02 Favored 'General case' 0 C--N 1.362 1.142 0 O-C-N 125.644 1.84 . . . . 75.2 109.412 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.9 t -115.77 132.81 64.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 107.657 -1.238 . . . . 72.33 107.657 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -140.89 160.3 26.64 Favored Glycine 0 CA--C 1.519 0.301 0 N-CA-C 111.775 -0.53 . . . . 53.2 111.775 173.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 61.02 27.54 17.4 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.79 0.836 . . . . 71.41 112.105 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.29 125.77 73.53 Favored Pre-proline 0 C--O 1.237 0.413 0 N-CA-C 111.7 0.259 . . . . 63.04 111.7 -174.137 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.35 150.68 37.05 Favored 'Trans proline' 0 C--N 1.36 1.164 0 C-N-CA 121.794 1.662 . . . . 73.22 110.8 165.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.8 m -22.16 -83.13 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 125.629 1.83 . . . . 73.32 115.788 -163.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.2 t60 52.33 -91.86 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 124.996 1.319 . . . . 72.24 112.01 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.7 m -100.15 120.92 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-O 121.053 0.454 . . . . 71.33 110.775 176.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.498 ' O ' HG23 ' A' ' 24' ' ' VAL . 47.2 m -88.39 177.53 6.8 Favored 'General case' 0 C--O 1.193 -1.887 0 CA-C-O 117.575 -1.202 . . . . 75.22 107.844 170.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.7 m -49.67 -49.97 45.31 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 120.344 1.429 . . . . 72.14 114.391 -169.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -39.35 94.24 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.092 0.957 . . . . 62.35 111.697 177.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.83 -32.51 57.63 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 115.262 -0.881 . . . . 74.21 111.488 -177.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 20' ' ' SER . 47.8 t -62.82 -47.32 93.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 108.228 -1.027 . . . . 71.45 108.228 170.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.13 -51.19 67.24 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 124.422 1.076 . . . . 75.53 111.862 177.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -73.89 -43.85 57.19 Favored 'General case' 0 C--O 1.276 2.46 0 N-CA-C 112.564 0.579 . . . . 72.24 112.564 -174.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -57.78 -46.72 84.19 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 115.177 -0.919 . . . . 64.02 110.132 177.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -78.35 -25.4 46.34 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 117.956 -1.021 . . . . 71.15 112.29 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -72.42 -28.98 63.3 Favored 'General case' 0 C--N 1.358 0.971 0 CA-C-N 118.971 0.805 . . . . 74.24 112.468 -179.654 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.66 -31.16 70.95 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 118.612 -1.235 . . . . 74.45 111.445 176.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.524 ' CD2' ' HB2' ' A' ' 62' ' ' ALA . 99.2 m-85 -87.94 -37.17 16.64 Favored 'General case' 0 C--O 1.219 -0.534 0 C-N-CA 121.193 -0.203 . . . . 62.32 111.174 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 29' ' ' ARG . . . -152.29 147.3 16.85 Favored Glycine 0 C--O 1.223 -0.589 0 N-CA-C 111.759 -0.536 . . . . 73.2 111.759 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -74.49 105.12 5.47 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 117.694 0.747 . . . . 75.22 112.937 -172.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.405 HG22 ' H ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -77.06 130.94 35.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 114.909 -1.041 . . . . 74.02 111.531 -175.537 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 56.2 mt -93.73 -47.9 6.56 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 114.418 -1.264 . . . . 74.14 111.083 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.447 ' HG3' ' HB3' ' A' ' 52' ' ' GLU . 0.1 OUTLIER -144.07 144.09 31.46 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.234 0.54 . . . . 73.41 109.996 173.811 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.6 t -132.15 120.47 22.32 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.058 -0.719 . . . . 73.13 109.058 178.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -129.45 125.95 37.64 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 120.454 -0.498 . . . . 75.35 111.384 -174.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 75.9 t -107.94 121.29 60.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 122.642 0.377 . . . . 74.12 110.121 -177.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -108.69 157.49 18.49 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 116.297 -0.41 . . . . 73.12 110.713 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.22 147.59 52.61 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.416 0.15 . . . . 61.05 110.908 172.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.3 t -101.1 167.06 10.47 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 110.014 -0.365 . . . . 55.41 110.014 173.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.9 m -75.43 -11.02 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 123.81 0.844 . . . . 72.52 112.411 177.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -80.25 -11.65 59.7 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 122.629 0.372 . . . . 71.25 111.222 176.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.43 -2.04 46.42 Favored Glycine 0 C--N 1.34 0.786 0 C-N-CA 121.426 -0.416 . . . . 72.31 113.886 176.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.39 143.24 27.12 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.211 0.529 . . . . 74.31 111.596 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -105.56 150.28 25.51 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.157 -0.929 . . . . 65.14 110.673 178.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -134.5 150.1 50.76 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 108.767 -0.827 . . . . 73.12 108.767 -177.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -129.31 137.14 50.84 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.143 0.497 . . . . 72.14 110.631 174.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.94 120.05 37.24 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 108.576 -0.898 . . . . 72.31 108.576 175.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 3.2 mp -120.32 111.56 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 119.158 -1.017 . . . . 71.43 111.114 -174.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.447 ' HB3' ' HG3' ' A' ' 36' ' ' LYS . 32.0 tt0 -113.45 108.0 16.61 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-O 120.813 0.339 . . . . 70.34 111.71 -172.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.28 170.51 8.24 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.269 -0.878 . . . . 55.45 111.954 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -78.85 -31.49 45.68 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 112.825 0.676 . . . . 73.15 112.825 175.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -120.35 125.01 46.95 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 122.241 1.019 . . . . 73.42 112.607 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.9 -46.01 25.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 113.99 -1.459 . . . . 71.51 113.931 -175.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.402 ' H ' ' HG2' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -76.18 -25.1 54.86 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.641 0.978 . . . . 65.22 113.641 -165.992 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.518 ' HB3' ' O ' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -80.0 -35.52 37.29 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.627 0.727 . . . . 74.14 111.707 177.52 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.33 -18.61 59.97 Favored 'General case' 0 C--O 1.257 1.49 0 C-N-CA 124.577 1.151 . . . . 73.02 112.767 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -53.15 -26.42 16.86 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 114.626 -1.17 . . . . 74.33 113.134 170.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.413 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -69.32 -34.69 75.04 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.208 0.603 . . . . 74.24 111.697 172.977 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.617 ' O ' ' HD2' ' A' ' 66' ' ' LYS . . . -66.57 -48.75 68.63 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 110.425 -0.213 . . . . 70.02 110.425 171.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.46 -30.78 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 C-N-CA 120.296 -0.561 . . . . 64.14 111.002 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.546 ' HA ' ' HB2' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -79.18 -21.04 46.95 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 118.916 0.78 . . . . 74.43 112.777 171.865 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.88 -37.26 76.0 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 118.885 0.766 . . . . 73.41 110.581 171.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.617 ' HD2' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -100.13 12.67 36.42 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 118.284 -1.367 . . . . 63.41 114.28 174.488 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.546 ' HB2' ' HA ' ' A' ' 64' ' ' LYS . 21.0 t70 -51.54 152.83 2.51 Favored 'General case' 0 N--CA 1.506 2.368 0 C-N-CA 126.998 2.119 . . . . 61.24 114.442 170.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.3 25.35 3.82 Favored Glycine 0 C--N 1.35 1.332 0 C-N-CA 119.554 -1.308 . . . . 63.35 113.948 -165.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.611 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 8.6 p -58.48 133.49 55.84 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 122.393 1.092 . . . . 74.4 113.147 -173.281 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.94 144.46 47.46 Favored 'General case' 0 C--O 1.256 1.404 0 CA-C-N 113.771 -1.559 . . . . 73.23 113.48 -171.084 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -143.56 147.66 34.76 Favored 'General case' 0 CA--C 1.553 1.089 0 O-C-N 125.834 1.959 . . . . 71.51 110.83 -172.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 74.14 66.07 0.09 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 122.484 1.135 . . . . 70.42 113.463 174.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.74 -10.25 62.45 Favored Glycine 0 N--CA 1.461 0.304 0 CA-C-N 114.263 -1.335 . . . . 71.43 113.302 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -119.64 122.51 41.68 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.063 -1.458 . . . . 73.31 107.063 161.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.59 102.16 13.93 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 118.446 -0.788 . . . . 74.41 110.676 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.611 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -165.49 60.18 0.11 Allowed 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 113.304 0.853 . . . . 73.14 113.304 179.911 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.4 tpp85 -93.67 117.21 29.8 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 120.585 -1.322 . . . . 64.45 111.031 -171.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.509 HG21 ' O ' ' A' ' 66' ' ' LYS . 2.2 m -128.59 120.96 53.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.902 -1.045 . . . . 73.12 109.346 174.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -148.93 145.4 27.39 Favored 'General case' 0 C--O 1.255 1.351 0 CA-C-O 121.97 0.89 . . . . 61.03 112.503 -178.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.1 m -89.47 123.48 66.68 Favored Pre-proline 0 CA--C 1.546 0.792 0 CA-C-N 115.012 -0.995 . . . . 73.34 110.042 167.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.438 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 66.9 Cg_endo -88.79 4.3 5.47 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.162 1.908 . . . . 72.34 113.335 166.085 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -95.01 -32.29 13.21 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 119.062 -0.494 . . . . 61.03 111.983 176.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.8 t30 54.54 78.33 0.17 Allowed 'General case' 0 N--CA 1.486 1.342 0 O-C-N 124.564 1.165 . . . . 73.33 111.118 -174.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 60.69 -166.45 0.2 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 125.167 1.387 . . . . 45.44 112.364 -175.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -95.36 9.78 38.68 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.354 -0.841 . . . . 74.31 109.041 171.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 . . . . . 0 C--O 1.253 1.286 0 CA-C-N 115.207 -0.906 . . . . 73.23 109.728 -173.887 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.0 0 N-CA-C 111.894 -0.482 . . . . 63.01 111.894 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.22 178.16 7.48 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 122.664 0.386 . . . . 71.53 111.126 -177.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -146.44 74.26 1.35 Allowed 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 121.195 0.521 . . . . 60.25 111.561 -168.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.1 mtt -149.37 145.05 26.79 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.069 0.948 . . . . 73.43 109.41 169.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.3 t -122.81 7.45 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 CA-C-O 121.883 0.849 . . . . 75.04 109.698 178.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.2 mt -99.94 86.85 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 O-C-N 121.343 -0.848 . . . . 73.04 111.294 -175.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.43 ' HG2' ' H ' ' A' ' 5' ' ' GLU . 6.7 ttt180 175.09 172.55 0.25 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 125.144 1.378 . . . . 74.4 109.505 170.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.43 ' H ' ' HG2' ' A' ' 4' ' ' ARG . 68.9 tt0 -127.08 128.88 46.95 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.374 0.669 . . . . 73.41 109.816 175.162 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.2 t -163.18 161.37 24.97 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 110.183 -0.303 . . . . 71.22 110.183 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.5 t -109.02 122.46 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 109.931 -0.396 . . . . 74.32 109.931 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.535 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . 80.3 p -84.96 140.41 31.09 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 122.655 0.382 . . . . 74.31 111.257 178.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.469 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 0.9 OUTLIER -126.22 149.98 48.68 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 111.952 0.353 . . . . 71.23 111.952 -177.183 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.0 mp -131.96 134.74 59.57 Favored 'Isoleucine or valine' 0 C--O 1.247 0.927 0 C-N-CA 123.882 0.873 . . . . 70.42 109.208 -178.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -115.82 115.21 25.87 Favored 'General case' 0 C--O 1.242 0.676 0 O-C-N 124.029 0.831 . . . . 65.32 109.613 177.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.447 HG23 HG22 ' A' ' 78' ' ' VAL . 3.4 p -119.74 111.43 32.8 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.819 0 CA-C-O 121.431 0.634 . . . . 75.23 110.867 172.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -123.52 158.79 18.16 Favored Glycine 0 CA--C 1.52 0.372 0 CA-C-N 116.077 -0.511 . . . . 21.54 113.522 -175.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.7 m120 62.25 26.63 15.96 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.235 1.014 . . . . 62.14 111.648 175.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.618 HD23 ' H ' ' A' ' 15' ' ' LEU . 1.5 pt? -82.57 125.11 76.84 Favored Pre-proline 0 CA--C 1.543 0.708 0 CA-C-O 120.878 0.37 . . . . 70.1 111.848 -170.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -86.45 125.99 2.59 Favored 'Trans proline' 0 C--N 1.363 1.326 0 C-N-CA 121.829 1.686 . . . . 73.11 113.081 175.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.8 m 26.01 62.82 0.07 Allowed 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 126.417 1.887 . . . . 42.2 114.887 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.475 ' HB3' HD12 ' A' ' 15' ' ' LEU . 0.5 OUTLIER -110.4 -134.31 0.35 Allowed 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.611 -0.722 . . . . 74.54 109.091 -171.493 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.2 m -69.76 126.04 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 111.993 0.368 . . . . 75.44 111.993 174.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.9 m -83.84 173.47 11.23 Favored 'General case' 0 C--O 1.211 -0.938 0 N-CA-C 108.403 -0.962 . . . . 43.33 108.403 173.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.6 t -60.15 -37.39 79.98 Favored 'General case' 0 CA--C 1.557 1.219 0 CA-C-N 118.969 0.804 . . . . 64.21 112.905 -174.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -66.61 -44.96 80.67 Favored 'General case' 0 C--O 1.251 1.172 0 C-N-CA 123.066 0.547 . . . . 73.31 110.808 176.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -68.4 -34.37 75.9 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.096 -0.956 . . . . 72.23 110.679 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.659 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 74.3 t -60.45 -51.72 69.79 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.588 0 N-CA-C 108.969 -0.752 . . . . 72.04 108.969 171.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.409 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 25.2 tt0 -57.01 -53.82 53.76 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 118.873 -0.584 . . . . 71.04 111.61 -177.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -76.4 -52.04 10.66 Favored 'General case' 0 C--O 1.26 1.629 0 CA-C-N 118.63 0.65 . . . . 74.23 112.113 -172.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.84 -39.0 66.92 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 120.685 -0.406 . . . . 73.01 110.057 -172.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.659 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 4.4 m-85 -77.57 -23.02 50.08 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 118.094 -0.955 . . . . 73.54 111.5 177.193 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 10.1 ptt180 -72.29 -25.9 61.76 Favored 'General case' 0 C--N 1.374 1.632 0 CA-C-N 120.065 1.302 . . . . 73.04 110.876 170.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.69 -25.86 65.89 Favored 'General case' 0 CA--C 1.561 1.388 0 C-N-CA 120.105 -0.638 . . . . 64.21 111.337 175.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.479 ' CG ' ' HB2' ' A' ' 62' ' ' ALA . 98.4 m-85 -89.32 -35.21 16.24 Favored 'General case' 0 C--O 1.216 -0.676 0 N-CA-C 111.974 0.361 . . . . 65.35 111.974 174.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 29' ' ' ARG . . . -156.9 137.94 5.67 Favored Glycine 0 C--O 1.228 -0.236 0 C-N-CA 120.884 -0.674 . . . . 64.33 111.668 177.141 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -62.06 114.73 3.57 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.142 0.577 . . . . 71.3 112.133 -175.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.61 124.76 39.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.948 0.88 . . . . 74.5 112.119 -173.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.5 mp -97.62 -36.84 10.15 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.208 -1.36 . . . . 74.34 110.327 175.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -145.43 131.25 19.07 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 120.694 0.283 . . . . 51.4 111.069 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -122.09 121.28 36.59 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 110.043 -0.355 . . . . 52.43 110.043 175.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -131.03 125.63 33.77 Favored 'General case' 0 C--O 1.219 -0.535 0 C-N-CA 120.432 -0.507 . . . . 74.12 110.277 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.01 119.31 61.06 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 CA-C-O 121.955 0.883 . . . . 72.24 110.837 176.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -117.46 157.69 25.8 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.256 -0.883 . . . . 73.54 110.348 -177.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.39 151.22 51.12 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 122.088 -0.382 . . . . 71.25 110.537 173.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.9 t -101.34 164.53 11.73 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 110.119 -0.326 . . . . 74.34 110.119 172.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.6 m -75.63 -10.28 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.78 0.832 . . . . 71.31 112.511 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -78.65 -9.29 59.33 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 122.682 0.393 . . . . 65.11 110.879 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.66 -5.01 43.27 Favored Glycine 0 C--N 1.344 0.999 0 C-N-CA 121.179 -0.534 . . . . 70.31 113.827 176.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -89.38 143.0 27.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.972 0.415 . . . . 71.2 111.444 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -107.71 149.86 27.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.648 -0.705 . . . . 72.22 109.635 175.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -137.49 150.13 47.33 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.426 -0.583 . . . . 73.52 109.426 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -127.6 138.61 52.91 Favored 'General case' 0 C--O 1.253 1.271 0 CA-C-O 121.718 0.771 . . . . 70.13 109.344 170.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -116.47 120.61 39.33 Favored 'General case' 0 C--O 1.252 1.216 0 CA-C-N 113.688 -1.596 . . . . 73.4 107.509 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.87 126.84 73.25 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.67 0 CA-C-N 115.611 -0.722 . . . . 71.44 111.111 -170.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -115.51 114.73 25.39 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 122.331 -0.23 . . . . 75.33 111.539 -178.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -109.47 169.22 8.84 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.351 0.26 . . . . 73.03 110.884 176.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -81.59 -31.18 32.65 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.22 0.452 . . . . 74.42 112.22 169.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -119.29 125.49 49.21 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-O 122.107 0.956 . . . . 50.21 112.816 -172.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.39 -44.99 18.45 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 115.644 1.72 . . . . 65.5 115.644 -177.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.76 -24.76 56.08 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 113.457 0.91 . . . . 73.14 113.457 -167.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.73 -27.43 40.61 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 121.494 0.664 . . . . 73.43 111.272 175.119 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.84 -25.06 61.82 Favored 'General case' 0 C--O 1.249 1.036 0 C-N-CA 124.265 1.026 . . . . 64.51 112.065 174.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.527 ' HA ' HG22 ' A' ' 63' ' ' ILE . . . -57.64 -27.85 63.19 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.048 -0.978 . . . . 75.32 112.859 177.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -67.83 -41.74 82.54 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 122.751 0.421 . . . . 72.22 111.149 174.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.479 ' HB2' ' CG ' ' A' ' 31' ' ' TYR . . . -64.05 -44.95 90.91 Favored 'General case' 0 C--O 1.237 0.417 0 O-C-N 123.55 0.531 . . . . 72.42 111.213 175.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.778 HG13 HG13 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -70.15 -29.93 41.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 119.936 -0.706 . . . . 63.21 110.999 179.145 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.02 -26.44 53.78 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.674 1.125 . . . . 74.12 112.331 176.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -85.98 -18.0 33.77 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 118.621 -1.232 . . . . 75.31 112.524 173.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt -100.14 8.18 44.06 Favored 'General case' 0 CA--C 1.558 1.259 0 O-C-N 121.794 -0.566 . . . . 74.24 111.3 172.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -60.37 152.25 25.83 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 126.596 1.958 . . . . 73.23 111.228 173.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.81 25.07 3.76 Favored Glycine 0 C--N 1.349 1.277 0 C-N-CA 120.166 -1.016 . . . . 73.13 113.715 -160.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.614 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 12.8 t -59.13 132.65 54.66 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.644 0.735 . . . . 63.03 111.439 178.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -135.63 134.7 39.54 Favored 'General case' 0 C--O 1.252 1.214 0 CA-C-N 114.134 -1.394 . . . . 70.1 112.993 -172.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -142.93 148.03 36.25 Favored 'General case' 0 CA--C 1.548 0.886 0 O-C-N 125.658 1.849 . . . . 75.15 109.574 -175.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 75.66 65.86 0.06 Allowed 'General case' 0 N--CA 1.5 2.041 0 CA-C-O 122.828 1.299 . . . . 54.55 114.206 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.02 -10.98 62.2 Favored Glycine 0 C--O 1.227 -0.325 0 CA-C-N 113.579 -1.646 . . . . 41.51 114.174 172.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -121.68 123.99 43.19 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.274 -1.38 . . . . 70.31 107.274 162.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.94 104.77 16.81 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 118.483 -0.77 . . . . 73.22 111.41 -177.01 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.614 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.4 OUTLIER -166.73 64.31 0.09 Allowed 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 113.394 0.887 . . . . 62.42 113.394 178.48 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.48 ' HD3' ' SG ' ' A' ' 69' ' ' CYS . 0.0 OUTLIER -93.37 115.61 28.17 Favored 'General case' 0 C--O 1.212 -0.907 0 O-C-N 120.909 -1.12 . . . . 71.34 110.324 -173.94 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.447 HG22 HG23 ' A' ' 12' ' ' VAL . 5.5 t -128.25 117.85 46.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 107.757 -1.201 . . . . 62.23 107.757 168.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -151.73 140.97 21.38 Favored 'General case' 0 C--O 1.244 0.775 0 C-N-CA 119.833 -0.747 . . . . 65.01 112.309 -177.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.778 HG13 HG13 ' A' ' 63' ' ' ILE . 15.3 m -91.74 125.46 57.31 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 115.918 -0.583 . . . . 63.41 111.879 168.356 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.469 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 60.3 Cg_endo -84.59 13.5 2.73 Favored 'Trans proline' 0 CA--C 1.547 1.125 0 C-N-CA 122.363 2.042 . . . . 71.24 113.806 165.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.535 ' CD2' ' HB2' ' A' ' 8' ' ' SER . 1.8 p90 -101.66 -20.45 15.0 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.422 0.555 . . . . 74.33 112.191 176.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 65.78 -78.34 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 125.022 1.329 . . . . 61.41 112.661 -170.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -155.44 -176.52 5.99 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.158 0.436 . . . . 63.31 110.311 177.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -84.29 122.5 28.98 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.206 -0.665 . . . . 64.25 109.206 176.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 . . . . . 0 C--O 1.249 1.077 0 O-C-N 124.315 1.009 . . . . 61.3 110.705 -179.821 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.116 0 N-CA-C 112.227 -0.349 . . . . 72.43 112.227 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 16.6 p -156.88 104.57 2.13 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 121.158 0.504 . . . . 73.42 110.552 177.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 0' ' ' HIS . . . . . 0.443 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 0.9 OUTLIER -150.19 -173.48 4.45 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.94 -0.763 . . . . 74.35 108.94 179.242 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.443 ' SD ' ' HB3' ' A' ' 0' ' ' HIS . 2.8 mpt? 70.81 146.7 0.07 Allowed 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 124.631 1.173 . . . . 63.1 113.818 172.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.8 m -132.78 159.92 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 115.773 -0.649 . . . . 73.5 111.324 177.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.8 tt -149.41 143.43 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 109.174 -0.676 . . . . 73.14 109.174 175.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -125.8 10.18 7.68 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.391 0.515 . . . . 72.43 112.391 -178.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -130.75 21.52 5.03 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.94 0.4 . . . . 63.21 111.297 -176.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.3 t -129.99 157.01 43.5 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.27 0.557 . . . . 71.23 111.116 -177.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.5 t -110.2 104.45 17.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 114.912 -1.04 . . . . 65.32 109.322 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.45 121.2 28.67 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 112.704 0.631 . . . . 73.52 112.704 -178.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.46 ' HD2' ' CE2' ' A' ' 50' ' ' PHE . 0.6 OUTLIER -136.27 159.7 40.94 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 122.825 0.45 . . . . 63.41 111.21 -173.344 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.1 mt -117.38 142.88 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.118 0.967 . . . . 71.22 108.531 -178.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -112.26 111.18 21.88 Favored 'General case' 0 C--N 1.349 0.58 0 N-CA-C 109.786 -0.449 . . . . 74.24 109.786 -177.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.685 HG12 HG13 ' A' ' 78' ' ' VAL . 26.2 m -123.95 108.08 20.0 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-O 121.946 0.879 . . . . 62.42 111.29 175.053 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -133.69 168.94 23.01 Favored Glycine 0 CA--C 1.518 0.261 0 N-CA-C 114.873 0.709 . . . . 64.1 114.873 -176.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.8 m120 58.36 21.43 8.32 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.838 1.255 . . . . 53.42 112.071 176.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.444 HD23 ' H ' ' A' ' 15' ' ' LEU . 1.2 pt? -90.88 149.78 40.86 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 112.338 0.495 . . . . 71.53 112.338 -167.116 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 75' ' ' LYS . 24.5 Cg_endo -65.02 137.57 53.2 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 123.144 2.563 . . . . 71.33 112.868 176.223 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.1 p 73.77 -41.73 0.5 Allowed 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 126.61 1.964 . . . . 65.44 111.692 -173.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 68.41 117.34 0.03 OUTLIER 'General case' 0 C--N 1.365 1.25 0 C-N-CA 125.7 1.6 . . . . 70.45 111.052 -177.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.8 m -69.71 128.84 33.69 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 CA-C-N 114.646 -1.161 . . . . 64.21 110.564 177.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.1 m -83.15 169.14 16.14 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 114.364 -1.289 . . . . 72.32 108.787 176.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.2 m -57.17 -41.87 80.08 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.654 0.612 . . . . 71.52 112.654 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -64.83 -47.68 77.1 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.154 0.581 . . . . 74.34 111.321 178.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -67.77 -44.28 77.82 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 114.646 -1.161 . . . . 75.22 111.037 -174.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.562 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 9.0 p -70.46 -34.93 59.77 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 CA-C-O 118.99 -0.529 . . . . 43.02 110.036 177.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -61.06 -52.7 63.85 Favored 'General case' 0 C--O 1.212 -0.888 0 CA-C-O 118.745 -0.645 . . . . 54.13 110.524 178.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -73.0 -51.11 19.48 Favored 'General case' 0 C--O 1.27 2.158 0 CA-C-N 118.12 0.418 . . . . 64.42 111.622 -174.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -69.22 -44.01 72.93 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 115.467 -0.788 . . . . 72.12 110.457 -173.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.562 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 0.7 OUTLIER -76.85 -25.13 52.81 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 118.676 -0.678 . . . . 75.15 111.534 179.32 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.7 ptt85 -72.44 -22.99 61.01 Favored 'General case' 0 C--N 1.365 1.257 0 CA-C-N 119.429 1.013 . . . . 75.33 111.834 174.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -29.71 70.45 Favored 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 119.543 -0.863 . . . . 72.32 111.421 170.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -88.77 -37.23 15.61 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.563 0.579 . . . . 71.22 112.563 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -154.74 171.83 33.13 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.501 -0.857 . . . . 73.15 112.587 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -82.0 113.09 19.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.571 0.701 . . . . 65.51 111.998 -175.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.86 126.4 43.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 114.803 -1.089 . . . . 71.41 110.586 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 26.2 mt -94.86 -43.11 8.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.488 -1.233 . . . . 70.0 109.568 178.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.05 153.33 33.77 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.491 0.316 . . . . 70.15 110.479 170.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 13.4 p -126.92 124.76 40.26 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.785 -0.45 . . . . 63.2 109.785 173.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -129.68 125.94 37.17 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-N 115.974 -0.557 . . . . 71.43 111.093 -176.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 72.1 t -112.08 123.02 67.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-O 121.041 0.448 . . . . 62.21 111.176 -174.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.13 161.32 22.0 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.069 -0.514 . . . . 71.3 110.869 -174.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.5 152.02 51.85 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 122.457 -0.152 . . . . 73.22 111.004 172.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.4 t -100.62 169.39 9.08 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 109.973 -0.38 . . . . 71.42 109.973 169.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.3 t -75.3 -15.45 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 C-N-CA 123.715 0.806 . . . . 73.3 111.259 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.3 m -75.88 -7.56 54.8 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.107 0.563 . . . . 44.05 112.175 -179.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.76 -4.74 53.53 Favored Glycine 0 C--N 1.341 0.844 0 C-N-CA 121.345 -0.455 . . . . 62.12 113.308 176.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.75 138.38 31.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.832 0.348 . . . . 75.01 110.791 178.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.44 147.93 38.54 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.741 -0.663 . . . . 62.13 110.546 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -136.22 165.91 24.64 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.187 0.517 . . . . 73.13 109.96 -171.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -141.35 139.72 33.6 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-N 115.328 -0.851 . . . . 61.23 109.96 171.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.46 ' CE2' ' HD2' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -114.43 118.69 34.52 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 113.996 -1.456 . . . . 71.34 107.263 -179.655 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.76 112.77 36.44 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.531 0 C-N-CA 119.556 -0.858 . . . . 73.33 111.151 -171.104 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -88.58 106.98 18.66 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-N 116.545 -0.298 . . . . 74.54 110.233 -170.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -114.27 143.46 44.82 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.58 -0.736 . . . . 74.33 112.021 -174.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -83.06 -28.38 29.61 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 120.558 -0.457 . . . . 72.12 111.83 172.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.61 126.68 49.66 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.864 0.84 . . . . 62.33 112.402 -178.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.708 ' HB3' ' HB2' ' A' ' 85' ' ' ARG . . . -80.41 -45.4 17.73 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 114.19 1.181 . . . . 73.04 114.19 179.185 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -75.31 -25.17 57.64 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.963 0.727 . . . . 73.21 112.963 -167.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -80.13 -34.73 37.55 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.505 0.669 . . . . 71.14 109.841 175.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.67 -24.09 65.38 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.785 1.234 . . . . 33.23 112.511 172.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.44 ' HA ' HG22 ' A' ' 63' ' ' ILE . . . -58.01 -25.0 60.53 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 114.572 1.323 . . . . 32.05 114.572 -174.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.21 -44.93 78.35 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 118.881 0.764 . . . . 51.1 111.483 173.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.36 -43.38 98.96 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 115.79 -0.641 . . . . 71.43 110.822 173.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.646 HG13 HG13 ' A' ' 80' ' ' VAL . 0.4 OUTLIER -68.21 -32.3 55.26 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.003 0 CA-C-O 118.852 -0.594 . . . . 72.34 111.359 -179.38 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.62 -26.24 41.21 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.384 0.993 . . . . 75.02 112.341 177.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -81.81 -20.68 38.57 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 119.486 -0.886 . . . . 73.53 111.458 175.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.674 ' HB2' HG11 ' A' ' 78' ' ' VAL . 69.5 mmtt -99.39 0.01 41.87 Favored 'General case' 0 CA--C 1.569 1.706 0 C-N-CA 120.189 -0.605 . . . . 73.11 111.335 172.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 35.0 t70 -70.42 154.83 41.47 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 125.695 1.598 . . . . 64.52 111.425 177.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.53 25.11 4.44 Favored Glycine 0 C--N 1.346 1.133 0 C-N-CA 119.637 -1.268 . . . . 61.33 112.058 -159.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.701 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 8.2 t -57.22 131.56 50.36 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 124.496 0.762 . . . . 74.51 111.837 -171.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.63 146.74 46.36 Favored 'General case' 0 C--O 1.252 1.22 0 CA-C-N 114.23 -1.35 . . . . 72.42 113.404 -170.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -143.58 147.8 34.95 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 126.116 1.766 . . . . 74.24 109.807 -173.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 76.3 66.71 0.06 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 122.686 1.232 . . . . 62.4 113.381 173.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.05 -11.71 63.96 Favored Glycine 0 C--N 1.337 0.638 0 CA-C-N 113.729 -1.578 . . . . 70.02 113.313 177.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -119.2 122.09 41.2 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 106.841 -1.54 . . . . 64.41 106.841 163.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.422 ' O ' ' HD3' ' A' ' 16' ' ' PRO . 0.5 OUTLIER -94.78 105.16 17.08 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 117.954 -1.022 . . . . 73.15 111.075 178.531 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.701 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -165.65 64.7 0.11 Allowed 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 115.283 1.586 . . . . 74.42 115.283 179.319 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.518 ' HA ' ' SG ' ' A' ' 69' ' ' CYS . 0.1 OUTLIER -95.34 113.64 25.33 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 121.8 2.091 . . . . 63.54 111.555 -176.199 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.685 HG13 HG12 ' A' ' 12' ' ' VAL . 95.3 t -131.52 120.76 46.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 121.22 -0.925 . . . . 74.23 109.474 174.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.498 ' HA ' HD11 ' A' ' 63' ' ' ILE . 0.5 OUTLIER -149.14 141.99 24.67 Favored 'General case' 0 C--O 1.258 1.525 0 N-CA-C 113.66 0.985 . . . . 74.01 113.66 173.444 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.646 HG13 HG13 ' A' ' 63' ' ' ILE . 2.3 m -89.76 126.95 56.06 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-N 114.033 -1.44 . . . . 72.35 109.645 159.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -84.24 16.96 1.81 Allowed 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.658 2.238 . . . . 72.2 112.44 170.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -86.33 -30.02 22.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.042 -0.981 . . . . 75.3 110.544 177.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 64.23 41.8 5.84 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 124.824 1.328 . . . . 74.11 110.768 -173.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 69.06 10.95 8.16 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 125.831 1.653 . . . . 74.14 113.001 -178.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.708 ' HB2' ' HB3' ' A' ' 56' ' ' ALA . 0.1 OUTLIER 70.54 108.56 0.06 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 126.262 1.825 . . . . 74.31 111.759 -178.067 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.256 1.408 0 CA-C-N 114.497 -1.229 . . . . 64.33 110.354 170.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.958 0 CA-C-O 119.74 -0.478 . . . . 53.44 112.406 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 4.6 t 68.7 -168.47 0.18 Allowed 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 125.151 1.38 . . . . 73.54 111.344 178.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 65.13 38.03 6.3 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.422 1.089 . . . . 75.25 110.734 176.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt -135.48 138.22 42.93 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.593 -0.731 . . . . 51.34 110.334 -177.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.9 p -147.45 115.18 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 CA-C-O 121.882 0.849 . . . . 73.05 111.004 177.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.1 mp -127.41 127.78 69.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 115.566 -0.743 . . . . 73.52 109.344 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.54 165.14 12.31 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 110.067 -0.345 . . . . 72.5 110.067 174.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 66.68 -171.29 0.19 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.013 1.325 . . . . 71.13 110.499 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.0 t 64.6 -173.03 0.17 Allowed 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.769 1.227 . . . . 73.52 111.067 -177.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -128.75 134.74 63.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 109.51 -0.552 . . . . 73.52 109.51 177.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.3 p -83.89 138.15 33.32 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.915 -0.584 . . . . 73.25 112.029 -178.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -138.01 158.43 44.35 Favored 'General case' 0 C--O 1.211 -0.948 0 CA-C-N 115.911 -0.586 . . . . 73.41 111.956 -175.903 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.6 mt -117.9 141.66 35.9 Favored 'Isoleucine or valine' 0 C--O 1.254 1.335 0 N-CA-C 109.842 -0.429 . . . . 64.01 109.842 174.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -108.25 119.41 39.41 Favored 'General case' 0 C--O 1.246 0.875 0 O-C-N 124.653 1.221 . . . . 74.34 109.148 178.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.5 ' HB ' HG13 ' A' ' 78' ' ' VAL . 3.6 p -123.14 110.39 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-O 121.918 0.866 . . . . 75.34 111.328 174.181 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -115.36 166.57 12.22 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-N 115.072 -0.967 . . . . 55.14 113.126 177.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 55.76 30.25 15.35 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.427 1.091 . . . . 74.32 113.083 175.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.494 ' H ' HD23 ' A' ' 15' ' ' LEU . 2.3 pt? -89.16 140.44 28.85 Favored Pre-proline 0 C--O 1.237 0.42 0 CA-C-N 116.341 -0.39 . . . . 73.05 111.773 -172.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -72.05 142.5 38.47 Favored 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 122.527 2.151 . . . . 70.42 112.254 174.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.0 p 77.64 -32.84 0.18 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 127.351 2.26 . . . . 71.23 113.201 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 69.34 120.29 0.03 OUTLIER 'General case' 0 C--N 1.365 1.26 0 C-N-CA 124.869 1.268 . . . . 74.42 110.513 -174.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.442 ' H ' HD11 ' A' ' 15' ' ' LEU . 22.8 m -74.87 126.32 35.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 CA-C-O 121.508 0.671 . . . . 72.44 109.479 173.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.524 ' HB2' ' OD2' ' A' ' 23' ' ' ASP . 19.2 m -81.97 160.68 23.27 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.951 -1.129 . . . . 61.52 107.951 177.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.2 p -60.68 -32.43 71.65 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.42 0.896 . . . . 44.04 113.42 -168.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.19 -38.61 51.17 Favored 'General case' 0 C--O 1.253 1.243 0 C-N-CA 123.844 0.858 . . . . 73.43 111.127 -178.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.524 ' OD2' ' HB2' ' A' ' 20' ' ' SER . 51.8 m-20 -67.28 -48.67 67.0 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 114.676 -1.147 . . . . 71.43 110.205 -179.011 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.463 HG13 ' SG ' ' A' ' 37' ' ' CYS . 9.3 p -69.73 -29.91 42.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 CA-C-N 114.482 -1.235 . . . . 52.21 110.57 177.197 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -57.75 -53.17 61.24 Favored 'General case' 0 C--N 1.359 1.001 0 CA-C-O 118.812 -0.614 . . . . 72.43 111.188 170.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -67.22 -48.07 68.92 Favored 'General case' 0 C--O 1.295 3.463 0 CA-C-O 122.127 0.965 . . . . 73.52 111.87 -178.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -58.93 -47.78 83.81 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-N 113.777 -1.556 . . . . 62.31 109.945 -175.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.475 ' HA ' ' CD1' ' A' ' 31' ' ' TYR . 14.9 m-85 -81.99 -15.76 52.63 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.092 0.775 . . . . 65.34 113.092 -179.026 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 23.4 mtp180 -60.4 -35.35 75.56 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 118.149 0.431 . . . . 64.53 110.446 164.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.74 -30.22 70.63 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 119.487 -0.885 . . . . 72.21 112.954 168.317 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.475 ' CD1' ' HA ' ' A' ' 28' ' ' PHE . 1.1 m-85 -77.65 -11.27 59.85 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 113.247 0.832 . . . . 74.43 113.247 -171.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 141.28 38.18 0.09 OUTLIER Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.125 -1.036 . . . . 33.4 113.102 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 60.4 95.98 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.895 1.278 . . . . 63.01 112.933 174.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.17 132.63 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 115.774 -0.648 . . . . 64.25 110.701 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.33 -28.62 12.87 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.432 -0.803 . . . . 71.03 109.844 174.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -142.72 129.26 20.2 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.444 -0.343 . . . . 73.4 110.478 -173.098 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.463 ' SG ' HG13 ' A' ' 24' ' ' VAL . 0.9 OUTLIER -127.73 113.47 16.04 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.624 -0.509 . . . . 42.43 109.624 175.089 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -128.12 124.02 35.89 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 120.393 -0.523 . . . . 60.42 110.747 -178.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 87.2 t -99.6 128.97 50.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 116.114 -0.493 . . . . 75.33 110.346 -177.139 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.467 ' HB2' ' HB2' ' A' ' 48' ' ' PHE . 71.6 mmtt -106.54 137.02 45.3 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.628 -0.714 . . . . 74.2 109.731 -178.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -130.75 126.15 35.68 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.843 -0.343 . . . . 65.35 110.6 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.0 t -101.04 164.95 11.56 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 120.915 0.388 . . . . 51.44 111.078 177.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.9 t -75.51 -14.08 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 C-N-CA 124.133 0.973 . . . . 73.24 110.872 178.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.2 m -75.52 -11.59 60.06 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.184 0.594 . . . . 73.45 112.401 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.63 -3.32 56.15 Favored Glycine 0 C--N 1.343 0.955 0 C-N-CA 121.343 -0.456 . . . . 53.24 113.743 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.16 143.72 26.89 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.507 0.67 . . . . 63.44 111.285 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.58 142.81 33.98 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.175 -0.92 . . . . 71.45 109.257 177.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.467 ' HB2' ' HB2' ' A' ' 40' ' ' LYS . 7.9 m-85 -137.13 153.31 50.54 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.11 -0.7 . . . . 45.3 109.11 178.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -137.38 139.51 40.79 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-O 121.332 0.587 . . . . 41.34 109.636 170.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -116.35 117.81 31.0 Favored 'General case' 0 C--O 1.252 1.193 0 CA-C-N 113.803 -1.544 . . . . 72.04 106.929 -179.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 3.1 mp -127.16 112.92 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 119.715 -0.794 . . . . 60.41 111.99 -170.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -107.42 107.53 18.45 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.607 -0.724 . . . . 71.32 111.918 -171.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -112.51 167.34 10.53 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 115.039 -0.982 . . . . 74.53 112.977 -177.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -82.3 -25.27 34.13 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 113.39 0.885 . . . . 74.21 113.39 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.5 121.57 39.72 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.388 0.994 . . . . 70.11 112.421 177.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.46 ' HB3' ' HB2' ' A' ' 85' ' ' ARG . . . -81.47 -45.63 15.73 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.294 -1.321 . . . . 75.11 114.563 -177.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.21 -23.59 51.4 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 112.533 0.568 . . . . 74.12 112.533 -171.305 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -75.28 -26.99 59.2 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.863 0.84 . . . . 73.53 110.142 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.15 -27.14 67.06 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 114.711 -1.131 . . . . 75.51 112.602 175.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.424 ' HA ' HG22 ' A' ' 63' ' ' ILE . . . -59.37 -30.53 68.48 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 114.607 1.336 . . . . 53.53 114.607 -171.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.517 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -67.89 -44.18 77.61 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 122.135 0.969 . . . . 74.1 112.21 176.858 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.51 -31.54 57.74 Favored 'General case' 0 C--O 1.253 1.284 0 CA-C-O 122.604 1.192 . . . . 75.2 111.38 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.433 ' O ' ' HB3' ' A' ' 67' ' ' ASP . 0.4 OUTLIER -70.48 -30.6 43.44 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.465 0 CA-C-O 118.456 -0.783 . . . . 73.25 109.714 174.562 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.517 ' HG3' ' O ' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -77.6 -20.93 53.13 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 119.611 1.096 . . . . 63.1 111.551 170.234 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.78 -27.02 63.6 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-O 118.481 -0.771 . . . . 74.45 111.67 170.03 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.469 ' HE3' ' OH ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -113.42 13.47 18.96 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 116.405 2.002 . . . . 71.23 116.405 166.129 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.433 ' HB3' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -73.2 158.21 35.66 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 123.989 0.915 . . . . 72.43 112.539 174.662 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 112.72 24.84 4.79 Favored Glycine 0 C--N 1.345 1.036 0 C-N-CA 120.215 -0.993 . . . . 72.05 111.522 -160.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 6.2 p -57.81 132.41 53.25 Favored 'General case' 0 C--N 1.352 0.699 0 CA-C-O 122.392 1.091 . . . . 74.31 112.248 -168.287 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -134.14 149.27 51.05 Favored 'General case' 0 C--O 1.263 1.763 0 CA-C-N 113.521 -1.672 . . . . 73.13 112.383 -166.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -143.8 146.34 33.02 Favored 'General case' 0 CA--C 1.557 1.246 0 CA-C-N 112.733 -2.03 . . . . 64.31 109.477 -175.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 75.12 66.86 0.07 Allowed 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 124.706 1.202 . . . . 72.54 114.057 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.55 -11.93 59.68 Favored Glycine 0 N--CA 1.464 0.53 0 CA-C-N 113.605 -1.634 . . . . 72.34 113.796 173.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -118.91 119.64 34.95 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 105.717 -1.957 . . . . 52.43 105.717 157.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.94 103.52 15.48 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 118.975 -0.536 . . . . 75.52 111.17 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 12.0 tp -168.78 73.79 0.1 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 118.094 0.406 . . . . 71.22 111.323 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.75 109.04 21.86 Favored 'General case' 0 C--O 1.206 -1.228 0 O-C-N 120.202 -1.562 . . . . 73.14 109.008 -175.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.5 HG13 ' HB ' ' A' ' 12' ' ' VAL . 2.0 t -133.03 125.83 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 O-C-N 121.243 -0.911 . . . . 41.11 109.593 176.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -150.15 163.63 37.72 Favored 'General case' 0 C--O 1.26 1.606 0 CA-C-O 122.6 1.19 . . . . 75.4 113.131 169.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.1 m -87.14 123.39 70.14 Favored Pre-proline 0 CA--C 1.555 1.164 0 CA-C-N 112.649 -2.068 . . . . 63.44 109.047 165.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.458 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 56.5 Cg_endo -85.04 10.36 3.78 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 121.798 1.665 . . . . 74.31 113.941 167.484 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.442 ' CE1' ' HB1' ' A' ' 56' ' ' ALA . 17.5 p90 -102.87 -60.75 1.5 Allowed 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 112.099 0.407 . . . . 75.2 112.099 175.237 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 54.01 30.39 11.74 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 126.047 1.739 . . . . 73.15 112.355 -173.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.91 127.28 10.67 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 112.399 0.518 . . . . 72.52 112.399 -175.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.46 ' HB2' ' HB3' ' A' ' 56' ' ' ALA . 8.9 tpt180 -171.73 142.97 1.62 Allowed 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.276 0.985 . . . . 75.13 110.797 174.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-N 114.769 -1.105 . . . . 72.13 108.281 168.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.746 0 CA-C-O 120.014 -0.326 . . . . 73.12 112.318 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 47.2 m 66.28 37.47 4.91 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.738 1.215 . . . . 74.44 114.24 170.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -146.59 159.98 42.74 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 122.548 0.339 . . . . 72.34 110.297 174.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.6 ptp -157.84 99.93 1.72 Allowed 'General case' 0 CA--C 1.547 0.858 0 O-C-N 123.824 0.703 . . . . 73.15 111.395 171.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.7 p -165.67 117.94 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.314 0 CA-C-O 121.112 0.482 . . . . 63.41 110.996 176.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.8 tt -162.11 130.34 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 CA-C-O 120.911 0.386 . . . . 54.33 110.892 174.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.8 mtt-85 -145.17 135.46 24.06 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.658 0.783 . . . . 65.05 109.894 172.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 61.6 19.34 10.33 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 124.647 1.179 . . . . 74.23 113.925 171.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.7 t -112.53 -7.77 13.88 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 111.417 0.154 . . . . 54.45 111.417 -173.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.7 m 59.05 138.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 C-N-CA 127.876 2.471 . . . . 71.45 115.254 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' A' ' 52' ' ' GLU . 75.3 m -85.36 119.77 26.1 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.077 -0.965 . . . . 74.14 110.382 176.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.611 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -140.56 156.29 46.34 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-N 115.654 -0.703 . . . . 74.5 112.147 -178.934 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.576 ' HB ' HD12 ' A' ' 51' ' ' ILE . 43.8 mt -113.43 137.91 44.88 Favored 'Isoleucine or valine' 0 C--O 1.258 1.534 0 N-CA-C 108.561 -0.903 . . . . 44.42 108.561 177.274 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -99.11 112.53 24.64 Favored 'General case' 0 C--N 1.363 1.196 0 O-C-N 126.456 2.347 . . . . 74.41 108.629 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.2 133.05 67.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 107.789 -1.189 . . . . 75.44 107.789 175.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -141.13 159.99 26.7 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 121.223 -0.513 . . . . 64.41 112.801 173.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.502 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 72.8 m-20 60.94 25.59 15.56 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.491 1.116 . . . . 51.12 112.953 171.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.424 HD11 HG22 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -85.58 146.62 44.58 Favored Pre-proline 0 CA--C 1.549 0.942 0 O-C-N 121.363 -0.836 . . . . 73.21 113.033 -163.215 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.28 151.7 43.71 Favored 'Trans proline' 0 C--N 1.361 1.234 0 C-N-CA 123.351 2.701 . . . . 61.14 113.407 174.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.5 p 74.6 -30.52 0.2 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 127.421 2.288 . . . . 71.42 113.422 -176.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 71.2 t60 67.47 106.12 0.05 OUTLIER 'General case' 0 C--N 1.359 0.999 0 C-N-CA 125.24 1.416 . . . . 75.41 110.872 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.424 HG22 HD11 ' A' ' 15' ' ' LEU . 7.7 m -82.59 131.06 34.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 CA-C-N 115.636 -0.711 . . . . 74.24 110.328 176.12 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.54 ' HB2' ' OD2' ' A' ' 23' ' ' ASP . 16.8 m -89.5 160.84 16.53 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-N 115.388 -0.824 . . . . 41.43 109.545 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.6 t -52.79 -43.37 65.83 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.932 0.893 . . . . 42.51 113.078 -174.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.08 -42.16 80.8 Favored 'General case' 0 C--O 1.25 1.085 0 C-N-CA 124.741 1.216 . . . . 72.54 112.36 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.54 ' OD2' ' HB2' ' A' ' 20' ' ' SER . 12.0 m-20 -66.72 -43.09 85.17 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.125 -0.943 . . . . 73.55 110.376 -178.251 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.496 ' CG1' HG12 ' A' ' 51' ' ' ILE . 39.1 t -64.19 -40.4 88.92 Favored 'Isoleucine or valine' 0 C--N 1.343 0.309 0 CA-C-N 115.082 -0.963 . . . . 70.45 110.088 174.089 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.504 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 10.9 tt0 -58.71 -49.95 75.71 Favored 'General case' 0 C--O 1.209 -1.049 0 CA-C-O 118.455 -0.783 . . . . 62.13 111.141 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.5 -46.43 22.48 Favored 'General case' 0 C--O 1.282 2.779 0 N-CA-C 113.686 0.995 . . . . 71.1 113.686 -178.366 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -59.32 -44.6 92.57 Favored 'General case' 0 C--N 1.36 1.037 0 CA-C-N 116.353 -0.385 . . . . 71.24 110.375 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.456 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 42.6 m-85 -80.62 -20.63 42.76 Favored 'General case' 0 C--O 1.211 -0.921 0 CA-C-O 117.929 -1.034 . . . . 74.15 112.869 176.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.504 ' HB3' ' O ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -66.61 -29.56 69.64 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 120.031 1.287 . . . . 71.13 111.671 172.544 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.86 -31.01 68.62 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 117.185 -1.806 . . . . 74.22 112.202 173.406 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.488 ' CD2' ' HB2' ' A' ' 62' ' ' ALA . 85.1 m-85 -87.36 -37.08 17.41 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.307 0.484 . . . . 53.41 112.307 -176.143 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -143.9 165.16 27.36 Favored Glycine 0 C--O 1.221 -0.669 0 N-CA-C 111.662 -0.575 . . . . 72.35 111.662 174.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -80.37 99.39 7.91 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 117.516 0.658 . . . . 63.12 110.579 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.84 132.57 31.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 121.884 0.849 . . . . 72.1 111.744 -171.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.0 mp -103.1 -38.44 7.3 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.212 -1.358 . . . . 74.51 111.371 -178.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.51 131.44 15.21 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 122.89 0.476 . . . . 45.21 110.487 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.8 m -121.26 124.33 44.36 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.836 -0.54 . . . . 75.31 110.667 171.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -128.44 132.86 48.44 Favored 'General case' 0 C--O 1.212 -0.911 0 CA-C-N 116.299 -0.41 . . . . 73.53 110.669 -178.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 p -119.19 120.15 62.93 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.173 0 CA-C-O 121.684 0.755 . . . . 43.43 111.077 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -108.56 157.84 18.11 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.703 -0.68 . . . . 74.53 110.625 -178.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.04 149.87 52.16 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 122.243 -0.285 . . . . 73.13 111.034 173.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.4 t -101.48 166.37 10.76 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 120.654 0.264 . . . . 52.23 110.339 172.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.9 t -75.32 -13.72 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 C-N-CA 124.224 1.01 . . . . 72.42 111.14 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.0 t -76.25 -12.42 60.08 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.063 0.545 . . . . 74.22 111.594 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.87 -3.7 41.79 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.25 -0.5 . . . . 75.04 113.667 177.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.99 152.74 21.52 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.064 0.459 . . . . 72.13 111.001 177.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.14 148.93 49.29 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.625 -0.716 . . . . 32.44 110.205 -177.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -134.61 149.41 50.57 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 109.458 -0.571 . . . . 63.44 109.458 -170.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -125.09 138.04 54.18 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.099 0.476 . . . . 54.1 110.648 174.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.52 118.65 34.35 Favored 'General case' 0 C--O 1.256 1.423 0 N-CA-C 107.975 -1.121 . . . . 74.25 107.975 173.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.611 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 3.7 mt -115.1 109.29 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 119.069 -1.052 . . . . 61.41 111.183 -174.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 8' ' ' SER . 34.1 tt0 -109.09 104.88 14.15 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.975 0.893 . . . . 71.34 111.345 -171.227 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -117.58 171.88 7.72 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 114.693 -1.14 . . . . 75.44 113.315 -179.38 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -79.2 -37.07 39.15 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 114.908 -1.042 . . . . 74.54 111.618 168.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -116.19 117.55 30.35 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 122.179 0.99 . . . . 44.53 111.138 -171.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.564 ' HB3' ' HG2' ' A' ' 85' ' ' ARG . . . -84.31 -46.11 12.12 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 113.62 -1.627 . . . . 64.31 115.373 -174.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.8 tmm_? -75.07 -28.53 60.39 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 121.294 0.568 . . . . 63.2 111.913 -168.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -79.17 -25.86 42.76 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-O 121.469 0.652 . . . . 74.21 111.54 177.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.35 -23.76 61.18 Favored 'General case' 0 C--O 1.251 1.151 0 CA-C-O 122.291 1.043 . . . . 62.21 112.245 173.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.81 -22.25 23.79 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 114.593 -1.185 . . . . 73.21 113.856 173.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.473 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 0.4 OUTLIER -66.74 -43.04 85.24 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.82 0.819 . . . . 73.32 110.547 173.51 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.488 ' HB2' ' CD2' ' A' ' 31' ' ' TYR . . . -64.03 -43.02 96.86 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 114.696 -1.138 . . . . 72.35 110.659 173.056 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.794 HG13 HG13 ' A' ' 80' ' ' VAL . 0.3 OUTLIER -66.82 -31.0 51.5 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.411 0 C-N-CA 120.202 -0.599 . . . . 64.41 111.477 178.143 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -80.18 -21.32 43.12 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.444 0.566 . . . . 72.41 112.172 176.927 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.409 ' HG2' ' HA ' ' A' ' 62' ' ' ALA . 15.7 pt-20 -85.38 -17.96 35.16 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 118.55 -1.26 . . . . 63.34 111.809 170.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 62' ' ' ALA . 67.4 mmtt -99.67 13.65 32.84 Favored 'General case' 0 CA--C 1.575 1.92 0 CA-C-O 121.622 0.725 . . . . 73.32 111.401 170.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -70.77 153.06 43.13 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 127.115 2.166 . . . . 72.4 114.329 -178.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 112.03 24.28 5.22 Favored Glycine 0 C--N 1.351 1.416 0 C-N-CA 120.268 -0.968 . . . . 72.1 114.53 -171.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 20.7 p -58.27 133.62 55.84 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 114.219 1.192 . . . . 73.24 114.219 -167.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.1 149.92 51.13 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-N 113.826 -1.534 . . . . 63.23 113.212 -168.111 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -143.5 149.38 37.42 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.442 1.897 . . . . 73.44 110.562 -171.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 74.34 64.87 0.08 Allowed 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 122.476 1.131 . . . . 72.14 113.466 174.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.94 -10.64 60.46 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 113.745 -1.57 . . . . 75.41 113.952 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -120.25 122.78 41.64 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.19 -1.411 . . . . 71.22 107.19 160.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.502 ' HB3' ' O ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -96.12 103.25 15.13 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 119.109 -0.472 . . . . 74.2 111.038 178.855 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 41.5 tp -162.29 69.84 0.28 Allowed 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 118.267 0.485 . . . . 54.14 112.01 177.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -97.86 113.14 24.88 Favored 'General case' 0 C--O 1.208 -1.097 0 O-C-N 119.451 -2.031 . . . . 74.45 109.703 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.8 t -130.1 120.48 49.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 107.893 -1.151 . . . . 62.3 107.893 171.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -149.01 141.33 24.12 Favored 'General case' 0 C--O 1.258 1.517 0 CA-C-O 123.075 1.417 . . . . 65.24 113.922 176.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.794 HG13 HG13 ' A' ' 63' ' ' ILE . 16.6 m -88.91 135.86 31.4 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 113.112 -1.858 . . . . 75.33 110.209 165.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -82.96 20.21 1.19 Allowed 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.19 1.927 . . . . 74.43 112.415 166.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -103.34 72.38 1.15 Allowed 'General case' 0 C--N 1.345 0.404 0 CA-C-O 121.828 0.823 . . . . 53.32 109.707 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -99.24 39.68 1.27 Allowed 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.838 -1.074 . . . . 71.5 109.128 177.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -169.49 39.12 0.03 OUTLIER 'General case' 0 C--O 1.238 0.484 0 CA-C-N 114.704 -1.135 . . . . 75.33 109.838 -174.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.564 ' HG2' ' HB3' ' A' ' 56' ' ' ALA . 7.3 tpt85 -134.75 1.89 3.11 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 112.168 0.433 . . . . 52.34 112.168 -171.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 . . . . . 0 C--O 1.255 1.352 0 CA-C-O 118.452 -0.785 . . . . 71.21 111.312 -178.223 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.197 0 N-CA-C 111.821 -0.512 . . . . 74.11 111.821 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 6.9 t -118.47 -178.01 3.43 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 110.186 -0.302 . . . . 64.24 110.186 -176.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -130.81 153.18 49.35 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 122.603 0.361 . . . . 74.23 111.254 -178.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -112.88 141.05 47.15 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.315 -0.402 . . . . 62.23 111.11 -178.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.7 t -119.84 128.93 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 116.344 -0.389 . . . . 43.12 110.128 -178.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.0 pp -116.72 165.77 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 120.633 0.254 . . . . 75.41 111.374 177.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -158.2 139.52 13.43 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.975 -0.557 . . . . 72.41 110.343 176.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 64.45 90.7 0.08 Allowed 'General case' 0 N--CA 1.481 1.08 0 O-C-N 124.985 1.428 . . . . 73.31 112.444 175.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.1 t -158.09 155.33 29.02 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.038 -0.528 . . . . 63.11 110.587 -177.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.5 m -109.15 138.09 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-O 120.826 0.346 . . . . 73.01 110.908 176.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.2 p -85.49 139.36 31.55 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.731 -0.213 . . . . 72.4 110.555 -178.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.491 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 0.3 OUTLIER -130.52 151.65 50.76 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.338 0.496 . . . . 60.31 112.338 -177.096 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.493 HG13 HG12 ' A' ' 80' ' ' VAL . 4.9 mp -121.13 132.33 70.8 Favored 'Isoleucine or valine' 0 C--O 1.247 0.95 0 N-CA-C 108.948 -0.76 . . . . 72.32 108.948 174.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -113.16 113.95 26.09 Favored 'General case' 0 C--O 1.244 0.813 0 O-C-N 124.21 0.944 . . . . 75.24 109.338 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 7.2 p -122.71 109.69 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 CA-C-O 122.503 1.144 . . . . 32.44 111.651 176.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -128.14 157.34 21.16 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-N 115.32 -0.855 . . . . 63.02 114.946 -174.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.435 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 15.3 m120 59.37 25.07 13.71 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.715 1.206 . . . . 54.44 111.944 175.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.467 HD23 ' H ' ' A' ' 15' ' ' LEU . 1.7 pt? -88.37 151.2 48.23 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 112.511 0.559 . . . . 71.05 112.511 -167.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -64.43 144.2 84.7 Favored 'Trans proline' 0 C--N 1.364 1.382 0 C-N-CA 122.901 2.401 . . . . 74.34 112.227 172.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.5 p 73.53 -31.03 0.22 Allowed 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 127.316 2.246 . . . . 43.33 113.046 -176.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 64.78 86.74 0.12 Allowed 'General case' 0 C--N 1.361 1.071 0 C-N-CA 125.746 1.618 . . . . 74.31 110.156 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.433 ' H ' HD11 ' A' ' 15' ' ' LEU . 8.2 p -69.18 133.74 31.35 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 CA-C-O 121.653 0.74 . . . . 75.13 110.521 -174.084 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.429 ' O ' HG22 ' A' ' 24' ' ' VAL . 25.5 m -90.46 169.33 11.14 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.358 -0.837 . . . . 44.03 110.207 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.3 p -61.82 -28.39 69.44 Favored 'General case' 0 C--O 1.21 -1.022 0 N-CA-C 113.509 0.929 . . . . 50.43 113.509 -175.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -71.85 -41.78 67.71 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 123.586 0.754 . . . . 62.14 111.852 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -73.68 -43.55 59.07 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.888 -0.597 . . . . 75.44 109.829 -172.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 20' ' ' SER . 2.2 m -68.62 -30.79 48.48 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.945 0 CA-C-O 118.179 -0.915 . . . . 74.55 111.175 170.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.0 -55.73 21.37 Favored 'General case' 0 C--O 1.195 -1.801 0 CA-C-O 118.003 -0.998 . . . . 71.42 109.094 172.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -73.84 -55.16 6.54 Favored 'General case' 0 C--O 1.276 2.462 0 C-N-CA 119.199 -1.001 . . . . 72.41 112.662 -175.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -76.64 -35.96 57.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.543 -0.753 . . . . 71.42 110.787 -168.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.31 -23.64 30.17 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 118.073 -0.965 . . . . 74.54 110.984 177.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.557 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 4.7 ptt85 -71.52 -22.94 61.71 Favored 'General case' 0 C--N 1.383 2.065 0 CA-C-N 120.193 1.36 . . . . 70.4 111.698 170.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.19 -33.5 67.54 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 119.005 -1.078 . . . . 63.21 110.91 169.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.514 ' CG ' ' HB2' ' A' ' 62' ' ' ALA . 90.0 m-85 -85.41 -38.02 19.16 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.327 0.492 . . . . 75.55 112.327 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' A' ' 29' ' ' ARG . . . -152.62 143.9 10.86 Favored Glycine 0 C--O 1.22 -0.779 0 C-N-CA 121.045 -0.598 . . . . 64.32 111.67 178.233 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -66.9 117.73 9.4 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 123.718 0.305 . . . . 74.4 111.05 -172.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.36 122.92 35.55 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-O 122.045 0.926 . . . . 63.33 111.278 -174.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 50.0 mt -100.61 -36.19 9.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.937 -1.029 . . . . 54.4 109.431 177.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.84 139.39 21.58 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.682 -0.69 . . . . 74.4 109.545 -177.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 18.7 p -136.9 118.76 15.17 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.252 0.549 . . . . 73.11 110.497 173.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -129.26 144.83 51.37 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 115.589 -0.732 . . . . 44.25 109.623 -179.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 84.9 t -117.64 129.06 74.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 121.069 0.461 . . . . 74.34 110.365 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -106.08 135.32 47.75 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.117 -0.697 . . . . 71.32 109.117 -178.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.91 125.06 36.75 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.753 -0.379 . . . . 63.13 110.424 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.1 t -102.16 164.42 11.7 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.463 -0.335 . . . . 71.42 111.481 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.7 t -75.04 -13.46 15.35 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 C-N-CA 123.748 0.819 . . . . 75.14 110.913 178.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.8 t -75.65 -10.83 59.77 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.066 0.546 . . . . 65.43 111.542 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.42 -4.12 59.95 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 120.92 -0.657 . . . . 52.05 113.226 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.81 139.12 30.85 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.339 0.59 . . . . 74.44 111.135 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.84 142.12 35.29 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.274 -0.876 . . . . 24.44 109.54 177.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 8.8 m-85 -136.25 149.43 48.5 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.438 -0.949 . . . . 71.21 108.438 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -132.82 138.52 47.11 Favored 'General case' 0 C--O 1.248 1.012 0 N-CA-C 109.212 -0.662 . . . . 42.42 109.212 172.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -118.09 117.93 30.51 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.113 -1.403 . . . . 72.45 107.836 -176.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.94 112.51 27.59 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.468 0 C-N-CA 120.176 -0.609 . . . . 70.35 111.033 -171.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -98.51 114.52 26.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.922 0.391 . . . . 72.13 111.186 -176.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -107.88 166.37 10.76 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.511 -0.768 . . . . 61.23 111.451 -178.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -80.61 -35.08 34.56 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 120.318 -0.553 . . . . 74.51 110.921 172.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.71 124.28 45.84 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.929 0.871 . . . . 72.24 112.363 -171.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.53 -46.16 16.26 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 113.74 -1.573 . . . . 72.34 114.529 -176.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.59 -21.94 57.37 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 112.727 0.64 . . . . 74.03 112.727 -169.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.419 ' HB3' ' O ' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -78.57 -33.1 47.91 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 121.35 0.595 . . . . 73.2 110.807 174.852 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.96 -24.88 63.41 Favored 'General case' 0 C--O 1.25 1.083 0 C-N-CA 124.4 1.08 . . . . 62.14 112.162 174.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.557 ' HA ' HG22 ' A' ' 63' ' ' ILE . . . -56.65 -26.63 56.65 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.164 -0.926 . . . . 62.32 113.34 178.449 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.43 ' HA ' ' HG3' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -69.27 -39.2 78.53 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 117.84 0.291 . . . . 75.52 111.257 174.734 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.514 ' HB2' ' CG ' ' A' ' 31' ' ' TYR . . . -66.17 -42.54 88.82 Favored 'General case' 0 C--O 1.245 0.851 0 C-N-CA 122.844 0.457 . . . . 62.31 111.139 174.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.778 HG13 HG13 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -70.32 -29.05 37.6 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 119.771 -0.772 . . . . 73.03 111.024 178.766 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.43 ' HG3' ' HA ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -78.96 -27.2 43.52 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.793 1.179 . . . . 73.33 112.438 174.811 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.49 -22.53 43.91 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 119.015 -1.074 . . . . 75.42 111.269 176.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -109.04 14.36 24.06 Favored 'General case' 0 CA--C 1.558 1.287 0 CA-C-O 121.35 0.595 . . . . 52.51 111.92 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -67.1 154.02 42.23 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 125.763 1.625 . . . . 71.34 110.902 169.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.15 21.75 5.81 Favored Glycine 0 C--N 1.343 0.931 0 C-N-CA 119.81 -1.186 . . . . 63.35 112.501 -162.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.67 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 14.3 p -59.81 132.03 52.72 Favored 'General case' 0 C--O 1.242 0.672 0 O-C-N 124.239 0.611 . . . . 62.01 111.888 -175.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.5 147.68 50.4 Favored 'General case' 0 C--O 1.254 1.315 0 CA-C-N 115.171 -0.922 . . . . 62.42 112.744 -169.363 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -143.16 146.34 33.63 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.335 1.854 . . . . 62.12 110.766 -173.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 74.16 67.56 0.09 Allowed 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 114.084 1.142 . . . . 75.32 114.084 177.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.67 -11.78 59.45 Favored Glycine 0 N--CA 1.462 0.415 0 CA-C-N 114.299 -1.319 . . . . 73.44 113.665 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -121.82 123.18 41.18 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.499 -1.297 . . . . 73.31 107.499 157.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.435 ' HB3' ' O ' ' A' ' 14' ' ' ASN . 0.3 OUTLIER -94.15 104.11 16.14 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 118.97 -0.538 . . . . 73.54 110.701 179.202 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.67 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -162.89 58.15 0.2 Allowed 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.438 1.273 . . . . 73.11 114.438 -175.228 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -95.27 113.83 25.55 Favored 'General case' 0 C--O 1.214 -0.774 0 CA-C-N 121.036 1.744 . . . . 73.4 110.838 -173.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.2 t -128.4 117.39 45.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 107.78 -1.192 . . . . 34.25 107.78 170.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.563 ' HA ' HD11 ' A' ' 63' ' ' ILE . 32.6 tt0 -151.98 144.97 24.49 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.799 0.809 . . . . 73.54 111.625 176.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.778 HG13 HG13 ' A' ' 63' ' ' ILE . 18.7 m -89.06 124.83 64.1 Favored Pre-proline 0 C--N 1.317 -0.836 0 CA-C-N 115.81 -0.632 . . . . 71.42 111.077 170.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.491 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 57.8 Cg_endo -80.37 5.92 5.74 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.036 1.824 . . . . 74.42 114.047 169.262 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -87.37 -32.61 19.5 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 119.933 -0.707 . . . . 74.41 111.809 175.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 52.45 71.64 0.46 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.887 1.275 . . . . 74.42 112.27 -175.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 63.07 -173.29 0.16 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.045 1.338 . . . . 63.14 112.849 -176.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -79.01 -67.95 0.7 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.88 0.371 . . . . 63.41 111.006 177.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 . . . . . 0 C--O 1.256 1.418 0 CA-C-N 115.583 -0.735 . . . . 74.42 110.238 -174.278 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.86 0 N-CA-C 112.057 -0.417 . . . . 72.03 112.057 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 11.7 p -143.78 156.97 44.68 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.077 0.551 . . . . 64.24 109.93 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -143.96 120.77 11.25 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 110.243 -0.28 . . . . 75.11 110.243 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.3 mtt -135.08 171.51 14.32 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.665 0.269 . . . . 73.12 111.532 178.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 31.2 m -95.3 145.98 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 116.213 -0.449 . . . . 25.32 111.52 -178.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.4 pt -128.15 145.7 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 115.963 -0.562 . . . . 71.35 111.154 178.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 37.6 mtt85 -143.9 127.23 16.76 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 116.239 -0.437 . . . . 73.2 110.105 175.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 59.71 79.75 0.22 Allowed 'General case' 0 N--CA 1.481 1.115 0 O-C-N 125.322 1.639 . . . . 63.45 112.02 178.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -138.95 155.77 47.77 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.963 -0.562 . . . . 73.11 110.349 -176.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.5 t -111.26 105.14 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 116.033 -0.531 . . . . 73.35 110.24 -178.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.9 t -83.0 122.28 28.1 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.738 -0.665 . . . . 72.32 111.401 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.528 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 1.6 ptp180 -143.93 155.86 44.22 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 112.501 0.556 . . . . 63.42 112.501 -175.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.675 HG12 HG12 ' A' ' 80' ' ' VAL . 6.7 mt -115.28 136.8 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 123.6 0.76 . . . . 74.54 109.896 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -105.63 117.6 34.44 Favored 'General case' 0 C--O 1.249 1.057 0 O-C-N 125.111 1.507 . . . . 63.54 109.728 177.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.517 HG12 HD22 ' A' ' 15' ' ' LEU . 59.4 t -119.68 109.51 26.46 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.055 0 CA-C-N 115.495 -0.775 . . . . 71.32 109.504 176.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -123.07 156.84 17.51 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.74 -0.743 . . . . 74.32 113.627 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.2 m120 59.11 32.42 22.12 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.029 0.932 . . . . 73.32 112.255 170.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.517 HD22 HG12 ' A' ' 12' ' ' VAL . 1.3 pt? -87.77 149.23 45.55 Favored Pre-proline 0 CA--C 1.543 0.707 0 N-CA-C 113.277 0.843 . . . . 74.21 113.277 -168.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -69.69 129.94 18.56 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 122.943 2.428 . . . . 73.24 112.647 172.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.7 p 48.3 101.62 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 125.949 1.7 . . . . 73.13 113.021 -169.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 38.0 p-80 -55.42 119.31 5.42 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.778 0.799 . . . . 65.52 112.218 -175.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.5 p -77.12 129.59 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 114.534 -1.212 . . . . 63.13 110.43 -175.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.3 m -83.6 165.75 18.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.401 -0.818 . . . . 73.02 110.207 -178.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 32.0 p -62.88 -28.2 69.88 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.723 0.809 . . . . 71.14 112.54 -174.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.06 -37.59 54.34 Favored 'General case' 0 C--O 1.253 1.249 0 CA-C-O 121.52 0.676 . . . . 75.14 110.809 -177.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -71.03 -44.42 65.86 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 114.652 -1.158 . . . . 75.03 110.564 -178.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.644 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 2.9 m -67.62 -31.52 52.86 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.872 0 CA-C-O 118.978 -0.534 . . . . 72.43 110.588 171.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 21' ' ' SER . 17.1 tt0 -58.41 -54.14 50.43 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 118.946 -0.55 . . . . 74.21 110.476 177.049 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -72.47 -54.02 10.47 Favored 'General case' 0 C--O 1.29 3.225 0 C-N-CA 119.829 -0.749 . . . . 52.14 112.512 -178.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -69.48 -44.58 70.86 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.676 -1.147 . . . . 74.21 109.689 -169.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.644 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 7.8 m-85 -77.95 -21.99 50.17 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-O 118.099 -0.953 . . . . 72.34 111.384 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.419 ' HB3' ' O ' ' A' ' 25' ' ' GLU . 3.6 ppt_? -68.44 -26.66 65.62 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 121.193 1.815 . . . . 71.25 111.402 171.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.48 -21.05 66.55 Favored 'General case' 0 CA--C 1.561 1.398 0 C-N-CA 118.304 -1.358 . . . . 71.52 112.442 169.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.437 ' OH ' ' HE3' ' A' ' 66' ' ' LYS . 5.2 m-30 -74.76 -37.22 62.52 Favored 'General case' 0 C--O 1.207 -1.173 0 N-CA-C 113.134 0.79 . . . . 73.04 113.134 -175.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 166.54 43.82 0.02 OUTLIER Glycine 0 N--CA 1.469 0.839 0 C-N-CA 118.943 -1.598 . . . . 64.11 114.061 -178.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.5 t30 62.05 99.28 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 125.217 1.407 . . . . 72.32 113.058 175.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.16 127.48 39.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 114.951 -1.022 . . . . 72.51 110.535 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -97.29 -32.25 12.0 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.536 -0.756 . . . . 73.35 109.932 176.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.01 132.15 15.38 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.001 -0.545 . . . . 61.12 109.697 -176.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.1 p -125.2 125.19 43.25 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 120.862 0.363 . . . . 64.31 110.041 172.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -129.41 130.99 46.67 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.825 -0.625 . . . . 73.31 110.144 -179.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.4 t -111.89 114.47 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.285 0.564 . . . . 71.22 110.035 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -107.12 139.93 40.76 Favored 'General case' 0 C--O 1.212 -0.915 0 CA-C-N 115.22 -0.9 . . . . 75.42 108.815 -178.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.83 148.22 52.54 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.313 0.96 . . . . 64.21 112.005 171.23 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.4 t -100.85 165.76 11.19 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 116.263 -0.426 . . . . 30.13 110.49 177.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.5 t -75.57 -11.47 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 C-N-CA 123.862 0.865 . . . . 73.23 110.937 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -76.46 -8.25 56.77 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 122.837 0.455 . . . . 65.41 111.63 178.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.83 -4.09 52.98 Favored Glycine 0 C--N 1.341 0.815 0 C-N-CA 121.248 -0.501 . . . . 54.21 112.869 175.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.89 135.24 33.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.994 0.426 . . . . 71.5 110.953 178.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.96 148.49 26.65 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.351 -0.841 . . . . 43.45 109.397 177.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.5 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 19.8 m-85 -136.13 153.21 51.35 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 123.641 0.588 . . . . 74.1 109.503 -176.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -136.0 137.86 41.66 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.997 -0.547 . . . . 74.14 109.62 174.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.44 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 0.4 OUTLIER -111.46 119.95 40.5 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 114.736 -1.12 . . . . 64.33 108.448 172.986 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.3 mp -123.87 113.92 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 119.997 -0.681 . . . . 71.52 111.145 -177.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -92.73 116.15 28.75 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.325 -0.852 . . . . 61.34 111.593 -169.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -109.84 152.94 25.11 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.782 1.03 . . . . 71.51 113.782 -177.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.41 -34.03 25.6 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 115.275 -0.875 . . . . 63.14 112.044 172.24 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -122.51 129.5 52.04 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.278 0.844 . . . . 74.41 113.278 -177.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.07 -45.99 31.32 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 113.98 -1.464 . . . . 54.31 114.339 -175.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.09 -25.23 52.05 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.324 0.861 . . . . 65.41 113.324 -170.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -76.47 -36.81 57.67 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.859 0.838 . . . . 63.14 109.331 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.65 -27.93 65.46 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 114.505 -1.225 . . . . 71.44 111.743 177.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.428 ' HB2' ' HB1' ' A' ' 84' ' ' ALA . . . -57.02 -35.45 69.28 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 114.227 1.195 . . . . 73.31 114.227 -176.154 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.556 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 0.5 OUTLIER -69.55 -40.51 76.79 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 122.122 0.963 . . . . 65.51 112.729 -179.437 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.553 ' O ' ' HG3' ' A' ' 65' ' ' GLU . . . -75.92 -36.48 59.39 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.674 -0.693 . . . . 73.2 110.598 178.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.58 HG13 HG13 ' A' ' 80' ' ' VAL . 0.4 OUTLIER -68.83 -28.85 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 O-C-N 121.875 -0.516 . . . . 54.43 110.575 176.659 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.556 ' HG3' ' O ' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -78.86 -23.0 45.23 Favored 'General case' 0 C--N 1.354 0.803 0 CA-C-N 118.295 0.498 . . . . 71.21 111.833 169.874 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.553 ' HG3' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -69.45 -29.41 67.09 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 120.192 -0.603 . . . . 75.41 110.88 172.189 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.621 ' HG3' HG11 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -105.03 7.81 34.13 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 114.767 1.395 . . . . 74.52 114.767 169.033 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -70.1 152.9 43.81 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 123.444 0.698 . . . . 73.13 111.25 173.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.02 23.7 4.49 Favored Glycine 0 C--N 1.342 0.865 0 C-N-CA 119.532 -1.318 . . . . 73.3 112.327 -155.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.556 ' SG ' ' HA ' ' A' ' 77' ' ' ARG . 6.1 t -55.81 136.75 51.03 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.815 0.846 . . . . 65.43 112.059 -178.147 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -123.82 146.16 48.56 Favored 'General case' 0 C--O 1.249 1.056 0 CA-C-N 114.808 -1.087 . . . . 72.4 112.928 -169.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -142.61 145.78 33.87 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 112.14 -2.3 . . . . 74.22 110.298 -173.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 73.24 66.87 0.1 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 114.302 1.223 . . . . 74.51 114.302 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.67 -12.6 59.56 Favored Glycine 0 C--N 1.335 0.474 0 CA-C-N 114.148 -1.387 . . . . 73.33 114.258 171.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -123.22 120.49 33.31 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 106.483 -1.673 . . . . 74.43 106.483 157.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.1 116.08 28.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 119.579 -0.248 . . . . 73.42 111.319 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -157.91 81.33 0.86 Allowed 'General case' 0 C--O 1.208 -1.107 0 N-CA-C 112.356 0.502 . . . . 52.01 112.356 178.173 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.556 ' HA ' ' SG ' ' A' ' 69' ' ' CYS . 7.4 tpp85 -97.85 113.26 25.02 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.576 1.08 . . . . 73.34 110.165 -178.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.621 HG11 ' HG3' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -133.22 115.88 24.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.662 -0.699 . . . . 64.03 109.441 169.743 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.18 155.09 36.02 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-O 121.802 0.811 . . . . 73.44 112.724 175.537 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.675 HG12 HG12 ' A' ' 10' ' ' ILE . 31.0 m -90.6 123.38 65.37 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 114.824 -1.08 . . . . 71.51 110.764 166.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.528 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 73.8 Cg_endo -88.17 9.15 3.84 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 122.061 1.84 . . . . 74.1 112.576 164.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -97.05 -13.28 22.35 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 120.576 -0.45 . . . . 70.34 111.887 176.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.3 m120 67.75 127.92 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.29 0 O-C-N 124.872 1.358 . . . . 71.42 111.948 -172.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.428 ' HB1' ' HB2' ' A' ' 60' ' ' ALA . . . -82.22 61.3 5.39 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.15 -0.932 . . . . 75.22 113.069 -167.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.18 34.52 21.09 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.555 1.542 . . . . 62.33 111.726 -179.042 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 . . . . . 0 C--O 1.254 1.31 0 O-C-N 124.52 1.138 . . . . 65.53 112.34 174.745 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.541 0.597 0 N-CA-C 110.451 -0.203 . . . . 73.52 110.451 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.21 158.5 44.26 Favored 'General case' 0 N--CA 1.509 2.518 0 CA-C-O 118.666 -0.683 . . . . 63.41 112.163 -177.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.547 ' HB ' HD12 ' A' ' 51' ' ' ILE . 6.2 mt -117.66 143.0 29.37 Favored 'Isoleucine or valine' 0 C--N 1.371 1.518 0 N-CA-C 107.258 -1.386 . . . . 71.22 107.258 -176.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -104.95 113.23 26.7 Favored 'General case' 0 CA--C 1.564 1.499 0 CA-C-O 117.996 -1.002 . . . . 74.24 111.413 -176.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.526 HG12 HG13 ' A' ' 78' ' ' VAL . 14.2 m -127.24 107.45 16.85 Favored 'Isoleucine or valine' 0 C--N 1.376 1.728 0 CA-C-N 121.166 1.803 . . . . 62.42 110.309 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.511 ' H ' ' HG3' ' A' ' 77' ' ' ARG . . . -134.7 -179.05 16.1 Favored Glycine 0 N--CA 1.485 1.941 0 O-C-N 120.86 -1.15 . . . . 64.1 113.987 -174.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.4 m120 49.72 23.22 0.94 Allowed 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 113.875 1.065 . . . . 53.42 113.875 -178.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.648 HD23 ' H ' ' A' ' 15' ' ' LEU . 2.2 pt? -91.14 141.59 26.51 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.236 1.014 . . . . 71.53 110.561 -167.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -64.46 133.55 37.77 Favored 'Trans proline' 0 C--N 1.365 1.404 0 C-N-CA 122.367 2.045 . . . . 71.33 111.807 177.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.5 p 82.13 -39.67 0.11 Allowed 'General case' 0 C--N 1.379 1.859 0 C-N-CA 126.73 2.012 . . . . 65.44 112.053 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 67.19 117.58 0.03 OUTLIER 'General case' 0 C--N 1.357 0.926 0 C-N-CA 125.278 1.431 . . . . 70.45 110.999 -173.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.474 ' H ' HD11 ' A' ' 15' ' ' LEU . 9.8 m -71.82 116.3 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.594 2.643 0 N-CA-C 107.312 -1.366 . . . . 64.21 107.312 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -79.25 155.8 28.4 Favored 'General case' 0 C--N 1.38 1.908 0 O-C-N 120.789 -1.194 . . . . 72.32 110.727 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 69.9 m -48.81 -43.34 38.19 Favored 'General case' 0 C--N 1.381 1.963 0 N-CA-C 115.911 1.819 . . . . 71.52 115.911 -173.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.99 -47.52 71.35 Favored 'General case' 0 CA--C 1.589 2.445 0 N-CA-C 113.865 1.061 . . . . 74.34 113.865 174.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -72.88 -35.97 67.25 Favored 'General case' 0 C--N 1.361 1.072 0 CA-C-O 119.089 -0.482 . . . . 75.22 112.286 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.511 ' O ' ' HB2' ' A' ' 28' ' ' PHE 0.262 1.7 p -69.41 -44.12 80.38 Favored 'Isoleucine or valine' 0 C--N 1.36 1.025 0 CA-C-O 118.107 -0.949 . . . . 43.02 110.683 176.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.488 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 22.1 tt0 -49.12 -60.44 2.79 Favored 'General case' 0 N--CA 1.507 2.405 0 CA-C-O 116.809 -1.567 . . . . 54.13 112.165 165.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -70.21 -61.82 1.63 Allowed 'General case' 0 C--O 1.303 3.912 0 CA-C-N 121.467 1.94 . . . . 64.42 114.417 -173.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -70.42 -34.34 72.39 Favored 'General case' 0 C--N 1.369 1.421 0 CA-C-O 117.111 -1.423 . . . . 72.12 112.622 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.511 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 1.2 m-85 -77.57 -35.82 52.7 Favored 'General case' 0 C--N 1.364 1.23 0 CA-C-N 121.939 2.154 . . . . 75.15 112.271 177.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.488 ' HB3' ' O ' ' A' ' 25' ' ' GLU . 5.2 ptt85 -53.21 -28.51 27.28 Favored 'General case' 0 N--CA 1.509 2.513 0 CA-C-O 115.87 -2.014 . . . . 75.33 115.338 166.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.63 -47.04 73.94 Favored 'General case' 0 N--CA 1.522 3.142 0 CA-C-N 123.485 2.857 . . . . 72.32 111.666 167.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.514 ' HB3' ' HA ' ' A' ' 59' ' ' ALA . 94.6 m-85 -76.39 -38.26 55.96 Favored 'General case' 0 CA--C 1.554 1.103 0 CA-C-O 118.302 -0.856 . . . . 71.22 112.532 -166.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -148.94 -175.43 21.39 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-N 120.001 1.273 . . . . 73.15 111.605 170.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -99.48 98.77 9.64 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 119.23 -0.988 . . . . 65.51 109.362 -166.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.49 134.6 29.17 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.409 0 N-CA-C 113.761 1.023 . . . . 71.41 113.761 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.46 -26.36 11.47 Favored 'General case' 0 CA--C 1.562 1.407 0 N-CA-C 110.092 -0.336 . . . . 70.0 110.092 172.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.8 pttm -153.92 153.82 32.72 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.528 0.731 . . . . 70.15 110.121 168.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -139.52 105.47 5.19 Favored 'General case' 0 C--N 1.356 0.873 0 N-CA-C 108.13 -1.063 . . . . 63.2 108.13 175.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -112.45 144.5 41.8 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 118.864 -1.135 . . . . 71.43 114.054 -176.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 69.4 t -97.09 113.93 32.75 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 N-CA-C 108.837 -0.801 . . . . 62.21 108.837 175.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -115.28 131.37 56.95 Favored 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 107.948 -1.13 . . . . 71.3 107.948 175.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.44 141.52 51.38 Favored 'General case' 0 CA--C 1.564 1.492 0 CA-C-N 121.8 2.091 . . . . 73.22 108.354 -170.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.585 HG23 ' H ' ' A' ' 44' ' ' SER . 6.4 t -100.81 173.51 6.48 Favored 'General case' 0 CA--C 1.565 1.539 0 CA-C-N 120.853 1.66 . . . . 71.42 111.977 -178.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.9 t -75.74 -9.3 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.305 0 C-N-CA 123.749 0.819 . . . . 73.3 112.377 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.585 ' H ' HG23 ' A' ' 42' ' ' THR . 0.8 OUTLIER -89.19 7.66 34.14 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 121.705 -0.622 . . . . 44.05 110.499 -175.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.54 -5.09 75.47 Favored Glycine 0 C--N 1.347 1.178 0 N-CA-C 115.436 0.934 . . . . 62.12 115.436 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.09 131.95 34.75 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 118.022 0.911 . . . . 75.01 110.031 176.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -105.63 146.26 29.93 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 109.393 -0.595 . . . . 62.13 109.393 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -129.3 148.75 51.25 Favored 'General case' 0 C--N 1.347 0.496 0 N-CA-C 108.942 -0.762 . . . . 73.13 108.942 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -121.29 135.57 55.09 Favored 'General case' 0 C--O 1.247 0.964 0 C-N-CA 119.855 -0.738 . . . . 61.23 110.257 168.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -108.92 122.15 46.62 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 114.048 -1.433 . . . . 71.34 108.229 -172.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.547 HD12 ' HB ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -126.92 108.6 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 C-N-CA 118.953 -1.099 . . . . 73.33 109.975 -165.071 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -89.27 103.99 16.57 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 120.508 -0.477 . . . . 74.54 110.905 -171.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -113.22 142.33 45.93 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 113.645 0.98 . . . . 74.33 113.645 -172.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -82.81 -34.5 26.94 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.742 -0.783 . . . . 72.12 112.565 172.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -117.75 120.25 37.38 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 108.991 -0.744 . . . . 62.33 108.991 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.528 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -77.87 -38.37 46.15 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 115.425 1.639 . . . . 73.04 115.425 167.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -60.21 -40.11 88.97 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 113.593 0.96 . . . . 73.21 113.593 -168.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -69.53 -49.18 56.87 Favored 'General case' 0 CA--C 1.582 2.18 0 N-CA-C 114.835 1.42 . . . . 71.14 114.835 169.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.514 ' HA ' ' HB3' ' A' ' 31' ' ' TYR . . . -52.76 -21.63 4.35 Favored 'General case' 0 CA--C 1.587 2.37 0 N-CA-C 115.541 1.682 . . . . 33.23 115.541 172.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.482 ' O ' ' HG3' ' A' ' 64' ' ' LYS . . . -47.01 -34.61 5.81 Favored 'General case' 0 CA--C 1.561 1.383 0 CA-C-O 116.269 -1.824 . . . . 32.05 114.565 173.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.426 ' O ' ' HB3' ' A' ' 65' ' ' GLU . 29.3 m-20 -52.5 -53.89 39.87 Favored 'General case' 0 N--CA 1.51 2.539 0 CA-C-N 121.517 1.962 . . . . 51.1 111.835 168.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.08 -43.54 95.11 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 118.504 0.593 . . . . 71.43 111.809 178.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.576 HD12 HG13 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -67.37 -39.61 83.06 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.415 0 C-N-CA 118.748 -1.181 . . . . 72.34 113.458 -174.454 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.492 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -65.92 -32.58 74.16 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.813 1.042 . . . . 75.02 113.813 167.492 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.426 ' HB3' ' O ' ' A' ' 61' ' ' ASP . 0.6 OUTLIER -76.95 -17.1 59.12 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.059 0.391 . . . . 73.53 111.196 -176.19 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt -109.78 12.01 24.18 Favored 'General case' 0 CA--C 1.577 1.984 0 CA-C-O 119.742 -0.171 . . . . 73.11 111.056 169.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.492 ' HB3' ' HA ' ' A' ' 64' ' ' LYS 0.373 0.0 OUTLIER -78.45 159.63 28.16 Favored 'General case' 0 N--CA 1.506 2.344 0 C-N-CA 123.664 0.786 . . . . 64.52 112.406 -176.028 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.55 29.55 2.24 Favored Glycine 0 N--CA 1.439 -1.166 0 CA-C-O 117.819 -1.545 . . . . 61.33 114.406 -161.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.81 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 18.2 t -49.63 126.16 13.03 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-N 118.314 1.057 . . . . 74.51 112.125 -175.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.53 145.47 47.08 Favored 'General case' 0 C--O 1.251 1.172 0 CA-C-N 113.208 -1.814 . . . . 72.42 112.464 -172.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -147.8 147.36 29.75 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 105.947 -1.872 . . . . 74.24 105.947 -168.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 72.35 63.03 0.12 Allowed 'General case' 0 N--CA 1.483 1.175 0 CA-C-O 122.347 1.07 . . . . 62.4 112.995 176.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 97.5 -13.92 63.77 Favored Glycine 0 N--CA 1.471 0.998 0 N-CA-C 116.632 1.413 . . . . 70.02 116.632 172.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -113.23 121.19 43.72 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 105.1 -2.185 . . . . 64.41 105.1 156.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.49 102.8 14.65 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 117.438 -1.268 . . . . 73.15 109.826 -173.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.81 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -162.94 72.53 0.32 Allowed 'General case' 0 N--CA 1.512 2.672 0 CA-C-N 121.328 1.876 . . . . 74.42 115.668 178.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.511 ' HG3' ' H ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -96.6 118.03 32.23 Favored 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 123.769 2.986 . . . . 63.54 111.702 -175.319 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.526 HG13 HG12 ' A' ' 12' ' ' VAL . 41.0 t -131.78 119.4 41.6 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.772 0 O-C-N 120.189 -1.569 . . . . 74.23 108.056 172.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -146.99 134.57 20.96 Favored 'General case' 0 C--N 1.384 2.107 0 CA-C-N 121.088 1.767 . . . . 74.01 112.841 -172.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.576 HG13 HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -93.12 126.54 50.62 Favored Pre-proline 0 N--CA 1.45 -0.467 0 CA-C-N 114.197 -1.365 . . . . 72.35 112.095 169.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -85.85 25.5 0.69 Allowed 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 122.147 1.898 . . . . 72.2 111.842 165.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.528 ' CD2' ' HB2' ' A' ' 56' ' ' ALA . 9.2 m-85 -110.95 -28.13 8.48 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 115.595 -0.73 . . . . 75.3 110.161 176.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 O-C-N 124.75 1.281 . . . . 74.11 112.145 -172.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.546 0.821 0 N-CA-C 109.649 -0.5 . . . . 74.35 109.649 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.565 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -140.49 159.84 41.3 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 118.633 -0.698 . . . . 71.33 112.322 -178.783 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.708 HG12 HG12 ' A' ' 80' ' ' VAL . 4.5 mt -114.04 138.73 42.93 Favored 'Isoleucine or valine' 0 C--O 1.264 1.855 0 CA-C-N 119.927 1.24 . . . . 53.42 107.725 170.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -102.79 114.53 28.86 Favored 'General case' 0 CA--C 1.561 1.401 0 O-C-N 125.903 2.002 . . . . 64.3 109.399 172.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.419 HG23 HG22 ' A' ' 78' ' ' VAL . 2.1 p -125.58 106.04 15.62 Favored 'Isoleucine or valine' 0 C--N 1.37 1.475 0 CA-C-N 120.62 1.555 . . . . 73.0 109.322 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -115.31 168.32 12.57 Favored Glycine 0 C--N 1.354 1.549 0 C-N-CA 120.687 -0.768 . . . . 64.11 112.274 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.0 m120 50.79 24.92 1.91 Allowed 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 114.617 1.34 . . . . 64.04 114.617 -177.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.422 HD23 ' H ' ' A' ' 15' ' ' LEU . 1.9 pt? -75.69 136.2 70.96 Favored Pre-proline 0 C--O 1.239 0.522 0 C-N-CA 123.335 0.654 . . . . 61.24 110.709 178.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -73.71 126.35 10.71 Favored 'Trans proline' 0 CA--C 1.553 1.468 0 C-N-CA 121.422 1.414 . . . . 71.11 111.685 175.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.5 t 60.33 100.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.005 0.922 . . . . 51.3 111.129 -174.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 -64.79 132.9 50.79 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.086 -0.506 . . . . 72.42 111.789 -177.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.7 m -66.02 121.43 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.895 0 CA-C-N 114.557 -1.201 . . . . 61.31 109.614 -176.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.84 154.06 28.66 Favored 'General case' 0 C--N 1.377 1.768 0 CA-C-N 119.212 0.914 . . . . 64.4 110.576 -176.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.9 p -47.18 -48.09 23.88 Favored 'General case' 0 C--N 1.375 1.699 0 N-CA-C 116.036 1.865 . . . . 72.14 116.036 -174.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.19 -46.46 75.84 Favored 'General case' 0 C--O 1.285 2.93 0 N-CA-C 114.41 1.263 . . . . 52.24 114.41 175.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -64.34 -35.45 80.9 Favored 'General case' 0 C--N 1.372 1.545 0 CA-C-O 118.002 -0.999 . . . . 74.22 110.142 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.528 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 1.2 t -66.82 -44.43 89.11 Favored 'Isoleucine or valine' 0 C--N 1.385 2.139 0 CA-C-O 116.552 -1.689 . . . . 72.11 110.722 174.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.01 -56.15 24.17 Favored 'General case' 0 C--N 1.373 1.602 0 CA-C-N 120.641 1.564 . . . . 72.35 110.747 177.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.55 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 12.9 m-80 -81.33 -57.01 3.68 Favored 'General case' 0 C--O 1.294 3.418 0 CA-C-N 122.156 2.253 . . . . 74.44 116.364 -176.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -68.36 -26.99 65.86 Favored 'General case' 0 C--N 1.354 0.777 0 C-N-CA 119.566 -0.854 . . . . 54.42 111.218 -175.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.528 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 35.7 m-85 -90.98 -22.55 20.77 Favored 'General case' 0 CA--C 1.565 1.544 0 C-N-CA 118.337 -1.345 . . . . 73.41 114.222 173.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.55 ' HG3' ' O ' ' A' ' 26' ' ' ASN 0.259 2.5 ppt_? -54.27 -28.34 41.12 Favored 'General case' 0 N--CA 1.503 2.218 0 CA-C-N 120.161 1.346 . . . . 72.01 112.285 163.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.566 ' O ' ' HD2' ' A' ' 30' ' ' LYS 0.257 1.7 tptm -52.03 -28.63 17.88 Favored 'General case' 0 N--CA 1.518 2.946 0 C-N-CA 118.445 -1.302 . . . . 64.25 113.742 168.433 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -80.22 -44.17 20.18 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 120.023 1.283 . . . . 63.0 111.488 -166.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -169.24 44.28 0.21 Allowed Glycine 0 C--N 1.341 0.859 0 C-N-CA 117.712 -2.185 . . . . 72.01 114.45 162.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 60.38 87.33 0.09 Allowed 'General case' 0 C--N 1.359 1.005 0 C-N-CA 123.983 0.913 . . . . 53.02 109.9 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.467 HG22 ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -67.36 138.45 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-N 114.976 -1.011 . . . . 70.43 112.471 -178.325 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.419 ' H ' HD22 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -103.31 -26.49 12.92 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 109.63 -0.507 . . . . 72.15 109.63 173.115 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp -149.66 137.36 20.17 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-O 118.826 -0.606 . . . . 64.22 109.889 -173.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -140.84 110.06 6.22 Favored 'General case' 0 C--N 1.364 1.226 0 CA-C-N 119.564 1.075 . . . . 71.14 109.268 176.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -109.13 146.59 33.84 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 117.762 -1.575 . . . . 73.33 112.847 177.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.8 t -114.27 110.6 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 106.317 -1.735 . . . . 74.52 106.317 176.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.0 mttm -121.45 137.25 54.8 Favored 'General case' 0 CA--C 1.563 1.446 0 CA-C-O 118.909 -0.567 . . . . 64.12 110.301 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.97 143.92 50.9 Favored 'General case' 0 C--N 1.371 1.516 0 CA-C-N 120.437 1.471 . . . . 64.1 108.122 -168.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.632 HG23 ' H ' ' A' ' 44' ' ' SER . 6.4 t -99.98 172.1 7.43 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-N 120.683 1.583 . . . . 71.22 110.941 -178.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.8 t -75.37 -9.95 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.208 0 C-N-CA 123.502 0.721 . . . . 64.04 112.077 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.632 ' H ' HG23 ' A' ' 42' ' ' THR . 0.8 OUTLIER -89.27 7.57 34.85 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 121.735 -0.603 . . . . 74.03 110.24 -177.307 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.73 -4.63 78.43 Favored Glycine 0 CA--C 1.537 1.417 0 N-CA-C 115.952 1.141 . . . . 61.34 115.952 178.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.94 131.79 33.99 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 118.429 1.115 . . . . 61.33 109.903 176.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.93 146.89 28.4 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 108.606 -0.887 . . . . 61.41 108.606 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -127.49 146.84 50.36 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 119.211 -0.995 . . . . 70.23 108.555 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.417 ' HB3' HG13 ' A' ' 12' ' ' VAL . . . -121.4 139.08 53.91 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 119.486 -0.886 . . . . 51.23 110.295 172.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -125.28 117.14 23.15 Favored 'General case' 0 C--O 1.263 1.803 0 N-CA-C 106.864 -1.532 . . . . 72.55 106.864 -167.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.33 113.12 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 114.351 1.241 . . . . 74.05 114.351 -163.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -90.21 108.81 19.98 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 115.002 -0.999 . . . . 70.4 112.604 -171.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -108.51 155.61 20.43 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 112.145 0.424 . . . . 73.21 112.145 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -81.72 -26.36 34.66 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 113.809 1.04 . . . . 70.12 113.809 173.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.48 120.89 39.49 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 119.208 0.913 . . . . 42.3 110.328 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.91 -35.87 59.64 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 114.773 1.397 . . . . 71.42 114.773 172.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.27 0.0 OUTLIER -80.71 -30.0 36.38 Favored 'General case' 0 CA--C 1.564 1.5 0 CA-C-N 120.828 1.649 . . . . 70.5 113.435 -167.144 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -62.21 -50.57 71.27 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-N 118.85 0.75 . . . . 74.34 112.521 175.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.0 -25.53 21.53 Favored 'General case' 0 CA--C 1.57 1.712 0 N-CA-C 116.369 1.989 . . . . 64.4 116.369 177.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.73 -43.05 57.9 Favored 'General case' 0 CA--C 1.581 2.171 0 C-N-CA 125.482 1.513 . . . . 44.11 114.231 178.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -53.54 -48.14 69.34 Favored 'General case' 0 N--CA 1.518 2.944 0 CA-C-N 119.654 1.116 . . . . 75.32 113.771 169.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.635 ' O ' ' HD2' ' A' ' 66' ' ' LYS . . . -72.19 -32.91 67.25 Favored 'General case' 0 C--N 1.31 -1.131 0 O-C-N 120.786 -1.197 . . . . 60.02 111.777 179.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.722 HD12 HG13 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -73.33 -41.04 57.51 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.053 0 CA-C-O 117.247 -1.358 . . . . 73.35 112.141 -177.264 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.48 -34.0 70.41 Favored 'General case' 0 CA--C 1.557 1.219 0 CA-C-N 120.505 1.502 . . . . 71.24 114.285 161.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.54 -23.89 66.98 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 120.816 1.644 . . . . 64.45 112.773 175.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.635 ' HD2' ' O ' ' A' ' 62' ' ' ALA 0.283 0.0 OUTLIER -110.48 16.89 21.29 Favored 'General case' 0 N--CA 1.514 2.738 0 N-CA-C 117.1 2.259 . . . . 61.24 117.1 160.64 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.418 0.0 OUTLIER -79.72 160.03 26.41 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 120.016 1.28 . . . . 71.15 113.945 -176.381 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.14 29.33 2.38 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 119.095 -1.526 . . . . 32.51 114.593 -158.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.791 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -53.06 125.95 19.01 Favored 'General case' 0 C--N 1.37 1.472 0 CA-C-N 117.268 0.534 . . . . 53.15 111.19 -178.195 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -131.23 150.76 52.01 Favored 'General case' 0 C--O 1.259 1.6 0 CA-C-N 115.63 -0.713 . . . . 70.23 112.018 -174.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -147.59 146.66 29.47 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 127.872 2.469 . . . . 70.33 107.508 -168.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 73.22 62.54 0.1 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.975 0.893 . . . . 42.11 112.844 -176.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.44 -13.19 61.5 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 117.157 1.623 . . . . 51.15 117.157 169.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -112.79 122.23 47.04 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 106.947 -1.501 . . . . 55.45 106.947 154.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.93 103.52 15.39 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 117.719 -1.134 . . . . 60.25 109.433 -175.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.791 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 14.3 tp -165.92 66.97 0.11 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 120.651 1.569 . . . . 54.33 112.485 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -96.54 110.83 23.15 Favored 'General case' 0 CA--C 1.569 1.704 0 CA-C-N 122.584 2.447 . . . . 74.25 109.733 -173.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.518 ' H ' ' HB3' ' A' ' 69' ' ' CYS . 22.6 t -123.48 115.54 45.69 Favored 'Isoleucine or valine' 0 C--N 1.358 0.967 0 O-C-N 120.577 -1.327 . . . . 74.34 107.806 170.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -138.7 143.12 38.98 Favored 'General case' 0 C--O 1.254 1.298 0 CA-C-N 120.574 1.533 . . . . 53.21 111.317 176.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.722 HG13 HD12 ' A' ' 63' ' ' ILE . 8.8 m -88.01 122.28 70.12 Favored Pre-proline 0 N--CA 1.437 -1.11 0 CA-C-N 114.622 -1.172 . . . . 72.44 111.412 168.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.565 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 61.2 Cg_endo -91.76 32.98 0.29 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.67 2.247 . . . . 63.22 111.447 159.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.3 10.62 5.33 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 112.58 0.585 . . . . 71.1 112.58 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 t30 . . . . . 0 N--CA 1.493 1.719 0 O-C-N 123.174 0.296 . . . . 61.53 111.427 -167.69 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 p . . . . . 0 CA--C 1.54 0.594 0 N-CA-C 109.723 -0.473 . . . . 60.32 109.723 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.439 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 3.2 ptt180 -124.99 151.29 45.74 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 120.251 -0.58 . . . . 63.43 111.716 -170.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.683 HD12 ' HB ' ' A' ' 51' ' ' ILE . 7.7 mt -116.94 137.17 51.71 Favored 'Isoleucine or valine' 0 C--O 1.259 1.569 0 CA-C-N 120.041 1.291 . . . . 74.3 108.855 -175.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -106.05 113.71 27.41 Favored 'General case' 0 CA--C 1.574 1.876 0 O-C-N 125.903 2.002 . . . . 73.32 110.359 176.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.666 HG23 HG22 ' A' ' 78' ' ' VAL . 1.1 p -125.87 103.89 12.37 Favored 'Isoleucine or valine' 0 C--N 1.375 1.674 0 CA-C-N 120.194 1.361 . . . . 61.11 108.949 177.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -118.26 175.01 15.53 Favored Glycine 0 C--N 1.353 1.478 0 C-N-CA 120.652 -0.785 . . . . 75.43 113.354 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 51.34 29.11 4.8 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 115.697 1.74 . . . . 70.3 115.697 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.429 HD11 ' H ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -87.26 150.86 50.29 Favored Pre-proline 0 CA--C 1.555 1.15 0 CA-C-N 119.27 0.941 . . . . 55.23 110.406 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -82.94 128.86 5.23 Favored 'Trans proline' 0 CA--C 1.567 2.149 0 C-N-CA 120.8 1.0 . . . . 43.24 112.487 177.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.5 p 113.6 -29.16 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.631 0 C-N-CA 128.736 2.814 . . . . 62.41 111.045 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 68.17 105.28 0.05 Allowed 'General case' 0 C--N 1.358 0.949 0 C-N-CA 124.859 1.264 . . . . 72.23 110.285 -167.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.52 HG21 HG13 ' A' ' 24' ' ' VAL . 7.4 p -76.6 118.32 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.292 0 CA-C-N 114.874 -1.057 . . . . 62.54 108.936 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.9 m -82.23 160.0 23.09 Favored 'General case' 0 CA--C 1.559 1.303 0 CA-C-O 117.744 -1.122 . . . . 55.25 108.449 178.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.453 ' O ' ' HB3' ' A' ' 25' ' ' GLU . 5.6 p -50.64 -39.77 51.37 Favored 'General case' 0 C--N 1.378 1.834 0 N-CA-C 115.3 1.592 . . . . 73.53 115.3 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.34 -33.08 73.03 Favored 'General case' 0 CA--C 1.576 1.963 0 N-CA-C 115.51 1.67 . . . . 71.34 115.51 177.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -68.34 -54.11 19.57 Favored 'General case' 0 C--O 1.283 2.844 0 CA-C-N 119.719 1.145 . . . . 75.41 111.295 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.52 HG13 HG21 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -57.7 -54.04 36.82 Favored 'Isoleucine or valine' 0 C--N 1.368 1.398 0 O-C-N 124.573 1.17 . . . . 43.31 111.389 176.668 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.453 ' HB3' ' O ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -49.36 -46.79 47.57 Favored 'General case' 0 CA--C 1.566 1.559 0 CA-C-O 116.931 -1.509 . . . . 74.31 114.836 170.205 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -71.39 -55.58 7.68 Favored 'General case' 0 C--O 1.295 3.481 0 CA-C-N 122.525 2.42 . . . . 70.42 112.634 -177.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -57.77 -38.82 76.1 Favored 'General case' 0 C--N 1.396 2.598 0 CA-C-O 118.965 -0.541 . . . . 42.44 111.551 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -83.54 -35.61 24.66 Favored 'General case' 0 C--N 1.359 1.008 0 C-N-CA 118.564 -1.255 . . . . 73.45 113.277 -178.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.421 ' HB3' ' O ' ' A' ' 25' ' ' GLU . 20.4 ptt85 -52.27 -36.62 53.22 Favored 'General case' 0 N--CA 1.507 2.409 0 CA-C-O 117.923 -1.037 . . . . 71.22 112.099 171.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.476 ' HE2' ' CG ' ' A' ' 31' ' ' TYR 0.289 0.0 OUTLIER -71.92 -30.84 65.77 Favored 'General case' 0 C--N 1.374 1.653 0 C-N-CA 116.311 -2.156 . . . . 62.44 112.71 -173.322 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.494 ' CB ' ' HA ' ' A' ' 59' ' ' ALA . 54.4 m-85 -82.75 -46.27 13.35 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 112.169 0.433 . . . . 74.1 112.169 177.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -150.14 143.76 11.1 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 118.671 0.669 . . . . 45.2 112.217 169.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -63.18 117.96 7.28 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 113.331 0.863 . . . . 72.2 113.331 -166.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.44 140.98 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-N 115.539 -0.755 . . . . 73.31 111.525 174.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.0 mp -103.8 -24.35 13.32 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 119.538 -0.865 . . . . 71.22 112.91 170.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.33 135.4 12.98 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 108.632 -0.877 . . . . 73.03 108.632 -175.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 41.8 t -145.96 115.2 7.07 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 120.125 1.33 . . . . 71.43 110.396 174.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.09 150.2 50.58 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 119.56 -0.856 . . . . 45.35 111.947 -176.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -116.07 116.72 53.21 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.53 0 CA-C-O 121.45 0.643 . . . . 73.22 110.578 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.0 mttp -108.53 141.99 39.61 Favored 'General case' 0 CA--C 1.565 1.531 0 C-N-CA 125.698 1.599 . . . . 70.44 107.762 -170.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.79 142.65 50.65 Favored 'General case' 0 CA--C 1.57 1.729 0 CA-C-N 122.329 2.331 . . . . 75.24 109.567 -177.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.613 HG23 ' H ' ' A' ' 44' ' ' SER . 5.0 t -100.59 176.88 5.18 Favored 'General case' 0 CA--C 1.568 1.64 0 CA-C-N 120.957 1.708 . . . . 64.22 111.572 176.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.4 t -77.33 -9.5 12.55 Favored 'Isoleucine or valine' 0 C--N 1.373 1.623 0 C-N-CA 123.834 0.854 . . . . 64.43 112.698 -176.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.613 ' H ' HG23 ' A' ' 42' ' ' THR . 8.9 t -90.72 2.62 55.83 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 121.584 -0.698 . . . . 60.34 111.03 -173.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.18 -7.26 68.02 Favored Glycine 0 CA--C 1.537 1.414 0 N-CA-C 115.184 0.834 . . . . 71.44 115.184 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.35 132.5 37.43 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 117.886 0.843 . . . . 74.44 108.89 167.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.75 145.55 43.42 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.743 -0.836 . . . . 74.35 108.743 -173.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -128.57 150.3 50.26 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.836 0.743 . . . . 74.33 110.693 -168.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -129.5 146.81 51.29 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.394 0.616 . . . . 74.3 112.045 175.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -132.9 114.09 13.63 Favored 'General case' 0 C--O 1.263 1.764 0 N-CA-C 106.442 -1.688 . . . . 71.33 106.442 -158.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.683 ' HB ' HD12 ' A' ' 10' ' ' ILE . 0.3 OUTLIER -124.29 110.52 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.662 0 C-N-CA 118.493 -1.283 . . . . 43.55 109.491 -173.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -109.74 103.09 11.86 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.464 -1.244 . . . . 31.22 110.158 -174.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.615 ' CE2' ' HB3' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -111.43 161.44 16.12 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 115.306 -0.861 . . . . 63.33 113.241 -174.502 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.14 -42.0 69.75 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 112.281 0.474 . . . . 71.1 112.281 173.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -113.17 114.8 27.29 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 118.54 -1.264 . . . . 74.43 109.901 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.97 -21.8 56.58 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 115.902 1.816 . . . . 61.53 115.902 169.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.293 10.6 ptm180 -75.69 -40.96 54.95 Favored 'General case' 0 CA--C 1.567 1.601 0 CA-C-N 120.402 1.455 . . . . 74.34 114.364 -172.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -77.68 -36.33 51.35 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 117.064 2.246 . . . . 53.13 117.064 177.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.615 ' HB3' ' CE2' ' A' ' 53' ' ' PHE 0.303 . . -75.27 -14.6 60.52 Favored 'General case' 0 CA--C 1.584 2.252 0 CA-C-N 120.564 1.529 . . . . 32.0 112.266 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -44.88 -35.74 2.96 Favored 'General case' 0 CA--C 1.583 2.239 0 CA-C-N 114.159 -1.382 . . . . 51.45 114.24 161.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.471 ' O ' ' HB3' ' A' ' 65' ' ' GLU . 46.3 m-20 -52.98 -54.75 30.46 Favored 'General case' 0 N--CA 1.507 2.384 0 CA-C-N 120.822 1.646 . . . . 54.32 113.311 164.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.406 ' O ' ' HG2' ' A' ' 66' ' ' LYS . . . -57.09 -35.78 69.81 Favored 'General case' 0 N--CA 1.507 2.385 0 CA-C-N 119.533 1.06 . . . . 61.42 113.816 171.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.456 HD12 HG13 ' A' ' 80' ' ' VAL 0.251 0.2 OUTLIER -73.53 -45.33 51.8 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.419 0 C-N-CA 119.157 -1.017 . . . . 13.43 113.443 -177.437 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.486 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -56.6 -30.46 63.25 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 120.319 1.418 . . . . 73.54 114.495 162.403 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.471 ' HB3' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -79.7 -20.46 46.47 Favored 'General case' 0 CA--C 1.55 0.967 0 O-C-N 120.825 -1.172 . . . . 72.21 111.84 -178.133 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 62' ' ' ALA . 60.7 mmtt -98.35 9.54 42.82 Favored 'General case' 0 CA--C 1.598 2.804 0 CA-C-O 118.697 -0.668 . . . . 64.41 112.533 163.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.486 ' HB3' ' HA ' ' A' ' 64' ' ' LYS 0.408 0.0 OUTLIER -79.79 160.54 26.12 Favored 'General case' 0 N--CA 1.516 2.858 0 CA-C-N 120.475 1.489 . . . . 71.21 114.619 -173.165 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.83 30.64 2.11 Favored Glycine 0 N--CA 1.439 -1.116 0 C-N-CA 118.529 -1.796 . . . . 74.22 115.466 -164.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.732 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -51.09 124.67 11.97 Favored 'General case' 0 C--N 1.372 1.577 0 O-C-N 124.65 0.853 . . . . 65.24 112.391 -173.791 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -133.4 150.73 51.79 Favored 'General case' 0 C--O 1.255 1.377 0 CA-C-N 115.574 -0.739 . . . . 51.32 112.311 -176.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -147.77 145.67 28.89 Favored 'General case' 0 C--N 1.354 0.795 0 C-N-CA 127.305 2.242 . . . . 75.34 106.574 -169.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 74.01 63.44 0.08 Allowed 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 113.17 0.804 . . . . 75.54 113.17 -175.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.32 -12.95 63.37 Favored Glycine 0 N--CA 1.472 1.057 0 N-CA-C 116.757 1.463 . . . . 73.21 116.757 168.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -113.43 121.28 43.84 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 106.309 -1.738 . . . . 64.51 106.309 152.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.28 104.05 15.93 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 117.431 -1.271 . . . . 74.32 109.454 -176.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.732 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -168.63 69.82 0.08 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 120.422 1.464 . . . . 71.24 112.273 179.347 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -95.77 108.83 21.19 Favored 'General case' 0 C--N 1.369 1.448 0 CA-C-N 122.443 2.383 . . . . 73.32 109.375 -171.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.666 HG22 HG23 ' A' ' 12' ' ' VAL . 50.1 t -127.77 118.39 48.88 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.888 0 O-C-N 120.828 -1.17 . . . . 61.42 109.098 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -146.61 144.9 29.85 Favored 'General case' 0 C--O 1.269 2.093 0 CA-C-N 120.651 1.569 . . . . 64.13 110.512 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.456 HG13 HD12 ' A' ' 63' ' ' ILE . 29.6 m -89.4 124.45 64.4 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-N 115.447 -0.797 . . . . 45.31 111.842 166.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.439 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 66.8 Cg_endo -86.57 29.9 0.49 Allowed 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 123.023 2.482 . . . . 71.11 113.747 168.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -128.71 -27.42 2.58 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.354 0.502 . . . . 71.44 112.354 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 N--CA 1.492 1.655 0 C-N-CA 124.581 1.152 . . . . 73.42 113.286 -176.756 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.51 ' OG ' ' HB2' ' A' ' 56' ' ' ALA . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 121.157 0.503 . . . . 71.2 112.127 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.498 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 11.3 ptt180 -143.81 152.9 41.8 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 113.792 1.034 . . . . 60.43 113.792 -172.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.6 HG12 HG12 ' A' ' 80' ' ' VAL . 7.8 mt -115.31 135.35 55.56 Favored 'Isoleucine or valine' 0 C--N 1.375 1.693 0 CA-C-N 120.199 1.363 . . . . 74.35 107.995 177.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -99.56 122.04 42.05 Favored 'General case' 0 CA--C 1.572 1.796 0 O-C-N 125.43 1.706 . . . . 75.2 110.283 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.469 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 67.3 t -124.71 110.99 26.48 Favored 'Isoleucine or valine' 0 C--N 1.366 1.32 0 O-C-N 120.643 -1.286 . . . . 72.33 108.594 -178.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.33 162.97 12.42 Favored Glycine 0 C--N 1.341 0.823 0 C-N-CA 119.135 -1.507 . . . . 53.2 112.209 173.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 51.16 22.93 1.42 Allowed 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 116.379 1.992 . . . . 71.41 116.379 178.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.02 125.41 91.41 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 123.45 0.7 . . . . 63.04 111.054 169.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -91.34 123.35 0.78 Allowed 'Trans proline' 0 CA--C 1.556 1.586 0 C-N-CA 121.873 1.715 . . . . 73.22 111.495 169.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.5 m 34.75 -100.66 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 124.741 1.216 . . . . 73.32 114.03 -173.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.4 t60 53.26 -88.95 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 126.243 1.817 . . . . 72.24 112.408 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.2 m -98.18 117.03 42.4 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.863 0 C-N-CA 119.435 -0.906 . . . . 71.33 109.713 177.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.9 m -80.76 170.96 15.62 Favored 'General case' 0 C--N 1.387 2.234 0 CA-C-O 117.197 -1.383 . . . . 75.22 109.076 166.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.9 m -46.53 -49.46 18.57 Favored 'General case' 0 C--O 1.27 2.148 0 CA-C-N 120.134 1.334 . . . . 72.14 114.492 -173.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.71 -43.59 97.64 Favored 'General case' 0 CA--C 1.578 2.03 0 CA-C-N 115.271 -0.877 . . . . 62.35 113.277 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.511 10.7 m-20 -76.99 -18.94 57.88 Favored 'General case' 0 CA--C 1.559 1.309 0 CA-C-O 115.715 -2.088 . . . . 74.21 114.146 172.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.429 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 2.0 t -59.65 -44.57 93.76 Favored 'Isoleucine or valine' 0 C--N 1.424 3.83 0 CA-C-N 123.411 2.823 . . . . 71.45 108.281 163.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.48 -54.52 45.61 Favored 'General case' 0 C--N 1.376 1.731 0 CA-C-O 116.455 -1.736 . . . . 75.53 112.677 174.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -73.81 -54.39 8.11 Favored 'General case' 1 C--O 1.309 4.187 0 CA-C-N 122.369 2.349 . . . . 72.24 114.793 -174.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -58.21 -37.06 74.08 Favored 'General case' 0 C--N 1.383 2.063 0 CA-C-O 117.325 -1.322 . . . . 64.02 110.428 177.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.429 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 47.3 m-85 -84.46 -24.2 29.58 Favored 'General case' 0 C--N 1.373 1.629 0 C-N-CA 115.716 -2.393 . . . . 71.15 113.457 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.53 ' HA ' HG22 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -64.95 -30.79 71.8 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 117.286 -1.34 . . . . 74.24 114.055 175.534 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.447 ' HE2' ' CD1' ' A' ' 31' ' ' TYR 0.323 0.0 OUTLIER -72.82 -34.8 67.09 Favored 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 113.354 -3.338 . . . . 74.45 111.986 175.338 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.547 ' HB3' ' HA ' ' A' ' 59' ' ' ALA . 57.8 m-85 -76.79 -40.96 46.41 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-O 118.975 -0.536 . . . . 62.32 110.783 -169.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -140.21 165.21 26.06 Favored Glycine 0 C--N 1.341 0.812 0 CA-C-O 118.309 -1.273 . . . . 73.2 110.666 152.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -76.71 102.77 6.35 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-N 119.95 1.875 . . . . 75.22 110.45 -174.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.53 HG22 ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -71.32 136.73 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 113.824 1.046 . . . . 74.02 113.824 -176.113 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.4 mt -89.55 -49.02 6.92 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 113.266 0.839 . . . . 74.14 113.266 166.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.65 128.2 20.18 Favored 'General case' 0 CA--C 1.585 2.322 0 CA-C-N 120.077 1.308 . . . . 73.41 111.901 173.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 4.8 m -105.65 111.03 23.56 Favored 'General case' 0 C--N 1.388 2.259 0 N-CA-C 107.473 -1.306 . . . . 73.13 107.473 166.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -113.11 139.93 48.31 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 117.855 -1.538 . . . . 75.35 111.41 176.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 t -113.0 110.09 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 106.77 -1.567 . . . . 74.12 106.77 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.7 mmtt -107.08 142.4 36.8 Favored 'General case' 0 CA--C 1.556 1.181 0 CA-C-O 118.792 -0.623 . . . . 73.12 109.455 175.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.39 142.78 51.01 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 120.063 1.302 . . . . 61.05 108.384 -170.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.614 HG23 ' H ' ' A' ' 44' ' ' SER . 12.0 t -100.01 167.75 10.29 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 120.45 1.477 . . . . 55.41 111.42 -178.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.0 m -61.84 -7.5 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.746 0 N-CA-C 115.993 1.849 . . . . 72.52 115.993 175.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.614 ' H ' HG23 ' A' ' 42' ' ' THR . 8.1 t -98.05 7.57 46.11 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 119.36 0.982 . . . . 71.25 110.517 -174.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.25 -4.35 77.22 Favored Glycine 0 CA--C 1.544 1.887 0 N-CA-C 115.717 1.047 . . . . 72.31 115.717 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -83.37 134.75 34.88 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-N 117.954 0.877 . . . . 74.31 110.485 177.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.31 149.75 25.07 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.619 -0.882 . . . . 65.14 108.619 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -125.12 145.02 50.13 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 118.915 -1.114 . . . . 73.12 109.568 175.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.469 ' HB3' ' HB ' ' A' ' 12' ' ' VAL . . . -115.47 137.88 51.59 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.915 -0.402 . . . . 72.14 109.915 176.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.47 115.85 16.71 Favored 'General case' 0 C--O 1.256 1.446 0 N-CA-C 108.168 -1.049 . . . . 72.31 108.168 -173.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.498 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 0.2 OUTLIER -123.76 108.77 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 C-N-CA 118.358 -1.337 . . . . 71.43 110.827 -171.693 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 8' ' ' SER . 33.6 tt0 -102.81 108.34 19.53 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 115.147 -0.933 . . . . 70.34 110.92 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.411 ' HB3' ' HA ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -114.95 156.33 25.23 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 118.748 -0.644 . . . . 55.45 112.673 -179.151 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -59.29 -32.44 70.04 Favored 'General case' 0 N--CA 1.516 2.834 0 N-CA-C 112.937 0.717 . . . . 73.15 112.937 166.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -115.41 113.0 23.16 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 119.151 -1.02 . . . . 73.42 109.966 -177.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.514 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -77.33 -41.39 40.71 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 116.084 1.883 . . . . 71.51 116.084 170.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.26 6.5 ptt180 -75.78 -33.33 60.17 Favored 'General case' 0 CA--C 1.573 1.864 0 N-CA-C 114.516 1.302 . . . . 65.22 114.516 -168.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.43 -44.97 73.79 Favored 'General case' 0 N--CA 1.518 2.934 0 CA-C-N 120.737 1.608 . . . . 74.14 114.034 173.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.547 ' HA ' ' HB3' ' A' ' 31' ' ' TYR . . . -50.02 -21.08 1.11 Allowed 'General case' 0 CA--C 1.598 2.821 0 N-CA-C 117.281 2.326 . . . . 73.02 117.281 171.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.409 ' O ' ' HG3' ' A' ' 64' ' ' LYS . . . -49.14 -34.15 13.61 Favored 'General case' 0 CA--C 1.585 2.319 0 CA-C-O 117.645 -1.169 . . . . 74.33 113.797 167.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.411 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 2.6 m-20 -52.39 -45.06 65.68 Favored 'General case' 0 C--N 1.394 2.519 0 CA-C-N 120.171 1.35 . . . . 74.24 113.789 165.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.503 ' O ' ' HD2' ' A' ' 66' ' ' LYS . . . -60.48 -54.02 50.49 Favored 'General case' 0 C--O 1.258 1.53 0 O-C-N 121.907 -0.496 . . . . 70.02 111.212 172.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.868 HD12 HG13 ' A' ' 80' ' ' VAL 0.262 0.4 OUTLIER -62.5 -41.22 91.09 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 C-N-CA 117.465 -1.694 . . . . 64.14 113.786 -173.948 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.447 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -62.06 -34.85 77.04 Favored 'General case' 0 CA--C 1.557 1.215 0 N-CA-C 115.588 1.699 . . . . 74.43 115.588 167.854 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 62' ' ' ALA . 0.2 OUTLIER -65.64 -34.83 79.13 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 121.168 1.804 . . . . 73.41 111.268 176.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.503 ' HD2' ' O ' ' A' ' 62' ' ' ALA 0.258 0.0 OUTLIER -103.07 18.42 21.73 Favored 'General case' 0 CA--C 1.575 1.921 0 C-N-CA 118.432 -1.307 . . . . 63.41 114.149 173.946 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.447 ' HB3' ' HA ' ' A' ' 64' ' ' LYS 0.323 0.5 OUTLIER -71.37 162.79 28.86 Favored 'General case' 0 N--CA 1.508 2.435 0 CA-C-N 118.975 0.807 . . . . 61.24 112.88 -174.857 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 120.44 31.99 1.19 Allowed Glycine 0 N--CA 1.438 -1.218 0 C-N-CA 119.024 -1.56 . . . . 63.35 115.533 -162.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.773 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -51.51 125.09 13.62 Favored 'General case' 0 C--N 1.375 1.704 0 CA-C-N 118.1 0.95 . . . . 74.4 111.768 176.444 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -133.66 149.36 51.56 Favored 'General case' 0 C--O 1.255 1.363 0 CA-C-N 114.766 -1.106 . . . . 73.23 111.482 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -148.25 144.66 27.8 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 126.225 1.81 . . . . 71.51 106.746 -166.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 68.89 65.98 0.29 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 124.244 0.965 . . . . 70.42 113.162 177.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.9 -12.34 60.81 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 116.86 1.504 . . . . 71.43 116.86 173.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -118.85 121.9 41.09 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 105.929 -1.878 . . . . 73.31 105.929 154.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.97 102.52 14.61 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 117.553 -1.213 . . . . 74.41 109.874 -172.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.773 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -169.2 58.64 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 CA-C-N 120.572 1.533 . . . . 73.14 114.419 -175.14 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.1 tpp85 -90.99 112.25 24.06 Favored 'General case' 0 CA--C 1.571 1.767 0 CA-C-N 122.258 2.299 . . . . 64.45 109.945 -170.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.502 ' H ' ' HB3' ' A' ' 69' ' ' CYS . 0.9 OUTLIER -119.78 121.69 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 O-C-N 120.325 -1.484 . . . . 73.12 108.678 173.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -146.58 132.5 19.13 Favored 'General case' 0 C--N 1.361 1.091 0 CA-C-N 119.75 1.159 . . . . 61.03 110.791 -165.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.868 HG13 HD12 ' A' ' 63' ' ' ILE . 7.8 m -89.62 124.56 63.78 Favored Pre-proline 0 C--N 1.349 0.559 0 C-N-CA 119.817 -0.753 . . . . 73.34 111.569 167.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.436 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 87.8 Cg_endo -89.91 17.17 1.58 Allowed 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 122.48 2.12 . . . . 72.34 113.625 166.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.514 ' CE1' ' HB1' ' A' ' 56' ' ' ALA . 5.6 p90 -110.74 -32.01 7.0 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.039 0.385 . . . . 61.03 112.039 175.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.0 t30 . . . . . 0 N--CA 1.501 2.096 0 C-N-CA 124.574 1.15 . . . . 73.33 110.692 -176.938 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.439 -0.994 0 N-CA-C 108.115 -1.068 . . . . 74.31 108.115 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.523 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 0.2 OUTLIER -118.83 153.27 34.77 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 121.305 -0.872 . . . . 71.23 109.036 -177.407 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.5 mp -138.16 134.92 44.78 Favored 'Isoleucine or valine' 0 C--O 1.264 1.82 0 CA-C-N 119.811 1.187 . . . . 70.42 108.269 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -105.33 114.95 29.44 Favored 'General case' 0 CA--C 1.571 1.751 0 O-C-N 125.664 1.852 . . . . 65.32 110.407 177.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.575 HG23 HG22 ' A' ' 78' ' ' VAL . 2.0 p -123.84 104.41 14.07 Favored 'Isoleucine or valine' 0 C--N 1.369 1.432 0 CA-C-N 120.333 1.424 . . . . 75.23 108.079 178.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.446 ' H ' ' HG3' ' A' ' 77' ' ' ARG . . . -121.33 177.24 16.41 Favored Glycine 0 C--N 1.346 1.134 0 C-N-CA 120.362 -0.923 . . . . 21.54 112.722 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.6 m120 50.72 24.34 1.67 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 114.792 1.405 . . . . 62.14 114.792 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.635 HD23 ' H ' ' A' ' 15' ' ' LEU . 1.7 pt? -79.71 123.54 83.94 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 123.812 0.845 . . . . 70.1 110.6 -178.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -89.51 120.11 0.95 Allowed 'Trans proline' 0 CA--C 1.559 1.729 0 C-N-CA 121.053 1.168 . . . . 73.11 112.186 172.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.7 m 39.05 43.42 0.8 Allowed 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 124.989 1.316 . . . . 42.2 114.034 178.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.425 ' HB3' HD12 ' A' ' 15' ' ' LEU . 5.2 t-160 -95.11 -93.37 0.19 Allowed 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 119.418 -0.325 . . . . 74.54 110.64 -166.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.7 m -103.23 119.16 51.33 Favored 'Isoleucine or valine' 0 CA--C 1.596 2.745 0 CA-C-N 118.627 0.649 . . . . 75.44 109.943 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.75 155.17 25.62 Favored 'General case' 0 C--N 1.392 2.429 0 CA-C-N 120.888 1.676 . . . . 43.33 110.155 171.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.0 t -48.12 -48.8 33.76 Favored 'General case' 0 C--N 1.371 1.53 0 N-CA-C 115.477 1.658 . . . . 64.21 115.477 -173.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.94 -43.46 86.36 Favored 'General case' 0 CA--C 1.582 2.208 0 N-CA-C 114.206 1.187 . . . . 73.31 114.206 176.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.03 -30.2 70.22 Favored 'General case' 0 C--N 1.364 1.204 0 CA-C-O 117.397 -1.287 . . . . 72.23 111.223 173.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.537 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 1.6 t -66.78 -43.05 90.1 Favored 'Isoleucine or valine' 0 C--N 1.391 2.399 0 CA-C-O 116.633 -1.651 . . . . 72.04 110.021 171.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.518 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 4.3 tt0 -61.05 -55.01 37.7 Favored 'General case' 0 C--N 1.365 1.247 0 CA-C-N 121.476 1.944 . . . . 71.04 111.48 176.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -71.82 -59.26 2.84 Favored 'General case' 0 C--O 1.284 2.901 0 CA-C-N 121.21 1.823 . . . . 74.23 112.796 -176.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -71.12 -31.52 67.86 Favored 'General case' 0 C--N 1.364 1.21 0 CA-C-O 117.178 -1.391 . . . . 73.01 112.711 -176.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.537 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 5.1 m-85 -82.78 -29.01 29.94 Favored 'General case' 0 C--N 1.375 1.698 0 CA-C-N 122.057 2.208 . . . . 73.54 112.55 176.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.518 ' HB3' ' O ' ' A' ' 25' ' ' GLU . 2.9 ptt180 -54.27 -32.52 56.42 Favored 'General case' 0 C--N 1.379 1.884 0 CA-C-O 115.777 -2.059 . . . . 73.04 114.824 161.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.85 -48.06 73.38 Favored 'General case' 0 N--CA 1.518 2.965 0 CA-C-N 122.479 2.4 . . . . 64.21 111.674 167.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -75.71 -38.29 58.71 Favored 'General case' 0 C--O 1.213 -0.865 0 CA-C-O 118.639 -0.696 . . . . 65.35 111.803 -168.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -149.2 154.92 26.07 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 119.473 1.033 . . . . 64.33 111.148 168.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -77.22 105.19 8.17 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-N 118.075 0.937 . . . . 71.3 110.722 -175.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.739 HG13 ' SG ' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -73.61 132.83 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 N-CA-C 114.286 1.217 . . . . 74.5 114.286 -176.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 11.1 mp -108.67 -23.26 11.88 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.883 -1.053 . . . . 74.34 110.861 175.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 52' ' ' GLU . 8.1 tmtm? -152.2 131.66 12.97 Favored 'General case' 0 CA--C 1.565 1.52 0 N-CA-C 108.576 -0.898 . . . . 51.4 108.576 -172.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.739 ' SG ' HG13 ' A' ' 34' ' ' ILE . 19.5 m -139.48 110.39 6.81 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 107.251 -1.388 . . . . 52.43 107.251 175.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -122.3 127.67 50.13 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 117.563 -1.655 . . . . 74.12 110.635 176.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -117.88 112.86 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-O 121.841 0.829 . . . . 72.24 110.042 -178.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.3 mtmt -120.38 146.85 45.77 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 114.439 -1.255 . . . . 73.54 109.98 -170.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.11 145.98 49.68 Favored 'General case' 0 C--N 1.368 1.397 0 CA-C-N 120.68 1.582 . . . . 71.25 108.464 -172.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.627 HG23 ' H ' ' A' ' 44' ' ' SER . 4.0 t -99.79 167.09 10.76 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 121.129 1.786 . . . . 74.34 111.138 174.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.5 m -66.74 -3.7 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.575 0 N-CA-C 116.038 1.866 . . . . 71.31 116.038 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.627 ' H ' HG23 ' A' ' 42' ' ' THR . 10.2 t -98.27 7.22 46.54 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 119.253 0.933 . . . . 65.11 109.639 -171.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.78 -5.7 73.76 Favored Glycine 0 CA--C 1.54 1.606 0 N-CA-C 115.2 0.84 . . . . 70.31 115.2 -175.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.45 130.89 34.34 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 118.201 1.0 . . . . 71.2 109.578 175.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.28 146.94 39.81 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 108.854 -0.795 . . . . 72.22 108.854 -175.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -129.63 150.84 50.78 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.526 1.057 . . . . 73.52 110.754 -176.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -127.34 147.47 50.26 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-O 121.713 0.768 . . . . 70.13 111.572 171.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -132.74 118.58 19.24 Favored 'General case' 0 C--O 1.266 1.924 0 N-CA-C 106.367 -1.716 . . . . 73.4 106.367 -164.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.79 114.02 26.35 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.079 0 C-N-CA 120.09 -0.644 . . . . 71.44 109.885 -162.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.41 ' HB2' ' HB3' ' A' ' 36' ' ' LYS . 45.8 mt-10 -109.44 109.14 19.9 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 120.541 -0.464 . . . . 75.33 112.108 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -107.0 160.63 15.39 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 119.4 -0.333 . . . . 73.03 111.428 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -80.49 -25.99 38.47 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 113.514 0.931 . . . . 74.42 113.514 177.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -115.86 119.57 36.4 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.402 -0.592 . . . . 50.21 109.402 -178.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.6 -33.12 58.44 Favored 'General case' 0 CA--C 1.56 1.356 0 N-CA-C 117.024 2.231 . . . . 65.5 117.024 174.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.352 0.0 OUTLIER -79.58 -29.25 41.19 Favored 'General case' 0 C--N 1.377 1.78 0 CA-C-N 122.095 2.225 . . . . 73.14 114.448 -170.391 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.2 -31.14 60.82 Favored 'General case' 0 CA--C 1.586 2.363 0 CA-C-N 121.281 1.855 . . . . 73.43 115.955 171.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.47 -24.27 54.77 Favored 'General case' 0 CA--C 1.586 2.36 0 CA-C-N 120.563 1.528 . . . . 64.51 114.222 170.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.565 ' HA ' HG22 ' A' ' 63' ' ' ILE . . . -49.78 -37.81 31.48 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-O 116.608 -1.663 . . . . 75.32 113.958 173.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.585 ' O ' ' HB3' ' A' ' 65' ' ' GLU . 31.7 m-20 -54.09 -51.65 63.49 Favored 'General case' 0 C--N 1.395 2.56 0 CA-C-N 120.178 1.354 . . . . 72.22 112.066 169.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.59 -39.22 87.32 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 117.144 -1.408 . . . . 72.42 113.04 174.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.762 HD12 HG13 ' A' ' 80' ' ' VAL 0.305 0.6 OUTLIER -73.78 -45.97 48.45 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 116.601 -2.04 . . . . 63.21 113.348 -176.854 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.98 -34.49 59.95 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 114.368 1.247 . . . . 74.12 114.368 166.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.585 ' HB3' ' O ' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -83.05 -22.47 33.52 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-N 119.454 1.025 . . . . 75.31 112.158 -175.098 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -100.07 14.23 31.38 Favored 'General case' 0 CA--C 1.57 1.735 0 CA-C-O 118.981 -0.533 . . . . 74.24 110.866 174.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.361 0.0 OUTLIER -77.36 162.89 26.91 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 113.674 0.99 . . . . 73.23 113.674 -168.651 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.75 29.58 2.01 Favored Glycine 0 N--CA 1.437 -1.269 0 CA-C-O 117.886 -1.508 . . . . 73.13 115.007 -158.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.675 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 44.8 t -51.37 126.23 16.49 Favored 'General case' 0 C--N 1.383 2.041 0 CA-C-O 122.123 0.963 . . . . 63.03 110.317 170.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -135.17 143.0 46.23 Favored 'General case' 0 C--O 1.252 1.236 0 CA-C-N 113.282 -1.781 . . . . 70.1 111.705 -176.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -155.51 144.8 20.94 Favored 'General case' 0 C--N 1.348 0.541 0 N-CA-C 106.695 -1.594 . . . . 75.15 106.695 -164.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 71.11 65.64 0.16 Allowed 'General case' 0 N--CA 1.512 2.658 0 CA-C-O 121.608 0.718 . . . . 54.55 111.86 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.2 -13.68 63.03 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 116.995 1.558 . . . . 41.51 116.995 174.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -122.93 125.37 45.19 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 106.037 -1.838 . . . . 70.31 106.037 161.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.69 105.9 18.1 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 117.506 -1.235 . . . . 73.22 110.491 -172.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.675 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.3 OUTLIER -169.1 69.71 0.07 Allowed 'General case' 0 N--CA 1.505 2.31 0 CA-C-N 120.944 1.702 . . . . 62.42 113.688 179.327 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.446 ' HG3' ' H ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -92.35 118.09 30.56 Favored 'General case' 0 CA--C 1.576 1.961 0 CA-C-N 122.761 2.528 . . . . 71.34 111.604 -172.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.575 HG22 HG23 ' A' ' 12' ' ' VAL . 42.6 t -126.87 115.89 42.96 Favored 'Isoleucine or valine' 0 C--N 1.371 1.536 0 O-C-N 120.761 -1.212 . . . . 62.23 107.753 168.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -149.83 137.65 20.18 Favored 'General case' 0 C--N 1.37 1.483 0 CA-C-N 119.852 1.205 . . . . 65.01 111.651 -179.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.762 HG13 HD12 ' A' ' 63' ' ' ILE . 35.5 m -90.81 128.35 48.51 Favored Pre-proline 0 N--CA 1.445 -0.71 0 CA-C-N 115.317 -0.856 . . . . 63.41 110.389 170.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.523 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 43.8 Cg_endo -87.06 31.25 0.45 Allowed 'Trans proline' 0 CA--C 1.553 1.428 0 C-N-CA 122.198 1.932 . . . . 71.24 112.482 162.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -120.51 -30.67 4.48 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 111.483 0.179 . . . . 74.33 111.483 175.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 15.7 m120 . . . . . 0 N--CA 1.497 1.885 0 C-N-CA 126.156 1.782 . . . . 61.41 113.485 -174.34 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.426 ' CB ' ' HB2' ' A' ' 56' ' ' ALA . 0.3 OUTLIER . . . . . 0 CA--C 1.529 0.162 0 N-CA-C 110.043 -0.354 . . . . 73.25 110.043 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -126.13 152.95 45.25 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 117.519 -1.229 . . . . 73.41 110.61 -179.343 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 mt -115.56 143.98 24.22 Favored 'Isoleucine or valine' 0 C--O 1.255 1.342 0 CA-C-N 121.223 1.829 . . . . 64.01 108.692 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -106.32 120.85 42.94 Favored 'General case' 0 CA--C 1.564 1.504 0 O-C-N 124.157 0.91 . . . . 74.34 110.324 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.577 HG23 HG22 ' A' ' 78' ' ' VAL . 1.5 p -124.57 105.84 15.81 Favored 'Isoleucine or valine' 0 C--N 1.376 1.753 0 CA-C-N 120.457 1.48 . . . . 75.34 109.024 177.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' A' ' 77' ' ' ARG . . . -114.57 166.79 12.19 Favored Glycine 0 C--N 1.355 1.618 0 C-N-CA 120.339 -0.934 . . . . 55.14 113.453 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 50.12 24.24 1.36 Allowed 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 115.102 1.519 . . . . 74.32 115.102 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.48 ' H ' HD23 ' A' ' 15' ' ' LEU . 2.4 pt? -71.47 141.52 85.58 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 124.297 1.039 . . . . 73.05 110.717 175.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -72.98 141.47 33.16 Favored 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 121.411 1.407 . . . . 70.42 111.169 173.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.9 p 86.25 -34.16 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 126.36 1.864 . . . . 71.23 112.652 170.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 71.08 121.82 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.106 1.362 . . . . 74.42 111.188 -175.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.0 m -75.84 118.15 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.442 0 N-CA-C 107.43 -1.322 . . . . 72.44 107.43 176.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.37 157.32 27.65 Favored 'General case' 0 C--N 1.383 2.036 0 O-C-N 120.025 -1.672 . . . . 61.52 109.472 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.44 ' HA ' HG12 ' A' ' 24' ' ' VAL . 44.8 p -49.84 -37.61 31.43 Favored 'General case' 0 C--N 1.38 1.934 0 N-CA-C 116.123 1.897 . . . . 44.04 116.123 -173.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -38.97 75.98 Favored 'General case' 0 CA--C 1.595 2.678 0 N-CA-C 114.637 1.347 . . . . 73.43 114.637 176.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.5 -32.59 68.39 Favored 'General case' 0 C--N 1.374 1.655 0 CA-C-N 120.301 1.409 . . . . 71.43 110.596 176.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.606 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 7.5 p -75.46 -34.03 28.86 Favored 'Isoleucine or valine' 0 C--N 1.391 2.403 0 N-CA-C 108.663 -0.866 . . . . 52.21 108.663 178.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.5 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 0.5 OUTLIER -60.16 -55.63 31.45 Favored 'General case' 0 CA--C 1.576 1.967 0 CA-C-O 117.187 -1.387 . . . . 72.43 113.717 168.83 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -65.4 -58.88 4.78 Favored 'General case' 0 C--O 1.299 3.666 0 CA-C-N 121.654 2.025 . . . . 73.52 113.37 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -57.7 -44.95 86.23 Favored 'General case' 0 C--N 1.385 2.133 0 CA-C-O 117.902 -1.047 . . . . 62.31 112.075 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.606 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 3.1 m-85 -79.66 -17.22 54.23 Favored 'General case' 0 CA--C 1.568 1.671 0 CA-C-N 120.373 1.442 . . . . 65.34 114.121 -176.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.501 ' HA ' HG22 ' A' ' 34' ' ' ILE 0.322 70.3 mtp180 -60.33 -32.01 70.84 Favored 'General case' 0 N--CA 1.535 3.819 0 CA-C-N 122.022 2.192 . . . . 64.53 110.942 170.368 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.512 ' HD2' ' O ' ' A' ' 30' ' ' LYS 0.283 0.2 OUTLIER -58.51 -21.1 50.92 Favored 'General case' 0 N--CA 1.509 2.486 0 C-N-CA 117.805 -1.558 . . . . 72.21 114.109 175.006 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.512 ' HB3' ' HB2' ' A' ' 59' ' ' ALA . 1.5 m-85 -84.86 -27.53 26.64 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.37 -0.831 . . . . 74.43 110.306 -165.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 175.32 32.99 0.04 OUTLIER Glycine 0 N--CA 1.437 -1.275 0 CA-C-O 118.783 -1.009 . . . . 33.4 113.598 174.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.2 t30 57.27 80.72 0.16 Allowed 'General case' 0 C--N 1.357 0.914 0 C-N-CA 124.525 1.13 . . . . 63.01 110.641 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.501 HG22 ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -68.49 141.24 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 CA-C-N 114.935 -1.03 . . . . 64.25 113.6 -175.424 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.434 ' H ' HD22 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -107.39 -25.25 11.52 Favored 'General case' 0 C--N 1.375 1.686 0 N-CA-C 110.577 -0.157 . . . . 71.03 110.577 176.494 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.84 130.91 26.36 Favored 'General case' 0 CA--C 1.56 1.343 0 N-CA-C 108.896 -0.779 . . . . 73.4 108.896 -168.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -141.28 111.08 6.54 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.025 -0.732 . . . . 42.43 109.025 -175.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -129.04 143.28 50.82 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 117.802 -1.559 . . . . 60.42 113.483 -177.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.0 t -116.21 114.6 46.58 Favored 'Isoleucine or valine' 0 C--N 1.345 0.383 0 N-CA-C 108.737 -0.838 . . . . 75.33 108.737 176.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -107.12 130.41 54.7 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-O 118.601 -0.714 . . . . 74.2 109.618 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -106.15 128.04 53.63 Favored 'General case' 0 C--N 1.379 1.857 0 CA-C-N 120.519 1.509 . . . . 65.35 112.391 -174.022 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.638 HG23 ' H ' ' A' ' 44' ' ' SER . 1.4 t -90.76 160.0 16.02 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 119.139 -1.024 . . . . 51.44 111.187 170.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.0 t -76.29 -9.95 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.415 0 C-N-CA 123.698 0.799 . . . . 73.24 112.376 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.638 ' H ' HG23 ' A' ' 42' ' ' THR . 7.3 m -83.16 7.84 14.89 Favored 'General case' 0 CA--C 1.556 1.185 0 O-C-N 121.873 -0.517 . . . . 73.45 111.282 -177.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.31 -4.57 76.55 Favored Glycine 0 C--N 1.351 1.385 0 N-CA-C 115.563 0.985 . . . . 53.24 115.563 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.77 134.42 33.68 Favored 'General case' 0 CA--C 1.561 1.366 0 CA-C-N 118.01 0.905 . . . . 63.44 110.776 176.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -103.86 144.97 30.79 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 107.333 -1.358 . . . . 71.45 107.333 176.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -132.57 149.87 52.25 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.225 0.92 . . . . 45.3 108.562 175.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.401 ' HB3' ' CG1' ' A' ' 12' ' ' VAL . . . -117.79 137.0 53.03 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 119.071 -1.052 . . . . 41.34 111.391 170.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -106.12 118.85 37.69 Favored 'General case' 0 C--O 1.268 2.068 0 CA-C-N 113.92 -1.491 . . . . 72.04 107.762 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 0.3 OUTLIER -125.96 111.36 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.505 0 C-N-CA 119.066 -1.054 . . . . 60.41 111.905 -174.486 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.59 105.8 17.71 Favored 'General case' 0 CA--C 1.556 1.205 0 CA-C-N 115.643 -0.708 . . . . 71.32 111.474 -174.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 3.0 p90 -115.2 166.87 11.36 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 114.493 1.294 . . . . 74.53 114.493 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -80.8 -27.82 36.51 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 114.843 1.423 . . . . 74.21 114.843 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.35 118.6 32.69 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 120.011 1.278 . . . . 70.11 111.593 175.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.46 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -77.42 -34.33 54.7 Favored 'General case' 0 CA--C 1.552 1.023 0 N-CA-C 116.78 2.141 . . . . 75.11 116.78 172.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.267 0.0 OUTLIER -80.35 -29.33 37.94 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-N 121.879 2.127 . . . . 74.12 113.034 -170.538 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.22 -38.18 90.14 Favored 'General case' 0 N--CA 1.506 2.364 0 N-CA-C 114.067 1.136 . . . . 73.53 114.067 176.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.512 ' HB2' ' HB3' ' A' ' 31' ' ' TYR . . . -53.58 -22.45 8.51 Favored 'General case' 0 CA--C 1.561 1.383 0 N-CA-C 115.755 1.761 . . . . 75.51 115.755 173.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.93 -45.89 60.64 Favored 'General case' 0 CA--C 1.582 2.211 0 N-CA-C 114.807 1.41 . . . . 53.53 114.807 -178.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -50.66 -51.7 46.78 Favored 'General case' 0 N--CA 1.524 3.268 0 CA-C-N 119.745 1.157 . . . . 74.1 112.459 170.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.49 ' O ' ' HD2' ' A' ' 66' ' ' LYS . . . -75.05 -31.61 61.33 Favored 'General case' 0 CA--C 1.555 1.151 0 O-C-N 121.213 -0.929 . . . . 75.2 111.994 -176.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.492 HD11 HG12 ' A' ' 78' ' ' VAL 0.296 0.0 OUTLIER -73.63 -42.37 55.25 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.875 0 O-C-N 120.058 -1.651 . . . . 73.25 113.118 179.293 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.492 ' HD2' ' N ' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -55.72 -33.84 64.6 Favored 'General case' 0 CA--C 1.559 1.291 0 CA-C-N 120.383 1.447 . . . . 63.1 114.815 162.861 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.492 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -63.65 -32.62 74.15 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 120.058 1.299 . . . . 74.45 112.252 172.364 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.49 ' HD2' ' O ' ' A' ' 62' ' ' ALA 0.269 0.0 OUTLIER -105.0 16.72 25.42 Favored 'General case' 0 CA--C 1.581 2.151 0 C-N-CA 117.09 -1.844 . . . . 71.23 115.566 166.661 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.475 ' HB3' ' HA ' ' A' ' 64' ' ' LYS 0.363 0.0 OUTLIER -79.26 159.61 27.2 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-N 119.092 0.86 . . . . 72.43 112.845 -177.361 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.1 31.44 2.05 Favored Glycine 0 N--CA 1.436 -1.365 0 C-N-CA 118.202 -1.951 . . . . 72.05 113.866 -164.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.733 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -50.97 124.82 12.1 Favored 'General case' 0 C--N 1.374 1.631 0 O-C-N 124.449 0.735 . . . . 74.31 111.328 -173.86 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -133.79 150.79 51.45 Favored 'General case' 0 C--O 1.252 1.232 0 CA-C-N 115.044 -0.98 . . . . 73.13 110.735 -173.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -149.65 142.47 24.7 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 105.159 -2.163 . . . . 64.31 105.159 -170.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 73.52 66.1 0.1 Allowed 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 113.014 0.746 . . . . 72.54 113.014 -176.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.33 -14.0 61.23 Favored Glycine 0 N--CA 1.478 1.463 0 N-CA-C 117.187 1.635 . . . . 72.34 117.187 169.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 -114.55 120.29 39.71 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 105.349 -2.093 . . . . 52.43 105.349 149.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.56 101.84 13.52 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.587 -1.245 . . . . 75.52 108.747 -175.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.733 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 13.1 tp -172.0 70.54 0.04 OUTLIER 'General case' 0 C--N 1.387 2.207 0 CA-C-N 120.809 1.641 . . . . 71.22 112.599 -174.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.42 ' HB3' ' O ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -96.51 113.26 24.82 Favored 'General case' 0 CA--C 1.566 1.572 0 CA-C-N 122.375 2.352 . . . . 73.14 109.56 -174.257 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.577 HG22 HG23 ' A' ' 12' ' ' VAL . 13.9 t -128.71 118.03 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.481 0 O-C-N 120.286 -1.509 . . . . 41.11 109.381 174.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -134.48 135.58 42.54 Favored 'General case' 0 C--O 1.263 1.807 0 CA-C-N 119.475 1.034 . . . . 75.4 109.944 -175.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.8 m -72.41 123.81 89.99 Favored Pre-proline 0 CA--C 1.551 1.017 0 CA-C-N 115.753 -0.658 . . . . 63.44 110.288 159.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -92.09 23.06 0.6 Allowed 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.441 2.094 . . . . 74.31 112.663 168.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.46 ' CE1' ' HB1' ' A' ' 56' ' ' ALA . 8.8 p90 -121.9 -57.61 1.79 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 121.403 -0.119 . . . . 75.2 110.88 176.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.6 t30 . . . . . 0 N--CA 1.496 1.83 0 C-N-CA 125.58 1.552 . . . . 73.15 112.764 -175.272 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.7 m . . . . . 0 CA--C 1.547 0.841 0 CA-C-O 120.26 0.076 . . . . 74.14 110.979 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -140.65 160.04 40.89 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 113.682 0.993 . . . . 74.5 113.682 -177.069 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.561 HG12 HG12 ' A' ' 80' ' ' VAL . 10.2 mt -112.57 136.56 48.44 Favored 'Isoleucine or valine' 0 C--O 1.259 1.564 0 N-CA-C 106.866 -1.531 . . . . 44.42 106.866 177.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -92.92 115.06 27.77 Favored 'General case' 0 CA--C 1.565 1.541 0 O-C-N 125.815 1.947 . . . . 74.41 109.045 177.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.409 HG22 HG13 ' A' ' 78' ' ' VAL . 38.5 t -123.57 115.29 44.86 Favored 'Isoleucine or valine' 0 C--N 1.366 1.316 0 CA-C-N 119.922 1.237 . . . . 75.44 109.042 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -121.63 171.03 14.95 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 119.276 -1.44 . . . . 64.41 113.738 173.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 50.81 25.69 2.25 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 115.367 1.618 . . . . 51.12 115.367 176.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.444 HD11 ' H ' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -79.24 140.84 57.06 Favored Pre-proline 0 CA--C 1.551 1.006 0 CA-C-N 119.144 0.883 . . . . 73.21 112.257 -170.265 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -76.15 142.69 24.75 Favored 'Trans proline' 0 CA--C 1.552 1.378 0 C-N-CA 122.992 2.461 . . . . 61.14 112.176 173.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.1 p 88.53 -32.25 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 126.719 2.008 . . . . 71.42 111.955 175.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 82.5 t60 69.13 105.29 0.06 Allowed 'General case' 0 C--N 1.361 1.069 0 C-N-CA 124.924 1.29 . . . . 75.41 111.184 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.444 ' H ' HD11 ' A' ' 15' ' ' LEU . 7.8 m -77.99 117.8 23.88 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.849 0 N-CA-C 109.127 -0.694 . . . . 74.24 109.127 -176.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.8 154.92 29.51 Favored 'General case' 0 C--N 1.378 1.839 0 CA-C-O 118.165 -0.921 . . . . 41.43 111.028 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.0 t -49.42 -46.52 47.74 Favored 'General case' 0 C--N 1.38 1.893 0 N-CA-C 114.821 1.415 . . . . 42.51 114.821 -177.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . 0.314 0.0 OUTLIER -55.23 -43.29 74.41 Favored 'General case' 0 CA--C 1.588 2.414 0 N-CA-C 115.246 1.573 . . . . 72.54 115.246 172.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.92 -37.84 87.12 Favored 'General case' 0 C--N 1.378 1.812 0 CA-C-O 117.903 -1.046 . . . . 73.55 110.726 176.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.2 t -64.89 -43.75 96.28 Favored 'Isoleucine or valine' 0 C--N 1.403 2.931 0 CA-C-N 119.551 1.069 . . . . 70.45 110.657 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.62 -52.72 63.77 Favored 'General case' 0 C--N 1.378 1.818 0 CA-C-O 116.201 -1.857 . . . . 62.13 111.12 176.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.558 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 1.8 m-20 -77.54 -55.28 5.5 Favored 'General case' 0 C--O 1.3 3.72 0 CA-C-N 122.713 2.506 . . . . 71.1 116.576 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.474 ' O ' ' HD2' ' A' ' 31' ' ' TYR . 19.8 tt0 -59.93 -39.96 87.26 Favored 'General case' 0 C--N 1.371 1.522 0 CA-C-O 117.335 -1.317 . . . . 71.24 111.698 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . 0.263 73.9 m-85 -82.28 -21.64 36.09 Favored 'General case' 0 CA--C 1.575 1.909 0 CA-C-N 121.918 2.145 . . . . 74.15 113.986 174.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.558 ' HG3' ' O ' ' A' ' 26' ' ' ASN 0.269 0.0 OUTLIER -59.72 -28.45 67.35 Favored 'General case' 0 N--CA 1.531 3.583 0 CA-C-N 120.864 1.665 . . . . 71.13 112.719 169.627 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.402 ' HE2' ' CD1' ' A' ' 31' ' ' TYR 0.325 0.0 OUTLIER -76.1 -36.21 59.01 Favored 'General case' 0 N--CA 1.506 2.338 0 C-N-CA 114.518 -2.873 . . . . 74.22 113.216 170.305 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.56 ' HB3' ' HA ' ' A' ' 59' ' ' ALA . 20.8 m-85 -76.68 -43.85 36.13 Favored 'General case' 0 CA--C 1.564 1.481 0 N-CA-C 112.681 0.623 . . . . 53.41 112.681 -164.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -132.45 -175.93 14.19 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.557 -1.017 . . . . 72.35 110.557 151.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -87.01 98.13 11.1 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.839 1.82 . . . . 63.12 109.6 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.428 ' HA ' ' HB3' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -75.37 141.02 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 113.349 0.87 . . . . 72.1 113.349 -178.653 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 11.1 mp -108.67 -24.14 11.48 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 122.758 0.423 . . . . 74.51 110.246 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.62 139.42 15.19 Favored 'General case' 0 CA--C 1.58 2.102 0 C-N-CA 123.794 0.837 . . . . 45.21 110.41 -170.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.427 ' SG ' HG13 ' A' ' 34' ' ' ILE . 62.0 m -138.79 112.3 8.22 Favored 'General case' 0 N--CA 1.507 2.382 0 N-CA-C 107.622 -1.251 . . . . 75.31 107.622 177.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -118.32 136.98 53.39 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 116.454 -2.098 . . . . 73.53 111.746 175.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -123.83 111.8 30.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 121.893 0.854 . . . . 43.43 109.266 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -115.77 152.61 32.95 Favored 'General case' 0 CA--C 1.559 1.318 0 CA-C-N 114.848 -1.069 . . . . 74.53 109.428 -172.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.39 146.24 50.85 Favored 'General case' 0 CA--C 1.565 1.528 0 CA-C-N 120.945 1.702 . . . . 73.13 108.838 -172.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.613 HG23 ' H ' ' A' ' 44' ' ' SER . 5.3 t -100.7 175.43 5.65 Favored 'General case' 0 CA--C 1.563 1.474 0 CA-C-N 120.698 1.59 . . . . 52.23 110.852 174.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.4 t -78.67 -8.53 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 123.545 0.738 . . . . 72.42 112.411 -175.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.613 ' H ' HG23 ' A' ' 42' ' ' THR . 7.1 t -89.15 4.72 47.58 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 122.937 0.495 . . . . 74.22 110.27 -175.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.13 -7.25 64.19 Favored Glycine 0 CA--C 1.534 1.26 0 N-CA-C 114.921 0.728 . . . . 75.04 114.921 -178.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.06 130.85 35.95 Favored 'General case' 0 CA--C 1.556 1.187 0 CA-C-N 117.877 0.838 . . . . 72.13 109.724 172.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.16 146.03 42.61 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.057 -0.72 . . . . 32.44 109.057 -173.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -128.29 148.51 50.66 Favored 'General case' 0 C--N 1.36 1.037 0 CA-C-N 119.63 1.105 . . . . 63.44 111.483 -173.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -123.61 146.27 48.3 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.162 0.801 . . . . 54.1 113.162 169.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -132.97 115.26 14.97 Favored 'General case' 0 C--O 1.267 2.005 0 N-CA-C 105.596 -2.002 . . . . 74.25 105.596 -165.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 1.4 mp -120.54 110.19 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.497 0 C-N-CA 118.371 -1.331 . . . . 61.41 111.378 -169.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -105.37 104.0 13.64 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-O 121.35 0.595 . . . . 71.34 111.754 -173.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.428 ' HB3' ' HA ' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -117.55 168.75 10.12 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 114.123 1.157 . . . . 75.44 114.123 -179.404 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -81.35 -33.86 32.14 Favored 'General case' 0 C--N 1.367 1.34 0 N-CA-C 113.963 1.098 . . . . 74.54 113.963 175.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -111.41 116.03 30.25 Favored 'General case' 0 C--N 1.349 0.576 0 N-CA-C 107.386 -1.338 . . . . 44.53 107.386 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.418 ' HB1' ' CD2' ' A' ' 82' ' ' PHE . . . -81.75 -28.78 33.15 Favored 'General case' 0 C--N 1.355 0.808 0 N-CA-C 114.647 1.351 . . . . 64.31 114.647 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.2 tmm_? -76.54 -41.07 47.96 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 114.2 1.185 . . . . 63.2 114.2 -170.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -70.65 -31.33 68.22 Favored 'General case' 0 CA--C 1.583 2.226 0 CA-C-N 121.459 1.936 . . . . 74.21 115.381 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.56 ' HA ' ' HB3' ' A' ' 31' ' ' TYR . . . -57.59 -22.16 43.32 Favored 'General case' 0 CA--C 1.596 2.743 0 N-CA-C 116.697 2.11 . . . . 62.21 116.697 169.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.451 ' HA ' HG22 ' A' ' 63' ' ' ILE . . . -50.47 -28.63 8.71 Favored 'General case' 0 CA--C 1.573 1.858 0 N-CA-C 114.758 1.392 . . . . 73.21 114.758 172.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.401 ' O ' ' HB3' ' A' ' 65' ' ' GLU . 5.5 m-20 -51.64 -54.42 28.15 Favored 'General case' 0 N--CA 1.504 2.266 0 CA-C-N 120.235 1.38 . . . . 73.32 112.644 162.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.64 -33.29 75.3 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 121.054 -1.029 . . . . 72.35 112.79 174.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.822 HD12 HG13 ' A' ' 80' ' ' VAL 0.303 0.0 OUTLIER -71.42 -46.41 64.31 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.607 0 C-N-CA 116.616 -2.034 . . . . 64.41 113.016 -178.619 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.526 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -55.06 -32.7 62.11 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 114.706 1.373 . . . . 72.41 114.706 164.221 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.401 ' HB3' ' O ' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -82.51 -18.37 41.81 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.702 1.137 . . . . 63.34 112.413 -176.537 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -101.29 15.05 30.04 Favored 'General case' 0 CA--C 1.588 2.428 0 CA-C-O 119.413 -0.327 . . . . 73.32 111.653 166.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.526 ' HB3' ' HA ' ' A' ' 64' ' ' LYS 0.378 0.2 OUTLIER -77.86 163.87 25.67 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 115.629 1.715 . . . . 72.4 115.629 -166.861 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.74 30.14 2.26 Favored Glycine 0 N--CA 1.432 -1.601 0 CA-C-O 117.224 -1.876 . . . . 72.1 115.62 -170.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.869 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -52.01 123.33 10.19 Favored 'General case' 0 C--N 1.382 2.019 0 CA-C-N 118.307 1.053 . . . . 73.24 111.577 -169.864 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.2 151.79 51.5 Favored 'General case' 0 C--O 1.258 1.504 0 CA-C-N 114.53 -1.213 . . . . 63.23 111.996 -170.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -148.75 145.28 27.55 Favored 'General case' 0 C--N 1.361 1.108 0 C-N-CA 126.97 2.108 . . . . 73.44 107.036 -163.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 70.42 64.33 0.2 Allowed 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 114.098 1.147 . . . . 72.14 114.098 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.21 -13.96 61.42 Favored Glycine 0 N--CA 1.476 1.31 0 N-CA-C 116.523 1.369 . . . . 75.41 116.523 172.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -118.42 120.34 37.29 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 105.956 -1.868 . . . . 71.22 105.956 153.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.53 107.37 19.78 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 118.051 -0.976 . . . . 74.2 109.774 -178.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.869 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 22.1 tp -163.08 70.44 0.25 Allowed 'General case' 0 C--O 1.192 -1.955 0 CA-C-N 120.114 1.324 . . . . 54.14 111.201 178.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -101.3 110.8 22.87 Favored 'General case' 0 CA--C 1.556 1.203 0 CA-C-N 122.537 2.426 . . . . 74.45 110.213 -170.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.479 HG12 HG12 ' A' ' 63' ' ' ILE . 90.8 t -126.88 118.23 49.97 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.732 0 O-C-N 120.097 -1.627 . . . . 62.3 107.5 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -145.28 131.43 19.41 Favored 'General case' 0 C--N 1.386 2.194 0 CA-C-N 120.694 1.588 . . . . 65.24 111.741 -170.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.822 HG13 HD12 ' A' ' 63' ' ' ILE . 15.7 m -88.44 134.24 34.79 Favored Pre-proline 0 C--N 1.349 0.576 0 CA-C-N 115.696 -0.684 . . . . 75.33 112.534 165.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -82.7 38.19 0.72 Allowed 'Trans proline' 0 CA--C 1.548 1.197 0 C-N-CA 122.322 2.014 . . . . 74.43 111.347 161.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.418 ' CD2' ' HB1' ' A' ' 56' ' ' ALA . 10.3 m-85 -125.56 52.01 1.67 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.452 -0.944 . . . . 53.32 108.452 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 61.7 m-20 . . . . . 0 CA--C 1.549 0.937 0 CA-C-N 115.597 -0.729 . . . . 71.5 110.055 175.022 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.622 0 CA-C-O 119.368 -0.348 . . . . 72.4 110.19 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.475 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 0.3 OUTLIER -138.71 159.19 42.72 Favored 'General case' 0 N--CA 1.509 2.524 0 CA-C-N 118.618 0.645 . . . . 60.31 111.909 -173.519 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.461 ' HB ' HD12 ' A' ' 51' ' ' ILE . 5.2 mp -134.48 133.77 54.79 Favored 'Isoleucine or valine' 0 C--O 1.269 2.082 0 N-CA-C 107.84 -1.17 . . . . 72.32 107.84 -177.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -108.54 114.4 28.2 Favored 'General case' 0 CA--C 1.57 1.731 0 O-C-N 125.877 1.986 . . . . 75.24 110.061 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.508 HG23 HG22 ' A' ' 78' ' ' VAL . 2.6 p -123.43 104.76 14.72 Favored 'Isoleucine or valine' 0 C--N 1.372 1.563 0 CA-C-N 120.555 1.525 . . . . 32.44 108.915 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -128.9 169.63 20.28 Favored Glycine 0 C--N 1.364 2.103 0 C-N-CA 120.374 -0.917 . . . . 63.02 114.747 -174.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.5 m120 49.24 24.8 1.06 Allowed 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 114.037 1.125 . . . . 54.44 114.037 -175.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.595 ' H ' HD23 ' A' ' 15' ' ' LEU . 2.0 pt? -85.12 149.98 54.03 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 125.439 1.496 . . . . 71.05 111.775 -171.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -72.13 140.98 35.27 Favored 'Trans proline' 0 C--N 1.367 1.532 0 C-N-CA 121.925 1.75 . . . . 74.34 111.56 173.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.4 p 82.5 -34.38 0.09 Allowed 'General case' 0 C--N 1.386 2.177 0 C-N-CA 126.857 2.063 . . . . 43.33 111.483 177.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 45.7 m-70 64.21 84.77 0.14 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.509 1.523 . . . . 74.31 110.109 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.576 ' H ' HD11 ' A' ' 15' ' ' LEU . 5.5 p -59.88 120.49 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.517 0 O-C-N 124.095 0.872 . . . . 75.13 110.503 -176.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.0 m -80.98 156.69 25.81 Favored 'General case' 0 C--N 1.363 1.174 0 CA-C-O 118.204 -0.903 . . . . 44.03 108.931 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.7 p -48.98 -37.29 19.79 Favored 'General case' 0 C--N 1.375 1.7 0 N-CA-C 115.795 1.776 . . . . 50.43 115.795 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . 0.255 0.0 OUTLIER -56.1 -47.62 77.71 Favored 'General case' 0 CA--C 1.588 2.433 0 N-CA-C 113.948 1.092 . . . . 62.14 113.948 173.191 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.457 ' HB2' HG23 ' A' ' 19' ' ' VAL . 13.6 m-20 -62.68 -50.97 69.06 Favored 'General case' 0 C--O 1.266 1.945 0 C-N-CA 123.686 0.794 . . . . 75.44 112.238 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.693 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -59.92 -46.18 94.26 Favored 'Isoleucine or valine' 0 C--N 1.372 1.55 0 CA-C-O 118.527 -0.749 . . . . 74.55 111.795 175.643 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.555 ' O ' ' HB3' ' A' ' 29' ' ' ARG 0.281 0.7 OUTLIER -52.5 -51.14 60.98 Favored 'General case' 0 C--O 1.202 -1.405 0 CA-C-O 115.647 -2.12 . . . . 71.42 112.049 171.217 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -71.73 -62.93 1.24 Allowed 'General case' 1 C--O 1.305 4.016 0 CA-C-N 124.537 3.335 . . . . 72.41 114.123 -178.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -72.8 -29.85 63.59 Favored 'General case' 0 C--N 1.371 1.512 0 O-C-N 120.495 -1.378 . . . . 71.42 112.118 -173.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.693 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 6.8 m-85 -84.05 -31.93 25.12 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 117.374 -1.298 . . . . 74.54 112.582 177.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.555 ' HB3' ' O ' ' A' ' 25' ' ' GLU . 3.3 ptt85 -51.46 -29.33 15.87 Favored 'General case' 0 N--CA 1.508 2.46 0 CA-C-O 116.353 -1.784 . . . . 70.4 114.355 164.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.41 -48.16 71.94 Favored 'General case' 0 N--CA 1.514 2.765 0 C-N-CA 114.775 -2.77 . . . . 63.21 113.2 164.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -79.99 -40.32 28.18 Favored 'General case' 0 CA--C 1.563 1.477 0 CA-C-N 119.082 0.856 . . . . 75.55 112.058 -170.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 29' ' ' ARG . . . -137.18 156.9 23.62 Favored Glycine 0 C--N 1.357 1.716 0 CA-C-N 120.245 1.384 . . . . 64.32 112.249 167.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -84.47 109.92 18.26 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.045 -0.724 . . . . 74.4 109.045 -170.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.74 121.42 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 113.439 0.904 . . . . 63.33 113.439 -176.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.81 -17.83 14.9 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.9 -0.778 . . . . 54.4 108.9 170.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -156.47 128.86 7.57 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 109.071 -0.714 . . . . 74.4 109.071 -165.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.4 p -143.04 107.99 4.92 Favored 'General case' 0 C--N 1.362 1.118 0 CA-C-N 119.34 0.973 . . . . 73.11 108.957 174.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -116.78 146.84 42.57 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 118.524 -1.27 . . . . 44.25 111.994 178.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.6 t -108.85 121.45 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 108.308 -0.997 . . . . 74.34 108.308 177.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -120.56 130.96 54.44 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 109.151 -0.685 . . . . 71.32 109.151 -176.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -121.98 128.6 51.66 Favored 'General case' 0 C--N 1.372 1.55 0 C-N-CA 117.839 -1.544 . . . . 63.13 111.127 -165.225 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.576 HG23 ' H ' ' A' ' 44' ' ' SER . 2.6 t -100.09 159.36 15.16 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 118.168 -1.413 . . . . 71.42 112.436 177.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.8 t -73.99 -7.99 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.408 0 C-N-CA 123.868 0.867 . . . . 75.14 112.377 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.576 ' H ' HG23 ' A' ' 42' ' ' THR . 7.4 t -85.23 7.78 20.81 Favored 'General case' 0 CA--C 1.55 0.968 0 O-C-N 121.489 -0.757 . . . . 65.43 110.601 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.34 -5.96 70.46 Favored Glycine 0 CA--C 1.532 1.13 0 N-CA-C 115.241 0.856 . . . . 52.05 115.241 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.48 132.38 33.94 Favored 'General case' 0 CA--C 1.558 1.283 0 CA-C-N 118.078 0.939 . . . . 74.44 110.713 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.91 142.38 34.87 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 107.439 -1.319 . . . . 24.44 107.439 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -130.79 145.99 52.12 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 106.944 -1.502 . . . . 71.21 106.944 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -118.22 138.2 52.5 Favored 'General case' 0 C--O 1.253 1.248 0 C-N-CA 119.114 -1.034 . . . . 42.42 109.798 173.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -116.84 120.45 38.54 Favored 'General case' 0 C--O 1.252 1.207 0 CA-C-N 114.516 -1.22 . . . . 72.45 108.848 -169.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.461 HD12 ' HB ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -132.84 112.66 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 123.122 0.263 . . . . 70.35 110.581 -166.902 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -103.07 113.11 26.31 Favored 'General case' 0 CA--C 1.565 1.529 0 CA-C-N 118.554 0.615 . . . . 72.13 112.169 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -108.74 164.14 12.64 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 112.742 0.645 . . . . 61.23 112.742 -176.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -78.85 -39.64 34.8 Favored 'General case' 0 N--CA 1.51 2.532 0 N-CA-C 113.37 0.878 . . . . 74.51 113.37 174.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.95 117.7 32.79 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 118.96 0.8 . . . . 72.24 109.615 -177.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.494 ' HB1' ' CD1' ' A' ' 82' ' ' PHE . . . -75.79 -26.32 57.21 Favored 'General case' 0 CA--C 1.556 1.19 0 N-CA-C 115.022 1.49 . . . . 72.34 115.022 175.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.321 0.0 OUTLIER -79.57 -28.2 41.16 Favored 'General case' 0 CA--C 1.57 1.74 0 CA-C-N 121.649 2.022 . . . . 74.03 114.803 -176.7 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.02 -30.23 49.89 Favored 'General case' 0 CA--C 1.591 2.552 0 CA-C-N 121.837 2.108 . . . . 73.2 115.668 174.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.74 -24.33 21.78 Favored 'General case' 0 CA--C 1.597 2.787 0 CA-C-N 120.551 1.523 . . . . 62.14 114.615 166.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.647 ' HA ' HG22 ' A' ' 63' ' ' ILE . . . -48.41 -39.37 22.28 Favored 'General case' 0 CA--C 1.569 1.691 0 C-N-CA 125.368 1.467 . . . . 62.32 114.061 173.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.459 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 2.1 m-20 -53.76 -50.82 65.17 Favored 'General case' 0 C--N 1.382 2.005 0 CA-C-N 120.473 1.488 . . . . 75.52 112.771 169.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.09 -44.99 91.98 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 118.454 -0.784 . . . . 62.31 112.65 174.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.717 HD12 HG13 ' A' ' 80' ' ' VAL 0.254 2.3 tt -69.94 -50.04 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 117.247 -1.781 . . . . 73.03 112.504 -174.648 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.53 ' HG3' ' O ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -56.9 -26.33 58.84 Favored 'General case' 0 CA--C 1.561 1.399 0 N-CA-C 115.57 1.692 . . . . 73.33 115.57 167.741 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.47 -20.11 37.53 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 121.369 1.895 . . . . 75.42 111.03 179.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.5 mttt -110.21 16.72 21.57 Favored 'General case' 0 CA--C 1.578 2.023 0 O-C-N 122.304 -0.248 . . . . 52.51 111.318 176.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.32 0.1 OUTLIER -78.23 161.4 27.32 Favored 'General case' 0 C--N 1.377 1.772 0 N-CA-C 112.988 0.736 . . . . 71.34 112.988 -176.188 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.38 26.04 3.57 Favored Glycine 0 N--CA 1.434 -1.499 0 C-N-CA 119.226 -1.464 . . . . 63.35 113.574 -160.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.819 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -55.15 123.63 14.29 Favored 'General case' 0 C--N 1.365 1.28 0 CA-C-N 117.545 0.672 . . . . 62.01 110.317 -176.628 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -133.19 151.3 51.96 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-N 115.792 -0.64 . . . . 62.42 112.122 -169.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -149.12 144.19 26.48 Favored 'General case' 0 C--N 1.354 0.78 0 C-N-CA 126.764 2.026 . . . . 62.12 106.779 -165.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 71.43 64.37 0.15 Allowed 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 113.43 0.9 . . . . 75.32 113.43 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.66 -13.72 62.35 Favored Glycine 0 N--CA 1.47 0.951 0 N-CA-C 117.081 1.592 . . . . 73.44 117.081 172.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -119.23 119.4 33.99 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 106.079 -1.823 . . . . 73.31 106.079 153.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.99 102.9 14.74 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 118.732 -1.187 . . . . 73.54 108.05 -171.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.819 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -160.57 65.99 0.32 Allowed 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 116.796 -1.574 . . . . 73.11 115.171 -177.673 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.29 114.86 27.29 Favored 'General case' 0 CA--C 1.578 2.05 0 CA-C-N 124.109 3.141 . . . . 73.4 111.962 -172.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.508 HG22 HG23 ' A' ' 12' ' ' VAL . 21.9 t -120.28 116.57 50.67 Favored 'Isoleucine or valine' 0 C--N 1.363 1.17 0 O-C-N 119.752 -1.842 . . . . 34.25 107.793 165.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -142.95 142.06 31.58 Favored 'General case' 0 C--N 1.362 1.116 0 C-N-CA 117.193 -1.803 . . . . 73.54 111.622 168.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.717 HG13 HD12 ' A' ' 63' ' ' ILE . 25.9 m -82.96 127.15 70.65 Favored Pre-proline 0 N--CA 1.442 -0.828 0 CA-C-N 114.676 -1.147 . . . . 71.42 110.556 169.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.475 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 57.9 Cg_endo -85.5 25.32 0.7 Allowed 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 121.6 1.533 . . . . 74.42 112.341 164.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.494 ' CD1' ' HB1' ' A' ' 56' ' ' ALA . 1.5 p90 -105.3 -31.59 9.01 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 120.414 -0.514 . . . . 74.41 111.048 174.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 N--CA 1.489 1.485 0 C-N-CA 125.057 1.343 . . . . 74.42 113.26 -177.481 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.546 0.794 0 N-CA-C 109.625 -0.509 . . . . 72.32 109.625 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.506 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 4.9 ptt180 -140.59 157.53 45.34 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 118.837 -0.601 . . . . 63.42 112.394 -177.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.8 mt -118.15 135.17 59.42 Favored 'Isoleucine or valine' 0 C--N 1.368 1.41 0 CA-C-N 119.47 1.032 . . . . 74.54 109.075 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -105.97 118.54 36.86 Favored 'General case' 0 CA--C 1.568 1.661 0 O-C-N 125.281 1.613 . . . . 63.54 110.445 -177.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.456 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 47.3 t -124.2 107.52 18.76 Favored 'Isoleucine or valine' 0 C--N 1.373 1.619 0 CA-C-N 120.439 1.472 . . . . 71.32 109.287 -177.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.449 ' H ' ' HG3' ' A' ' 77' ' ' ARG . . . -120.18 163.93 13.88 Favored Glycine 0 C--N 1.344 1.021 0 C-N-CA 118.845 -1.645 . . . . 74.32 112.818 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.44 ' HB3' ' HB2' ' A' ' 75' ' ' LYS . 8.3 m120 50.45 26.89 2.53 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 114.772 1.397 . . . . 73.32 114.772 177.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.411 HD23 ' H ' ' A' ' 15' ' ' LEU . 0.9 OUTLIER -74.69 149.72 86.09 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.543 1.537 . . . . 74.21 111.415 -177.22 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -79.92 129.17 7.89 Favored 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 121.565 1.51 . . . . 73.24 111.27 176.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 96.7 p 57.55 102.56 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 124.647 1.179 . . . . 73.13 112.357 -171.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 32.0 p-80 -57.15 125.31 22.13 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.529 -0.76 . . . . 65.52 111.781 -177.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.513 HG23 ' HB2' ' A' ' 23' ' ' ASP . 2.9 p -77.61 119.29 26.01 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 CA-C-N 114.85 -1.068 . . . . 63.13 109.006 -176.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.0 m -79.4 157.37 27.6 Favored 'General case' 0 C--N 1.369 1.45 0 CA-C-O 117.955 -1.022 . . . . 73.02 108.581 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.8 p -48.97 -37.53 20.43 Favored 'General case' 0 C--N 1.375 1.698 0 N-CA-C 115.926 1.825 . . . . 71.14 115.926 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.584 ' H ' ' HD3' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -56.6 -40.72 75.79 Favored 'General case' 0 N--CA 1.507 2.381 0 N-CA-C 114.547 1.314 . . . . 75.14 114.547 172.692 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.513 ' HB2' HG23 ' A' ' 19' ' ' VAL . 7.5 m-20 -70.7 -45.93 64.07 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 118.955 0.798 . . . . 75.03 111.173 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.704 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 2.4 m -61.63 -49.75 83.07 Favored 'Isoleucine or valine' 0 C--N 1.372 1.572 0 N-CA-C 112.085 0.402 . . . . 72.43 112.085 174.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -50.09 -53.69 25.51 Favored 'General case' 0 CA--C 1.562 1.411 0 CA-C-O 116.528 -1.701 . . . . 74.21 113.226 171.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -73.09 -63.07 1.25 Allowed 'General case' 0 C--O 1.302 3.843 0 CA-C-N 122.901 2.591 . . . . 52.14 114.29 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -72.54 -30.79 64.76 Favored 'General case' 0 C--N 1.365 1.265 0 C-N-CA 119.031 -1.068 . . . . 74.21 111.172 -174.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.704 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 17.9 m-85 -85.85 -23.19 27.21 Favored 'General case' 0 CA--C 1.56 1.341 0 CA-C-N 119.536 1.062 . . . . 72.34 111.391 -178.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.434 ' HA ' HG22 ' A' ' 34' ' ' ILE 0.295 1.8 ppt_? -60.62 -24.5 65.56 Favored 'General case' 0 C--N 1.401 2.828 0 CA-C-N 120.602 1.546 . . . . 71.25 112.341 165.181 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . 0.297 0.0 OUTLIER -53.55 -30.77 43.47 Favored 'General case' 0 N--CA 1.508 2.466 0 C-N-CA 117.123 -1.831 . . . . 71.52 114.042 164.237 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -85.67 -49.47 7.96 Favored 'General case' 0 C--O 1.214 -0.793 0 CA-C-N 121.564 1.984 . . . . 73.04 112.279 -157.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -160.55 39.9 0.44 Allowed Glycine 0 C--N 1.355 1.613 0 C-N-CA 117.89 -2.1 . . . . 64.11 114.507 171.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.3 t30 69.33 93.78 0.08 Allowed 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 124.37 1.068 . . . . 72.32 111.435 173.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.434 HG22 ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -73.95 129.75 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-N 115.537 -0.756 . . . . 72.51 112.553 179.407 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.79 -21.73 12.54 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 109.553 -0.536 . . . . 73.35 109.553 174.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.22 131.63 15.67 Favored 'General case' 0 CA--C 1.561 1.394 0 N-CA-C 108.57 -0.9 . . . . 61.12 108.57 -173.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -138.55 110.59 7.28 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 120.126 1.33 . . . . 64.31 109.803 176.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -118.64 145.98 45.02 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 117.875 -1.53 . . . . 73.31 111.499 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 37.1 t -114.9 112.76 41.36 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 N-CA-C 107.623 -1.251 . . . . 71.22 107.623 172.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -114.7 129.83 56.74 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 114.825 -1.079 . . . . 75.42 108.739 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.09 144.52 51.48 Favored 'General case' 0 C--N 1.369 1.433 0 CA-C-N 121.004 1.729 . . . . 64.21 108.998 -171.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.49 HG23 ' H ' ' A' ' 44' ' ' SER . 8.8 t -99.06 170.99 8.32 Favored 'General case' 0 CA--C 1.558 1.288 0 CA-C-N 120.499 1.5 . . . . 30.13 111.738 -178.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.7 t -73.63 -7.07 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.368 0 C-N-CA 124.113 0.965 . . . . 73.23 112.577 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.49 ' H ' HG23 ' A' ' 42' ' ' THR . 8.5 t -85.41 8.36 19.19 Favored 'General case' 0 CA--C 1.55 0.965 0 O-C-N 121.59 -0.694 . . . . 65.41 111.04 -177.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.42 -4.89 75.73 Favored Glycine 0 C--N 1.351 1.4 0 N-CA-C 115.178 0.831 . . . . 54.21 115.178 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.19 131.27 34.24 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 117.726 0.763 . . . . 71.5 110.484 176.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -105.34 147.76 27.81 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 108.045 -1.094 . . . . 43.45 108.045 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -126.67 147.27 49.95 Favored 'General case' 0 C--N 1.352 0.7 0 C-N-CA 118.609 -1.236 . . . . 74.1 109.7 177.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.456 ' HB3' ' HB ' ' A' ' 12' ' ' VAL . . . -117.08 138.75 51.41 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 120.538 -0.465 . . . . 74.14 109.751 176.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.13 113.83 15.58 Favored 'General case' 0 C--O 1.261 1.662 0 N-CA-C 106.709 -1.589 . . . . 64.33 106.709 -175.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.44 ' N ' HD12 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -129.18 113.9 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 C-N-CA 118.699 -1.2 . . . . 71.52 109.72 -170.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -91.62 115.38 28.0 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 114.567 -1.197 . . . . 61.34 112.481 -172.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -109.39 159.58 16.89 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 114.279 1.214 . . . . 71.51 114.279 -177.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -82.04 -43.33 18.07 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 120.115 -0.634 . . . . 63.14 112.315 172.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.451 ' OD1' ' HD2' ' A' ' 57' ' ' ARG . 6.0 t0 -116.41 127.02 54.26 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 118.923 0.783 . . . . 74.41 110.896 -174.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.03 -22.21 53.38 Favored 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 115.548 1.684 . . . . 54.31 115.548 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.451 ' HD2' ' OD1' ' A' ' 55' ' ' ASP 0.289 0.0 OUTLIER -76.73 -41.32 45.47 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 121.939 2.154 . . . . 65.41 113.273 -173.191 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -62.69 -48.85 77.5 Favored 'General case' 0 N--CA 1.505 2.319 0 CA-C-N 120.217 1.371 . . . . 63.14 113.499 178.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.55 -24.62 33.25 Favored 'General case' 0 CA--C 1.567 1.596 0 N-CA-C 115.477 1.658 . . . . 71.44 115.477 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.401 ' O ' ' HG3' ' A' ' 64' ' ' LYS . . . -46.68 -44.37 18.55 Favored 'General case' 0 CA--C 1.576 1.967 0 C-N-CA 125.31 1.444 . . . . 73.31 114.025 173.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -51.83 -53.47 39.81 Favored 'General case' 0 N--CA 1.514 2.739 0 CA-C-N 119.523 1.056 . . . . 65.51 112.822 173.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.629 ' O ' ' HD2' ' A' ' 66' ' ' LYS . . . -75.67 -30.21 59.32 Favored 'General case' 0 C--N 1.31 -1.141 0 O-C-N 120.467 -1.396 . . . . 73.2 112.868 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 63' ' ' ILE 0.256 5.9 mm -68.78 -46.23 79.78 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.921 0 C-N-CA 118.174 -1.41 . . . . 54.43 111.915 179.205 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -56.94 -32.83 66.38 Favored 'General case' 0 CA--C 1.562 1.44 0 N-CA-C 115.155 1.539 . . . . 71.21 115.155 164.831 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -64.36 -28.39 69.66 Favored 'General case' 0 N--CA 1.507 2.377 0 CA-C-N 120.542 1.519 . . . . 75.41 113.201 173.12 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.629 ' HD2' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -107.41 15.17 25.19 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 116.221 1.934 . . . . 74.52 116.221 164.6 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.33 0.0 OUTLIER -78.63 157.21 28.73 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 120.238 1.381 . . . . 73.13 110.941 179.597 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.52 30.85 1.77 Allowed Glycine 0 N--CA 1.428 -1.889 0 C-N-CA 117.526 -2.273 . . . . 73.3 113.622 -151.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.739 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 6.9 t -49.07 132.69 19.04 Favored 'General case' 0 C--N 1.376 1.74 0 CA-C-O 122.062 0.934 . . . . 65.43 111.049 172.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.41 ' HB2' ' HB2' ' A' ' 76' ' ' LEU . 1.2 m-20 -128.92 147.13 50.81 Favored 'General case' 0 C--O 1.246 0.914 0 CA-C-N 113.951 -1.477 . . . . 72.4 112.836 -170.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.63 144.91 24.72 Favored 'General case' 0 C--N 1.355 0.83 0 C-N-CA 126.83 2.052 . . . . 74.22 108.154 -156.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 70.91 62.28 0.18 Allowed 'General case' 0 N--CA 1.501 2.086 0 O-C-N 123.611 0.569 . . . . 74.51 112.473 173.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.95 -14.79 64.15 Favored Glycine 0 N--CA 1.472 1.036 0 N-CA-C 116.952 1.541 . . . . 73.33 116.952 173.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -123.11 119.74 31.19 Favored 'General case' 0 C--O 1.211 -0.942 0 N-CA-C 104.592 -2.373 . . . . 74.43 104.592 159.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.44 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -104.54 131.44 51.93 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 118.02 -1.472 . . . . 73.42 111.281 -177.548 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.739 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -171.33 70.69 0.05 OUTLIER 'General case' 0 C--O 1.199 -1.594 0 CA-C-O 117.981 -1.009 . . . . 52.01 110.589 -178.417 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.449 ' HG3' ' H ' ' A' ' 13' ' ' GLY . 2.0 tpp85 -93.0 115.62 28.29 Favored 'General case' 0 CA--C 1.571 1.763 0 CA-C-N 121.572 1.987 . . . . 73.34 111.411 -172.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.04 116.09 48.76 Favored 'Isoleucine or valine' 0 C--N 1.361 1.079 0 N-CA-C 107.558 -1.275 . . . . 64.03 107.558 163.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.2 tp10 -134.46 138.66 44.93 Favored 'General case' 0 C--N 1.363 1.178 0 CA-C-N 119.576 1.08 . . . . 73.44 110.427 174.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.0 m -90.3 122.39 67.48 Favored Pre-proline 0 N--CA 1.439 -0.998 0 C-N-CA 120.016 -0.673 . . . . 71.51 110.579 170.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 75.5 Cg_endo -89.74 22.77 0.76 Allowed 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 121.887 1.725 . . . . 74.1 113.378 168.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.446 ' HD2' ' N ' ' A' ' 9' ' ' ARG . 0.8 OUTLIER -113.32 -16.84 12.43 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 120.009 -0.676 . . . . 70.34 112.417 175.426 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.6 m120 . . . . . 0 N--CA 1.49 1.545 0 O-C-N 124.957 1.411 . . . . 71.42 110.271 -171.13 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.548 0.877 0 N-CA-C 112.092 0.405 . . . . 74.22 112.092 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.499 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -126.59 154.76 43.5 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.044 0.757 . . . . 73.43 113.044 -176.299 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.776 HD13 HG13 ' A' ' 63' ' ' ILE . 23.4 mt -116.79 141.17 36.07 Favored 'Isoleucine or valine' 0 C--O 1.254 1.31 0 CA-C-N 119.446 1.021 . . . . 75.34 108.637 179.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -101.71 116.99 33.96 Favored 'General case' 0 CA--C 1.572 1.797 0 O-C-N 125.991 2.057 . . . . 70.41 110.073 177.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.491 ' CG1' HG22 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -127.37 105.67 14.15 Favored 'Isoleucine or valine' 0 C--N 1.381 1.95 0 CA-C-N 119.348 0.977 . . . . 73.12 108.754 179.843 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -113.12 -175.66 19.36 Favored Glycine 0 CA--C 1.521 0.445 0 CA-C-O 118.504 -1.164 . . . . 73.33 112.991 176.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.7 m120 54.09 28.8 9.34 Favored 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 115.701 1.741 . . . . 74.1 115.701 170.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.3 mt -89.08 150.79 45.87 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 123.51 0.724 . . . . 73.54 111.629 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -59.35 130.73 37.21 Favored 'Trans proline' 0 CA--C 1.556 1.582 0 C-N-CA 123.095 2.53 . . . . 61.22 113.232 173.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.0 p 71.98 -5.11 1.79 Allowed 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 126.473 1.909 . . . . 71.22 114.525 168.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 71.54 129.8 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.062 1.345 . . . . 74.13 110.605 -173.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.9 m -91.68 119.78 39.61 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.443 0 N-CA-C 107.424 -1.324 . . . . 73.15 107.424 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.44 157.47 24.91 Favored 'General case' 0 C--N 1.381 1.972 0 O-C-N 120.263 -1.523 . . . . 64.02 109.991 -175.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.0 p -58.96 -34.25 71.58 Favored 'General case' 0 C--N 1.378 1.836 0 N-CA-C 115.835 1.791 . . . . 64.42 115.835 -174.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.4 ' HA ' ' HG2' ' A' ' 25' ' ' GLU 0.274 0.0 OUTLIER -60.75 -39.14 87.61 Favored 'General case' 0 CA--C 1.582 2.199 0 N-CA-C 115.477 1.658 . . . . 73.21 115.477 172.377 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -65.32 -50.47 65.54 Favored 'General case' 0 C--O 1.279 2.622 0 CA-C-N 119.87 1.214 . . . . 73.4 111.329 178.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.7 m -62.94 -43.75 99.19 Favored 'Isoleucine or valine' 0 C--N 1.376 1.759 0 O-C-N 123.546 0.529 . . . . 53.31 111.877 177.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.4 ' HG2' ' HA ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -54.13 -50.16 67.54 Favored 'General case' 0 C--O 1.191 -2.015 0 CA-C-O 115.195 -2.336 . . . . 75.44 115.202 169.03 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.41 -56.63 7.81 Favored 'General case' 0 C--O 1.283 2.85 0 CA-C-N 123.257 2.753 . . . . 51.32 114.071 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -61.18 -44.56 97.1 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 117.903 -1.046 . . . . 64.3 111.71 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -74.59 -28.54 60.95 Favored 'General case' 0 C--O 1.209 -1.04 0 CA-C-N 120.857 1.662 . . . . 62.33 114.194 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.417 ' C ' ' HE ' ' A' ' 29' ' ' ARG 0.379 0.0 OUTLIER -57.62 -37.88 74.03 Favored 'General case' 0 N--CA 1.526 3.353 0 CA-C-N 121.285 1.857 . . . . 74.33 114.252 164.025 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.41 ' HE2' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -56.6 -47.75 78.91 Favored 'General case' 0 N--CA 1.508 2.475 0 C-N-CA 116.194 -2.202 . . . . 64.3 110.319 167.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.554 ' HB3' ' HA ' ' A' ' 59' ' ' ALA . 35.2 m-85 -72.64 -39.47 67.16 Favored 'General case' 0 CA--C 1.564 1.505 0 CA-C-O 118.065 -0.969 . . . . 70.32 112.79 -166.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -150.11 176.07 28.91 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-N 119.965 1.257 . . . . 74.22 110.722 161.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 47.1 m-20 -83.58 101.14 11.26 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.249 2.024 . . . . 75.31 111.077 -176.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.91 134.41 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.108 0.48 . . . . 64.31 112.034 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.5 mp -102.77 -24.86 13.69 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 116.097 -0.501 . . . . 74.51 111.992 171.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.53 138.0 13.97 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 109.249 -0.648 . . . . 74.43 109.249 -173.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -140.27 108.73 5.86 Favored 'General case' 0 C--N 1.359 0.982 0 CA-C-N 118.727 0.694 . . . . 72.43 109.545 178.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -120.8 143.68 48.71 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 117.852 -1.539 . . . . 61.15 112.643 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -127.15 112.8 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 CA-C-O 121.452 0.644 . . . . 62.43 110.284 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.5 mttm -113.41 152.43 30.07 Favored 'General case' 0 CA--C 1.56 1.336 0 CA-C-O 118.018 -0.991 . . . . 73.23 108.874 -174.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.37 147.19 50.27 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-N 121.755 2.071 . . . . 70.51 109.061 -174.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.682 HG23 ' H ' ' A' ' 44' ' ' SER . 5.8 t -98.88 175.65 5.87 Favored 'General case' 0 CA--C 1.565 1.53 0 CA-C-N 120.816 1.644 . . . . 72.11 111.356 175.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.5 t -77.51 -8.99 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.387 0 C-N-CA 123.486 0.714 . . . . 71.32 112.115 -178.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.682 ' H ' HG23 ' A' ' 42' ' ' THR . 8.2 t -86.14 -0.8 56.53 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 121.773 -0.579 . . . . 54.03 110.753 -177.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.06 -7.46 66.81 Favored Glycine 0 CA--C 1.534 1.258 0 N-CA-C 114.977 0.751 . . . . 52.23 114.977 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.31 132.26 37.38 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 117.728 0.764 . . . . 73.32 108.952 170.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.88 145.35 44.68 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.022 -0.733 . . . . 51.21 109.022 -171.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -127.04 151.16 48.97 Favored 'General case' 0 C--N 1.363 1.16 0 CA-C-N 119.783 1.174 . . . . 74.53 112.0 -170.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -127.57 147.0 50.34 Favored 'General case' 0 C--N 1.351 0.642 0 CA-C-O 121.705 0.764 . . . . 70.05 111.831 175.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -132.69 113.31 12.84 Favored 'General case' 0 C--O 1.256 1.407 0 N-CA-C 105.392 -2.077 . . . . 73.33 105.392 -164.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 0.6 OUTLIER -126.38 108.91 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 C-N-CA 118.186 -1.406 . . . . 73.15 108.865 -170.525 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -106.27 106.0 16.3 Favored 'General case' 0 CA--C 1.549 0.905 0 O-C-N 124.6 1.187 . . . . 72.43 110.233 -173.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.19 146.6 39.0 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-O 118.681 -0.676 . . . . 74.21 112.766 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -57.46 -24.21 54.4 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 114.657 1.354 . . . . 72.25 114.657 166.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -114.09 113.42 24.7 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 119.603 1.092 . . . . 74.34 109.015 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.29 -43.68 32.37 Favored 'General case' 0 CA--C 1.554 1.103 0 N-CA-C 115.426 1.639 . . . . 72.43 115.426 172.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.305 0.0 OUTLIER -77.49 -29.57 52.66 Favored 'General case' 0 C--N 1.373 1.589 0 CA-C-N 121.117 1.78 . . . . 75.35 114.916 -167.831 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.17 -30.17 63.36 Favored 'General case' 0 CA--C 1.581 2.17 0 N-CA-C 116.353 1.983 . . . . 74.43 116.353 176.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.554 ' HA ' ' HB3' ' A' ' 31' ' ' TYR . . . -72.99 -19.28 61.24 Favored 'General case' 0 CA--C 1.585 2.302 0 CA-C-N 120.367 1.439 . . . . 44.13 111.993 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -48.58 -29.78 4.62 Favored 'General case' 0 CA--C 1.572 1.825 0 CA-C-O 116.97 -1.49 . . . . 35.42 114.325 170.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.565 ' O ' ' HB3' ' A' ' 65' ' ' GLU . 18.8 m-20 -51.88 -53.38 41.31 Favored 'General case' 0 C--N 1.398 2.708 0 CA-C-N 121.025 1.739 . . . . 62.32 111.571 164.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.02 -34.8 79.3 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-O 117.824 -1.084 . . . . 72.33 113.689 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.776 HG13 HD13 ' A' ' 10' ' ' ILE 0.281 0.0 OUTLIER -72.92 -35.93 50.34 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.685 0 C-N-CA 116.457 -2.097 . . . . 74.22 113.727 -178.741 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.61 -32.95 74.58 Favored 'General case' 0 C--N 1.362 1.143 0 CA-C-N 119.848 1.204 . . . . 73.52 113.678 163.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.565 ' HB3' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -83.38 -19.28 36.35 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 113.206 0.817 . . . . 74.41 113.206 -172.804 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -100.35 13.64 33.75 Favored 'General case' 0 CA--C 1.571 1.784 0 O-C-N 122.207 -0.308 . . . . 74.33 110.329 173.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.302 0.1 OUTLIER -77.02 161.94 27.93 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 118.422 0.555 . . . . 71.43 112.296 -167.463 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 119.85 28.41 1.89 Allowed Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 119.452 -1.356 . . . . 72.23 114.681 -155.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.702 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 0.8 OUTLIER -47.94 132.68 15.02 Favored 'General case' 0 C--N 1.377 1.768 0 C-N-CA 124.573 1.149 . . . . 75.3 109.811 179.238 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -56.95 102.06 0.07 Allowed 'General case' 0 C--N 1.384 2.105 0 O-C-N 125.216 1.573 . . . . 73.23 112.362 -160.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -153.92 139.3 17.64 Favored 'General case' 0 N--CA 1.439 -0.998 0 O-C-N 125.252 1.595 . . . . 71.22 107.303 -178.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 67.32 54.12 0.73 Allowed 'General case' 0 N--CA 1.508 2.461 0 C-N-CA 123.501 0.72 . . . . 64.41 111.892 172.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.73 -9.06 32.01 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 117.893 1.917 . . . . 75.31 117.893 176.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -115.54 119.54 36.52 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.245 1.522 . . . . 70.44 107.993 -174.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.03 100.83 12.59 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 117.966 -1.016 . . . . 52.31 111.643 -167.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.702 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -162.49 103.95 1.08 Allowed 'General case' 0 C--O 1.158 -3.749 0 CA-C-O 117.081 -1.438 . . . . 74.03 107.935 170.498 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.67 109.9 21.33 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 123.533 2.879 . . . . 65.54 107.257 -170.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.491 HG22 ' CG1' ' A' ' 12' ' ' VAL . 88.4 t -128.38 117.21 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.548 0 CA-C-N 120.481 1.491 . . . . 63.22 108.573 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -150.22 135.53 18.02 Favored 'General case' 0 C--N 1.381 1.972 0 CA-C-N 120.339 1.427 . . . . 72.24 110.144 -174.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.679 HG13 HD12 ' A' ' 63' ' ' ILE . 19.0 m -77.93 122.27 85.29 Favored Pre-proline 0 C--N 1.36 1.052 0 CA-C-O 121.618 0.723 . . . . 55.24 110.892 161.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.499 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 72.2 Cg_endo -90.78 13.69 2.13 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.402 2.068 . . . . 60.15 113.362 165.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -102.41 -45.72 5.0 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.055 -0.72 . . . . 55.24 109.055 170.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 . . . . . 0 N--CA 1.492 1.668 0 O-C-N 125.058 1.474 . . . . 63.22 110.302 -178.2 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 111.725 0.268 . . . . 63.23 111.725 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.454 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -141.16 154.66 45.97 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 113.351 0.871 . . . . 75.51 113.351 -175.06 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.6 mt -116.65 141.72 33.45 Favored 'Isoleucine or valine' 0 C--O 1.26 1.644 0 N-CA-C 108.418 -0.956 . . . . 71.11 108.418 -179.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -100.7 118.02 35.97 Favored 'General case' 0 CA--C 1.566 1.568 0 O-C-N 125.775 1.922 . . . . 74.32 110.374 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.475 HG13 HG22 ' A' ' 78' ' ' VAL . 57.9 t -125.78 106.24 15.79 Favored 'Isoleucine or valine' 0 C--N 1.375 1.677 0 CA-C-N 119.849 1.204 . . . . 73.12 109.889 177.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.17 -178.07 20.9 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 118.582 -1.121 . . . . 54.43 111.818 174.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.5 m120 50.13 24.2 1.36 Allowed 'General case' 0 N--CA 1.509 2.489 0 N-CA-C 116.579 2.066 . . . . 63.2 116.579 172.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.616 HD12 ' HB3' ' A' ' 18' ' ' HIS . 2.4 pt? -89.18 123.93 66.01 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 123.401 0.681 . . . . 61.34 111.001 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -84.33 126.67 3.72 Favored 'Trans proline' 0 CA--C 1.559 1.74 0 C-N-CA 121.415 1.41 . . . . 62.33 112.855 174.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.1 m 33.42 60.55 0.47 Allowed 'General case' 0 C--N 1.386 2.154 0 C-N-CA 125.772 1.629 . . . . 55.53 114.271 174.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.616 ' HB3' HD12 ' A' ' 15' ' ' LEU . 7.3 t60 -109.58 -128.29 0.28 Allowed 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.65 -0.704 . . . . 73.31 109.671 -168.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.9 m -83.37 121.59 36.41 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.695 0 CA-C-N 118.384 0.538 . . . . 70.35 110.983 -174.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -81.43 165.56 21.17 Favored 'General case' 0 C--N 1.369 1.434 0 CA-C-O 117.571 -1.204 . . . . 72.14 109.134 176.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.6 p -47.79 -46.78 30.84 Favored 'General case' 0 C--N 1.382 2.008 0 N-CA-C 116.065 1.876 . . . . 63.24 116.065 -173.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.25 -42.03 96.69 Favored 'General case' 0 CA--C 1.577 2.0 0 N-CA-C 114.517 1.303 . . . . 65.55 114.517 178.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.352 0.6 OUTLIER -67.41 -27.24 66.91 Favored 'General case' 0 CA--C 1.565 1.543 0 CA-C-N 120.036 1.289 . . . . 61.41 112.958 172.783 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.441 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 2.3 t -71.11 -38.78 72.65 Favored 'Isoleucine or valine' 0 C--N 1.406 3.055 0 CA-C-N 120.266 1.394 . . . . 64.34 107.734 175.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.601 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -65.79 -56.82 9.94 Favored 'General case' 0 CA--C 1.555 1.138 0 CA-C-O 117.129 -1.415 . . . . 75.4 112.198 179.488 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.11 -54.92 19.69 Favored 'General case' 0 C--O 1.299 3.666 0 CA-C-N 121.739 2.063 . . . . 72.32 115.58 176.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.78 -37.83 80.18 Favored 'General case' 0 C--N 1.387 2.209 0 CA-C-O 118.126 -0.94 . . . . 53.25 112.136 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.441 ' HB2' ' O ' ' A' ' 24' ' ' VAL 0.256 63.4 m-85 -83.87 -21.9 31.82 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-O 115.832 -2.033 . . . . 72.22 114.188 178.312 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.601 ' HG3' ' O ' ' A' ' 25' ' ' GLU 0.372 10.6 mtp180 -61.95 -36.05 80.25 Favored 'General case' 0 N--CA 1.524 3.225 0 CA-C-N 122.689 2.495 . . . . 72.12 109.115 169.466 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.84 -45.86 89.06 Favored 'General case' 0 N--CA 1.509 2.52 0 C-N-CA 116.879 -1.929 . . . . 64.32 112.179 172.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.56 ' HB3' ' HA ' ' A' ' 59' ' ' ALA . 13.7 m-85 -71.83 -40.35 69.16 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 112.746 0.647 . . . . 75.01 112.746 -169.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -151.5 163.72 30.01 Favored Glycine 0 C--O 1.213 -1.184 0 CA-C-O 117.346 -1.808 . . . . 71.31 108.591 156.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -72.59 101.18 2.95 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 121.188 2.494 . . . . 44.42 111.402 -170.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.49 HG22 ' HB3' ' A' ' 53' ' ' PHE . 2.1 pp -73.81 142.41 14.91 Favored 'Isoleucine or valine' 0 C--N 1.359 0.983 0 C-N-CA 120.089 -0.645 . . . . 73.45 112.602 -174.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.1 mp -97.37 -45.5 6.44 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 115.912 -0.585 . . . . 74.21 112.131 174.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.05 152.99 38.34 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-N 118.697 0.681 . . . . 61.23 110.558 172.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 3.3 m -137.62 107.4 6.26 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 106.756 -1.572 . . . . 72.52 106.756 176.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -115.88 143.41 45.46 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 118.544 -1.263 . . . . 63.41 111.288 -175.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -123.62 113.14 36.05 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-O 121.27 0.557 . . . . 74.34 110.239 -173.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 48.1 mttm -116.76 146.14 43.02 Favored 'General case' 0 CA--C 1.563 1.445 0 CA-C-O 117.968 -1.015 . . . . 55.34 109.956 -173.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.42 146.31 50.13 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 121.508 1.958 . . . . 71.12 108.771 -170.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.601 HG23 ' H ' ' A' ' 44' ' ' SER . 5.1 t -99.33 167.41 10.67 Favored 'General case' 0 C--N 1.363 1.164 0 CA-C-N 120.358 1.435 . . . . 75.23 111.398 175.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.3 m -66.39 -5.32 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.472 0 N-CA-C 116.262 1.949 . . . . 75.43 116.262 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.601 ' H ' HG23 ' A' ' 42' ' ' THR . 0.8 OUTLIER -98.83 4.81 47.64 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 119.507 1.049 . . . . 75.4 110.14 -172.373 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.37 -6.82 74.99 Favored Glycine 0 CA--C 1.543 1.781 0 N-CA-C 115.238 0.855 . . . . 62.22 115.238 -176.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -80.78 131.52 35.43 Favored 'General case' 0 CA--C 1.554 1.133 0 CA-C-N 118.267 1.034 . . . . 73.31 109.248 171.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.93 147.45 43.13 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-O 118.565 -0.731 . . . . 73.3 109.319 -171.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -129.57 151.62 49.99 Favored 'General case' 0 C--N 1.367 1.327 0 CA-C-N 119.541 1.064 . . . . 70.24 111.619 -173.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -134.29 144.01 48.08 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.919 0.866 . . . . 75.44 111.598 175.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -131.59 114.67 15.12 Favored 'General case' 0 C--O 1.265 1.88 0 N-CA-C 105.591 -2.003 . . . . 71.25 105.591 -159.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 0.3 OUTLIER -120.01 107.6 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 C-N-CA 119.271 -0.972 . . . . 74.21 109.713 -165.79 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -114.04 104.7 12.4 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.126 -0.488 . . . . 61.53 111.04 -169.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.49 ' HB3' HG22 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -114.12 160.73 18.62 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.831 1.048 . . . . 74.32 113.831 -177.035 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -73.09 -28.7 62.44 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 112.741 0.645 . . . . 61.41 112.741 167.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -113.8 112.42 23.37 Favored 'General case' 0 C--N 1.351 0.659 0 C-N-CA 118.571 -1.252 . . . . 60.33 109.277 176.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.34 -44.71 35.47 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 116.058 1.873 . . . . 72.44 116.058 170.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.97 -34.9 76.08 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 113.846 1.054 . . . . 73.32 113.846 -169.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -75.96 -32.64 59.6 Favored 'General case' 0 CA--C 1.586 2.358 0 N-CA-C 115.897 1.814 . . . . 64.44 115.897 176.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.56 ' HA ' ' HB3' ' A' ' 31' ' ' TYR . . . -64.93 -19.81 66.13 Favored 'General case' 0 CA--C 1.595 2.694 0 N-CA-C 114.884 1.439 . . . . 75.44 114.884 173.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -48.46 -31.83 6.89 Favored 'General case' 0 CA--C 1.578 2.055 0 N-CA-C 115.047 1.499 . . . . 74.1 115.047 171.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.406 ' O ' ' HB3' ' A' ' 65' ' ' GLU . 14.9 m-20 -51.21 -52.97 39.5 Favored 'General case' 0 N--CA 1.507 2.424 0 CA-C-N 119.915 1.234 . . . . 62.21 111.77 164.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.58 -31.32 71.95 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 117.13 -1.414 . . . . 73.21 114.023 175.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . 0.343 0.3 OUTLIER -73.59 -42.49 55.51 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.199 0 C-N-CA 115.578 -2.449 . . . . 74.31 113.895 177.612 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.16 -27.42 65.65 Favored 'General case' 0 CA--C 1.56 1.328 0 CA-C-N 120.158 1.345 . . . . 72.53 113.691 165.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.406 ' HB3' ' O ' ' A' ' 61' ' ' ASP . 1.2 tt0 -77.59 -29.31 51.91 Favored 'General case' 0 CA--C 1.549 0.937 0 O-C-N 121.31 -0.869 . . . . 73.13 112.45 178.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 43.0 mmtt -96.01 13.0 28.48 Favored 'General case' 0 CA--C 1.584 2.259 0 N-CA-C 112.861 0.689 . . . . 74.4 112.861 172.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.323 0.2 OUTLIER -76.23 164.97 25.54 Favored 'General case' 0 N--CA 1.51 2.534 0 CA-C-N 119.825 1.193 . . . . 74.4 111.922 -171.059 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.76 31.19 1.05 Allowed Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 118.652 -1.737 . . . . 74.14 114.801 -153.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.647 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 59.5 m -44.68 139.49 2.89 Favored 'General case' 0 C--N 1.393 2.492 0 CA-C-N 117.767 0.784 . . . . 74.03 111.852 171.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.406 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 7.9 t0 -58.05 99.79 0.05 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 O-C-N 125.038 1.461 . . . . 71.43 110.774 -169.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -155.63 139.29 16.05 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 125.551 1.54 . . . . 75.44 109.63 -175.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 66.06 51.39 1.31 Allowed 'General case' 0 N--CA 1.509 2.506 0 C-N-CA 123.148 0.579 . . . . 73.23 111.935 168.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.9 -11.01 36.84 Favored Glycine 0 CA--C 1.541 1.69 0 N-CA-C 117.456 1.742 . . . . 53.32 117.456 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' A' ' 70' ' ' ASP . 8.8 t30 -114.83 118.9 34.84 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 119.608 1.704 . . . . 74.51 108.84 -177.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.96 107.59 19.88 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 113.57 0.952 . . . . 70.32 113.57 -176.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.647 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -159.35 108.87 1.89 Allowed 'General case' 0 C--O 1.167 -3.261 0 N-CA-C 107.48 -1.304 . . . . 74.04 107.48 165.847 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 -90.79 107.58 19.28 Favored 'General case' 0 CA--C 1.554 1.098 0 CA-C-N 122.728 2.513 . . . . 72.03 108.028 -175.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.475 HG22 HG13 ' A' ' 12' ' ' VAL . 57.7 t -127.28 111.46 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 O-C-N 120.771 -1.206 . . . . 55.21 108.776 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -149.44 133.68 17.33 Favored 'General case' 0 C--O 1.257 1.475 0 CA-C-N 120.565 1.529 . . . . 64.32 110.615 -166.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.8 m -73.47 126.14 90.16 Favored Pre-proline 0 C--N 1.37 1.491 0 CA-C-O 121.363 0.601 . . . . 73.11 111.88 164.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -96.49 17.31 0.68 Allowed 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.367 2.711 . . . . 53.3 113.959 164.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -114.32 -26.38 8.02 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 120.574 -0.45 . . . . 75.32 112.063 176.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 CA--C 1.569 1.683 0 O-C-N 124.583 1.177 . . . . 72.44 113.43 -175.998 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 t . . . . . 0 CA--C 1.548 0.878 0 N-CA-C 110.188 -0.301 . . . . 74.35 110.188 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.551 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 0.3 OUTLIER -141.87 160.34 40.4 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 112.66 0.615 . . . . 71.33 112.66 -176.726 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.797 HG12 HG12 ' A' ' 80' ' ' VAL . 3.7 mt -113.64 136.9 48.59 Favored 'Isoleucine or valine' 0 C--O 1.246 0.911 0 N-CA-C 109.075 -0.713 . . . . 53.42 109.075 176.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -111.35 112.86 24.93 Favored 'General case' 0 C--N 1.354 0.761 0 O-C-N 124.619 1.2 . . . . 64.3 108.923 172.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 4.0 p -124.42 110.38 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-O 121.577 0.703 . . . . 73.0 111.422 175.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -117.62 159.24 14.22 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.918 -0.583 . . . . 64.11 112.458 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.1 m120 60.87 28.98 18.72 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.996 0.918 . . . . 64.04 111.925 175.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.538 HD23 ' H ' ' A' ' 15' ' ' LEU . 2.1 pt? -85.04 137.46 37.5 Favored Pre-proline 0 C--O 1.239 0.528 0 CA-C-N 115.873 -0.603 . . . . 61.24 111.564 -172.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -69.23 126.92 14.26 Favored 'Trans proline' 0 C--N 1.36 1.142 0 C-N-CA 122.23 1.954 . . . . 71.11 112.055 174.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.6 t 52.23 92.24 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.96 0 O-C-N 124.672 1.233 . . . . 51.3 111.956 -173.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 34.0 p-80 -58.71 131.61 51.41 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.652 -0.703 . . . . 72.42 111.325 -177.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.3 m -72.45 133.54 31.58 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-N 115.079 -0.964 . . . . 61.31 111.525 -176.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.414 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -83.03 157.08 23.05 Favored 'General case' 0 C--O 1.212 -0.888 0 CA-C-N 114.968 -1.015 . . . . 64.4 110.541 -178.923 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.2 p -60.17 -31.42 70.1 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.097 1.517 . . . . 72.14 115.097 -166.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.63 -47.11 67.47 Favored 'General case' 0 C--O 1.249 1.058 0 CA-C-O 121.747 0.784 . . . . 52.24 110.673 176.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -66.62 -40.23 88.68 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 113.686 -1.597 . . . . 74.22 110.436 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.588 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 57.2 t -59.93 -46.73 93.62 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 O-C-N 123.899 0.749 . . . . 72.11 109.654 170.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.516 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 0.3 OUTLIER -58.92 -54.4 47.52 Favored 'General case' 0 C--O 1.204 -1.327 0 CA-C-O 118.667 -0.683 . . . . 72.35 111.326 -175.784 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.488 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 5.7 m-80 -79.97 -49.78 11.36 Favored 'General case' 0 C--O 1.278 2.564 0 N-CA-C 114.523 1.305 . . . . 74.44 114.523 -177.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -68.69 -35.54 77.33 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 120.407 -0.517 . . . . 54.42 109.961 -173.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.588 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 59.0 m-85 -85.31 -18.22 34.52 Favored 'General case' 0 CA--C 1.556 1.195 0 N-CA-C 113.671 0.989 . . . . 73.41 113.671 172.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.516 ' HB3' ' O ' ' A' ' 25' ' ' GLU . 2.3 ppt_? -64.85 -25.36 67.87 Favored 'General case' 0 N--CA 1.503 2.191 0 CA-C-N 120.387 1.448 . . . . 72.01 110.768 167.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.76 -30.95 57.84 Favored 'General case' 0 CA--C 1.565 1.523 0 O-C-N 123.455 0.472 . . . . 64.25 111.879 168.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.507 ' CD1' ' HA ' ' A' ' 28' ' ' PHE . 1.0 OUTLIER -74.9 -17.57 60.55 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.493 0.717 . . . . 63.0 111.659 -175.448 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 140.84 57.73 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 119.358 -1.401 . . . . 72.01 113.399 174.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 55.28 98.0 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 125.573 1.549 . . . . 53.02 113.302 173.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.91 124.54 36.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.295 -1.32 . . . . 70.43 110.993 -177.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -90.01 -42.68 11.0 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 114.898 -1.047 . . . . 72.15 109.744 175.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -144.34 139.43 28.5 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.842 -0.617 . . . . 64.22 110.693 -177.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 8.5 p -129.57 123.24 30.86 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.133 -0.485 . . . . 71.14 110.009 172.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -130.33 128.14 40.87 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 116.497 -0.319 . . . . 73.33 110.21 177.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.9 t -109.81 116.99 53.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 120.945 0.402 . . . . 74.52 109.925 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt -108.25 157.55 18.24 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.095 -0.502 . . . . 64.12 110.741 -177.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.98 147.98 52.68 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 122.248 -0.282 . . . . 64.1 110.401 173.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.1 t -101.16 165.28 11.38 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.81 -0.441 . . . . 71.22 109.81 171.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.5 t -74.52 -15.23 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 123.787 0.835 . . . . 64.04 110.797 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.9 m -75.56 -9.8 58.89 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.952 -0.567 . . . . 74.03 111.929 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.43 -4.31 47.49 Favored Glycine 0 C--N 1.342 0.912 0 C-N-CA 121.534 -0.365 . . . . 61.34 113.7 175.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -89.53 141.58 28.45 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.1 0.476 . . . . 61.33 111.37 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -106.23 149.6 26.71 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.614 -0.721 . . . . 61.41 110.041 176.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.435 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 2.1 m-85 -136.68 151.29 49.11 Favored 'General case' 0 C--O 1.223 -0.303 0 N-CA-C 109.25 -0.648 . . . . 70.23 109.25 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -127.35 139.61 52.75 Favored 'General case' 0 C--O 1.248 0.976 0 N-CA-C 109.528 -0.545 . . . . 51.23 109.528 169.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -120.53 115.44 23.44 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 106.717 -1.586 . . . . 72.55 106.717 -176.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -133.67 112.26 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 N-CA-C 113.787 1.032 . . . . 74.05 113.787 -166.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -90.84 114.76 27.26 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.531 0.567 . . . . 70.4 112.531 -173.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -110.24 161.94 15.1 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 115.967 -0.56 . . . . 73.21 110.713 176.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -83.09 -30.12 28.23 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.237 0.458 . . . . 70.12 112.237 174.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.48 125.65 49.4 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.836 0.827 . . . . 42.3 112.409 -176.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.53 -45.73 24.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 113.893 -1.503 . . . . 71.42 113.492 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -23.43 53.63 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.005 0.743 . . . . 70.5 113.005 -168.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -73.61 -34.01 64.84 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.786 0.803 . . . . 74.34 109.887 176.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.01 -27.74 61.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.708 -1.133 . . . . 64.4 112.658 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.56 -33.44 63.87 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.246 1.202 . . . . 44.11 114.246 -175.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.521 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 17.4 m-20 -70.99 -37.67 72.71 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.564 0.697 . . . . 75.32 112.711 177.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.49 ' O ' ' HG3' ' A' ' 65' ' ' GLU . . . -75.74 -36.08 60.01 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.736 0.779 . . . . 60.02 111.097 177.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.851 HG13 HG13 ' A' ' 80' ' ' VAL . 0.4 OUTLIER -68.13 -31.83 53.42 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.231 0 CA-C-O 117.918 -1.039 . . . . 73.35 109.748 174.892 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.521 ' HG3' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -77.11 -20.68 55.34 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 120.201 1.364 . . . . 71.24 111.506 172.659 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -71.73 -27.47 63.02 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 119.438 -0.905 . . . . 64.45 111.394 170.565 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.42 13.9 19.03 Favored 'General case' 0 N--CA 1.511 2.622 0 N-CA-C 116.578 2.066 . . . . 61.24 116.578 167.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.466 ' HB3' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -73.3 158.21 35.55 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 124.663 1.185 . . . . 71.15 112.229 176.215 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.83 23.38 5.01 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 119.981 -1.104 . . . . 32.51 112.259 -159.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 15.8 p -57.22 134.52 56.0 Favored 'General case' 0 C--O 1.24 0.582 0 O-C-N 124.895 0.997 . . . . 53.15 113.125 -173.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.63 149.07 52.62 Favored 'General case' 0 C--O 1.257 1.462 0 CA-C-N 114.242 -1.345 . . . . 70.23 112.605 -170.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -143.81 145.61 32.48 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 112.504 -2.134 . . . . 70.33 110.778 -171.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 73.02 67.95 0.11 Allowed 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 122.569 1.176 . . . . 42.11 114.142 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.88 -11.2 57.5 Favored Glycine 0 C--N 1.333 0.414 0 CA-C-N 113.786 -1.552 . . . . 51.15 114.081 176.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -121.51 123.78 42.83 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.527 -1.286 . . . . 55.45 107.527 158.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.63 103.4 15.33 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 119.222 -0.418 . . . . 60.25 110.962 178.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 13.9 tp -165.41 70.93 0.15 Allowed 'General case' 0 C--O 1.206 -1.186 0 C-N-CA 119.937 -0.705 . . . . 54.33 112.261 177.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -96.76 111.4 23.58 Favored 'General case' 0 C--O 1.209 -1.075 0 O-C-N 119.834 -1.791 . . . . 74.25 109.701 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 t -129.17 119.64 49.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 107.492 -1.299 . . . . 74.34 107.492 170.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -148.16 141.95 25.69 Favored 'General case' 0 C--O 1.247 0.939 0 C-N-CA 119.81 -0.756 . . . . 53.21 111.289 176.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.851 HG13 HG13 ' A' ' 63' ' ' ILE . 19.1 m -89.9 121.95 68.38 Favored Pre-proline 0 N--CA 1.438 -1.035 0 CA-C-N 114.75 -1.114 . . . . 72.44 110.194 166.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.551 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 72.2 Cg_endo -88.21 21.58 0.99 Allowed 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 121.89 1.727 . . . . 63.22 112.503 164.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.455 ' HD2' ' N ' ' A' ' 9' ' ' ARG . 0.2 OUTLIER -116.71 13.1 15.09 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 113.13 0.789 . . . . 71.1 113.13 179.504 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.3 t30 . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 120.925 0.393 . . . . 61.53 111.137 -171.563 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.4 p . . . . . 0 CA--C 1.538 0.5 0 N-CA-C 112.328 0.492 . . . . 60.32 112.328 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.518 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 8.8 ptt180 -132.56 150.51 52.15 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.7 -0.682 . . . . 63.43 112.39 -171.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 34.2 mt -118.51 142.47 33.16 Favored 'Isoleucine or valine' 0 C--O 1.247 0.937 0 C-N-CA 122.963 0.505 . . . . 74.3 110.121 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -111.81 114.65 27.74 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 124.874 1.359 . . . . 73.32 109.466 175.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 2.7 p -123.27 108.04 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 CA-C-O 122.286 1.041 . . . . 61.11 111.799 175.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 77' ' ' ARG . . . -118.66 164.12 13.03 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 114.998 -1.001 . . . . 75.43 113.821 -176.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 58.15 24.74 11.66 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.873 1.269 . . . . 70.3 113.588 170.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -90.25 150.35 42.96 Favored Pre-proline 0 CA--C 1.552 1.023 0 N-CA-C 111.47 0.174 . . . . 55.23 111.47 -174.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 75' ' ' LYS . 57.3 Cg_endo -75.8 150.76 35.21 Favored 'Trans proline' 0 C--N 1.364 1.374 0 C-N-CA 122.771 2.314 . . . . 43.24 113.268 -178.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.7 p 79.88 -21.79 0.31 Allowed 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 127.334 2.254 . . . . 62.41 112.687 -177.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 66.18 107.37 0.04 OUTLIER 'General case' 0 C--N 1.357 0.918 0 C-N-CA 125.236 1.415 . . . . 72.23 110.415 -171.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.402 HG21 HG13 ' A' ' 24' ' ' VAL . 9.9 p -83.04 128.4 38.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 CA-C-N 115.217 -0.902 . . . . 62.54 109.023 175.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 m -91.1 167.95 11.99 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.298 -0.865 . . . . 55.25 109.759 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.4 p -57.28 -39.83 76.5 Favored 'General case' 0 C--O 1.218 -0.605 0 O-C-N 123.892 0.745 . . . . 73.53 112.778 -175.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.4 -39.38 90.5 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.125 0.97 . . . . 71.34 112.78 178.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -75.2 -46.98 30.47 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 116.138 -0.483 . . . . 75.41 111.323 -171.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.402 HG13 HG21 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -67.5 -32.96 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 115.967 -0.56 . . . . 43.31 110.969 173.285 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -58.96 -44.94 91.58 Favored 'General case' 0 C--O 1.206 -1.231 0 CA-C-O 118.639 -0.696 . . . . 74.31 110.811 172.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.448 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 2.0 t-20 -70.67 -48.92 52.34 Favored 'General case' 0 C--O 1.279 2.647 0 CA-C-O 121.631 0.729 . . . . 70.42 111.336 -177.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -61.7 -42.71 99.3 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-N 114.003 -1.453 . . . . 42.44 111.063 -176.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -82.55 -26.04 32.8 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 117.823 -1.084 . . . . 73.45 112.511 178.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 26' ' ' ASN . 46.8 ptt85 -69.92 -33.06 71.66 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 119.327 0.967 . . . . 71.22 111.374 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.07 -26.57 66.8 Favored 'General case' 0 C--N 1.362 1.13 0 C-N-CA 118.796 -1.162 . . . . 62.44 111.541 -177.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.536 ' CD2' ' HB2' ' A' ' 62' ' ' ALA . 69.2 m-85 -92.89 -39.73 11.0 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 111.622 0.23 . . . . 74.1 111.622 178.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -153.39 133.52 4.02 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 111.647 -0.581 . . . . 45.2 111.647 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -64.74 118.09 8.44 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 113.447 0.906 . . . . 72.2 113.447 -168.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.68 139.45 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 114.686 -1.143 . . . . 73.31 111.278 -174.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.3 mp -102.12 -43.72 5.66 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.085 -0.961 . . . . 71.22 111.509 -176.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.92 132.98 20.32 Favored 'General case' 0 C--O 1.213 -0.842 0 N-CA-C 108.951 -0.759 . . . . 73.03 108.951 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.9 t -137.73 119.64 15.34 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 109.73 -0.47 . . . . 71.43 109.73 175.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -130.82 147.66 52.5 Favored 'General case' 0 C--O 1.22 -0.479 0 C-N-CA 120.592 -0.443 . . . . 45.35 111.315 -177.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.2 p -117.12 124.56 73.16 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 CA-C-O 121.535 0.683 . . . . 73.22 111.428 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.92 163.7 12.9 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.565 -0.743 . . . . 70.44 110.071 -178.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.76 150.92 52.1 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 122.001 -0.437 . . . . 75.24 110.9 172.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 15.3 t -100.32 169.47 9.09 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 110.072 -0.344 . . . . 64.22 110.072 172.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.6 t -74.91 -18.13 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.132 0 C-N-CA 123.79 0.836 . . . . 64.43 111.089 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.6 t -75.79 -12.87 60.26 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 122.866 0.467 . . . . 60.34 111.846 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.46 -3.56 43.21 Favored Glycine 0 C--N 1.34 0.783 0 C-N-CA 121.347 -0.454 . . . . 71.44 113.92 175.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.0 144.63 26.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.976 0.417 . . . . 74.44 110.556 176.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.74 147.9 41.6 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.013 -0.539 . . . . 74.35 110.263 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 0.9 OUTLIER -136.77 147.28 46.57 Favored 'General case' 0 C--O 1.217 -0.63 0 N-CA-C 109.411 -0.588 . . . . 74.33 109.411 -175.004 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -121.84 140.39 52.44 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 121.385 0.612 . . . . 74.3 109.91 176.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -113.62 118.09 33.42 Favored 'General case' 0 C--O 1.257 1.479 0 CA-C-N 113.633 -1.621 . . . . 71.33 107.833 -176.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.518 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 4.2 mp -118.25 110.07 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 O-C-N 123.607 0.567 . . . . 43.55 110.781 -174.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -115.52 105.06 12.36 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 121.834 0.826 . . . . 31.22 111.214 -171.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -114.11 171.58 7.52 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.137 1.162 . . . . 63.33 114.137 -177.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -75.28 -43.54 50.62 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 114.713 -1.13 . . . . 71.1 111.554 171.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -117.25 121.92 42.53 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 122.331 1.062 . . . . 74.43 112.078 -175.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.501 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -78.45 -43.53 26.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 112.883 -1.962 . . . . 61.53 113.99 -175.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -74.27 -25.86 59.86 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.39 0.885 . . . . 74.34 113.39 -169.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.488 ' HB3' ' O ' ' A' ' 31' ' ' TYR . 1.3 m-20 -80.75 -44.95 17.81 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.971 0.36 . . . . 53.13 111.971 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.48 -24.05 64.64 Favored 'General case' 0 C--O 1.251 1.147 0 C-N-CA 124.221 1.008 . . . . 32.0 111.747 176.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -53.3 -23.36 8.93 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.441 -1.254 . . . . 51.45 114.128 172.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.457 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -63.51 -47.05 83.29 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 118.823 0.738 . . . . 54.32 111.674 171.194 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.536 ' HB2' ' CD2' ' A' ' 31' ' ' TYR . . . -65.24 -39.92 93.33 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.938 -0.574 . . . . 61.42 110.24 174.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -66.81 -31.28 52.8 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 C-N-CA 120.28 -0.568 . . . . 13.43 111.381 177.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -80.21 -23.35 40.99 Favored 'General case' 0 C--N 1.351 0.631 0 N-CA-C 112.881 0.697 . . . . 73.54 112.881 176.875 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.495 ' HG2' ' HA ' ' A' ' 62' ' ' ALA . 10.2 pt-20 -81.52 -19.55 41.94 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 118.987 -1.085 . . . . 72.21 111.454 171.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 62' ' ' ALA . 68.9 mmtt -92.36 -6.07 50.89 Favored 'General case' 0 CA--C 1.57 1.731 0 CA-C-N 118.451 0.569 . . . . 64.41 111.474 169.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.43 ' HB2' ' HA ' ' A' ' 64' ' ' LYS . 38.3 t70 -64.77 153.33 40.21 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 126.321 1.848 . . . . 71.21 112.746 178.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.71 23.82 4.88 Favored Glycine 0 C--N 1.343 0.942 0 C-N-CA 119.94 -1.124 . . . . 74.22 113.626 -163.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 24.5 p -58.7 133.1 55.63 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-O 122.196 0.998 . . . . 65.24 113.214 -169.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.37 149.13 49.61 Favored 'General case' 0 C--O 1.261 1.69 0 CA-C-N 114.09 -1.413 . . . . 51.32 112.907 -170.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -143.52 145.53 32.63 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 126.112 1.765 . . . . 75.34 111.224 -174.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 73.38 68.61 0.11 Allowed 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 114.554 1.316 . . . . 75.54 114.554 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.66 -10.99 59.37 Favored Glycine 0 N--CA 1.462 0.388 0 CA-C-N 114.188 -1.369 . . . . 73.21 113.778 175.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -120.51 122.6 40.98 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 107.065 -1.458 . . . . 64.51 107.065 155.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.47 ' O ' ' HD3' ' A' ' 16' ' ' PRO . 0.3 OUTLIER -95.08 102.39 14.2 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 117.961 -1.019 . . . . 74.32 110.286 178.573 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.54 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.3 OUTLIER -168.51 67.78 0.07 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 113.599 0.963 . . . . 71.24 113.599 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.403 ' HB3' ' O ' ' A' ' 13' ' ' GLY . 23.8 tpt180 -95.85 111.1 23.16 Favored 'General case' 0 C--O 1.2 -1.529 0 CA-C-N 120.829 1.649 . . . . 73.32 110.157 -176.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.451 ' H ' ' HB3' ' A' ' 69' ' ' CYS . 2.7 t -130.1 118.12 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 108.317 -0.994 . . . . 61.42 108.317 175.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -149.84 147.26 27.75 Favored 'General case' 0 C--O 1.255 1.345 0 C-N-CA 119.825 -0.75 . . . . 64.13 112.264 176.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.9 m -88.74 124.7 64.99 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 114.791 -1.095 . . . . 45.31 111.373 168.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.49 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 61.5 Cg_endo -87.08 12.03 3.08 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.132 1.888 . . . . 71.11 113.958 167.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.501 ' CE1' ' HB1' ' A' ' 56' ' ' ALA . 10.7 p90 -102.26 -25.79 13.55 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.847 0.684 . . . . 71.44 112.847 177.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.7 m120 . . . . . 0 N--CA 1.488 1.472 0 C-N-CA 124.255 1.022 . . . . 73.42 113.198 -176.366 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 CA--C 1.538 0.493 0 CA-C-O 120.681 0.276 . . . . 71.2 110.814 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 24.2 ptt180 -143.68 152.57 41.49 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-N 115.837 -0.62 . . . . 60.43 111.851 -176.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 52.9 mt -116.98 135.46 57.28 Favored 'Isoleucine or valine' 0 C--O 1.256 1.421 0 C-N-CA 122.924 0.489 . . . . 74.35 109.849 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -103.0 115.13 30.02 Favored 'General case' 0 C--N 1.362 1.142 0 O-C-N 125.644 1.84 . . . . 75.2 109.412 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.9 t -115.77 132.81 64.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 107.657 -1.238 . . . . 72.33 107.657 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -140.89 160.3 26.64 Favored Glycine 0 CA--C 1.519 0.301 0 N-CA-C 111.775 -0.53 . . . . 53.2 111.775 173.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 61.02 27.54 17.4 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.79 0.836 . . . . 71.41 112.105 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.29 125.77 73.53 Favored Pre-proline 0 C--O 1.237 0.413 0 N-CA-C 111.7 0.259 . . . . 63.04 111.7 -174.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.35 150.68 37.05 Favored 'Trans proline' 0 C--N 1.36 1.164 0 C-N-CA 121.794 1.662 . . . . 73.22 110.8 165.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.8 m -22.16 -83.13 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 125.629 1.83 . . . . 73.32 115.788 -163.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.2 t60 52.33 -91.86 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 124.996 1.319 . . . . 72.24 112.01 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.7 m -100.15 120.92 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-O 121.053 0.454 . . . . 71.33 110.775 176.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.498 ' O ' HG23 ' A' ' 24' ' ' VAL . 47.2 m -88.39 177.53 6.8 Favored 'General case' 0 C--O 1.193 -1.887 0 CA-C-O 117.575 -1.202 . . . . 75.22 107.844 170.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.7 m -49.67 -49.97 45.31 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 120.344 1.429 . . . . 72.14 114.391 -169.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -39.35 94.24 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.092 0.957 . . . . 62.35 111.697 177.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.83 -32.51 57.63 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 115.262 -0.881 . . . . 74.21 111.488 -177.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 20' ' ' SER . 47.8 t -62.82 -47.32 93.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 108.228 -1.027 . . . . 71.45 108.228 170.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.13 -51.19 67.24 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 124.422 1.076 . . . . 75.53 111.862 177.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -73.89 -43.85 57.19 Favored 'General case' 0 C--O 1.276 2.46 0 N-CA-C 112.564 0.579 . . . . 72.24 112.564 -174.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -57.78 -46.72 84.19 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 115.177 -0.919 . . . . 64.02 110.132 177.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -78.35 -25.4 46.34 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 117.956 -1.021 . . . . 71.15 112.29 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -72.42 -28.98 63.3 Favored 'General case' 0 C--N 1.358 0.971 0 CA-C-N 118.971 0.805 . . . . 74.24 112.468 -179.654 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.66 -31.16 70.95 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 118.612 -1.235 . . . . 74.45 111.445 176.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.524 ' CD2' ' HB2' ' A' ' 62' ' ' ALA . 99.2 m-85 -87.94 -37.17 16.64 Favored 'General case' 0 C--O 1.219 -0.534 0 C-N-CA 121.193 -0.203 . . . . 62.32 111.174 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 29' ' ' ARG . . . -152.29 147.3 16.85 Favored Glycine 0 C--O 1.223 -0.589 0 N-CA-C 111.759 -0.536 . . . . 73.2 111.759 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -74.49 105.12 5.47 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 117.694 0.747 . . . . 75.22 112.937 -172.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.405 HG22 ' H ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -77.06 130.94 35.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 114.909 -1.041 . . . . 74.02 111.531 -175.537 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 56.2 mt -93.73 -47.9 6.56 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 114.418 -1.264 . . . . 74.14 111.083 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.447 ' HG3' ' HB3' ' A' ' 52' ' ' GLU . 0.1 OUTLIER -144.07 144.09 31.46 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.234 0.54 . . . . 73.41 109.996 173.811 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.6 t -132.15 120.47 22.32 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.058 -0.719 . . . . 73.13 109.058 178.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -129.45 125.95 37.64 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 120.454 -0.498 . . . . 75.35 111.384 -174.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 75.9 t -107.94 121.29 60.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 122.642 0.377 . . . . 74.12 110.121 -177.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -108.69 157.49 18.49 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 116.297 -0.41 . . . . 73.12 110.713 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.22 147.59 52.61 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.416 0.15 . . . . 61.05 110.908 172.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.3 t -101.1 167.06 10.47 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 110.014 -0.365 . . . . 55.41 110.014 173.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.9 m -75.43 -11.02 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 123.81 0.844 . . . . 72.52 112.411 177.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -80.25 -11.65 59.7 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 122.629 0.372 . . . . 71.25 111.222 176.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.43 -2.04 46.42 Favored Glycine 0 C--N 1.34 0.786 0 C-N-CA 121.426 -0.416 . . . . 72.31 113.886 176.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.39 143.24 27.12 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.211 0.529 . . . . 74.31 111.596 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -105.56 150.28 25.51 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.157 -0.929 . . . . 65.14 110.673 178.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -134.5 150.1 50.76 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 108.767 -0.827 . . . . 73.12 108.767 -177.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -129.31 137.14 50.84 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.143 0.497 . . . . 72.14 110.631 174.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.94 120.05 37.24 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 108.576 -0.898 . . . . 72.31 108.576 175.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 3.2 mp -120.32 111.56 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 119.158 -1.017 . . . . 71.43 111.114 -174.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.447 ' HB3' ' HG3' ' A' ' 36' ' ' LYS . 32.0 tt0 -113.45 108.0 16.61 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-O 120.813 0.339 . . . . 70.34 111.71 -172.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.28 170.51 8.24 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.269 -0.878 . . . . 55.45 111.954 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -78.85 -31.49 45.68 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 112.825 0.676 . . . . 73.15 112.825 175.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -120.35 125.01 46.95 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 122.241 1.019 . . . . 73.42 112.607 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.9 -46.01 25.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 113.99 -1.459 . . . . 71.51 113.931 -175.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.402 ' H ' ' HG2' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -76.18 -25.1 54.86 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.641 0.978 . . . . 65.22 113.641 -165.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.518 ' HB3' ' O ' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -80.0 -35.52 37.29 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.627 0.727 . . . . 74.14 111.707 177.52 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.33 -18.61 59.97 Favored 'General case' 0 C--O 1.257 1.49 0 C-N-CA 124.577 1.151 . . . . 73.02 112.767 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -53.15 -26.42 16.86 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 114.626 -1.17 . . . . 74.33 113.134 170.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.413 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -69.32 -34.69 75.04 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.208 0.603 . . . . 74.24 111.697 172.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.617 ' O ' ' HD2' ' A' ' 66' ' ' LYS . . . -66.57 -48.75 68.63 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 110.425 -0.213 . . . . 70.02 110.425 171.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.46 -30.78 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 C-N-CA 120.296 -0.561 . . . . 64.14 111.002 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.546 ' HA ' ' HB2' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -79.18 -21.04 46.95 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 118.916 0.78 . . . . 74.43 112.777 171.865 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.88 -37.26 76.0 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 118.885 0.766 . . . . 73.41 110.581 171.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.617 ' HD2' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -100.13 12.67 36.42 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 118.284 -1.367 . . . . 63.41 114.28 174.488 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.546 ' HB2' ' HA ' ' A' ' 64' ' ' LYS . 21.0 t70 -51.54 152.83 2.51 Favored 'General case' 0 N--CA 1.506 2.368 0 C-N-CA 126.998 2.119 . . . . 61.24 114.442 170.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.3 25.35 3.82 Favored Glycine 0 C--N 1.35 1.332 0 C-N-CA 119.554 -1.308 . . . . 63.35 113.948 -165.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.611 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 8.6 p -58.48 133.49 55.84 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 122.393 1.092 . . . . 74.4 113.147 -173.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.94 144.46 47.46 Favored 'General case' 0 C--O 1.256 1.404 0 CA-C-N 113.771 -1.559 . . . . 73.23 113.48 -171.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -143.56 147.66 34.76 Favored 'General case' 0 CA--C 1.553 1.089 0 O-C-N 125.834 1.959 . . . . 71.51 110.83 -172.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 74.14 66.07 0.09 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 122.484 1.135 . . . . 70.42 113.463 174.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.74 -10.25 62.45 Favored Glycine 0 N--CA 1.461 0.304 0 CA-C-N 114.263 -1.335 . . . . 71.43 113.302 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -119.64 122.51 41.68 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.063 -1.458 . . . . 73.31 107.063 161.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.59 102.16 13.93 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 118.446 -0.788 . . . . 74.41 110.676 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.611 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -165.49 60.18 0.11 Allowed 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 113.304 0.853 . . . . 73.14 113.304 179.911 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.4 tpp85 -93.67 117.21 29.8 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 120.585 -1.322 . . . . 64.45 111.031 -171.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.509 HG21 ' O ' ' A' ' 66' ' ' LYS . 2.2 m -128.59 120.96 53.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.902 -1.045 . . . . 73.12 109.346 174.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -148.93 145.4 27.39 Favored 'General case' 0 C--O 1.255 1.351 0 CA-C-O 121.97 0.89 . . . . 61.03 112.503 -178.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.1 m -89.47 123.48 66.68 Favored Pre-proline 0 CA--C 1.546 0.792 0 CA-C-N 115.012 -0.995 . . . . 73.34 110.042 167.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.438 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 66.9 Cg_endo -88.79 4.3 5.47 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.162 1.908 . . . . 72.34 113.335 166.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -95.01 -32.29 13.21 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 119.062 -0.494 . . . . 61.03 111.983 176.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.8 t30 . . . . . 0 N--CA 1.486 1.342 0 O-C-N 124.564 1.165 . . . . 73.33 111.118 -174.242 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.535 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . 80.3 p . . . . . 0 CA--C 1.546 0.817 0 N-CA-C 111.257 0.095 . . . . 74.31 111.257 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.469 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 0.9 OUTLIER -126.22 149.98 48.68 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 111.952 0.353 . . . . 71.23 111.952 -177.183 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.0 mp -131.96 134.74 59.57 Favored 'Isoleucine or valine' 0 C--O 1.247 0.927 0 C-N-CA 123.882 0.873 . . . . 70.42 109.208 -178.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -115.82 115.21 25.87 Favored 'General case' 0 C--O 1.242 0.676 0 O-C-N 124.029 0.831 . . . . 65.32 109.613 177.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.447 HG23 HG22 ' A' ' 78' ' ' VAL . 3.4 p -119.74 111.43 32.8 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.819 0 CA-C-O 121.431 0.634 . . . . 75.23 110.867 172.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -123.52 158.79 18.16 Favored Glycine 0 CA--C 1.52 0.372 0 CA-C-N 116.077 -0.511 . . . . 21.54 113.522 -175.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.7 m120 62.25 26.63 15.96 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.235 1.014 . . . . 62.14 111.648 175.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.618 HD23 ' H ' ' A' ' 15' ' ' LEU . 1.5 pt? -82.57 125.11 76.84 Favored Pre-proline 0 CA--C 1.543 0.708 0 CA-C-O 120.878 0.37 . . . . 70.1 111.848 -170.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -86.45 125.99 2.59 Favored 'Trans proline' 0 C--N 1.363 1.326 0 C-N-CA 121.829 1.686 . . . . 73.11 113.081 175.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.8 m 26.01 62.82 0.07 Allowed 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 126.417 1.887 . . . . 42.2 114.887 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.475 ' HB3' HD12 ' A' ' 15' ' ' LEU . 0.5 OUTLIER -110.4 -134.31 0.35 Allowed 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.611 -0.722 . . . . 74.54 109.091 -171.493 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.2 m -69.76 126.04 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 111.993 0.368 . . . . 75.44 111.993 174.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.9 m -83.84 173.47 11.23 Favored 'General case' 0 C--O 1.211 -0.938 0 N-CA-C 108.403 -0.962 . . . . 43.33 108.403 173.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.6 t -60.15 -37.39 79.98 Favored 'General case' 0 CA--C 1.557 1.219 0 CA-C-N 118.969 0.804 . . . . 64.21 112.905 -174.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -66.61 -44.96 80.67 Favored 'General case' 0 C--O 1.251 1.172 0 C-N-CA 123.066 0.547 . . . . 73.31 110.808 176.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -68.4 -34.37 75.9 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.096 -0.956 . . . . 72.23 110.679 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.659 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 74.3 t -60.45 -51.72 69.79 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.588 0 N-CA-C 108.969 -0.752 . . . . 72.04 108.969 171.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.409 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 25.2 tt0 -57.01 -53.82 53.76 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 118.873 -0.584 . . . . 71.04 111.61 -177.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -76.4 -52.04 10.66 Favored 'General case' 0 C--O 1.26 1.629 0 CA-C-N 118.63 0.65 . . . . 74.23 112.113 -172.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.84 -39.0 66.92 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 120.685 -0.406 . . . . 73.01 110.057 -172.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.659 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 4.4 m-85 -77.57 -23.02 50.08 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 118.094 -0.955 . . . . 73.54 111.5 177.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 10.1 ptt180 -72.29 -25.9 61.76 Favored 'General case' 0 C--N 1.374 1.632 0 CA-C-N 120.065 1.302 . . . . 73.04 110.876 170.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.69 -25.86 65.89 Favored 'General case' 0 CA--C 1.561 1.388 0 C-N-CA 120.105 -0.638 . . . . 64.21 111.337 175.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.479 ' CG ' ' HB2' ' A' ' 62' ' ' ALA . 98.4 m-85 -89.32 -35.21 16.24 Favored 'General case' 0 C--O 1.216 -0.676 0 N-CA-C 111.974 0.361 . . . . 65.35 111.974 174.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 29' ' ' ARG . . . -156.9 137.94 5.67 Favored Glycine 0 C--O 1.228 -0.236 0 C-N-CA 120.884 -0.674 . . . . 64.33 111.668 177.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -62.06 114.73 3.57 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.142 0.577 . . . . 71.3 112.133 -175.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.61 124.76 39.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.948 0.88 . . . . 74.5 112.119 -173.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.5 mp -97.62 -36.84 10.15 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.208 -1.36 . . . . 74.34 110.327 175.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -145.43 131.25 19.07 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 120.694 0.283 . . . . 51.4 111.069 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -122.09 121.28 36.59 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 110.043 -0.355 . . . . 52.43 110.043 175.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -131.03 125.63 33.77 Favored 'General case' 0 C--O 1.219 -0.535 0 C-N-CA 120.432 -0.507 . . . . 74.12 110.277 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.01 119.31 61.06 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 CA-C-O 121.955 0.883 . . . . 72.24 110.837 176.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -117.46 157.69 25.8 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.256 -0.883 . . . . 73.54 110.348 -177.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.39 151.22 51.12 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 122.088 -0.382 . . . . 71.25 110.537 173.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.9 t -101.34 164.53 11.73 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 110.119 -0.326 . . . . 74.34 110.119 172.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.6 m -75.63 -10.28 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.78 0.832 . . . . 71.31 112.511 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -78.65 -9.29 59.33 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 122.682 0.393 . . . . 65.11 110.879 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.66 -5.01 43.27 Favored Glycine 0 C--N 1.344 0.999 0 C-N-CA 121.179 -0.534 . . . . 70.31 113.827 176.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -89.38 143.0 27.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.972 0.415 . . . . 71.2 111.444 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -107.71 149.86 27.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.648 -0.705 . . . . 72.22 109.635 175.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -137.49 150.13 47.33 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.426 -0.583 . . . . 73.52 109.426 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -127.6 138.61 52.91 Favored 'General case' 0 C--O 1.253 1.271 0 CA-C-O 121.718 0.771 . . . . 70.13 109.344 170.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -116.47 120.61 39.33 Favored 'General case' 0 C--O 1.252 1.216 0 CA-C-N 113.688 -1.596 . . . . 73.4 107.509 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.87 126.84 73.25 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.67 0 CA-C-N 115.611 -0.722 . . . . 71.44 111.111 -170.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -115.51 114.73 25.39 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 122.331 -0.23 . . . . 75.33 111.539 -178.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -109.47 169.22 8.84 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.351 0.26 . . . . 73.03 110.884 176.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -81.59 -31.18 32.65 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.22 0.452 . . . . 74.42 112.22 169.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -119.29 125.49 49.21 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-O 122.107 0.956 . . . . 50.21 112.816 -172.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.39 -44.99 18.45 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 115.644 1.72 . . . . 65.5 115.644 -177.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.76 -24.76 56.08 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 113.457 0.91 . . . . 73.14 113.457 -167.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.73 -27.43 40.61 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 121.494 0.664 . . . . 73.43 111.272 175.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.84 -25.06 61.82 Favored 'General case' 0 C--O 1.249 1.036 0 C-N-CA 124.265 1.026 . . . . 64.51 112.065 174.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.527 ' HA ' HG22 ' A' ' 63' ' ' ILE . . . -57.64 -27.85 63.19 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.048 -0.978 . . . . 75.32 112.859 177.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -67.83 -41.74 82.54 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 122.751 0.421 . . . . 72.22 111.149 174.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.479 ' HB2' ' CG ' ' A' ' 31' ' ' TYR . . . -64.05 -44.95 90.91 Favored 'General case' 0 C--O 1.237 0.417 0 O-C-N 123.55 0.531 . . . . 72.42 111.213 175.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.778 HG13 HG13 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -70.15 -29.93 41.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 119.936 -0.706 . . . . 63.21 110.999 179.145 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.02 -26.44 53.78 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.674 1.125 . . . . 74.12 112.331 176.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -85.98 -18.0 33.77 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 118.621 -1.232 . . . . 75.31 112.524 173.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt -100.14 8.18 44.06 Favored 'General case' 0 CA--C 1.558 1.259 0 O-C-N 121.794 -0.566 . . . . 74.24 111.3 172.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -60.37 152.25 25.83 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 126.596 1.958 . . . . 73.23 111.228 173.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.81 25.07 3.76 Favored Glycine 0 C--N 1.349 1.277 0 C-N-CA 120.166 -1.016 . . . . 73.13 113.715 -160.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.614 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 12.8 t -59.13 132.65 54.66 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.644 0.735 . . . . 63.03 111.439 178.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -135.63 134.7 39.54 Favored 'General case' 0 C--O 1.252 1.214 0 CA-C-N 114.134 -1.394 . . . . 70.1 112.993 -172.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -142.93 148.03 36.25 Favored 'General case' 0 CA--C 1.548 0.886 0 O-C-N 125.658 1.849 . . . . 75.15 109.574 -175.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 75.66 65.86 0.06 Allowed 'General case' 0 N--CA 1.5 2.041 0 CA-C-O 122.828 1.299 . . . . 54.55 114.206 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.02 -10.98 62.2 Favored Glycine 0 C--O 1.227 -0.325 0 CA-C-N 113.579 -1.646 . . . . 41.51 114.174 172.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -121.68 123.99 43.19 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.274 -1.38 . . . . 70.31 107.274 162.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.94 104.77 16.81 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 118.483 -0.77 . . . . 73.22 111.41 -177.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.614 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.4 OUTLIER -166.73 64.31 0.09 Allowed 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 113.394 0.887 . . . . 62.42 113.394 178.48 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.48 ' HD3' ' SG ' ' A' ' 69' ' ' CYS . 0.0 OUTLIER -93.37 115.61 28.17 Favored 'General case' 0 C--O 1.212 -0.907 0 O-C-N 120.909 -1.12 . . . . 71.34 110.324 -173.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.447 HG22 HG23 ' A' ' 12' ' ' VAL . 5.5 t -128.25 117.85 46.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 107.757 -1.201 . . . . 62.23 107.757 168.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -151.73 140.97 21.38 Favored 'General case' 0 C--O 1.244 0.775 0 C-N-CA 119.833 -0.747 . . . . 65.01 112.309 -177.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.778 HG13 HG13 ' A' ' 63' ' ' ILE . 15.3 m -91.74 125.46 57.31 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 115.918 -0.583 . . . . 63.41 111.879 168.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.469 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 60.3 Cg_endo -84.59 13.5 2.73 Favored 'Trans proline' 0 CA--C 1.547 1.125 0 C-N-CA 122.363 2.042 . . . . 71.24 113.806 165.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.535 ' CD2' ' HB2' ' A' ' 8' ' ' SER . 1.8 p90 -101.66 -20.45 15.0 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.422 0.555 . . . . 74.33 112.191 176.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.494 1.729 0 C-N-CA 125.022 1.329 . . . . 61.41 112.661 -170.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.547 0.858 0 N-CA-C 112.704 0.631 . . . . 73.52 112.704 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.46 ' HD2' ' CE2' ' A' ' 50' ' ' PHE . 0.6 OUTLIER -136.27 159.7 40.94 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 122.825 0.45 . . . . 63.41 111.21 -173.344 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.1 mt -117.38 142.88 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.118 0.967 . . . . 71.22 108.531 -178.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -112.26 111.18 21.88 Favored 'General case' 0 C--N 1.349 0.58 0 N-CA-C 109.786 -0.449 . . . . 74.24 109.786 -177.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.685 HG12 HG13 ' A' ' 78' ' ' VAL . 26.2 m -123.95 108.08 20.0 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-O 121.946 0.879 . . . . 62.42 111.29 175.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -133.69 168.94 23.01 Favored Glycine 0 CA--C 1.518 0.261 0 N-CA-C 114.873 0.709 . . . . 64.1 114.873 -176.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.8 m120 58.36 21.43 8.32 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.838 1.255 . . . . 53.42 112.071 176.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.444 HD23 ' H ' ' A' ' 15' ' ' LEU . 1.2 pt? -90.88 149.78 40.86 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 112.338 0.495 . . . . 71.53 112.338 -167.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 75' ' ' LYS . 24.5 Cg_endo -65.02 137.57 53.2 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 123.144 2.563 . . . . 71.33 112.868 176.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.1 p 73.77 -41.73 0.5 Allowed 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 126.61 1.964 . . . . 65.44 111.692 -173.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 68.41 117.34 0.03 OUTLIER 'General case' 0 C--N 1.365 1.25 0 C-N-CA 125.7 1.6 . . . . 70.45 111.052 -177.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.8 m -69.71 128.84 33.69 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 CA-C-N 114.646 -1.161 . . . . 64.21 110.564 177.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.1 m -83.15 169.14 16.14 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 114.364 -1.289 . . . . 72.32 108.787 176.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.2 m -57.17 -41.87 80.08 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.654 0.612 . . . . 71.52 112.654 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -64.83 -47.68 77.1 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.154 0.581 . . . . 74.34 111.321 178.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -67.77 -44.28 77.82 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 114.646 -1.161 . . . . 75.22 111.037 -174.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.562 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 9.0 p -70.46 -34.93 59.77 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 CA-C-O 118.99 -0.529 . . . . 43.02 110.036 177.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -61.06 -52.7 63.85 Favored 'General case' 0 C--O 1.212 -0.888 0 CA-C-O 118.745 -0.645 . . . . 54.13 110.524 178.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -73.0 -51.11 19.48 Favored 'General case' 0 C--O 1.27 2.158 0 CA-C-N 118.12 0.418 . . . . 64.42 111.622 -174.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -69.22 -44.01 72.93 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 115.467 -0.788 . . . . 72.12 110.457 -173.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.562 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 0.7 OUTLIER -76.85 -25.13 52.81 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 118.676 -0.678 . . . . 75.15 111.534 179.32 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.7 ptt85 -72.44 -22.99 61.01 Favored 'General case' 0 C--N 1.365 1.257 0 CA-C-N 119.429 1.013 . . . . 75.33 111.834 174.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -29.71 70.45 Favored 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 119.543 -0.863 . . . . 72.32 111.421 170.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -88.77 -37.23 15.61 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.563 0.579 . . . . 71.22 112.563 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -154.74 171.83 33.13 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.501 -0.857 . . . . 73.15 112.587 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -82.0 113.09 19.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.571 0.701 . . . . 65.51 111.998 -175.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.86 126.4 43.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 114.803 -1.089 . . . . 71.41 110.586 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 26.2 mt -94.86 -43.11 8.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.488 -1.233 . . . . 70.0 109.568 178.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.05 153.33 33.77 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.491 0.316 . . . . 70.15 110.479 170.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 13.4 p -126.92 124.76 40.26 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.785 -0.45 . . . . 63.2 109.785 173.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -129.68 125.94 37.17 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-N 115.974 -0.557 . . . . 71.43 111.093 -176.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 72.1 t -112.08 123.02 67.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-O 121.041 0.448 . . . . 62.21 111.176 -174.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.13 161.32 22.0 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.069 -0.514 . . . . 71.3 110.869 -174.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.5 152.02 51.85 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 122.457 -0.152 . . . . 73.22 111.004 172.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.4 t -100.62 169.39 9.08 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 109.973 -0.38 . . . . 71.42 109.973 169.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.3 t -75.3 -15.45 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 C-N-CA 123.715 0.806 . . . . 73.3 111.259 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.3 m -75.88 -7.56 54.8 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.107 0.563 . . . . 44.05 112.175 -179.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.76 -4.74 53.53 Favored Glycine 0 C--N 1.341 0.844 0 C-N-CA 121.345 -0.455 . . . . 62.12 113.308 176.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.75 138.38 31.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.832 0.348 . . . . 75.01 110.791 178.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.44 147.93 38.54 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.741 -0.663 . . . . 62.13 110.546 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -136.22 165.91 24.64 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.187 0.517 . . . . 73.13 109.96 -171.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -141.35 139.72 33.6 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-N 115.328 -0.851 . . . . 61.23 109.96 171.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.46 ' CE2' ' HD2' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -114.43 118.69 34.52 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 113.996 -1.456 . . . . 71.34 107.263 -179.655 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.76 112.77 36.44 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.531 0 C-N-CA 119.556 -0.858 . . . . 73.33 111.151 -171.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -88.58 106.98 18.66 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-N 116.545 -0.298 . . . . 74.54 110.233 -170.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -114.27 143.46 44.82 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.58 -0.736 . . . . 74.33 112.021 -174.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -83.06 -28.38 29.61 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 120.558 -0.457 . . . . 72.12 111.83 172.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.61 126.68 49.66 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.864 0.84 . . . . 62.33 112.402 -178.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.41 -45.4 17.73 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 114.19 1.181 . . . . 73.04 114.19 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -75.31 -25.17 57.64 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.963 0.727 . . . . 73.21 112.963 -167.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -80.13 -34.73 37.55 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.505 0.669 . . . . 71.14 109.841 175.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.67 -24.09 65.38 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.785 1.234 . . . . 33.23 112.511 172.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.44 ' HA ' HG22 ' A' ' 63' ' ' ILE . . . -58.01 -25.0 60.53 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 114.572 1.323 . . . . 32.05 114.572 -174.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.21 -44.93 78.35 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 118.881 0.764 . . . . 51.1 111.483 173.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.36 -43.38 98.96 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 115.79 -0.641 . . . . 71.43 110.822 173.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.646 HG13 HG13 ' A' ' 80' ' ' VAL . 0.4 OUTLIER -68.21 -32.3 55.26 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.003 0 CA-C-O 118.852 -0.594 . . . . 72.34 111.359 -179.38 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.62 -26.24 41.21 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.384 0.993 . . . . 75.02 112.341 177.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -81.81 -20.68 38.57 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 119.486 -0.886 . . . . 73.53 111.458 175.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.674 ' HB2' HG11 ' A' ' 78' ' ' VAL . 69.5 mmtt -99.39 0.01 41.87 Favored 'General case' 0 CA--C 1.569 1.706 0 C-N-CA 120.189 -0.605 . . . . 73.11 111.335 172.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 35.0 t70 -70.42 154.83 41.47 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 125.695 1.598 . . . . 64.52 111.425 177.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.53 25.11 4.44 Favored Glycine 0 C--N 1.346 1.133 0 C-N-CA 119.637 -1.268 . . . . 61.33 112.058 -159.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.701 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 8.2 t -57.22 131.56 50.36 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 124.496 0.762 . . . . 74.51 111.837 -171.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.63 146.74 46.36 Favored 'General case' 0 C--O 1.252 1.22 0 CA-C-N 114.23 -1.35 . . . . 72.42 113.404 -170.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -143.58 147.8 34.95 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 126.116 1.766 . . . . 74.24 109.807 -173.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 76.3 66.71 0.06 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 122.686 1.232 . . . . 62.4 113.381 173.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.05 -11.71 63.96 Favored Glycine 0 C--N 1.337 0.638 0 CA-C-N 113.729 -1.578 . . . . 70.02 113.313 177.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -119.2 122.09 41.2 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 106.841 -1.54 . . . . 64.41 106.841 163.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.422 ' O ' ' HD3' ' A' ' 16' ' ' PRO . 0.5 OUTLIER -94.78 105.16 17.08 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 117.954 -1.022 . . . . 73.15 111.075 178.531 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.701 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -165.65 64.7 0.11 Allowed 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 115.283 1.586 . . . . 74.42 115.283 179.319 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.518 ' HA ' ' SG ' ' A' ' 69' ' ' CYS . 0.1 OUTLIER -95.34 113.64 25.33 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 121.8 2.091 . . . . 63.54 111.555 -176.199 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.685 HG13 HG12 ' A' ' 12' ' ' VAL . 95.3 t -131.52 120.76 46.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 121.22 -0.925 . . . . 74.23 109.474 174.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.498 ' HA ' HD11 ' A' ' 63' ' ' ILE . 0.5 OUTLIER -149.14 141.99 24.67 Favored 'General case' 0 C--O 1.258 1.525 0 N-CA-C 113.66 0.985 . . . . 74.01 113.66 173.444 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.646 HG13 HG13 ' A' ' 63' ' ' ILE . 2.3 m -89.76 126.95 56.06 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-N 114.033 -1.44 . . . . 72.35 109.645 159.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -84.24 16.96 1.81 Allowed 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.658 2.238 . . . . 72.2 112.44 170.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -86.33 -30.02 22.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.042 -0.981 . . . . 75.3 110.544 177.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.482 1.142 0 O-C-N 124.824 1.328 . . . . 74.11 110.768 -173.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.3 p . . . . . 0 CA--C 1.53 0.194 0 N-CA-C 112.029 0.381 . . . . 73.25 112.029 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -138.01 158.43 44.35 Favored 'General case' 0 C--O 1.211 -0.948 0 CA-C-N 115.911 -0.586 . . . . 73.41 111.956 -175.903 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.6 mt -117.9 141.66 35.9 Favored 'Isoleucine or valine' 0 C--O 1.254 1.335 0 N-CA-C 109.842 -0.429 . . . . 64.01 109.842 174.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -108.25 119.41 39.41 Favored 'General case' 0 C--O 1.246 0.875 0 O-C-N 124.653 1.221 . . . . 74.34 109.148 178.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.5 ' HB ' HG13 ' A' ' 78' ' ' VAL . 3.6 p -123.14 110.39 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-O 121.918 0.866 . . . . 75.34 111.328 174.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -115.36 166.57 12.22 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-N 115.072 -0.967 . . . . 55.14 113.126 177.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 55.76 30.25 15.35 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.427 1.091 . . . . 74.32 113.083 175.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.494 HD23 ' H ' ' A' ' 15' ' ' LEU . 2.3 pt? -89.16 140.44 28.85 Favored Pre-proline 0 C--O 1.237 0.42 0 CA-C-N 116.341 -0.39 . . . . 73.05 111.773 -172.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -72.05 142.5 38.47 Favored 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 122.527 2.151 . . . . 70.42 112.254 174.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.0 p 77.64 -32.84 0.18 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 127.351 2.26 . . . . 71.23 113.201 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 69.34 120.29 0.03 OUTLIER 'General case' 0 C--N 1.365 1.26 0 C-N-CA 124.869 1.268 . . . . 74.42 110.513 -174.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.442 ' H ' HD11 ' A' ' 15' ' ' LEU . 22.8 m -74.87 126.32 35.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 CA-C-O 121.508 0.671 . . . . 72.44 109.479 173.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.524 ' HB2' ' OD2' ' A' ' 23' ' ' ASP . 19.2 m -81.97 160.68 23.27 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.951 -1.129 . . . . 61.52 107.951 177.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.2 p -60.68 -32.43 71.65 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.42 0.896 . . . . 44.04 113.42 -168.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.19 -38.61 51.17 Favored 'General case' 0 C--O 1.253 1.243 0 C-N-CA 123.844 0.858 . . . . 73.43 111.127 -178.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.524 ' OD2' ' HB2' ' A' ' 20' ' ' SER . 51.8 m-20 -67.28 -48.67 67.0 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 114.676 -1.147 . . . . 71.43 110.205 -179.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.463 HG13 ' SG ' ' A' ' 37' ' ' CYS . 9.3 p -69.73 -29.91 42.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 CA-C-N 114.482 -1.235 . . . . 52.21 110.57 177.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -57.75 -53.17 61.24 Favored 'General case' 0 C--N 1.359 1.001 0 CA-C-O 118.812 -0.614 . . . . 72.43 111.188 170.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -67.22 -48.07 68.92 Favored 'General case' 0 C--O 1.295 3.463 0 CA-C-O 122.127 0.965 . . . . 73.52 111.87 -178.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -58.93 -47.78 83.81 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-N 113.777 -1.556 . . . . 62.31 109.945 -175.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.475 ' HA ' ' CD1' ' A' ' 31' ' ' TYR . 14.9 m-85 -81.99 -15.76 52.63 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.092 0.775 . . . . 65.34 113.092 -179.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 23.4 mtp180 -60.4 -35.35 75.56 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 118.149 0.431 . . . . 64.53 110.446 164.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.74 -30.22 70.63 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 119.487 -0.885 . . . . 72.21 112.954 168.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.475 ' CD1' ' HA ' ' A' ' 28' ' ' PHE . 1.1 m-85 -77.65 -11.27 59.85 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 113.247 0.832 . . . . 74.43 113.247 -171.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 141.28 38.18 0.09 OUTLIER Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.125 -1.036 . . . . 33.4 113.102 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 60.4 95.98 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.895 1.278 . . . . 63.01 112.933 174.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.17 132.63 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 115.774 -0.648 . . . . 64.25 110.701 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.33 -28.62 12.87 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.432 -0.803 . . . . 71.03 109.844 174.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -142.72 129.26 20.2 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.444 -0.343 . . . . 73.4 110.478 -173.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.463 ' SG ' HG13 ' A' ' 24' ' ' VAL . 0.9 OUTLIER -127.73 113.47 16.04 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.624 -0.509 . . . . 42.43 109.624 175.089 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -128.12 124.02 35.89 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 120.393 -0.523 . . . . 60.42 110.747 -178.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 87.2 t -99.6 128.97 50.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 116.114 -0.493 . . . . 75.33 110.346 -177.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.467 ' HB2' ' HB2' ' A' ' 48' ' ' PHE . 71.6 mmtt -106.54 137.02 45.3 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.628 -0.714 . . . . 74.2 109.731 -178.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -130.75 126.15 35.68 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.843 -0.343 . . . . 65.35 110.6 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.0 t -101.04 164.95 11.56 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 120.915 0.388 . . . . 51.44 111.078 177.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.9 t -75.51 -14.08 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 C-N-CA 124.133 0.973 . . . . 73.24 110.872 178.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.2 m -75.52 -11.59 60.06 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.184 0.594 . . . . 73.45 112.401 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.63 -3.32 56.15 Favored Glycine 0 C--N 1.343 0.955 0 C-N-CA 121.343 -0.456 . . . . 53.24 113.743 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.16 143.72 26.89 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.507 0.67 . . . . 63.44 111.285 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.58 142.81 33.98 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.175 -0.92 . . . . 71.45 109.257 177.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.467 ' HB2' ' HB2' ' A' ' 40' ' ' LYS . 7.9 m-85 -137.13 153.31 50.54 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.11 -0.7 . . . . 45.3 109.11 178.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -137.38 139.51 40.79 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-O 121.332 0.587 . . . . 41.34 109.636 170.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -116.35 117.81 31.0 Favored 'General case' 0 C--O 1.252 1.193 0 CA-C-N 113.803 -1.544 . . . . 72.04 106.929 -179.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 3.1 mp -127.16 112.92 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 119.715 -0.794 . . . . 60.41 111.99 -170.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -107.42 107.53 18.45 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.607 -0.724 . . . . 71.32 111.918 -171.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -112.51 167.34 10.53 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 115.039 -0.982 . . . . 74.53 112.977 -177.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -82.3 -25.27 34.13 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 113.39 0.885 . . . . 74.21 113.39 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.5 121.57 39.72 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.388 0.994 . . . . 70.11 112.421 177.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.442 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -81.47 -45.63 15.73 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.294 -1.321 . . . . 75.11 114.563 -177.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.21 -23.59 51.4 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 112.533 0.568 . . . . 74.12 112.533 -171.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -75.28 -26.99 59.2 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.863 0.84 . . . . 73.53 110.142 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.15 -27.14 67.06 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 114.711 -1.131 . . . . 75.51 112.602 175.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.424 ' HA ' HG22 ' A' ' 63' ' ' ILE . . . -59.37 -30.53 68.48 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 114.607 1.336 . . . . 53.53 114.607 -171.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.517 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -67.89 -44.18 77.61 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 122.135 0.969 . . . . 74.1 112.21 176.858 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.51 -31.54 57.74 Favored 'General case' 0 C--O 1.253 1.284 0 CA-C-O 122.604 1.192 . . . . 75.2 111.38 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.433 ' O ' ' HB3' ' A' ' 67' ' ' ASP . 0.4 OUTLIER -70.48 -30.6 43.44 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.465 0 CA-C-O 118.456 -0.783 . . . . 73.25 109.714 174.562 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.517 ' HG3' ' O ' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -77.6 -20.93 53.13 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 119.611 1.096 . . . . 63.1 111.551 170.234 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.78 -27.02 63.6 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-O 118.481 -0.771 . . . . 74.45 111.67 170.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.469 ' HE3' ' OH ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -113.42 13.47 18.96 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 116.405 2.002 . . . . 71.23 116.405 166.129 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.433 ' HB3' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -73.2 158.21 35.66 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 123.989 0.915 . . . . 72.43 112.539 174.662 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 112.72 24.84 4.79 Favored Glycine 0 C--N 1.345 1.036 0 C-N-CA 120.215 -0.993 . . . . 72.05 111.522 -160.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 6.2 p -57.81 132.41 53.25 Favored 'General case' 0 C--N 1.352 0.699 0 CA-C-O 122.392 1.091 . . . . 74.31 112.248 -168.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -134.14 149.27 51.05 Favored 'General case' 0 C--O 1.263 1.763 0 CA-C-N 113.521 -1.672 . . . . 73.13 112.383 -166.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -143.8 146.34 33.02 Favored 'General case' 0 CA--C 1.557 1.246 0 CA-C-N 112.733 -2.03 . . . . 64.31 109.477 -175.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 75.12 66.86 0.07 Allowed 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 124.706 1.202 . . . . 72.54 114.057 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.55 -11.93 59.68 Favored Glycine 0 N--CA 1.464 0.53 0 CA-C-N 113.605 -1.634 . . . . 72.34 113.796 173.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -118.91 119.64 34.95 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 105.717 -1.957 . . . . 52.43 105.717 157.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.94 103.52 15.48 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 118.975 -0.536 . . . . 75.52 111.17 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 12.0 tp -168.78 73.79 0.1 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 118.094 0.406 . . . . 71.22 111.323 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.75 109.04 21.86 Favored 'General case' 0 C--O 1.206 -1.228 0 O-C-N 120.202 -1.562 . . . . 73.14 109.008 -175.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.5 HG13 ' HB ' ' A' ' 12' ' ' VAL . 2.0 t -133.03 125.83 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 O-C-N 121.243 -0.911 . . . . 41.11 109.593 176.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -150.15 163.63 37.72 Favored 'General case' 0 C--O 1.26 1.606 0 CA-C-O 122.6 1.19 . . . . 75.4 113.131 169.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.1 m -87.14 123.39 70.14 Favored Pre-proline 0 CA--C 1.555 1.164 0 CA-C-N 112.649 -2.068 . . . . 63.44 109.047 165.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.458 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 56.5 Cg_endo -85.04 10.36 3.78 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 121.798 1.665 . . . . 74.31 113.941 167.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.442 ' CE1' ' HB1' ' A' ' 56' ' ' ALA . 17.5 p90 -102.87 -60.75 1.5 Allowed 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 112.099 0.407 . . . . 75.2 112.099 175.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.6 t30 . . . . . 0 N--CA 1.487 1.418 0 C-N-CA 126.047 1.739 . . . . 73.15 112.355 -173.691 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' A' ' 52' ' ' GLU . 75.3 m . . . . . 0 N--CA 1.452 -0.348 0 CA-C-O 121.018 0.437 . . . . 74.14 110.382 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.611 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -140.56 156.29 46.34 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-N 115.654 -0.703 . . . . 74.5 112.147 -178.934 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.576 ' HB ' HD12 ' A' ' 51' ' ' ILE . 43.8 mt -113.43 137.91 44.88 Favored 'Isoleucine or valine' 0 C--O 1.258 1.534 0 N-CA-C 108.561 -0.903 . . . . 44.42 108.561 177.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -99.11 112.53 24.64 Favored 'General case' 0 C--N 1.363 1.196 0 O-C-N 126.456 2.347 . . . . 74.41 108.629 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.2 133.05 67.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 107.789 -1.189 . . . . 75.44 107.789 175.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -141.13 159.99 26.7 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 121.223 -0.513 . . . . 64.41 112.801 173.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.502 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 72.8 m-20 60.94 25.59 15.56 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.491 1.116 . . . . 51.12 112.953 171.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.424 HD11 HG22 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -85.58 146.62 44.58 Favored Pre-proline 0 CA--C 1.549 0.942 0 O-C-N 121.363 -0.836 . . . . 73.21 113.033 -163.215 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.28 151.7 43.71 Favored 'Trans proline' 0 C--N 1.361 1.234 0 C-N-CA 123.351 2.701 . . . . 61.14 113.407 174.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.5 p 74.6 -30.52 0.2 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 127.421 2.288 . . . . 71.42 113.422 -176.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 71.2 t60 67.47 106.12 0.05 OUTLIER 'General case' 0 C--N 1.359 0.999 0 C-N-CA 125.24 1.416 . . . . 75.41 110.872 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.424 HG22 HD11 ' A' ' 15' ' ' LEU . 7.7 m -82.59 131.06 34.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 CA-C-N 115.636 -0.711 . . . . 74.24 110.328 176.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.54 ' HB2' ' OD2' ' A' ' 23' ' ' ASP . 16.8 m -89.5 160.84 16.53 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-N 115.388 -0.824 . . . . 41.43 109.545 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.6 t -52.79 -43.37 65.83 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.932 0.893 . . . . 42.51 113.078 -174.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.08 -42.16 80.8 Favored 'General case' 0 C--O 1.25 1.085 0 C-N-CA 124.741 1.216 . . . . 72.54 112.36 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.54 ' OD2' ' HB2' ' A' ' 20' ' ' SER . 12.0 m-20 -66.72 -43.09 85.17 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.125 -0.943 . . . . 73.55 110.376 -178.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.496 ' CG1' HG12 ' A' ' 51' ' ' ILE . 39.1 t -64.19 -40.4 88.92 Favored 'Isoleucine or valine' 0 C--N 1.343 0.309 0 CA-C-N 115.082 -0.963 . . . . 70.45 110.088 174.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.504 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 10.9 tt0 -58.71 -49.95 75.71 Favored 'General case' 0 C--O 1.209 -1.049 0 CA-C-O 118.455 -0.783 . . . . 62.13 111.141 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.5 -46.43 22.48 Favored 'General case' 0 C--O 1.282 2.779 0 N-CA-C 113.686 0.995 . . . . 71.1 113.686 -178.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -59.32 -44.6 92.57 Favored 'General case' 0 C--N 1.36 1.037 0 CA-C-N 116.353 -0.385 . . . . 71.24 110.375 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.456 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 42.6 m-85 -80.62 -20.63 42.76 Favored 'General case' 0 C--O 1.211 -0.921 0 CA-C-O 117.929 -1.034 . . . . 74.15 112.869 176.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.504 ' HB3' ' O ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -66.61 -29.56 69.64 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 120.031 1.287 . . . . 71.13 111.671 172.544 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.86 -31.01 68.62 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 117.185 -1.806 . . . . 74.22 112.202 173.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.488 ' CD2' ' HB2' ' A' ' 62' ' ' ALA . 85.1 m-85 -87.36 -37.08 17.41 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.307 0.484 . . . . 53.41 112.307 -176.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -143.9 165.16 27.36 Favored Glycine 0 C--O 1.221 -0.669 0 N-CA-C 111.662 -0.575 . . . . 72.35 111.662 174.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -80.37 99.39 7.91 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 117.516 0.658 . . . . 63.12 110.579 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.84 132.57 31.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 121.884 0.849 . . . . 72.1 111.744 -171.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.0 mp -103.1 -38.44 7.3 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.212 -1.358 . . . . 74.51 111.371 -178.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.51 131.44 15.21 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 122.89 0.476 . . . . 45.21 110.487 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.8 m -121.26 124.33 44.36 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.836 -0.54 . . . . 75.31 110.667 171.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -128.44 132.86 48.44 Favored 'General case' 0 C--O 1.212 -0.911 0 CA-C-N 116.299 -0.41 . . . . 73.53 110.669 -178.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 p -119.19 120.15 62.93 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.173 0 CA-C-O 121.684 0.755 . . . . 43.43 111.077 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -108.56 157.84 18.11 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.703 -0.68 . . . . 74.53 110.625 -178.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.04 149.87 52.16 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 122.243 -0.285 . . . . 73.13 111.034 173.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.4 t -101.48 166.37 10.76 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 120.654 0.264 . . . . 52.23 110.339 172.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.9 t -75.32 -13.72 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 C-N-CA 124.224 1.01 . . . . 72.42 111.14 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.0 t -76.25 -12.42 60.08 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.063 0.545 . . . . 74.22 111.594 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.87 -3.7 41.79 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.25 -0.5 . . . . 75.04 113.667 177.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.99 152.74 21.52 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.064 0.459 . . . . 72.13 111.001 177.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.14 148.93 49.29 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.625 -0.716 . . . . 32.44 110.205 -177.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -134.61 149.41 50.57 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 109.458 -0.571 . . . . 63.44 109.458 -170.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -125.09 138.04 54.18 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.099 0.476 . . . . 54.1 110.648 174.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.52 118.65 34.35 Favored 'General case' 0 C--O 1.256 1.423 0 N-CA-C 107.975 -1.121 . . . . 74.25 107.975 173.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.611 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 3.7 mt -115.1 109.29 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 119.069 -1.052 . . . . 61.41 111.183 -174.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 8' ' ' SER . 34.1 tt0 -109.09 104.88 14.15 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.975 0.893 . . . . 71.34 111.345 -171.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -117.58 171.88 7.72 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 114.693 -1.14 . . . . 75.44 113.315 -179.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -79.2 -37.07 39.15 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 114.908 -1.042 . . . . 74.54 111.618 168.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -116.19 117.55 30.35 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 122.179 0.99 . . . . 44.53 111.138 -171.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -84.31 -46.11 12.12 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 113.62 -1.627 . . . . 64.31 115.373 -174.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.8 tmm_? -75.07 -28.53 60.39 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 121.294 0.568 . . . . 63.2 111.913 -168.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -79.17 -25.86 42.76 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-O 121.469 0.652 . . . . 74.21 111.54 177.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.35 -23.76 61.18 Favored 'General case' 0 C--O 1.251 1.151 0 CA-C-O 122.291 1.043 . . . . 62.21 112.245 173.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.81 -22.25 23.79 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 114.593 -1.185 . . . . 73.21 113.856 173.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.473 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 0.4 OUTLIER -66.74 -43.04 85.24 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.82 0.819 . . . . 73.32 110.547 173.51 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.488 ' HB2' ' CD2' ' A' ' 31' ' ' TYR . . . -64.03 -43.02 96.86 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 114.696 -1.138 . . . . 72.35 110.659 173.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.794 HG13 HG13 ' A' ' 80' ' ' VAL . 0.3 OUTLIER -66.82 -31.0 51.5 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.411 0 C-N-CA 120.202 -0.599 . . . . 64.41 111.477 178.143 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -80.18 -21.32 43.12 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.444 0.566 . . . . 72.41 112.172 176.927 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.409 ' HG2' ' HA ' ' A' ' 62' ' ' ALA . 15.7 pt-20 -85.38 -17.96 35.16 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 118.55 -1.26 . . . . 63.34 111.809 170.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 62' ' ' ALA . 67.4 mmtt -99.67 13.65 32.84 Favored 'General case' 0 CA--C 1.575 1.92 0 CA-C-O 121.622 0.725 . . . . 73.32 111.401 170.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -70.77 153.06 43.13 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 127.115 2.166 . . . . 72.4 114.329 -178.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 112.03 24.28 5.22 Favored Glycine 0 C--N 1.351 1.416 0 C-N-CA 120.268 -0.968 . . . . 72.1 114.53 -171.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 20.7 p -58.27 133.62 55.84 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 114.219 1.192 . . . . 73.24 114.219 -167.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.1 149.92 51.13 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-N 113.826 -1.534 . . . . 63.23 113.212 -168.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -143.5 149.38 37.42 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.442 1.897 . . . . 73.44 110.562 -171.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 74.34 64.87 0.08 Allowed 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 122.476 1.131 . . . . 72.14 113.466 174.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.94 -10.64 60.46 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 113.745 -1.57 . . . . 75.41 113.952 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -120.25 122.78 41.64 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.19 -1.411 . . . . 71.22 107.19 160.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.502 ' HB3' ' O ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -96.12 103.25 15.13 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 119.109 -0.472 . . . . 74.2 111.038 178.855 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 41.5 tp -162.29 69.84 0.28 Allowed 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 118.267 0.485 . . . . 54.14 112.01 177.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -97.86 113.14 24.88 Favored 'General case' 0 C--O 1.208 -1.097 0 O-C-N 119.451 -2.031 . . . . 74.45 109.703 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.8 t -130.1 120.48 49.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 107.893 -1.151 . . . . 62.3 107.893 171.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -149.01 141.33 24.12 Favored 'General case' 0 C--O 1.258 1.517 0 CA-C-O 123.075 1.417 . . . . 65.24 113.922 176.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.794 HG13 HG13 ' A' ' 63' ' ' ILE . 16.6 m -88.91 135.86 31.4 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 113.112 -1.858 . . . . 75.33 110.209 165.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -82.96 20.21 1.19 Allowed 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.19 1.927 . . . . 74.43 112.415 166.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -103.34 72.38 1.15 Allowed 'General case' 0 C--N 1.345 0.404 0 CA-C-O 121.828 0.823 . . . . 53.32 109.707 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 . . . . . 0 C--N 1.313 -1.006 0 CA-C-N 114.838 -1.074 . . . . 71.5 109.128 177.387 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.2 p . . . . . 0 CA--C 1.54 0.558 0 N-CA-C 110.555 -0.165 . . . . 72.4 110.555 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.491 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 0.3 OUTLIER -130.52 151.65 50.76 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.338 0.496 . . . . 60.31 112.338 -177.096 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.493 HG13 HG12 ' A' ' 80' ' ' VAL . 4.9 mp -121.13 132.33 70.8 Favored 'Isoleucine or valine' 0 C--O 1.247 0.95 0 N-CA-C 108.948 -0.76 . . . . 72.32 108.948 174.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -113.16 113.95 26.09 Favored 'General case' 0 C--O 1.244 0.813 0 O-C-N 124.21 0.944 . . . . 75.24 109.338 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 7.2 p -122.71 109.69 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 CA-C-O 122.503 1.144 . . . . 32.44 111.651 176.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -128.14 157.34 21.16 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-N 115.32 -0.855 . . . . 63.02 114.946 -174.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.435 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 15.3 m120 59.37 25.07 13.71 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.715 1.206 . . . . 54.44 111.944 175.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.467 HD23 ' H ' ' A' ' 15' ' ' LEU . 1.7 pt? -88.37 151.2 48.23 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 112.511 0.559 . . . . 71.05 112.511 -167.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -64.43 144.2 84.7 Favored 'Trans proline' 0 C--N 1.364 1.382 0 C-N-CA 122.901 2.401 . . . . 74.34 112.227 172.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.5 p 73.53 -31.03 0.22 Allowed 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 127.316 2.246 . . . . 43.33 113.046 -176.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 64.78 86.74 0.12 Allowed 'General case' 0 C--N 1.361 1.071 0 C-N-CA 125.746 1.618 . . . . 74.31 110.156 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.433 ' H ' HD11 ' A' ' 15' ' ' LEU . 8.2 p -69.18 133.74 31.35 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 CA-C-O 121.653 0.74 . . . . 75.13 110.521 -174.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.429 ' O ' HG22 ' A' ' 24' ' ' VAL . 25.5 m -90.46 169.33 11.14 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.358 -0.837 . . . . 44.03 110.207 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.3 p -61.82 -28.39 69.44 Favored 'General case' 0 C--O 1.21 -1.022 0 N-CA-C 113.509 0.929 . . . . 50.43 113.509 -175.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -71.85 -41.78 67.71 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 123.586 0.754 . . . . 62.14 111.852 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -73.68 -43.55 59.07 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.888 -0.597 . . . . 75.44 109.829 -172.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 20' ' ' SER . 2.2 m -68.62 -30.79 48.48 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.945 0 CA-C-O 118.179 -0.915 . . . . 74.55 111.175 170.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.0 -55.73 21.37 Favored 'General case' 0 C--O 1.195 -1.801 0 CA-C-O 118.003 -0.998 . . . . 71.42 109.094 172.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -73.84 -55.16 6.54 Favored 'General case' 0 C--O 1.276 2.462 0 C-N-CA 119.199 -1.001 . . . . 72.41 112.662 -175.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -76.64 -35.96 57.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.543 -0.753 . . . . 71.42 110.787 -168.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.31 -23.64 30.17 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 118.073 -0.965 . . . . 74.54 110.984 177.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.557 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 4.7 ptt85 -71.52 -22.94 61.71 Favored 'General case' 0 C--N 1.383 2.065 0 CA-C-N 120.193 1.36 . . . . 70.4 111.698 170.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.19 -33.5 67.54 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 119.005 -1.078 . . . . 63.21 110.91 169.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.514 ' CG ' ' HB2' ' A' ' 62' ' ' ALA . 90.0 m-85 -85.41 -38.02 19.16 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.327 0.492 . . . . 75.55 112.327 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' A' ' 29' ' ' ARG . . . -152.62 143.9 10.86 Favored Glycine 0 C--O 1.22 -0.779 0 C-N-CA 121.045 -0.598 . . . . 64.32 111.67 178.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -66.9 117.73 9.4 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 123.718 0.305 . . . . 74.4 111.05 -172.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.36 122.92 35.55 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-O 122.045 0.926 . . . . 63.33 111.278 -174.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 50.0 mt -100.61 -36.19 9.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.937 -1.029 . . . . 54.4 109.431 177.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.84 139.39 21.58 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.682 -0.69 . . . . 74.4 109.545 -177.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 18.7 p -136.9 118.76 15.17 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.252 0.549 . . . . 73.11 110.497 173.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -129.26 144.83 51.37 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 115.589 -0.732 . . . . 44.25 109.623 -179.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 84.9 t -117.64 129.06 74.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 121.069 0.461 . . . . 74.34 110.365 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -106.08 135.32 47.75 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.117 -0.697 . . . . 71.32 109.117 -178.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.91 125.06 36.75 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.753 -0.379 . . . . 63.13 110.424 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.1 t -102.16 164.42 11.7 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.463 -0.335 . . . . 71.42 111.481 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.7 t -75.04 -13.46 15.35 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 C-N-CA 123.748 0.819 . . . . 75.14 110.913 178.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.8 t -75.65 -10.83 59.77 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.066 0.546 . . . . 65.43 111.542 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.42 -4.12 59.95 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 120.92 -0.657 . . . . 52.05 113.226 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.81 139.12 30.85 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.339 0.59 . . . . 74.44 111.135 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.84 142.12 35.29 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.274 -0.876 . . . . 24.44 109.54 177.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 8.8 m-85 -136.25 149.43 48.5 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.438 -0.949 . . . . 71.21 108.438 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -132.82 138.52 47.11 Favored 'General case' 0 C--O 1.248 1.012 0 N-CA-C 109.212 -0.662 . . . . 42.42 109.212 172.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -118.09 117.93 30.51 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.113 -1.403 . . . . 72.45 107.836 -176.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.94 112.51 27.59 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.468 0 C-N-CA 120.176 -0.609 . . . . 70.35 111.033 -171.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -98.51 114.52 26.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.922 0.391 . . . . 72.13 111.186 -176.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -107.88 166.37 10.76 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.511 -0.768 . . . . 61.23 111.451 -178.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -80.61 -35.08 34.56 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 120.318 -0.553 . . . . 74.51 110.921 172.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.71 124.28 45.84 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.929 0.871 . . . . 72.24 112.363 -171.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.53 -46.16 16.26 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 113.74 -1.573 . . . . 72.34 114.529 -176.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.59 -21.94 57.37 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 112.727 0.64 . . . . 74.03 112.727 -169.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.419 ' HB3' ' O ' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -78.57 -33.1 47.91 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 121.35 0.595 . . . . 73.2 110.807 174.852 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.96 -24.88 63.41 Favored 'General case' 0 C--O 1.25 1.083 0 C-N-CA 124.4 1.08 . . . . 62.14 112.162 174.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.557 ' HA ' HG22 ' A' ' 63' ' ' ILE . . . -56.65 -26.63 56.65 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.164 -0.926 . . . . 62.32 113.34 178.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.43 ' HA ' ' HG3' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -69.27 -39.2 78.53 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 117.84 0.291 . . . . 75.52 111.257 174.734 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.514 ' HB2' ' CG ' ' A' ' 31' ' ' TYR . . . -66.17 -42.54 88.82 Favored 'General case' 0 C--O 1.245 0.851 0 C-N-CA 122.844 0.457 . . . . 62.31 111.139 174.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.778 HG13 HG13 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -70.32 -29.05 37.6 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 119.771 -0.772 . . . . 73.03 111.024 178.766 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.43 ' HG3' ' HA ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -78.96 -27.2 43.52 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.793 1.179 . . . . 73.33 112.438 174.811 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.49 -22.53 43.91 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 119.015 -1.074 . . . . 75.42 111.269 176.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -109.04 14.36 24.06 Favored 'General case' 0 CA--C 1.558 1.287 0 CA-C-O 121.35 0.595 . . . . 52.51 111.92 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -67.1 154.02 42.23 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 125.763 1.625 . . . . 71.34 110.902 169.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.15 21.75 5.81 Favored Glycine 0 C--N 1.343 0.931 0 C-N-CA 119.81 -1.186 . . . . 63.35 112.501 -162.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.67 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 14.3 p -59.81 132.03 52.72 Favored 'General case' 0 C--O 1.242 0.672 0 O-C-N 124.239 0.611 . . . . 62.01 111.888 -175.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.5 147.68 50.4 Favored 'General case' 0 C--O 1.254 1.315 0 CA-C-N 115.171 -0.922 . . . . 62.42 112.744 -169.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -143.16 146.34 33.63 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.335 1.854 . . . . 62.12 110.766 -173.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 74.16 67.56 0.09 Allowed 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 114.084 1.142 . . . . 75.32 114.084 177.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.67 -11.78 59.45 Favored Glycine 0 N--CA 1.462 0.415 0 CA-C-N 114.299 -1.319 . . . . 73.44 113.665 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -121.82 123.18 41.18 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.499 -1.297 . . . . 73.31 107.499 157.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.435 ' HB3' ' O ' ' A' ' 14' ' ' ASN . 0.3 OUTLIER -94.15 104.11 16.14 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 118.97 -0.538 . . . . 73.54 110.701 179.202 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.67 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -162.89 58.15 0.2 Allowed 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.438 1.273 . . . . 73.11 114.438 -175.228 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -95.27 113.83 25.55 Favored 'General case' 0 C--O 1.214 -0.774 0 CA-C-N 121.036 1.744 . . . . 73.4 110.838 -173.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.2 t -128.4 117.39 45.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 107.78 -1.192 . . . . 34.25 107.78 170.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.563 ' HA ' HD11 ' A' ' 63' ' ' ILE . 32.6 tt0 -151.98 144.97 24.49 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.799 0.809 . . . . 73.54 111.625 176.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.778 HG13 HG13 ' A' ' 63' ' ' ILE . 18.7 m -89.06 124.83 64.1 Favored Pre-proline 0 C--N 1.317 -0.836 0 CA-C-N 115.81 -0.632 . . . . 71.42 111.077 170.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.491 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 57.8 Cg_endo -80.37 5.92 5.74 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.036 1.824 . . . . 74.42 114.047 169.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -87.37 -32.61 19.5 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 119.933 -0.707 . . . . 74.41 111.809 175.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 N--CA 1.486 1.356 0 C-N-CA 124.887 1.275 . . . . 74.42 112.27 -175.744 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.9 t . . . . . 0 CA--C 1.548 0.881 0 CA-C-O 120.417 0.151 . . . . 72.32 111.401 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.528 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 1.6 ptp180 -143.93 155.86 44.22 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 112.501 0.556 . . . . 63.42 112.501 -175.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.675 HG12 HG12 ' A' ' 80' ' ' VAL . 6.7 mt -115.28 136.8 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 123.6 0.76 . . . . 74.54 109.896 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -105.63 117.6 34.44 Favored 'General case' 0 C--O 1.249 1.057 0 O-C-N 125.111 1.507 . . . . 63.54 109.728 177.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.517 HG12 HD22 ' A' ' 15' ' ' LEU . 59.4 t -119.68 109.51 26.46 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.055 0 CA-C-N 115.495 -0.775 . . . . 71.32 109.504 176.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -123.07 156.84 17.51 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.74 -0.743 . . . . 74.32 113.627 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.2 m120 59.11 32.42 22.12 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.029 0.932 . . . . 73.32 112.255 170.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.517 HD22 HG12 ' A' ' 12' ' ' VAL . 1.3 pt? -87.77 149.23 45.55 Favored Pre-proline 0 CA--C 1.543 0.707 0 N-CA-C 113.277 0.843 . . . . 74.21 113.277 -168.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -69.69 129.94 18.56 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 122.943 2.428 . . . . 73.24 112.647 172.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.7 p 48.3 101.62 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 125.949 1.7 . . . . 73.13 113.021 -169.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 38.0 p-80 -55.42 119.31 5.42 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.778 0.799 . . . . 65.52 112.218 -175.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.5 p -77.12 129.59 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 114.534 -1.212 . . . . 63.13 110.43 -175.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.3 m -83.6 165.75 18.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.401 -0.818 . . . . 73.02 110.207 -178.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 32.0 p -62.88 -28.2 69.88 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.723 0.809 . . . . 71.14 112.54 -174.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.06 -37.59 54.34 Favored 'General case' 0 C--O 1.253 1.249 0 CA-C-O 121.52 0.676 . . . . 75.14 110.809 -177.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -71.03 -44.42 65.86 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 114.652 -1.158 . . . . 75.03 110.564 -178.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.644 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 2.9 m -67.62 -31.52 52.86 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.872 0 CA-C-O 118.978 -0.534 . . . . 72.43 110.588 171.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 21' ' ' SER . 17.1 tt0 -58.41 -54.14 50.43 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 118.946 -0.55 . . . . 74.21 110.476 177.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -72.47 -54.02 10.47 Favored 'General case' 0 C--O 1.29 3.225 0 C-N-CA 119.829 -0.749 . . . . 52.14 112.512 -178.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -69.48 -44.58 70.86 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.676 -1.147 . . . . 74.21 109.689 -169.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.644 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 7.8 m-85 -77.95 -21.99 50.17 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-O 118.099 -0.953 . . . . 72.34 111.384 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.419 ' HB3' ' O ' ' A' ' 25' ' ' GLU . 3.6 ppt_? -68.44 -26.66 65.62 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 121.193 1.815 . . . . 71.25 111.402 171.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.48 -21.05 66.55 Favored 'General case' 0 CA--C 1.561 1.398 0 C-N-CA 118.304 -1.358 . . . . 71.52 112.442 169.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.437 ' OH ' ' HE3' ' A' ' 66' ' ' LYS . 5.2 m-30 -74.76 -37.22 62.52 Favored 'General case' 0 C--O 1.207 -1.173 0 N-CA-C 113.134 0.79 . . . . 73.04 113.134 -175.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 166.54 43.82 0.02 OUTLIER Glycine 0 N--CA 1.469 0.839 0 C-N-CA 118.943 -1.598 . . . . 64.11 114.061 -178.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.5 t30 62.05 99.28 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 125.217 1.407 . . . . 72.32 113.058 175.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.16 127.48 39.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 114.951 -1.022 . . . . 72.51 110.535 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -97.29 -32.25 12.0 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.536 -0.756 . . . . 73.35 109.932 176.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.01 132.15 15.38 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.001 -0.545 . . . . 61.12 109.697 -176.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.1 p -125.2 125.19 43.25 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 120.862 0.363 . . . . 64.31 110.041 172.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -129.41 130.99 46.67 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.825 -0.625 . . . . 73.31 110.144 -179.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.4 t -111.89 114.47 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.285 0.564 . . . . 71.22 110.035 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -107.12 139.93 40.76 Favored 'General case' 0 C--O 1.212 -0.915 0 CA-C-N 115.22 -0.9 . . . . 75.42 108.815 -178.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.83 148.22 52.54 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.313 0.96 . . . . 64.21 112.005 171.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.4 t -100.85 165.76 11.19 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 116.263 -0.426 . . . . 30.13 110.49 177.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.5 t -75.57 -11.47 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 C-N-CA 123.862 0.865 . . . . 73.23 110.937 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -76.46 -8.25 56.77 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 122.837 0.455 . . . . 65.41 111.63 178.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.83 -4.09 52.98 Favored Glycine 0 C--N 1.341 0.815 0 C-N-CA 121.248 -0.501 . . . . 54.21 112.869 175.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.89 135.24 33.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.994 0.426 . . . . 71.5 110.953 178.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.96 148.49 26.65 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.351 -0.841 . . . . 43.45 109.397 177.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.5 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 19.8 m-85 -136.13 153.21 51.35 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 123.641 0.588 . . . . 74.1 109.503 -176.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -136.0 137.86 41.66 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.997 -0.547 . . . . 74.14 109.62 174.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.44 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 0.4 OUTLIER -111.46 119.95 40.5 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 114.736 -1.12 . . . . 64.33 108.448 172.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.3 mp -123.87 113.92 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 119.997 -0.681 . . . . 71.52 111.145 -177.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -92.73 116.15 28.75 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.325 -0.852 . . . . 61.34 111.593 -169.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -109.84 152.94 25.11 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.782 1.03 . . . . 71.51 113.782 -177.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.41 -34.03 25.6 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 115.275 -0.875 . . . . 63.14 112.044 172.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -122.51 129.5 52.04 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.278 0.844 . . . . 74.41 113.278 -177.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.07 -45.99 31.32 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 113.98 -1.464 . . . . 54.31 114.339 -175.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.09 -25.23 52.05 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.324 0.861 . . . . 65.41 113.324 -170.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -76.47 -36.81 57.67 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.859 0.838 . . . . 63.14 109.331 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.65 -27.93 65.46 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 114.505 -1.225 . . . . 71.44 111.743 177.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.02 -35.45 69.28 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 114.227 1.195 . . . . 73.31 114.227 -176.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.556 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 0.5 OUTLIER -69.55 -40.51 76.79 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 122.122 0.963 . . . . 65.51 112.729 -179.437 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.553 ' O ' ' HG3' ' A' ' 65' ' ' GLU . . . -75.92 -36.48 59.39 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.674 -0.693 . . . . 73.2 110.598 178.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.58 HG13 HG13 ' A' ' 80' ' ' VAL . 0.4 OUTLIER -68.83 -28.85 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 O-C-N 121.875 -0.516 . . . . 54.43 110.575 176.659 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.556 ' HG3' ' O ' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -78.86 -23.0 45.23 Favored 'General case' 0 C--N 1.354 0.803 0 CA-C-N 118.295 0.498 . . . . 71.21 111.833 169.874 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.553 ' HG3' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -69.45 -29.41 67.09 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 120.192 -0.603 . . . . 75.41 110.88 172.189 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.621 ' HG3' HG11 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -105.03 7.81 34.13 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 114.767 1.395 . . . . 74.52 114.767 169.033 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -70.1 152.9 43.81 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 123.444 0.698 . . . . 73.13 111.25 173.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.02 23.7 4.49 Favored Glycine 0 C--N 1.342 0.865 0 C-N-CA 119.532 -1.318 . . . . 73.3 112.327 -155.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.556 ' SG ' ' HA ' ' A' ' 77' ' ' ARG . 6.1 t -55.81 136.75 51.03 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.815 0.846 . . . . 65.43 112.059 -178.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -123.82 146.16 48.56 Favored 'General case' 0 C--O 1.249 1.056 0 CA-C-N 114.808 -1.087 . . . . 72.4 112.928 -169.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -142.61 145.78 33.87 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 112.14 -2.3 . . . . 74.22 110.298 -173.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 73.24 66.87 0.1 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 114.302 1.223 . . . . 74.51 114.302 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.67 -12.6 59.56 Favored Glycine 0 C--N 1.335 0.474 0 CA-C-N 114.148 -1.387 . . . . 73.33 114.258 171.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -123.22 120.49 33.31 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 106.483 -1.673 . . . . 74.43 106.483 157.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.1 116.08 28.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 119.579 -0.248 . . . . 73.42 111.319 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -157.91 81.33 0.86 Allowed 'General case' 0 C--O 1.208 -1.107 0 N-CA-C 112.356 0.502 . . . . 52.01 112.356 178.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.556 ' HA ' ' SG ' ' A' ' 69' ' ' CYS . 7.4 tpp85 -97.85 113.26 25.02 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.576 1.08 . . . . 73.34 110.165 -178.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.621 HG11 ' HG3' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -133.22 115.88 24.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.662 -0.699 . . . . 64.03 109.441 169.743 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.18 155.09 36.02 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-O 121.802 0.811 . . . . 73.44 112.724 175.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.675 HG12 HG12 ' A' ' 10' ' ' ILE . 31.0 m -90.6 123.38 65.37 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 114.824 -1.08 . . . . 71.51 110.764 166.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.528 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 73.8 Cg_endo -88.17 9.15 3.84 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 122.061 1.84 . . . . 74.1 112.576 164.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -97.05 -13.28 22.35 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 120.576 -0.45 . . . . 70.34 111.887 176.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.3 m120 . . . . . 0 N--CA 1.485 1.29 0 O-C-N 124.872 1.358 . . . . 71.42 111.948 -172.484 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.045 0 N-CA-C 111.911 -0.476 . . . . 72.43 111.911 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 13.9 p -158.4 101.43 1.7 Allowed 'General case' 0 C--O 1.242 0.669 0 CA-C-O 121.192 0.52 . . . . 73.42 110.931 178.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . 0.532 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 0.8 OUTLIER -149.07 -174.54 4.67 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 118.791 -0.623 . . . . 74.35 109.407 179.309 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.532 ' SD ' ' HB3' ' A' ' 0' ' ' HIS . 2.7 mpt? 70.75 148.3 0.08 Allowed 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 124.96 1.304 . . . . 63.1 113.743 172.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.0 m -134.34 162.37 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 115.643 -0.708 . . . . 73.5 111.058 177.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.1 tt -153.69 121.24 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 CA-C-O 120.906 0.384 . . . . 73.14 110.664 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -114.56 46.52 1.37 Allowed 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.837 -0.539 . . . . 72.43 112.368 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -157.87 21.24 0.26 Allowed 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 109.866 -0.42 . . . . 63.21 109.866 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.6 t -127.43 178.68 5.92 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.991 -0.443 . . . . 71.23 110.108 -177.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -133.53 105.29 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.915 0 N-CA-C 107.158 -1.423 . . . . 65.32 107.158 177.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.65 119.57 27.04 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.163 -0.926 . . . . 73.52 110.451 -174.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.21 158.5 44.26 Favored 'General case' 0 N--CA 1.509 2.518 0 CA-C-O 118.666 -0.683 . . . . 63.41 112.163 -177.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.547 ' HB ' HD12 ' A' ' 51' ' ' ILE . 6.2 mt -117.66 143.0 29.37 Favored 'Isoleucine or valine' 0 C--N 1.371 1.518 0 N-CA-C 107.258 -1.386 . . . . 71.22 107.258 -176.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -104.95 113.23 26.7 Favored 'General case' 0 CA--C 1.564 1.499 0 CA-C-O 117.996 -1.002 . . . . 74.24 111.413 -176.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.526 HG12 HG13 ' A' ' 78' ' ' VAL . 14.2 m -127.24 107.45 16.85 Favored 'Isoleucine or valine' 0 C--N 1.376 1.728 0 CA-C-N 121.166 1.803 . . . . 62.42 110.309 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.511 ' H ' ' HG3' ' A' ' 77' ' ' ARG . . . -134.7 -179.05 16.1 Favored Glycine 0 N--CA 1.485 1.941 0 O-C-N 120.86 -1.15 . . . . 64.1 113.987 -174.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.4 m120 49.72 23.22 0.94 Allowed 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 113.875 1.065 . . . . 53.42 113.875 -178.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.648 HD23 ' H ' ' A' ' 15' ' ' LEU . 2.2 pt? -91.14 141.59 26.51 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.236 1.014 . . . . 71.53 110.561 -167.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -64.46 133.55 37.77 Favored 'Trans proline' 0 C--N 1.365 1.404 0 C-N-CA 122.367 2.045 . . . . 71.33 111.807 177.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.5 p 82.13 -39.67 0.11 Allowed 'General case' 0 C--N 1.379 1.859 0 C-N-CA 126.73 2.012 . . . . 65.44 112.053 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 67.19 117.58 0.03 OUTLIER 'General case' 0 C--N 1.357 0.926 0 C-N-CA 125.278 1.431 . . . . 70.45 110.999 -173.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.474 ' H ' HD11 ' A' ' 15' ' ' LEU . 9.8 m -71.82 116.3 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.594 2.643 0 N-CA-C 107.312 -1.366 . . . . 64.21 107.312 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -79.25 155.8 28.4 Favored 'General case' 0 C--N 1.38 1.908 0 O-C-N 120.789 -1.194 . . . . 72.32 110.727 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 69.9 m -48.81 -43.34 38.19 Favored 'General case' 0 C--N 1.381 1.963 0 N-CA-C 115.911 1.819 . . . . 71.52 115.911 -173.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.99 -47.52 71.35 Favored 'General case' 0 CA--C 1.589 2.445 0 N-CA-C 113.865 1.061 . . . . 74.34 113.865 174.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -72.88 -35.97 67.25 Favored 'General case' 0 C--N 1.361 1.072 0 CA-C-O 119.089 -0.482 . . . . 75.22 112.286 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.511 ' O ' ' HB2' ' A' ' 28' ' ' PHE 0.262 1.7 p -69.41 -44.12 80.38 Favored 'Isoleucine or valine' 0 C--N 1.36 1.025 0 CA-C-O 118.107 -0.949 . . . . 43.02 110.683 176.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.488 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 22.1 tt0 -49.12 -60.44 2.79 Favored 'General case' 0 N--CA 1.507 2.405 0 CA-C-O 116.809 -1.567 . . . . 54.13 112.165 165.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -70.21 -61.82 1.63 Allowed 'General case' 0 C--O 1.303 3.912 0 CA-C-N 121.467 1.94 . . . . 64.42 114.417 -173.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -70.42 -34.34 72.39 Favored 'General case' 0 C--N 1.369 1.421 0 CA-C-O 117.111 -1.423 . . . . 72.12 112.622 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.511 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 1.2 m-85 -77.57 -35.82 52.7 Favored 'General case' 0 C--N 1.364 1.23 0 CA-C-N 121.939 2.154 . . . . 75.15 112.271 177.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.488 ' HB3' ' O ' ' A' ' 25' ' ' GLU . 5.2 ptt85 -53.21 -28.51 27.28 Favored 'General case' 0 N--CA 1.509 2.513 0 CA-C-O 115.87 -2.014 . . . . 75.33 115.338 166.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.63 -47.04 73.94 Favored 'General case' 0 N--CA 1.522 3.142 0 CA-C-N 123.485 2.857 . . . . 72.32 111.666 167.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.514 ' HB3' ' HA ' ' A' ' 59' ' ' ALA . 94.6 m-85 -76.39 -38.26 55.96 Favored 'General case' 0 CA--C 1.554 1.103 0 CA-C-O 118.302 -0.856 . . . . 71.22 112.532 -166.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -148.94 -175.43 21.39 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-N 120.001 1.273 . . . . 73.15 111.605 170.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -99.48 98.77 9.64 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 119.23 -0.988 . . . . 65.51 109.362 -166.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.49 134.6 29.17 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.409 0 N-CA-C 113.761 1.023 . . . . 71.41 113.761 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.46 -26.36 11.47 Favored 'General case' 0 CA--C 1.562 1.407 0 N-CA-C 110.092 -0.336 . . . . 70.0 110.092 172.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.8 pttm -153.92 153.82 32.72 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.528 0.731 . . . . 70.15 110.121 168.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -139.52 105.47 5.19 Favored 'General case' 0 C--N 1.356 0.873 0 N-CA-C 108.13 -1.063 . . . . 63.2 108.13 175.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -112.45 144.5 41.8 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 118.864 -1.135 . . . . 71.43 114.054 -176.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 69.4 t -97.09 113.93 32.75 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 N-CA-C 108.837 -0.801 . . . . 62.21 108.837 175.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -115.28 131.37 56.95 Favored 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 107.948 -1.13 . . . . 71.3 107.948 175.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.44 141.52 51.38 Favored 'General case' 0 CA--C 1.564 1.492 0 CA-C-N 121.8 2.091 . . . . 73.22 108.354 -170.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.585 HG23 ' H ' ' A' ' 44' ' ' SER . 6.4 t -100.81 173.51 6.48 Favored 'General case' 0 CA--C 1.565 1.539 0 CA-C-N 120.853 1.66 . . . . 71.42 111.977 -178.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.9 t -75.74 -9.3 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.305 0 C-N-CA 123.749 0.819 . . . . 73.3 112.377 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.585 ' H ' HG23 ' A' ' 42' ' ' THR . 0.8 OUTLIER -89.19 7.66 34.14 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 121.705 -0.622 . . . . 44.05 110.499 -175.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.54 -5.09 75.47 Favored Glycine 0 C--N 1.347 1.178 0 N-CA-C 115.436 0.934 . . . . 62.12 115.436 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.09 131.95 34.75 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 118.022 0.911 . . . . 75.01 110.031 176.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -105.63 146.26 29.93 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 109.393 -0.595 . . . . 62.13 109.393 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -129.3 148.75 51.25 Favored 'General case' 0 C--N 1.347 0.496 0 N-CA-C 108.942 -0.762 . . . . 73.13 108.942 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -121.29 135.57 55.09 Favored 'General case' 0 C--O 1.247 0.964 0 C-N-CA 119.855 -0.738 . . . . 61.23 110.257 168.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -108.92 122.15 46.62 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 114.048 -1.433 . . . . 71.34 108.229 -172.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.547 HD12 ' HB ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -126.92 108.6 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 C-N-CA 118.953 -1.099 . . . . 73.33 109.975 -165.071 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -89.27 103.99 16.57 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 120.508 -0.477 . . . . 74.54 110.905 -171.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -113.22 142.33 45.93 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 113.645 0.98 . . . . 74.33 113.645 -172.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -82.81 -34.5 26.94 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.742 -0.783 . . . . 72.12 112.565 172.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -117.75 120.25 37.38 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 108.991 -0.744 . . . . 62.33 108.991 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.528 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . . . -77.87 -38.37 46.15 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 115.425 1.639 . . . . 73.04 115.425 167.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -60.21 -40.11 88.97 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 113.593 0.96 . . . . 73.21 113.593 -168.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -69.53 -49.18 56.87 Favored 'General case' 0 CA--C 1.582 2.18 0 N-CA-C 114.835 1.42 . . . . 71.14 114.835 169.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.514 ' HA ' ' HB3' ' A' ' 31' ' ' TYR . . . -52.76 -21.63 4.35 Favored 'General case' 0 CA--C 1.587 2.37 0 N-CA-C 115.541 1.682 . . . . 33.23 115.541 172.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.482 ' O ' ' HG3' ' A' ' 64' ' ' LYS . . . -47.01 -34.61 5.81 Favored 'General case' 0 CA--C 1.561 1.383 0 CA-C-O 116.269 -1.824 . . . . 32.05 114.565 173.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.426 ' O ' ' HB3' ' A' ' 65' ' ' GLU . 29.3 m-20 -52.5 -53.89 39.87 Favored 'General case' 0 N--CA 1.51 2.539 0 CA-C-N 121.517 1.962 . . . . 51.1 111.835 168.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.08 -43.54 95.11 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 118.504 0.593 . . . . 71.43 111.809 178.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.576 HD12 HG13 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -67.37 -39.61 83.06 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.415 0 C-N-CA 118.748 -1.181 . . . . 72.34 113.458 -174.454 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.492 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -65.92 -32.58 74.16 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.813 1.042 . . . . 75.02 113.813 167.492 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.426 ' HB3' ' O ' ' A' ' 61' ' ' ASP . 0.6 OUTLIER -76.95 -17.1 59.12 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.059 0.391 . . . . 73.53 111.196 -176.19 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt -109.78 12.01 24.18 Favored 'General case' 0 CA--C 1.577 1.984 0 CA-C-O 119.742 -0.171 . . . . 73.11 111.056 169.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.492 ' HB3' ' HA ' ' A' ' 64' ' ' LYS 0.373 0.0 OUTLIER -78.45 159.63 28.16 Favored 'General case' 0 N--CA 1.506 2.344 0 C-N-CA 123.664 0.786 . . . . 64.52 112.406 -176.028 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.55 29.55 2.24 Favored Glycine 0 N--CA 1.439 -1.166 0 CA-C-O 117.819 -1.545 . . . . 61.33 114.406 -161.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.81 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 18.2 t -49.63 126.16 13.03 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-N 118.314 1.057 . . . . 74.51 112.125 -175.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.53 145.47 47.08 Favored 'General case' 0 C--O 1.251 1.172 0 CA-C-N 113.208 -1.814 . . . . 72.42 112.464 -172.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -147.8 147.36 29.75 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 105.947 -1.872 . . . . 74.24 105.947 -168.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 72.35 63.03 0.12 Allowed 'General case' 0 N--CA 1.483 1.175 0 CA-C-O 122.347 1.07 . . . . 62.4 112.995 176.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 97.5 -13.92 63.77 Favored Glycine 0 N--CA 1.471 0.998 0 N-CA-C 116.632 1.413 . . . . 70.02 116.632 172.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -113.23 121.19 43.72 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 105.1 -2.185 . . . . 64.41 105.1 156.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.49 102.8 14.65 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 117.438 -1.268 . . . . 73.15 109.826 -173.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.81 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -162.94 72.53 0.32 Allowed 'General case' 0 N--CA 1.512 2.672 0 CA-C-N 121.328 1.876 . . . . 74.42 115.668 178.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.511 ' HG3' ' H ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -96.6 118.03 32.23 Favored 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 123.769 2.986 . . . . 63.54 111.702 -175.319 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.526 HG13 HG12 ' A' ' 12' ' ' VAL . 41.0 t -131.78 119.4 41.6 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.772 0 O-C-N 120.189 -1.569 . . . . 74.23 108.056 172.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -146.99 134.57 20.96 Favored 'General case' 0 C--N 1.384 2.107 0 CA-C-N 121.088 1.767 . . . . 74.01 112.841 -172.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.576 HG13 HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -93.12 126.54 50.62 Favored Pre-proline 0 N--CA 1.45 -0.467 0 CA-C-N 114.197 -1.365 . . . . 72.35 112.095 169.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -85.85 25.5 0.69 Allowed 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 122.147 1.898 . . . . 72.2 111.842 165.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.528 ' CD2' ' HB2' ' A' ' 56' ' ' ALA . 9.2 m-85 -110.95 -28.13 8.48 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 115.595 -0.73 . . . . 75.3 110.161 176.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 53.77 54.4 9.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 124.75 1.281 . . . . 74.11 112.145 -172.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 68.96 -3.44 1.47 Allowed 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 125.224 1.41 . . . . 74.14 114.135 -175.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 76.12 133.76 0.05 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 125.281 1.613 . . . . 74.31 110.047 -173.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 . . . . . 0 C--O 1.25 1.082 0 CA-C-N 115.575 -0.739 . . . . 64.33 109.055 -175.891 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.84 0 N-CA-C 111.651 -0.58 . . . . 35.11 111.651 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 8.7 t -155.76 145.46 21.2 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 110.13 -0.322 . . . . 72.44 110.13 176.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -137.25 156.53 48.17 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.684 -0.858 . . . . 73.15 108.684 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 mpp? -127.92 14.24 6.85 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.128 0.49 . . . . 72.33 110.832 174.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.6 m -123.72 -173.89 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 109.33 -0.619 . . . . 74.54 109.33 -177.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 55.4 mt 69.89 77.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 O-C-N 124.415 1.072 . . . . 73.4 109.642 177.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.28 88.56 6.52 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-N 115.592 -0.731 . . . . 75.12 110.387 177.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 175.94 173.21 0.34 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.29 1.036 . . . . 62.41 108.713 -172.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.0 m 75.32 -157.67 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.403 1.081 . . . . 54.44 110.386 -178.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.0 p -153.5 135.48 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-O 120.997 0.427 . . . . 73.45 109.889 -175.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.23 128.11 34.21 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.924 -0.58 . . . . 74.35 109.649 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.565 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -140.49 159.84 41.3 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 118.633 -0.698 . . . . 71.33 112.322 -178.783 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.708 HG12 HG12 ' A' ' 80' ' ' VAL . 4.5 mt -114.04 138.73 42.93 Favored 'Isoleucine or valine' 0 C--O 1.264 1.855 0 CA-C-N 119.927 1.24 . . . . 53.42 107.725 170.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -102.79 114.53 28.86 Favored 'General case' 0 CA--C 1.561 1.401 0 O-C-N 125.903 2.002 . . . . 64.3 109.399 172.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.419 HG23 HG22 ' A' ' 78' ' ' VAL . 2.1 p -125.58 106.04 15.62 Favored 'Isoleucine or valine' 0 C--N 1.37 1.475 0 CA-C-N 120.62 1.555 . . . . 73.0 109.322 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -115.31 168.32 12.57 Favored Glycine 0 C--N 1.354 1.549 0 C-N-CA 120.687 -0.768 . . . . 64.11 112.274 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.0 m120 50.79 24.92 1.91 Allowed 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 114.617 1.34 . . . . 64.04 114.617 -177.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.422 HD23 ' H ' ' A' ' 15' ' ' LEU . 1.9 pt? -75.69 136.2 70.96 Favored Pre-proline 0 C--O 1.239 0.522 0 C-N-CA 123.335 0.654 . . . . 61.24 110.709 178.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -73.71 126.35 10.71 Favored 'Trans proline' 0 CA--C 1.553 1.468 0 C-N-CA 121.422 1.414 . . . . 71.11 111.685 175.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.5 t 60.33 100.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.005 0.922 . . . . 51.3 111.129 -174.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 -64.79 132.9 50.79 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.086 -0.506 . . . . 72.42 111.789 -177.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.7 m -66.02 121.43 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.895 0 CA-C-N 114.557 -1.201 . . . . 61.31 109.614 -176.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.84 154.06 28.66 Favored 'General case' 0 C--N 1.377 1.768 0 CA-C-N 119.212 0.914 . . . . 64.4 110.576 -176.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.9 p -47.18 -48.09 23.88 Favored 'General case' 0 C--N 1.375 1.699 0 N-CA-C 116.036 1.865 . . . . 72.14 116.036 -174.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.19 -46.46 75.84 Favored 'General case' 0 C--O 1.285 2.93 0 N-CA-C 114.41 1.263 . . . . 52.24 114.41 175.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -64.34 -35.45 80.9 Favored 'General case' 0 C--N 1.372 1.545 0 CA-C-O 118.002 -0.999 . . . . 74.22 110.142 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.528 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 1.2 t -66.82 -44.43 89.11 Favored 'Isoleucine or valine' 0 C--N 1.385 2.139 0 CA-C-O 116.552 -1.689 . . . . 72.11 110.722 174.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.01 -56.15 24.17 Favored 'General case' 0 C--N 1.373 1.602 0 CA-C-N 120.641 1.564 . . . . 72.35 110.747 177.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.55 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 12.9 m-80 -81.33 -57.01 3.68 Favored 'General case' 0 C--O 1.294 3.418 0 CA-C-N 122.156 2.253 . . . . 74.44 116.364 -176.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -68.36 -26.99 65.86 Favored 'General case' 0 C--N 1.354 0.777 0 C-N-CA 119.566 -0.854 . . . . 54.42 111.218 -175.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.528 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 35.7 m-85 -90.98 -22.55 20.77 Favored 'General case' 0 CA--C 1.565 1.544 0 C-N-CA 118.337 -1.345 . . . . 73.41 114.222 173.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.55 ' HG3' ' O ' ' A' ' 26' ' ' ASN 0.259 2.5 ppt_? -54.27 -28.34 41.12 Favored 'General case' 0 N--CA 1.503 2.218 0 CA-C-N 120.161 1.346 . . . . 72.01 112.285 163.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.566 ' O ' ' HD2' ' A' ' 30' ' ' LYS 0.257 1.7 tptm -52.03 -28.63 17.88 Favored 'General case' 0 N--CA 1.518 2.946 0 C-N-CA 118.445 -1.302 . . . . 64.25 113.742 168.433 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -80.22 -44.17 20.18 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 120.023 1.283 . . . . 63.0 111.488 -166.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -169.24 44.28 0.21 Allowed Glycine 0 C--N 1.341 0.859 0 C-N-CA 117.712 -2.185 . . . . 72.01 114.45 162.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 60.38 87.33 0.09 Allowed 'General case' 0 C--N 1.359 1.005 0 C-N-CA 123.983 0.913 . . . . 53.02 109.9 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.467 HG22 ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -67.36 138.45 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-N 114.976 -1.011 . . . . 70.43 112.471 -178.325 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.419 ' H ' HD22 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -103.31 -26.49 12.92 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 109.63 -0.507 . . . . 72.15 109.63 173.115 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp -149.66 137.36 20.17 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-O 118.826 -0.606 . . . . 64.22 109.889 -173.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -140.84 110.06 6.22 Favored 'General case' 0 C--N 1.364 1.226 0 CA-C-N 119.564 1.075 . . . . 71.14 109.268 176.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -109.13 146.59 33.84 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 117.762 -1.575 . . . . 73.33 112.847 177.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.8 t -114.27 110.6 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 106.317 -1.735 . . . . 74.52 106.317 176.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.0 mttm -121.45 137.25 54.8 Favored 'General case' 0 CA--C 1.563 1.446 0 CA-C-O 118.909 -0.567 . . . . 64.12 110.301 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.97 143.92 50.9 Favored 'General case' 0 C--N 1.371 1.516 0 CA-C-N 120.437 1.471 . . . . 64.1 108.122 -168.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.632 HG23 ' H ' ' A' ' 44' ' ' SER . 6.4 t -99.98 172.1 7.43 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-N 120.683 1.583 . . . . 71.22 110.941 -178.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.8 t -75.37 -9.95 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.208 0 C-N-CA 123.502 0.721 . . . . 64.04 112.077 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.632 ' H ' HG23 ' A' ' 42' ' ' THR . 0.8 OUTLIER -89.27 7.57 34.85 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 121.735 -0.603 . . . . 74.03 110.24 -177.307 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.73 -4.63 78.43 Favored Glycine 0 CA--C 1.537 1.417 0 N-CA-C 115.952 1.141 . . . . 61.34 115.952 178.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.94 131.79 33.99 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 118.429 1.115 . . . . 61.33 109.903 176.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.93 146.89 28.4 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 108.606 -0.887 . . . . 61.41 108.606 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -127.49 146.84 50.36 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 119.211 -0.995 . . . . 70.23 108.555 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.417 ' HB3' HG13 ' A' ' 12' ' ' VAL . . . -121.4 139.08 53.91 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 119.486 -0.886 . . . . 51.23 110.295 172.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -125.28 117.14 23.15 Favored 'General case' 0 C--O 1.263 1.803 0 N-CA-C 106.864 -1.532 . . . . 72.55 106.864 -167.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.33 113.12 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 114.351 1.241 . . . . 74.05 114.351 -163.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -90.21 108.81 19.98 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 115.002 -0.999 . . . . 70.4 112.604 -171.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -108.51 155.61 20.43 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 112.145 0.424 . . . . 73.21 112.145 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -81.72 -26.36 34.66 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 113.809 1.04 . . . . 70.12 113.809 173.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.48 120.89 39.49 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 119.208 0.913 . . . . 42.3 110.328 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.91 -35.87 59.64 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 114.773 1.397 . . . . 71.42 114.773 172.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.27 0.0 OUTLIER -80.71 -30.0 36.38 Favored 'General case' 0 CA--C 1.564 1.5 0 CA-C-N 120.828 1.649 . . . . 70.5 113.435 -167.144 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -62.21 -50.57 71.27 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-N 118.85 0.75 . . . . 74.34 112.521 175.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.0 -25.53 21.53 Favored 'General case' 0 CA--C 1.57 1.712 0 N-CA-C 116.369 1.989 . . . . 64.4 116.369 177.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.73 -43.05 57.9 Favored 'General case' 0 CA--C 1.581 2.171 0 C-N-CA 125.482 1.513 . . . . 44.11 114.231 178.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -53.54 -48.14 69.34 Favored 'General case' 0 N--CA 1.518 2.944 0 CA-C-N 119.654 1.116 . . . . 75.32 113.771 169.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.635 ' O ' ' HD2' ' A' ' 66' ' ' LYS . . . -72.19 -32.91 67.25 Favored 'General case' 0 C--N 1.31 -1.131 0 O-C-N 120.786 -1.197 . . . . 60.02 111.777 179.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.722 HD12 HG13 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -73.33 -41.04 57.51 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.053 0 CA-C-O 117.247 -1.358 . . . . 73.35 112.141 -177.264 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.48 -34.0 70.41 Favored 'General case' 0 CA--C 1.557 1.219 0 CA-C-N 120.505 1.502 . . . . 71.24 114.285 161.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.54 -23.89 66.98 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 120.816 1.644 . . . . 64.45 112.773 175.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.635 ' HD2' ' O ' ' A' ' 62' ' ' ALA 0.283 0.0 OUTLIER -110.48 16.89 21.29 Favored 'General case' 0 N--CA 1.514 2.738 0 N-CA-C 117.1 2.259 . . . . 61.24 117.1 160.64 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.418 0.0 OUTLIER -79.72 160.03 26.41 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 120.016 1.28 . . . . 71.15 113.945 -176.381 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.14 29.33 2.38 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 119.095 -1.526 . . . . 32.51 114.593 -158.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.791 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -53.06 125.95 19.01 Favored 'General case' 0 C--N 1.37 1.472 0 CA-C-N 117.268 0.534 . . . . 53.15 111.19 -178.195 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -131.23 150.76 52.01 Favored 'General case' 0 C--O 1.259 1.6 0 CA-C-N 115.63 -0.713 . . . . 70.23 112.018 -174.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -147.59 146.66 29.47 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 127.872 2.469 . . . . 70.33 107.508 -168.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 73.22 62.54 0.1 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.975 0.893 . . . . 42.11 112.844 -176.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.44 -13.19 61.5 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 117.157 1.623 . . . . 51.15 117.157 169.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -112.79 122.23 47.04 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 106.947 -1.501 . . . . 55.45 106.947 154.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.93 103.52 15.39 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 117.719 -1.134 . . . . 60.25 109.433 -175.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.791 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 14.3 tp -165.92 66.97 0.11 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 120.651 1.569 . . . . 54.33 112.485 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -96.54 110.83 23.15 Favored 'General case' 0 CA--C 1.569 1.704 0 CA-C-N 122.584 2.447 . . . . 74.25 109.733 -173.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.518 ' H ' ' HB3' ' A' ' 69' ' ' CYS . 22.6 t -123.48 115.54 45.69 Favored 'Isoleucine or valine' 0 C--N 1.358 0.967 0 O-C-N 120.577 -1.327 . . . . 74.34 107.806 170.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -138.7 143.12 38.98 Favored 'General case' 0 C--O 1.254 1.298 0 CA-C-N 120.574 1.533 . . . . 53.21 111.317 176.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.722 HG13 HD12 ' A' ' 63' ' ' ILE . 8.8 m -88.01 122.28 70.12 Favored Pre-proline 0 N--CA 1.437 -1.11 0 CA-C-N 114.622 -1.172 . . . . 72.44 111.412 168.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.565 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 61.2 Cg_endo -91.76 32.98 0.29 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.67 2.247 . . . . 63.22 111.447 159.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.3 10.62 5.33 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 112.58 0.585 . . . . 71.1 112.58 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -79.31 69.92 5.62 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 123.174 0.296 . . . . 61.53 111.427 -167.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -170.44 40.11 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.014 0.926 . . . . 64.24 109.785 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.5 ttt-85 67.04 -75.28 0.06 Allowed 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 125.805 1.642 . . . . 70.23 113.879 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 . . . . . 0 C--O 1.25 1.125 0 N-CA-C 108.715 -0.846 . . . . 74.23 108.715 171.333 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.932 0 N-CA-C 111.949 -0.46 . . . . 51.31 111.949 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 48.0 t -144.24 124.41 13.71 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.445 0.298 . . . . 51.23 111.036 -177.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -152.7 151.42 30.53 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.339 0.656 . . . . 73.53 110.551 177.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 ptp -152.46 94.99 1.97 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.18 0.592 . . . . 74.1 111.628 175.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.9 t -130.31 151.13 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 109.125 -0.694 . . . . 75.05 109.125 176.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.5 tt -70.44 98.34 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.131 0 CA-C-O 121.636 0.731 . . . . 43.33 111.448 175.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.0 mtm-85 -135.48 151.89 50.82 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 109.322 -0.621 . . . . 75.25 109.322 167.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -112.76 100.05 8.39 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 121.028 -0.269 . . . . 53.13 110.985 -170.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.4 t -153.43 -170.29 3.55 Favored 'General case' 0 CA--C 1.556 1.202 0 N-CA-C 108.919 -0.771 . . . . 71.41 108.919 -174.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.57 114.77 18.66 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.885 0 N-CA-C 107.114 -1.439 . . . . 71.23 107.114 175.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 p -83.64 124.03 30.4 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 114.195 -1.366 . . . . 60.32 109.723 -173.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.439 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 3.2 ptt180 -124.99 151.29 45.74 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 120.251 -0.58 . . . . 63.43 111.716 -170.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.683 HD12 ' HB ' ' A' ' 51' ' ' ILE . 7.7 mt -116.94 137.17 51.71 Favored 'Isoleucine or valine' 0 C--O 1.259 1.569 0 CA-C-N 120.041 1.291 . . . . 74.3 108.855 -175.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -106.05 113.71 27.41 Favored 'General case' 0 CA--C 1.574 1.876 0 O-C-N 125.903 2.002 . . . . 73.32 110.359 176.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.666 HG23 HG22 ' A' ' 78' ' ' VAL . 1.1 p -125.87 103.89 12.37 Favored 'Isoleucine or valine' 0 C--N 1.375 1.674 0 CA-C-N 120.194 1.361 . . . . 61.11 108.949 177.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -118.26 175.01 15.53 Favored Glycine 0 C--N 1.353 1.478 0 C-N-CA 120.652 -0.785 . . . . 75.43 113.354 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 51.34 29.11 4.8 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 115.697 1.74 . . . . 70.3 115.697 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.429 HD11 ' H ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -87.26 150.86 50.29 Favored Pre-proline 0 CA--C 1.555 1.15 0 CA-C-N 119.27 0.941 . . . . 55.23 110.406 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -82.94 128.86 5.23 Favored 'Trans proline' 0 CA--C 1.567 2.149 0 C-N-CA 120.8 1.0 . . . . 43.24 112.487 177.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.5 p 113.6 -29.16 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.631 0 C-N-CA 128.736 2.814 . . . . 62.41 111.045 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 68.17 105.28 0.05 Allowed 'General case' 0 C--N 1.358 0.949 0 C-N-CA 124.859 1.264 . . . . 72.23 110.285 -167.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.52 HG21 HG13 ' A' ' 24' ' ' VAL . 7.4 p -76.6 118.32 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.292 0 CA-C-N 114.874 -1.057 . . . . 62.54 108.936 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.9 m -82.23 160.0 23.09 Favored 'General case' 0 CA--C 1.559 1.303 0 CA-C-O 117.744 -1.122 . . . . 55.25 108.449 178.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.453 ' O ' ' HB3' ' A' ' 25' ' ' GLU . 5.6 p -50.64 -39.77 51.37 Favored 'General case' 0 C--N 1.378 1.834 0 N-CA-C 115.3 1.592 . . . . 73.53 115.3 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.34 -33.08 73.03 Favored 'General case' 0 CA--C 1.576 1.963 0 N-CA-C 115.51 1.67 . . . . 71.34 115.51 177.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -68.34 -54.11 19.57 Favored 'General case' 0 C--O 1.283 2.844 0 CA-C-N 119.719 1.145 . . . . 75.41 111.295 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.52 HG13 HG21 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -57.7 -54.04 36.82 Favored 'Isoleucine or valine' 0 C--N 1.368 1.398 0 O-C-N 124.573 1.17 . . . . 43.31 111.389 176.668 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.453 ' HB3' ' O ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -49.36 -46.79 47.57 Favored 'General case' 0 CA--C 1.566 1.559 0 CA-C-O 116.931 -1.509 . . . . 74.31 114.836 170.205 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -71.39 -55.58 7.68 Favored 'General case' 0 C--O 1.295 3.481 0 CA-C-N 122.525 2.42 . . . . 70.42 112.634 -177.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -57.77 -38.82 76.1 Favored 'General case' 0 C--N 1.396 2.598 0 CA-C-O 118.965 -0.541 . . . . 42.44 111.551 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -83.54 -35.61 24.66 Favored 'General case' 0 C--N 1.359 1.008 0 C-N-CA 118.564 -1.255 . . . . 73.45 113.277 -178.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.421 ' HB3' ' O ' ' A' ' 25' ' ' GLU . 20.4 ptt85 -52.27 -36.62 53.22 Favored 'General case' 0 N--CA 1.507 2.409 0 CA-C-O 117.923 -1.037 . . . . 71.22 112.099 171.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.476 ' HE2' ' CG ' ' A' ' 31' ' ' TYR 0.289 0.0 OUTLIER -71.92 -30.84 65.77 Favored 'General case' 0 C--N 1.374 1.653 0 C-N-CA 116.311 -2.156 . . . . 62.44 112.71 -173.322 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.494 ' CB ' ' HA ' ' A' ' 59' ' ' ALA . 54.4 m-85 -82.75 -46.27 13.35 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 112.169 0.433 . . . . 74.1 112.169 177.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -150.14 143.76 11.1 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 118.671 0.669 . . . . 45.2 112.217 169.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -63.18 117.96 7.28 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 113.331 0.863 . . . . 72.2 113.331 -166.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.44 140.98 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-N 115.539 -0.755 . . . . 73.31 111.525 174.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.0 mp -103.8 -24.35 13.32 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 119.538 -0.865 . . . . 71.22 112.91 170.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.33 135.4 12.98 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 108.632 -0.877 . . . . 73.03 108.632 -175.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 41.8 t -145.96 115.2 7.07 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 120.125 1.33 . . . . 71.43 110.396 174.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.09 150.2 50.58 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 119.56 -0.856 . . . . 45.35 111.947 -176.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -116.07 116.72 53.21 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.53 0 CA-C-O 121.45 0.643 . . . . 73.22 110.578 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.0 mttp -108.53 141.99 39.61 Favored 'General case' 0 CA--C 1.565 1.531 0 C-N-CA 125.698 1.599 . . . . 70.44 107.762 -170.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.79 142.65 50.65 Favored 'General case' 0 CA--C 1.57 1.729 0 CA-C-N 122.329 2.331 . . . . 75.24 109.567 -177.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.613 HG23 ' H ' ' A' ' 44' ' ' SER . 5.0 t -100.59 176.88 5.18 Favored 'General case' 0 CA--C 1.568 1.64 0 CA-C-N 120.957 1.708 . . . . 64.22 111.572 176.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.4 t -77.33 -9.5 12.55 Favored 'Isoleucine or valine' 0 C--N 1.373 1.623 0 C-N-CA 123.834 0.854 . . . . 64.43 112.698 -176.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.613 ' H ' HG23 ' A' ' 42' ' ' THR . 8.9 t -90.72 2.62 55.83 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 121.584 -0.698 . . . . 60.34 111.03 -173.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.18 -7.26 68.02 Favored Glycine 0 CA--C 1.537 1.414 0 N-CA-C 115.184 0.834 . . . . 71.44 115.184 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.35 132.5 37.43 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 117.886 0.843 . . . . 74.44 108.89 167.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.75 145.55 43.42 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.743 -0.836 . . . . 74.35 108.743 -173.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -128.57 150.3 50.26 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.836 0.743 . . . . 74.33 110.693 -168.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -129.5 146.81 51.29 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.394 0.616 . . . . 74.3 112.045 175.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -132.9 114.09 13.63 Favored 'General case' 0 C--O 1.263 1.764 0 N-CA-C 106.442 -1.688 . . . . 71.33 106.442 -158.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.683 ' HB ' HD12 ' A' ' 10' ' ' ILE . 0.3 OUTLIER -124.29 110.52 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.662 0 C-N-CA 118.493 -1.283 . . . . 43.55 109.491 -173.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -109.74 103.09 11.86 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.464 -1.244 . . . . 31.22 110.158 -174.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.615 ' CE2' ' HB3' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -111.43 161.44 16.12 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 115.306 -0.861 . . . . 63.33 113.241 -174.502 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.14 -42.0 69.75 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 112.281 0.474 . . . . 71.1 112.281 173.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -113.17 114.8 27.29 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 118.54 -1.264 . . . . 74.43 109.901 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.97 -21.8 56.58 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 115.902 1.816 . . . . 61.53 115.902 169.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.293 10.6 ptm180 -75.69 -40.96 54.95 Favored 'General case' 0 CA--C 1.567 1.601 0 CA-C-N 120.402 1.455 . . . . 74.34 114.364 -172.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -77.68 -36.33 51.35 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 117.064 2.246 . . . . 53.13 117.064 177.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.615 ' HB3' ' CE2' ' A' ' 53' ' ' PHE 0.303 . . -75.27 -14.6 60.52 Favored 'General case' 0 CA--C 1.584 2.252 0 CA-C-N 120.564 1.529 . . . . 32.0 112.266 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -44.88 -35.74 2.96 Favored 'General case' 0 CA--C 1.583 2.239 0 CA-C-N 114.159 -1.382 . . . . 51.45 114.24 161.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.471 ' O ' ' HB3' ' A' ' 65' ' ' GLU . 46.3 m-20 -52.98 -54.75 30.46 Favored 'General case' 0 N--CA 1.507 2.384 0 CA-C-N 120.822 1.646 . . . . 54.32 113.311 164.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.406 ' O ' ' HG2' ' A' ' 66' ' ' LYS . . . -57.09 -35.78 69.81 Favored 'General case' 0 N--CA 1.507 2.385 0 CA-C-N 119.533 1.06 . . . . 61.42 113.816 171.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.456 HD12 HG13 ' A' ' 80' ' ' VAL 0.251 0.2 OUTLIER -73.53 -45.33 51.8 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.419 0 C-N-CA 119.157 -1.017 . . . . 13.43 113.443 -177.437 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.486 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -56.6 -30.46 63.25 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 120.319 1.418 . . . . 73.54 114.495 162.403 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.471 ' HB3' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -79.7 -20.46 46.47 Favored 'General case' 0 CA--C 1.55 0.967 0 O-C-N 120.825 -1.172 . . . . 72.21 111.84 -178.133 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 62' ' ' ALA . 60.7 mmtt -98.35 9.54 42.82 Favored 'General case' 0 CA--C 1.598 2.804 0 CA-C-O 118.697 -0.668 . . . . 64.41 112.533 163.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.486 ' HB3' ' HA ' ' A' ' 64' ' ' LYS 0.408 0.0 OUTLIER -79.79 160.54 26.12 Favored 'General case' 0 N--CA 1.516 2.858 0 CA-C-N 120.475 1.489 . . . . 71.21 114.619 -173.165 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.83 30.64 2.11 Favored Glycine 0 N--CA 1.439 -1.116 0 C-N-CA 118.529 -1.796 . . . . 74.22 115.466 -164.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.732 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -51.09 124.67 11.97 Favored 'General case' 0 C--N 1.372 1.577 0 O-C-N 124.65 0.853 . . . . 65.24 112.391 -173.791 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -133.4 150.73 51.79 Favored 'General case' 0 C--O 1.255 1.377 0 CA-C-N 115.574 -0.739 . . . . 51.32 112.311 -176.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -147.77 145.67 28.89 Favored 'General case' 0 C--N 1.354 0.795 0 C-N-CA 127.305 2.242 . . . . 75.34 106.574 -169.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 74.01 63.44 0.08 Allowed 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 113.17 0.804 . . . . 75.54 113.17 -175.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.32 -12.95 63.37 Favored Glycine 0 N--CA 1.472 1.057 0 N-CA-C 116.757 1.463 . . . . 73.21 116.757 168.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -113.43 121.28 43.84 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 106.309 -1.738 . . . . 64.51 106.309 152.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.28 104.05 15.93 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 117.431 -1.271 . . . . 74.32 109.454 -176.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.732 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -168.63 69.82 0.08 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 120.422 1.464 . . . . 71.24 112.273 179.347 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -95.77 108.83 21.19 Favored 'General case' 0 C--N 1.369 1.448 0 CA-C-N 122.443 2.383 . . . . 73.32 109.375 -171.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.666 HG22 HG23 ' A' ' 12' ' ' VAL . 50.1 t -127.77 118.39 48.88 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.888 0 O-C-N 120.828 -1.17 . . . . 61.42 109.098 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -146.61 144.9 29.85 Favored 'General case' 0 C--O 1.269 2.093 0 CA-C-N 120.651 1.569 . . . . 64.13 110.512 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.456 HG13 HD12 ' A' ' 63' ' ' ILE . 29.6 m -89.4 124.45 64.4 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-N 115.447 -0.797 . . . . 45.31 111.842 166.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.439 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 66.8 Cg_endo -86.57 29.9 0.49 Allowed 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 123.023 2.482 . . . . 71.11 113.747 168.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -128.71 -27.42 2.58 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.354 0.502 . . . . 71.44 112.354 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 57.26 77.53 0.27 Allowed 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 124.581 1.152 . . . . 73.42 113.286 -176.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 63.79 -148.19 0.31 Allowed 'General case' 0 C--N 1.373 1.609 0 C-N-CA 123.899 0.879 . . . . 41.34 110.619 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 7.8 ttt85 -129.41 86.89 2.47 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 121.008 -1.057 . . . . 75.43 110.075 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 . . . . . 0 C--N 1.356 0.849 0 CA-C-O 118.427 -0.796 . . . . 71.35 109.703 -165.624 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.896 0 N-CA-C 112.013 -0.435 . . . . 54.44 112.013 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 40.2 m -112.37 -83.91 0.58 Allowed 'General case' 0 C--O 1.219 -0.525 0 CA-C-O 118.717 -0.659 . . . . 60.42 111.489 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 68.76 92.01 0.09 Allowed 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 125.499 1.52 . . . . 73.42 110.334 -177.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpp? -102.92 159.12 15.78 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 120.836 -0.346 . . . . 70.12 110.353 -176.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 66.2 t 77.2 -63.24 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 C-N-CA 125.813 1.645 . . . . 75.2 111.615 176.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.617 HG22 ' HD2' ' A' ' 4' ' ' ARG . 2.8 mm 69.31 -67.18 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 126.816 2.047 . . . . 73.14 112.121 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.617 ' HD2' HG22 ' A' ' 3' ' ' ILE . 2.5 ptm180 -177.18 39.11 0.01 OUTLIER 'General case' 0 C--N 1.366 1.302 0 CA-C-N 119.061 0.846 . . . . 74.15 110.508 -169.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 78.87 121.73 0.05 OUTLIER 'General case' 0 N--CA 1.506 2.338 0 C-N-CA 125.962 1.705 . . . . 71.22 110.727 173.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.4 t -151.5 166.41 31.2 Favored 'General case' 0 CA--C 1.549 0.922 0 O-C-N 120.956 -1.09 . . . . 73.31 110.946 -174.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.3 m -115.0 119.94 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-O 121.22 0.534 . . . . 62.13 110.279 177.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.51 ' OG ' ' HB2' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -86.1 121.06 28.17 Favored 'General case' 0 C--O 1.249 1.072 0 CA-C-O 121.157 0.503 . . . . 71.2 112.127 -176.205 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.498 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 11.3 ptt180 -143.81 152.9 41.8 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 113.792 1.034 . . . . 60.43 113.792 -172.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.6 HG12 HG12 ' A' ' 80' ' ' VAL . 7.8 mt -115.31 135.35 55.56 Favored 'Isoleucine or valine' 0 C--N 1.375 1.693 0 CA-C-N 120.199 1.363 . . . . 74.35 107.995 177.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -99.56 122.04 42.05 Favored 'General case' 0 CA--C 1.572 1.796 0 O-C-N 125.43 1.706 . . . . 75.2 110.283 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.469 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 67.3 t -124.71 110.99 26.48 Favored 'Isoleucine or valine' 0 C--N 1.366 1.32 0 O-C-N 120.643 -1.286 . . . . 72.33 108.594 -178.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.33 162.97 12.42 Favored Glycine 0 C--N 1.341 0.823 0 C-N-CA 119.135 -1.507 . . . . 53.2 112.209 173.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 51.16 22.93 1.42 Allowed 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 116.379 1.992 . . . . 71.41 116.379 178.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.02 125.41 91.41 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 123.45 0.7 . . . . 63.04 111.054 169.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -91.34 123.35 0.78 Allowed 'Trans proline' 0 CA--C 1.556 1.586 0 C-N-CA 121.873 1.715 . . . . 73.22 111.495 169.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.5 m 34.75 -100.66 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 124.741 1.216 . . . . 73.32 114.03 -173.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.4 t60 53.26 -88.95 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 126.243 1.817 . . . . 72.24 112.408 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.2 m -98.18 117.03 42.4 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.863 0 C-N-CA 119.435 -0.906 . . . . 71.33 109.713 177.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.9 m -80.76 170.96 15.62 Favored 'General case' 0 C--N 1.387 2.234 0 CA-C-O 117.197 -1.383 . . . . 75.22 109.076 166.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.9 m -46.53 -49.46 18.57 Favored 'General case' 0 C--O 1.27 2.148 0 CA-C-N 120.134 1.334 . . . . 72.14 114.492 -173.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.71 -43.59 97.64 Favored 'General case' 0 CA--C 1.578 2.03 0 CA-C-N 115.271 -0.877 . . . . 62.35 113.277 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.511 10.7 m-20 -76.99 -18.94 57.88 Favored 'General case' 0 CA--C 1.559 1.309 0 CA-C-O 115.715 -2.088 . . . . 74.21 114.146 172.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.429 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 2.0 t -59.65 -44.57 93.76 Favored 'Isoleucine or valine' 0 C--N 1.424 3.83 0 CA-C-N 123.411 2.823 . . . . 71.45 108.281 163.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.48 -54.52 45.61 Favored 'General case' 0 C--N 1.376 1.731 0 CA-C-O 116.455 -1.736 . . . . 75.53 112.677 174.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -73.81 -54.39 8.11 Favored 'General case' 1 C--O 1.309 4.187 0 CA-C-N 122.369 2.349 . . . . 72.24 114.793 -174.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -58.21 -37.06 74.08 Favored 'General case' 0 C--N 1.383 2.063 0 CA-C-O 117.325 -1.322 . . . . 64.02 110.428 177.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.429 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 47.3 m-85 -84.46 -24.2 29.58 Favored 'General case' 0 C--N 1.373 1.629 0 C-N-CA 115.716 -2.393 . . . . 71.15 113.457 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.53 ' HA ' HG22 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -64.95 -30.79 71.8 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 117.286 -1.34 . . . . 74.24 114.055 175.534 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.447 ' HE2' ' CD1' ' A' ' 31' ' ' TYR 0.323 0.0 OUTLIER -72.82 -34.8 67.09 Favored 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 113.354 -3.338 . . . . 74.45 111.986 175.338 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.547 ' HB3' ' HA ' ' A' ' 59' ' ' ALA . 57.8 m-85 -76.79 -40.96 46.41 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-O 118.975 -0.536 . . . . 62.32 110.783 -169.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -140.21 165.21 26.06 Favored Glycine 0 C--N 1.341 0.812 0 CA-C-O 118.309 -1.273 . . . . 73.2 110.666 152.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -76.71 102.77 6.35 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-N 119.95 1.875 . . . . 75.22 110.45 -174.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.53 HG22 ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -71.32 136.73 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 113.824 1.046 . . . . 74.02 113.824 -176.113 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.4 mt -89.55 -49.02 6.92 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 113.266 0.839 . . . . 74.14 113.266 166.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.65 128.2 20.18 Favored 'General case' 0 CA--C 1.585 2.322 0 CA-C-N 120.077 1.308 . . . . 73.41 111.901 173.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 4.8 m -105.65 111.03 23.56 Favored 'General case' 0 C--N 1.388 2.259 0 N-CA-C 107.473 -1.306 . . . . 73.13 107.473 166.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -113.11 139.93 48.31 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 117.855 -1.538 . . . . 75.35 111.41 176.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 t -113.0 110.09 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 106.77 -1.567 . . . . 74.12 106.77 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.7 mmtt -107.08 142.4 36.8 Favored 'General case' 0 CA--C 1.556 1.181 0 CA-C-O 118.792 -0.623 . . . . 73.12 109.455 175.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.39 142.78 51.01 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 120.063 1.302 . . . . 61.05 108.384 -170.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.614 HG23 ' H ' ' A' ' 44' ' ' SER . 12.0 t -100.01 167.75 10.29 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 120.45 1.477 . . . . 55.41 111.42 -178.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.0 m -61.84 -7.5 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.746 0 N-CA-C 115.993 1.849 . . . . 72.52 115.993 175.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.614 ' H ' HG23 ' A' ' 42' ' ' THR . 8.1 t -98.05 7.57 46.11 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 119.36 0.982 . . . . 71.25 110.517 -174.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.25 -4.35 77.22 Favored Glycine 0 CA--C 1.544 1.887 0 N-CA-C 115.717 1.047 . . . . 72.31 115.717 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -83.37 134.75 34.88 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-N 117.954 0.877 . . . . 74.31 110.485 177.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.31 149.75 25.07 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.619 -0.882 . . . . 65.14 108.619 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -125.12 145.02 50.13 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 118.915 -1.114 . . . . 73.12 109.568 175.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.469 ' HB3' ' HB ' ' A' ' 12' ' ' VAL . . . -115.47 137.88 51.59 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.915 -0.402 . . . . 72.14 109.915 176.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.47 115.85 16.71 Favored 'General case' 0 C--O 1.256 1.446 0 N-CA-C 108.168 -1.049 . . . . 72.31 108.168 -173.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.498 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 0.2 OUTLIER -123.76 108.77 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 C-N-CA 118.358 -1.337 . . . . 71.43 110.827 -171.693 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 8' ' ' SER . 33.6 tt0 -102.81 108.34 19.53 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 115.147 -0.933 . . . . 70.34 110.92 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.411 ' HB3' ' HA ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -114.95 156.33 25.23 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 118.748 -0.644 . . . . 55.45 112.673 -179.151 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -59.29 -32.44 70.04 Favored 'General case' 0 N--CA 1.516 2.834 0 N-CA-C 112.937 0.717 . . . . 73.15 112.937 166.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -115.41 113.0 23.16 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 119.151 -1.02 . . . . 73.42 109.966 -177.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.514 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -77.33 -41.39 40.71 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 116.084 1.883 . . . . 71.51 116.084 170.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.26 6.5 ptt180 -75.78 -33.33 60.17 Favored 'General case' 0 CA--C 1.573 1.864 0 N-CA-C 114.516 1.302 . . . . 65.22 114.516 -168.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.43 -44.97 73.79 Favored 'General case' 0 N--CA 1.518 2.934 0 CA-C-N 120.737 1.608 . . . . 74.14 114.034 173.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.547 ' HA ' ' HB3' ' A' ' 31' ' ' TYR . . . -50.02 -21.08 1.11 Allowed 'General case' 0 CA--C 1.598 2.821 0 N-CA-C 117.281 2.326 . . . . 73.02 117.281 171.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.409 ' O ' ' HG3' ' A' ' 64' ' ' LYS . . . -49.14 -34.15 13.61 Favored 'General case' 0 CA--C 1.585 2.319 0 CA-C-O 117.645 -1.169 . . . . 74.33 113.797 167.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.411 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 2.6 m-20 -52.39 -45.06 65.68 Favored 'General case' 0 C--N 1.394 2.519 0 CA-C-N 120.171 1.35 . . . . 74.24 113.789 165.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.503 ' O ' ' HD2' ' A' ' 66' ' ' LYS . . . -60.48 -54.02 50.49 Favored 'General case' 0 C--O 1.258 1.53 0 O-C-N 121.907 -0.496 . . . . 70.02 111.212 172.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.868 HD12 HG13 ' A' ' 80' ' ' VAL 0.262 0.4 OUTLIER -62.5 -41.22 91.09 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 C-N-CA 117.465 -1.694 . . . . 64.14 113.786 -173.948 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.447 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -62.06 -34.85 77.04 Favored 'General case' 0 CA--C 1.557 1.215 0 N-CA-C 115.588 1.699 . . . . 74.43 115.588 167.854 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 62' ' ' ALA . 0.2 OUTLIER -65.64 -34.83 79.13 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 121.168 1.804 . . . . 73.41 111.268 176.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.503 ' HD2' ' O ' ' A' ' 62' ' ' ALA 0.258 0.0 OUTLIER -103.07 18.42 21.73 Favored 'General case' 0 CA--C 1.575 1.921 0 C-N-CA 118.432 -1.307 . . . . 63.41 114.149 173.946 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.447 ' HB3' ' HA ' ' A' ' 64' ' ' LYS 0.323 0.5 OUTLIER -71.37 162.79 28.86 Favored 'General case' 0 N--CA 1.508 2.435 0 CA-C-N 118.975 0.807 . . . . 61.24 112.88 -174.857 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 120.44 31.99 1.19 Allowed Glycine 0 N--CA 1.438 -1.218 0 C-N-CA 119.024 -1.56 . . . . 63.35 115.533 -162.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.773 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -51.51 125.09 13.62 Favored 'General case' 0 C--N 1.375 1.704 0 CA-C-N 118.1 0.95 . . . . 74.4 111.768 176.444 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -133.66 149.36 51.56 Favored 'General case' 0 C--O 1.255 1.363 0 CA-C-N 114.766 -1.106 . . . . 73.23 111.482 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -148.25 144.66 27.8 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 126.225 1.81 . . . . 71.51 106.746 -166.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 68.89 65.98 0.29 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 124.244 0.965 . . . . 70.42 113.162 177.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.9 -12.34 60.81 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 116.86 1.504 . . . . 71.43 116.86 173.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -118.85 121.9 41.09 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 105.929 -1.878 . . . . 73.31 105.929 154.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.97 102.52 14.61 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 117.553 -1.213 . . . . 74.41 109.874 -172.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.773 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -169.2 58.64 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 CA-C-N 120.572 1.533 . . . . 73.14 114.419 -175.14 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.1 tpp85 -90.99 112.25 24.06 Favored 'General case' 0 CA--C 1.571 1.767 0 CA-C-N 122.258 2.299 . . . . 64.45 109.945 -170.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.502 ' H ' ' HB3' ' A' ' 69' ' ' CYS . 0.9 OUTLIER -119.78 121.69 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 O-C-N 120.325 -1.484 . . . . 73.12 108.678 173.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -146.58 132.5 19.13 Favored 'General case' 0 C--N 1.361 1.091 0 CA-C-N 119.75 1.159 . . . . 61.03 110.791 -165.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.868 HG13 HD12 ' A' ' 63' ' ' ILE . 7.8 m -89.62 124.56 63.78 Favored Pre-proline 0 C--N 1.349 0.559 0 C-N-CA 119.817 -0.753 . . . . 73.34 111.569 167.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.436 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 87.8 Cg_endo -89.91 17.17 1.58 Allowed 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 122.48 2.12 . . . . 72.34 113.625 166.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.514 ' CE1' ' HB1' ' A' ' 56' ' ' ALA . 5.6 p90 -110.74 -32.01 7.0 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.039 0.385 . . . . 61.03 112.039 175.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.0 t30 59.65 73.51 0.48 Allowed 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 124.574 1.15 . . . . 73.33 110.692 -176.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 59.62 -156.79 0.34 Allowed 'General case' 0 C--N 1.379 1.851 0 C-N-CA 124.066 0.946 . . . . 45.44 111.371 -178.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -118.29 71.66 0.84 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.806 -1.184 . . . . 74.31 109.003 176.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 . . . . . 0 C--O 1.251 1.177 0 N-CA-C 107.629 -1.248 . . . . 73.23 107.629 -153.633 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.141 0 N-CA-C 111.86 -0.496 . . . . 63.01 111.86 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.08 -176.69 4.15 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 110.19 -0.3 . . . . 71.53 110.19 -177.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -152.27 78.82 1.23 Allowed 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 120.906 0.384 . . . . 60.25 111.08 -171.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 mtt -156.64 139.31 15.08 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.361 1.064 . . . . 73.43 109.345 171.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.2 t -129.35 49.62 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-O 122.357 1.075 . . . . 75.04 108.857 173.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.9 mt -126.54 63.65 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 O-C-N 121.389 -0.819 . . . . 73.04 109.2 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -167.57 -160.57 0.36 Allowed 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 109.438 -0.579 . . . . 74.4 109.438 171.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -166.3 133.72 2.71 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 107.85 -1.167 . . . . 73.41 107.85 -170.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.0 t -169.23 -164.77 0.48 Allowed 'General case' 0 CA--C 1.562 1.439 0 N-CA-C 109.26 -0.644 . . . . 71.22 109.26 -178.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.24 127.52 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 108.448 -0.945 . . . . 74.32 108.448 170.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.1 p -83.72 130.03 34.95 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 114.769 -1.105 . . . . 74.31 108.115 173.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.523 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 0.2 OUTLIER -118.83 153.27 34.77 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 121.305 -0.872 . . . . 71.23 109.036 -177.407 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.5 mp -138.16 134.92 44.78 Favored 'Isoleucine or valine' 0 C--O 1.264 1.82 0 CA-C-N 119.811 1.187 . . . . 70.42 108.269 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -105.33 114.95 29.44 Favored 'General case' 0 CA--C 1.571 1.751 0 O-C-N 125.664 1.852 . . . . 65.32 110.407 177.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.575 HG23 HG22 ' A' ' 78' ' ' VAL . 2.0 p -123.84 104.41 14.07 Favored 'Isoleucine or valine' 0 C--N 1.369 1.432 0 CA-C-N 120.333 1.424 . . . . 75.23 108.079 178.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.446 ' H ' ' HG3' ' A' ' 77' ' ' ARG . . . -121.33 177.24 16.41 Favored Glycine 0 C--N 1.346 1.134 0 C-N-CA 120.362 -0.923 . . . . 21.54 112.722 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.6 m120 50.72 24.34 1.67 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 114.792 1.405 . . . . 62.14 114.792 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.635 HD23 ' H ' ' A' ' 15' ' ' LEU . 1.7 pt? -79.71 123.54 83.94 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 123.812 0.845 . . . . 70.1 110.6 -178.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -89.51 120.11 0.95 Allowed 'Trans proline' 0 CA--C 1.559 1.729 0 C-N-CA 121.053 1.168 . . . . 73.11 112.186 172.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.7 m 39.05 43.42 0.8 Allowed 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 124.989 1.316 . . . . 42.2 114.034 178.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.425 ' HB3' HD12 ' A' ' 15' ' ' LEU . 5.2 t-160 -95.11 -93.37 0.19 Allowed 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 119.418 -0.325 . . . . 74.54 110.64 -166.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.7 m -103.23 119.16 51.33 Favored 'Isoleucine or valine' 0 CA--C 1.596 2.745 0 CA-C-N 118.627 0.649 . . . . 75.44 109.943 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.75 155.17 25.62 Favored 'General case' 0 C--N 1.392 2.429 0 CA-C-N 120.888 1.676 . . . . 43.33 110.155 171.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.0 t -48.12 -48.8 33.76 Favored 'General case' 0 C--N 1.371 1.53 0 N-CA-C 115.477 1.658 . . . . 64.21 115.477 -173.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.94 -43.46 86.36 Favored 'General case' 0 CA--C 1.582 2.208 0 N-CA-C 114.206 1.187 . . . . 73.31 114.206 176.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.03 -30.2 70.22 Favored 'General case' 0 C--N 1.364 1.204 0 CA-C-O 117.397 -1.287 . . . . 72.23 111.223 173.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.537 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 1.6 t -66.78 -43.05 90.1 Favored 'Isoleucine or valine' 0 C--N 1.391 2.399 0 CA-C-O 116.633 -1.651 . . . . 72.04 110.021 171.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.518 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 4.3 tt0 -61.05 -55.01 37.7 Favored 'General case' 0 C--N 1.365 1.247 0 CA-C-N 121.476 1.944 . . . . 71.04 111.48 176.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -71.82 -59.26 2.84 Favored 'General case' 0 C--O 1.284 2.901 0 CA-C-N 121.21 1.823 . . . . 74.23 112.796 -176.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -71.12 -31.52 67.86 Favored 'General case' 0 C--N 1.364 1.21 0 CA-C-O 117.178 -1.391 . . . . 73.01 112.711 -176.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.537 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 5.1 m-85 -82.78 -29.01 29.94 Favored 'General case' 0 C--N 1.375 1.698 0 CA-C-N 122.057 2.208 . . . . 73.54 112.55 176.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.518 ' HB3' ' O ' ' A' ' 25' ' ' GLU . 2.9 ptt180 -54.27 -32.52 56.42 Favored 'General case' 0 C--N 1.379 1.884 0 CA-C-O 115.777 -2.059 . . . . 73.04 114.824 161.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.85 -48.06 73.38 Favored 'General case' 0 N--CA 1.518 2.965 0 CA-C-N 122.479 2.4 . . . . 64.21 111.674 167.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -75.71 -38.29 58.71 Favored 'General case' 0 C--O 1.213 -0.865 0 CA-C-O 118.639 -0.696 . . . . 65.35 111.803 -168.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -149.2 154.92 26.07 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 119.473 1.033 . . . . 64.33 111.148 168.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -77.22 105.19 8.17 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-N 118.075 0.937 . . . . 71.3 110.722 -175.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.739 HG13 ' SG ' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -73.61 132.83 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 N-CA-C 114.286 1.217 . . . . 74.5 114.286 -176.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 11.1 mp -108.67 -23.26 11.88 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.883 -1.053 . . . . 74.34 110.861 175.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 52' ' ' GLU . 8.1 tmtm? -152.2 131.66 12.97 Favored 'General case' 0 CA--C 1.565 1.52 0 N-CA-C 108.576 -0.898 . . . . 51.4 108.576 -172.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.739 ' SG ' HG13 ' A' ' 34' ' ' ILE . 19.5 m -139.48 110.39 6.81 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 107.251 -1.388 . . . . 52.43 107.251 175.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -122.3 127.67 50.13 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 117.563 -1.655 . . . . 74.12 110.635 176.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -117.88 112.86 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-O 121.841 0.829 . . . . 72.24 110.042 -178.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.3 mtmt -120.38 146.85 45.77 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 114.439 -1.255 . . . . 73.54 109.98 -170.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.11 145.98 49.68 Favored 'General case' 0 C--N 1.368 1.397 0 CA-C-N 120.68 1.582 . . . . 71.25 108.464 -172.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.627 HG23 ' H ' ' A' ' 44' ' ' SER . 4.0 t -99.79 167.09 10.76 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 121.129 1.786 . . . . 74.34 111.138 174.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.5 m -66.74 -3.7 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.575 0 N-CA-C 116.038 1.866 . . . . 71.31 116.038 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.627 ' H ' HG23 ' A' ' 42' ' ' THR . 10.2 t -98.27 7.22 46.54 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 119.253 0.933 . . . . 65.11 109.639 -171.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.78 -5.7 73.76 Favored Glycine 0 CA--C 1.54 1.606 0 N-CA-C 115.2 0.84 . . . . 70.31 115.2 -175.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.45 130.89 34.34 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 118.201 1.0 . . . . 71.2 109.578 175.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.28 146.94 39.81 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 108.854 -0.795 . . . . 72.22 108.854 -175.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -129.63 150.84 50.78 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.526 1.057 . . . . 73.52 110.754 -176.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -127.34 147.47 50.26 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-O 121.713 0.768 . . . . 70.13 111.572 171.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -132.74 118.58 19.24 Favored 'General case' 0 C--O 1.266 1.924 0 N-CA-C 106.367 -1.716 . . . . 73.4 106.367 -164.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.79 114.02 26.35 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.079 0 C-N-CA 120.09 -0.644 . . . . 71.44 109.885 -162.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.41 ' HB2' ' HB3' ' A' ' 36' ' ' LYS . 45.8 mt-10 -109.44 109.14 19.9 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 120.541 -0.464 . . . . 75.33 112.108 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -107.0 160.63 15.39 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 119.4 -0.333 . . . . 73.03 111.428 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -80.49 -25.99 38.47 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 113.514 0.931 . . . . 74.42 113.514 177.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -115.86 119.57 36.4 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.402 -0.592 . . . . 50.21 109.402 -178.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.6 -33.12 58.44 Favored 'General case' 0 CA--C 1.56 1.356 0 N-CA-C 117.024 2.231 . . . . 65.5 117.024 174.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.352 0.0 OUTLIER -79.58 -29.25 41.19 Favored 'General case' 0 C--N 1.377 1.78 0 CA-C-N 122.095 2.225 . . . . 73.14 114.448 -170.391 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.2 -31.14 60.82 Favored 'General case' 0 CA--C 1.586 2.363 0 CA-C-N 121.281 1.855 . . . . 73.43 115.955 171.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.47 -24.27 54.77 Favored 'General case' 0 CA--C 1.586 2.36 0 CA-C-N 120.563 1.528 . . . . 64.51 114.222 170.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.565 ' HA ' HG22 ' A' ' 63' ' ' ILE . . . -49.78 -37.81 31.48 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-O 116.608 -1.663 . . . . 75.32 113.958 173.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.585 ' O ' ' HB3' ' A' ' 65' ' ' GLU . 31.7 m-20 -54.09 -51.65 63.49 Favored 'General case' 0 C--N 1.395 2.56 0 CA-C-N 120.178 1.354 . . . . 72.22 112.066 169.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.59 -39.22 87.32 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 117.144 -1.408 . . . . 72.42 113.04 174.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.762 HD12 HG13 ' A' ' 80' ' ' VAL 0.305 0.6 OUTLIER -73.78 -45.97 48.45 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 116.601 -2.04 . . . . 63.21 113.348 -176.854 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.98 -34.49 59.95 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 114.368 1.247 . . . . 74.12 114.368 166.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.585 ' HB3' ' O ' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -83.05 -22.47 33.52 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-N 119.454 1.025 . . . . 75.31 112.158 -175.098 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -100.07 14.23 31.38 Favored 'General case' 0 CA--C 1.57 1.735 0 CA-C-O 118.981 -0.533 . . . . 74.24 110.866 174.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.361 0.0 OUTLIER -77.36 162.89 26.91 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 113.674 0.99 . . . . 73.23 113.674 -168.651 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.75 29.58 2.01 Favored Glycine 0 N--CA 1.437 -1.269 0 CA-C-O 117.886 -1.508 . . . . 73.13 115.007 -158.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.675 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 44.8 t -51.37 126.23 16.49 Favored 'General case' 0 C--N 1.383 2.041 0 CA-C-O 122.123 0.963 . . . . 63.03 110.317 170.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -135.17 143.0 46.23 Favored 'General case' 0 C--O 1.252 1.236 0 CA-C-N 113.282 -1.781 . . . . 70.1 111.705 -176.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -155.51 144.8 20.94 Favored 'General case' 0 C--N 1.348 0.541 0 N-CA-C 106.695 -1.594 . . . . 75.15 106.695 -164.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 71.11 65.64 0.16 Allowed 'General case' 0 N--CA 1.512 2.658 0 CA-C-O 121.608 0.718 . . . . 54.55 111.86 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.2 -13.68 63.03 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 116.995 1.558 . . . . 41.51 116.995 174.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -122.93 125.37 45.19 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 106.037 -1.838 . . . . 70.31 106.037 161.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.69 105.9 18.1 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 117.506 -1.235 . . . . 73.22 110.491 -172.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.675 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.3 OUTLIER -169.1 69.71 0.07 Allowed 'General case' 0 N--CA 1.505 2.31 0 CA-C-N 120.944 1.702 . . . . 62.42 113.688 179.327 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.446 ' HG3' ' H ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -92.35 118.09 30.56 Favored 'General case' 0 CA--C 1.576 1.961 0 CA-C-N 122.761 2.528 . . . . 71.34 111.604 -172.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.575 HG22 HG23 ' A' ' 12' ' ' VAL . 42.6 t -126.87 115.89 42.96 Favored 'Isoleucine or valine' 0 C--N 1.371 1.536 0 O-C-N 120.761 -1.212 . . . . 62.23 107.753 168.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -149.83 137.65 20.18 Favored 'General case' 0 C--N 1.37 1.483 0 CA-C-N 119.852 1.205 . . . . 65.01 111.651 -179.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.762 HG13 HD12 ' A' ' 63' ' ' ILE . 35.5 m -90.81 128.35 48.51 Favored Pre-proline 0 N--CA 1.445 -0.71 0 CA-C-N 115.317 -0.856 . . . . 63.41 110.389 170.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.523 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 43.8 Cg_endo -87.06 31.25 0.45 Allowed 'Trans proline' 0 CA--C 1.553 1.428 0 C-N-CA 122.198 1.932 . . . . 71.24 112.482 162.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -120.51 -30.67 4.48 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 111.483 0.179 . . . . 74.33 111.483 175.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 15.7 m120 69.93 -54.25 0.61 Allowed 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 126.156 1.782 . . . . 61.41 113.485 -174.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -175.11 -177.95 1.13 Allowed 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 107.862 -1.162 . . . . 63.31 107.862 -176.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -88.01 155.34 19.87 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 108.354 -0.98 . . . . 64.25 108.354 175.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 . . . . . 0 C--O 1.252 1.188 0 CA-C-O 118.144 -0.931 . . . . 61.3 108.771 -178.633 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.015 0 CA-C-O 119.465 -0.631 . . . . 53.44 112.322 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 4.9 t 70.27 -168.91 0.16 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.05 1.34 . . . . 73.54 111.039 178.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 14.0 t-160 65.77 38.84 5.02 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.435 1.094 . . . . 75.25 110.838 175.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 mtt -136.23 137.71 41.09 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.567 -0.742 . . . . 51.34 109.944 -177.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.3 p -146.82 115.51 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 CA-C-O 122.008 0.909 . . . . 73.05 110.796 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.1 mt -131.3 122.96 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 115.323 -0.853 . . . . 73.52 109.301 -174.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.46 159.74 14.8 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 119.038 -0.506 . . . . 72.5 109.878 176.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 74.38 163.41 0.27 Allowed 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 124.586 1.155 . . . . 71.13 109.391 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.8 t 83.78 -166.28 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 124.564 1.146 . . . . 73.52 108.361 175.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.71 135.88 59.39 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 CA-C-O 121.345 0.593 . . . . 73.52 110.143 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.426 ' CB ' ' HB2' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -81.41 127.88 33.25 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.263 -1.335 . . . . 73.25 110.043 176.797 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -126.13 152.95 45.25 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 117.519 -1.229 . . . . 73.41 110.61 -179.343 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 mt -115.56 143.98 24.22 Favored 'Isoleucine or valine' 0 C--O 1.255 1.342 0 CA-C-N 121.223 1.829 . . . . 64.01 108.692 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -106.32 120.85 42.94 Favored 'General case' 0 CA--C 1.564 1.504 0 O-C-N 124.157 0.91 . . . . 74.34 110.324 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.577 HG23 HG22 ' A' ' 78' ' ' VAL . 1.5 p -124.57 105.84 15.81 Favored 'Isoleucine or valine' 0 C--N 1.376 1.753 0 CA-C-N 120.457 1.48 . . . . 75.34 109.024 177.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' A' ' 77' ' ' ARG . . . -114.57 166.79 12.19 Favored Glycine 0 C--N 1.355 1.618 0 C-N-CA 120.339 -0.934 . . . . 55.14 113.453 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 50.12 24.24 1.36 Allowed 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 115.102 1.519 . . . . 74.32 115.102 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.48 ' H ' HD23 ' A' ' 15' ' ' LEU . 2.4 pt? -71.47 141.52 85.58 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 124.297 1.039 . . . . 73.05 110.717 175.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -72.98 141.47 33.16 Favored 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 121.411 1.407 . . . . 70.42 111.169 173.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.9 p 86.25 -34.16 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 126.36 1.864 . . . . 71.23 112.652 170.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 71.08 121.82 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.106 1.362 . . . . 74.42 111.188 -175.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.0 m -75.84 118.15 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.442 0 N-CA-C 107.43 -1.322 . . . . 72.44 107.43 176.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.37 157.32 27.65 Favored 'General case' 0 C--N 1.383 2.036 0 O-C-N 120.025 -1.672 . . . . 61.52 109.472 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.44 ' HA ' HG12 ' A' ' 24' ' ' VAL . 44.8 p -49.84 -37.61 31.43 Favored 'General case' 0 C--N 1.38 1.934 0 N-CA-C 116.123 1.897 . . . . 44.04 116.123 -173.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -38.97 75.98 Favored 'General case' 0 CA--C 1.595 2.678 0 N-CA-C 114.637 1.347 . . . . 73.43 114.637 176.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.5 -32.59 68.39 Favored 'General case' 0 C--N 1.374 1.655 0 CA-C-N 120.301 1.409 . . . . 71.43 110.596 176.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.606 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 7.5 p -75.46 -34.03 28.86 Favored 'Isoleucine or valine' 0 C--N 1.391 2.403 0 N-CA-C 108.663 -0.866 . . . . 52.21 108.663 178.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.5 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 0.5 OUTLIER -60.16 -55.63 31.45 Favored 'General case' 0 CA--C 1.576 1.967 0 CA-C-O 117.187 -1.387 . . . . 72.43 113.717 168.83 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -65.4 -58.88 4.78 Favored 'General case' 0 C--O 1.299 3.666 0 CA-C-N 121.654 2.025 . . . . 73.52 113.37 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -57.7 -44.95 86.23 Favored 'General case' 0 C--N 1.385 2.133 0 CA-C-O 117.902 -1.047 . . . . 62.31 112.075 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.606 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 3.1 m-85 -79.66 -17.22 54.23 Favored 'General case' 0 CA--C 1.568 1.671 0 CA-C-N 120.373 1.442 . . . . 65.34 114.121 -176.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.501 ' HA ' HG22 ' A' ' 34' ' ' ILE 0.322 70.3 mtp180 -60.33 -32.01 70.84 Favored 'General case' 0 N--CA 1.535 3.819 0 CA-C-N 122.022 2.192 . . . . 64.53 110.942 170.368 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.512 ' HD2' ' O ' ' A' ' 30' ' ' LYS 0.283 0.2 OUTLIER -58.51 -21.1 50.92 Favored 'General case' 0 N--CA 1.509 2.486 0 C-N-CA 117.805 -1.558 . . . . 72.21 114.109 175.006 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.512 ' HB3' ' HB2' ' A' ' 59' ' ' ALA . 1.5 m-85 -84.86 -27.53 26.64 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.37 -0.831 . . . . 74.43 110.306 -165.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 175.32 32.99 0.04 OUTLIER Glycine 0 N--CA 1.437 -1.275 0 CA-C-O 118.783 -1.009 . . . . 33.4 113.598 174.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.2 t30 57.27 80.72 0.16 Allowed 'General case' 0 C--N 1.357 0.914 0 C-N-CA 124.525 1.13 . . . . 63.01 110.641 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.501 HG22 ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -68.49 141.24 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 CA-C-N 114.935 -1.03 . . . . 64.25 113.6 -175.424 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.434 ' H ' HD22 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -107.39 -25.25 11.52 Favored 'General case' 0 C--N 1.375 1.686 0 N-CA-C 110.577 -0.157 . . . . 71.03 110.577 176.494 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.84 130.91 26.36 Favored 'General case' 0 CA--C 1.56 1.343 0 N-CA-C 108.896 -0.779 . . . . 73.4 108.896 -168.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -141.28 111.08 6.54 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.025 -0.732 . . . . 42.43 109.025 -175.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -129.04 143.28 50.82 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 117.802 -1.559 . . . . 60.42 113.483 -177.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.0 t -116.21 114.6 46.58 Favored 'Isoleucine or valine' 0 C--N 1.345 0.383 0 N-CA-C 108.737 -0.838 . . . . 75.33 108.737 176.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -107.12 130.41 54.7 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-O 118.601 -0.714 . . . . 74.2 109.618 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -106.15 128.04 53.63 Favored 'General case' 0 C--N 1.379 1.857 0 CA-C-N 120.519 1.509 . . . . 65.35 112.391 -174.022 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.638 HG23 ' H ' ' A' ' 44' ' ' SER . 1.4 t -90.76 160.0 16.02 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 119.139 -1.024 . . . . 51.44 111.187 170.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.0 t -76.29 -9.95 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.415 0 C-N-CA 123.698 0.799 . . . . 73.24 112.376 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.638 ' H ' HG23 ' A' ' 42' ' ' THR . 7.3 m -83.16 7.84 14.89 Favored 'General case' 0 CA--C 1.556 1.185 0 O-C-N 121.873 -0.517 . . . . 73.45 111.282 -177.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.31 -4.57 76.55 Favored Glycine 0 C--N 1.351 1.385 0 N-CA-C 115.563 0.985 . . . . 53.24 115.563 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.77 134.42 33.68 Favored 'General case' 0 CA--C 1.561 1.366 0 CA-C-N 118.01 0.905 . . . . 63.44 110.776 176.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -103.86 144.97 30.79 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 107.333 -1.358 . . . . 71.45 107.333 176.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -132.57 149.87 52.25 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.225 0.92 . . . . 45.3 108.562 175.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.401 ' HB3' ' CG1' ' A' ' 12' ' ' VAL . . . -117.79 137.0 53.03 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 119.071 -1.052 . . . . 41.34 111.391 170.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -106.12 118.85 37.69 Favored 'General case' 0 C--O 1.268 2.068 0 CA-C-N 113.92 -1.491 . . . . 72.04 107.762 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 0.3 OUTLIER -125.96 111.36 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.505 0 C-N-CA 119.066 -1.054 . . . . 60.41 111.905 -174.486 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.59 105.8 17.71 Favored 'General case' 0 CA--C 1.556 1.205 0 CA-C-N 115.643 -0.708 . . . . 71.32 111.474 -174.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 3.0 p90 -115.2 166.87 11.36 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 114.493 1.294 . . . . 74.53 114.493 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -80.8 -27.82 36.51 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 114.843 1.423 . . . . 74.21 114.843 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.35 118.6 32.69 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 120.011 1.278 . . . . 70.11 111.593 175.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.46 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -77.42 -34.33 54.7 Favored 'General case' 0 CA--C 1.552 1.023 0 N-CA-C 116.78 2.141 . . . . 75.11 116.78 172.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.267 0.0 OUTLIER -80.35 -29.33 37.94 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-N 121.879 2.127 . . . . 74.12 113.034 -170.538 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.22 -38.18 90.14 Favored 'General case' 0 N--CA 1.506 2.364 0 N-CA-C 114.067 1.136 . . . . 73.53 114.067 176.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.512 ' HB2' ' HB3' ' A' ' 31' ' ' TYR . . . -53.58 -22.45 8.51 Favored 'General case' 0 CA--C 1.561 1.383 0 N-CA-C 115.755 1.761 . . . . 75.51 115.755 173.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.93 -45.89 60.64 Favored 'General case' 0 CA--C 1.582 2.211 0 N-CA-C 114.807 1.41 . . . . 53.53 114.807 -178.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -50.66 -51.7 46.78 Favored 'General case' 0 N--CA 1.524 3.268 0 CA-C-N 119.745 1.157 . . . . 74.1 112.459 170.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.49 ' O ' ' HD2' ' A' ' 66' ' ' LYS . . . -75.05 -31.61 61.33 Favored 'General case' 0 CA--C 1.555 1.151 0 O-C-N 121.213 -0.929 . . . . 75.2 111.994 -176.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.492 HD11 HG12 ' A' ' 78' ' ' VAL 0.296 0.0 OUTLIER -73.63 -42.37 55.25 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.875 0 O-C-N 120.058 -1.651 . . . . 73.25 113.118 179.293 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.492 ' HD2' ' N ' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -55.72 -33.84 64.6 Favored 'General case' 0 CA--C 1.559 1.291 0 CA-C-N 120.383 1.447 . . . . 63.1 114.815 162.861 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.492 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -63.65 -32.62 74.15 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 120.058 1.299 . . . . 74.45 112.252 172.364 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.49 ' HD2' ' O ' ' A' ' 62' ' ' ALA 0.269 0.0 OUTLIER -105.0 16.72 25.42 Favored 'General case' 0 CA--C 1.581 2.151 0 C-N-CA 117.09 -1.844 . . . . 71.23 115.566 166.661 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.475 ' HB3' ' HA ' ' A' ' 64' ' ' LYS 0.363 0.0 OUTLIER -79.26 159.61 27.2 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-N 119.092 0.86 . . . . 72.43 112.845 -177.361 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.1 31.44 2.05 Favored Glycine 0 N--CA 1.436 -1.365 0 C-N-CA 118.202 -1.951 . . . . 72.05 113.866 -164.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.733 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -50.97 124.82 12.1 Favored 'General case' 0 C--N 1.374 1.631 0 O-C-N 124.449 0.735 . . . . 74.31 111.328 -173.86 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -133.79 150.79 51.45 Favored 'General case' 0 C--O 1.252 1.232 0 CA-C-N 115.044 -0.98 . . . . 73.13 110.735 -173.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -149.65 142.47 24.7 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 105.159 -2.163 . . . . 64.31 105.159 -170.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 73.52 66.1 0.1 Allowed 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 113.014 0.746 . . . . 72.54 113.014 -176.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.33 -14.0 61.23 Favored Glycine 0 N--CA 1.478 1.463 0 N-CA-C 117.187 1.635 . . . . 72.34 117.187 169.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 -114.55 120.29 39.71 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 105.349 -2.093 . . . . 52.43 105.349 149.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.56 101.84 13.52 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.587 -1.245 . . . . 75.52 108.747 -175.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.733 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 13.1 tp -172.0 70.54 0.04 OUTLIER 'General case' 0 C--N 1.387 2.207 0 CA-C-N 120.809 1.641 . . . . 71.22 112.599 -174.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.42 ' HB3' ' O ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -96.51 113.26 24.82 Favored 'General case' 0 CA--C 1.566 1.572 0 CA-C-N 122.375 2.352 . . . . 73.14 109.56 -174.257 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.577 HG22 HG23 ' A' ' 12' ' ' VAL . 13.9 t -128.71 118.03 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.481 0 O-C-N 120.286 -1.509 . . . . 41.11 109.381 174.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -134.48 135.58 42.54 Favored 'General case' 0 C--O 1.263 1.807 0 CA-C-N 119.475 1.034 . . . . 75.4 109.944 -175.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.8 m -72.41 123.81 89.99 Favored Pre-proline 0 CA--C 1.551 1.017 0 CA-C-N 115.753 -0.658 . . . . 63.44 110.288 159.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -92.09 23.06 0.6 Allowed 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.441 2.094 . . . . 74.31 112.663 168.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.46 ' CE1' ' HB1' ' A' ' 56' ' ' ALA . 8.8 p90 -121.9 -57.61 1.79 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 121.403 -0.119 . . . . 75.2 110.88 176.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.6 t30 48.69 43.9 21.03 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 125.58 1.552 . . . . 73.15 112.764 -175.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -161.16 143.84 12.49 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 121.182 -0.949 . . . . 72.52 111.053 -171.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 168.9 150.55 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 C-N-CA 124.739 1.216 . . . . 75.13 109.436 -178.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 C--O 1.249 1.075 0 N-CA-C 107.234 -1.395 . . . . 72.13 107.234 167.161 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.16 0 CA-C-O 120.012 -0.326 . . . . 73.12 112.456 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 42.3 m 64.65 39.71 6.32 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.727 1.211 . . . . 74.44 114.167 170.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -148.12 160.98 42.33 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 109.873 -0.417 . . . . 72.34 109.873 174.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.5 ptp -160.93 97.12 1.14 Allowed 'General case' 0 N--CA 1.478 0.944 0 O-C-N 123.879 0.737 . . . . 73.15 111.188 173.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.7 p -163.59 113.41 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.197 0 CA-C-O 121.378 0.609 . . . . 63.41 110.948 177.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.3 tt -163.31 124.73 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.231 0 O-C-N 122.127 -0.358 . . . . 54.33 111.149 177.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -141.28 136.31 31.49 Favored 'General case' 0 C--N 1.355 0.808 0 N-CA-C 107.695 -1.224 . . . . 65.05 107.695 171.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 73.26 5.29 5.04 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 123.882 0.739 . . . . 74.23 112.71 167.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.9 t -99.46 -12.13 20.48 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.947 -0.47 . . . . 54.45 112.072 -171.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . 0.298 3.4 m 64.14 116.5 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.476 0 C-N-CA 126.751 2.02 . . . . 71.45 113.475 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.7 m -74.68 119.82 19.38 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.941 -0.572 . . . . 74.14 110.979 -177.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -140.65 160.04 40.89 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 113.682 0.993 . . . . 74.5 113.682 -177.069 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.561 HG12 HG12 ' A' ' 80' ' ' VAL . 10.2 mt -112.57 136.56 48.44 Favored 'Isoleucine or valine' 0 C--O 1.259 1.564 0 N-CA-C 106.866 -1.531 . . . . 44.42 106.866 177.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -92.92 115.06 27.77 Favored 'General case' 0 CA--C 1.565 1.541 0 O-C-N 125.815 1.947 . . . . 74.41 109.045 177.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.409 HG22 HG13 ' A' ' 78' ' ' VAL . 38.5 t -123.57 115.29 44.86 Favored 'Isoleucine or valine' 0 C--N 1.366 1.316 0 CA-C-N 119.922 1.237 . . . . 75.44 109.042 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -121.63 171.03 14.95 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 119.276 -1.44 . . . . 64.41 113.738 173.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 50.81 25.69 2.25 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 115.367 1.618 . . . . 51.12 115.367 176.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.444 HD11 ' H ' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -79.24 140.84 57.06 Favored Pre-proline 0 CA--C 1.551 1.006 0 CA-C-N 119.144 0.883 . . . . 73.21 112.257 -170.265 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -76.15 142.69 24.75 Favored 'Trans proline' 0 CA--C 1.552 1.378 0 C-N-CA 122.992 2.461 . . . . 61.14 112.176 173.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.1 p 88.53 -32.25 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 126.719 2.008 . . . . 71.42 111.955 175.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 82.5 t60 69.13 105.29 0.06 Allowed 'General case' 0 C--N 1.361 1.069 0 C-N-CA 124.924 1.29 . . . . 75.41 111.184 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.444 ' H ' HD11 ' A' ' 15' ' ' LEU . 7.8 m -77.99 117.8 23.88 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.849 0 N-CA-C 109.127 -0.694 . . . . 74.24 109.127 -176.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.8 154.92 29.51 Favored 'General case' 0 C--N 1.378 1.839 0 CA-C-O 118.165 -0.921 . . . . 41.43 111.028 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.0 t -49.42 -46.52 47.74 Favored 'General case' 0 C--N 1.38 1.893 0 N-CA-C 114.821 1.415 . . . . 42.51 114.821 -177.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . 0.314 0.0 OUTLIER -55.23 -43.29 74.41 Favored 'General case' 0 CA--C 1.588 2.414 0 N-CA-C 115.246 1.573 . . . . 72.54 115.246 172.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.92 -37.84 87.12 Favored 'General case' 0 C--N 1.378 1.812 0 CA-C-O 117.903 -1.046 . . . . 73.55 110.726 176.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.2 t -64.89 -43.75 96.28 Favored 'Isoleucine or valine' 0 C--N 1.403 2.931 0 CA-C-N 119.551 1.069 . . . . 70.45 110.657 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.62 -52.72 63.77 Favored 'General case' 0 C--N 1.378 1.818 0 CA-C-O 116.201 -1.857 . . . . 62.13 111.12 176.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.558 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 1.8 m-20 -77.54 -55.28 5.5 Favored 'General case' 0 C--O 1.3 3.72 0 CA-C-N 122.713 2.506 . . . . 71.1 116.576 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.474 ' O ' ' HD2' ' A' ' 31' ' ' TYR . 19.8 tt0 -59.93 -39.96 87.26 Favored 'General case' 0 C--N 1.371 1.522 0 CA-C-O 117.335 -1.317 . . . . 71.24 111.698 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . 0.263 73.9 m-85 -82.28 -21.64 36.09 Favored 'General case' 0 CA--C 1.575 1.909 0 CA-C-N 121.918 2.145 . . . . 74.15 113.986 174.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.558 ' HG3' ' O ' ' A' ' 26' ' ' ASN 0.269 0.0 OUTLIER -59.72 -28.45 67.35 Favored 'General case' 0 N--CA 1.531 3.583 0 CA-C-N 120.864 1.665 . . . . 71.13 112.719 169.627 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.402 ' HE2' ' CD1' ' A' ' 31' ' ' TYR 0.325 0.0 OUTLIER -76.1 -36.21 59.01 Favored 'General case' 0 N--CA 1.506 2.338 0 C-N-CA 114.518 -2.873 . . . . 74.22 113.216 170.305 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.56 ' HB3' ' HA ' ' A' ' 59' ' ' ALA . 20.8 m-85 -76.68 -43.85 36.13 Favored 'General case' 0 CA--C 1.564 1.481 0 N-CA-C 112.681 0.623 . . . . 53.41 112.681 -164.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -132.45 -175.93 14.19 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.557 -1.017 . . . . 72.35 110.557 151.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -87.01 98.13 11.1 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.839 1.82 . . . . 63.12 109.6 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.428 ' HA ' ' HB3' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -75.37 141.02 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 113.349 0.87 . . . . 72.1 113.349 -178.653 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 11.1 mp -108.67 -24.14 11.48 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 122.758 0.423 . . . . 74.51 110.246 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.62 139.42 15.19 Favored 'General case' 0 CA--C 1.58 2.102 0 C-N-CA 123.794 0.837 . . . . 45.21 110.41 -170.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.427 ' SG ' HG13 ' A' ' 34' ' ' ILE . 62.0 m -138.79 112.3 8.22 Favored 'General case' 0 N--CA 1.507 2.382 0 N-CA-C 107.622 -1.251 . . . . 75.31 107.622 177.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -118.32 136.98 53.39 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 116.454 -2.098 . . . . 73.53 111.746 175.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -123.83 111.8 30.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 121.893 0.854 . . . . 43.43 109.266 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -115.77 152.61 32.95 Favored 'General case' 0 CA--C 1.559 1.318 0 CA-C-N 114.848 -1.069 . . . . 74.53 109.428 -172.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.39 146.24 50.85 Favored 'General case' 0 CA--C 1.565 1.528 0 CA-C-N 120.945 1.702 . . . . 73.13 108.838 -172.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.613 HG23 ' H ' ' A' ' 44' ' ' SER . 5.3 t -100.7 175.43 5.65 Favored 'General case' 0 CA--C 1.563 1.474 0 CA-C-N 120.698 1.59 . . . . 52.23 110.852 174.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.4 t -78.67 -8.53 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 123.545 0.738 . . . . 72.42 112.411 -175.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.613 ' H ' HG23 ' A' ' 42' ' ' THR . 7.1 t -89.15 4.72 47.58 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 122.937 0.495 . . . . 74.22 110.27 -175.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.13 -7.25 64.19 Favored Glycine 0 CA--C 1.534 1.26 0 N-CA-C 114.921 0.728 . . . . 75.04 114.921 -178.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.06 130.85 35.95 Favored 'General case' 0 CA--C 1.556 1.187 0 CA-C-N 117.877 0.838 . . . . 72.13 109.724 172.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.16 146.03 42.61 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.057 -0.72 . . . . 32.44 109.057 -173.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -128.29 148.51 50.66 Favored 'General case' 0 C--N 1.36 1.037 0 CA-C-N 119.63 1.105 . . . . 63.44 111.483 -173.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -123.61 146.27 48.3 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.162 0.801 . . . . 54.1 113.162 169.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -132.97 115.26 14.97 Favored 'General case' 0 C--O 1.267 2.005 0 N-CA-C 105.596 -2.002 . . . . 74.25 105.596 -165.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 1.4 mp -120.54 110.19 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.497 0 C-N-CA 118.371 -1.331 . . . . 61.41 111.378 -169.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -105.37 104.0 13.64 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-O 121.35 0.595 . . . . 71.34 111.754 -173.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.428 ' HB3' ' HA ' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -117.55 168.75 10.12 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 114.123 1.157 . . . . 75.44 114.123 -179.404 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -81.35 -33.86 32.14 Favored 'General case' 0 C--N 1.367 1.34 0 N-CA-C 113.963 1.098 . . . . 74.54 113.963 175.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -111.41 116.03 30.25 Favored 'General case' 0 C--N 1.349 0.576 0 N-CA-C 107.386 -1.338 . . . . 44.53 107.386 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.499 ' HB3' ' HE ' ' A' ' 85' ' ' ARG . . . -81.75 -28.78 33.15 Favored 'General case' 0 C--N 1.355 0.808 0 N-CA-C 114.647 1.351 . . . . 64.31 114.647 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.2 tmm_? -76.54 -41.07 47.96 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 114.2 1.185 . . . . 63.2 114.2 -170.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -70.65 -31.33 68.22 Favored 'General case' 0 CA--C 1.583 2.226 0 CA-C-N 121.459 1.936 . . . . 74.21 115.381 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.56 ' HA ' ' HB3' ' A' ' 31' ' ' TYR . . . -57.59 -22.16 43.32 Favored 'General case' 0 CA--C 1.596 2.743 0 N-CA-C 116.697 2.11 . . . . 62.21 116.697 169.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.451 ' HA ' HG22 ' A' ' 63' ' ' ILE . . . -50.47 -28.63 8.71 Favored 'General case' 0 CA--C 1.573 1.858 0 N-CA-C 114.758 1.392 . . . . 73.21 114.758 172.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.401 ' O ' ' HB3' ' A' ' 65' ' ' GLU . 5.5 m-20 -51.64 -54.42 28.15 Favored 'General case' 0 N--CA 1.504 2.266 0 CA-C-N 120.235 1.38 . . . . 73.32 112.644 162.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.64 -33.29 75.3 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 121.054 -1.029 . . . . 72.35 112.79 174.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.822 HD12 HG13 ' A' ' 80' ' ' VAL 0.303 0.0 OUTLIER -71.42 -46.41 64.31 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.607 0 C-N-CA 116.616 -2.034 . . . . 64.41 113.016 -178.619 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.526 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -55.06 -32.7 62.11 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 114.706 1.373 . . . . 72.41 114.706 164.221 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.401 ' HB3' ' O ' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -82.51 -18.37 41.81 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.702 1.137 . . . . 63.34 112.413 -176.537 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -101.29 15.05 30.04 Favored 'General case' 0 CA--C 1.588 2.428 0 CA-C-O 119.413 -0.327 . . . . 73.32 111.653 166.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.526 ' HB3' ' HA ' ' A' ' 64' ' ' LYS 0.378 0.2 OUTLIER -77.86 163.87 25.67 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 115.629 1.715 . . . . 72.4 115.629 -166.861 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.74 30.14 2.26 Favored Glycine 0 N--CA 1.432 -1.601 0 CA-C-O 117.224 -1.876 . . . . 72.1 115.62 -170.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.869 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -52.01 123.33 10.19 Favored 'General case' 0 C--N 1.382 2.019 0 CA-C-N 118.307 1.053 . . . . 73.24 111.577 -169.864 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.2 151.79 51.5 Favored 'General case' 0 C--O 1.258 1.504 0 CA-C-N 114.53 -1.213 . . . . 63.23 111.996 -170.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -148.75 145.28 27.55 Favored 'General case' 0 C--N 1.361 1.108 0 C-N-CA 126.97 2.108 . . . . 73.44 107.036 -163.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 70.42 64.33 0.2 Allowed 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 114.098 1.147 . . . . 72.14 114.098 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.21 -13.96 61.42 Favored Glycine 0 N--CA 1.476 1.31 0 N-CA-C 116.523 1.369 . . . . 75.41 116.523 172.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -118.42 120.34 37.29 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 105.956 -1.868 . . . . 71.22 105.956 153.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.53 107.37 19.78 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 118.051 -0.976 . . . . 74.2 109.774 -178.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.869 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 22.1 tp -163.08 70.44 0.25 Allowed 'General case' 0 C--O 1.192 -1.955 0 CA-C-N 120.114 1.324 . . . . 54.14 111.201 178.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -101.3 110.8 22.87 Favored 'General case' 0 CA--C 1.556 1.203 0 CA-C-N 122.537 2.426 . . . . 74.45 110.213 -170.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.479 HG12 HG12 ' A' ' 63' ' ' ILE . 90.8 t -126.88 118.23 49.97 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.732 0 O-C-N 120.097 -1.627 . . . . 62.3 107.5 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -145.28 131.43 19.41 Favored 'General case' 0 C--N 1.386 2.194 0 CA-C-N 120.694 1.588 . . . . 65.24 111.741 -170.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.822 HG13 HD12 ' A' ' 63' ' ' ILE . 15.7 m -88.44 134.24 34.79 Favored Pre-proline 0 C--N 1.349 0.576 0 CA-C-N 115.696 -0.684 . . . . 75.33 112.534 165.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -82.7 38.19 0.72 Allowed 'Trans proline' 0 CA--C 1.548 1.197 0 C-N-CA 122.322 2.014 . . . . 74.43 111.347 161.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.418 ' CD2' ' HB1' ' A' ' 56' ' ' ALA . 10.3 m-85 -125.56 52.01 1.67 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.452 -0.944 . . . . 53.32 108.452 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 61.7 m-20 -84.45 46.16 1.2 Allowed 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 115.597 -0.729 . . . . 71.5 110.055 175.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -170.16 33.4 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.628 1.171 . . . . 75.33 110.501 -172.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.499 ' HE ' ' HB3' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -144.5 43.48 1.39 Allowed 'General case' 0 N--CA 1.481 1.087 0 O-C-N 122.232 -0.292 . . . . 52.34 111.054 178.437 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.252 1.189 0 CA-C-O 118.419 -0.801 . . . . 71.21 109.992 177.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.077 0 N-CA-C 111.685 -0.566 . . . . 74.11 111.685 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 6.0 t -116.16 -178.32 3.38 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 110.248 -0.279 . . . . 64.24 110.248 -176.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -131.01 154.02 48.62 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 122.524 0.33 . . . . 74.23 111.343 -177.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -113.19 143.74 43.88 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.115 -0.493 . . . . 62.23 111.112 -177.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.4 t -119.88 127.17 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 116.372 -0.377 . . . . 43.12 110.325 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.1 pt -115.07 145.03 21.33 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 N-CA-C 109.756 -0.461 . . . . 75.41 109.756 176.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -135.95 142.54 44.61 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-O 118.485 -0.769 . . . . 72.41 110.893 169.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 68.34 84.08 0.15 Allowed 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 124.433 1.093 . . . . 73.31 111.202 171.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.0 t -145.32 165.14 29.3 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.424 -0.798 . . . . 63.11 110.918 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.7 m -114.72 126.37 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 108.857 -0.794 . . . . 73.01 108.857 176.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.13 137.45 34.07 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 119.368 -0.348 . . . . 72.4 110.19 -177.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.475 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 0.3 OUTLIER -138.71 159.19 42.72 Favored 'General case' 0 N--CA 1.509 2.524 0 CA-C-N 118.618 0.645 . . . . 60.31 111.909 -173.519 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.461 ' HB ' HD12 ' A' ' 51' ' ' ILE . 5.2 mp -134.48 133.77 54.79 Favored 'Isoleucine or valine' 0 C--O 1.269 2.082 0 N-CA-C 107.84 -1.17 . . . . 72.32 107.84 -177.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -108.54 114.4 28.2 Favored 'General case' 0 CA--C 1.57 1.731 0 O-C-N 125.877 1.986 . . . . 75.24 110.061 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.508 HG23 HG22 ' A' ' 78' ' ' VAL . 2.6 p -123.43 104.76 14.72 Favored 'Isoleucine or valine' 0 C--N 1.372 1.563 0 CA-C-N 120.555 1.525 . . . . 32.44 108.915 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -128.9 169.63 20.28 Favored Glycine 0 C--N 1.364 2.103 0 C-N-CA 120.374 -0.917 . . . . 63.02 114.747 -174.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.5 m120 49.24 24.8 1.06 Allowed 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 114.037 1.125 . . . . 54.44 114.037 -175.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.595 ' H ' HD23 ' A' ' 15' ' ' LEU . 2.0 pt? -85.12 149.98 54.03 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 125.439 1.496 . . . . 71.05 111.775 -171.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -72.13 140.98 35.27 Favored 'Trans proline' 0 C--N 1.367 1.532 0 C-N-CA 121.925 1.75 . . . . 74.34 111.56 173.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.4 p 82.5 -34.38 0.09 Allowed 'General case' 0 C--N 1.386 2.177 0 C-N-CA 126.857 2.063 . . . . 43.33 111.483 177.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 45.7 m-70 64.21 84.77 0.14 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.509 1.523 . . . . 74.31 110.109 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.576 ' H ' HD11 ' A' ' 15' ' ' LEU . 5.5 p -59.88 120.49 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.517 0 O-C-N 124.095 0.872 . . . . 75.13 110.503 -176.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.0 m -80.98 156.69 25.81 Favored 'General case' 0 C--N 1.363 1.174 0 CA-C-O 118.204 -0.903 . . . . 44.03 108.931 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.7 p -48.98 -37.29 19.79 Favored 'General case' 0 C--N 1.375 1.7 0 N-CA-C 115.795 1.776 . . . . 50.43 115.795 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . 0.255 0.0 OUTLIER -56.1 -47.62 77.71 Favored 'General case' 0 CA--C 1.588 2.433 0 N-CA-C 113.948 1.092 . . . . 62.14 113.948 173.191 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.457 ' HB2' HG23 ' A' ' 19' ' ' VAL . 13.6 m-20 -62.68 -50.97 69.06 Favored 'General case' 0 C--O 1.266 1.945 0 C-N-CA 123.686 0.794 . . . . 75.44 112.238 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.693 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -59.92 -46.18 94.26 Favored 'Isoleucine or valine' 0 C--N 1.372 1.55 0 CA-C-O 118.527 -0.749 . . . . 74.55 111.795 175.643 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.555 ' O ' ' HB3' ' A' ' 29' ' ' ARG 0.281 0.7 OUTLIER -52.5 -51.14 60.98 Favored 'General case' 0 C--O 1.202 -1.405 0 CA-C-O 115.647 -2.12 . . . . 71.42 112.049 171.217 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -71.73 -62.93 1.24 Allowed 'General case' 1 C--O 1.305 4.016 0 CA-C-N 124.537 3.335 . . . . 72.41 114.123 -178.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -72.8 -29.85 63.59 Favored 'General case' 0 C--N 1.371 1.512 0 O-C-N 120.495 -1.378 . . . . 71.42 112.118 -173.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.693 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 6.8 m-85 -84.05 -31.93 25.12 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 117.374 -1.298 . . . . 74.54 112.582 177.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.555 ' HB3' ' O ' ' A' ' 25' ' ' GLU . 3.3 ptt85 -51.46 -29.33 15.87 Favored 'General case' 0 N--CA 1.508 2.46 0 CA-C-O 116.353 -1.784 . . . . 70.4 114.355 164.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.41 -48.16 71.94 Favored 'General case' 0 N--CA 1.514 2.765 0 C-N-CA 114.775 -2.77 . . . . 63.21 113.2 164.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -79.99 -40.32 28.18 Favored 'General case' 0 CA--C 1.563 1.477 0 CA-C-N 119.082 0.856 . . . . 75.55 112.058 -170.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 29' ' ' ARG . . . -137.18 156.9 23.62 Favored Glycine 0 C--N 1.357 1.716 0 CA-C-N 120.245 1.384 . . . . 64.32 112.249 167.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -84.47 109.92 18.26 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.045 -0.724 . . . . 74.4 109.045 -170.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.74 121.42 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 113.439 0.904 . . . . 63.33 113.439 -176.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.81 -17.83 14.9 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.9 -0.778 . . . . 54.4 108.9 170.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -156.47 128.86 7.57 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 109.071 -0.714 . . . . 74.4 109.071 -165.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.4 p -143.04 107.99 4.92 Favored 'General case' 0 C--N 1.362 1.118 0 CA-C-N 119.34 0.973 . . . . 73.11 108.957 174.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -116.78 146.84 42.57 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 118.524 -1.27 . . . . 44.25 111.994 178.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.6 t -108.85 121.45 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 108.308 -0.997 . . . . 74.34 108.308 177.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -120.56 130.96 54.44 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 109.151 -0.685 . . . . 71.32 109.151 -176.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -121.98 128.6 51.66 Favored 'General case' 0 C--N 1.372 1.55 0 C-N-CA 117.839 -1.544 . . . . 63.13 111.127 -165.225 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.576 HG23 ' H ' ' A' ' 44' ' ' SER . 2.6 t -100.09 159.36 15.16 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 118.168 -1.413 . . . . 71.42 112.436 177.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.8 t -73.99 -7.99 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.408 0 C-N-CA 123.868 0.867 . . . . 75.14 112.377 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.576 ' H ' HG23 ' A' ' 42' ' ' THR . 7.4 t -85.23 7.78 20.81 Favored 'General case' 0 CA--C 1.55 0.968 0 O-C-N 121.489 -0.757 . . . . 65.43 110.601 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.34 -5.96 70.46 Favored Glycine 0 CA--C 1.532 1.13 0 N-CA-C 115.241 0.856 . . . . 52.05 115.241 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.48 132.38 33.94 Favored 'General case' 0 CA--C 1.558 1.283 0 CA-C-N 118.078 0.939 . . . . 74.44 110.713 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.91 142.38 34.87 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 107.439 -1.319 . . . . 24.44 107.439 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -130.79 145.99 52.12 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 106.944 -1.502 . . . . 71.21 106.944 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -118.22 138.2 52.5 Favored 'General case' 0 C--O 1.253 1.248 0 C-N-CA 119.114 -1.034 . . . . 42.42 109.798 173.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -116.84 120.45 38.54 Favored 'General case' 0 C--O 1.252 1.207 0 CA-C-N 114.516 -1.22 . . . . 72.45 108.848 -169.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.461 HD12 ' HB ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -132.84 112.66 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 123.122 0.263 . . . . 70.35 110.581 -166.902 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -103.07 113.11 26.31 Favored 'General case' 0 CA--C 1.565 1.529 0 CA-C-N 118.554 0.615 . . . . 72.13 112.169 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -108.74 164.14 12.64 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 112.742 0.645 . . . . 61.23 112.742 -176.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -78.85 -39.64 34.8 Favored 'General case' 0 N--CA 1.51 2.532 0 N-CA-C 113.37 0.878 . . . . 74.51 113.37 174.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.95 117.7 32.79 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 118.96 0.8 . . . . 72.24 109.615 -177.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.494 ' HB1' ' CD1' ' A' ' 82' ' ' PHE . . . -75.79 -26.32 57.21 Favored 'General case' 0 CA--C 1.556 1.19 0 N-CA-C 115.022 1.49 . . . . 72.34 115.022 175.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.321 0.0 OUTLIER -79.57 -28.2 41.16 Favored 'General case' 0 CA--C 1.57 1.74 0 CA-C-N 121.649 2.022 . . . . 74.03 114.803 -176.7 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.02 -30.23 49.89 Favored 'General case' 0 CA--C 1.591 2.552 0 CA-C-N 121.837 2.108 . . . . 73.2 115.668 174.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.74 -24.33 21.78 Favored 'General case' 0 CA--C 1.597 2.787 0 CA-C-N 120.551 1.523 . . . . 62.14 114.615 166.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.647 ' HA ' HG22 ' A' ' 63' ' ' ILE . . . -48.41 -39.37 22.28 Favored 'General case' 0 CA--C 1.569 1.691 0 C-N-CA 125.368 1.467 . . . . 62.32 114.061 173.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.459 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 2.1 m-20 -53.76 -50.82 65.17 Favored 'General case' 0 C--N 1.382 2.005 0 CA-C-N 120.473 1.488 . . . . 75.52 112.771 169.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.09 -44.99 91.98 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 118.454 -0.784 . . . . 62.31 112.65 174.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.717 HD12 HG13 ' A' ' 80' ' ' VAL 0.254 2.3 tt -69.94 -50.04 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 117.247 -1.781 . . . . 73.03 112.504 -174.648 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.53 ' HG3' ' O ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -56.9 -26.33 58.84 Favored 'General case' 0 CA--C 1.561 1.399 0 N-CA-C 115.57 1.692 . . . . 73.33 115.57 167.741 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.47 -20.11 37.53 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 121.369 1.895 . . . . 75.42 111.03 179.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.5 mttt -110.21 16.72 21.57 Favored 'General case' 0 CA--C 1.578 2.023 0 O-C-N 122.304 -0.248 . . . . 52.51 111.318 176.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.32 0.1 OUTLIER -78.23 161.4 27.32 Favored 'General case' 0 C--N 1.377 1.772 0 N-CA-C 112.988 0.736 . . . . 71.34 112.988 -176.188 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.38 26.04 3.57 Favored Glycine 0 N--CA 1.434 -1.499 0 C-N-CA 119.226 -1.464 . . . . 63.35 113.574 -160.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.819 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -55.15 123.63 14.29 Favored 'General case' 0 C--N 1.365 1.28 0 CA-C-N 117.545 0.672 . . . . 62.01 110.317 -176.628 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -133.19 151.3 51.96 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-N 115.792 -0.64 . . . . 62.42 112.122 -169.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -149.12 144.19 26.48 Favored 'General case' 0 C--N 1.354 0.78 0 C-N-CA 126.764 2.026 . . . . 62.12 106.779 -165.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 71.43 64.37 0.15 Allowed 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 113.43 0.9 . . . . 75.32 113.43 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.66 -13.72 62.35 Favored Glycine 0 N--CA 1.47 0.951 0 N-CA-C 117.081 1.592 . . . . 73.44 117.081 172.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -119.23 119.4 33.99 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 106.079 -1.823 . . . . 73.31 106.079 153.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.99 102.9 14.74 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 118.732 -1.187 . . . . 73.54 108.05 -171.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.819 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -160.57 65.99 0.32 Allowed 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 116.796 -1.574 . . . . 73.11 115.171 -177.673 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.29 114.86 27.29 Favored 'General case' 0 CA--C 1.578 2.05 0 CA-C-N 124.109 3.141 . . . . 73.4 111.962 -172.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.508 HG22 HG23 ' A' ' 12' ' ' VAL . 21.9 t -120.28 116.57 50.67 Favored 'Isoleucine or valine' 0 C--N 1.363 1.17 0 O-C-N 119.752 -1.842 . . . . 34.25 107.793 165.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -142.95 142.06 31.58 Favored 'General case' 0 C--N 1.362 1.116 0 C-N-CA 117.193 -1.803 . . . . 73.54 111.622 168.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.717 HG13 HD12 ' A' ' 63' ' ' ILE . 25.9 m -82.96 127.15 70.65 Favored Pre-proline 0 N--CA 1.442 -0.828 0 CA-C-N 114.676 -1.147 . . . . 71.42 110.556 169.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.475 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 57.9 Cg_endo -85.5 25.32 0.7 Allowed 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 121.6 1.533 . . . . 74.42 112.341 164.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.494 ' CD1' ' HB1' ' A' ' 56' ' ' ALA . 1.5 p90 -105.3 -31.59 9.01 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 120.414 -0.514 . . . . 74.41 111.048 174.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 50.7 69.98 0.57 Allowed 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 125.057 1.343 . . . . 74.42 113.26 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 66.47 -157.4 0.25 Allowed 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 124.247 1.019 . . . . 63.14 111.754 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -96.13 -83.7 0.37 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 118.996 0.816 . . . . 63.41 110.254 -172.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 . . . . . 0 C--O 1.256 1.419 0 CA-C-O 118.704 -0.665 . . . . 74.42 109.816 177.684 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.97 0 N-CA-C 112.206 -0.358 . . . . 72.03 112.206 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . 0.424 ' O ' ' HB3' ' A' ' 86' ' ' GLU . 6.6 p -145.73 159.48 43.11 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 123.041 0.536 . . . . 64.24 109.588 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 47.7 m80 -145.45 121.57 10.78 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 110.033 -0.358 . . . . 75.11 110.033 177.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.3 mtt -135.97 173.49 11.65 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.269 0.228 . . . . 73.12 111.458 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.7 m -97.51 143.54 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 116.307 -0.406 . . . . 25.32 111.737 -177.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.2 pt -127.68 132.53 68.95 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.261 0 CA-C-N 115.796 -0.638 . . . . 71.35 109.667 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 52.9 mtt85 -133.37 123.53 25.55 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-O 117.944 -1.027 . . . . 73.2 108.448 173.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 76.24 72.83 0.08 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 124.141 0.901 . . . . 63.45 110.206 170.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.4 t -140.95 166.35 25.01 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.509 -0.745 . . . . 73.11 110.248 -176.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.08 110.87 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 121.04 0.448 . . . . 73.35 109.943 177.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.79 124.52 31.0 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 115.363 -0.835 . . . . 72.32 109.625 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.506 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 4.9 ptt180 -140.59 157.53 45.34 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 118.837 -0.601 . . . . 63.42 112.394 -177.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.8 mt -118.15 135.17 59.42 Favored 'Isoleucine or valine' 0 C--N 1.368 1.41 0 CA-C-N 119.47 1.032 . . . . 74.54 109.075 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -105.97 118.54 36.86 Favored 'General case' 0 CA--C 1.568 1.661 0 O-C-N 125.281 1.613 . . . . 63.54 110.445 -177.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.456 ' HB ' ' HB3' ' A' ' 49' ' ' ALA . 47.3 t -124.2 107.52 18.76 Favored 'Isoleucine or valine' 0 C--N 1.373 1.619 0 CA-C-N 120.439 1.472 . . . . 71.32 109.287 -177.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.449 ' H ' ' HG3' ' A' ' 77' ' ' ARG . . . -120.18 163.93 13.88 Favored Glycine 0 C--N 1.344 1.021 0 C-N-CA 118.845 -1.645 . . . . 74.32 112.818 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.44 ' HB3' ' HB2' ' A' ' 75' ' ' LYS . 8.3 m120 50.45 26.89 2.53 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 114.772 1.397 . . . . 73.32 114.772 177.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.411 HD23 ' H ' ' A' ' 15' ' ' LEU . 0.9 OUTLIER -74.69 149.72 86.09 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.543 1.537 . . . . 74.21 111.415 -177.22 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -79.92 129.17 7.89 Favored 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 121.565 1.51 . . . . 73.24 111.27 176.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 96.7 p 57.55 102.56 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 124.647 1.179 . . . . 73.13 112.357 -171.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 32.0 p-80 -57.15 125.31 22.13 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.529 -0.76 . . . . 65.52 111.781 -177.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.513 HG23 ' HB2' ' A' ' 23' ' ' ASP . 2.9 p -77.61 119.29 26.01 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 CA-C-N 114.85 -1.068 . . . . 63.13 109.006 -176.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.0 m -79.4 157.37 27.6 Favored 'General case' 0 C--N 1.369 1.45 0 CA-C-O 117.955 -1.022 . . . . 73.02 108.581 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.8 p -48.97 -37.53 20.43 Favored 'General case' 0 C--N 1.375 1.698 0 N-CA-C 115.926 1.825 . . . . 71.14 115.926 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.584 ' H ' ' HD3' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -56.6 -40.72 75.79 Favored 'General case' 0 N--CA 1.507 2.381 0 N-CA-C 114.547 1.314 . . . . 75.14 114.547 172.692 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.513 ' HB2' HG23 ' A' ' 19' ' ' VAL . 7.5 m-20 -70.7 -45.93 64.07 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 118.955 0.798 . . . . 75.03 111.173 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.704 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 2.4 m -61.63 -49.75 83.07 Favored 'Isoleucine or valine' 0 C--N 1.372 1.572 0 N-CA-C 112.085 0.402 . . . . 72.43 112.085 174.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -50.09 -53.69 25.51 Favored 'General case' 0 CA--C 1.562 1.411 0 CA-C-O 116.528 -1.701 . . . . 74.21 113.226 171.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -73.09 -63.07 1.25 Allowed 'General case' 0 C--O 1.302 3.843 0 CA-C-N 122.901 2.591 . . . . 52.14 114.29 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -72.54 -30.79 64.76 Favored 'General case' 0 C--N 1.365 1.265 0 C-N-CA 119.031 -1.068 . . . . 74.21 111.172 -174.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.704 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 17.9 m-85 -85.85 -23.19 27.21 Favored 'General case' 0 CA--C 1.56 1.341 0 CA-C-N 119.536 1.062 . . . . 72.34 111.391 -178.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.434 ' HA ' HG22 ' A' ' 34' ' ' ILE 0.295 1.8 ppt_? -60.62 -24.5 65.56 Favored 'General case' 0 C--N 1.401 2.828 0 CA-C-N 120.602 1.546 . . . . 71.25 112.341 165.181 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . 0.297 0.0 OUTLIER -53.55 -30.77 43.47 Favored 'General case' 0 N--CA 1.508 2.466 0 C-N-CA 117.123 -1.831 . . . . 71.52 114.042 164.237 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -85.67 -49.47 7.96 Favored 'General case' 0 C--O 1.214 -0.793 0 CA-C-N 121.564 1.984 . . . . 73.04 112.279 -157.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -160.55 39.9 0.44 Allowed Glycine 0 C--N 1.355 1.613 0 C-N-CA 117.89 -2.1 . . . . 64.11 114.507 171.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.3 t30 69.33 93.78 0.08 Allowed 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 124.37 1.068 . . . . 72.32 111.435 173.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.434 HG22 ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -73.95 129.75 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-N 115.537 -0.756 . . . . 72.51 112.553 179.407 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.79 -21.73 12.54 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 109.553 -0.536 . . . . 73.35 109.553 174.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.22 131.63 15.67 Favored 'General case' 0 CA--C 1.561 1.394 0 N-CA-C 108.57 -0.9 . . . . 61.12 108.57 -173.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -138.55 110.59 7.28 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 120.126 1.33 . . . . 64.31 109.803 176.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -118.64 145.98 45.02 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 117.875 -1.53 . . . . 73.31 111.499 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 37.1 t -114.9 112.76 41.36 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 N-CA-C 107.623 -1.251 . . . . 71.22 107.623 172.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -114.7 129.83 56.74 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 114.825 -1.079 . . . . 75.42 108.739 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.09 144.52 51.48 Favored 'General case' 0 C--N 1.369 1.433 0 CA-C-N 121.004 1.729 . . . . 64.21 108.998 -171.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.49 HG23 ' H ' ' A' ' 44' ' ' SER . 8.8 t -99.06 170.99 8.32 Favored 'General case' 0 CA--C 1.558 1.288 0 CA-C-N 120.499 1.5 . . . . 30.13 111.738 -178.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.7 t -73.63 -7.07 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.368 0 C-N-CA 124.113 0.965 . . . . 73.23 112.577 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.49 ' H ' HG23 ' A' ' 42' ' ' THR . 8.5 t -85.41 8.36 19.19 Favored 'General case' 0 CA--C 1.55 0.965 0 O-C-N 121.59 -0.694 . . . . 65.41 111.04 -177.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.42 -4.89 75.73 Favored Glycine 0 C--N 1.351 1.4 0 N-CA-C 115.178 0.831 . . . . 54.21 115.178 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.19 131.27 34.24 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 117.726 0.763 . . . . 71.5 110.484 176.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -105.34 147.76 27.81 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 108.045 -1.094 . . . . 43.45 108.045 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -126.67 147.27 49.95 Favored 'General case' 0 C--N 1.352 0.7 0 C-N-CA 118.609 -1.236 . . . . 74.1 109.7 177.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.456 ' HB3' ' HB ' ' A' ' 12' ' ' VAL . . . -117.08 138.75 51.41 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 120.538 -0.465 . . . . 74.14 109.751 176.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.13 113.83 15.58 Favored 'General case' 0 C--O 1.261 1.662 0 N-CA-C 106.709 -1.589 . . . . 64.33 106.709 -175.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.44 ' N ' HD12 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -129.18 113.9 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 C-N-CA 118.699 -1.2 . . . . 71.52 109.72 -170.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -91.62 115.38 28.0 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 114.567 -1.197 . . . . 61.34 112.481 -172.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -109.39 159.58 16.89 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 114.279 1.214 . . . . 71.51 114.279 -177.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -82.04 -43.33 18.07 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 120.115 -0.634 . . . . 63.14 112.315 172.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.451 ' OD1' ' HD2' ' A' ' 57' ' ' ARG . 6.0 t0 -116.41 127.02 54.26 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 118.923 0.783 . . . . 74.41 110.896 -174.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.03 -22.21 53.38 Favored 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 115.548 1.684 . . . . 54.31 115.548 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.451 ' HD2' ' OD1' ' A' ' 55' ' ' ASP 0.289 0.0 OUTLIER -76.73 -41.32 45.47 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 121.939 2.154 . . . . 65.41 113.273 -173.191 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -62.69 -48.85 77.5 Favored 'General case' 0 N--CA 1.505 2.319 0 CA-C-N 120.217 1.371 . . . . 63.14 113.499 178.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.55 -24.62 33.25 Favored 'General case' 0 CA--C 1.567 1.596 0 N-CA-C 115.477 1.658 . . . . 71.44 115.477 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.401 ' O ' ' HG3' ' A' ' 64' ' ' LYS . . . -46.68 -44.37 18.55 Favored 'General case' 0 CA--C 1.576 1.967 0 C-N-CA 125.31 1.444 . . . . 73.31 114.025 173.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -51.83 -53.47 39.81 Favored 'General case' 0 N--CA 1.514 2.739 0 CA-C-N 119.523 1.056 . . . . 65.51 112.822 173.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.629 ' O ' ' HD2' ' A' ' 66' ' ' LYS . . . -75.67 -30.21 59.32 Favored 'General case' 0 C--N 1.31 -1.141 0 O-C-N 120.467 -1.396 . . . . 73.2 112.868 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 63' ' ' ILE 0.256 5.9 mm -68.78 -46.23 79.78 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.921 0 C-N-CA 118.174 -1.41 . . . . 54.43 111.915 179.205 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -56.94 -32.83 66.38 Favored 'General case' 0 CA--C 1.562 1.44 0 N-CA-C 115.155 1.539 . . . . 71.21 115.155 164.831 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -64.36 -28.39 69.66 Favored 'General case' 0 N--CA 1.507 2.377 0 CA-C-N 120.542 1.519 . . . . 75.41 113.201 173.12 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.629 ' HD2' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -107.41 15.17 25.19 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 116.221 1.934 . . . . 74.52 116.221 164.6 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.33 0.0 OUTLIER -78.63 157.21 28.73 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 120.238 1.381 . . . . 73.13 110.941 179.597 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.52 30.85 1.77 Allowed Glycine 0 N--CA 1.428 -1.889 0 C-N-CA 117.526 -2.273 . . . . 73.3 113.622 -151.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.739 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 6.9 t -49.07 132.69 19.04 Favored 'General case' 0 C--N 1.376 1.74 0 CA-C-O 122.062 0.934 . . . . 65.43 111.049 172.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.41 ' HB2' ' HB2' ' A' ' 76' ' ' LEU . 1.2 m-20 -128.92 147.13 50.81 Favored 'General case' 0 C--O 1.246 0.914 0 CA-C-N 113.951 -1.477 . . . . 72.4 112.836 -170.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.63 144.91 24.72 Favored 'General case' 0 C--N 1.355 0.83 0 C-N-CA 126.83 2.052 . . . . 74.22 108.154 -156.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 70.91 62.28 0.18 Allowed 'General case' 0 N--CA 1.501 2.086 0 O-C-N 123.611 0.569 . . . . 74.51 112.473 173.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.95 -14.79 64.15 Favored Glycine 0 N--CA 1.472 1.036 0 N-CA-C 116.952 1.541 . . . . 73.33 116.952 173.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -123.11 119.74 31.19 Favored 'General case' 0 C--O 1.211 -0.942 0 N-CA-C 104.592 -2.373 . . . . 74.43 104.592 159.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.44 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -104.54 131.44 51.93 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 118.02 -1.472 . . . . 73.42 111.281 -177.548 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.739 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -171.33 70.69 0.05 OUTLIER 'General case' 0 C--O 1.199 -1.594 0 CA-C-O 117.981 -1.009 . . . . 52.01 110.589 -178.417 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.449 ' HG3' ' H ' ' A' ' 13' ' ' GLY . 2.0 tpp85 -93.0 115.62 28.29 Favored 'General case' 0 CA--C 1.571 1.763 0 CA-C-N 121.572 1.987 . . . . 73.34 111.411 -172.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.04 116.09 48.76 Favored 'Isoleucine or valine' 0 C--N 1.361 1.079 0 N-CA-C 107.558 -1.275 . . . . 64.03 107.558 163.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.2 tp10 -134.46 138.66 44.93 Favored 'General case' 0 C--N 1.363 1.178 0 CA-C-N 119.576 1.08 . . . . 73.44 110.427 174.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.0 m -90.3 122.39 67.48 Favored Pre-proline 0 N--CA 1.439 -0.998 0 C-N-CA 120.016 -0.673 . . . . 71.51 110.579 170.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 75.5 Cg_endo -89.74 22.77 0.76 Allowed 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 121.887 1.725 . . . . 74.1 113.378 168.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.446 ' HD2' ' N ' ' A' ' 9' ' ' ARG . 0.8 OUTLIER -113.32 -16.84 12.43 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 120.009 -0.676 . . . . 70.34 112.417 175.426 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.6 m120 70.87 123.9 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 124.957 1.411 . . . . 71.42 110.271 -171.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.66 60.04 2.64 Favored 'General case' 0 C--N 1.365 1.259 0 CA-C-N 119.481 1.037 . . . . 75.22 113.123 -173.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.48 39.17 5.23 Favored 'General case' 0 C--N 1.366 1.313 0 C-N-CA 125.681 1.592 . . . . 62.33 110.393 178.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.424 ' HB3' ' O ' ' A' ' -1' ' ' SER . 19.3 mm-40 . . . . . 0 CA--C 1.552 1.051 0 C-N-CA 124.091 0.956 . . . . 65.53 112.958 170.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.511 0 N-CA-C 112.116 -0.394 . . . . 61.22 112.116 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 23.4 p -135.14 -9.6 2.27 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 122.748 0.419 . . . . 64.13 112.117 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -142.78 174.52 10.58 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.205 0.202 . . . . 72.25 110.826 178.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.476 ' SD ' ' HD3' ' A' ' 85' ' ' ARG . 30.6 ttp -164.1 87.65 0.5 Allowed 'General case' 0 C--N 1.345 0.408 0 O-C-N 123.621 0.576 . . . . 74.32 109.567 175.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 44.0 t 69.26 136.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 C-N-CA 125.467 1.507 . . . . 71.21 112.668 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.0 tt -130.93 -46.78 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.202 0 O-C-N 121.2 -0.937 . . . . 61.01 112.728 174.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.6 tpt180 -171.98 54.52 0.02 OUTLIER 'General case' 0 C--N 1.355 0.805 0 CA-C-N 119.21 0.914 . . . . 71.13 109.803 -173.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 68.96 92.59 0.08 Allowed 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 124.574 1.15 . . . . 74.34 110.88 177.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.1 t -121.38 -166.83 1.41 Allowed 'General case' 0 CA--C 1.551 0.995 0 O-C-N 121.094 -1.004 . . . . 64.14 110.573 -178.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.9 m -142.58 115.55 3.71 Favored 'Isoleucine or valine' 0 C--N 1.353 0.745 0 N-CA-C 106.637 -1.616 . . . . 70.21 106.637 175.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.68 122.88 29.22 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 122.017 -0.427 . . . . 74.22 112.092 -172.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.499 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -126.59 154.76 43.5 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.044 0.757 . . . . 73.43 113.044 -176.299 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.776 HD13 HG13 ' A' ' 63' ' ' ILE . 23.4 mt -116.79 141.17 36.07 Favored 'Isoleucine or valine' 0 C--O 1.254 1.31 0 CA-C-N 119.446 1.021 . . . . 75.34 108.637 179.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -101.71 116.99 33.96 Favored 'General case' 0 CA--C 1.572 1.797 0 O-C-N 125.991 2.057 . . . . 70.41 110.073 177.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.491 ' CG1' HG22 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -127.37 105.67 14.15 Favored 'Isoleucine or valine' 0 C--N 1.381 1.95 0 CA-C-N 119.348 0.977 . . . . 73.12 108.754 179.843 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -113.12 -175.66 19.36 Favored Glycine 0 CA--C 1.521 0.445 0 CA-C-O 118.504 -1.164 . . . . 73.33 112.991 176.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.7 m120 54.09 28.8 9.34 Favored 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 115.701 1.741 . . . . 74.1 115.701 170.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.3 mt -89.08 150.79 45.87 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 123.51 0.724 . . . . 73.54 111.629 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -59.35 130.73 37.21 Favored 'Trans proline' 0 CA--C 1.556 1.582 0 C-N-CA 123.095 2.53 . . . . 61.22 113.232 173.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.0 p 71.98 -5.11 1.79 Allowed 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 126.473 1.909 . . . . 71.22 114.525 168.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 71.54 129.8 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.062 1.345 . . . . 74.13 110.605 -173.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.9 m -91.68 119.78 39.61 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.443 0 N-CA-C 107.424 -1.324 . . . . 73.15 107.424 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.44 157.47 24.91 Favored 'General case' 0 C--N 1.381 1.972 0 O-C-N 120.263 -1.523 . . . . 64.02 109.991 -175.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.0 p -58.96 -34.25 71.58 Favored 'General case' 0 C--N 1.378 1.836 0 N-CA-C 115.835 1.791 . . . . 64.42 115.835 -174.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.4 ' HA ' ' HG2' ' A' ' 25' ' ' GLU 0.274 0.0 OUTLIER -60.75 -39.14 87.61 Favored 'General case' 0 CA--C 1.582 2.199 0 N-CA-C 115.477 1.658 . . . . 73.21 115.477 172.377 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -65.32 -50.47 65.54 Favored 'General case' 0 C--O 1.279 2.622 0 CA-C-N 119.87 1.214 . . . . 73.4 111.329 178.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.7 m -62.94 -43.75 99.19 Favored 'Isoleucine or valine' 0 C--N 1.376 1.759 0 O-C-N 123.546 0.529 . . . . 53.31 111.877 177.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.4 ' HG2' ' HA ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -54.13 -50.16 67.54 Favored 'General case' 0 C--O 1.191 -2.015 0 CA-C-O 115.195 -2.336 . . . . 75.44 115.202 169.03 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.41 -56.63 7.81 Favored 'General case' 0 C--O 1.283 2.85 0 CA-C-N 123.257 2.753 . . . . 51.32 114.071 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -61.18 -44.56 97.1 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 117.903 -1.046 . . . . 64.3 111.71 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -74.59 -28.54 60.95 Favored 'General case' 0 C--O 1.209 -1.04 0 CA-C-N 120.857 1.662 . . . . 62.33 114.194 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.417 ' C ' ' HE ' ' A' ' 29' ' ' ARG 0.379 0.0 OUTLIER -57.62 -37.88 74.03 Favored 'General case' 0 N--CA 1.526 3.353 0 CA-C-N 121.285 1.857 . . . . 74.33 114.252 164.025 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.41 ' HE2' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -56.6 -47.75 78.91 Favored 'General case' 0 N--CA 1.508 2.475 0 C-N-CA 116.194 -2.202 . . . . 64.3 110.319 167.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.554 ' HB3' ' HA ' ' A' ' 59' ' ' ALA . 35.2 m-85 -72.64 -39.47 67.16 Favored 'General case' 0 CA--C 1.564 1.505 0 CA-C-O 118.065 -0.969 . . . . 70.32 112.79 -166.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -150.11 176.07 28.91 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-N 119.965 1.257 . . . . 74.22 110.722 161.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 47.1 m-20 -83.58 101.14 11.26 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.249 2.024 . . . . 75.31 111.077 -176.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.91 134.41 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.108 0.48 . . . . 64.31 112.034 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.5 mp -102.77 -24.86 13.69 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 116.097 -0.501 . . . . 74.51 111.992 171.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.53 138.0 13.97 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 109.249 -0.648 . . . . 74.43 109.249 -173.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -140.27 108.73 5.86 Favored 'General case' 0 C--N 1.359 0.982 0 CA-C-N 118.727 0.694 . . . . 72.43 109.545 178.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -120.8 143.68 48.71 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 117.852 -1.539 . . . . 61.15 112.643 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -127.15 112.8 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 CA-C-O 121.452 0.644 . . . . 62.43 110.284 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.5 mttm -113.41 152.43 30.07 Favored 'General case' 0 CA--C 1.56 1.336 0 CA-C-O 118.018 -0.991 . . . . 73.23 108.874 -174.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.37 147.19 50.27 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-N 121.755 2.071 . . . . 70.51 109.061 -174.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.682 HG23 ' H ' ' A' ' 44' ' ' SER . 5.8 t -98.88 175.65 5.87 Favored 'General case' 0 CA--C 1.565 1.53 0 CA-C-N 120.816 1.644 . . . . 72.11 111.356 175.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.5 t -77.51 -8.99 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.387 0 C-N-CA 123.486 0.714 . . . . 71.32 112.115 -178.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.682 ' H ' HG23 ' A' ' 42' ' ' THR . 8.2 t -86.14 -0.8 56.53 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 121.773 -0.579 . . . . 54.03 110.753 -177.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.06 -7.46 66.81 Favored Glycine 0 CA--C 1.534 1.258 0 N-CA-C 114.977 0.751 . . . . 52.23 114.977 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.31 132.26 37.38 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 117.728 0.764 . . . . 73.32 108.952 170.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.88 145.35 44.68 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.022 -0.733 . . . . 51.21 109.022 -171.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -127.04 151.16 48.97 Favored 'General case' 0 C--N 1.363 1.16 0 CA-C-N 119.783 1.174 . . . . 74.53 112.0 -170.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -127.57 147.0 50.34 Favored 'General case' 0 C--N 1.351 0.642 0 CA-C-O 121.705 0.764 . . . . 70.05 111.831 175.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -132.69 113.31 12.84 Favored 'General case' 0 C--O 1.256 1.407 0 N-CA-C 105.392 -2.077 . . . . 73.33 105.392 -164.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 0.6 OUTLIER -126.38 108.91 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 C-N-CA 118.186 -1.406 . . . . 73.15 108.865 -170.525 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -106.27 106.0 16.3 Favored 'General case' 0 CA--C 1.549 0.905 0 O-C-N 124.6 1.187 . . . . 72.43 110.233 -173.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.19 146.6 39.0 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-O 118.681 -0.676 . . . . 74.21 112.766 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -57.46 -24.21 54.4 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 114.657 1.354 . . . . 72.25 114.657 166.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -114.09 113.42 24.7 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 119.603 1.092 . . . . 74.34 109.015 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.29 -43.68 32.37 Favored 'General case' 0 CA--C 1.554 1.103 0 N-CA-C 115.426 1.639 . . . . 72.43 115.426 172.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.305 0.0 OUTLIER -77.49 -29.57 52.66 Favored 'General case' 0 C--N 1.373 1.589 0 CA-C-N 121.117 1.78 . . . . 75.35 114.916 -167.831 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.17 -30.17 63.36 Favored 'General case' 0 CA--C 1.581 2.17 0 N-CA-C 116.353 1.983 . . . . 74.43 116.353 176.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.554 ' HA ' ' HB3' ' A' ' 31' ' ' TYR . . . -72.99 -19.28 61.24 Favored 'General case' 0 CA--C 1.585 2.302 0 CA-C-N 120.367 1.439 . . . . 44.13 111.993 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -48.58 -29.78 4.62 Favored 'General case' 0 CA--C 1.572 1.825 0 CA-C-O 116.97 -1.49 . . . . 35.42 114.325 170.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.565 ' O ' ' HB3' ' A' ' 65' ' ' GLU . 18.8 m-20 -51.88 -53.38 41.31 Favored 'General case' 0 C--N 1.398 2.708 0 CA-C-N 121.025 1.739 . . . . 62.32 111.571 164.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.02 -34.8 79.3 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-O 117.824 -1.084 . . . . 72.33 113.689 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.776 HG13 HD13 ' A' ' 10' ' ' ILE 0.281 0.0 OUTLIER -72.92 -35.93 50.34 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.685 0 C-N-CA 116.457 -2.097 . . . . 74.22 113.727 -178.741 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.61 -32.95 74.58 Favored 'General case' 0 C--N 1.362 1.143 0 CA-C-N 119.848 1.204 . . . . 73.52 113.678 163.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.565 ' HB3' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -83.38 -19.28 36.35 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 113.206 0.817 . . . . 74.41 113.206 -172.804 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -100.35 13.64 33.75 Favored 'General case' 0 CA--C 1.571 1.784 0 O-C-N 122.207 -0.308 . . . . 74.33 110.329 173.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.302 0.1 OUTLIER -77.02 161.94 27.93 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 118.422 0.555 . . . . 71.43 112.296 -167.463 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 119.85 28.41 1.89 Allowed Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 119.452 -1.356 . . . . 72.23 114.681 -155.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.702 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 0.8 OUTLIER -47.94 132.68 15.02 Favored 'General case' 0 C--N 1.377 1.768 0 C-N-CA 124.573 1.149 . . . . 75.3 109.811 179.238 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -56.95 102.06 0.07 Allowed 'General case' 0 C--N 1.384 2.105 0 O-C-N 125.216 1.573 . . . . 73.23 112.362 -160.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -153.92 139.3 17.64 Favored 'General case' 0 N--CA 1.439 -0.998 0 O-C-N 125.252 1.595 . . . . 71.22 107.303 -178.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 67.32 54.12 0.73 Allowed 'General case' 0 N--CA 1.508 2.461 0 C-N-CA 123.501 0.72 . . . . 64.41 111.892 172.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.73 -9.06 32.01 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 117.893 1.917 . . . . 75.31 117.893 176.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -115.54 119.54 36.52 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.245 1.522 . . . . 70.44 107.993 -174.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.03 100.83 12.59 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 117.966 -1.016 . . . . 52.31 111.643 -167.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.702 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -162.49 103.95 1.08 Allowed 'General case' 0 C--O 1.158 -3.749 0 CA-C-O 117.081 -1.438 . . . . 74.03 107.935 170.498 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.67 109.9 21.33 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 123.533 2.879 . . . . 65.54 107.257 -170.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.491 HG22 ' CG1' ' A' ' 12' ' ' VAL . 88.4 t -128.38 117.21 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.548 0 CA-C-N 120.481 1.491 . . . . 63.22 108.573 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -150.22 135.53 18.02 Favored 'General case' 0 C--N 1.381 1.972 0 CA-C-N 120.339 1.427 . . . . 72.24 110.144 -174.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.679 HG13 HD12 ' A' ' 63' ' ' ILE . 19.0 m -77.93 122.27 85.29 Favored Pre-proline 0 C--N 1.36 1.052 0 CA-C-O 121.618 0.723 . . . . 55.24 110.892 161.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.499 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 72.2 Cg_endo -90.78 13.69 2.13 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.402 2.068 . . . . 60.15 113.362 165.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -102.41 -45.72 5.0 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.055 -0.72 . . . . 55.24 109.055 170.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 51.52 55.68 9.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 125.058 1.474 . . . . 63.22 110.302 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -165.31 175.87 8.83 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 121.471 -0.768 . . . . 71.33 109.725 -162.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.476 ' HD3' ' SD ' ' A' ' 1' ' ' MET . 49.3 ttt180 -120.72 147.65 45.01 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 108.609 -0.886 . . . . 74.34 108.609 172.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 . . . . . 0 C--O 1.246 0.887 0 N-CA-C 107.304 -1.369 . . . . 71.03 107.304 167.485 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.057 0 N-CA-C 111.138 -0.785 . . . . 52.4 111.138 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 83.4 p -153.16 136.46 15.74 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 112.441 0.534 . . . . 63.53 112.441 -176.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -130.86 -88.16 0.48 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.483 0.713 . . . . 71.21 110.602 173.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ptp -169.32 112.81 0.52 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.866 0.466 . . . . 71.52 111.168 -177.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 60.9 t -130.97 -46.11 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 O-C-N 122.15 -0.344 . . . . 73.24 110.989 169.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.7 tt -61.77 107.03 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 113.54 0.941 . . . . 64.24 113.54 -169.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.46 152.22 43.59 Favored 'General case' 0 C--N 1.353 0.722 0 CA-C-N 115.668 -0.696 . . . . 74.53 109.807 167.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 65.14 46.18 2.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 123.855 0.722 . . . . 74.44 111.359 175.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.3 t -154.8 164.46 38.78 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 116.155 -0.475 . . . . 73.42 109.985 -177.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.7 m -114.37 126.68 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 109.785 -0.45 . . . . 74.23 109.785 -177.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 t -84.96 124.21 31.41 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 122.252 -0.28 . . . . 63.23 111.725 -178.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.454 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -141.16 154.66 45.97 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 113.351 0.871 . . . . 75.51 113.351 -175.06 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.6 mt -116.65 141.72 33.45 Favored 'Isoleucine or valine' 0 C--O 1.26 1.644 0 N-CA-C 108.418 -0.956 . . . . 71.11 108.418 -179.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -100.7 118.02 35.97 Favored 'General case' 0 CA--C 1.566 1.568 0 O-C-N 125.775 1.922 . . . . 74.32 110.374 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.475 HG13 HG22 ' A' ' 78' ' ' VAL . 57.9 t -125.78 106.24 15.79 Favored 'Isoleucine or valine' 0 C--N 1.375 1.677 0 CA-C-N 119.849 1.204 . . . . 73.12 109.889 177.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.17 -178.07 20.9 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 118.582 -1.121 . . . . 54.43 111.818 174.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.5 m120 50.13 24.2 1.36 Allowed 'General case' 0 N--CA 1.509 2.489 0 N-CA-C 116.579 2.066 . . . . 63.2 116.579 172.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.616 HD12 ' HB3' ' A' ' 18' ' ' HIS . 2.4 pt? -89.18 123.93 66.01 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 123.401 0.681 . . . . 61.34 111.001 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -84.33 126.67 3.72 Favored 'Trans proline' 0 CA--C 1.559 1.74 0 C-N-CA 121.415 1.41 . . . . 62.33 112.855 174.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.1 m 33.42 60.55 0.47 Allowed 'General case' 0 C--N 1.386 2.154 0 C-N-CA 125.772 1.629 . . . . 55.53 114.271 174.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.616 ' HB3' HD12 ' A' ' 15' ' ' LEU . 7.3 t60 -109.58 -128.29 0.28 Allowed 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.65 -0.704 . . . . 73.31 109.671 -168.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.9 m -83.37 121.59 36.41 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.695 0 CA-C-N 118.384 0.538 . . . . 70.35 110.983 -174.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -81.43 165.56 21.17 Favored 'General case' 0 C--N 1.369 1.434 0 CA-C-O 117.571 -1.204 . . . . 72.14 109.134 176.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.6 p -47.79 -46.78 30.84 Favored 'General case' 0 C--N 1.382 2.008 0 N-CA-C 116.065 1.876 . . . . 63.24 116.065 -173.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.25 -42.03 96.69 Favored 'General case' 0 CA--C 1.577 2.0 0 N-CA-C 114.517 1.303 . . . . 65.55 114.517 178.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.352 0.6 OUTLIER -67.41 -27.24 66.91 Favored 'General case' 0 CA--C 1.565 1.543 0 CA-C-N 120.036 1.289 . . . . 61.41 112.958 172.783 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.441 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 2.3 t -71.11 -38.78 72.65 Favored 'Isoleucine or valine' 0 C--N 1.406 3.055 0 CA-C-N 120.266 1.394 . . . . 64.34 107.734 175.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.601 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -65.79 -56.82 9.94 Favored 'General case' 0 CA--C 1.555 1.138 0 CA-C-O 117.129 -1.415 . . . . 75.4 112.198 179.488 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.11 -54.92 19.69 Favored 'General case' 0 C--O 1.299 3.666 0 CA-C-N 121.739 2.063 . . . . 72.32 115.58 176.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.78 -37.83 80.18 Favored 'General case' 0 C--N 1.387 2.209 0 CA-C-O 118.126 -0.94 . . . . 53.25 112.136 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.441 ' HB2' ' O ' ' A' ' 24' ' ' VAL 0.256 63.4 m-85 -83.87 -21.9 31.82 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-O 115.832 -2.033 . . . . 72.22 114.188 178.312 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.601 ' HG3' ' O ' ' A' ' 25' ' ' GLU 0.372 10.6 mtp180 -61.95 -36.05 80.25 Favored 'General case' 0 N--CA 1.524 3.225 0 CA-C-N 122.689 2.495 . . . . 72.12 109.115 169.466 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.84 -45.86 89.06 Favored 'General case' 0 N--CA 1.509 2.52 0 C-N-CA 116.879 -1.929 . . . . 64.32 112.179 172.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.56 ' HB3' ' HA ' ' A' ' 59' ' ' ALA . 13.7 m-85 -71.83 -40.35 69.16 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 112.746 0.647 . . . . 75.01 112.746 -169.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -151.5 163.72 30.01 Favored Glycine 0 C--O 1.213 -1.184 0 CA-C-O 117.346 -1.808 . . . . 71.31 108.591 156.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -72.59 101.18 2.95 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 121.188 2.494 . . . . 44.42 111.402 -170.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.49 HG22 ' HB3' ' A' ' 53' ' ' PHE . 2.1 pp -73.81 142.41 14.91 Favored 'Isoleucine or valine' 0 C--N 1.359 0.983 0 C-N-CA 120.089 -0.645 . . . . 73.45 112.602 -174.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.1 mp -97.37 -45.5 6.44 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 115.912 -0.585 . . . . 74.21 112.131 174.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.05 152.99 38.34 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-N 118.697 0.681 . . . . 61.23 110.558 172.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 3.3 m -137.62 107.4 6.26 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 106.756 -1.572 . . . . 72.52 106.756 176.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -115.88 143.41 45.46 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 118.544 -1.263 . . . . 63.41 111.288 -175.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -123.62 113.14 36.05 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-O 121.27 0.557 . . . . 74.34 110.239 -173.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 48.1 mttm -116.76 146.14 43.02 Favored 'General case' 0 CA--C 1.563 1.445 0 CA-C-O 117.968 -1.015 . . . . 55.34 109.956 -173.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.42 146.31 50.13 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 121.508 1.958 . . . . 71.12 108.771 -170.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.601 HG23 ' H ' ' A' ' 44' ' ' SER . 5.1 t -99.33 167.41 10.67 Favored 'General case' 0 C--N 1.363 1.164 0 CA-C-N 120.358 1.435 . . . . 75.23 111.398 175.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.3 m -66.39 -5.32 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.472 0 N-CA-C 116.262 1.949 . . . . 75.43 116.262 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.601 ' H ' HG23 ' A' ' 42' ' ' THR . 0.8 OUTLIER -98.83 4.81 47.64 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 119.507 1.049 . . . . 75.4 110.14 -172.373 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.37 -6.82 74.99 Favored Glycine 0 CA--C 1.543 1.781 0 N-CA-C 115.238 0.855 . . . . 62.22 115.238 -176.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -80.78 131.52 35.43 Favored 'General case' 0 CA--C 1.554 1.133 0 CA-C-N 118.267 1.034 . . . . 73.31 109.248 171.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.93 147.45 43.13 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-O 118.565 -0.731 . . . . 73.3 109.319 -171.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -129.57 151.62 49.99 Favored 'General case' 0 C--N 1.367 1.327 0 CA-C-N 119.541 1.064 . . . . 70.24 111.619 -173.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -134.29 144.01 48.08 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.919 0.866 . . . . 75.44 111.598 175.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -131.59 114.67 15.12 Favored 'General case' 0 C--O 1.265 1.88 0 N-CA-C 105.591 -2.003 . . . . 71.25 105.591 -159.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 0.3 OUTLIER -120.01 107.6 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 C-N-CA 119.271 -0.972 . . . . 74.21 109.713 -165.79 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -114.04 104.7 12.4 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.126 -0.488 . . . . 61.53 111.04 -169.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.49 ' HB3' HG22 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -114.12 160.73 18.62 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.831 1.048 . . . . 74.32 113.831 -177.035 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -73.09 -28.7 62.44 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 112.741 0.645 . . . . 61.41 112.741 167.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -113.8 112.42 23.37 Favored 'General case' 0 C--N 1.351 0.659 0 C-N-CA 118.571 -1.252 . . . . 60.33 109.277 176.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.34 -44.71 35.47 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 116.058 1.873 . . . . 72.44 116.058 170.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.97 -34.9 76.08 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 113.846 1.054 . . . . 73.32 113.846 -169.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -75.96 -32.64 59.6 Favored 'General case' 0 CA--C 1.586 2.358 0 N-CA-C 115.897 1.814 . . . . 64.44 115.897 176.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.56 ' HA ' ' HB3' ' A' ' 31' ' ' TYR . . . -64.93 -19.81 66.13 Favored 'General case' 0 CA--C 1.595 2.694 0 N-CA-C 114.884 1.439 . . . . 75.44 114.884 173.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -48.46 -31.83 6.89 Favored 'General case' 0 CA--C 1.578 2.055 0 N-CA-C 115.047 1.499 . . . . 74.1 115.047 171.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.406 ' O ' ' HB3' ' A' ' 65' ' ' GLU . 14.9 m-20 -51.21 -52.97 39.5 Favored 'General case' 0 N--CA 1.507 2.424 0 CA-C-N 119.915 1.234 . . . . 62.21 111.77 164.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.58 -31.32 71.95 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 117.13 -1.414 . . . . 73.21 114.023 175.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . 0.343 0.3 OUTLIER -73.59 -42.49 55.51 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.199 0 C-N-CA 115.578 -2.449 . . . . 74.31 113.895 177.612 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.16 -27.42 65.65 Favored 'General case' 0 CA--C 1.56 1.328 0 CA-C-N 120.158 1.345 . . . . 72.53 113.691 165.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.406 ' HB3' ' O ' ' A' ' 61' ' ' ASP . 1.2 tt0 -77.59 -29.31 51.91 Favored 'General case' 0 CA--C 1.549 0.937 0 O-C-N 121.31 -0.869 . . . . 73.13 112.45 178.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 43.0 mmtt -96.01 13.0 28.48 Favored 'General case' 0 CA--C 1.584 2.259 0 N-CA-C 112.861 0.689 . . . . 74.4 112.861 172.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.323 0.2 OUTLIER -76.23 164.97 25.54 Favored 'General case' 0 N--CA 1.51 2.534 0 CA-C-N 119.825 1.193 . . . . 74.4 111.922 -171.059 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.76 31.19 1.05 Allowed Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 118.652 -1.737 . . . . 74.14 114.801 -153.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.647 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 59.5 m -44.68 139.49 2.89 Favored 'General case' 0 C--N 1.393 2.492 0 CA-C-N 117.767 0.784 . . . . 74.03 111.852 171.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.406 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 7.9 t0 -58.05 99.79 0.05 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 O-C-N 125.038 1.461 . . . . 71.43 110.774 -169.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -155.63 139.29 16.05 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 125.551 1.54 . . . . 75.44 109.63 -175.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 66.06 51.39 1.31 Allowed 'General case' 0 N--CA 1.509 2.506 0 C-N-CA 123.148 0.579 . . . . 73.23 111.935 168.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.9 -11.01 36.84 Favored Glycine 0 CA--C 1.541 1.69 0 N-CA-C 117.456 1.742 . . . . 53.32 117.456 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' A' ' 70' ' ' ASP . 8.8 t30 -114.83 118.9 34.84 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 119.608 1.704 . . . . 74.51 108.84 -177.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.96 107.59 19.88 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 113.57 0.952 . . . . 70.32 113.57 -176.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.647 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -159.35 108.87 1.89 Allowed 'General case' 0 C--O 1.167 -3.261 0 N-CA-C 107.48 -1.304 . . . . 74.04 107.48 165.847 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 -90.79 107.58 19.28 Favored 'General case' 0 CA--C 1.554 1.098 0 CA-C-N 122.728 2.513 . . . . 72.03 108.028 -175.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.475 HG22 HG13 ' A' ' 12' ' ' VAL . 57.7 t -127.28 111.46 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 O-C-N 120.771 -1.206 . . . . 55.21 108.776 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -149.44 133.68 17.33 Favored 'General case' 0 C--O 1.257 1.475 0 CA-C-N 120.565 1.529 . . . . 64.32 110.615 -166.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.8 m -73.47 126.14 90.16 Favored Pre-proline 0 C--N 1.37 1.491 0 CA-C-O 121.363 0.601 . . . . 73.11 111.88 164.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -96.49 17.31 0.68 Allowed 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.367 2.711 . . . . 53.3 113.959 164.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -114.32 -26.38 8.02 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 120.574 -0.45 . . . . 75.32 112.063 176.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 54.94 73.79 0.39 Allowed 'General case' 0 CA--C 1.569 1.683 0 O-C-N 124.583 1.177 . . . . 72.44 113.43 -175.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 72.81 -99.41 0.03 OUTLIER 'General case' 0 C--N 1.369 1.431 0 C-N-CA 125.109 1.363 . . . . 53.53 112.838 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 14.1 ttt180 -167.9 26.63 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 109.052 -0.722 . . . . 75.31 109.052 -176.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.296 -1.335 . . . . 73.42 111.794 -171.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.935 0 N-CA-C 111.467 -0.653 . . . . 35.11 111.467 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 84' ' ' ALA . 9.6 t -153.0 147.09 25.51 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 116.972 0.386 . . . . 72.44 110.61 176.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -136.04 158.84 43.44 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 109.251 -0.648 . . . . 73.15 109.251 177.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 mpp? -130.27 11.95 5.49 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.193 0.52 . . . . 72.33 110.748 173.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.7 m -121.3 -179.13 1.75 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 115.933 -0.576 . . . . 74.54 109.566 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.0 mt 71.73 101.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 O-C-N 124.752 1.282 . . . . 73.4 110.798 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.94 77.79 1.14 Allowed 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.343 0.592 . . . . 75.12 110.497 -175.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -167.07 -163.91 0.57 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.26 -1.336 . . . . 62.41 108.979 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.3 m 65.85 -159.42 0.27 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.925 0.89 . . . . 54.44 110.948 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.3 p -151.29 136.58 10.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 121.247 0.546 . . . . 73.45 110.642 177.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 t -80.88 123.52 28.35 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.508 -0.769 . . . . 74.35 110.188 178.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.551 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 0.3 OUTLIER -141.87 160.34 40.4 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 112.66 0.615 . . . . 71.33 112.66 -176.726 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.797 HG12 HG12 ' A' ' 80' ' ' VAL . 3.7 mt -113.64 136.9 48.59 Favored 'Isoleucine or valine' 0 C--O 1.246 0.911 0 N-CA-C 109.075 -0.713 . . . . 53.42 109.075 176.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -111.35 112.86 24.93 Favored 'General case' 0 C--N 1.354 0.761 0 O-C-N 124.619 1.2 . . . . 64.3 108.923 172.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 4.0 p -124.42 110.38 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-O 121.577 0.703 . . . . 73.0 111.422 175.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -117.62 159.24 14.22 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.918 -0.583 . . . . 64.11 112.458 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.1 m120 60.87 28.98 18.72 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.996 0.918 . . . . 64.04 111.925 175.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.538 HD23 ' H ' ' A' ' 15' ' ' LEU . 2.1 pt? -85.04 137.46 37.5 Favored Pre-proline 0 C--O 1.239 0.528 0 CA-C-N 115.873 -0.603 . . . . 61.24 111.564 -172.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -69.23 126.92 14.26 Favored 'Trans proline' 0 C--N 1.36 1.142 0 C-N-CA 122.23 1.954 . . . . 71.11 112.055 174.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.6 t 52.23 92.24 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.96 0 O-C-N 124.672 1.233 . . . . 51.3 111.956 -173.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 34.0 p-80 -58.71 131.61 51.41 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.652 -0.703 . . . . 72.42 111.325 -177.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.3 m -72.45 133.54 31.58 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-N 115.079 -0.964 . . . . 61.31 111.525 -176.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.414 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -83.03 157.08 23.05 Favored 'General case' 0 C--O 1.212 -0.888 0 CA-C-N 114.968 -1.015 . . . . 64.4 110.541 -178.923 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.2 p -60.17 -31.42 70.1 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.097 1.517 . . . . 72.14 115.097 -166.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.63 -47.11 67.47 Favored 'General case' 0 C--O 1.249 1.058 0 CA-C-O 121.747 0.784 . . . . 52.24 110.673 176.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -66.62 -40.23 88.68 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 113.686 -1.597 . . . . 74.22 110.436 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.588 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 57.2 t -59.93 -46.73 93.62 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 O-C-N 123.899 0.749 . . . . 72.11 109.654 170.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.516 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 0.3 OUTLIER -58.92 -54.4 47.52 Favored 'General case' 0 C--O 1.204 -1.327 0 CA-C-O 118.667 -0.683 . . . . 72.35 111.326 -175.784 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.488 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 5.7 m-80 -79.97 -49.78 11.36 Favored 'General case' 0 C--O 1.278 2.564 0 N-CA-C 114.523 1.305 . . . . 74.44 114.523 -177.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -68.69 -35.54 77.33 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 120.407 -0.517 . . . . 54.42 109.961 -173.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.588 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 59.0 m-85 -85.31 -18.22 34.52 Favored 'General case' 0 CA--C 1.556 1.195 0 N-CA-C 113.671 0.989 . . . . 73.41 113.671 172.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.516 ' HB3' ' O ' ' A' ' 25' ' ' GLU . 2.3 ppt_? -64.85 -25.36 67.87 Favored 'General case' 0 N--CA 1.503 2.191 0 CA-C-N 120.387 1.448 . . . . 72.01 110.768 167.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.76 -30.95 57.84 Favored 'General case' 0 CA--C 1.565 1.523 0 O-C-N 123.455 0.472 . . . . 64.25 111.879 168.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.507 ' CD1' ' HA ' ' A' ' 28' ' ' PHE . 1.0 OUTLIER -74.9 -17.57 60.55 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.493 0.717 . . . . 63.0 111.659 -175.448 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 140.84 57.73 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 119.358 -1.401 . . . . 72.01 113.399 174.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 55.28 98.0 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 125.573 1.549 . . . . 53.02 113.302 173.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.91 124.54 36.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.295 -1.32 . . . . 70.43 110.993 -177.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -90.01 -42.68 11.0 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 114.898 -1.047 . . . . 72.15 109.744 175.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -144.34 139.43 28.5 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.842 -0.617 . . . . 64.22 110.693 -177.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 8.5 p -129.57 123.24 30.86 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.133 -0.485 . . . . 71.14 110.009 172.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -130.33 128.14 40.87 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 116.497 -0.319 . . . . 73.33 110.21 177.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.9 t -109.81 116.99 53.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 120.945 0.402 . . . . 74.52 109.925 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt -108.25 157.55 18.24 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.095 -0.502 . . . . 64.12 110.741 -177.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.98 147.98 52.68 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 122.248 -0.282 . . . . 64.1 110.401 173.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.1 t -101.16 165.28 11.38 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.81 -0.441 . . . . 71.22 109.81 171.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.5 t -74.52 -15.23 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 123.787 0.835 . . . . 64.04 110.797 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.9 m -75.56 -9.8 58.89 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.952 -0.567 . . . . 74.03 111.929 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.43 -4.31 47.49 Favored Glycine 0 C--N 1.342 0.912 0 C-N-CA 121.534 -0.365 . . . . 61.34 113.7 175.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -89.53 141.58 28.45 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.1 0.476 . . . . 61.33 111.37 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -106.23 149.6 26.71 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.614 -0.721 . . . . 61.41 110.041 176.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.435 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 2.1 m-85 -136.68 151.29 49.11 Favored 'General case' 0 C--O 1.223 -0.303 0 N-CA-C 109.25 -0.648 . . . . 70.23 109.25 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -127.35 139.61 52.75 Favored 'General case' 0 C--O 1.248 0.976 0 N-CA-C 109.528 -0.545 . . . . 51.23 109.528 169.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -120.53 115.44 23.44 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 106.717 -1.586 . . . . 72.55 106.717 -176.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -133.67 112.26 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 N-CA-C 113.787 1.032 . . . . 74.05 113.787 -166.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -90.84 114.76 27.26 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.531 0.567 . . . . 70.4 112.531 -173.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -110.24 161.94 15.1 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 115.967 -0.56 . . . . 73.21 110.713 176.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -83.09 -30.12 28.23 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.237 0.458 . . . . 70.12 112.237 174.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.48 125.65 49.4 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.836 0.827 . . . . 42.3 112.409 -176.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.53 -45.73 24.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 113.893 -1.503 . . . . 71.42 113.492 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -23.43 53.63 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.005 0.743 . . . . 70.5 113.005 -168.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -73.61 -34.01 64.84 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.786 0.803 . . . . 74.34 109.887 176.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.01 -27.74 61.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.708 -1.133 . . . . 64.4 112.658 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.56 -33.44 63.87 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.246 1.202 . . . . 44.11 114.246 -175.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.521 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 17.4 m-20 -70.99 -37.67 72.71 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.564 0.697 . . . . 75.32 112.711 177.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.49 ' O ' ' HG3' ' A' ' 65' ' ' GLU . . . -75.74 -36.08 60.01 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.736 0.779 . . . . 60.02 111.097 177.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.851 HG13 HG13 ' A' ' 80' ' ' VAL . 0.4 OUTLIER -68.13 -31.83 53.42 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.231 0 CA-C-O 117.918 -1.039 . . . . 73.35 109.748 174.892 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.521 ' HG3' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -77.11 -20.68 55.34 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 120.201 1.364 . . . . 71.24 111.506 172.659 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -71.73 -27.47 63.02 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 119.438 -0.905 . . . . 64.45 111.394 170.565 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.42 13.9 19.03 Favored 'General case' 0 N--CA 1.511 2.622 0 N-CA-C 116.578 2.066 . . . . 61.24 116.578 167.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.466 ' HB3' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -73.3 158.21 35.55 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 124.663 1.185 . . . . 71.15 112.229 176.215 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.83 23.38 5.01 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 119.981 -1.104 . . . . 32.51 112.259 -159.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 15.8 p -57.22 134.52 56.0 Favored 'General case' 0 C--O 1.24 0.582 0 O-C-N 124.895 0.997 . . . . 53.15 113.125 -173.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.63 149.07 52.62 Favored 'General case' 0 C--O 1.257 1.462 0 CA-C-N 114.242 -1.345 . . . . 70.23 112.605 -170.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -143.81 145.61 32.48 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 112.504 -2.134 . . . . 70.33 110.778 -171.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 73.02 67.95 0.11 Allowed 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 122.569 1.176 . . . . 42.11 114.142 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.88 -11.2 57.5 Favored Glycine 0 C--N 1.333 0.414 0 CA-C-N 113.786 -1.552 . . . . 51.15 114.081 176.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -121.51 123.78 42.83 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.527 -1.286 . . . . 55.45 107.527 158.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.63 103.4 15.33 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 119.222 -0.418 . . . . 60.25 110.962 178.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 13.9 tp -165.41 70.93 0.15 Allowed 'General case' 0 C--O 1.206 -1.186 0 C-N-CA 119.937 -0.705 . . . . 54.33 112.261 177.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -96.76 111.4 23.58 Favored 'General case' 0 C--O 1.209 -1.075 0 O-C-N 119.834 -1.791 . . . . 74.25 109.701 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 t -129.17 119.64 49.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 107.492 -1.299 . . . . 74.34 107.492 170.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -148.16 141.95 25.69 Favored 'General case' 0 C--O 1.247 0.939 0 C-N-CA 119.81 -0.756 . . . . 53.21 111.289 176.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.851 HG13 HG13 ' A' ' 63' ' ' ILE . 19.1 m -89.9 121.95 68.38 Favored Pre-proline 0 N--CA 1.438 -1.035 0 CA-C-N 114.75 -1.114 . . . . 72.44 110.194 166.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.551 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 72.2 Cg_endo -88.21 21.58 0.99 Allowed 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 121.89 1.727 . . . . 63.22 112.503 164.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.455 ' HD2' ' N ' ' A' ' 9' ' ' ARG . 0.2 OUTLIER -116.71 13.1 15.09 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 113.13 0.789 . . . . 71.1 113.13 179.504 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -76.94 78.9 3.5 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.925 0.393 . . . . 61.53 111.137 -171.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' ' -1' ' ' SER . . . -173.95 23.51 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.28 -1.327 . . . . 64.24 109.909 -177.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 74.72 -56.2 0.64 Allowed 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.615 1.566 . . . . 70.23 112.546 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 . . . . . 0 C--O 1.252 1.212 0 N-CA-C 108.742 -0.836 . . . . 74.23 108.742 177.16 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.962 0 N-CA-C 112.263 -0.335 . . . . 51.31 112.263 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 39.5 t -141.55 127.87 19.87 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.65 0.262 . . . . 51.23 110.981 -177.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -152.32 152.5 32.19 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.302 0.641 . . . . 73.53 110.217 177.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 ptp -153.21 89.56 1.37 Allowed 'General case' 0 CA--C 1.547 0.838 0 CA-C-O 121.201 0.524 . . . . 74.1 111.532 174.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 42.6 t -126.82 147.47 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 109.103 -0.703 . . . . 75.05 109.103 174.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.4 tt -67.08 112.36 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 CA-C-O 121.92 0.867 . . . . 43.33 111.827 178.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.0 mtm-85 -152.02 133.8 14.82 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.196 -0.911 . . . . 75.25 109.717 174.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -92.93 99.77 12.35 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.873 0.844 . . . . 53.13 111.485 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.5 t -158.12 154.72 27.93 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 114.853 -1.067 . . . . 71.41 109.484 -177.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -105.23 117.35 50.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 109.263 -0.643 . . . . 71.23 109.263 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.4 p -83.39 128.03 34.17 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.07 -0.514 . . . . 60.32 112.328 -174.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.518 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 8.8 ptt180 -132.56 150.51 52.15 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.7 -0.682 . . . . 63.43 112.39 -171.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 34.2 mt -118.51 142.47 33.16 Favored 'Isoleucine or valine' 0 C--O 1.247 0.937 0 C-N-CA 122.963 0.505 . . . . 74.3 110.121 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -111.81 114.65 27.74 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 124.874 1.359 . . . . 73.32 109.466 175.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 2.7 p -123.27 108.04 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 CA-C-O 122.286 1.041 . . . . 61.11 111.799 175.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 77' ' ' ARG . . . -118.66 164.12 13.03 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 114.998 -1.001 . . . . 75.43 113.821 -176.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 58.15 24.74 11.66 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.873 1.269 . . . . 70.3 113.588 170.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -90.25 150.35 42.96 Favored Pre-proline 0 CA--C 1.552 1.023 0 N-CA-C 111.47 0.174 . . . . 55.23 111.47 -174.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 75' ' ' LYS . 57.3 Cg_endo -75.8 150.76 35.21 Favored 'Trans proline' 0 C--N 1.364 1.374 0 C-N-CA 122.771 2.314 . . . . 43.24 113.268 -178.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.7 p 79.88 -21.79 0.31 Allowed 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 127.334 2.254 . . . . 62.41 112.687 -177.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 66.18 107.37 0.04 OUTLIER 'General case' 0 C--N 1.357 0.918 0 C-N-CA 125.236 1.415 . . . . 72.23 110.415 -171.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.402 HG21 HG13 ' A' ' 24' ' ' VAL . 9.9 p -83.04 128.4 38.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 CA-C-N 115.217 -0.902 . . . . 62.54 109.023 175.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 m -91.1 167.95 11.99 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.298 -0.865 . . . . 55.25 109.759 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.4 p -57.28 -39.83 76.5 Favored 'General case' 0 C--O 1.218 -0.605 0 O-C-N 123.892 0.745 . . . . 73.53 112.778 -175.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.4 -39.38 90.5 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.125 0.97 . . . . 71.34 112.78 178.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -75.2 -46.98 30.47 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 116.138 -0.483 . . . . 75.41 111.323 -171.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.402 HG13 HG21 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -67.5 -32.96 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 115.967 -0.56 . . . . 43.31 110.969 173.285 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -58.96 -44.94 91.58 Favored 'General case' 0 C--O 1.206 -1.231 0 CA-C-O 118.639 -0.696 . . . . 74.31 110.811 172.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.448 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 2.0 t-20 -70.67 -48.92 52.34 Favored 'General case' 0 C--O 1.279 2.647 0 CA-C-O 121.631 0.729 . . . . 70.42 111.336 -177.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -61.7 -42.71 99.3 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-N 114.003 -1.453 . . . . 42.44 111.063 -176.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -82.55 -26.04 32.8 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 117.823 -1.084 . . . . 73.45 112.511 178.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 26' ' ' ASN . 46.8 ptt85 -69.92 -33.06 71.66 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 119.327 0.967 . . . . 71.22 111.374 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.07 -26.57 66.8 Favored 'General case' 0 C--N 1.362 1.13 0 C-N-CA 118.796 -1.162 . . . . 62.44 111.541 -177.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.536 ' CD2' ' HB2' ' A' ' 62' ' ' ALA . 69.2 m-85 -92.89 -39.73 11.0 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 111.622 0.23 . . . . 74.1 111.622 178.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -153.39 133.52 4.02 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 111.647 -0.581 . . . . 45.2 111.647 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -64.74 118.09 8.44 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 113.447 0.906 . . . . 72.2 113.447 -168.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.68 139.45 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 114.686 -1.143 . . . . 73.31 111.278 -174.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.3 mp -102.12 -43.72 5.66 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.085 -0.961 . . . . 71.22 111.509 -176.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.92 132.98 20.32 Favored 'General case' 0 C--O 1.213 -0.842 0 N-CA-C 108.951 -0.759 . . . . 73.03 108.951 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.9 t -137.73 119.64 15.34 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 109.73 -0.47 . . . . 71.43 109.73 175.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -130.82 147.66 52.5 Favored 'General case' 0 C--O 1.22 -0.479 0 C-N-CA 120.592 -0.443 . . . . 45.35 111.315 -177.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.2 p -117.12 124.56 73.16 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 CA-C-O 121.535 0.683 . . . . 73.22 111.428 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.92 163.7 12.9 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.565 -0.743 . . . . 70.44 110.071 -178.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.76 150.92 52.1 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 122.001 -0.437 . . . . 75.24 110.9 172.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 15.3 t -100.32 169.47 9.09 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 110.072 -0.344 . . . . 64.22 110.072 172.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.6 t -74.91 -18.13 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.132 0 C-N-CA 123.79 0.836 . . . . 64.43 111.089 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.6 t -75.79 -12.87 60.26 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 122.866 0.467 . . . . 60.34 111.846 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.46 -3.56 43.21 Favored Glycine 0 C--N 1.34 0.783 0 C-N-CA 121.347 -0.454 . . . . 71.44 113.92 175.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.0 144.63 26.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.976 0.417 . . . . 74.44 110.556 176.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.74 147.9 41.6 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.013 -0.539 . . . . 74.35 110.263 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 0.9 OUTLIER -136.77 147.28 46.57 Favored 'General case' 0 C--O 1.217 -0.63 0 N-CA-C 109.411 -0.588 . . . . 74.33 109.411 -175.004 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -121.84 140.39 52.44 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 121.385 0.612 . . . . 74.3 109.91 176.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -113.62 118.09 33.42 Favored 'General case' 0 C--O 1.257 1.479 0 CA-C-N 113.633 -1.621 . . . . 71.33 107.833 -176.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.518 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 4.2 mp -118.25 110.07 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 O-C-N 123.607 0.567 . . . . 43.55 110.781 -174.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -115.52 105.06 12.36 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 121.834 0.826 . . . . 31.22 111.214 -171.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -114.11 171.58 7.52 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.137 1.162 . . . . 63.33 114.137 -177.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -75.28 -43.54 50.62 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 114.713 -1.13 . . . . 71.1 111.554 171.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -117.25 121.92 42.53 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 122.331 1.062 . . . . 74.43 112.078 -175.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.643 ' HB3' ' HB2' ' A' ' 85' ' ' ARG . . . -78.45 -43.53 26.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 112.883 -1.962 . . . . 61.53 113.99 -175.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -74.27 -25.86 59.86 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.39 0.885 . . . . 74.34 113.39 -169.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.488 ' HB3' ' O ' ' A' ' 31' ' ' TYR . 1.3 m-20 -80.75 -44.95 17.81 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.971 0.36 . . . . 53.13 111.971 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.48 -24.05 64.64 Favored 'General case' 0 C--O 1.251 1.147 0 C-N-CA 124.221 1.008 . . . . 32.0 111.747 176.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -53.3 -23.36 8.93 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.441 -1.254 . . . . 51.45 114.128 172.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.457 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -63.51 -47.05 83.29 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 118.823 0.738 . . . . 54.32 111.674 171.194 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.536 ' HB2' ' CD2' ' A' ' 31' ' ' TYR . . . -65.24 -39.92 93.33 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.938 -0.574 . . . . 61.42 110.24 174.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -66.81 -31.28 52.8 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 C-N-CA 120.28 -0.568 . . . . 13.43 111.381 177.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -80.21 -23.35 40.99 Favored 'General case' 0 C--N 1.351 0.631 0 N-CA-C 112.881 0.697 . . . . 73.54 112.881 176.875 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.495 ' HG2' ' HA ' ' A' ' 62' ' ' ALA . 10.2 pt-20 -81.52 -19.55 41.94 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 118.987 -1.085 . . . . 72.21 111.454 171.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 62' ' ' ALA . 68.9 mmtt -92.36 -6.07 50.89 Favored 'General case' 0 CA--C 1.57 1.731 0 CA-C-N 118.451 0.569 . . . . 64.41 111.474 169.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.43 ' HB2' ' HA ' ' A' ' 64' ' ' LYS . 38.3 t70 -64.77 153.33 40.21 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 126.321 1.848 . . . . 71.21 112.746 178.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.71 23.82 4.88 Favored Glycine 0 C--N 1.343 0.942 0 C-N-CA 119.94 -1.124 . . . . 74.22 113.626 -163.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 24.5 p -58.7 133.1 55.63 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-O 122.196 0.998 . . . . 65.24 113.214 -169.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.37 149.13 49.61 Favored 'General case' 0 C--O 1.261 1.69 0 CA-C-N 114.09 -1.413 . . . . 51.32 112.907 -170.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -143.52 145.53 32.63 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 126.112 1.765 . . . . 75.34 111.224 -174.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 73.38 68.61 0.11 Allowed 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 114.554 1.316 . . . . 75.54 114.554 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.66 -10.99 59.37 Favored Glycine 0 N--CA 1.462 0.388 0 CA-C-N 114.188 -1.369 . . . . 73.21 113.778 175.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -120.51 122.6 40.98 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 107.065 -1.458 . . . . 64.51 107.065 155.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.47 ' O ' ' HD3' ' A' ' 16' ' ' PRO . 0.3 OUTLIER -95.08 102.39 14.2 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 117.961 -1.019 . . . . 74.32 110.286 178.573 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.54 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.3 OUTLIER -168.51 67.78 0.07 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 113.599 0.963 . . . . 71.24 113.599 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.403 ' HB3' ' O ' ' A' ' 13' ' ' GLY . 23.8 tpt180 -95.85 111.1 23.16 Favored 'General case' 0 C--O 1.2 -1.529 0 CA-C-N 120.829 1.649 . . . . 73.32 110.157 -176.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.451 ' H ' ' HB3' ' A' ' 69' ' ' CYS . 2.7 t -130.1 118.12 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 108.317 -0.994 . . . . 61.42 108.317 175.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -149.84 147.26 27.75 Favored 'General case' 0 C--O 1.255 1.345 0 C-N-CA 119.825 -0.75 . . . . 64.13 112.264 176.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.9 m -88.74 124.7 64.99 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 114.791 -1.095 . . . . 45.31 111.373 168.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.49 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 61.5 Cg_endo -87.08 12.03 3.08 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.132 1.888 . . . . 71.11 113.958 167.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.501 ' CE1' ' HB1' ' A' ' 56' ' ' ALA . 10.7 p90 -102.26 -25.79 13.55 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.847 0.684 . . . . 71.44 112.847 177.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.7 m120 55.97 70.43 0.64 Allowed 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.255 1.022 . . . . 73.42 113.198 -176.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 62.52 -173.11 0.15 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 125.169 1.388 . . . . 41.34 112.901 -177.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.643 ' HB2' ' HB3' ' A' ' 56' ' ' ALA . 7.5 ttt85 -100.64 75.21 1.72 Allowed 'General case' 0 C--N 1.334 -0.103 0 O-C-N 121.573 -0.705 . . . . 75.43 109.494 178.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 . . . . . 0 C--O 1.24 0.582 0 CA-C-O 117.656 -1.164 . . . . 71.35 110.233 -176.981 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.928 0 N-CA-C 111.714 -0.554 . . . . 54.44 111.714 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 66.5 m -110.46 -80.25 0.58 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 119.429 -0.32 . . . . 60.42 111.515 -178.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 66.73 90.32 0.09 Allowed 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 125.228 1.411 . . . . 73.42 111.305 -178.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpp? -104.54 160.65 14.77 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 116.449 -0.341 . . . . 70.12 110.368 -176.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 76.4 t 76.32 -63.29 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 C-N-CA 125.473 1.509 . . . . 75.2 111.616 177.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.7 mm 70.35 -87.3 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 125.331 1.452 . . . . 73.14 111.532 176.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -160.45 52.45 0.31 Allowed 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 118.556 0.616 . . . . 74.15 110.747 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 73.31 121.12 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 126.055 1.742 . . . . 71.22 112.043 176.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.5 163.66 38.52 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.518 -0.31 . . . . 73.31 111.651 -176.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.2 m -114.36 128.68 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 116.014 -0.539 . . . . 62.13 110.568 176.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.5 t -85.46 119.13 25.48 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.482 -0.326 . . . . 71.2 110.814 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 24.2 ptt180 -143.68 152.57 41.49 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-N 115.837 -0.62 . . . . 60.43 111.851 -176.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 52.9 mt -116.98 135.46 57.28 Favored 'Isoleucine or valine' 0 C--O 1.256 1.421 0 C-N-CA 122.924 0.489 . . . . 74.35 109.849 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -103.0 115.13 30.02 Favored 'General case' 0 C--N 1.362 1.142 0 O-C-N 125.644 1.84 . . . . 75.2 109.412 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.9 t -115.77 132.81 64.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 107.657 -1.238 . . . . 72.33 107.657 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -140.89 160.3 26.64 Favored Glycine 0 CA--C 1.519 0.301 0 N-CA-C 111.775 -0.53 . . . . 53.2 111.775 173.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 61.02 27.54 17.4 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.79 0.836 . . . . 71.41 112.105 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.29 125.77 73.53 Favored Pre-proline 0 C--O 1.237 0.413 0 N-CA-C 111.7 0.259 . . . . 63.04 111.7 -174.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.35 150.68 37.05 Favored 'Trans proline' 0 C--N 1.36 1.164 0 C-N-CA 121.794 1.662 . . . . 73.22 110.8 165.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.8 m -22.16 -83.13 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 125.629 1.83 . . . . 73.32 115.788 -163.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.2 t60 52.33 -91.86 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 124.996 1.319 . . . . 72.24 112.01 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.7 m -100.15 120.92 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-O 121.053 0.454 . . . . 71.33 110.775 176.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.498 ' O ' HG23 ' A' ' 24' ' ' VAL . 47.2 m -88.39 177.53 6.8 Favored 'General case' 0 C--O 1.193 -1.887 0 CA-C-O 117.575 -1.202 . . . . 75.22 107.844 170.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.7 m -49.67 -49.97 45.31 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 120.344 1.429 . . . . 72.14 114.391 -169.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -39.35 94.24 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.092 0.957 . . . . 62.35 111.697 177.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.83 -32.51 57.63 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 115.262 -0.881 . . . . 74.21 111.488 -177.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 20' ' ' SER . 47.8 t -62.82 -47.32 93.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 108.228 -1.027 . . . . 71.45 108.228 170.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.13 -51.19 67.24 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 124.422 1.076 . . . . 75.53 111.862 177.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -73.89 -43.85 57.19 Favored 'General case' 0 C--O 1.276 2.46 0 N-CA-C 112.564 0.579 . . . . 72.24 112.564 -174.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -57.78 -46.72 84.19 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 115.177 -0.919 . . . . 64.02 110.132 177.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -78.35 -25.4 46.34 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 117.956 -1.021 . . . . 71.15 112.29 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -72.42 -28.98 63.3 Favored 'General case' 0 C--N 1.358 0.971 0 CA-C-N 118.971 0.805 . . . . 74.24 112.468 -179.654 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.66 -31.16 70.95 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 118.612 -1.235 . . . . 74.45 111.445 176.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.524 ' CD2' ' HB2' ' A' ' 62' ' ' ALA . 99.2 m-85 -87.94 -37.17 16.64 Favored 'General case' 0 C--O 1.219 -0.534 0 C-N-CA 121.193 -0.203 . . . . 62.32 111.174 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 29' ' ' ARG . . . -152.29 147.3 16.85 Favored Glycine 0 C--O 1.223 -0.589 0 N-CA-C 111.759 -0.536 . . . . 73.2 111.759 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -74.49 105.12 5.47 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 117.694 0.747 . . . . 75.22 112.937 -172.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.405 HG22 ' H ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -77.06 130.94 35.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 114.909 -1.041 . . . . 74.02 111.531 -175.537 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 56.2 mt -93.73 -47.9 6.56 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 114.418 -1.264 . . . . 74.14 111.083 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.447 ' HG3' ' HB3' ' A' ' 52' ' ' GLU . 0.1 OUTLIER -144.07 144.09 31.46 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.234 0.54 . . . . 73.41 109.996 173.811 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.6 t -132.15 120.47 22.32 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.058 -0.719 . . . . 73.13 109.058 178.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -129.45 125.95 37.64 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 120.454 -0.498 . . . . 75.35 111.384 -174.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 75.9 t -107.94 121.29 60.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 122.642 0.377 . . . . 74.12 110.121 -177.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -108.69 157.49 18.49 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 116.297 -0.41 . . . . 73.12 110.713 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.22 147.59 52.61 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.416 0.15 . . . . 61.05 110.908 172.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.3 t -101.1 167.06 10.47 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 110.014 -0.365 . . . . 55.41 110.014 173.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.9 m -75.43 -11.02 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 123.81 0.844 . . . . 72.52 112.411 177.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -80.25 -11.65 59.7 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 122.629 0.372 . . . . 71.25 111.222 176.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.43 -2.04 46.42 Favored Glycine 0 C--N 1.34 0.786 0 C-N-CA 121.426 -0.416 . . . . 72.31 113.886 176.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.39 143.24 27.12 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.211 0.529 . . . . 74.31 111.596 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -105.56 150.28 25.51 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.157 -0.929 . . . . 65.14 110.673 178.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -134.5 150.1 50.76 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 108.767 -0.827 . . . . 73.12 108.767 -177.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -129.31 137.14 50.84 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.143 0.497 . . . . 72.14 110.631 174.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.94 120.05 37.24 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 108.576 -0.898 . . . . 72.31 108.576 175.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 3.2 mp -120.32 111.56 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 119.158 -1.017 . . . . 71.43 111.114 -174.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.447 ' HB3' ' HG3' ' A' ' 36' ' ' LYS . 32.0 tt0 -113.45 108.0 16.61 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-O 120.813 0.339 . . . . 70.34 111.71 -172.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.28 170.51 8.24 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.269 -0.878 . . . . 55.45 111.954 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -78.85 -31.49 45.68 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 112.825 0.676 . . . . 73.15 112.825 175.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -120.35 125.01 46.95 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 122.241 1.019 . . . . 73.42 112.607 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.9 -46.01 25.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 113.99 -1.459 . . . . 71.51 113.931 -175.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.402 ' H ' ' HG2' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -76.18 -25.1 54.86 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.641 0.978 . . . . 65.22 113.641 -165.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.518 ' HB3' ' O ' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -80.0 -35.52 37.29 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.627 0.727 . . . . 74.14 111.707 177.52 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.33 -18.61 59.97 Favored 'General case' 0 C--O 1.257 1.49 0 C-N-CA 124.577 1.151 . . . . 73.02 112.767 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -53.15 -26.42 16.86 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 114.626 -1.17 . . . . 74.33 113.134 170.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.413 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -69.32 -34.69 75.04 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.208 0.603 . . . . 74.24 111.697 172.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.617 ' O ' ' HD2' ' A' ' 66' ' ' LYS . . . -66.57 -48.75 68.63 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 110.425 -0.213 . . . . 70.02 110.425 171.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.46 -30.78 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 C-N-CA 120.296 -0.561 . . . . 64.14 111.002 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.546 ' HA ' ' HB2' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -79.18 -21.04 46.95 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 118.916 0.78 . . . . 74.43 112.777 171.865 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.88 -37.26 76.0 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 118.885 0.766 . . . . 73.41 110.581 171.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.617 ' HD2' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -100.13 12.67 36.42 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 118.284 -1.367 . . . . 63.41 114.28 174.488 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.546 ' HB2' ' HA ' ' A' ' 64' ' ' LYS . 21.0 t70 -51.54 152.83 2.51 Favored 'General case' 0 N--CA 1.506 2.368 0 C-N-CA 126.998 2.119 . . . . 61.24 114.442 170.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.3 25.35 3.82 Favored Glycine 0 C--N 1.35 1.332 0 C-N-CA 119.554 -1.308 . . . . 63.35 113.948 -165.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.611 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 8.6 p -58.48 133.49 55.84 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 122.393 1.092 . . . . 74.4 113.147 -173.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.94 144.46 47.46 Favored 'General case' 0 C--O 1.256 1.404 0 CA-C-N 113.771 -1.559 . . . . 73.23 113.48 -171.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -143.56 147.66 34.76 Favored 'General case' 0 CA--C 1.553 1.089 0 O-C-N 125.834 1.959 . . . . 71.51 110.83 -172.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 74.14 66.07 0.09 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 122.484 1.135 . . . . 70.42 113.463 174.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.74 -10.25 62.45 Favored Glycine 0 N--CA 1.461 0.304 0 CA-C-N 114.263 -1.335 . . . . 71.43 113.302 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -119.64 122.51 41.68 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.063 -1.458 . . . . 73.31 107.063 161.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.59 102.16 13.93 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 118.446 -0.788 . . . . 74.41 110.676 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.611 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -165.49 60.18 0.11 Allowed 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 113.304 0.853 . . . . 73.14 113.304 179.911 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.4 tpp85 -93.67 117.21 29.8 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 120.585 -1.322 . . . . 64.45 111.031 -171.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.509 HG21 ' O ' ' A' ' 66' ' ' LYS . 2.2 m -128.59 120.96 53.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.902 -1.045 . . . . 73.12 109.346 174.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -148.93 145.4 27.39 Favored 'General case' 0 C--O 1.255 1.351 0 CA-C-O 121.97 0.89 . . . . 61.03 112.503 -178.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.1 m -89.47 123.48 66.68 Favored Pre-proline 0 CA--C 1.546 0.792 0 CA-C-N 115.012 -0.995 . . . . 73.34 110.042 167.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.438 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 66.9 Cg_endo -88.79 4.3 5.47 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.162 1.908 . . . . 72.34 113.335 166.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -95.01 -32.29 13.21 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 119.062 -0.494 . . . . 61.03 111.983 176.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.8 t30 54.54 78.33 0.17 Allowed 'General case' 0 N--CA 1.486 1.342 0 O-C-N 124.564 1.165 . . . . 73.33 111.118 -174.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 60.69 -166.45 0.2 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 125.167 1.387 . . . . 45.44 112.364 -175.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -95.36 9.78 38.68 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.354 -0.841 . . . . 74.31 109.041 171.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 . . . . . 0 C--O 1.253 1.286 0 CA-C-N 115.207 -0.906 . . . . 73.23 109.728 -173.887 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.0 0 N-CA-C 111.894 -0.482 . . . . 63.01 111.894 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.22 178.16 7.48 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 122.664 0.386 . . . . 71.53 111.126 -177.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -146.44 74.26 1.35 Allowed 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 121.195 0.521 . . . . 60.25 111.561 -168.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.1 mtt -149.37 145.05 26.79 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.069 0.948 . . . . 73.43 109.41 169.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.3 t -122.81 7.45 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 CA-C-O 121.883 0.849 . . . . 75.04 109.698 178.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.2 mt -99.94 86.85 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 O-C-N 121.343 -0.848 . . . . 73.04 111.294 -175.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.43 ' HG2' ' H ' ' A' ' 5' ' ' GLU . 6.7 ttt180 175.09 172.55 0.25 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 125.144 1.378 . . . . 74.4 109.505 170.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.43 ' H ' ' HG2' ' A' ' 4' ' ' ARG . 68.9 tt0 -127.08 128.88 46.95 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.374 0.669 . . . . 73.41 109.816 175.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.2 t -163.18 161.37 24.97 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 110.183 -0.303 . . . . 71.22 110.183 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.5 t -109.02 122.46 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 109.931 -0.396 . . . . 74.32 109.931 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.535 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . 80.3 p -84.96 140.41 31.09 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 122.655 0.382 . . . . 74.31 111.257 178.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.469 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 0.9 OUTLIER -126.22 149.98 48.68 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 111.952 0.353 . . . . 71.23 111.952 -177.183 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.0 mp -131.96 134.74 59.57 Favored 'Isoleucine or valine' 0 C--O 1.247 0.927 0 C-N-CA 123.882 0.873 . . . . 70.42 109.208 -178.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -115.82 115.21 25.87 Favored 'General case' 0 C--O 1.242 0.676 0 O-C-N 124.029 0.831 . . . . 65.32 109.613 177.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.447 HG23 HG22 ' A' ' 78' ' ' VAL . 3.4 p -119.74 111.43 32.8 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.819 0 CA-C-O 121.431 0.634 . . . . 75.23 110.867 172.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -123.52 158.79 18.16 Favored Glycine 0 CA--C 1.52 0.372 0 CA-C-N 116.077 -0.511 . . . . 21.54 113.522 -175.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.7 m120 62.25 26.63 15.96 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.235 1.014 . . . . 62.14 111.648 175.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.618 HD23 ' H ' ' A' ' 15' ' ' LEU . 1.5 pt? -82.57 125.11 76.84 Favored Pre-proline 0 CA--C 1.543 0.708 0 CA-C-O 120.878 0.37 . . . . 70.1 111.848 -170.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -86.45 125.99 2.59 Favored 'Trans proline' 0 C--N 1.363 1.326 0 C-N-CA 121.829 1.686 . . . . 73.11 113.081 175.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.8 m 26.01 62.82 0.07 Allowed 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 126.417 1.887 . . . . 42.2 114.887 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.475 ' HB3' HD12 ' A' ' 15' ' ' LEU . 0.5 OUTLIER -110.4 -134.31 0.35 Allowed 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.611 -0.722 . . . . 74.54 109.091 -171.493 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.2 m -69.76 126.04 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 111.993 0.368 . . . . 75.44 111.993 174.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.9 m -83.84 173.47 11.23 Favored 'General case' 0 C--O 1.211 -0.938 0 N-CA-C 108.403 -0.962 . . . . 43.33 108.403 173.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.6 t -60.15 -37.39 79.98 Favored 'General case' 0 CA--C 1.557 1.219 0 CA-C-N 118.969 0.804 . . . . 64.21 112.905 -174.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -66.61 -44.96 80.67 Favored 'General case' 0 C--O 1.251 1.172 0 C-N-CA 123.066 0.547 . . . . 73.31 110.808 176.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -68.4 -34.37 75.9 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.096 -0.956 . . . . 72.23 110.679 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.659 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 74.3 t -60.45 -51.72 69.79 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.588 0 N-CA-C 108.969 -0.752 . . . . 72.04 108.969 171.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.409 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 25.2 tt0 -57.01 -53.82 53.76 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 118.873 -0.584 . . . . 71.04 111.61 -177.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -76.4 -52.04 10.66 Favored 'General case' 0 C--O 1.26 1.629 0 CA-C-N 118.63 0.65 . . . . 74.23 112.113 -172.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.84 -39.0 66.92 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 120.685 -0.406 . . . . 73.01 110.057 -172.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.659 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 4.4 m-85 -77.57 -23.02 50.08 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 118.094 -0.955 . . . . 73.54 111.5 177.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 10.1 ptt180 -72.29 -25.9 61.76 Favored 'General case' 0 C--N 1.374 1.632 0 CA-C-N 120.065 1.302 . . . . 73.04 110.876 170.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.69 -25.86 65.89 Favored 'General case' 0 CA--C 1.561 1.388 0 C-N-CA 120.105 -0.638 . . . . 64.21 111.337 175.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.479 ' CG ' ' HB2' ' A' ' 62' ' ' ALA . 98.4 m-85 -89.32 -35.21 16.24 Favored 'General case' 0 C--O 1.216 -0.676 0 N-CA-C 111.974 0.361 . . . . 65.35 111.974 174.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 29' ' ' ARG . . . -156.9 137.94 5.67 Favored Glycine 0 C--O 1.228 -0.236 0 C-N-CA 120.884 -0.674 . . . . 64.33 111.668 177.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -62.06 114.73 3.57 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.142 0.577 . . . . 71.3 112.133 -175.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.61 124.76 39.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.948 0.88 . . . . 74.5 112.119 -173.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.5 mp -97.62 -36.84 10.15 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.208 -1.36 . . . . 74.34 110.327 175.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -145.43 131.25 19.07 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 120.694 0.283 . . . . 51.4 111.069 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -122.09 121.28 36.59 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 110.043 -0.355 . . . . 52.43 110.043 175.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -131.03 125.63 33.77 Favored 'General case' 0 C--O 1.219 -0.535 0 C-N-CA 120.432 -0.507 . . . . 74.12 110.277 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.01 119.31 61.06 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 CA-C-O 121.955 0.883 . . . . 72.24 110.837 176.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -117.46 157.69 25.8 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.256 -0.883 . . . . 73.54 110.348 -177.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.39 151.22 51.12 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 122.088 -0.382 . . . . 71.25 110.537 173.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.9 t -101.34 164.53 11.73 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 110.119 -0.326 . . . . 74.34 110.119 172.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.6 m -75.63 -10.28 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.78 0.832 . . . . 71.31 112.511 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -78.65 -9.29 59.33 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 122.682 0.393 . . . . 65.11 110.879 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.66 -5.01 43.27 Favored Glycine 0 C--N 1.344 0.999 0 C-N-CA 121.179 -0.534 . . . . 70.31 113.827 176.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -89.38 143.0 27.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.972 0.415 . . . . 71.2 111.444 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -107.71 149.86 27.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.648 -0.705 . . . . 72.22 109.635 175.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -137.49 150.13 47.33 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.426 -0.583 . . . . 73.52 109.426 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -127.6 138.61 52.91 Favored 'General case' 0 C--O 1.253 1.271 0 CA-C-O 121.718 0.771 . . . . 70.13 109.344 170.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -116.47 120.61 39.33 Favored 'General case' 0 C--O 1.252 1.216 0 CA-C-N 113.688 -1.596 . . . . 73.4 107.509 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.87 126.84 73.25 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.67 0 CA-C-N 115.611 -0.722 . . . . 71.44 111.111 -170.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -115.51 114.73 25.39 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 122.331 -0.23 . . . . 75.33 111.539 -178.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -109.47 169.22 8.84 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.351 0.26 . . . . 73.03 110.884 176.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -81.59 -31.18 32.65 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.22 0.452 . . . . 74.42 112.22 169.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -119.29 125.49 49.21 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-O 122.107 0.956 . . . . 50.21 112.816 -172.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.39 -44.99 18.45 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 115.644 1.72 . . . . 65.5 115.644 -177.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.76 -24.76 56.08 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 113.457 0.91 . . . . 73.14 113.457 -167.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.73 -27.43 40.61 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 121.494 0.664 . . . . 73.43 111.272 175.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.84 -25.06 61.82 Favored 'General case' 0 C--O 1.249 1.036 0 C-N-CA 124.265 1.026 . . . . 64.51 112.065 174.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.527 ' HA ' HG22 ' A' ' 63' ' ' ILE . . . -57.64 -27.85 63.19 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.048 -0.978 . . . . 75.32 112.859 177.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -67.83 -41.74 82.54 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 122.751 0.421 . . . . 72.22 111.149 174.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.479 ' HB2' ' CG ' ' A' ' 31' ' ' TYR . . . -64.05 -44.95 90.91 Favored 'General case' 0 C--O 1.237 0.417 0 O-C-N 123.55 0.531 . . . . 72.42 111.213 175.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.778 HG13 HG13 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -70.15 -29.93 41.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 119.936 -0.706 . . . . 63.21 110.999 179.145 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.02 -26.44 53.78 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.674 1.125 . . . . 74.12 112.331 176.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -85.98 -18.0 33.77 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 118.621 -1.232 . . . . 75.31 112.524 173.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt -100.14 8.18 44.06 Favored 'General case' 0 CA--C 1.558 1.259 0 O-C-N 121.794 -0.566 . . . . 74.24 111.3 172.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -60.37 152.25 25.83 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 126.596 1.958 . . . . 73.23 111.228 173.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.81 25.07 3.76 Favored Glycine 0 C--N 1.349 1.277 0 C-N-CA 120.166 -1.016 . . . . 73.13 113.715 -160.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.614 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 12.8 t -59.13 132.65 54.66 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.644 0.735 . . . . 63.03 111.439 178.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -135.63 134.7 39.54 Favored 'General case' 0 C--O 1.252 1.214 0 CA-C-N 114.134 -1.394 . . . . 70.1 112.993 -172.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -142.93 148.03 36.25 Favored 'General case' 0 CA--C 1.548 0.886 0 O-C-N 125.658 1.849 . . . . 75.15 109.574 -175.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 75.66 65.86 0.06 Allowed 'General case' 0 N--CA 1.5 2.041 0 CA-C-O 122.828 1.299 . . . . 54.55 114.206 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.02 -10.98 62.2 Favored Glycine 0 C--O 1.227 -0.325 0 CA-C-N 113.579 -1.646 . . . . 41.51 114.174 172.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -121.68 123.99 43.19 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.274 -1.38 . . . . 70.31 107.274 162.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.94 104.77 16.81 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 118.483 -0.77 . . . . 73.22 111.41 -177.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.614 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.4 OUTLIER -166.73 64.31 0.09 Allowed 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 113.394 0.887 . . . . 62.42 113.394 178.48 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.48 ' HD3' ' SG ' ' A' ' 69' ' ' CYS . 0.0 OUTLIER -93.37 115.61 28.17 Favored 'General case' 0 C--O 1.212 -0.907 0 O-C-N 120.909 -1.12 . . . . 71.34 110.324 -173.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.447 HG22 HG23 ' A' ' 12' ' ' VAL . 5.5 t -128.25 117.85 46.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 107.757 -1.201 . . . . 62.23 107.757 168.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -151.73 140.97 21.38 Favored 'General case' 0 C--O 1.244 0.775 0 C-N-CA 119.833 -0.747 . . . . 65.01 112.309 -177.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.778 HG13 HG13 ' A' ' 63' ' ' ILE . 15.3 m -91.74 125.46 57.31 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 115.918 -0.583 . . . . 63.41 111.879 168.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.469 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 60.3 Cg_endo -84.59 13.5 2.73 Favored 'Trans proline' 0 CA--C 1.547 1.125 0 C-N-CA 122.363 2.042 . . . . 71.24 113.806 165.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.535 ' CD2' ' HB2' ' A' ' 8' ' ' SER . 1.8 p90 -101.66 -20.45 15.0 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.422 0.555 . . . . 74.33 112.191 176.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 65.78 -78.34 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 125.022 1.329 . . . . 61.41 112.661 -170.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -155.44 -176.52 5.99 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.158 0.436 . . . . 63.31 110.311 177.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -84.29 122.5 28.98 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.206 -0.665 . . . . 64.25 109.206 176.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 . . . . . 0 C--O 1.249 1.077 0 O-C-N 124.315 1.009 . . . . 61.3 110.705 -179.821 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.116 0 N-CA-C 112.227 -0.349 . . . . 72.43 112.227 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 16.6 p -156.88 104.57 2.13 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 121.158 0.504 . . . . 73.42 110.552 177.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . 0.443 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 0.9 OUTLIER -150.19 -173.48 4.45 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.94 -0.763 . . . . 74.35 108.94 179.242 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.443 ' SD ' ' HB3' ' A' ' 0' ' ' HIS . 2.8 mpt? 70.81 146.7 0.07 Allowed 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 124.631 1.173 . . . . 63.1 113.818 172.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.8 m -132.78 159.92 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 115.773 -0.649 . . . . 73.5 111.324 177.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.8 tt -149.41 143.43 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 109.174 -0.676 . . . . 73.14 109.174 175.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -125.8 10.18 7.68 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.391 0.515 . . . . 72.43 112.391 -178.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -130.75 21.52 5.03 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.94 0.4 . . . . 63.21 111.297 -176.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.3 t -129.99 157.01 43.5 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.27 0.557 . . . . 71.23 111.116 -177.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.5 t -110.2 104.45 17.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 114.912 -1.04 . . . . 65.32 109.322 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.45 121.2 28.67 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 112.704 0.631 . . . . 73.52 112.704 -178.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.46 ' HD2' ' CE2' ' A' ' 50' ' ' PHE . 0.6 OUTLIER -136.27 159.7 40.94 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 122.825 0.45 . . . . 63.41 111.21 -173.344 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.1 mt -117.38 142.88 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.118 0.967 . . . . 71.22 108.531 -178.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -112.26 111.18 21.88 Favored 'General case' 0 C--N 1.349 0.58 0 N-CA-C 109.786 -0.449 . . . . 74.24 109.786 -177.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.685 HG12 HG13 ' A' ' 78' ' ' VAL . 26.2 m -123.95 108.08 20.0 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-O 121.946 0.879 . . . . 62.42 111.29 175.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -133.69 168.94 23.01 Favored Glycine 0 CA--C 1.518 0.261 0 N-CA-C 114.873 0.709 . . . . 64.1 114.873 -176.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.8 m120 58.36 21.43 8.32 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.838 1.255 . . . . 53.42 112.071 176.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.444 HD23 ' H ' ' A' ' 15' ' ' LEU . 1.2 pt? -90.88 149.78 40.86 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 112.338 0.495 . . . . 71.53 112.338 -167.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 75' ' ' LYS . 24.5 Cg_endo -65.02 137.57 53.2 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 123.144 2.563 . . . . 71.33 112.868 176.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.1 p 73.77 -41.73 0.5 Allowed 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 126.61 1.964 . . . . 65.44 111.692 -173.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 68.41 117.34 0.03 OUTLIER 'General case' 0 C--N 1.365 1.25 0 C-N-CA 125.7 1.6 . . . . 70.45 111.052 -177.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.8 m -69.71 128.84 33.69 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 CA-C-N 114.646 -1.161 . . . . 64.21 110.564 177.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.1 m -83.15 169.14 16.14 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 114.364 -1.289 . . . . 72.32 108.787 176.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.2 m -57.17 -41.87 80.08 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.654 0.612 . . . . 71.52 112.654 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -64.83 -47.68 77.1 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.154 0.581 . . . . 74.34 111.321 178.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -67.77 -44.28 77.82 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 114.646 -1.161 . . . . 75.22 111.037 -174.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.562 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 9.0 p -70.46 -34.93 59.77 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 CA-C-O 118.99 -0.529 . . . . 43.02 110.036 177.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -61.06 -52.7 63.85 Favored 'General case' 0 C--O 1.212 -0.888 0 CA-C-O 118.745 -0.645 . . . . 54.13 110.524 178.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -73.0 -51.11 19.48 Favored 'General case' 0 C--O 1.27 2.158 0 CA-C-N 118.12 0.418 . . . . 64.42 111.622 -174.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -69.22 -44.01 72.93 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 115.467 -0.788 . . . . 72.12 110.457 -173.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.562 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 0.7 OUTLIER -76.85 -25.13 52.81 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 118.676 -0.678 . . . . 75.15 111.534 179.32 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.7 ptt85 -72.44 -22.99 61.01 Favored 'General case' 0 C--N 1.365 1.257 0 CA-C-N 119.429 1.013 . . . . 75.33 111.834 174.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -29.71 70.45 Favored 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 119.543 -0.863 . . . . 72.32 111.421 170.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -88.77 -37.23 15.61 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.563 0.579 . . . . 71.22 112.563 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -154.74 171.83 33.13 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.501 -0.857 . . . . 73.15 112.587 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -82.0 113.09 19.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.571 0.701 . . . . 65.51 111.998 -175.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.86 126.4 43.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 114.803 -1.089 . . . . 71.41 110.586 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 26.2 mt -94.86 -43.11 8.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.488 -1.233 . . . . 70.0 109.568 178.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.05 153.33 33.77 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.491 0.316 . . . . 70.15 110.479 170.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 13.4 p -126.92 124.76 40.26 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.785 -0.45 . . . . 63.2 109.785 173.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -129.68 125.94 37.17 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-N 115.974 -0.557 . . . . 71.43 111.093 -176.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 72.1 t -112.08 123.02 67.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-O 121.041 0.448 . . . . 62.21 111.176 -174.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.13 161.32 22.0 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.069 -0.514 . . . . 71.3 110.869 -174.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.5 152.02 51.85 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 122.457 -0.152 . . . . 73.22 111.004 172.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.4 t -100.62 169.39 9.08 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 109.973 -0.38 . . . . 71.42 109.973 169.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.3 t -75.3 -15.45 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 C-N-CA 123.715 0.806 . . . . 73.3 111.259 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.3 m -75.88 -7.56 54.8 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.107 0.563 . . . . 44.05 112.175 -179.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.76 -4.74 53.53 Favored Glycine 0 C--N 1.341 0.844 0 C-N-CA 121.345 -0.455 . . . . 62.12 113.308 176.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.75 138.38 31.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.832 0.348 . . . . 75.01 110.791 178.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.44 147.93 38.54 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.741 -0.663 . . . . 62.13 110.546 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -136.22 165.91 24.64 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.187 0.517 . . . . 73.13 109.96 -171.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -141.35 139.72 33.6 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-N 115.328 -0.851 . . . . 61.23 109.96 171.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.46 ' CE2' ' HD2' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -114.43 118.69 34.52 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 113.996 -1.456 . . . . 71.34 107.263 -179.655 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.76 112.77 36.44 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.531 0 C-N-CA 119.556 -0.858 . . . . 73.33 111.151 -171.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -88.58 106.98 18.66 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-N 116.545 -0.298 . . . . 74.54 110.233 -170.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -114.27 143.46 44.82 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.58 -0.736 . . . . 74.33 112.021 -174.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -83.06 -28.38 29.61 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 120.558 -0.457 . . . . 72.12 111.83 172.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.61 126.68 49.66 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.864 0.84 . . . . 62.33 112.402 -178.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.708 ' HB3' ' HB2' ' A' ' 85' ' ' ARG . . . -80.41 -45.4 17.73 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 114.19 1.181 . . . . 73.04 114.19 179.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -75.31 -25.17 57.64 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.963 0.727 . . . . 73.21 112.963 -167.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -80.13 -34.73 37.55 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.505 0.669 . . . . 71.14 109.841 175.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.67 -24.09 65.38 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.785 1.234 . . . . 33.23 112.511 172.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.44 ' HA ' HG22 ' A' ' 63' ' ' ILE . . . -58.01 -25.0 60.53 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 114.572 1.323 . . . . 32.05 114.572 -174.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.21 -44.93 78.35 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 118.881 0.764 . . . . 51.1 111.483 173.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.36 -43.38 98.96 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 115.79 -0.641 . . . . 71.43 110.822 173.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.646 HG13 HG13 ' A' ' 80' ' ' VAL . 0.4 OUTLIER -68.21 -32.3 55.26 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.003 0 CA-C-O 118.852 -0.594 . . . . 72.34 111.359 -179.38 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.62 -26.24 41.21 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.384 0.993 . . . . 75.02 112.341 177.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -81.81 -20.68 38.57 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 119.486 -0.886 . . . . 73.53 111.458 175.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.674 ' HB2' HG11 ' A' ' 78' ' ' VAL . 69.5 mmtt -99.39 0.01 41.87 Favored 'General case' 0 CA--C 1.569 1.706 0 C-N-CA 120.189 -0.605 . . . . 73.11 111.335 172.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 35.0 t70 -70.42 154.83 41.47 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 125.695 1.598 . . . . 64.52 111.425 177.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.53 25.11 4.44 Favored Glycine 0 C--N 1.346 1.133 0 C-N-CA 119.637 -1.268 . . . . 61.33 112.058 -159.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.701 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 8.2 t -57.22 131.56 50.36 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 124.496 0.762 . . . . 74.51 111.837 -171.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.63 146.74 46.36 Favored 'General case' 0 C--O 1.252 1.22 0 CA-C-N 114.23 -1.35 . . . . 72.42 113.404 -170.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -143.58 147.8 34.95 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 126.116 1.766 . . . . 74.24 109.807 -173.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 76.3 66.71 0.06 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 122.686 1.232 . . . . 62.4 113.381 173.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.05 -11.71 63.96 Favored Glycine 0 C--N 1.337 0.638 0 CA-C-N 113.729 -1.578 . . . . 70.02 113.313 177.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -119.2 122.09 41.2 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 106.841 -1.54 . . . . 64.41 106.841 163.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.422 ' O ' ' HD3' ' A' ' 16' ' ' PRO . 0.5 OUTLIER -94.78 105.16 17.08 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 117.954 -1.022 . . . . 73.15 111.075 178.531 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.701 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -165.65 64.7 0.11 Allowed 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 115.283 1.586 . . . . 74.42 115.283 179.319 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.518 ' HA ' ' SG ' ' A' ' 69' ' ' CYS . 0.1 OUTLIER -95.34 113.64 25.33 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 121.8 2.091 . . . . 63.54 111.555 -176.199 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.685 HG13 HG12 ' A' ' 12' ' ' VAL . 95.3 t -131.52 120.76 46.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 121.22 -0.925 . . . . 74.23 109.474 174.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.498 ' HA ' HD11 ' A' ' 63' ' ' ILE . 0.5 OUTLIER -149.14 141.99 24.67 Favored 'General case' 0 C--O 1.258 1.525 0 N-CA-C 113.66 0.985 . . . . 74.01 113.66 173.444 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.646 HG13 HG13 ' A' ' 63' ' ' ILE . 2.3 m -89.76 126.95 56.06 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-N 114.033 -1.44 . . . . 72.35 109.645 159.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -84.24 16.96 1.81 Allowed 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.658 2.238 . . . . 72.2 112.44 170.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -86.33 -30.02 22.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.042 -0.981 . . . . 75.3 110.544 177.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 64.23 41.8 5.84 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 124.824 1.328 . . . . 74.11 110.768 -173.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 69.06 10.95 8.16 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 125.831 1.653 . . . . 74.14 113.001 -178.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.708 ' HB2' ' HB3' ' A' ' 56' ' ' ALA . 0.1 OUTLIER 70.54 108.56 0.06 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 126.262 1.825 . . . . 74.31 111.759 -178.067 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.256 1.408 0 CA-C-N 114.497 -1.229 . . . . 64.33 110.354 170.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.958 0 CA-C-O 119.74 -0.478 . . . . 53.44 112.406 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 4.6 t 68.7 -168.47 0.18 Allowed 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 125.151 1.38 . . . . 73.54 111.344 178.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 65.13 38.03 6.3 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.422 1.089 . . . . 75.25 110.734 176.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt -135.48 138.22 42.93 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.593 -0.731 . . . . 51.34 110.334 -177.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.9 p -147.45 115.18 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 CA-C-O 121.882 0.849 . . . . 73.05 111.004 177.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.1 mp -127.41 127.78 69.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 115.566 -0.743 . . . . 73.52 109.344 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.54 165.14 12.31 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 110.067 -0.345 . . . . 72.5 110.067 174.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 66.68 -171.29 0.19 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.013 1.325 . . . . 71.13 110.499 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.0 t 64.6 -173.03 0.17 Allowed 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.769 1.227 . . . . 73.52 111.067 -177.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -128.75 134.74 63.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 109.51 -0.552 . . . . 73.52 109.51 177.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.3 p -83.89 138.15 33.32 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.915 -0.584 . . . . 73.25 112.029 -178.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -138.01 158.43 44.35 Favored 'General case' 0 C--O 1.211 -0.948 0 CA-C-N 115.911 -0.586 . . . . 73.41 111.956 -175.903 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.6 mt -117.9 141.66 35.9 Favored 'Isoleucine or valine' 0 C--O 1.254 1.335 0 N-CA-C 109.842 -0.429 . . . . 64.01 109.842 174.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -108.25 119.41 39.41 Favored 'General case' 0 C--O 1.246 0.875 0 O-C-N 124.653 1.221 . . . . 74.34 109.148 178.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.5 ' HB ' HG13 ' A' ' 78' ' ' VAL . 3.6 p -123.14 110.39 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-O 121.918 0.866 . . . . 75.34 111.328 174.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -115.36 166.57 12.22 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-N 115.072 -0.967 . . . . 55.14 113.126 177.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 55.76 30.25 15.35 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.427 1.091 . . . . 74.32 113.083 175.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.494 ' H ' HD23 ' A' ' 15' ' ' LEU . 2.3 pt? -89.16 140.44 28.85 Favored Pre-proline 0 C--O 1.237 0.42 0 CA-C-N 116.341 -0.39 . . . . 73.05 111.773 -172.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -72.05 142.5 38.47 Favored 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 122.527 2.151 . . . . 70.42 112.254 174.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.0 p 77.64 -32.84 0.18 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 127.351 2.26 . . . . 71.23 113.201 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 69.34 120.29 0.03 OUTLIER 'General case' 0 C--N 1.365 1.26 0 C-N-CA 124.869 1.268 . . . . 74.42 110.513 -174.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.442 ' H ' HD11 ' A' ' 15' ' ' LEU . 22.8 m -74.87 126.32 35.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 CA-C-O 121.508 0.671 . . . . 72.44 109.479 173.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.524 ' HB2' ' OD2' ' A' ' 23' ' ' ASP . 19.2 m -81.97 160.68 23.27 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.951 -1.129 . . . . 61.52 107.951 177.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.2 p -60.68 -32.43 71.65 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.42 0.896 . . . . 44.04 113.42 -168.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.19 -38.61 51.17 Favored 'General case' 0 C--O 1.253 1.243 0 C-N-CA 123.844 0.858 . . . . 73.43 111.127 -178.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.524 ' OD2' ' HB2' ' A' ' 20' ' ' SER . 51.8 m-20 -67.28 -48.67 67.0 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 114.676 -1.147 . . . . 71.43 110.205 -179.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.463 HG13 ' SG ' ' A' ' 37' ' ' CYS . 9.3 p -69.73 -29.91 42.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 CA-C-N 114.482 -1.235 . . . . 52.21 110.57 177.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -57.75 -53.17 61.24 Favored 'General case' 0 C--N 1.359 1.001 0 CA-C-O 118.812 -0.614 . . . . 72.43 111.188 170.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -67.22 -48.07 68.92 Favored 'General case' 0 C--O 1.295 3.463 0 CA-C-O 122.127 0.965 . . . . 73.52 111.87 -178.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -58.93 -47.78 83.81 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-N 113.777 -1.556 . . . . 62.31 109.945 -175.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.475 ' HA ' ' CD1' ' A' ' 31' ' ' TYR . 14.9 m-85 -81.99 -15.76 52.63 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.092 0.775 . . . . 65.34 113.092 -179.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 23.4 mtp180 -60.4 -35.35 75.56 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 118.149 0.431 . . . . 64.53 110.446 164.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.74 -30.22 70.63 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 119.487 -0.885 . . . . 72.21 112.954 168.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.475 ' CD1' ' HA ' ' A' ' 28' ' ' PHE . 1.1 m-85 -77.65 -11.27 59.85 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 113.247 0.832 . . . . 74.43 113.247 -171.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 141.28 38.18 0.09 OUTLIER Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.125 -1.036 . . . . 33.4 113.102 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 60.4 95.98 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.895 1.278 . . . . 63.01 112.933 174.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.17 132.63 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 115.774 -0.648 . . . . 64.25 110.701 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.33 -28.62 12.87 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.432 -0.803 . . . . 71.03 109.844 174.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -142.72 129.26 20.2 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.444 -0.343 . . . . 73.4 110.478 -173.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.463 ' SG ' HG13 ' A' ' 24' ' ' VAL . 0.9 OUTLIER -127.73 113.47 16.04 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.624 -0.509 . . . . 42.43 109.624 175.089 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -128.12 124.02 35.89 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 120.393 -0.523 . . . . 60.42 110.747 -178.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 87.2 t -99.6 128.97 50.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 116.114 -0.493 . . . . 75.33 110.346 -177.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.467 ' HB2' ' HB2' ' A' ' 48' ' ' PHE . 71.6 mmtt -106.54 137.02 45.3 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.628 -0.714 . . . . 74.2 109.731 -178.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -130.75 126.15 35.68 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.843 -0.343 . . . . 65.35 110.6 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.0 t -101.04 164.95 11.56 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 120.915 0.388 . . . . 51.44 111.078 177.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.9 t -75.51 -14.08 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 C-N-CA 124.133 0.973 . . . . 73.24 110.872 178.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.2 m -75.52 -11.59 60.06 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.184 0.594 . . . . 73.45 112.401 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.63 -3.32 56.15 Favored Glycine 0 C--N 1.343 0.955 0 C-N-CA 121.343 -0.456 . . . . 53.24 113.743 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.16 143.72 26.89 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.507 0.67 . . . . 63.44 111.285 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.58 142.81 33.98 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.175 -0.92 . . . . 71.45 109.257 177.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.467 ' HB2' ' HB2' ' A' ' 40' ' ' LYS . 7.9 m-85 -137.13 153.31 50.54 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.11 -0.7 . . . . 45.3 109.11 178.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -137.38 139.51 40.79 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-O 121.332 0.587 . . . . 41.34 109.636 170.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -116.35 117.81 31.0 Favored 'General case' 0 C--O 1.252 1.193 0 CA-C-N 113.803 -1.544 . . . . 72.04 106.929 -179.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 3.1 mp -127.16 112.92 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 119.715 -0.794 . . . . 60.41 111.99 -170.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -107.42 107.53 18.45 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.607 -0.724 . . . . 71.32 111.918 -171.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -112.51 167.34 10.53 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 115.039 -0.982 . . . . 74.53 112.977 -177.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -82.3 -25.27 34.13 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 113.39 0.885 . . . . 74.21 113.39 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.5 121.57 39.72 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.388 0.994 . . . . 70.11 112.421 177.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.46 ' HB3' ' HB2' ' A' ' 85' ' ' ARG . . . -81.47 -45.63 15.73 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.294 -1.321 . . . . 75.11 114.563 -177.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.21 -23.59 51.4 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 112.533 0.568 . . . . 74.12 112.533 -171.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -75.28 -26.99 59.2 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.863 0.84 . . . . 73.53 110.142 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.15 -27.14 67.06 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 114.711 -1.131 . . . . 75.51 112.602 175.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.424 ' HA ' HG22 ' A' ' 63' ' ' ILE . . . -59.37 -30.53 68.48 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 114.607 1.336 . . . . 53.53 114.607 -171.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.517 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -67.89 -44.18 77.61 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 122.135 0.969 . . . . 74.1 112.21 176.858 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.51 -31.54 57.74 Favored 'General case' 0 C--O 1.253 1.284 0 CA-C-O 122.604 1.192 . . . . 75.2 111.38 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.433 ' O ' ' HB3' ' A' ' 67' ' ' ASP . 0.4 OUTLIER -70.48 -30.6 43.44 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.465 0 CA-C-O 118.456 -0.783 . . . . 73.25 109.714 174.562 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.517 ' HG3' ' O ' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -77.6 -20.93 53.13 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 119.611 1.096 . . . . 63.1 111.551 170.234 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.78 -27.02 63.6 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-O 118.481 -0.771 . . . . 74.45 111.67 170.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.469 ' HE3' ' OH ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -113.42 13.47 18.96 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 116.405 2.002 . . . . 71.23 116.405 166.129 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.433 ' HB3' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -73.2 158.21 35.66 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 123.989 0.915 . . . . 72.43 112.539 174.662 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 112.72 24.84 4.79 Favored Glycine 0 C--N 1.345 1.036 0 C-N-CA 120.215 -0.993 . . . . 72.05 111.522 -160.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 6.2 p -57.81 132.41 53.25 Favored 'General case' 0 C--N 1.352 0.699 0 CA-C-O 122.392 1.091 . . . . 74.31 112.248 -168.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -134.14 149.27 51.05 Favored 'General case' 0 C--O 1.263 1.763 0 CA-C-N 113.521 -1.672 . . . . 73.13 112.383 -166.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -143.8 146.34 33.02 Favored 'General case' 0 CA--C 1.557 1.246 0 CA-C-N 112.733 -2.03 . . . . 64.31 109.477 -175.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 75.12 66.86 0.07 Allowed 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 124.706 1.202 . . . . 72.54 114.057 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.55 -11.93 59.68 Favored Glycine 0 N--CA 1.464 0.53 0 CA-C-N 113.605 -1.634 . . . . 72.34 113.796 173.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -118.91 119.64 34.95 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 105.717 -1.957 . . . . 52.43 105.717 157.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.94 103.52 15.48 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 118.975 -0.536 . . . . 75.52 111.17 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 12.0 tp -168.78 73.79 0.1 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 118.094 0.406 . . . . 71.22 111.323 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.75 109.04 21.86 Favored 'General case' 0 C--O 1.206 -1.228 0 O-C-N 120.202 -1.562 . . . . 73.14 109.008 -175.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.5 HG13 ' HB ' ' A' ' 12' ' ' VAL . 2.0 t -133.03 125.83 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 O-C-N 121.243 -0.911 . . . . 41.11 109.593 176.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -150.15 163.63 37.72 Favored 'General case' 0 C--O 1.26 1.606 0 CA-C-O 122.6 1.19 . . . . 75.4 113.131 169.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.1 m -87.14 123.39 70.14 Favored Pre-proline 0 CA--C 1.555 1.164 0 CA-C-N 112.649 -2.068 . . . . 63.44 109.047 165.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.458 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 56.5 Cg_endo -85.04 10.36 3.78 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 121.798 1.665 . . . . 74.31 113.941 167.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.442 ' CE1' ' HB1' ' A' ' 56' ' ' ALA . 17.5 p90 -102.87 -60.75 1.5 Allowed 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 112.099 0.407 . . . . 75.2 112.099 175.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.6 t30 54.01 30.39 11.74 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 126.047 1.739 . . . . 73.15 112.355 -173.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.91 127.28 10.67 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 112.399 0.518 . . . . 72.52 112.399 -175.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.46 ' HB2' ' HB3' ' A' ' 56' ' ' ALA . 8.9 tpt180 -171.73 142.97 1.62 Allowed 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.276 0.985 . . . . 75.13 110.797 174.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-N 114.769 -1.105 . . . . 72.13 108.281 168.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.746 0 CA-C-O 120.014 -0.326 . . . . 73.12 112.318 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 47.2 m 66.28 37.47 4.91 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.738 1.215 . . . . 74.44 114.24 170.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -146.59 159.98 42.74 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 122.548 0.339 . . . . 72.34 110.297 174.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.6 ptp -157.84 99.93 1.72 Allowed 'General case' 0 CA--C 1.547 0.858 0 O-C-N 123.824 0.703 . . . . 73.15 111.395 171.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.7 p -165.67 117.94 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.314 0 CA-C-O 121.112 0.482 . . . . 63.41 110.996 176.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.8 tt -162.11 130.34 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 CA-C-O 120.911 0.386 . . . . 54.33 110.892 174.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.8 mtt-85 -145.17 135.46 24.06 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.658 0.783 . . . . 65.05 109.894 172.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 61.6 19.34 10.33 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 124.647 1.179 . . . . 74.23 113.925 171.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.7 t -112.53 -7.77 13.88 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 111.417 0.154 . . . . 54.45 111.417 -173.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.7 m 59.05 138.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 C-N-CA 127.876 2.471 . . . . 71.45 115.254 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' A' ' 52' ' ' GLU . 75.3 m -85.36 119.77 26.1 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.077 -0.965 . . . . 74.14 110.382 176.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.611 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -140.56 156.29 46.34 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-N 115.654 -0.703 . . . . 74.5 112.147 -178.934 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.576 ' HB ' HD12 ' A' ' 51' ' ' ILE . 43.8 mt -113.43 137.91 44.88 Favored 'Isoleucine or valine' 0 C--O 1.258 1.534 0 N-CA-C 108.561 -0.903 . . . . 44.42 108.561 177.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -99.11 112.53 24.64 Favored 'General case' 0 C--N 1.363 1.196 0 O-C-N 126.456 2.347 . . . . 74.41 108.629 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.2 133.05 67.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 107.789 -1.189 . . . . 75.44 107.789 175.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -141.13 159.99 26.7 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 121.223 -0.513 . . . . 64.41 112.801 173.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.502 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 72.8 m-20 60.94 25.59 15.56 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.491 1.116 . . . . 51.12 112.953 171.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.424 HD11 HG22 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -85.58 146.62 44.58 Favored Pre-proline 0 CA--C 1.549 0.942 0 O-C-N 121.363 -0.836 . . . . 73.21 113.033 -163.215 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.28 151.7 43.71 Favored 'Trans proline' 0 C--N 1.361 1.234 0 C-N-CA 123.351 2.701 . . . . 61.14 113.407 174.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.5 p 74.6 -30.52 0.2 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 127.421 2.288 . . . . 71.42 113.422 -176.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 71.2 t60 67.47 106.12 0.05 OUTLIER 'General case' 0 C--N 1.359 0.999 0 C-N-CA 125.24 1.416 . . . . 75.41 110.872 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.424 HG22 HD11 ' A' ' 15' ' ' LEU . 7.7 m -82.59 131.06 34.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 CA-C-N 115.636 -0.711 . . . . 74.24 110.328 176.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.54 ' HB2' ' OD2' ' A' ' 23' ' ' ASP . 16.8 m -89.5 160.84 16.53 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-N 115.388 -0.824 . . . . 41.43 109.545 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.6 t -52.79 -43.37 65.83 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.932 0.893 . . . . 42.51 113.078 -174.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.08 -42.16 80.8 Favored 'General case' 0 C--O 1.25 1.085 0 C-N-CA 124.741 1.216 . . . . 72.54 112.36 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.54 ' OD2' ' HB2' ' A' ' 20' ' ' SER . 12.0 m-20 -66.72 -43.09 85.17 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.125 -0.943 . . . . 73.55 110.376 -178.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.496 ' CG1' HG12 ' A' ' 51' ' ' ILE . 39.1 t -64.19 -40.4 88.92 Favored 'Isoleucine or valine' 0 C--N 1.343 0.309 0 CA-C-N 115.082 -0.963 . . . . 70.45 110.088 174.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.504 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 10.9 tt0 -58.71 -49.95 75.71 Favored 'General case' 0 C--O 1.209 -1.049 0 CA-C-O 118.455 -0.783 . . . . 62.13 111.141 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.5 -46.43 22.48 Favored 'General case' 0 C--O 1.282 2.779 0 N-CA-C 113.686 0.995 . . . . 71.1 113.686 -178.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -59.32 -44.6 92.57 Favored 'General case' 0 C--N 1.36 1.037 0 CA-C-N 116.353 -0.385 . . . . 71.24 110.375 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.456 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 42.6 m-85 -80.62 -20.63 42.76 Favored 'General case' 0 C--O 1.211 -0.921 0 CA-C-O 117.929 -1.034 . . . . 74.15 112.869 176.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.504 ' HB3' ' O ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -66.61 -29.56 69.64 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 120.031 1.287 . . . . 71.13 111.671 172.544 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.86 -31.01 68.62 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 117.185 -1.806 . . . . 74.22 112.202 173.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.488 ' CD2' ' HB2' ' A' ' 62' ' ' ALA . 85.1 m-85 -87.36 -37.08 17.41 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.307 0.484 . . . . 53.41 112.307 -176.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -143.9 165.16 27.36 Favored Glycine 0 C--O 1.221 -0.669 0 N-CA-C 111.662 -0.575 . . . . 72.35 111.662 174.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -80.37 99.39 7.91 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 117.516 0.658 . . . . 63.12 110.579 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.84 132.57 31.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 121.884 0.849 . . . . 72.1 111.744 -171.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.0 mp -103.1 -38.44 7.3 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.212 -1.358 . . . . 74.51 111.371 -178.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.51 131.44 15.21 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 122.89 0.476 . . . . 45.21 110.487 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.8 m -121.26 124.33 44.36 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.836 -0.54 . . . . 75.31 110.667 171.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -128.44 132.86 48.44 Favored 'General case' 0 C--O 1.212 -0.911 0 CA-C-N 116.299 -0.41 . . . . 73.53 110.669 -178.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 p -119.19 120.15 62.93 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.173 0 CA-C-O 121.684 0.755 . . . . 43.43 111.077 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -108.56 157.84 18.11 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.703 -0.68 . . . . 74.53 110.625 -178.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.04 149.87 52.16 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 122.243 -0.285 . . . . 73.13 111.034 173.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.4 t -101.48 166.37 10.76 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 120.654 0.264 . . . . 52.23 110.339 172.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.9 t -75.32 -13.72 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 C-N-CA 124.224 1.01 . . . . 72.42 111.14 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.0 t -76.25 -12.42 60.08 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.063 0.545 . . . . 74.22 111.594 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.87 -3.7 41.79 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.25 -0.5 . . . . 75.04 113.667 177.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.99 152.74 21.52 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.064 0.459 . . . . 72.13 111.001 177.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.14 148.93 49.29 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.625 -0.716 . . . . 32.44 110.205 -177.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -134.61 149.41 50.57 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 109.458 -0.571 . . . . 63.44 109.458 -170.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -125.09 138.04 54.18 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.099 0.476 . . . . 54.1 110.648 174.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.52 118.65 34.35 Favored 'General case' 0 C--O 1.256 1.423 0 N-CA-C 107.975 -1.121 . . . . 74.25 107.975 173.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.611 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 3.7 mt -115.1 109.29 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 119.069 -1.052 . . . . 61.41 111.183 -174.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 8' ' ' SER . 34.1 tt0 -109.09 104.88 14.15 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.975 0.893 . . . . 71.34 111.345 -171.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -117.58 171.88 7.72 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 114.693 -1.14 . . . . 75.44 113.315 -179.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -79.2 -37.07 39.15 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 114.908 -1.042 . . . . 74.54 111.618 168.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -116.19 117.55 30.35 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 122.179 0.99 . . . . 44.53 111.138 -171.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.564 ' HB3' ' HG2' ' A' ' 85' ' ' ARG . . . -84.31 -46.11 12.12 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 113.62 -1.627 . . . . 64.31 115.373 -174.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.8 tmm_? -75.07 -28.53 60.39 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 121.294 0.568 . . . . 63.2 111.913 -168.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -79.17 -25.86 42.76 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-O 121.469 0.652 . . . . 74.21 111.54 177.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.35 -23.76 61.18 Favored 'General case' 0 C--O 1.251 1.151 0 CA-C-O 122.291 1.043 . . . . 62.21 112.245 173.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.81 -22.25 23.79 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 114.593 -1.185 . . . . 73.21 113.856 173.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.473 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 0.4 OUTLIER -66.74 -43.04 85.24 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.82 0.819 . . . . 73.32 110.547 173.51 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.488 ' HB2' ' CD2' ' A' ' 31' ' ' TYR . . . -64.03 -43.02 96.86 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 114.696 -1.138 . . . . 72.35 110.659 173.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.794 HG13 HG13 ' A' ' 80' ' ' VAL . 0.3 OUTLIER -66.82 -31.0 51.5 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.411 0 C-N-CA 120.202 -0.599 . . . . 64.41 111.477 178.143 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -80.18 -21.32 43.12 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.444 0.566 . . . . 72.41 112.172 176.927 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.409 ' HG2' ' HA ' ' A' ' 62' ' ' ALA . 15.7 pt-20 -85.38 -17.96 35.16 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 118.55 -1.26 . . . . 63.34 111.809 170.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 62' ' ' ALA . 67.4 mmtt -99.67 13.65 32.84 Favored 'General case' 0 CA--C 1.575 1.92 0 CA-C-O 121.622 0.725 . . . . 73.32 111.401 170.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -70.77 153.06 43.13 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 127.115 2.166 . . . . 72.4 114.329 -178.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 112.03 24.28 5.22 Favored Glycine 0 C--N 1.351 1.416 0 C-N-CA 120.268 -0.968 . . . . 72.1 114.53 -171.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 20.7 p -58.27 133.62 55.84 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 114.219 1.192 . . . . 73.24 114.219 -167.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.1 149.92 51.13 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-N 113.826 -1.534 . . . . 63.23 113.212 -168.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -143.5 149.38 37.42 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.442 1.897 . . . . 73.44 110.562 -171.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 74.34 64.87 0.08 Allowed 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 122.476 1.131 . . . . 72.14 113.466 174.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.94 -10.64 60.46 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 113.745 -1.57 . . . . 75.41 113.952 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -120.25 122.78 41.64 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.19 -1.411 . . . . 71.22 107.19 160.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.502 ' HB3' ' O ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -96.12 103.25 15.13 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 119.109 -0.472 . . . . 74.2 111.038 178.855 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 41.5 tp -162.29 69.84 0.28 Allowed 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 118.267 0.485 . . . . 54.14 112.01 177.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -97.86 113.14 24.88 Favored 'General case' 0 C--O 1.208 -1.097 0 O-C-N 119.451 -2.031 . . . . 74.45 109.703 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.8 t -130.1 120.48 49.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 107.893 -1.151 . . . . 62.3 107.893 171.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -149.01 141.33 24.12 Favored 'General case' 0 C--O 1.258 1.517 0 CA-C-O 123.075 1.417 . . . . 65.24 113.922 176.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.794 HG13 HG13 ' A' ' 63' ' ' ILE . 16.6 m -88.91 135.86 31.4 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 113.112 -1.858 . . . . 75.33 110.209 165.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -82.96 20.21 1.19 Allowed 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.19 1.927 . . . . 74.43 112.415 166.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -103.34 72.38 1.15 Allowed 'General case' 0 C--N 1.345 0.404 0 CA-C-O 121.828 0.823 . . . . 53.32 109.707 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -99.24 39.68 1.27 Allowed 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.838 -1.074 . . . . 71.5 109.128 177.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -169.49 39.12 0.03 OUTLIER 'General case' 0 C--O 1.238 0.484 0 CA-C-N 114.704 -1.135 . . . . 75.33 109.838 -174.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.564 ' HG2' ' HB3' ' A' ' 56' ' ' ALA . 7.3 tpt85 -134.75 1.89 3.11 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 112.168 0.433 . . . . 52.34 112.168 -171.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 . . . . . 0 C--O 1.255 1.352 0 CA-C-O 118.452 -0.785 . . . . 71.21 111.312 -178.223 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.197 0 N-CA-C 111.821 -0.512 . . . . 74.11 111.821 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 6.9 t -118.47 -178.01 3.43 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 110.186 -0.302 . . . . 64.24 110.186 -176.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -130.81 153.18 49.35 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 122.603 0.361 . . . . 74.23 111.254 -178.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -112.88 141.05 47.15 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.315 -0.402 . . . . 62.23 111.11 -178.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.7 t -119.84 128.93 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 116.344 -0.389 . . . . 43.12 110.128 -178.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.0 pp -116.72 165.77 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 120.633 0.254 . . . . 75.41 111.374 177.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -158.2 139.52 13.43 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.975 -0.557 . . . . 72.41 110.343 176.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 64.45 90.7 0.08 Allowed 'General case' 0 N--CA 1.481 1.08 0 O-C-N 124.985 1.428 . . . . 73.31 112.444 175.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.1 t -158.09 155.33 29.02 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.038 -0.528 . . . . 63.11 110.587 -177.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.5 m -109.15 138.09 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-O 120.826 0.346 . . . . 73.01 110.908 176.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.2 p -85.49 139.36 31.55 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.731 -0.213 . . . . 72.4 110.555 -178.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.491 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 0.3 OUTLIER -130.52 151.65 50.76 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.338 0.496 . . . . 60.31 112.338 -177.096 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.493 HG13 HG12 ' A' ' 80' ' ' VAL . 4.9 mp -121.13 132.33 70.8 Favored 'Isoleucine or valine' 0 C--O 1.247 0.95 0 N-CA-C 108.948 -0.76 . . . . 72.32 108.948 174.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -113.16 113.95 26.09 Favored 'General case' 0 C--O 1.244 0.813 0 O-C-N 124.21 0.944 . . . . 75.24 109.338 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 7.2 p -122.71 109.69 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 CA-C-O 122.503 1.144 . . . . 32.44 111.651 176.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -128.14 157.34 21.16 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-N 115.32 -0.855 . . . . 63.02 114.946 -174.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.435 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 15.3 m120 59.37 25.07 13.71 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.715 1.206 . . . . 54.44 111.944 175.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.467 HD23 ' H ' ' A' ' 15' ' ' LEU . 1.7 pt? -88.37 151.2 48.23 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 112.511 0.559 . . . . 71.05 112.511 -167.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -64.43 144.2 84.7 Favored 'Trans proline' 0 C--N 1.364 1.382 0 C-N-CA 122.901 2.401 . . . . 74.34 112.227 172.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.5 p 73.53 -31.03 0.22 Allowed 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 127.316 2.246 . . . . 43.33 113.046 -176.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 64.78 86.74 0.12 Allowed 'General case' 0 C--N 1.361 1.071 0 C-N-CA 125.746 1.618 . . . . 74.31 110.156 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.433 ' H ' HD11 ' A' ' 15' ' ' LEU . 8.2 p -69.18 133.74 31.35 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 CA-C-O 121.653 0.74 . . . . 75.13 110.521 -174.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.429 ' O ' HG22 ' A' ' 24' ' ' VAL . 25.5 m -90.46 169.33 11.14 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.358 -0.837 . . . . 44.03 110.207 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.3 p -61.82 -28.39 69.44 Favored 'General case' 0 C--O 1.21 -1.022 0 N-CA-C 113.509 0.929 . . . . 50.43 113.509 -175.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -71.85 -41.78 67.71 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 123.586 0.754 . . . . 62.14 111.852 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -73.68 -43.55 59.07 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.888 -0.597 . . . . 75.44 109.829 -172.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 20' ' ' SER . 2.2 m -68.62 -30.79 48.48 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.945 0 CA-C-O 118.179 -0.915 . . . . 74.55 111.175 170.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.0 -55.73 21.37 Favored 'General case' 0 C--O 1.195 -1.801 0 CA-C-O 118.003 -0.998 . . . . 71.42 109.094 172.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -73.84 -55.16 6.54 Favored 'General case' 0 C--O 1.276 2.462 0 C-N-CA 119.199 -1.001 . . . . 72.41 112.662 -175.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -76.64 -35.96 57.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.543 -0.753 . . . . 71.42 110.787 -168.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.31 -23.64 30.17 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 118.073 -0.965 . . . . 74.54 110.984 177.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.557 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 4.7 ptt85 -71.52 -22.94 61.71 Favored 'General case' 0 C--N 1.383 2.065 0 CA-C-N 120.193 1.36 . . . . 70.4 111.698 170.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.19 -33.5 67.54 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 119.005 -1.078 . . . . 63.21 110.91 169.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.514 ' CG ' ' HB2' ' A' ' 62' ' ' ALA . 90.0 m-85 -85.41 -38.02 19.16 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.327 0.492 . . . . 75.55 112.327 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' A' ' 29' ' ' ARG . . . -152.62 143.9 10.86 Favored Glycine 0 C--O 1.22 -0.779 0 C-N-CA 121.045 -0.598 . . . . 64.32 111.67 178.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -66.9 117.73 9.4 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 123.718 0.305 . . . . 74.4 111.05 -172.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.36 122.92 35.55 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-O 122.045 0.926 . . . . 63.33 111.278 -174.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 50.0 mt -100.61 -36.19 9.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.937 -1.029 . . . . 54.4 109.431 177.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.84 139.39 21.58 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.682 -0.69 . . . . 74.4 109.545 -177.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 18.7 p -136.9 118.76 15.17 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.252 0.549 . . . . 73.11 110.497 173.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -129.26 144.83 51.37 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 115.589 -0.732 . . . . 44.25 109.623 -179.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 84.9 t -117.64 129.06 74.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 121.069 0.461 . . . . 74.34 110.365 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -106.08 135.32 47.75 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.117 -0.697 . . . . 71.32 109.117 -178.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.91 125.06 36.75 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.753 -0.379 . . . . 63.13 110.424 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.1 t -102.16 164.42 11.7 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.463 -0.335 . . . . 71.42 111.481 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.7 t -75.04 -13.46 15.35 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 C-N-CA 123.748 0.819 . . . . 75.14 110.913 178.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.8 t -75.65 -10.83 59.77 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.066 0.546 . . . . 65.43 111.542 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.42 -4.12 59.95 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 120.92 -0.657 . . . . 52.05 113.226 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.81 139.12 30.85 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.339 0.59 . . . . 74.44 111.135 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.84 142.12 35.29 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.274 -0.876 . . . . 24.44 109.54 177.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 8.8 m-85 -136.25 149.43 48.5 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.438 -0.949 . . . . 71.21 108.438 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -132.82 138.52 47.11 Favored 'General case' 0 C--O 1.248 1.012 0 N-CA-C 109.212 -0.662 . . . . 42.42 109.212 172.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -118.09 117.93 30.51 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.113 -1.403 . . . . 72.45 107.836 -176.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.94 112.51 27.59 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.468 0 C-N-CA 120.176 -0.609 . . . . 70.35 111.033 -171.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -98.51 114.52 26.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.922 0.391 . . . . 72.13 111.186 -176.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -107.88 166.37 10.76 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.511 -0.768 . . . . 61.23 111.451 -178.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -80.61 -35.08 34.56 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 120.318 -0.553 . . . . 74.51 110.921 172.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.71 124.28 45.84 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.929 0.871 . . . . 72.24 112.363 -171.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.53 -46.16 16.26 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 113.74 -1.573 . . . . 72.34 114.529 -176.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.59 -21.94 57.37 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 112.727 0.64 . . . . 74.03 112.727 -169.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.419 ' HB3' ' O ' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -78.57 -33.1 47.91 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 121.35 0.595 . . . . 73.2 110.807 174.852 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.96 -24.88 63.41 Favored 'General case' 0 C--O 1.25 1.083 0 C-N-CA 124.4 1.08 . . . . 62.14 112.162 174.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.557 ' HA ' HG22 ' A' ' 63' ' ' ILE . . . -56.65 -26.63 56.65 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.164 -0.926 . . . . 62.32 113.34 178.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.43 ' HA ' ' HG3' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -69.27 -39.2 78.53 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 117.84 0.291 . . . . 75.52 111.257 174.734 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.514 ' HB2' ' CG ' ' A' ' 31' ' ' TYR . . . -66.17 -42.54 88.82 Favored 'General case' 0 C--O 1.245 0.851 0 C-N-CA 122.844 0.457 . . . . 62.31 111.139 174.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.778 HG13 HG13 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -70.32 -29.05 37.6 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 119.771 -0.772 . . . . 73.03 111.024 178.766 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.43 ' HG3' ' HA ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -78.96 -27.2 43.52 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.793 1.179 . . . . 73.33 112.438 174.811 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.49 -22.53 43.91 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 119.015 -1.074 . . . . 75.42 111.269 176.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -109.04 14.36 24.06 Favored 'General case' 0 CA--C 1.558 1.287 0 CA-C-O 121.35 0.595 . . . . 52.51 111.92 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -67.1 154.02 42.23 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 125.763 1.625 . . . . 71.34 110.902 169.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.15 21.75 5.81 Favored Glycine 0 C--N 1.343 0.931 0 C-N-CA 119.81 -1.186 . . . . 63.35 112.501 -162.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.67 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 14.3 p -59.81 132.03 52.72 Favored 'General case' 0 C--O 1.242 0.672 0 O-C-N 124.239 0.611 . . . . 62.01 111.888 -175.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.5 147.68 50.4 Favored 'General case' 0 C--O 1.254 1.315 0 CA-C-N 115.171 -0.922 . . . . 62.42 112.744 -169.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -143.16 146.34 33.63 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.335 1.854 . . . . 62.12 110.766 -173.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 74.16 67.56 0.09 Allowed 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 114.084 1.142 . . . . 75.32 114.084 177.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.67 -11.78 59.45 Favored Glycine 0 N--CA 1.462 0.415 0 CA-C-N 114.299 -1.319 . . . . 73.44 113.665 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -121.82 123.18 41.18 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.499 -1.297 . . . . 73.31 107.499 157.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.435 ' HB3' ' O ' ' A' ' 14' ' ' ASN . 0.3 OUTLIER -94.15 104.11 16.14 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 118.97 -0.538 . . . . 73.54 110.701 179.202 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.67 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER -162.89 58.15 0.2 Allowed 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.438 1.273 . . . . 73.11 114.438 -175.228 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -95.27 113.83 25.55 Favored 'General case' 0 C--O 1.214 -0.774 0 CA-C-N 121.036 1.744 . . . . 73.4 110.838 -173.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.2 t -128.4 117.39 45.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 107.78 -1.192 . . . . 34.25 107.78 170.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.563 ' HA ' HD11 ' A' ' 63' ' ' ILE . 32.6 tt0 -151.98 144.97 24.49 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.799 0.809 . . . . 73.54 111.625 176.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.778 HG13 HG13 ' A' ' 63' ' ' ILE . 18.7 m -89.06 124.83 64.1 Favored Pre-proline 0 C--N 1.317 -0.836 0 CA-C-N 115.81 -0.632 . . . . 71.42 111.077 170.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.491 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 57.8 Cg_endo -80.37 5.92 5.74 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.036 1.824 . . . . 74.42 114.047 169.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -87.37 -32.61 19.5 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 119.933 -0.707 . . . . 74.41 111.809 175.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 52.45 71.64 0.46 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.887 1.275 . . . . 74.42 112.27 -175.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 63.07 -173.29 0.16 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.045 1.338 . . . . 63.14 112.849 -176.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -79.01 -67.95 0.7 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.88 0.371 . . . . 63.41 111.006 177.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 . . . . . 0 C--O 1.256 1.418 0 CA-C-N 115.583 -0.735 . . . . 74.42 110.238 -174.278 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.86 0 N-CA-C 112.057 -0.417 . . . . 72.03 112.057 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 11.7 p -143.78 156.97 44.68 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.077 0.551 . . . . 64.24 109.93 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -143.96 120.77 11.25 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 110.243 -0.28 . . . . 75.11 110.243 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.3 mtt -135.08 171.51 14.32 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.665 0.269 . . . . 73.12 111.532 178.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 31.2 m -95.3 145.98 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 116.213 -0.449 . . . . 25.32 111.52 -178.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.4 pt -128.15 145.7 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 115.963 -0.562 . . . . 71.35 111.154 178.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 37.6 mtt85 -143.9 127.23 16.76 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 116.239 -0.437 . . . . 73.2 110.105 175.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 59.71 79.75 0.22 Allowed 'General case' 0 N--CA 1.481 1.115 0 O-C-N 125.322 1.639 . . . . 63.45 112.02 178.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -138.95 155.77 47.77 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.963 -0.562 . . . . 73.11 110.349 -176.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.5 t -111.26 105.14 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 116.033 -0.531 . . . . 73.35 110.24 -178.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.9 t -83.0 122.28 28.1 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.738 -0.665 . . . . 72.32 111.401 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.528 ' O ' ' HD2' ' A' ' 81' ' ' PRO . 1.6 ptp180 -143.93 155.86 44.22 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 112.501 0.556 . . . . 63.42 112.501 -175.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.675 HG12 HG12 ' A' ' 80' ' ' VAL . 6.7 mt -115.28 136.8 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 123.6 0.76 . . . . 74.54 109.896 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -105.63 117.6 34.44 Favored 'General case' 0 C--O 1.249 1.057 0 O-C-N 125.111 1.507 . . . . 63.54 109.728 177.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.517 HG12 HD22 ' A' ' 15' ' ' LEU . 59.4 t -119.68 109.51 26.46 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.055 0 CA-C-N 115.495 -0.775 . . . . 71.32 109.504 176.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -123.07 156.84 17.51 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.74 -0.743 . . . . 74.32 113.627 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.2 m120 59.11 32.42 22.12 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.029 0.932 . . . . 73.32 112.255 170.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.517 HD22 HG12 ' A' ' 12' ' ' VAL . 1.3 pt? -87.77 149.23 45.55 Favored Pre-proline 0 CA--C 1.543 0.707 0 N-CA-C 113.277 0.843 . . . . 74.21 113.277 -168.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -69.69 129.94 18.56 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 122.943 2.428 . . . . 73.24 112.647 172.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.7 p 48.3 101.62 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 125.949 1.7 . . . . 73.13 113.021 -169.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 38.0 p-80 -55.42 119.31 5.42 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.778 0.799 . . . . 65.52 112.218 -175.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.5 p -77.12 129.59 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 114.534 -1.212 . . . . 63.13 110.43 -175.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.3 m -83.6 165.75 18.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.401 -0.818 . . . . 73.02 110.207 -178.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 32.0 p -62.88 -28.2 69.88 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.723 0.809 . . . . 71.14 112.54 -174.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.06 -37.59 54.34 Favored 'General case' 0 C--O 1.253 1.249 0 CA-C-O 121.52 0.676 . . . . 75.14 110.809 -177.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -71.03 -44.42 65.86 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 114.652 -1.158 . . . . 75.03 110.564 -178.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.644 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 2.9 m -67.62 -31.52 52.86 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.872 0 CA-C-O 118.978 -0.534 . . . . 72.43 110.588 171.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 21' ' ' SER . 17.1 tt0 -58.41 -54.14 50.43 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 118.946 -0.55 . . . . 74.21 110.476 177.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -72.47 -54.02 10.47 Favored 'General case' 0 C--O 1.29 3.225 0 C-N-CA 119.829 -0.749 . . . . 52.14 112.512 -178.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -69.48 -44.58 70.86 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.676 -1.147 . . . . 74.21 109.689 -169.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.644 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 7.8 m-85 -77.95 -21.99 50.17 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-O 118.099 -0.953 . . . . 72.34 111.384 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.419 ' HB3' ' O ' ' A' ' 25' ' ' GLU . 3.6 ppt_? -68.44 -26.66 65.62 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 121.193 1.815 . . . . 71.25 111.402 171.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.48 -21.05 66.55 Favored 'General case' 0 CA--C 1.561 1.398 0 C-N-CA 118.304 -1.358 . . . . 71.52 112.442 169.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.437 ' OH ' ' HE3' ' A' ' 66' ' ' LYS . 5.2 m-30 -74.76 -37.22 62.52 Favored 'General case' 0 C--O 1.207 -1.173 0 N-CA-C 113.134 0.79 . . . . 73.04 113.134 -175.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 166.54 43.82 0.02 OUTLIER Glycine 0 N--CA 1.469 0.839 0 C-N-CA 118.943 -1.598 . . . . 64.11 114.061 -178.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.5 t30 62.05 99.28 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 125.217 1.407 . . . . 72.32 113.058 175.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.16 127.48 39.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 114.951 -1.022 . . . . 72.51 110.535 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -97.29 -32.25 12.0 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.536 -0.756 . . . . 73.35 109.932 176.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.01 132.15 15.38 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.001 -0.545 . . . . 61.12 109.697 -176.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.1 p -125.2 125.19 43.25 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 120.862 0.363 . . . . 64.31 110.041 172.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -129.41 130.99 46.67 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.825 -0.625 . . . . 73.31 110.144 -179.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.4 t -111.89 114.47 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.285 0.564 . . . . 71.22 110.035 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -107.12 139.93 40.76 Favored 'General case' 0 C--O 1.212 -0.915 0 CA-C-N 115.22 -0.9 . . . . 75.42 108.815 -178.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.83 148.22 52.54 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.313 0.96 . . . . 64.21 112.005 171.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.4 t -100.85 165.76 11.19 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 116.263 -0.426 . . . . 30.13 110.49 177.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.5 t -75.57 -11.47 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 C-N-CA 123.862 0.865 . . . . 73.23 110.937 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -76.46 -8.25 56.77 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 122.837 0.455 . . . . 65.41 111.63 178.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.83 -4.09 52.98 Favored Glycine 0 C--N 1.341 0.815 0 C-N-CA 121.248 -0.501 . . . . 54.21 112.869 175.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.89 135.24 33.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.994 0.426 . . . . 71.5 110.953 178.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.96 148.49 26.65 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.351 -0.841 . . . . 43.45 109.397 177.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.5 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 19.8 m-85 -136.13 153.21 51.35 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 123.641 0.588 . . . . 74.1 109.503 -176.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -136.0 137.86 41.66 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.997 -0.547 . . . . 74.14 109.62 174.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.44 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 0.4 OUTLIER -111.46 119.95 40.5 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 114.736 -1.12 . . . . 64.33 108.448 172.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.3 mp -123.87 113.92 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 119.997 -0.681 . . . . 71.52 111.145 -177.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -92.73 116.15 28.75 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.325 -0.852 . . . . 61.34 111.593 -169.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -109.84 152.94 25.11 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.782 1.03 . . . . 71.51 113.782 -177.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.41 -34.03 25.6 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 115.275 -0.875 . . . . 63.14 112.044 172.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -122.51 129.5 52.04 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.278 0.844 . . . . 74.41 113.278 -177.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.07 -45.99 31.32 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 113.98 -1.464 . . . . 54.31 114.339 -175.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.09 -25.23 52.05 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.324 0.861 . . . . 65.41 113.324 -170.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -76.47 -36.81 57.67 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.859 0.838 . . . . 63.14 109.331 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.65 -27.93 65.46 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 114.505 -1.225 . . . . 71.44 111.743 177.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.428 ' HB2' ' HB1' ' A' ' 84' ' ' ALA . . . -57.02 -35.45 69.28 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 114.227 1.195 . . . . 73.31 114.227 -176.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.556 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 0.5 OUTLIER -69.55 -40.51 76.79 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 122.122 0.963 . . . . 65.51 112.729 -179.437 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.553 ' O ' ' HG3' ' A' ' 65' ' ' GLU . . . -75.92 -36.48 59.39 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.674 -0.693 . . . . 73.2 110.598 178.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.58 HG13 HG13 ' A' ' 80' ' ' VAL . 0.4 OUTLIER -68.83 -28.85 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 O-C-N 121.875 -0.516 . . . . 54.43 110.575 176.659 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.556 ' HG3' ' O ' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -78.86 -23.0 45.23 Favored 'General case' 0 C--N 1.354 0.803 0 CA-C-N 118.295 0.498 . . . . 71.21 111.833 169.874 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.553 ' HG3' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -69.45 -29.41 67.09 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 120.192 -0.603 . . . . 75.41 110.88 172.189 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.621 ' HG3' HG11 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -105.03 7.81 34.13 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 114.767 1.395 . . . . 74.52 114.767 169.033 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -70.1 152.9 43.81 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 123.444 0.698 . . . . 73.13 111.25 173.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.02 23.7 4.49 Favored Glycine 0 C--N 1.342 0.865 0 C-N-CA 119.532 -1.318 . . . . 73.3 112.327 -155.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.556 ' SG ' ' HA ' ' A' ' 77' ' ' ARG . 6.1 t -55.81 136.75 51.03 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.815 0.846 . . . . 65.43 112.059 -178.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -123.82 146.16 48.56 Favored 'General case' 0 C--O 1.249 1.056 0 CA-C-N 114.808 -1.087 . . . . 72.4 112.928 -169.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -142.61 145.78 33.87 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 112.14 -2.3 . . . . 74.22 110.298 -173.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 73.24 66.87 0.1 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 114.302 1.223 . . . . 74.51 114.302 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.67 -12.6 59.56 Favored Glycine 0 C--N 1.335 0.474 0 CA-C-N 114.148 -1.387 . . . . 73.33 114.258 171.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -123.22 120.49 33.31 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 106.483 -1.673 . . . . 74.43 106.483 157.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.1 116.08 28.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 119.579 -0.248 . . . . 73.42 111.319 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -157.91 81.33 0.86 Allowed 'General case' 0 C--O 1.208 -1.107 0 N-CA-C 112.356 0.502 . . . . 52.01 112.356 178.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.556 ' HA ' ' SG ' ' A' ' 69' ' ' CYS . 7.4 tpp85 -97.85 113.26 25.02 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.576 1.08 . . . . 73.34 110.165 -178.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.621 HG11 ' HG3' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -133.22 115.88 24.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.662 -0.699 . . . . 64.03 109.441 169.743 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.18 155.09 36.02 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-O 121.802 0.811 . . . . 73.44 112.724 175.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.675 HG12 HG12 ' A' ' 10' ' ' ILE . 31.0 m -90.6 123.38 65.37 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 114.824 -1.08 . . . . 71.51 110.764 166.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.528 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 73.8 Cg_endo -88.17 9.15 3.84 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 122.061 1.84 . . . . 74.1 112.576 164.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -97.05 -13.28 22.35 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 120.576 -0.45 . . . . 70.34 111.887 176.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.3 m120 67.75 127.92 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.29 0 O-C-N 124.872 1.358 . . . . 71.42 111.948 -172.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.428 ' HB1' ' HB2' ' A' ' 60' ' ' ALA . . . -82.22 61.3 5.39 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.15 -0.932 . . . . 75.22 113.069 -167.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.18 34.52 21.09 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.555 1.542 . . . . 62.33 111.726 -179.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 . . . . . 0 C--O 1.254 1.31 0 O-C-N 124.52 1.138 . . . . 65.53 112.34 174.745 . . . . . . . . 0 0 . 1 stop_ save_